PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hoskin, SL; Wilson, SJ; Sabroe, RA; McEuen, AR; Grattan, CE; Greaves, MW; Black, AK; Black, MM; Walls, AF				Hoskin, SL; Wilson, SJ; Sabroe, RA; McEuen, AR; Grattan, CE; Greaves, MW; Black, AK; Black, MM; Walls, AF			Basophil infiltration of weals in chronic idiopathic urticaria	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Southampton, Southampton SO9 5NH, Hants, England; Barnsley Dist Gen Hosp, Barnsley, England; W Norwich Hosp, Norwich, Norfolk, England; St Thomas Hosp, London, England	University of Southampton; Guy's & St Thomas' NHS Foundation Trust									0	7	7	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		229	S87	S87		10.1016/S0091-6749(02)81365-3	http://dx.doi.org/10.1016/S0091-6749(02)81365-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX		Bronze			2022-12-18	WOS:000173744800228
J	Jones, KL; Johnson, DL; Van Maarseveen, ND; Chambers, CD; Schatz, M				Jones, KL; Johnson, DL; Van Maarseveen, ND; Chambers, CD; Schatz, M			Salmeterol use and pregnancy outcome: A prospective multi-center study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Calif San Diego, La Jolla, CA 92093 USA; Kaiser Permanente, San Diego, CA USA	University of California System; University of California San Diego; Kaiser Permanente			Jones, Kenneth/GXF-4945-2022						0	7	8	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		459	S156	S156		10.1016/S0091-6749(02)81595-0	http://dx.doi.org/10.1016/S0091-6749(02)81595-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX					2022-12-18	WOS:000173744800458
J	Lim, DL; Shek, LP; Shaikh, WA; Baratawidjaja, K; Trakultivakorn, M; Vichyanond, P; Cheong, N; Chua, KY; Lee, BW				Lim, DL; Shek, LP; Shaikh, WA; Baratawidjaja, K; Trakultivakorn, M; Vichyanond, P; Cheong, N; Chua, KY; Lee, BW			Pattern of sensitization of Blomia tropicalis and its recombinant allergens in four tropical Asian populations	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Natl Univ Singapore, Singapore 117548, Singapore; Allergy & Asthma Clin, Bombay, Maharashtra, India; Univ Indonesia, Jakarta, Indonesia; Chang Mai Univ, Siriraj Hosp, Chang Mai, Thailand; Mahidol Univ, Bangkok 10700, Thailand	National University of Singapore; University of Indonesia; Mahidol University			Shek, Lynette/D-8016-2015						0	7	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		531	S179	S179		10.1016/S0091-6749(02)81667-0	http://dx.doi.org/10.1016/S0091-6749(02)81667-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX					2022-12-18	WOS:000173744800530
J	Mills, KL; Thomas, WR; Smith, WA				Mills, KL; Thomas, WR; Smith, WA			Characterization of the group 4 allergens of the house dust mite	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									TVW Telethon Inst Child Hlth Res, Perth, WA, Australia	Telethon Kids Institute; University of Western Australia									0	7	8	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		532	S180	S180		10.1016/S0091-6749(02)81668-2	http://dx.doi.org/10.1016/S0091-6749(02)81668-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX		Bronze			2022-12-18	WOS:000173744800531
J	Palmer, GW; Dibbern, DA; Burks, W; Bannon, GA; Bock, SA; Dreskin, SC				Palmer, GW; Dibbern, DA; Burks, W; Bannon, GA; Bock, SA; Dreskin, SC			Relative potency of the major peanut allergens, Ara h1 and Ara h2, in a functional assay	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Colorado, Denver, CO 80202 USA; Univ Arkansas, Little Rock, AR 72204 USA; Natl Jewish Med & Res Ctr, Denver, CO USA	University of Colorado System; University of Colorado Denver; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; National Jewish Health									0	7	7	0	6	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		918	S300	S300		10.1016/S0091-6749(02)82053-X	http://dx.doi.org/10.1016/S0091-6749(02)82053-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX					2022-12-18	WOS:000173744800915
J	Sims, EJ; Lipworth, BJ				Sims, EJ; Lipworth, BJ			Sustained bronchoprotection with montelukast but not formoterol as add on therapy in asthmatics with the homozygous glycine 16 b2 adrenoceptor genotype	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Dundee, Dundee DD1 4HN, Scotland	University of Dundee									0	7	7	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		461	S157	S157		10.1016/S0091-6749(02)81597-4	http://dx.doi.org/10.1016/S0091-6749(02)81597-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX					2022-12-18	WOS:000173744800460
J	Kanny, G; Beaudouin, E; Moneret-Vautrin, DA				Kanny, G; Beaudouin, E; Moneret-Vautrin, DA			IgE-mediated allergy to granisetron and safe use of ondansetron	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Univ Hosp, Hop Cent, Dept Internal Med & Clin Immunol & Allergy, F-54000 Nancy, France	CHU de Nancy	Kanny, G (corresponding author), Univ Hosp, Hop Cent, Dept Internal Med & Clin Immunol & Allergy, 29 Ave Lattre de Tassigny,CO 34, F-54000 Nancy, France.		Kanny, Gisèle/AHA-8910-2022					CHEN M, 1993, ANN INTERN MED, V119, P862, DOI 10.7326/0003-4819-119-8-199310150-00026; Frigerio C, 1996, LANCET, V347, P1484, DOI 10.1016/S0140-6736(96)91720-1; Kataja V, 1996, LANCET, V347, P584, DOI 10.1016/S0140-6736(96)91275-1; KOSSEY JL, 1994, ANN PHARMACOTHER, V28, P1029, DOI 10.1177/106002809402800906; MATA E, 1992, ALLERGY, V47, P471, DOI 10.1111/j.1398-9995.1992.tb00667.x; MONERETVAUTRIN DA, 1993, CLIN EXP ALLERGY, V23, P629, DOI 10.1111/j.1365-2222.1993.tb01788.x; Ross AK, 1998, ANESTH ANALG, V87, P779, DOI 10.1097/00000539-199810000-00007	7	7	7	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2001	108	6					1059	1060		10.1067/mai.2001.119744	http://dx.doi.org/10.1067/mai.2001.119744			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	505WK	11742289				2022-12-18	WOS:000172938400027
J	Terada, T; Kaneko, H; Li, AL; Kasahara, K; Ibe, M; Yokota, S; Kondo, N				Terada, T; Kaneko, H; Li, AL; Kasahara, K; Ibe, M; Yokota, S; Kondo, N			Analysis of Ig subclass deficiency: First reported case of IgG2, IgG4, and IgA deficiency caused by deletion of Cal, psi C gamma, C gamma 2, C gamma 4, and C epsilon in a Mongoloid patient	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						IgG2 deficiency; IgG2; IgG4; IgA deficiency; IgH gene deletion	COMMON VARIABLE IMMUNODEFICIENCY; MATERNAL UNIPARENTAL DISOMY; CYTIDINE DEAMINASE AID; CONSTANT-REGION; GENE DELETIONS; CHROMOSOME 14; CHAIN GENES; MULTIPLE; SWITCH; CELLS	Background: The cause of Ig class or subclass deficiencies has been unclear except for IgH gene deletions and a homozygous 1-base insertion (1793insG) in C gamma2 exon 4 of IgG2 deficiency. In addition, there are no reports that IgH gene deletions are found in patients who are Mongoloid (a category that includes most of the people of Asia, such as the Japanese, Chinese, Indonesians and Malaysians). Objective: To investigate the cause of Ig subclass deficiency, we extensively investigated 4 Japanese patients with low serum IgG2 levels. Patient 1 was a 23-month-old girl whose serum IgG2, IgG4, and IgA levels were under the detection limits; she also had idiopathic thrombocytopenic purpura. Patient 2 was a 5-year-old boy whose serum IgG2 level was under the detection limit. Patient 3 was a 14-month-old boy whose serum IgG2 and IgG4 levels were under the detection limits. Patient 4 was 3-year-old girl whose IgG2 level was low and whose IgA level was under the detection limit. Methods: DNA was extracted from neutrophils, and Southern blot analysis was performed. Results: Southern blot analysis revealed that patient I had lost the C alpha1, psiC gamma, C gamma2, C gamma4, and C epsilon genes and was a homozygous carrier of the deletion described above. Her mother was of the heterozygous genotype. DNA from patients 2, 3, and 4 revealed no deletions in comparison with control DNA. Conclusion: This is a report of the first case of a Mongoloid in whom IgG2, IgG4, and IgA deficiency was caused by deletion of C alpha1, psiC gamma, C gamma2, C gamma4, and C epsilon. Our finding contributes to investigations of Ig subclass deficiency.	Gifu Univ, Sch Med, Dept Pediat, Gifu 5008705, Japan; Yokohama City Univ, Sch Med, Dept Pediat, Yokohama, Kanagawa 232, Japan	Gifu University; Yokohama City University	Terada, T (corresponding author), Gifu Univ, Sch Med, Dept Pediat, 40 Tsukasa Machi, Gifu 5008705, Japan.							BOTTARO A, 1989, EXP CLIN IMMUNOGENET, V6, P55; BOTTARO A, 1989, IMMUNOGENETICS, V29, P44, DOI 10.1007/BF02341612; CHAABANI H, 1985, AM J HUM GENET, V37, P1164; COX DW, 1982, NATURE, V297, P428, DOI 10.1038/297428a0; Depiero A, 2001, J ALLERGY CLIN IMMUN, V107, P1051, DOI 10.1067/mai.2001.115094; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; Espanol T, 1996, CLIN IMMUNOL IMMUNOP, V80, P333, DOI 10.1006/clin.1996.0132; ESSER C, 1990, ANNU REV IMMUNOL, V8, P717, DOI 10.1146/annurev.iy.08.040190.003441; FIORE M, 1995, EUR J IMMUNOGENET, V22, P403, DOI 10.1111/j.1744-313X.1995.tb00255.x; Fokstuen S, 1999, J PEDIATR-US, V134, P689, DOI 10.1016/S0022-3476(99)70282-9; FRANAGAN JG, 1982, NATURE, V300, P709; FUJIEDA S, 1995, J IMMUNOL, V155, P2318; GAUCHAT JF, 1990, J EXP MED, V172, P463, DOI 10.1084/jem.172.2.463; GREY HM, 1964, J EXP MED, V120, P253, DOI 10.1084/jem.120.2.253; HAMMARSTROM L, 1985, LANCET, V1, P778; HISAJIMA H, 1983, P NATL ACAD SCI-BIOL, V80, P2995, DOI 10.1073/pnas.80.10.2995; HOFKER MH, 1989, P NATL ACAD SCI USA, V86, P5567, DOI 10.1073/pnas.86.14.5567; Johnson ML, 1997, CLIN EXP IMMUNOL, V108, P477, DOI 10.1046/j.1365-2249.1997.3801278.x; KIRSCH IR, 1981, NATURE, V293, P585, DOI 10.1038/293585a0; KOTZOT D, 1995, HUM MOL GENET, V4, P583, DOI 10.1093/hmg/4.4.583; Lefranc M P, 1983, Mol Biol Med, V1, P207; LEFRANC MP, 1982, NATURE, V300, P760, DOI 10.1038/300760a0; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; MAYUMI M, 1983, J IMMUNOL, V130, P671; MCBRIDE OW, 1982, NUCLEIC ACIDS RES, V10, P8155, DOI 10.1093/nar/10.24.8155; MIGONE N, 1984, P NATL ACAD SCI-BIOL, V81, P5811, DOI 10.1073/pnas.81.18.5811; Miyoshi O, 1998, J HUM GENET, V43, P138, DOI 10.1007/s100380050056; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; NISHIDA Y, 1982, P NATL ACAD SCI-BIOL, V79, P3833, DOI 10.1073/pnas.79.12.3833; PLEBANI A, 1993, YEAR IMMUN, V7, P231; Plebani A, 1993, Immunodeficiency, V4, P245; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Sanlaville D, 2000, J MED GENET, V37, P525, DOI 10.1136/jmg.37.7.525; SELIGMANN M, 1991, CLIN EXP IMMUNOL, V84, P23; Smith C I, 1986, Monogr Allergy, V20, P18; SMITH CIE, 1989, J IMMUNOL, V142, P4514; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SUGITA K, 1993, INT J HEMATOL, V57, P27; Sutton VR, 2000, AM J MED GENET, V93, P381, DOI 10.1002/1096-8628(20000828)93:5<381::AID-AJMG7>3.0.CO;2-9; TAKAHASHI N, 1982, CELL, V29, P671, DOI 10.1016/0092-8674(82)90183-0; Tashita H, 1998, J CLIN INVEST, V101, P677, DOI 10.1172/JCI1672; TERRY WD, 1964, SCIENCE, V146, P400, DOI 10.1126/science.146.3642.400; Vorechovsky I, 1999, AM J HUM GENET, V64, P1096, DOI 10.1086/302326; Winfield JB, 1997, CLIN EXP IMMUNOL, V109, P1, DOI 10.1046/j.1365-2249.1997.00439.x	46	7	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2001	108	4					602	606		10.1067/mai.2001.118293	http://dx.doi.org/10.1067/mai.2001.118293			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	485NK	11590388	Bronze			2022-12-18	WOS:000171760300021
J	Woodmansee, DP; Christiansen, SC				Woodmansee, DP; Christiansen, SC			Improvement in atopic dermatitis in infants with the introduction of an elemental formula	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							FOOD HYPERSENSITIVITY		Scripps Clin & Naval Med Ctr, San Diego, CA USA; Scripps Res Inst, La Jolla, CA USA	Scripps Research Institute; Scripps Research Institute	Woodmansee, DP (corresponding author), Scripps Clin & Naval Med Ctr, 2650 Stockton Rd,Bldg 624, San Diego, CA USA.							Burks AW, 1998, J PEDIATR-US, V132, P132, DOI 10.1016/S0022-3476(98)70498-6; HILL DJ, 1995, J ALLERGY CLIN IMMUN, V96, P386, DOI 10.1016/S0091-6749(95)70058-7; Leung DYM, 2000, J ALLERGY CLIN IMMUN, V105, P860, DOI 10.1067/mai.2000.106484; LUCAS A, 1990, BRIT MED J, V300, P837, DOI 10.1136/bmj.300.6728.837; SAMPSON HA, 1992, PEDIATRICS, V90, P463; SAMPSON HA, 1983, J ALLERGY CLIN IMMUN, V71, P473, DOI 10.1016/0091-6749(83)90464-5; Zeiger R, 1992, PEDIAT ALLERG IMM-UK, V3, P110, DOI [DOI 10.1111/J.1399-3038.1992.TB00035.X, 10.1111/j.1399-3038.1992.tb00035.x]	7	7	7	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2001	108	2					309	309		10.1067/mai.2001.116986	http://dx.doi.org/10.1067/mai.2001.116986			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	465HY	11496254				2022-12-18	WOS:000170584600026
J	Lacy, P; Moqbel, R				Lacy, P; Moqbel, R			Fusion protein vesicle-associated membrane protein 2 is implicated in IFN-gamma-induced piecemeal degranulation in human eosinophils from atopic individuals (vol 107, pg 671, 2001)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Correction																		Lacy P, 2001, J ALLERGY CLIN IMMUN, V107, P671, DOI 10.1067/mai.2001.113562	1	7	7	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2001	107	6					1008	1008						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	445JR					2022-12-18	WOS:000169454800011
J	Peebles, RS; Wagner, EM; Liu, MC; Proud, D; Hamilton, RG; Togias, A				Peebles, RS; Wagner, EM; Liu, MC; Proud, D; Hamilton, RG; Togias, A			Allergen-induced changes in airway responsiveness are not related to indices of airway edema	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						inflammation; methacholine; bronchoalveolar lavage; peripheral airway resistance; fibrinogen; eosinophilic cationic protein; eosinophils; allergen challenge	PERIPHERAL AIRWAYS; ASTHMATIC SUBJECTS; ANTIGEN CHALLENGE; REACTIVITY; RESPONSES; LUNG; HYPERRESPONSIVENESS; METHACHOLINE; INFLAMMATION; BRADYKININ	Background: The mechanisms behind airway hyperresponsiveness in asthma are unknown, Airway wall edema has been proposed as one possible culprit of this phenomenon. Objective: To test the hypothesis that airway edema may be the cause of allergen-induced increases in airway responsiveness in asthma, this trial aimed at determining the relationship between allergen-induced changes in airway responsiveness to inhaled methacholine and indirect indices of edema, namely peripheral airway resistance and the levels of the plasma protein fibrinogen in bronchoalveolar lavage (BAL) fluids. Methods: Twenty-six atopic individuals with mild asthma were subjected to bronchoscopy at baseline and 28 hours after allergen inhalation, Before each bronchoscopy, methacholine bronchoprovocation was performed. During bronchoscopy, peripheral airway resistance measurements were obtained by wedged bronchoscopy, BAL fluids were analyzed for fibrinogen, as well as for eosinophilic cationic protein. Cytology was performed, and cytokine gene expression was assessed with competitive reverse transcriptase PCR from cell pellets. Results: A significant increase in airway responsiveness to methacholine was recorded after allergen, but this did not correlate with changes in peripheral airway resistance (which was not affected) or with BAL fibrinogen (which decreased after allergen), Other BAL outcomes confirmed that airway inflammation was produced and was characterized by a T(H)2 cytokine pattern. Conclusions: Airway responsiveness in asthma increases after exposure to allergen in the absence of increased indirect indices of edema. The role of edema in this phenomenon should therefore be tested more vigorously.	Johns Hopkins Univ, Sch Med, Dept Med, Div Clin Immunol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Togias, A (corresponding author), Johns Hopkins Asthma & Allergy Ctr, 5501 Hopkins Bayview Circle, Baltimore, MD 21224 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061277] Funding Source: NIH RePORTER; NHLBI NIH HHS [R0-1 HL61277] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Berman AR, 1996, AM J RESP CRIT CARE, V154, P418, DOI 10.1164/ajrccm.154.2.8756816; BERMAN AR, 1995, J APPL PHYSIOL, V78, P1844, DOI 10.1152/jappl.1995.78.5.1844; CALHOUN WJ, 1993, AM REV RESPIR DIS, V147, P1465, DOI 10.1164/ajrccm/147.6_Pt_1.1465; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P503, DOI 10.1111/j.1365-2222.1977.tb01481.x; DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373; FISH JE, 1981, J APPL PHYSIOL, V50, P1079, DOI 10.1152/jappl.1981.50.5.1079; Gauvreau GM, 1999, AM J RESP CRIT CARE, V159, P31, DOI 10.1164/ajrccm.159.1.9804030; HUANG SK, 1994, J IMMUNOL METHODS, V168, P167, DOI 10.1016/0022-1759(94)90052-3; INNERS CR, 1979, J APPL PHYSIOL, V46, P67, DOI 10.1152/jappl.1979.46.1.67; JAMES AL, 1989, AM REV RESPIR DIS, V139, P242, DOI 10.1164/ajrccm/139.1.242; KAMINSKY DA, 1995, AM J RESP CRIT CARE, V152, P1784, DOI 10.1164/ajrccm.152.6.8520737; LAIFOOK SJ, 1984, RESP PHYSIOL, V55, P223, DOI 10.1016/0034-5687(84)90024-0; LIU MC, 1991, AM REV RESPIR DIS, V144, P51, DOI 10.1164/ajrccm/144.1.51; MACKLEM P T, 1989, European Respiratory Journal, V2, p516S; Mitnzer W, 1991, LUNG SCI F, P1053; MORENO RH, 1986, AM REV RESPIR DIS, V133, P1171; PARE PD, 1997, LUNG SCI FDN, P1355; Peebles R. S., 1997, Journal of Allergy and Clinical Immunology, V99, pS411; Peebles RS, 1998, J APPL PHYSIOL, V84, P1500, DOI 10.1152/jappl.1998.84.5.1500; PERSSON CGA, 1995, CLIN EXP ALLERGY, V23, P807; RAPHAEL GD, 1988, AM REV RESPIR DIS, V138, P413, DOI 10.1164/ajrccm/138.2.413; SALOMONSSON P, 1992, AM REV RESPIR DIS, V146, P1535, DOI 10.1164/ajrccm/146.6.1535; SKLOOT G, 1995, J CLIN INVEST, V96, P2393, DOI 10.1172/JCI118296; *TASK FORC GUID ST, 1988, J ALLERGY CLIN IMMUN, V82, P487; VIOLANTE B, 1992, AM REV RESPIR DIS, V146, P127, DOI 10.1164/ajrccm/146.1.127; Wagner EM, 1998, AM J RESP CRIT CARE, V157, P447, DOI 10.1164/ajrccm.157.2.9611043; WAGNER EM, 1990, AM REV RESPIR DIS, V141, P584, DOI 10.1164/ajrccm/141.3.584; WEINMANN GG, 1995, AM J RESP CRIT CARE, V152, P1175, DOI 10.1164/ajrccm.152.4.7551367; YAGER D, 1989, J APPL PHYSIOL, V66, P2873, DOI 10.1152/jappl.1989.66.6.2873	29	7	8	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2001	107	5					805	811						7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	434JX	11344346				2022-12-18	WOS:000168812300007
J	Anthes, J; Eckel, S; Richard, C; West, R; Greenfeder, S; Saluja, S; Van Truong, M; Hesk, D; Kreutner, W; Egan, RW; Billah, M				Anthes, J; Eckel, S; Richard, C; West, R; Greenfeder, S; Saluja, S; Van Truong, M; Hesk, D; Kreutner, W; Egan, RW; Billah, M			Characterization of [(3)h]desloratadine at the human H1 receptor	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA	Merck & Company; Schering Plough Corporation									0	7	7	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		526	S160	S160						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300524
J	Dahl, R; Baker, RC; Pauwels, R				Dahl, R; Baker, RC; Pauwels, R			Seasonal rhinitis and asthma. Effects of topical nasal and/or orally inhaled fluticasone propionate. the SPIRA study (FNM40001)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; Glaxo Wellcome plc, Uxbridge, Middx, England; State Univ Ghent, B-9000 Ghent, Belgium	Aarhus University; GlaxoSmithKline; Ghent University			Dahl, Ronahl/F-8170-2013						0	7	7	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		507	S154	S154						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300506
J	Kellerman, DJ; Bennett, WD; Zeman, KL; Foy, C; Gorden, JC; Shaffer, CL; Johnson, FL				Kellerman, DJ; Bennett, WD; Zeman, KL; Foy, C; Gorden, JC; Shaffer, CL; Johnson, FL			Dose response relationship of the P2Y2 agonist INS365 on mucociliary clearance	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Inspire Pharmaceut Inc, Durham, NC USA; Univ N Carolina, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill									0	7	7	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		541	S164	S165						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300539
J	Matheu, V; Zapatero, L; Alcazar, M; Martinez-Molero, MI; Baeza, ML				Matheu, V; Zapatero, L; Alcazar, M; Martinez-Molero, MI; Baeza, ML			IgE-mediated reaction to a banana-flavored drug additive	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							MEASLES; GELATIN; MUMPS		Univ Madrid, Hosp Gen Gregorio Maranon, Madrid 3, Spain	General University Gregorio Maranon Hospital	Matheu, V (corresponding author), Univ Madrid, Hosp Gen Gregorio Maranon, Madrid 3, Spain.		Matheu, Victor/AAU-3043-2020	Matheu, Victor/0000-0002-0469-800X				KELSO JM, 1993, J ALLERGY CLIN IMMUN, V91, P867, DOI 10.1016/0091-6749(93)90344-F; MONERETVAUTRIN DA, 1995, B ACAD NAT MED PARIS, V179, P161; Nakayama T, 1999, J ALLERGY CLIN IMMUN, V103, P321, DOI 10.1016/S0091-6749(99)70508-7; Szepfalusi Z, 1997, EUR J PEDIATR, V156, P199, DOI 10.1007/s004310050582; TROTTER AC, 1994, ANN ALLERGY, V72, P25	5	7	7	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2000	106	6					1202	1203						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	384ER	11112910				2022-12-18	WOS:000165930300029
J	Hanninen, AR; Kalkkinen, N; Mikkola, JH; Helin, J; Turjanmaa, K; Reunala, T; Palosuo, T				Hanninen, AR; Kalkkinen, N; Mikkola, JH; Helin, J; Turjanmaa, K; Reunala, T; Palosuo, T			Prohevein-like defense protein of tobacco is a cross-reactive allergen for latex-allergic patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						tobacco; latex allergy; prohevein; IgE			Natl Publ Hlth Inst, Immunobiol Lab, FIN-00300 Helsinki, Finland; Univ Helsinki, Inst Biotechnol, Helsinki, Finland; Inst Occupat Hlth, Helsinki, Finland; Univ Tampere, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Tampere, Finland	Finland National Institute for Health & Welfare; University of Helsinki; Finnish Institute of Occupational Health; Tampere University; Tampere University Hospital	Palosuo, T (corresponding author), Natl Publ Hlth Inst, Immunobiol Lab, Mannerheimintie 166, FIN-00300 Helsinki, Finland.		Kalkkinen, Nisse EJ/B-3923-2010					BREDERODE FT, 1991, PLANT MOL BIOL, V17, P1117, DOI 10.1007/BF00028729; Hanninen AR, 1999, J ALLERGY CLIN IMMUN, V104, P194, DOI 10.1016/S0091-6749(99)70135-1; Mikkola J, 1998, J ALLERGY CLIN IMMUN, V101, pS153; Ortega N, 1999, ANN ALLERG ASTHMA IM, V82, P194, DOI 10.1016/S1081-1206(10)62596-3; PONSTEIN AS, 1994, PLANT PHYSIOL, V104, P109, DOI 10.1104/pp.104.1.109; Shah DM, 1997, CURR OPIN BIOTECH, V8, P208, DOI 10.1016/S0958-1669(97)80104-8	6	7	7	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2000	106	4					778	779						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	365ZP	11031351				2022-12-18	WOS:000089980600024
J	Amasaki, Y; Miyatake, S; Arai, N; Arai, K				Amasaki, Y; Miyatake, S; Arai, N; Arai, K			Regulation of nuclear factor of activated T-cell family transcription factors during T-cell development in the thymus	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Meeting on New Trends in Immunopharmacology 1998	JUL   25, 1998	TOKYO, JAPAN			transcription factors; cyclosporin A; T lymphocytes; thymocyte differentiation	CD4(+)CD8(+) THYMOCYTES; NEGATIVE SELECTION; NFAT-FAMILY; CYTOKINE PRODUCTION; POSITIVE SELECTION; SIGNALING EVENTS; IN-VITRO; CALCINEURIN; EXPRESSION; INDUCTION	Background: T lymphocytes undergo a series of developmental events in the thymus, and signaling through the T-cell antigen receptor is crucial in this differential program. The nuclear factor of activated T cells (NFATs) may be involved in transcriptional induction of cytokine genes and other immunoregulatory genes in T cells. Objectives: We have examined the distribution of 3 NEAT family members (NFAT1, NFATc, and NFATx) in human fetal thymocytes, by using semiquantitative RT-PCR and electrophoretic mobility shift assay. Results: The messenger RNA of NFATx was expressed in all T-lymphocyte subsets tested, and expression was highest in CD4(+)CD8(+) thymocytes. Conversely, mRNA of NFAT1 was preferentially expressed in mature CD4(+) single-positive cells. NFATc mRNA was present at lo iv levels in all subsets but was strongly induced by treatment with phorbol ester plus calcium ionophore. Using electrophoretic mobility shift assay we observed stimulation-dependent NFAT-DNA binding in CD4(+)CD8(+) thymocytes, which was largely dependent on NFATx protein. This DNA-binding activity was inhibited by cyclosporin A, which indicated that NFATx nuclear translocation in CD4(+)CD8(+) thymocytes was regulated by calcineurin phosphatase. In contrast, NFAT1 and NFATc (and to some extent NFATx) were responsible for NEAT DNA binding in the CD4(+) cells. Conclusions: Expression of NEAT family members is differentially regulated during T-cell development, and NFATx may be involved in T-cell antigen receptor/calcineurin-dependent signaling in CD4(+)CD8(+) thymocytes.	Univ Tokyo, Inst Med Sci, Dept Mol & Dev Biol, Tokyo 108, Japan; DNAX Res Inst Mol & Cellular Biol Inc, Dept Signal Signaling, Palo Alto, CA 94304 USA	University of Tokyo; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Arai, K (corresponding author), Univ Tokyo, Inst Med Sci, Dept Mol & Dev Biol, 4-6-1 Shirokanedai, Tokyo 108, Japan.							Amasaki Y, 1998, J IMMUNOL, V160, P2324; ANDERSON G, 1995, J IMMUNOL, V154, P3636; ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; CHEN D, 1993, MOL CELL BIOL, V13, P228, DOI 10.1128/MCB.13.1.228; COTTREZ F, 1994, NUCLEIC ACIDS RES, V22, P2712, DOI 10.1093/nar/22.13.2712; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; FISCHER M, 1991, J IMMUNOL, V146, P3452; GAO EK, 1988, NATURE, V336, P176, DOI 10.1038/336176a0; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; Groux H, 1997, J IMMUNOL, V158, P5627; Guidos CJ, 1996, CURR OPIN IMMUNOL, V8, P225, DOI 10.1016/S0952-7915(96)80061-6; HO SN, 1995, J BIOL CHEM, V270, P19898, DOI 10.1074/jbc.270.34.19898; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; Imamura R, 1998, J IMMUNOL, V161, P3455; Iwata M, 1996, EUR J IMMUNOL, V26, P2081, DOI 10.1002/eji.1830260918; JAIN JN, 1995, J BIOL CHEM, V270, P4138, DOI 10.1074/jbc.270.8.4138; JAIN JN, 1993, J IMMUNOL, V151, P837; JIE L, 1997, MOL BIOL CELL, V8, P157; KANG SM, 1992, MOL CELL BIOL, V12, P3149, DOI 10.1128/MCB.12.7.3149; KUBO M, 1994, J BIOL CHEM, V269, P19441; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Luo C, 1996, J EXP MED, V184, P141, DOI 10.1084/jem.184.1.141; Luo C, 1996, MOL CELL BIOL, V16, P3955; Lyakh L, 1997, MOL CELL BIOL, V17, P2475, DOI 10.1128/MCB.17.5.2475; Masuda ES, 1997, MOL CELL BIOL, V17, P2066, DOI 10.1128/MCB.17.4.2066; MASUDA ES, 1995, MOL CELL BIOL, V15, P2697; MASUDA ES, 1993, IMMUNOLOGIST, V1, P198; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; MCCAFFREY PG, 1994, NUCLEIC ACIDS RES, V22, P2134, DOI 10.1093/nar/22.11.2134; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; Ohoka Y, 1996, INT IMMUNOL, V8, P297, DOI 10.1093/intimm/8.3.297; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; Qian DP, 1997, CURR OPIN CELL BIOL, V9, P205, DOI 10.1016/S0955-0674(97)80064-6; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; RIEGEL JS, 1990, J IMMUNOL, V144, P3611; Rincon M, 1996, MOL CELL BIOL, V16, P1074; Shao H, 1997, J EXP MED, V185, P731, DOI 10.1084/jem.185.4.731; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Simon AK, 1996, INT IMMUNOL, V8, P1421, DOI 10.1093/intimm/8.9.1421; SPITS H, 1995, BLOOD, V85, P2654, DOI 10.1182/blood.V85.10.2654.bloodjournal85102654; VANDEKERCKHOVE BAE, 1994, J IMMUNOL, V152, P1738; VONBOEHMER H, 1991, CURR OPIN IMMUNOL, V3, P210, DOI 10.1016/0952-7915(91)90052-3; WANG AM, 1989, P NATL ACAD SCI USA, V86, P9717, DOI 10.1073/pnas.86.24.9717; WANG CR, 1995, J EXP MED, V181, P927, DOI 10.1084/jem.181.3.927; Wang DZ, 1995, ANN NY ACAD SCI, V766, P182, DOI 10.1111/j.1749-6632.1995.tb26661.x; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1	49	7	7	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2000	106	1	2	S			S1	S9						9	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	339NF	10887328				2022-12-18	WOS:000088482600001
J	Askenase, P				Askenase, P			Gee whiz: CpG DNA allergy therapy!	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							GRASS-POLLEN IMMUNOTHERAPY; AIRWAY INFLAMMATION; INTERFERON-GAMMA; IFN-GAMMA; T-LYMPHOCYTES; MESSENGER-RNA; IGE SYNTHESIS; MURINE MODEL; MOUSE MODEL; TH2 CELLS		Yale Univ, Sch Med, Dept Med, Allergy & Clin Immunol Sect, New Haven, CT 06520 USA	Yale University	Askenase, P (corresponding author), Yale Univ, Sch Med, Dept Med, Allergy & Clin Immunol Sect, 333 Cedar St,LCI 904, New Haven, CT 06520 USA.							ABRAMSON MJ, 1995, AM J RESP CRIT CARE, V151, P969; Akdis CA, 1998, J CLIN INVEST, V102, P98, DOI 10.1172/JCI2250; Bellinghausen I, 1997, EUR J IMMUNOL, V27, P1131, DOI 10.1002/eji.1830270513; Bohle B, 1999, EUR J IMMUNOL, V29, P2344, DOI 10.1002/(SICI)1521-4141(199907)29:07<2344::AID-IMMU2344>3.0.CO;2-R; Broide D, 1998, J IMMUNOL, V161, P7054; Cho HJ, 2000, J ALLERGY CLIN IMMUN, V105, pS163, DOI 10.1016/S0091-6749(00)90927-8; Chu RS, 1997, J EXP MED, V186, P1623, DOI 10.1084/jem.186.10.1623; Cohn L, 1999, J EXP MED, V190, P1309, DOI 10.1084/jem.190.9.1309; Creticos PS, 2000, J ALLERGY CLIN IMMUN, V105, pS70, DOI 10.1016/S0091-6749(00)90645-6; Creticos PS, 1996, NEW ENGL J MED, V334, P501, DOI 10.1056/NEJM199602223340804; Durham SR, 1998, J ALLERGY CLIN IMMUN, V102, P157, DOI 10.1016/S0091-6749(98)70079-X; Durham SR, 1996, J ALLERGY CLIN IMMUN, V97, P1356, DOI 10.1016/S0091-6749(96)70205-1; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Hartmann G, 1999, P NATL ACAD SCI USA, V96, P9305, DOI 10.1073/pnas.96.16.9305; Horner A, 2000, J ALLERGY CLIN IMMUN, V105, pS69, DOI 10.1016/S0091-6749(00)90643-2; Huang TJ, 1999, AM J RESP CRIT CARE, V159, pA509; HUS CH, 1996, NAT MED, V2, P540; Jahn-Schmid B, 1999, J ALLERGY CLIN IMMUN, V104, P1015, DOI 10.1016/S0091-6749(99)70083-7; JOSS A, 2000, IN PRESS INTERLEUKIN; JUTEL M, 1995, J IMMUNOL, V154, P4187; Kline JN, 1999, J ALLERGY CLIN IMMUN, V104, P1258, DOI 10.1016/S0091-6749(99)70022-9; Kline JN, 1998, J IMMUNOL, V160, P2555; KLINE JN, 2000, J RESP CLIN CARE MED, V161, pA21; Kranzer K, 2000, IMMUNOLOGY, V99, P170, DOI 10.1046/j.1365-2567.2000.00964.x; Lack G, 1997, J ALLERGY CLIN IMMUN, V99, P530, DOI 10.1016/S0091-6749(97)70081-2; Marshall JD, 2000, J ALLERGY CLIN IMMUN, V105, pS76, DOI 10.1016/S0091-6749(00)90663-8; Meissner N, 1999, CLIN EXP ALLERGY, V29, P618; MUELLER HL, 1969, JAMA-J AM MED ASSOC, V26, P1379; NELSON HS, 1998, ALLERGY PRINCIPLES P, P1050; O'Brien RM, 2000, CLIN EXP ALLERGY, V30, P333; OBrien RM, 1997, CLIN EXP ALLERGY, V27, P46, DOI 10.1046/j.1365-2222.1997.d01-424.x; Randolph DA, 1999, J CLIN INVEST, V104, P1021, DOI 10.1172/JCI7631; Randolph DA, 1999, J IMMUNOL, V162, P2375; REID MJ, 1986, J ALLERGY CLIN IMMUN, V78, P590, DOI 10.1016/0091-6749(86)90076-X; SECRIST H, 1993, J EXP MED, V178, P2123, DOI 10.1084/jem.178.6.2123; Shirota H, 2000, AM J RESP CELL MOL, V22, P176, DOI 10.1165/ajrcmb.22.2.3772; Sur S, 1999, J IMMUNOL, V162, P6284; TAMIR R, 1987, J ALLERGY CLIN IMMUN, V79, P591, DOI 10.1016/S0091-6749(87)80154-9; Tighe H, 2000, J ALLERGY CLIN IMMUN, V106, P124, DOI 10.1067/mai.2000.107927; VARNEY VA, 1993, J CLIN INVEST, V92, P644, DOI 10.1172/JCI116633; Wild JS, 2000, J IMMUNOL, V164, P2701, DOI 10.4049/jimmunol.164.5.2701; YUNGINGER JW, 1998, ALLERGY PRINCIPLES P, P1063	42	7	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2000	106	1	1				37	40		10.1067/mai.2000.108363	http://dx.doi.org/10.1067/mai.2000.108363			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	337ZH	10887302				2022-12-18	WOS:000088393300004
J	Kurasawa, K; Hashimoto, Y; Kasai, M; Iwamoto, I				Kurasawa, K; Hashimoto, Y; Kasai, M; Iwamoto, I			The Fas antigen is involved in thymic T-cell development as a costimulatory molecule, but not in the deletion of neglected thymocytes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Meeting on New Trends in Immunopharmacology 1998	JUL 25, 1998	TOKYO, JAPAN			Fas; thymoctye development; positive selection; costimulatory molecule	TUMOR-NECROSIS-FACTOR; RECEPTOR TRANSGENIC MICE; POSITIVE SELECTION; NEGATIVE SELECTION; SURFACE ANTIGEN; CD4(+)CD8(+) THYMOCYTES; MONOCLONAL-ANTIBODY; FAS/APO-1 CD95; DEATH DOMAIN; LPR/LPR MICE	To determine whether the Fas antigen (Fas) is involved in thymic T-cell development, we introduced the lymphoproliferation (lpr) mutation into a T-cell receptor-alpha beta transgenic mouse (DO10 mouse) and generated 4 genotypes of T-cell receptor transgenic mice homozygous or heterozygous for the Ipr mutation with selecting or nonselecting H-2 haplotype. Unexpectedly, we found that the homozygous Fas mutation (lpr/lpr) induced a marked reduction in CD4(+)CD8(+) double-positive (DP) thymocytes in mice with nonselecting background and that the thymus showed severe cortical atrophy. We also found that the homozygous Fas mutation inhibited the activation of DP thymocytes in the process of positive selection, as indicated by the lower levels of CD5 and CD69 expressions on DP thymocytes in lpr/lpr mice with both selecting and nonselecting background than those of lpr/+ mice. Furthermore, we found a significant skewing from CD4(+) to CD8(+) single-positive thymocytes in lpr/lpr mice with nonselecting background compared with that in the corresponding lpr/+ mice. Taken together, these results indicate that Fas is involved in thymic T-cell development, DP thymocyte generation and positive selection, as a costimulatory molecule but is not involved in the deletion of neglected thymocytes.	Chiba Univ, Sch Med, Dept Internal Med 2, Chiba 2608670, Japan	Chiba University	Iwamoto, I (corresponding author), Chiba Univ, Sch Med, Dept Internal Med, 1-8-1 Inohana, Chiba 2608670, Japan.							ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; AGGARWAL BB, 1995, FEBS LETT, V364, P5, DOI 10.1016/0014-5793(95)00339-B; ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; ALDERSON MR, 1993, J EXP MED, V178, P2231, DOI 10.1084/jem.178.6.2231; ANDERSON G, 1994, J EXP MED, V179, P2027, DOI 10.1084/jem.179.6.2027; ARASE H, 1994, J EXP MED, V180, P423, DOI 10.1084/jem.180.2.423; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; ASHTONRICKARDT PG, 1994, IMMUNOL TODAY, V15, P362, DOI 10.1016/0167-5699(94)90174-0; BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; BIX M, 1992, NATURE, V359, P330, DOI 10.1038/359330a0; BLUTHMANN H, 1988, NATURE, V334, P156, DOI 10.1038/334156a0; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; BORGULYA P, 1991, EMBO J, V10, P913, DOI 10.1002/j.1460-2075.1991.tb08024.x; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Buer J, 1997, J EXP MED, V185, P1541, DOI 10.1084/jem.185.9.1541; Castro JE, 1996, IMMUNITY, V5, P617, DOI 10.1016/S1074-7613(00)80275-7; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; DRAPPA J, 1993, P NATL ACAD SCI USA, V90, P10340, DOI 10.1073/pnas.90.21.10340; DUTZ JP, 1995, J IMMUNOL, V154, P2588; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; JAMESON SC, 1995, IMMUNITY, V2, P1, DOI 10.1016/1074-7613(95)90074-8; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KEARSE KP, 1995, J EXP MED, V181, P193, DOI 10.1084/jem.181.1.193; Kurasawa K, 1999, CELL IMMUNOL, V194, P127, DOI 10.1006/cimm.1999.1502; LUCAS B, 1995, J EXP MED, V181, P1623, DOI 10.1084/jem.181.5.1623; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; MOUNTZ JD, 1990, J EXP MED, V172, P1805, DOI 10.1084/jem.172.6.1805; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; NISHIMURA Y, 1995, J IMMUNOL, V154, P4395; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; OEHM A, 1992, J BIOL CHEM, V267, P10709; OGASAWARA J, 1995, J EXP MED, V181, P485, DOI 10.1084/jem.181.2.485; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; OHASHI PS, 1990, NATURE, V346, P861, DOI 10.1038/346861a0; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; PAWLOWSKI T, 1993, NATURE, V364, P642, DOI 10.1038/364642a0; Ponton A, 1996, J BIOL CHEM, V271, P8991, DOI 10.1074/jbc.271.15.8991; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; RUSSELL JH, 1993, P NATL ACAD SCI USA, V90, P4409, DOI 10.1073/pnas.90.10.4409; SHORTMAN K, 1994, NATURE, V372, P44, DOI 10.1038/372044a0; SIDMAN CL, 1992, EUR J IMMUNOL, V22, P499, DOI 10.1002/eji.1830220231; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; SUDA T, 1995, J IMMUNOL, V154, P3806; SUDA T, 1994, J EXP MED, V179, P873, DOI 10.1084/jem.179.3.873; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; Sytwu HK, 1996, IMMUNITY, V5, P17, DOI 10.1016/S1074-7613(00)80306-4; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; VANMEERWIJK JPM, 1993, SCIENCE, V261, P911, DOI 10.1126/science.8102208; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; Walsh CM, 1998, IMMUNITY, V8, P439, DOI 10.1016/S1074-7613(00)80549-X; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; ZHOU T, 1991, J IMMUNOL, V147, P466; ZUNIGAPFLUCKER JC, 1995, SCIENCE, V268, P1906, DOI 10.1126/science.7541554	68	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2000	106	1	2	S			S19	S31		10.1067/mai.2000.106773	http://dx.doi.org/10.1067/mai.2000.106773			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	339NF	10887330				2022-12-18	WOS:000088482600003
J	Parnia, S; Frew, AJ				Parnia, S; Frew, AJ			Chemokines and atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						atopic dermatitis; chemokines	RANTES MESSENGER-RNA; HUMAN CC-CHEMOKINE; HUMAN EOSINOPHIL; IN-SITU; EPITHELIAL-CELLS; PROTEIN; EXPRESSION; RECEPTOR; EOTAXIN; ASTHMA		Southampton Gen Hosp, Southampton SO16 6YD, Hants, England	University of Southampton	Frew, AJ (corresponding author), Southampton Gen Hosp, Mailpoint 810, Southampton SO16 6YD, Hants, England.		Kelly, Frank J/C-6125-2009	Kelly, Frank J/0000-0003-2558-8392; parnia, sam/0000-0002-6158-4404				Berkman N, 1996, AM J RESP CRIT CARE, V154, P1804, DOI 10.1164/ajrccm.154.6.8970374; Bochner BS, 1999, J ALLERGY CLIN IMMUN, V103, P527, DOI 10.1016/S0091-6749(99)70481-1; BRUIJNZEEL PLB, 1993, CLIN EXP ALLERGY, V23, P97, DOI 10.1111/j.1365-2222.1993.tb00304.x; CRUIKSHANK WW, 1995, AM J RESP CELL MOL, V13, P738, DOI 10.1165/ajrcmb.13.6.7576712; DAHINDEN CA, 1994, J EXP MED, V179, P751, DOI 10.1084/jem.179.2.751; Fahy JV, 1997, AM J RESP CRIT CARE, V155, P1095, DOI 10.1164/ajrccm.155.3.9116993; Faul JL, 1997, EUR RESPIR J, V10, P301, DOI 10.1183/09031936.97.10020301; Forssmann U, 1997, J EXP MED, V185, P2171, DOI 10.1084/jem.185.12.2171; GREWE M, 1995, J INVEST DERMATOL, V105, P407, DOI 10.1111/1523-1747.ep12321078; HANIFIN JM, 1980, ACTA DERM-VENEREOL S, V92, P44, DOI [10.2340/00015555924447, DOI 10.2340/00015555924447]; Humbert M, 1997, AM J RESP CELL MOL, V16, P1; KAPP A, 1993, ALLERGY, V48, P1, DOI 10.1111/j.1398-9995.1993.tb02167.x; LEIFERMAN KM, 1985, NEW ENGL J MED, V313, P282, DOI 10.1056/NEJM198508013130502; Nickel R, 1999, J ALLERGY CLIN IMMUN, V104, P723, DOI 10.1016/S0091-6749(99)70281-2; Noso N, 1996, J IMMUNOL, V156, P1946; Ohtoshi T, 1998, J ALLERGY CLIN IMMUN, V101, P778, DOI 10.1016/S0091-6749(98)70307-0; PLATTSMILLS TAE, 1983, CLIN EXP DERMATOL, V8, P233, DOI 10.1111/j.1365-2230.1983.tb01776.x; Ponath PD, 1996, J CLIN INVEST, V97, P604, DOI 10.1172/JCI118456; ROT A, 1992, J EXP MED, V176, P1489, DOI 10.1084/jem.176.6.1489; Salvi SS, 2000, AM J RESP CRIT CARE, V161, P550, DOI 10.1164/ajrccm.161.2.9905052; Shinkai A, 1999, J IMMUNOL, V163, P1602; Stellato C, 1997, J CLIN INVEST, V99, P926, DOI 10.1172/JCI119257; Sur S, 1996, J ALLERGY CLIN IMMUN, V97, P1272, DOI 10.1016/S0091-6749(96)70195-1; SUR S, 1993, AM REV RESPIR DIS, V148, P713, DOI 10.1164/ajrccm/148.3.713; Takizawa H, 1999, J IMMUNOL, V162, P4705; Tan BB, 1996, LANCET, V347, P15, DOI 10.1016/S0140-6736(96)91556-1; Thepen T, 1996, J ALLERGY CLIN IMMUN, V97, P828, DOI 10.1016/S0091-6749(96)80161-8; Vestergaard C, 1999, J CLIN INVEST, V104, P1097, DOI 10.1172/JCI7613; WEBER M, 1995, J IMMUNOL, V154, P4166; White JR, 1997, J LEUKOCYTE BIOL, V62, P667, DOI 10.1002/jlb.62.5.667; Yamada H, 1996, INT ARCH ALLERGY IMM, V111, P19, DOI 10.1159/000237408; Yawalkar N, 1999, J INVEST DERMATOL, V113, P43, DOI 10.1046/j.1523-1747.1999.00619.x	32	7	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2000	105	5					892	894		10.1067/mai.2000.106570	http://dx.doi.org/10.1067/mai.2000.106570			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	316TW	10808167				2022-12-18	WOS:000087185000005
J	Agrawal, DK; Berro, A; Kreutner, W; Townley, RG				Agrawal, DK; Berro, A; Kreutner, W; Townley, RG			Anti-inflammatory properties of desloratadine (DCL): Effect on eosinophil chemotaxis, adhesion and release of superoxide anions	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Creighton Univ, Sch Med, Ctr Allerg Dis, Omaha, NE USA; Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA	Creighton University; Merck & Company; Schering Plough Corporation			Agrawal, Devendra/GLR-3925-2022	Agrawal, Devendra/0000-0001-5445-0013					0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		49	S16	S17		10.1016/S0091-6749(00)90481-0	http://dx.doi.org/10.1016/S0091-6749(00)90481-0			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR					2022-12-18	WOS:000085530100049
J	Borish, LC; Nelson, HS; Corren, J; Bensch, G; Busse, W; Whitmore, J; Agosti, J				Borish, LC; Nelson, HS; Corren, J; Bensch, G; Busse, W; Whitmore, J; Agosti, J			Phase I/II study of recombinant interleukin-4 receptor (IL-4R) in adult patients with moderate asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Natl Jewish Med & Res Ctr, Denver, CO USA; Natl Jewish Med & Res Ctr, Los Angeles, CA USA; Natl Jewish Med & Res Ctr, Stockton, CA USA; Univ Wisconsin, Madison, WI USA; WI Immunex Corp, Seattle, WA USA	National Jewish Health; National Jewish Health; National Jewish Health; University of Wisconsin System; University of Wisconsin Madison; Immunex Corporation									0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		828	S282	S282						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR					2022-12-18	WOS:000085530100824
J	Eidelman, F; Darzentas, N				Eidelman, F; Darzentas, N			Efficacy of allergy immunotherapy in the elderly	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Florida, Gainesville, FL 32611 USA; Cleveland Clin Florida, Ft Lauderdale, FL USA	State University System of Florida; University of Florida; Cleveland Clinic Foundation									0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		920	S313	S313		10.1016/S0091-6749(00)91348-4	http://dx.doi.org/10.1016/S0091-6749(00)91348-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR					2022-12-18	WOS:000085530100916
J	Empedrad, RB; Earl, HS; Gruchalla, RS				Empedrad, RB; Earl, HS; Gruchalla, RS			Determination of nonirritating skin test concentrations of commonly-used antimicrobial drugs	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Texas, SW Med Ctr, Dallas, TX USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas									0	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		803	S272	S272		10.1016/S0091-6749(00)91231-4	http://dx.doi.org/10.1016/S0091-6749(00)91231-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR		Bronze			2022-12-18	WOS:000085530100799
J	Heithoff, K; Meltzer, EO; Mellars, L; Salmun, LM				Heithoff, K; Meltzer, EO; Mellars, L; Salmun, LM			Desloratadine improves quality of life in patients with seasonal allergic rhinitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA; Allergy & Asthma Med Grp, San Diego, CA USA	Merck & Company; Schering Plough Corporation									0	7	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		1121	S383	S384		10.1016/S0091-6749(00)91547-1	http://dx.doi.org/10.1016/S0091-6749(00)91547-1			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR					2022-12-18	WOS:000085530101115
J	Atkins, P				Atkins, P			Chlorofluorocarbon to hydrofluoroalkane formulations: An industry perspective	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						chlorofluorocarbon; hydrofluoroalkane; metered dose inhalers; transition; ozone depletion		The medications prescribed to treat asthma are provided in a range of delivery systems, designed to give patients a choice in how they take their inhaled medication. These include the mainstay of asthma therapy, the metered dose inhaler (MDI), and the breath-operated inhalers. One of the major challenges that all the leading companies in the respiratory area have faced in recent years is the environmental effects of chlorofluorocarbons. The pharmaceutical industry recognized the need to reformulate MDI products containing chlorofluorocarbons, and a number of companies began to develop alternatives in the late 1980s, To help facilitate this change in products, an industry consortium was formed (International Pharmaceutical Aerosol Consortium), and this has managed many of the overarching issues. After an extensive search was conducted the most suitable alternatives were the hydrofluoroalkanes, which do not contain chlorine, are ozone friendly, and have lower global-warming potentials than the chlorofluorocarbons that they are replacing, To date it is estimated that the industry has invested over $1.0 billion ($US) on global research and development efforts. The first countries to launch the nonchlorofluorocarbon MDIs hare been in Europe, and now salbutamol and 2 inhaled steroids are widely available across Europe in their nonchlorofluorocarbon form Clinical testing has been extensive, and patient acceptance of the new products has proved to be high, Maintaining the smooth progress of the global transition is important, and continued dialogue between all key stakeholders should ensure success in this area.	Glaxo Wellcome Res & Dev Ltd, Resp Therapeut Dev, Grp Med Regulatory & Prod Strategy, Uxbridge UB11 1BT, Middx, England	GlaxoSmithKline	Atkins, P (corresponding author), Glaxo Wellcome Res & Dev Ltd, Resp Therapeut Dev, Grp Med Regulatory & Prod Strategy, Stockley Pk W, Uxbridge UB11 1BT, Middx, England.							Ayres JG, 1998, BRIT MED J, V317, P926; BORNKESSEL B, 1998, DTSCH APOTHEKERZEITU, V138, P1; MOLINA MJ, 1974, NATURE, V249, P810, DOI 10.1038/249810a0; *NAT HEART LUNG BL, 1992, US DEP HLTH HUM SERV; Partridge MR, 1998, EUR RESPIR J, V11, P1006, DOI 10.1183/09031936.98.11051006; REMETTA J, 1999, COMMUNICATION    AUG; *WHO, 1997, WHO REP 1997	7	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1999	104	6					S268	S270		10.1016/S0091-6749(99)70044-8	http://dx.doi.org/10.1016/S0091-6749(99)70044-8			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266FD	10588988				2022-12-18	WOS:000084289200044
J	Berger, M				Berger, M			Goals of therapy in antibody deficiency syndromes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							CYSTIC-FIBROSIS; COMPUTED-TOMOGRAPHY; LUNG-DISEASE; BRONCHIECTASIS; HYPOGAMMAGLOBULINEMIA; IMMUNODEFICIENCY; INFLAMMATION; DISORDERS; CT		Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Sch Med, Dept Pediat,Div Allergy Immunol & Rheumatol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Berger, M (corresponding author), Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Sch Med, Dept Pediat,Div Allergy Immunol & Rheumatol, Cleveland, OH 44106 USA.							AMMANN AJ, 1982, CLIN IMMUNOL IMMUNOP, V22, P60, DOI 10.1016/0090-1229(82)90022-8; BERGER M, 1991, CLIN REV ALLERG, V9, P119; BRUTON OC, 1952, PEDIATRICS, V9, P722; CURTIN JJ, 1991, CLIN RADIOL, V44, P82, DOI 10.1016/S0009-9260(05)80501-X; Feydy A, 1996, BRIT J RADIOL, V69, P1108, DOI 10.1259/0007-1285-69-828-1108; Hansell DM, 1998, RADIOL CLIN N AM, V36, P107, DOI 10.1016/S0033-8389(05)70009-9; HEALY MJR, 1971, HYPOGAMMAGLOBULINAEM, P122; KONSTAN MW, 1995, NEW ENGL J MED, V332, P848, DOI 10.1056/NEJM199503303321303; KONSTAN MW, 1994, AM J RESP CRIT CARE, V150, P448, DOI 10.1164/ajrccm.150.2.8049828; LLEWELLYNJONES CG, 1995, EUR RESPIR J, V8, P1479; Manson D, 1997, PEDIATR RADIOL, V27, P794, DOI 10.1007/s002470050235; MCGUINNESS G, 1995, SEMIN ULTRASOUND CT, V16, P395, DOI 10.1016/0887-2171(95)90028-4; Newson T, 1999, EUR J PEDIATR, V158, P29, DOI 10.1007/s004310051004; OBREGON RG, 1994, CHEST, V106, P490, DOI 10.1378/chest.106.2.490; PANG JA, 1989, CLIN RADIOL, V40, P40, DOI 10.1016/S0009-9260(89)80018-2; PIROFSKY B, 1984, AM J MED S, V7, P653; ROIFMAN CM, 1985, AM J MED, V79, P171, DOI 10.1016/0002-9343(85)90006-3; ROIFMAN CM, 1987, LANCET, V1, P1075; Smith IE, 1996, BRIT J RADIOL, V69, P589, DOI 10.1259/0007-1285-69-823-589; STOCKLEY RA, 1987, CLIN CHEST MED, V8, P481; WATTS WJ, 1986, AM REV RESPIR DIS, V134, P699	21	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1999	104	5					911	913		10.1016/S0091-6749(99)70067-9	http://dx.doi.org/10.1016/S0091-6749(99)70067-9			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	257JH	10550731				2022-12-18	WOS:000083778400009
J	Ten, RM; Carmona, EM; Babovic-Vuksanovic, D; Katzmann, JA				Ten, RM; Carmona, EM; Babovic-Vuksanovic, D; Katzmann, JA			Mannose-binding lectin deficiency associated with neutrophil chemotactic unresponsiveness to C5a	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						mannose-binding lectin deficiency; C5a; neutrophil chemotaxis; G-CSF	PROTEIN GENE; RECEPTOR; COMPLEMENT; MUTATIONS; PROBE	Background: Mannose-binding lectin (MBL) plays an important role in host defense by activating the complement cascade. Objective: Three children with a history of recurrent infections since infancy were found to have MBL deficiency associated with a neutrophil chemotactic unresponsiveness specific to C5a. We have studied the genomic sequence of the C5a receptor (C5aR) in 2 of the subjects to determine whether this unresponsiveness was due to a genetic mutation or to aberrant complement activation associated with the MBL deficiency, Methods: MBL genotype analysis was performed by PCR-based methods with use of specific primers and restriction enzymes to detect the 3 previously reported mutations, Expression of C5aR was analyzed by now cytometry. The C5aR gene was amplified from the patient's genomic DNA by PCR and sequenced bg standard procedures. Results: C5aR was found to be expressed normally on the neutrophils of one of the subjects. Sequence analysis of the C5aR gene revealed a point mutation that substituted threonine at position 261 for alanine in one patient but no abnormality in the other, suggesting gene polymorphism Treatment of 2 patients with granulocyte-colony stimulating factor corrected the neutrophil chemotactic abnormality in vitro and induced a significant clinical improvement, Conclusion: MBL deficiency can be associated with neutrophil chemotactic unresponsiveness to C5a and it is clinically manifested by recurrent and chronic infections. Treatment of these patients with granulocyte colony-stimulating factor results in normalization of neutrophil chemotaxis against Cia and significant clearing of infections.	Mayo Clin & Mayo Fdn, Div Allergy & Immunol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Clin Biochem & Immunol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Med Genet, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Ten, RM (corresponding author), Mayo Clin & Mayo Fdn, Div Allergy & Immunol, 200 2nd St SW, Rochester, MN 55905 USA.							AMATRUDA TT, 1993, J BIOL CHEM, V268, P10139; Babovic-Vuksanovic D, 1999, ANN ALLERG ASTHMA IM, V82, P134, DOI 10.1016/S1081-1206(10)62586-0; Carulli G, 1997, HAEMATOLOGICA, V82, P606; DIDSBURY JR, 1991, P NATL ACAD SCI USA, V88, P11564, DOI 10.1073/pnas.88.24.11564; GARRED P, 1993, CLIN EXP IMMUNOL, V94, P99; GERARD NP, 1990, BIOCHEMISTRY-US, V29, P9274, DOI 10.1021/bi00491a024; Hopken UE, 1997, J EXP MED, V186, P749, DOI 10.1084/jem.186.5.749; Hugli T E, 1978, Adv Immunol, V26, P1, DOI 10.1016/S0065-2776(08)60228-X; JOHNSON RJ, 1985, J BIOL CHEM, V260, P7161; KILPATRICK DC, 1995, HUM REPROD, V10, P2501; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; Lipscombe R. J., 1992, Human Molecular Genetics, V1, P709, DOI 10.1093/hmg/1.9.709; MADSEN HO, 1994, IMMUNOGENETICS, V40, P37, DOI 10.1007/BF00163962; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; Matsushita M, 1998, MOL IMMUNOL, V35, P349, DOI 10.1016/S0161-5890(98)90607-1; MATSUSHITA M, 1992, J EXP MED, V176, P1492; MERY L, 1993, EUR J HAEMATOL, V51, P282; MORGAN EL, 1993, J IMMUNOL, V151, P377; NELSON RD, 1975, J IMMUNOL, V115, P1650; NORMA P, 1991, NATURE, V349, P614; ROLLINS TE, 1985, J BIOL CHEM, V260, P7157; SUMMERFIELD JA, 1995, LANCET, V345, P886, DOI 10.1016/S0140-6736(95)90009-8; SYNDERMAN R, 1986, MED CLIN N AM, V70, P217; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1; Whaley K, 1997, SEMIN LIVER DIS, V17, P297, DOI 10.1055/s-2007-1007206	26	7	8	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1999	104	2	1				419	424		10.1016/S0091-6749(99)70387-8	http://dx.doi.org/10.1016/S0091-6749(99)70387-8			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	232HH	10452765				2022-12-18	WOS:000082364800036
J	Fisch, P; Millner, M; Muller, SM; Wahn, U; Friedrich, W; Renz, H				Fisch, P; Millner, M; Muller, SM; Wahn, U; Friedrich, W; Renz, H			Expansion of gamma delta T cells in an infant with severe combined immunodeficiency syndrome after disseminated BCG infection and bone marrow transplantation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									Humboldt Univ, Klinikum Rudolf Virchow, Inst Clin Chem & Biochem, D-13353 Berlin, Germany; Univ Freiburg, Dept Pathol, D-7800 Freiburg, Germany; Humboldt Univ, Klinikum Rudolf Virchow, Dept Pediat Pneumol, Berlin, Germany; Humboldt Univ, Klinikum Rudolf Virchow, Dept Immunol, Berlin, Germany; Univ Ulm, Childrens Hosp, Ulm, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Freiburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ulm University	Renz, H (corresponding author), Humboldt Univ, Klinikum Rudolf Virchow, Inst Clin Chem & Biochem, Augustenburger Pl 1, D-13353 Berlin, Germany.							ABRAMOWSKY C, 1993, AM J CLIN PATHOL, V100, P52, DOI 10.1093/ajcp/100.1.52; DeLibero G, 1997, IMMUNOL TODAY, V18, P22, DOI 10.1016/S0167-5699(97)80010-2; IZZO AA, 1992, J EXP MED, V176, P581, DOI 10.1084/jem.176.2.581; VIALE M, 1992, BONE MARROW TRANSPL, V10, P249; WAHN V, 1991, J IMMUNOL, V147, P2934	5	7	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1999	103	6					1218	1219		10.1016/S0091-6749(99)70205-8	http://dx.doi.org/10.1016/S0091-6749(99)70205-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	207GT	10359912	Bronze			2022-12-18	WOS:000080929500039
J	Nakamura, H; Nakao, T; Ujiie, H; Karasuno, T; Teshima, H; Komatsu, K; Ishiguro, S; Hiraoka, A; Masaoka, T				Nakamura, H; Nakao, T; Ujiie, H; Karasuno, T; Teshima, H; Komatsu, K; Ishiguro, S; Hiraoka, A; Masaoka, T			Induction of autologous graft-versus-host disease after autologous peripheral blood stem cell transplantation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Conference on New Trends in Immunopharmacology 1997	JUL   12, 1997	TOKYO, JAPAN	Novartis Pharma K K Tokyo		autologous graft-versus-host disease; autologous peripheral blood stem cell transplantation; tacrolimus	BONE-MARROW TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; CYCLOSPORINE; LYMPHOCYTES	Background: Autologous graft-versus-host disease has been reported after the administration of cyclosporine in patients who have received autologous bone marrow transplantation. Objective: The purpose of this study was to determine whether autologous graft-versus-host disease could be induced in recipients of autologous peripheral blood stem cell transplantation and whether tacrolimus induced the disease instead of cyclosporine. Methods: Twelve patients with acute leukemia and 5 patients with malignant lymphoma received either cyclosporine (1 mg/kg/day) or tacrolimus (0.05 mg/kg/day) orally after autologous bone marrow or peripheral blood stem cell transplantation. Results: Autologous graft-versus host disease of the shin, confirmed by histopathologic criteria, occurred in 40% of the patients at 8 to 25 days after transplantation and lasted 3 to 15 days. The frequency of autologous graft-versus-host disease was approximately the same (40%) irrespective of the source of the graft (bone marrow cells or peripheral blood stem cells) and the drug used for induction (cyclosporine or tacrolimus). Conclusions: This pilot study suggests that autologous graft-versus-host disease can be induced in recipients of autologous peripheral blood stem cell transplantation by cyclosporine or tacrolimus.	Osaka Med Ctr Canc & Cardiovasc Dis, Dept Tumor Biochem, Dept Med 5th, Higashinari Ku, Osaka 537, Japan; Osaka Med Ctr Canc & Cardiovasc Dis, Dept Pathol, Osaka 537, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka Medical Center for Cancer & Cardiovascular Diseases	Nakamura, H (corresponding author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Tumor Biochem, Dept Med 5th, Higashinari Ku, 3-3 Nakamichi 1 Chome, Osaka 537, Japan.							COOPER MH, 1991, TRANSPLANT P, V23, P3234; GALE RP, 1984, LANCET, V2, P28, DOI 10.1016/S0140-6736(84)92009-9; HESS AD, 1985, J EXP MED, V161, P718, DOI 10.1084/jem.161.4.718; HOOD AF, 1987, ARCH DERMATOL, V123, P745, DOI 10.1001/archderm.123.6.745; JONES RJ, 1989, LANCET, V1, P754; Karasuno T, 1997, INT J HEMATOL, V65, P105; KERSEY JH, 1987, NEW ENGL J MED, V317, P461, DOI 10.1056/NEJM198708203170801; LEE CK, 1995, BONE MARROW TRANSPL, V16, P175; LERNER KG, 1974, TRANSPLANT P, V6, P367; Moreb JS, 1997, BONE MARROW TRANSPL, V19, P101, DOI 10.1038/sj.bmt.1700615; SCHLOSSMAN SF, 1976, P NATL ACAD SCI USA, V73, P1288, DOI 10.1073/pnas.73.4.1288; SIEGERT W, 1990, BONE MARROW TRANSPL, V6, P97; TALBOT DC, 1990, BONE MARROW TRANSPL, V6, P17; TRINCHIERI G, 1994, BLOOD, V84, P4008, DOI 10.1182/blood.V84.12.4008.bloodjournal84124008; YEAGER AM, 1992, BLOOD, V79, P3031; YEAGER AM, 1993, LEUKEMIA LYMPHOMA, V11, P215, DOI 10.3109/10428199309086998	16	7	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1999	103	5	2	S			S457	S461		10.1016/S0091-6749(99)70162-4	http://dx.doi.org/10.1016/S0091-6749(99)70162-4			5	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	199TV	10329849				2022-12-18	WOS:000080500200008
J	Oshiba, A; Gelfand, EW				Oshiba, A; Gelfand, EW			Engagement of the B-cell antigen receptor by antigen negatively regulates IgE production by antigen-specific B cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						antigen-specific B cells; tetanus toxin; B-cell antigen receptor	HELPER T-CELLS; LYMPHOCYTES-B; COGNATE INTERACTIONS; IMMUNOGLOBULIN; DIFFERENTIATION; INTERLEUKIN-4; ANTIBODIES; ACTIVATION; INDUCTION; GROWTH	Background: Functional differentiation of B lymphocytes can he regulated at different levels. Such B-cell responses, to a large extent, are under the control of T cells and the release of soluble factors from these cells. Crosslinking of B-cell antigen receptors also can direct B-cell differentiation, although the mechanisms are not well defined and the effects on specific antibody production have not been examined. Objective: This study was conducted to determine whether crosslinking of the B-cell antigen receptor hy antigen or antibody to the B-cell receptor could modulate specific antibody production, especially IgE production. Methods: Antigen-specific human B cells were isolated and incubated with antigen or antibody to the B-cell antigen receptor, Specific antibody production was examined, as were surface isotype expression and levels of Ig heavy chain mRNA in T cell-independent cultures. Results: The addition of antigen or anti-IgM antibody enhanced IgM and IgG antibody production in the presence of anti-CD40 and IL-4 but downregulated IgE synthesis. These changes in isotope production paralleled changes in the frequencies of surface Ig(+) B cells and Ig mRNA levels. Exogenous IL-6 abolished the antigen-mediated downregulation of IgE production. Conclusions: These studies indicate that signals delivered by means of the B-cell antigen receptor regulate antibody production in a distinct manner, resulting in enhanced IgM and IgG responses but leading to the inhibition of IgE production. Endogenous IL-6 production by B cells may counter the negative regulatory effects of antigen on IgE synthesis. We suggest that although antigen-mediated T/B-cell interactions play a major role in IgM- and IgG-specific antibody production, antigen-independent interactions may be more effective for T-cell dependent, IL-4-induced IgE production by antigen-specific B cells. Furthermore, these findings provide a basis for further understanding of allergic responses and modulation by immunotherapy, where repented exposure to large concentrations of allergen, administered by means of injection, enhance IgG responses and downregulate IgE synthesis.	Natl Jewish Med & Res Ctr, Dept Pediat, Div Basic Sci, Denver, CO USA	National Jewish Health	Gelfand, EW (corresponding author), 1400 Jackson St, Denver, CO 80206 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029704] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-36577, AI-29704] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BURDIN N, 1995, J IMMUNOL, V154, P2533; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; COOPER MD, 1980, IMMUNOL REV, V52, P29, DOI 10.1111/j.1600-065X.1980.tb00329.x; DEL PG, 1988, J IMMUNOL, V140, P4193; EGELAND T, 1988, SCAND J IMMUNOL, V27, P439, DOI 10.1111/j.1365-3083.1988.tb02369.x; ENGVALL E, 1972, J IMMUNOL, V109, P129; GASCAN H, 1991, J EXP MED, V173, P747, DOI 10.1084/jem.173.3.747; GAUCHAT JF, 1990, J EXP MED, V172, P463, DOI 10.1084/jem.172.2.463; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; Jeppson JD, 1998, J IMMUNOL, V161, P1738; KEARNEY JF, 1978, J IMMUNOL, V120, P158; KEARNEY JF, 1976, J IMMUNOL, V116, P1664; KIRSCH IR, 1982, SCIENCE, V216, P301, DOI 10.1126/science.6801764; KUMAGAI K, 1979, J IMMUNOL METHODS, V29, P17, DOI 10.1016/0022-1759(79)90121-2; LEE WT, 1986, J IMMUNOL, V136, P4573; MAX EE, 1982, CELL, V29, P691, DOI 10.1016/0092-8674(82)90185-4; NOELLE RJ, 1983, P NATL ACAD SCI-BIOL, V80, P6628, DOI 10.1073/pnas.80.21.6628; NOELLE RJ, 1989, J IMMUNOL, V143, P1807; NOELLE RJ, 1990, IMMUNOL TODAY, V11, P361, DOI 10.1016/0167-5699(90)90142-V; NUSTAD K, 1984, EUR SURG RES, V2, P80; Oshiba A, 1996, J IMMUNOL, V157, P4870; OSHIBA A, 1994, CLIN IMMUNOL IMMUNOP, V72, P342, DOI 10.1006/clin.1994.1151; OSHIBA A, 1991, J ALLERGY CLIN IMMUN, V87, P729; PARRONCHI P, 1990, J IMMUNOL, V144, P2102; PECANHA LMT, 1993, J IMMUNOL, V150, P2160; PELLEGRINO MA, 1975, CLIN IMMUNOL IMMUNOP, V3, P324, DOI 10.1016/0090-1229(75)90019-7; PENE J, 1988, J IMMUNOL, V141, P1218; RAVETCH JV, 1981, CELL, V27, P583, DOI 10.1016/0092-8674(81)90400-1; RENZ H, 1992, CLIN IMMUNOL IMMUNOP, V64, P233, DOI 10.1016/0090-1229(92)90205-3; THYPHRONITIS G, 1989, P NATL ACAD SCI USA, V86, P5580, DOI 10.1073/pnas.86.14.5580; VERCELLI D, 1989, J EXP MED, V169, P1295, DOI 10.1084/jem.169.4.1295; VITETTA ES, 1987, IMMUNOL REV, V99, P193, DOI 10.1111/j.1600-065X.1987.tb01178.x; WHALEN BJ, 1988, J IMMUNOL, V141, P2230; WHEELER K, 1993, EUR J IMMUNOL, V23, P1165, DOI 10.1002/eji.1830230528; ZELAZOWSKI P, 1995, J IMMUNOL, V154, P1223	35	7	8	0	4	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1999	103	2	1				341	348		10.1016/S0091-6749(99)70511-7	http://dx.doi.org/10.1016/S0091-6749(99)70511-7			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	167JW	9949328				2022-12-18	WOS:000078630100024
J	Jimenez, S; Caraballo, L; Chua, KY; Mercado, D; Puerta, L; Mendoza, D				Jimenez, S; Caraballo, L; Chua, KY; Mercado, D; Puerta, L; Mendoza, D			IgE antibody responses to recombinant allergens of Blomia tropicalis (Bt) and Dermatophagoides pteronyssinus (Dp).	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Cartagena, Cartagena 117548, Colombia; Natl Univ Singapore, Singapore, Singapore	Universidad de Cartagena; National University of Singapore			Mendoza, Dary/GLV-4951-2022	Mendoza, Dary/0000-0003-0609-6480					0	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		708	S185	S185						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000711
J	Minshall, EM; Chakir, J; Laviolette, M; Olivenstein, R; Zhu, Z; Elias, JA; Hamid, QA				Minshall, EM; Chakir, J; Laviolette, M; Olivenstein, R; Zhu, Z; Elias, JA; Hamid, QA			Interleukin-11 mRNA expression is increased in severe asthma: Localization to eosinophils.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada; Laval Hosp, Quebec City, PQ, Canada; Yale Univ, Sch Med, New Haven, CT USA	McGill University; Yale University									0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		222	S58	S58						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000229
J	Rabjohn, P; Burks, AW; Sampson, HA; Bannon, GA				Rabjohn, P; Burks, AW; Sampson, HA; Bannon, GA			Mutational analysis of the IgE-binding epitopes of the peanut allergen, Ara h 3: a member of the glycinin family of seed-storage proteins.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Arkansas Med Sci, Little Rock, AR 72205 USA; Mt Sinai Sch Med, New York, NY 10029 USA	University of Arkansas System; University of Arkansas Medical Sciences; Icahn School of Medicine at Mount Sinai									0	7	10	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		387	S101	S101						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000392
J	Reese, PR; Mather, DB; Mahajan, P; Woodring, A				Reese, PR; Mather, DB; Mahajan, P; Woodring, A			Combination of salmeterol/fluticasone propionate via Diskus (R) improves quality of life in asthma patients.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA	GlaxoSmithKline									0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		265	S69	S69						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000272
J	Walker, R; Jacobs, J; Tankersley, M; Hagan, L; Freeman, T				Walker, R; Jacobs, J; Tankersley, M; Hagan, L; Freeman, T			Rush immunotherapy (RIT) for the prevention of debilitating large local reactions (LLR) secondary to imported fire ant (IFA) stings.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Wilford Hall USAF Med Ctr, San Antonio, TX 78236 USA	United States Department of Defense; United States Air Force									0	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		691	S180	S181						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000694
J	Cockcroft, DW				Cockcroft, DW			Inhaled beta(2)-agonists and airway responses to allergen	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Festschrift Meeting in Honor of Jerry Dolovich	MAY   24, 1997	HAMILTON, CANADA	McMaster Univ, Fac Hlth Sci, Astra Canada			LATE ASTHMATIC RESPONSE; BRONCHIAL RESPONSIVENESS; BETA-AGONISTS; TOLERANCE; SALMETEROL; CORTICOSTEROIDS; METHACHOLINE; SALBUTAMOL; ALBUTEROL; INCREASE	A series of investigations show that the regular use of inhaled beta(2)-agonists will increase all aspects of the airway response to allergen. The mechanism of this effect is uncertain; however, it appears to he different from the mechanism that produces tolerance to beta(2)-agonist effects. One possibility is that the regular use of beta(2)-agonists might induce a mast cell beta-receptor dysfunction that might make mast cells more prone to release mediators, As a result beta(2)-agonist use plus allergen exposure might cause more mediator release than does allergen exposure alone. The corollary of this is that beta(2)-agonist use plus allergen exposure might cause more airway inflammation than does allergen exposure alone. These hypotheses are both testable, I believe that this is a clinically important phenomenon and may well be a major reason for beta(2)-agonist-induced worsened asthma control. Further investigations are indicated to identify the mechanism and the clinical relevance of the phenomenon.	Royal Univ Hosp, Div Resp Med, Dept Med, Saskatoon, SK S7N OXO, Canada	University of Saskatchewan	Cockcroft, DW (corresponding author), Royal Univ Hosp, Div Resp Med, Dept Med, Ellis Hall,Room 551, Saskatoon, SK S7N OXO, Canada.							Bhagat R, 1996, J ALLERGY CLIN IMMUN, V97, P47, DOI 10.1016/S0091-6749(96)70282-8; BHAGAT R, 1995, CHEST, V108, P1235, DOI 10.1378/chest.108.5.1235; CHEUNG D, 1992, NEW ENGL J MED, V327, P1198, DOI 10.1056/NEJM199210223271703; COCKCROFT DW, 1995, AM J RESP CRIT CARE, V152, P1485, DOI 10.1164/ajrccm.152.5.7582281; COCKCROFT DW, 1995, J ALLERGY CLIN IMMUN, V96, P44, DOI 10.1016/S0091-6749(95)70031-5; COCKCROFT DW, 1993, LANCET, V342, P833, DOI 10.1016/0140-6736(93)92695-P; Cockcroft DW, 1996, THORAX, V51, P1051, DOI 10.1136/thx.51.10.1051; COCKEROFT GW, 1997, CAN RESP J, V4, P37; Gauvreau GM, 1997, AM J RESP CRIT CARE, V156, P1738, DOI 10.1164/ajrccm.156.6.96-08042; Giannini D, 1996, CHEST, V110, P1452, DOI 10.1378/chest.110.6.1452; Kalra S, 1996, CHEST, V109, P953, DOI 10.1378/chest.109.4.953; KERREBIJN KF, 1987, J ALLERGY CLIN IMMUN, V79, P653, DOI 10.1016/S0091-6749(87)80163-X; LAI CKW, 1989, AM REV RESPIR DIS, V140, P917, DOI 10.1164/ajrccm/140.4.917; OBYRNE PM, 1987, AM REV RESPIR DIS, V136, P740, DOI 10.1164/ajrccm/136.3.740; OCONNOR BJ, 1992, NEW ENGL J MED, V327, P1204, DOI 10.1056/NEJM199210223271704; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; VATHENEN AS, 1988, LANCET, V1, P554	18	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1998	102	5					S96	S99		10.1016/S0091-6749(98)70038-7	http://dx.doi.org/10.1016/S0091-6749(98)70038-7			4	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	139MR	9819316				2022-12-18	WOS:000077033400034
J	Jones, M; Graham, C; Taylor, AN; Sarlo, K; Hoyle, V; Karol, MH				Jones, M; Graham, C; Taylor, AN; Sarlo, K; Hoyle, V; Karol, MH			Immunologic cross-reactivity between respiratory chemical sensitizers: Reactive dyes and cyanuric chloride	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						cyanuric chloride; reactive dyes; sensitizers; IgE antibody	ALLERGENS	Background: CyCl is a low molecular weight reactive chemical used as an intermediate in the production of plastics, herbicides, pharmaceuticals, and fiber-reactive dyes. It is a potent inducer of specific IgE antibody: The CyCl functionality; is a structural component of monochlorotriazine and dichlorotriazine dyes. Objective: We have investigated the immunologic cross-reactivity between cyanuric chloride (CyCl) and reactive dyes and it was hypothesized that this moiety might be a dye epitope and that it might stimulate an allergic antibody response in dye-exposed workers. Methods: To test this hypothesis, we have used sera with IgE antibodies to CyCl and also sera from dye-exposed workers who have ICE antibodies to Procion Orange MX2R, an azo dye containing the dichlorotriazine group. As a control group we have used dye-exposed workers with IgE antibody to Remazol Black B, a diazo dye containing the vinyl sulfone-reactive group. Results: Using RAST and RAST inhibitions, we identified negligible cross-reactivity between CyCl and dichlorotriazine dye. Conclusion: The results of this study imply that the allergenic moiety on the dye residue resides in the chromophore rather than in the common structural component of CyCl and dichlolotriazine dyes.	Natl Heart & Lung Inst, Imperial Coll Sch Med, Dept Occupat & Environm Med, London SW3 6LR, England; Univ Pittsburgh, Dept Occupat & Environm Hlth, Pittsburgh, PA USA; Procter & Gamble Co, Cincinnati, OH USA	Imperial College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Procter & Gamble	Jones, M (corresponding author), Natl Heart & Lung Inst, Imperial Coll Sch Med, Dept Occupat Med, Manresa Rd, London SW3 6LR, England.							DOCKER A, 1987, BRIT J IND MED, V44, P534; Graham C, 1997, REGUL TOXICOL PHARM, V26, P296, DOI 10.1006/rtph.1997.1170; Holliday MR, 1996, J APPL TOXICOL, V16, P65, DOI 10.1002/(SICI)1099-1263(199601)16:1<65::AID-JAT306>3.0.CO;2-T; KAROL MH, 1995, ALLERGY, V50, P48, DOI 10.1111/j.1398-9995.1995.tb02482.x; KIMBER I, 1989, ARCH TOXICOL, V63, P274, DOI 10.1007/BF00278640; LUCZYNSKA CM, 1986, J IMMUNOL METHODS, V95, P177, DOI 10.1016/0022-1759(86)90404-7; MOIRA CY, 1986, AM REV RESPIR DIS, V133, P686; ROMANO C, 1992, AM J IND MED, V21, P209, DOI 10.1002/ajim.4700210210; Rydzynski K, 1994, Int J Occup Med Environ Health, V7, P149; SMOLIN EM, 1959, CHEM HETEROCYCLIC CO, P116	10	7	7	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1998	102	5					835	840		10.1016/S0091-6749(98)70025-9	http://dx.doi.org/10.1016/S0091-6749(98)70025-9			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	139MR	9819302				2022-12-18	WOS:000077033400019
J	Ohkubo, K; Baraniuk, JN; Hohman, R; Merida, M; Hersh, LB; Kaliner, MA				Ohkubo, K; Baraniuk, JN; Hohman, R; Merida, M; Hersh, LB; Kaliner, MA			Aminopeptidase activity in human nasal mucosa	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						enkephalin-degrading aminopeptidase; puromycin sensitive aminopeptidase; aminopeptidase M; glandular secretion; bradykinin; rhinitis	ENKEPHALIN-DEGRADING AMINOPEPTIDASE; ANGIOTENSIN-CONVERTING ENZYME; RAT-BRAIN; RHINITIS; METABOLISM; SECRETIONS; BRADYKININ; ALLERGEN; LOCATION; CLONING	Background: Aminopeptidases activate bradykinin and degrade many inflammatory peptides, Objective: The objective of this study was to identify the types of aminopeptidase activities in human nasal mucosa, Methods: Human nasal mucosa was homogenized (n = 12), and cytoplasmic (S2) and membrane-rich (P2) fractions were obtained. Several aminopeptidase (Ap) activities were defined by (1) substrate specificity with leucine-enkephalin (leu-Ap) and alanine-nitroanilide (ala-Ap), (2) inhibitor studies with puromycin and bestatin, (3) enzyme activity histochemistry (zymography), ( 1) immunohistochemistry, and (5) gel electrophoresis, Human volunteers had methacholine, histamine, and allergen nasal provocations to determine the mechanisms controlling nasal aminopeptidase secretion in vivo. Results: P2 was the largest reservoir of puromycin-resistant aminopeptidase activity (630 pmol leu-enk/min/mg protein). S2 contained 32 pmol Iue-enk/min/mg activity, with 80% representing puromycin-resistant activity and 20% puromycin-sensitive aminopeptidase (PS-Ap). Ala-Ap was detected in both P2 and St fractions and was localized by zymography to epithelial and gland cells. Anti-rat brain-soluble PS-rip IgG detected immunoreactive material in epithelium, glands, and endothelium. In nasal provocation studies, leu-AP correlated with glandular exocytosis but not vascular leak. Conclusions: The predominant aminopeptidase in human nasal epithelial and submucosal gland cells n as membrane-bound puromycin-resistant aminopeptidase, A novel soluble puromycin-resistant aminopeptidase and lower amounts of soluble PS-Ap were also detected.	Georgetown Univ, Med Ctr, Div Rheumatol Allergy & Immunol, Washington, DC 20007 USA; Nippon Med Sch, Dept Otolaryngol, Tokyo 113, Japan; Oncor Inc, Gaithersburg, MD USA; Georgetown Univ, Med Ctr, Dept Otorhinolaryngol, Washington, DC 20007 USA; Georgetown Univ, Med Ctr, Dept Pediat, Washington, DC 20007 USA; Univ Kentucky, Albert B Chandler Med Ctr, Lexington, KY 40536 USA; Washington Hosp Ctr, Inst Asthma & Allergy, Washington, DC USA	Georgetown University; Nippon Medical School; Georgetown University; Georgetown University; University of Kentucky; MedStar Washington Hospital Center	Baraniuk, JN (corresponding author), Georgetown Univ, Med Ctr, Div Rheumatol Allergy & Immunol, Lower Level Gorman Bldg,3800 Reservoir Rd NW, Washington, DC 20007 USA.			Baraniuk, James Nicholas/0000-0002-1866-4177	NIAID NIH HHS [AI24203] Funding Source: Medline; NIDA NIH HHS [DA02243] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002243] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AHMAD S, 1992, J PHARMACOL EXP THER, V260, P1257; DIENER U, 1981, CLIN CHIM ACTA, V112, P149, DOI 10.1016/0009-8981(81)90373-9; Erbeznik H, 1997, ARCH BIOCHEM BIOPHYS, V344, P228, DOI 10.1006/abbi.1997.0210; ERDOS EG, 1962, BIOCHEM PHARMACOL, V11, P585, DOI 10.1016/0006-2952(62)90119-3; Gao XP, 1997, J LAB CLIN MED, V130, P395, DOI 10.1016/S0022-2143(97)90039-1; GOLDBARG JA, 1958, CANCER, V11, P283, DOI 10.1002/1097-0142(195803/04)11:2<283::AID-CNCR2820110209>3.0.CO;2-8; HANNER M, 1990, BIOCHIM BIOPHYS ACTA, V1033, P148, DOI 10.1016/0304-4165(90)90005-H; HAYASHI M, 1977, J BIOCHEM, V81, P631, DOI 10.1093/oxfordjournals.jbchem.a131498; HERSH LB, 1981, J NEUROCHEM, V36, P171, DOI 10.1111/j.1471-4159.1981.tb02392.x; HERSH LB, 1985, J NEUROCHEM, V44, P1427, DOI 10.1111/j.1471-4159.1985.tb08779.x; HERSH LB, 1981, BIOCHEMISTRY-US, V20, P2350; Holmes KV, 1997, ADV EXP MED BIOL, V412, P125; KAULBACH HC, 1992, J ALLERGY CLIN IMMUN, V89, P599, DOI 10.1016/0091-6749(92)90328-Y; KNIGHT M, 1978, J BIOL CHEM, V253, P3843; LOOK AT, 1989, J CLIN INVEST, V83, P1299, DOI 10.1172/JCI114015; MALFROY B, 1989, BIOCHEM BIOPH RES CO, V161, P236, DOI 10.1016/0006-291X(89)91586-6; NAKANISHI M, 1989, J BIOCHEM-TOKYO, V106, P826, DOI 10.1093/oxfordjournals.jbchem.a122938; OHKUBO K, 1993, AM J RESP CELL MOL, V9, P557, DOI 10.1165/ajrcmb/9.5.557; Ohkubo K, 1995, J ALLERGY CLIN IMMUN, V96, P924, DOI 10.1016/S0091-6749(95)70230-X; OHKUBO K, 1994, AM J RESP CELL MOL, V11, P173, DOI 10.1165/ajrcmb.11.2.8049077; PETERS JE, 1973, CLIN CHIM ACTA, V45, P177, DOI 10.1016/0009-8981(73)90407-5; PETERS JE, 1972, CLIN CHIM ACTA, V36, P289, DOI 10.1016/0009-8981(72)90002-2; PROUD D, 1983, J CLIN INVEST, V72, P1678, DOI 10.1172/JCI111127; PROUD D, 1987, J IMMUNOL, V138, P428; RAJAKULASINGAM K, 1991, J PHYSIOL-LONDON, V437, P557; RAPHAEL GD, 1989, AM REV RESPIR DIS, V139, P791, DOI 10.1164/ajrccm/139.3.791; SCHNEBLI HP, 1979, BIOCHIM BIOPHYS ACTA, V569, P89, DOI 10.1016/0005-2744(79)90084-6; Tobler AR, 1997, J NEUROCHEM, V68, P889; WARD PE, 1991, BIOCHEM PHARMACOL, V42, P721, DOI 10.1016/0006-2952(91)90028-4	29	7	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1998	102	5					741	750		10.1016/S0091-6749(98)70013-2	http://dx.doi.org/10.1016/S0091-6749(98)70013-2			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	139MR	9819290	Green Published, hybrid			2022-12-18	WOS:000077033400007
J	Stempel, DA; Busse, WW				Stempel, DA; Busse, WW			Inhaled corticosteroids first-line preventive therapy in asthma: Evidence from the current medical literature - Preface	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									Virginia Mason Med Ctr, Dept Allergy & Immunol, Seattle, WA 98004 USA; Univ Wisconsin, Dept Med, Madison, WI 53792 USA	Virginia Mason Medical Center; University of Wisconsin System; University of Wisconsin Madison	Stempel, DA (corresponding author), Virginia Mason Med Ctr, Dept Allergy & Immunol, Seattle, WA 98004 USA.							Mannino D M, 1998, MMWR CDC Surveill Summ, V47, P1; *NAT ASTHM ED PREV, 1997, NIH NAT HEART LUNG B	2	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1998	102	4	2				S1	S1						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	133CT					2022-12-18	WOS:000076669400001
J	Sussman, GL; Liss, GM; Wasserman, S				Sussman, GL; Liss, GM; Wasserman, S			Update on the Hamilton, Ontario latex sensitization study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											Sussman, GL (corresponding author), 202 St Clair Ave W, Toronto, ON M4V 1R2, Canada.							SUSSMAN, 1998, J ALLERGY CLIN IMMUN, V101, P171	1	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1998	102	2					333	333		10.1016/S0091-6749(98)70110-1	http://dx.doi.org/10.1016/S0091-6749(98)70110-1			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	113EH	9723685				2022-12-18	WOS:000075537100034
J	Lynch, NR; Puccio, FS; Di Prisco, MC; Escudero, JE; Nozzolino, M; Hazel, LA; Smith, WA; Thomas, WR				Lynch, NR; Puccio, FS; Di Prisco, MC; Escudero, JE; Nozzolino, M; Hazel, LA; Smith, WA; Thomas, WR			Association between allergic disease and reactivity to recombinant Der p 2 allergen of house dust mites in a tropical situation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							EXPRESSION; IGE		Cent Univ Venezuela, Inst Biomed, Caracas 1010A, Venezuela; Minist Sanidad & Asistencia Social, Ambulatorio Norte, Caracas, Venezuela; Princess Margaret Hosp Children, Inst Child Hlth Res, Subiaco, WA, Australia	University of Central Venezuela; Telethon Kids Institute; University of Western Australia	Lynch, NR (corresponding author), Cent Univ Venezuela, Inst Biomed, Aptdo 4043, Caracas 1010A, Venezuela.		Lynch, Natalie/GSI-7336-2022					Aalberse RC, 1996, IMMUNOL CELL BIOL, V74, P201, DOI 10.1038/icb.1996.28; CHUA KY, 1990, INT ARCH ALLER A IMM, V91, P124, DOI 10.1159/000235102; HAGEL I, 1993, INT ARCH ALLERGY IMM, V101, P209, DOI 10.1159/000236521; Lynch N. R., 1992, Allergy and immunity to helminths: common mechanisms or divergent pathways., P51; Lynch NR, 1997, INT ARCH ALLERGY IMM, V114, P59, DOI 10.1159/000237644; PASTORELLO EA, 1995, J ALLERGY CLIN IMMUN, V96, P580, DOI 10.1016/S0091-6749(95)70255-5	6	7	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1998	101	4	1				562	564		10.1016/S0091-6749(98)70367-7	http://dx.doi.org/10.1016/S0091-6749(98)70367-7			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZH469	9564815				2022-12-18	WOS:000073113500025
J	Zacharisen, MC; Kurup, V				Zacharisen, MC; Kurup, V			Anaphylaxis it beans	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							FOOD		Med Coll Wisconsin, Ctr Asthma & Allergy, Milwaukee, WI 53201 USA	Medical College of Wisconsin	Zacharisen, MC (corresponding author), Med Coll Wisconsin, Ctr Asthma & Allergy, 9000 W Wisconsin Ave, Milwaukee, WI 53201 USA.							BERNHISELBROADBENT J, 1989, J ALLERGY CLIN IMMUN, V83, P435, DOI 10.1016/0091-6749(89)90130-9; BOCK SA, 1992, J ALLERGY CLIN IMMUN, V90, P683, DOI 10.1016/0091-6749(92)90143-P; GOLBERT TM, 1969, J ALLERGY, V44, P96, DOI 10.1016/0021-8707(69)90005-7; KASPERICK G, 1984, Journal of Allergy and Clinical Immunology, V73, P176; KURUP VP, 1997, MANUAL CLIN LAB IMMU, P908	5	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1998	101	4	1				556	557		10.1016/S0091-6749(98)70365-3	http://dx.doi.org/10.1016/S0091-6749(98)70365-3			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZH469	9564811				2022-12-18	WOS:000073113500021
J	Durham, SR; Ying, S; Meng, Q; Humbert, M; Gould, H; Kay, AB				Durham, SR; Ying, S; Meng, Q; Humbert, M; Gould, H; Kay, AB			Local expression of germline gene transcripts (I epsilon) and RNA for the heavy chain IgE (C epsilon) in the bronchial mucosa in atopic and non-atopic asthma.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									NHLI, Imperial Coll, Sch Med, London, England; Univ London Kings Coll, Randall Inst, London WC2R 2LS, England	Imperial College London; University of London; King's College London									0	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			668	S162	S162						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800668
J	Hoffman, DR; Severino, MG; Campi, P; Turillazzi, S; Zerboni, R				Hoffman, DR; Severino, MG; Campi, P; Turillazzi, S; Zerboni, R			Protease is an important allergen in European Polistes wasp venom allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									E Carolina Univ, Sch Med, Greenville, NC 27858 USA; Univ Florence, Florence, Italy	University of North Carolina; East Carolina University; University of Florence									0	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			144	S33	S33						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800145
J	Musken, H; Franz, JT; Fernandez-Caldas, E; Maranon, F; Masuch, G; Bergmann, KC				Musken, H; Franz, JT; Fernandez-Caldas, E; Maranon, F; Masuch, G; Bergmann, KC			Psocoptera spp (dust lice): A new source of indoor allergens in Germany?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Bergmann, Karl-Christian/AAA-4104-2019						0	7	7	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			121	S28	S28						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800122
J	Plebani, A; Stringa, M; Priglione, I; Facchetti, P; Ghiotto, F; Airoldi, I; Giacchino, R; Cristina, E; Porta, F; Grossi, CE; Pistoia, V				Plebani, A; Stringa, M; Priglione, I; Facchetti, P; Ghiotto, F; Airoldi, I; Giacchino, R; Cristina, E; Porta, F; Grossi, CE; Pistoia, V			Engrafted maternal T cells in human severe combined immunodeficiency: Evidence for a T-H2 phenotype and a potential role of apoptosis on the restriction of T-cell receptor variable beta repertoire	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							DIVERSITY		Ist Giannina Gaslini, Clin Pediat 2, Dept Pediat, I-16147 Genoa, Italy; Ist Giannina Gaslini, Div Infect Dis, I-16147 Genoa, Italy; Ist Giannina Gaslini, Lab Oncol, I-16147 Genoa, Italy; Univ Genoa, Inst Human Genet, Genoa, Italy; Univ Brescia, Dept Pediat, Brescia, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Brescia	Plebani, A (corresponding author), Ist Giannina Gaslini, Clin Pediat 2, Dept Pediat, I-16147 Genoa, Italy.		Plebani, Alessandro/C-8593-2011; airoldi, irma/I-6169-2017; Ghiotto, Fabio/K-1955-2018	airoldi, irma/0000-0002-4352-8396; Ghiotto, Fabio/0000-0002-2301-8698				BOUSSIOTIS VA, 1994, SCIENCE, V266, P1039, DOI 10.1126/science.7973657; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; Facchetti P, 1996, CANCER IMMUNOL IMMUN, V42, P170, DOI 10.1007/s002620050267; GO C, 1993, J IMMUNOL, V150, P367; KNOBLOCH C, 1991, J IMMUNOL, V146, P4157; KRENGER W, 1995, J IMMUNOL, V155, P585; MELAMED I, 1994, CLIN EXP IMMUNOL, V95, P14; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; O'Reilly R J, 1989, Immunodefic Rev, V1, P273; SOTTINI A, 1995, BLOOD, V85, P2105, DOI 10.1182/blood.V85.8.2105.bloodjournal8582105	10	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	1				131	134		10.1016/S0091-6749(98)70207-6	http://dx.doi.org/10.1016/S0091-6749(98)70207-6			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YR872	9449515				2022-12-18	WOS:000071539800023
J	Tovey, E; Graham, J; O'Meara, T; Widmer, F; Lovborg, U; Jones, A; Sporik, R				Tovey, E; Graham, J; O'Meara, T; Widmer, F; Lovborg, U; Jones, A; Sporik, R			A new in vitro immunodiagnostic method.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Inst Resp Med, Sydney, NSW, Australia				Tovey, Euan R/G-8604-2017	Tovey, Euan R/0000-0002-1802-7266					0	7	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			536	S129	S129						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800536
J	Yeang, HY				Yeang, HY			Impact of biologic variation on latex allergenicity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Rubber Res Inst Malaysia, Biotechnol & Strateg Res Div, Kuala Lumpur 50450, Malaysia	Institute Penyelidikan Getah Malaysia	Yeang, HY (corresponding author), Rubber Res Inst Malaysia, Biotechnol & Strateg Res Div, 260 Jalan Ampang, Kuala Lumpur 50450, Malaysia.							Hamilton RG, 1996, J ALLERGY CLIN IMMUN, V98, P872, DOI 10.1016/S0091-6749(96)80003-0; 1997, J ALLERGY CLIN IMMUN, V99, P580	2	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	1				145	145						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YR872	9449523				2022-12-18	WOS:000071539800031
J	Leynadier, F; Hassani, Y; Chabane, MH; Benguedda, AC; Abbadi, MC; Guerin, L				Leynadier, F; Hassani, Y; Chabane, MH; Benguedda, AC; Abbadi, MC; Guerin, L			Allergic reactions to North African scorpion venom evaluated by skin test and specific IgE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									INST PASTEUR,IMMUNOL LAB,ALGIERS,ALGERIA; UNIV PARIS 06,CTR ALLERGIE,HOP ROTHSCHILD,FAC MED ST ANTOINE,F-75015 PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Rothschild - APHP; Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Leynadier, F (corresponding author), UNIV PARIS 06,SERV MED INTERNE,HOP ROTHSCHILD,FAC MED ST ANTOINE,33 BD PICPUS,F-75015 PARIS,FRANCE.							DEMAIN JG, 1995, J ALLERGY CLIN IMMUN, V95, P135, DOI 10.1016/S0091-6749(95)70163-X; DIB G, 1995, J ALLERGY CLIN IMMUN, V96, P465, DOI 10.1016/S0091-6749(95)70288-1; GOYFFON M, 1982, TOXICON, V20, P337, DOI 10.1016/0041-0101(82)90240-9; GRANIER C, 1989, MOL IMMUNOL, V26, P503, DOI 10.1016/0161-5890(89)90001-1; Rochat H, 1979, Adv Cytopharmacol, V3, P325	5	7	26	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1997	99	6	1				851	853		10.1016/S0091-6749(97)80022-X	http://dx.doi.org/10.1016/S0091-6749(97)80022-X			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XH193	9215256				2022-12-18	WOS:A1997XH19300021
J	Bannon, GA; Li, XF; Rabjohn, P; Stanley, JS; Burks, AW; Huang, SK; Sampson, HA				Bannon, GA; Li, XF; Rabjohn, P; Stanley, JS; Burks, AW; Huang, SK; Sampson, HA			Ara h 3, a peanut allergen identified by using peanut sensitive patient sera absorbed with soy proteins.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV ARKANSAS,SCH MED,LITTLE ROCK,AR 72204; JOHNS HOPKINS UNIV,BALTIMORE,MD	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Johns Hopkins University									0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			568	568						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14200566
J	Broide, D; Orozco, EM; Roman, M; Carson, DA				Broide, D; Orozco, EM; Roman, M; Carson, DA			Intradermal gene vaccination down-regulates both arms of the allergic response.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV CALIF SAN DIEGO,LA JOLLA,CA 92093	University of California System; University of California San Diego									0	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			523	523						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14200521
J	Desrosiers, M; Baroody, FM; Proud, D; Lichtenstein, LM; KageySobotka, A; Naclerio, RM				Desrosiers, M; Baroody, FM; Proud, D; Lichtenstein, LM; KageySobotka, A; Naclerio, RM			Treatment with hot, humid air reduces the nasal response to allergen challenge	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						humidity; heat; nasal provocation; nasal airway resistance; allergic rhinitis	LOCAL HYPERTHERMIA; RHINITIS; HISTAMINE; SYMPTOMS; RELEASE; ANTIGEN	Ten subjects with asymptomatic seasonal allergy, outside of their allergy season, underwent allergen provocation following 1 hour of exposure to air at either 20 degrees C and 30% relative humidity (RH) or air at 37 degrees C and 90% RH. The ipsilateral al changes following antigen challenge were compared under the two conditions. Conditioning of the nose to 37 degrees C, 90% RH reduced total histamine release (7.9 +/- 1.8 ng vs 4.2 +/- 1.3 ng; p less than or equal to 0.05), sneezes (6 +/- 2 vs 3 +/- 1; p less than or equal to 0.05), pruritus (score of 17.4 +/- 6.0 vs score of 2.0 +/- 1.8 out of a total score of 100, p less than or equal to 0.01), nasal airway resistance (1.4 +/- 0.8 kPa/L/sec vs 0.2 +/- 0.1 kPa/L/sec; p less than or equal to 0.05), human serum albumin levels (389.6 +/- 53.4 mu g vs 242.2 +/- 37.9 mu g; p less than or equal to 0.05), and congestion (score of 23.8 +/- 4.8 vs score of 10.6 +/- 5.4 out of a total score of too, p less than or equal to 0.01). It had ilo effect on the volume of secretions (p = 0.8), lactoferrin levels (p = 0.3), or rhinorrhea (p = 1.0). Thus air at 37 degrees C and 90% RH partially reduces the early response to antigen. its effects are greatest on histamine release, the vascular response, and neural responses, with no effect on the glandular response. The mechanisms underlying these effects are unknown.	JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21218; UNIV CHICAGO,DEPT OTOLARYNGOL HEAD & NECK SURG,CHICAGO,IL 60637	Johns Hopkins University; University of Chicago					NIAID NIH HHS [AI 08270] Funding Source: Medline; NIDCD NIH HHS [R01 DC02714-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI008270, R37AI008270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002714] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BAROODY FM, 1994, AM J RESP CRIT CARE, V149, P1457, DOI 10.1164/ajrccm.149.6.7516250; CHURCH MK, 1982, J IMMUNOL, V129, P2116; DESROSIERS M, IN PRESS ANN OTOL RH; DINARELLO CA, 1986, CANCER RES, V46, P6236; GEORGITIS JW, 1993, ANN ALLERGY, V71, P385; JANKOWSKI R, 1995, AM J RHINOL, V9, P241, DOI 10.2500/105065895781808865; JOHNSTON SL, 1993, J ALLERGY CLIN IMMUN, V92, P850, DOI 10.1016/0091-6749(93)90063-L; JOHNSTON SL, 1992, THORAX, V47, P592, DOI 10.1136/thx.47.8.592; KAUFMANN SHE, 1990, IMMUNOL TODAY, V11, P129, DOI 10.1016/0167-5699(90)90050-J; KONNO A, 1985, ANN ALLERGY, V54, P50; MANN SFP, 1979, J APPL PHYSIOL, V46, P205; MONGAR JL, 1957, J PHYSIOL-LONDON, V135, P320, DOI 10.1113/jphysiol.1957.sp005713; OPHIR D, 1988, ANN ALLERGY, V60, P239; OPHIR D, 1988, ANN OTO RHINOL LARYN, V97, P257; OPHIR D, 1987, AM J OTOLARYNG, V3, P149; OPPENHEIMER J, 1993, J ALLERGY CLIN IMMUN, V92, P56, DOI 10.1016/0091-6749(93)90037-G; RAPHAEL GD, 1989, J CLIN INVEST, V84, P1528, DOI 10.1172/JCI114329; TOGIAS A, 1990, AM REV RESPIR DIS, V141, P1428, DOI 10.1164/ajrccm/141.6.1428; TYRRELL D, 1989, BRIT MED J, V298, P1280, DOI 10.1136/bmj.298.6683.1280; WAGENMANN M, 1994, J ALLERGY CLIN IMMUN, V93, P594, DOI 10.1016/S0091-6749(94)70071-0; Willatt D. J., 1993, Rhinology (Utrecht), V31, P63; YERUSHALMI A, 1982, P NATL ACAD SCI-BIOL, V79, P4766, DOI 10.1073/pnas.79.15.4766; YERUSHALMI A, 1980, CR ACAD SCI D NAT, V291, P957	23	7	8	0	5	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	1				77	86						10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WD061	9003214				2022-12-18	WOS:A1997WD06100011
J	Falcoz, C; Mackie, AE; Moss, J; Horton, J; Ventresca, GP; Brown, A; Field, E; Harding, SM; Wire, P; Bye, A				Falcoz, C; Mackie, AE; Moss, J; Horton, J; Ventresca, GP; Brown, A; Field, E; Harding, SM; Wire, P; Bye, A			Pharmacokinetics of fluticasone propionate inhaled from the Diskhaler(R) and the Diskus(R) after repeat doses in healthy subjects and asthmatic patients.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									GLAXO WELLCOME RES & DEV LTD,CLIN PHARMACOL,GREENFORD,MIDDX,ENGLAND; GLAXO WELLCOME RES & DEV LTD,CLIN RES,RES TRIANGLE PK,NC	GlaxoSmithKline; GlaxoSmithKline									0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			2041	2041						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14202035
J	Devalia, JL; Rusznak, C; Abdelaziz, MM; Davies, RJ				Devalia, JL; Rusznak, C; Abdelaziz, MM; Davies, RJ			Nedocromil sodium and airway inflammation in vivo and in vitro	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; epithelial cell function; activated eosinophils eosinophil adhesion; eosinophil chemotaxis	BRONCHIAL EPITHELIAL-CELLS; MAJOR BASIC-PROTEIN; TRACHEAL EPITHELIUM; HUMAN EOSINOPHILS; HUMAN-LUNG; IN-VITRO; INHIBITION; INVITRO; ASTHMA; INTERLEUKIN-8	We conducted a series of studies investigating the antiinflammatory effects of nedocromil sodium, with particular reference to its effects on human bronchial epithelial cells and eosinophils in vitro and on eosinophils in vivo. Nedocromil sodium produced a dose-related inhibition of ozone-induced IL-8 release from human branchial epithelial cells and also attenuated the release of granulocyte macrophage colony-stimulating factor; tremor necrosis factor-alpha, and soluble intercellular adhesion molecule 1. The culture medium from human bronchial epithelial cell cultures, containing the proinflammatory cytokines IL-8, granulocyte macrophage colony-stimulating factor, ''regulated on activation normal T expressed and secreted'' IL-1 beta, and tumor necrosis factor-alpha, increased eosinophil chemotaxis and eosinophil adhesion to cultured human endothelial cells. The chemotaxis and increased adhesion were blocked in the presence of nedocromil sodium. The drug also abrogated the epithelial cell dysfunction (assessed as ciliary beat frequency) induced by the presence of activated eosinophils and blocked the release of eosinophil cationic protein fram the eosinophils. We also conducted a double-blind placebo-controlled study of the effects of regular albuterol 200 mu g or nedocromil sodium 4 mg, both given four times daily for 16 weeks, on inflammatory cell numbers in bronchial biopsy and bronchoalveolar lavage samples. Assessed in terms of total and activated eosinophils in biopsy samples, inflammation decreased with nedocromil sodium and was significantly different from a deterioration with albuterol, although neither of these changes was significantly different from that with placebo treatment. Levels of eosinophil cationic protein in bronchoalveolar lavage samples showed a similar trend.	LONDON CHEST HOSP,ST BARTHOLOMEWS & ROYAL LONDON SCH MED & DENT,DEPT ASTHMA & ALLERG RESP DIS,LONDON E2 9LX,ENGLAND	University of London; Queen Mary University London								ABDELAZIZ MM, 1995, AM J RESP CELL MOL, V13, P728, DOI 10.1165/ajrcmb.13.6.7576711; Alton EWFW, 1996, J ALLERGY CLIN IMMUN, V98, pS102, DOI 10.1016/S0091-6749(96)80136-9; AYARS GH, 1989, AM REV RESPIR DIS, V140, P125; BORISH L, 1992, CLIN EXP ALLERGY, V22, P984, DOI 10.1111/j.1365-2222.1992.tb03025.x; BRUIJNZEEL PLB, 1989, BRIT J PHARMACOL, V96, P631, DOI 10.1111/j.1476-5381.1989.tb11862.x; DEVALIA JL, 1993, AM J RESP CELL MOL, V9, P271, DOI 10.1165/ajrcmb/9.3.271; DEVALIA JL, 1993, RESP MED, V87, P405, DOI 10.1016/0954-6111(93)90064-7; DEVALIA JL, 1992, AM J RESP CELL MOL, V7, P270, DOI 10.1165/ajrcmb/7.3.270; FRIGAS E, 1980, LAB INVEST, V42, P35; LEUNG KBP, 1988, THORAX, V43, P756, DOI 10.1136/thx.43.10.756; MANOLITSAS ND, 1995, AM J RESP CRIT CARE, V151, P1925, DOI 10.1164/ajrccm.151.6.7767541; MARINI M, 1992, PULM PHARMACOL, V5, P61, DOI 10.1016/0952-0600(92)90019-D; MATTOLI S, 1990, INT ARCH ALLER A IMM, V92, P16, DOI 10.1159/000235218; MOTOJIMA S, 1989, AM REV RESPIR DIS, V139, P801, DOI 10.1164/ajrccm/139.3.801; PETERS MJ, 1993, AM REV RESPIR DIS, V147, pA772; PRETOLANI M, 1993, J ALLERGY CLIN IMMUN, V91, P809, DOI 10.1016/0091-6749(93)90201-P; RUSZNAK C, 1994, ALLERGY, V49, P21, DOI 10.1111/j.1398-9995.1994.tb04234.x; SHUTE J, 1994, CLIN EXP ALLERGY, V24, P203, DOI 10.1111/j.1365-2222.1994.tb00220.x; THOREL T, 1988, INT ARCH ALLER A IMM, V85, P232, DOI 10.1159/000234508; TRIGG CJ, 1994, AM J RESP CRIT CARE, V150, P17, DOI 10.1164/ajrccm.150.1.8025745; VITTORI E, 1992, J ALLERGY CLIN IMMUN, V90, P76, DOI 10.1016/S0091-6749(06)80013-8; WANG JH, 1994, J ALLERGY CLIN IMMUN, V94, P1025, DOI 10.1016/0091-6749(94)90121-X; Wang JH, 1996, AM J RESP CELL MOL, V14, P27, DOI 10.1165/ajrcmb.14.1.8534483; WEGNER CD, 1992, CHEST, V101, pS34, DOI 10.1378/chest.101.3.34S	24	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1996	98	5	2	S			S51	S57		10.1016/S0091-6749(96)80129-1	http://dx.doi.org/10.1016/S0091-6749(96)80129-1			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VW140	8939177				2022-12-18	WOS:A1996VW14000010
J	Ferrari, S; Pietroiusti, A; Galanti, A; Compagnucci, M; Fontana, L				Ferrari, S; Pietroiusti, A; Galanti, A; Compagnucci, M; Fontana, L			Paroxysmal atrial fibrillation after insect sting	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							HEART		UNIV ROMA TOR VERGATA,CATTEDRA IMMUNOL CLIN ED ALLERGOL,I-00173 ROME,ITALY; UNIV ROMA TOR VERGATA,CATTEDRA SEMEIOT METODOL CLIN,I-00173 ROME,ITALY	University of Rome Tor Vergata; University of Rome Tor Vergata				PIETROIUSTI, Antonio/0000-0002-4056-1801				KOVANEN PT, 1995, CIRCULATION, V92, P1084, DOI 10.1161/01.CIR.92.5.1084; Mueller UR, 1990, INSECT STING ALLERGY, P33; REISMAN RE, 1994, NEW ENGL J MED, V331, P523, DOI 10.1056/NEJM199408253310808; VALEN G, 1994, ACTA PHYSIOL SCAND, V150, P413, DOI 10.1111/j.1748-1716.1994.tb09706.x; WASSERMAN SI, 1986, J ALLERGY CLIN IMMUN, V77, P663, DOI 10.1016/0091-6749(86)90405-7	5	7	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1996	98	4					759	761		10.1016/S0091-6749(96)70124-0	http://dx.doi.org/10.1016/S0091-6749(96)70124-0			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VM665	8876551				2022-12-18	WOS:A1996VM66500008
J	Onn, A; Levo, Y; Kivity, S				Onn, A; Levo, Y; Kivity, S			Familial cholinergic urticaria	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									TEL AVIV UNIV,SOURASKY MED CTR,SACKLET FAC MED,DEPT INTERNAL MED T,IL-69978 TEL AVIV,ISRAEL; TEL AVIV UNIV,SOURASKY MED CTR,SACKLET FAC MED,CHEST & ALLERGY INST,IL-69978 TEL AVIV,ISRAEL	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center								COMMENS CA, 1978, BRIT J DERMATOL, V98, P47, DOI 10.1111/j.1365-2133.1978.tb07332.x; SIBBALD RG, 1984, DERMATOL CLIN, V3, P57; SORER NA, 1980, NEW ENGL J MED, V302, P604; TARIQ M, 1994, AM FAM PHYSICIAN, V49, P411; ZUBERBIER T, 1994, J AM ACAD DERMATOL, V31, P978, DOI 10.1016/S0190-9622(94)70267-5	5	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1996	98	4					847	849		10.1016/S0091-6749(96)70137-9	http://dx.doi.org/10.1016/S0091-6749(96)70137-9			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VM665	8876564				2022-12-18	WOS:A1996VM66500021
J	Schkade, PA; Routes, JM				Schkade, PA; Routes, JM			Hypersensitivity pneumonitis in a patient with hypogammaglobulinemia	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NATL JEWISH CTR IMMUNOL & RESP MED,DEPT MED,DIV CLIN IMMUNOL & ALLERGY,DENVER,CO 80206; FITZSIMONS ARMY MED CTR,ALLERGY IMMUNOL SERV,AURORA,CO 80045; UNIV COLORADO,HLTH SCI CTR,DEPT MED,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,DEPT IMMUNOL,DENVER,CO	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver			Routes, john/AAA-4833-2021	Routes, john/0000-0001-8378-3773				KAWANAMI O, 1983, AM J PATHOL, V110, P275; RICHERSON HB, 1982, CLIN REV ALLERG, V1, P469; SCHUYLER M, 1992, AM REV RESPIR DIS, V146, P1582, DOI 10.1164/ajrccm/146.6.1582; SCHUYLER M, 1991, CELL IMMUNOL, V136, P313; SEMANZATO G, 1986, J IMMUNOL, V137, P1164	5	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1996	98	3					710	712		10.1016/S0091-6749(96)70108-2	http://dx.doi.org/10.1016/S0091-6749(96)70108-2			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VJ428	8828552				2022-12-18	WOS:A1996VJ42800031
J	Lavaud, F				Lavaud, F			Cross-sensitization between latex and fruits	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALLERGY; AVOCADO; BANANA				Lavaud, F (corresponding author), CHU REIMS,HOP MAISON BLANCHE,DEPT MALAD RESP,45 RUE COGNACQ JAY,F-51092 REIMS,FRANCE.							AHLROTH M, 1995, J ALLERGY CLIN IMMUN, V96, P167, DOI 10.1016/S0091-6749(95)70004-8; ANDRE F, 1995, ALLERGY S26, V50, P125; BRUGNAMI G, 1995, J ALLERGY CLIN IMMUN, V96, P457, DOI 10.1016/S0091-6749(95)70287-3; DECORRES LF, 1993, ANN ALLERGY, V70, P35; LAVAUD F, 1992, LANCET, V339, P492, DOI 10.1016/0140-6736(92)91100-M; LAVAUD F, 1995, J ALLERGY CLIN IMMUN, V95, P557, DOI 10.1016/S0091-6749(95)70318-7; MRAIHI L, 1991, J ALLERGY CLIN IMMUN, V87, P129, DOI 10.1016/0091-6749(91)90224-C	7	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1996	98	2					473	473		10.1016/S0091-6749(96)70179-3	http://dx.doi.org/10.1016/S0091-6749(96)70179-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VC995	8757231	Bronze			2022-12-18	WOS:A1996VC99500034
J	Weinberger, MS; Davidson, TM; Broide, DH				Weinberger, MS; Davidson, TM; Broide, DH			Differential expression of vascular cell adhesion molecule mRNA and protein in nasal mucosa in response to IL-1 or tumor necrosis factor	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						nasal mucosa; IL-1; tumor necrosis factor; vascular cell adhesion molecule; intercellular adhesion molecule	COLONY-STIMULATING FACTOR; ENDOTHELIAL-CELLS; EOSINOPHIL ADHERENCE; MESSENGER-RNA; ASTHMA; INTERLEUKIN-1; ACTIVATION; INVIVO; NEUTROPHILS; MECHANISMS	IL-1 and tumor necrosis factor (TNF) are cytokines that share many overlapping functions, including induction of expression of the vascular cell adhesion molecule (VCAM) by endothelial cells. However, because most studies of cytokine induction of adhesion molecules have used human umbilical vein endothelial cells (HUVECs) and not microvascular endothelial cells, the functional significance of such observations to sites of allergic inflammation, such as the nasal mucosa, are at present unknown. We have therefore used nasal mucosa to compare the functional response of these microvascular endothelial cells with HUVECs. HUVECs or nasal mucosal explants were stimulated in vitro with varying concentration of IL-1 or TNF for 0 to 48 hours, and VCAM mRNA and protein expression were determined by means of immunostaining and in situ hybridization. TNF and IL-1 were equivalent in their ability to induce VCAM mRNA and protein expression by HUVECs. In contrast, TNF was significantly more potent than IL-1 inducing VCAM mRNA and protein expression by nasal mucosal microvascular endothelial cells. The recovery of significant amount of IL-1 after incubation of recombinant IL-1 with nasal mucosa, as well as the ability of IL-1 to induce intercellular adhesion molecule expression by nasal mucosa, suggests that neither degradation of IL-1 nor downregulation of IL-1 receptors in nasal mucosa is likely to explain the inability of IL-1 to induce VCAM expression by nasal mucosa. These studies suggest that microvascular endothelial cells in the nasal mucosa differ functionally from HUVECs and that TNF may be more important than IL-1 in induction of VCAM expression in the nasal mucosa.	UNIV CALIF SAN DIEGO,DIV HEAD & NECK SURG,SAN DIEGO,CA 92093; UNIV CALIF SAN DIEGO,DEPT MED,SAN DIEGO,CA 92093	University of California System; University of California San Diego; University of California System; University of California San Diego				Broide, David/0000-0001-8405-9090	NIAID NIH HHS [AI31595, AI29974, AI33977] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI031595, R29AI029974, R01AI033977] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AUNG UK, 1991, J IMMUNOL, V146, P521; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; BEVILACQUA MP, 1993, ANNU REV IMMUNOL, V11, P767, DOI 10.1146/annurev.iy.11.040193.004003; BOCHNER BS, 1990, J ALLERGY CLIN IMMUN, V86, P830, DOI 10.1016/S0091-6749(05)80143-5; BOCHNER BS, 1991, J EXP MED, V173, P1553, DOI 10.1084/jem.173.6.1553; BRISCOE DM, 1992, J IMMUNOL, V149, P2954; BROIDE DH, 1992, J ALLERGY CLIN IMMUN, V89, P958, DOI 10.1016/0091-6749(92)90218-Q; BROIDE DH, 1991, J ALLERGY CLIN IMMUN, V88, P637, DOI 10.1016/0091-6749(91)90158-K; BROIDE DH, 1992, J CLIN INVEST, V90, P1414, DOI 10.1172/JCI116008; BROIDE DH, 1991, J CLIN INVEST, V88, P1048, DOI 10.1172/JCI115366; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; DOBRINA A, 1991, J CLIN INVEST, V88, P20, DOI 10.1172/JCI115278; EBISAWA M, 1994, J IMMUNOL, V153, P2153; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; FIRESTEIN GS, 1991, ARTHRITIS RHEUM, V34, P1094, DOI 10.1002/art.1780340905; GROVES RW, 1992, J INVEST DERMATOL, V98, P384, DOI 10.1111/1523-1747.ep12499816; IADEMARCO MF, 1995, J CLIN INVEST, V95, P264, DOI 10.1172/JCI117650; MONTEFORT S, 1994, J CLIN INVEST, V93, P1411, DOI 10.1172/JCI117118; MONTEFORT S, 1992, AM J RESP CELL MOL, V7, P393, DOI 10.1165/ajrcmb/7.4.393; MOQBEL R, 1991, J EXP MED, V174, P749, DOI 10.1084/jem.174.3.749; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; PETZELBAUER P, 1993, J IMMUNOL, V151, P5062; POBER JS, 1986, J IMMUNOL, V137, P1893; RESNICK MB, 1993, AM J RESP CELL MOL, V8, P349, DOI 10.1165/ajrcmb/8.4.349; RICE GE, 1989, SCIENCE, V246, P1303, DOI 10.1126/science.2588007; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; SCHLEIMER RP, 1992, J IMMUNOL, V148, P1086; SMART SJ, 1994, AM J PHYSIOL, V266, pL238, DOI 10.1152/ajplung.1994.266.3.L238; SRIRAMARAO P, 1994, J IMMUNOL, V153, P4238; SWERLICK RA, 1992, J IMMUNOL, V149, P698; SYMON FA, 1994, J EXP MED, V180, P371, DOI 10.1084/jem.180.1.371; TEPPER RI, 1990, CELL, V62, P457, DOI 10.1016/0092-8674(90)90011-3; THORNHILL MH, 1990, J IMMUNOL, V145, P865; VONANDRIAN UH, 1992, AM J PHYSIOL, V263, pH1034, DOI 10.1152/ajpheart.1992.263.4.H1034; VONANDRIAN UH, 1991, P NATL ACAD SCI USA, V88, P7538, DOI 10.1073/pnas.88.17.7538; WALSH GM, 1991, J IMMUNOL, V146, P3419; WALSH LJ, 1991, P NATL ACAD SCI USA, V88, P4220, DOI 10.1073/pnas.88.10.4220; WELLER PF, 1991, P NATL ACAD SCI USA, V88, P7430, DOI 10.1073/pnas.88.16.7430; WELLER PF, 1991, NEW ENGL J MED, V324, P1110	39	7	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1996	97	2					662	671		10.1016/S0091-6749(96)70312-3	http://dx.doi.org/10.1016/S0091-6749(96)70312-3			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TW087	8621852				2022-12-18	WOS:A1996TW08700012
J	BAUER, K; SERTL, K; KAIK, B; KAIK, G				BAUER, K; SERTL, K; KAIK, B; KAIK, G			EFFECT OF SOLUTION AND SUSPENSION TYPE AEROSOL OF FORMOTEROL ON TREMOR RESPONSE AND AIRWAYS IN PATIENTS WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						SOLUTION AND SUSPENSION AEROSOLS; FORMOTEROL TREMOR; BRONCHODILATION; ASTHMA	METERED-DOSE-INHALER; DRY POWDER; INHALATION; DEPOSITION; SALBUTAMOL; BRONCHODILATOR; DEVICE; CANDIDIASIS; FENOTEROL; STEROIDS	Background: Aerosol delivery and deposition to the oropharynx and the lungs have been found to be different for solution-type and suspension-type metered-dose aerosols used for treatment of asthma. We investigated possible differences in clinical effects between solution and suspension metered-dose formoterol aerosols. Methods: A total of 24 patients with asthma (forced expiratory volume in 1 second, less than or equal to 70% predicted) inhaled single doses (12 mu g or 24 mu g) of formoterol solution and suspension so that we could investigate the immediate tremor, airway, and cardiovascular responses in a randomized, double-blind, crossover trial. Fenoterol suspension aerosol (400 mu g) was used for comparison (single-blind, poststudy,nonrandomized administration). Fenoterol (400 mu g) as a rescue medication was inhaled after 120 minutes on each of the 5 study days. Results: The order of mean (+/- SEM) maximum tremor acceleration was as follows: 12 mu g formoterol solution (67.92 +/- 4.54 cm . sec(-2)) < 24 mu g solution (73.46 +/- 4.51 cm . sec(-2)) < 12 mu g suspension (80.87 +/- 5.08 cm . sec(-2)) < fenoterol (84.13 +/- 4.21 cm . sec(-2)) < 24 mu g formoterol suspension (88.54 +/- 6.26 cm . sec(-2)). Maximum increase in specific airway conductance ranged from 0.48 +/- 0.03 to 0.55 +/- 0.04 sec(-1) . kPa(-1) for all drugs (p > 0.05). No change in cardiovascular parameters occurred (p > 0.05). Conclusion: No difference in the bronchial response to either formulation of formoterol was found. Tremor response to suspension aerosol (24 mu g > 12 mu g) was higher than that to solution aerosol (24 mu g > 12 mu g), indicating possible differences in systemic absorption because of a different deposition pattern. Rescue medication demonstrated systemic effects on tremor that were additive to those of formoterol.	UNIV VIENNA, SCH MED, DEPT PNEUMOL, A-1090 VIENNA, AUSTRIA; KAISER FRANZ JOSEF HOSP, DEPT INTERNAL MED 2, VIENNA, AUSTRIA	University of Vienna; Kaiser-Franz-Josef Hospital								ARVIDSSON P, 1989, EUR RESPIR J, V2, P325; BAUER K, 1993, CLIN PHARMACOL THER, V53, P76, DOI 10.1038/clpt.1993.11; BAUER KG, 1993, BRIT J CLIN PHARMACO, V36, P285, DOI 10.1111/j.1365-2125.1993.tb00366.x; BELL JH, 1973, J PHARM PHARMACOL, V25, pP32; COLLIER JG, 1980, BRIT J CLIN PHARMACO, V9, P273, DOI 10.1111/j.1365-2125.1980.tb04837.x; DEROM EY, 1992, THORAX, V47, P30, DOI 10.1136/thx.47.1.30; DOLOVICH M, 1983, CHEST, V84, P36, DOI 10.1378/chest.84.1.36; GRIECO MH, 1980, ANN ALLERGY, V45, P231; KESTEN S, 1991, AM REV RESPIR DIS, V144, P622, DOI 10.1164/ajrccm/144.3_Pt_1.622; KIM CS, 1987, AM REV RESPIR DIS, V135, P157; KUNG M, 1987, CHEST, V91, P382, DOI 10.1378/chest.91.3.382; LAROS CD, 1977, RESPIRATION, V34, P131, DOI 10.1159/000193807; LOFDAHL CG, 1989, ALLERGY, V44, P264, DOI 10.1111/j.1398-9995.1989.tb01068.x; MAESEN FPV, 1992, CHEST, V102, P1544, DOI 10.1378/chest.102.5.1544; MOREN F, 1978, INT J PHARM, V1, P205, DOI 10.1016/0378-5173(78)90009-1; NEWMAN SP, 1984, THORAX, V39, P935, DOI 10.1136/thx.39.12.935; NEWMAN SP, 1985, CHEST, V88, pS152, DOI 10.1378/chest.88.2.152S; NEWMAN SP, 1981, THORAX, V36, P52, DOI 10.1136/thx.36.1.52; NEWNHAM DM, 1993, BRIT J CLIN PHARMACO, V36, P445, DOI 10.1111/j.1365-2125.1993.tb00393.x; OHASHI K, 1980, BRIT J CLIN PHARMACO, V9, pP120, DOI 10.1111/j.1365-2125.1980.tb04822.x; PATERSON JW, 1968, LANCET, V2, P426; SCIARRA JJ, 1978, J PHARM SCI, V67, P1428, DOI 10.1002/jps.2600671027; SHORT MD, 1981, CHEST, V80, P918; SYKES AP, 1990, RESP MED, V84, P135, DOI 10.1016/S0954-6111(08)80016-9; TOOGOOD JH, 1980, J ALLERGY CLIN IMMUN, V65, P145, DOI 10.1016/0091-6749(80)90200-6; WALLIN A, 1990, THORAX, V45, P259, DOI 10.1136/thx.45.4.259; WEGENER T, 1992, CHEST, V102, P535, DOI 10.1378/chest.102.2.535; WILLEY RF, 1976, BRIT J DIS CHEST, V70, P32, DOI 10.1016/0007-0971(76)90004-8; WILLIAMS AJ, 1983, THORAX, V38, P813, DOI 10.1136/thx.38.11.813; 1992, 24 JOINT FORM COMM B, P113	30	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1995	96	4					495	501		10.1016/S0091-6749(95)70293-8	http://dx.doi.org/10.1016/S0091-6749(95)70293-8			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TA095	7560661				2022-12-18	WOS:A1995TA09500010
J	TOMITA, K; TANIGAWA, T; YAJIMA, H; FUKUTANI, K; MATSUMOTO, Y; TANAKA, Y; SASAKI, T				TOMITA, K; TANIGAWA, T; YAJIMA, H; FUKUTANI, K; MATSUMOTO, Y; TANAKA, Y; SASAKI, T			IDENTIFICATION AND CHARACTERIZATION OF MONOCYTE SUBPOPULATIONS FROM PATIENTS WITH BRONCHIAL-ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ASTHMA; BLOOD MONOCYTES; INTERLEUKIN-1; LYSOSOMAL ENZYME; ELECTRON MICROSCOPY	COLONY-STIMULATING FACTOR; DIFFERENTIAL INTERLEUKIN-1 ELABORATION; HUMAN-BLOOD MONOCYTES; ALVEOLAR MACROPHAGES; INCREASED NUMBERS; HETEROGENEITY; GENERATION; GRANULOCYTE; ACTIVATION; CELLS	Monocytes ave inflammatory cells that accumulate in the airway in asthma. Monocytes constitute a heterogenous cell population in normal subjects. The heterogeneity of monocytes from nine patients with mild asthma and nine normal subjects was studied by means of discontinuous density gradient centrifugation with use of bovine serum albumin. The rate of low-density monocytes recovered from patients with asthma was higher than that obtained from normal subjects. The functional activity of monocyte fractions from asthmatic and control subjects was assessed by using the release of interleukin-1 beta (IL-1 beta) and the intensity of lysosomal enzymes, such as acid phosphatase and nonspecific esterase. The low-density cells produced less IL-1 beta than did cells of higher density in normal subjects. The IL-1 beta release was increased in low-density monocytes from subjects with asthma when compared with the same fraction from normal subjects (p < 0.01). The low-density monocytes had a higher activity of lysosomal enzymes than did cells of higher density in both asthmatic and normal subjects. Electron microscopic studies showed that low-density monocytes from the subjects with mild asthma appeared to have the morphologic characteristics of activated cells with more vacuoles in this periphery. This study shows that low-density monocytes from subjects with asthma retain the ability to be activated in vivo and in vitro and may orchestrate immune reactions in mild asthma.	TOTTORI UNIV,SCH MED,DEPT BACTERIOL,YONAGO,TOTTORI 683,JAPAN	Tottori University	TOMITA, K (corresponding author), TOTTORI UNIV,SCH MED,DEPT INTERNAL MED 3,36-1 NISHI MACHI,YONAGO,TOTTORI 683,JAPAN.		Matsumoto, Yoichiro/M-4093-2014; Tanigawa, Tetsuya/J-6131-2019	Tanigawa, Tetsuya/0000-0002-9305-1637				AAS K, 1981, ALLERGY, V36, P3, DOI 10.1111/j.1398-9995.1981.tb01818.x; ALBAS ABV, 1979, J EXP MED, V149, P1504; ARNOUX B, 1982, AGENTS ACTIONS, V12, P713, DOI 10.1007/BF01965089; BARCA T, 1962, J HISTOCHEM CYTOCHEM, V10, P741; BELLINI A, 1993, CHEST, V103, P997, DOI 10.1378/chest.103.4.997; BEVILACQUA MP, 1985, J CLIN INVEST, V76, P2003, DOI 10.1172/JCI112200; BOWDEN DH, 1980, LAB INVEST, V42, P511; CARROLL MP, 1985, J ALLERGY CLIN IMMUN, V75, P290, DOI 10.1016/0091-6749(85)90060-0; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; CHANEZ P, 1991, AM REV RESPIR DIS, V144, P923, DOI 10.1164/ajrccm/144.4.923; CHEN BD, 1988, J IMMUNOL, V141, P139; CLUZEL M, 1987, J ALLERGY CLIN IMMUN, V80, P195, DOI 10.1016/0091-6749(87)90129-1; CORRIGAN CJ, 1988, LANCET, V1, P1129; DONNELLY RP, 1990, J IMMUNOL, V145, P569; DURHAM SR, 1984, NEW ENGL J MED, V311, P1398, DOI 10.1056/NEJM198411293112202; ELIAS JA, 1987, J LEUKOCYTE BIOL, V42, P114, DOI 10.1002/jlb.42.2.114; ELIAS JA, 1985, BLOOD, V66, P298; ELIAS JA, 1985, J IMMUNOL, V135, P3198; ENK C, 1988, INT ARCH ALLER A IMM, V85, P308, DOI 10.1159/000234522; FERRO TJ, 1987, AM REV RESPIR DIS, V135, P682; FUKUDA T, 1985, AM REV RESPIR DIS, V132, P981; GERBERICK G F, 1986, Journal of Immunology, V137, P114; GIN W, 1985, AM REV RESPIR DIS, V132, P1199; GIN W, 1985, J ALLERGY CLIN IMMUN, V76, P682; HASKILL S, 1988, J IMMUNOL, V140, P1690; HOWELL CJ, 1989, AM REV RESPIR DIS, V140, P1340, DOI 10.1164/ajrccm/140.5.1340; INABA K, 1992, J EXP MED, V175, P1157, DOI 10.1084/jem.175.5.1157; INAMURA N, 1990, J LEUKOCYTE BIOL, V47, P528, DOI 10.1002/jlb.47.6.528; KAY AB, 1981, CLIN EXP IMMUNOL, V44, P576; KHANSARI N, 1985, EUR J IMMUNOL, V15, P48, DOI 10.1002/eji.1830150110; KLOPROGGE E, 1989, J ALLERGY CLIN IMMUN, V83, P393, DOI 10.1016/0091-6749(89)90124-3; LEDER LD, 1964, KLIN WOCHENSCHR, V42, P553, DOI 10.1007/BF01486688; MATTOLI S, 1991, J ALLERGY CLIN IMMUN, V87, P794, DOI 10.1016/0091-6749(91)90125-8; MELEWICZ FM, 1981, J IMMUNOL, V126, P1592; METCALF D, 1982, J CELL PHYSIOL, V111, P275, DOI 10.1002/jcp.1041110308; MIYAGAWA H, 1990, INT ARCH ALLER A IMM, V93, P8, DOI 10.1159/000235272; NORRIS DA, 1979, J IMMUNOL, V123, P166; PICKER LJ, 1980, J IMMUNOL, V124, P2557; POSTON RN, 1992, AM REV RESPIR DIS, V145, P918, DOI 10.1164/ajrccm/145.4_Pt_1.918; RANKIN JA, 1982, NATURE, V297, P329, DOI 10.1038/297329a0; SCHELLITO J, 1984, AM REV RESPIR DIS, V129, P747; SELIG W, 1992, EUR J PHARMACOL, V213, P331, DOI 10.1016/0014-2999(92)90621-A; SHANNON BT, 1983, J NATL CANCER I, V71, P1157; SNAPPER JR, 1990, AM REV RESPIR DIS, V141, P531, DOI 10.1164/ajrccm/141.3.531; TICE DG, 1981, J RETICULOENDOTH SOC, V29, P459; VACHIER I, 1992, AM REV RESPIR DIS, V146, P1161, DOI 10.1164/ajrccm/146.5_Pt_1.1161; WILKINSON JRW, 1989, J CLIN INVEST, V84, P1930, DOI 10.1172/JCI114381	47	7	7	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1995	96	2					230	238		10.1016/S0091-6749(95)70012-9	http://dx.doi.org/10.1016/S0091-6749(95)70012-9			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RQ001	7636060	Bronze			2022-12-18	WOS:A1995RQ00100012
J	KNIGHT, A				KNIGHT, A			THE DIFFERENTIAL-DIAGNOSIS OF RHINORRHEA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						RHINORRHEA; DIAGNOSIS; CONJUNCTIVITIS; SINUSITIS; VASOMOTOR; INFLAMMATORY	PERENNIAL RHINITIS; RELEASE	Rhinorrhea disrupts the quality of life of a large segment of the population. The first step to treating it properly is to make an accurate diagnosis of its underlying cause. This is not always a simple proposition, however, because rhinorrhea has many causes that can easily be confused in clinical practice. Diagnosis has come to rely increasingly on testing, but test costs add significantly to the health-care burden. This article reviews the use of medical logic in the differential diagnosis of rhinorrhea and describes the relative usefulness of various testing methods.			KNIGHT, A (corresponding author), SUNNYBROOK HLTH SCI CTR,DIV CLIN IMMUNOL,2075 BAYVIEW AVE HG-40,N YORK,ON M4N 3M5,CANADA.							BORTS MR, 1992, J ALLERGY CLIN IMMUN, V90, P1065, DOI 10.1016/0091-6749(92)90124-K; GEORGITIS JW, 1992, J ALLERGY CLIN IMMUN, V90, P1071, DOI 10.1016/0091-6749(92)90125-L; GWALTNEY JM, 1994, NEW ENGL J MED, V330, P25, DOI 10.1056/NEJM199401063300105; JACOBS RL, 1987, IMMUNOL ALLERGY CLIN, V7, P93; MULLARKEY MF, 1980, J ALLERGY CLIN IMMUN, V65, P122, DOI 10.1016/0091-6749(80)90196-7; NACLERIO RM, 1983, AM REV RESPIR DIS, V128, P597; OSTERBALLE O, 1979, ALLERGY, V34, P175, DOI 10.1111/j.1398-9995.1979.tb01565.x; PASTORELLO EA, 1994, J ALLERGY CLIN IMMUN, V93, P85, DOI 10.1016/0091-6749(94)90236-4; SAMTER M, 1968, ANN INTERN MED, V68, P975, DOI 10.7326/0003-4819-68-5-975; SLAVIN RG, 1987, IMMUNOLOGY ALLERGY C	10	7	7	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1995	95	5	2				1080	1083		10.1016/S0091-6749(95)70211-3	http://dx.doi.org/10.1016/S0091-6749(95)70211-3			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QY918	7751525				2022-12-18	WOS:A1995QY91800003
J	NACLERIO, RM; BAROODY, FM				NACLERIO, RM; BAROODY, FM			IN-VIVO HUMAN MODELS FOR THE STUDY OF ANTICHOLINERGIC DRUGS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ATROPINE; IPRATROPIUM; ANTIGEN; METHACHOLINE; RHINITIS; HISTAMINE; NASAL PROVOCATION; CHOLINERGIC; PARASYMPATHETIC	HUMAN NASAL-MUCOSA; SECRETIONS; HISTAMINE; RHINITIS; METHACHOLINE; NEUROPEPTIDES; INNERVATION; PEPTIDE; PROTEIN; COLD	Background: The parasympathetic nervous system plays an important role in the nasal response to external stimuli. Objective: To review studies showing the role of the parasympathetic nervous system in the nasal response and the effect of topical, intranasal anticholinergic agents on that response. Method: Literature review of in vivo human studies. Results: Nasal provocation with methacholine leads to glandular stimulation. The response to methacholine provocation can be blocked by treatment with ipratropium bromide. Stimulation of one nostril with histamine, antigen, and cold, dry air leads to a bilateral secretory response that is partially inhibited by topical treatment with atropine. Conclusion: Topical anticholinergic agents should be useful in the reduction of glandular hypersecretion regardless of the etiology.			NACLERIO, RM (corresponding author), UNIV CHICAGO,5841 S MARYLAND AVE,MC 1035,CHICAGO,IL 60637, USA.				NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002714] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC02714] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Andersen, 1982, NOSE UPPER AIRWAY PH, P45; BARANIUK JN, 1990, AM J PHYSIOL, V258, pL81, DOI 10.1152/ajplung.1990.258.2.L81; BARANIUK JN, 1991, AM J RESP CELL MOL, V4, P228, DOI 10.1165/ajrcmb/4.3.228; BARANIUK JN, 1990, J CLIN INVEST, V86, P825, DOI 10.1172/JCI114780; BARANIUK JN, 1992, AM J PHYSIOL, V262, pL48, DOI 10.1152/ajplung.1992.262.1.L48; BARNES PJ, 1991, AM REV RESPIR DIS, V144, P1187, DOI 10.1164/ajrccm/144.5.1187; BAROODY FM, 1994, AM J RESP CRIT CARE, V149, P1457, DOI 10.1164/ajrccm.149.6.7516250; BAROODY FM, 1992, J ALLERGY CLIN IMMUN, V89, P1065, DOI 10.1016/0091-6749(92)90290-I; BAROODY FM, 1993, J APPL PHYSIOL, V74, P2661, DOI 10.1152/jappl.1993.74.6.2661; BORUM P, 1978, Rhinology (Utrecht), V16, P225; BROFELDT S, 1986, AM REV RESPIR DIS, V133, P1138; CAUNA N, 1972, J NEUROCYTOL, V1, P49, DOI 10.1007/BF01098645; ECCLES R, 1990, J PHARM PHARMACOL, V42, P652, DOI 10.1111/j.2042-7158.1990.tb06625.x; HAUSERKRONGERGE.C, 1993, ACTA OTOLARYNGOL STO, P387; ISCHII T, 1970, J NEUROCYTOL, V32, P153; ISHII T, 1970, PRACT-OTO-RHINO-LARY, V32, P153; JANKOWSKI R, 1993, RHINOLOGY, V32, P97; KNOWLES GK, 1981, CLIN ALLERGY, V11, P287, DOI 10.1111/j.1365-2222.1981.tb01596.x; KONNO A, 1979, ANN OTOL, V88, P25866; MALMBERG H, 1989, ACTA OTO-LARYNGOL, V107, P446, DOI 10.3109/00016488909127538; RAPHAEL G, 1989, J ALLERGY CLIN IMMUN, V83, P110, DOI 10.1016/0091-6749(89)90484-3; RAPHAEL GD, 1991, J ALLERGY CLIN IMMUN, V88, P33, DOI 10.1016/0091-6749(91)90298-3; RAPHAEL GD, 1989, AM REV RESPIR DIS, V139, P791, DOI 10.1164/ajrccm/139.3.791; RUCCI L, 1989, AGENTS ACTIONS, V28, P224, DOI 10.1007/BF01967406; SHELHAMER JH, 1980, J CLIN INVEST, V66, P1400, DOI 10.1172/JCI109993; SHORE SA, 1992, J APPL PHYSIOL, V73, P1847, DOI 10.1152/jappl.1992.73.5.1847; SJOGREN I, 1988, ACTA OTO-LARYNGOL, V106, P453, DOI 10.3109/00016488809122270; SOLWAY J, 1991, J APPL PHYSIOL, V71, P2077, DOI 10.1152/jappl.1991.71.6.2077; TOGIAS AG, 1988, AM REV RESPIR DIS, V137, P625, DOI 10.1164/ajrccm/137.3.625; WAGENMANN M, 1994, CLIN EXP ALLERGY, V24, P288, DOI 10.1111/j.1365-2222.1994.tb00233.x	30	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1995	95	5	2				1069	1079		10.1016/S0091-6749(95)70210-5	http://dx.doi.org/10.1016/S0091-6749(95)70210-5			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QY918	7751524				2022-12-18	WOS:A1995QY91800002
J	KULCZYCKI, A				KULCZYCKI, A			ASPARTAME-INDUCED HIVES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							URTICARIA				KULCZYCKI, A (corresponding author), WASHINGTON UNIV,SCH MED,BOX 8122,660 S EUCLID AVE,ST LOUIS,MO 63110, USA.							BERNSTEIN IL, 1988, J ALLERGY CLIN IMMUN, V82, P494; GEHA R, 1993, J ALLERGY CLIN IMMUN, V92, P513, DOI 10.1016/0091-6749(93)90075-Q; KULCZYCKI A, 1986, ANN INTERN MED, V104, P207, DOI 10.7326/0003-4819-104-2-207; KULCZYCKI A, 1992, ALLERGY THEORY PRACT, P217	4	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1995	95	2					639	640		10.1016/S0091-6749(95)70330-6	http://dx.doi.org/10.1016/S0091-6749(95)70330-6			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QH697	7852678	Bronze			2022-12-18	WOS:A1995QH69700020
J	DESROCHES, A; PARADIS, L; KNANI, J; HEJJAOUI, A; DHIVERT, H; MICHEL, FB; BOUSQUET, J				DESROCHES, A; PARADIS, L; KNANI, J; HEJJAOUI, A; DHIVERT, H; MICHEL, FB; BOUSQUET, J			SPECIFIC IMMUNOTHERAPY PREVENTS THE ONSET OF NEW SENSITIZATIONS IN MONOSENSITIZED CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Bousquet, Jean/O-4221-2019						0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				309	309						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400673
J	HANSEN, TK; BINDSLEVJENSEN, C; SKOV, PS; POULSEN, LK				HANSEN, TK; BINDSLEVJENSEN, C; SKOV, PS; POULSEN, LK			CLINICAL REACTIVITY TO FISH STUDIED BY MULTIPLE DOUBLE-BLIND PLACEBO-CONTROLLED FOOD CHALLENGES (DBPCFC)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Bindslev-Jensen, Carsten/H-1877-2011; Poulsen, Lars K/J-3065-2019	Bindslev-Jensen, Carsten/0000-0002-8940-038X; Poulsen, Lars K/0000-0002-1730-847X					0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				328	328						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400749
J	HEFLE, SL; BUSH, RK; LEHRER, SB; MALO, JL; CARTIER, A				HEFLE, SL; BUSH, RK; LEHRER, SB; MALO, JL; CARTIER, A			SNOW CRAB ALLERGY - IDENTIFICATION OF IGE-BINDING PROTEINS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				332	332						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400766
J	KANEKO, M; JARJOUR, NN; SWANSON, M; BUSSE, WW; GLEICH, GJ; KITA, H				KANEKO, M; JARJOUR, NN; SWANSON, M; BUSSE, WW; GLEICH, GJ; KITA, H			ALLERGEN-SPECIFIC IGE AND IGA IN BRONCHOALVEOLAR LAVAGE (BAL) FLUIDS FROM PATIENTS WITH ALLERGY INDUCE EOSINOPHIL DEGRANULATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				339	339						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400792
J	SAMPSON, HA; HO, DG				SAMPSON, HA; HO, DG			UTILITY OF THE PHARMACIA CAP SYSTEM RAST FEIA(TM) [CAP] IN DIAGNOSING IGE-MEDIATED FOOD HYPERSENSITIVITY [FH]	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				329	329						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400754
J	TORRES, MJ; BLANCA, M; GARCIA, J; VEGA, JM; FERNANDEZ, J; TERRADOS, S; MOYA, MC; MIRANDA, A; CARMONA, MJ				TORRES, MJ; BLANCA, M; GARCIA, J; VEGA, JM; FERNANDEZ, J; TERRADOS, S; MOYA, MC; MIRANDA, A; CARMONA, MJ			EVALUATION OF A LARGE COHORT OF SUBJECTS ALLERGIC TO PENICILLINS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									CARLOS HAYA HOSP,ALLERGY UNIT,MALAGA,SPAIN	Hospital Carlos Haya			Torres, María José/T-3518-2017; Torres, Maria/GVU-3391-2022	Torres, María José/0000-0001-5228-471X; 					0	7	7	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				285	285						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400576
J	MACGLASHAN, D				MACGLASHAN, D			SIGNAL-TRANSDUCTION - MECHANISMS IN BASOPHILS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							NONRELEASING HUMAN BASOPHILS; HISTAMINE-RELEASE; IGE; CALCIUM; RELEASABILITY; OSCILLATIONS; CA2+				MACGLASHAN, D (corresponding author), JOHNS HOPKINS UNIV,CTR ASTHMA & ALLERGY,BALTIMORE,MD 21224, USA.							FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; HOOK WA, 1991, J IMMUNOL, V147, P2670; KEIZER J, 1992, BIOPHYS J, V61, P649, DOI 10.1016/S0006-3495(92)81870-2; KNOL EF, 1992, J ALLERGY CLIN IMMUN, V90, P92, DOI 10.1016/S0091-6749(06)80015-1; MACGLASHAN D, 1983, J IMMUNOL, V130, P2337; MACGLASHAN D, 1994, J IMMUNOL, V152, P3006; MACGLASHAN D, 1991, J IMMUNOL, V147, P2259; MACGLASHAN DW, 1986, J IMMUNOL, V136, P2231; MACGLASHAN DW, 1993, J ALLERGY CLIN IMMUN, V91, P605, DOI 10.1016/0091-6749(93)90266-I; NGUYEN KL, 1990, J ALLERGY CLIN IMMUN, V85, P1020, DOI 10.1016/0091-6749(90)90046-7; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; WARNER JA, 1989, J IMMUNOL, V142, P1669	13	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1994	94	6	2	S			1146	1151		10.1016/0091-6749(94)90324-7	http://dx.doi.org/10.1016/0091-6749(94)90324-7			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QA020	7798552				2022-12-18	WOS:A1994QA02000004
J	LICCARDI, G; DAMATO, G				LICCARDI, G; DAMATO, G			ORAL ALLERGY SYNDROME IN A SUBJECT WITH A HIGHLY RELEVANT MONOSENSITIZATION TO EGG	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							FOODS				LICCARDI, G (corresponding author), HOSP A CARDARELLI,DEPT CHEST DIS,DIV PNEUMOL & ALLERGOL,VIA A CARDARELLI 9,I-80131 NAPLES,ITALY.							AAS K, 1972, ACTA ALLERGOL, V27, P439; AMLOT PL, 1987, CLIN ALLERGY, V17, P33, DOI 10.1111/j.1365-2222.1987.tb02317.x; ORTOLANI C, 1989, J ALLERGY CLIN IMMUN, V83, P683, DOI 10.1016/0091-6749(89)90083-3; ORTOLANI C, 1988, ANN ALLERGY, V61, P47; 1991, ANN ALLERGY, V67, P299	5	7	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1994	94	5					931	932		10.1016/0091-6749(94)90162-7	http://dx.doi.org/10.1016/0091-6749(94)90162-7			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PR240	7963161				2022-12-18	WOS:A1994PR24000019
J	BLANCA, M				BLANCA, M			THE CONTRIBUTION OF THE SIDE-CHAIN OF PENICILLINS IN THE INDUCTION OF ALLERGIC REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							MONOCLONAL-ANTIBODIES; AMOXICILLIN				BLANCA, M (corresponding author), CARLOS HAYA HOSP,ALLERG DIS RES UNIT,MALAGA,SPAIN.							ADKINSON NF, 1991, CLIN EXP ALLERGY, V20, P445; AUDICANA M, 1994, ALLERGY, V49, P108, DOI 10.1111/j.1398-9995.1994.tb00809.x; BLANCA M, 1990, CLIN EXP ALLERGY, V20, P475, DOI 10.1111/j.1365-2222.1990.tb03139.x; BLANCA M, 1991, ALLERGY, V46, P632, DOI 10.1111/j.1398-9995.1991.tb00635.x; CARSON JL, 1989, PHARMACOEPIDEM DR S, P173; MAYORGA C, 1992, INT ARCH ALLERGY IMM, V99, P443, DOI 10.1159/000236307; NAGAKURA N, 1991, J ANTIMICROB CHEMOTH, V28, P357, DOI 10.1093/jac/28.3.357; TERRADOS S, 1993, J ALLERGY CLIN IMMUN, V91, P263	8	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1994	94	3	1				562	563		10.1016/0091-6749(94)90218-6	http://dx.doi.org/10.1016/0091-6749(94)90218-6			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PG907	8083465				2022-12-18	WOS:A1994PG90700020
J	COOKSON, W				COOKSON, W			THE GENETICS OF ATOPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material	New Trends in Immunopharmacology 1993 Conference	JUL   17, 1993	TOKYO, JAPAN				CHROMOSOME-11Q; LINKAGE; INFANCY; IGE		UNIV OXFORD,NUFFIELD DEPT MED,OXFORD,ENGLAND	University of Oxford			Bonini, Sergio/T-6594-2019; Cookson, William/HHC-1790-2022	Bonini, Sergio/0000-0003-0079-3031; 				AMELUNG PJ, 1992, CLIN EXP ALLERGY, V22, P1077, DOI 10.1111/j.1365-2222.1992.tb00133.x; ARSHAD SH, 1992, LANCET, V339, P1493, DOI 10.1016/0140-6736(92)91260-F; CLINE MG, 1989, THORAX, V44, P425, DOI 10.1136/thx.44.5.425; COOKSON WOCM, 1992, LANCET, V340, P381, DOI 10.1016/0140-6736(92)91468-N; COOKSON WOCM, 1989, LANCET, V1, P1292; HOLT PG, 1990, PEDIATR ALLERGY IMMU, V1, P3; MAGNUSSON CGM, 1988, ALLERGY, V43, P241, DOI 10.1111/j.1398-9995.1988.tb00896.x; MOFFATT MF, 1992, CLIN EXP ALLERGY, V22, P1046, DOI 10.1111/j.1365-2222.1992.tb00128.x; RICH SS, 1992, CLIN EXP ALLERGY, V22, P1070, DOI 10.1111/j.1365-2222.1992.tb00132.x; SANDFORD AJ, 1993, LANCET, V341, P332, DOI 10.1016/0140-6736(93)90136-5	10	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1994	94	3	2	S			643	644		10.1016/0091-6749(94)90141-4	http://dx.doi.org/10.1016/0091-6749(94)90141-4			2	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PH235	8083473				2022-12-18	WOS:A1994PH23500010
J	KOH, YY; LIM, HS; MIN, KU				KOH, YY; LIM, HS; MIN, KU			AIRWAY RESPONSIVENESS TO ALLERGEN IS INCREASED 24 HOURS AFTER EXERCISE CHALLENGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						AIRWAY RESPONSIVENESS; EXERCISE CHALLENGE; ALLERGEN CHALLENGE	LATE ASTHMATIC RESPONSES; WESTERN RED CEDAR; BRONCHIAL RESPONSIVENESS; DELAYED BRONCHOCONSTRICTION; HISTAMINE; REACTIVITY; METHACHOLINE; IMMEDIATE; CHILDREN; HYPERRESPONSIVENESS	Although exercise is one of the most ubiquitous triggers of acute bouts of asthma, the changes in airway responsiveness before and after exercise are not well defined. Specifically, the effect of the changes in airway responsiveness induced by exercise has not been studied on subsequent allergen exposure. To test whether the reactivity to allergen is altered by preceding exercise and to define possible factors determining it, we subjected 24 children with atopic asthma to the relevant allergen challenge on two occasions: one as a control without a preceding procedure and the other 24 hours after exercise challenge. Mean postallergen maximal percent falls in forced expiratory volume in 1 second from baseline (Delta FEV(1)) of the whole group were higher after the exercise challenge compared with those of control in both early (<1 hour) and late (3 to 10 hours) phases. The changes of postallergen maximal Delta FEV(1) between the control and post-exercise allergen challenges were not related to the early bronchial response to the preceding exercise challenge. Late asthmatic responses to exercise developed in six children, and the changes in both early and late phases were significantly higher in these children, compared with those without late asthmatic responses. Furthermore, the changes were well correlated with the magnitude of the late-phase response to preceding exercise in the group as a whole. It is concluded that an increased airway responsiveness to allergen occurs 24 hours after exercise in some patients with asthma. As the changes are related to a late bronchial response to exercise, late asthmatic response to exercise when it occurs, may be associated with increased asthmatic symptoms for as long as 24 hours after exercise.	SEOUL NATL UNIV,COLL MED,DEPT INTERNAL MED,SEOUL,SOUTH KOREA	Seoul National University (SNU)	KOH, YY (corresponding author), SEOUL NATL UNIV,COLL MED,DEPT PEDIAT,CHONGNO KU,28 YONGON DONG,SEOUL 110744,SOUTH KOREA.		Koh, Young Yull/J-5368-2012; Koh, Young Yull/D-6059-2012; Min, Kyung-Up/J-5468-2012					ANDERSON SD, 1982, EUR J RESPIR DIS, V63, P459; BIERMAN CW, 1984, J ALLERGY CLIN IMMUN, V74, P701, DOI 10.1016/0091-6749(84)90233-1; BONER AL, 1992, PEDIATR PULM, V14, P156, DOI 10.1002/ppul.1950140304; BONER AL, 1990, ANN ALLERGY, V65, P284; BOULET LP, 1983, J ALLERGY CLIN IMMUN, V71, P399, DOI 10.1016/0091-6749(83)90069-6; BOULET LP, 1987, J ALLERGY CLIN IMMUN, V80, P655, DOI 10.1016/0091-6749(87)90284-3; CARTIER A, 1982, J ALLERGY CLIN IMMUN, V70, P170, DOI 10.1016/0091-6749(82)90038-0; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; COCKCROFT DW, 1979, AM REV RESPIR DIS, V119, P505; COCKCROFT DW, 1987, THORAX, V42, P302, DOI 10.1136/thx.42.4.302; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P503, DOI 10.1111/j.1365-2222.1977.tb01481.x; COCKCROFT DW, 1984, CLIN ALLERGY, V14, P61, DOI 10.1111/j.1365-2222.1984.tb02191.x; COCKCROFT DW, 1987, AM REV RESPIR DIS, V135, P264; COCKCROFT DW, 1983, LANCET, V2, P253; CRIMI E, 1992, AM REV RESPIR DIS, V146, P507, DOI 10.1164/ajrccm/146.2.507; CRIMI E, 1986, ANN ALLERGY, V56, P183; FELDMAN CH, 1982, AM REV RESPIR DIS, V125, P195; FORESI A, 1986, J ALLERGY CLIN IMMUN, V78, P1130, DOI 10.1016/0091-6749(86)90262-9; HAHN AG, 1984, THORAX, V39, P919, DOI 10.1136/thx.39.12.919; HARGREAVE FE, 1981, J ALLERGY CLIN IMMUN, V68, P347, DOI 10.1016/0091-6749(81)90132-9; IIKURA Y, 1985, J ALLERGY CLIN IMMUN, V75, P285, DOI 10.1016/0091-6749(85)90059-4; JARJOUR NN, 1992, J ALLERGY CLIN IMMUN, V89, P60, DOI 10.1016/S0091-6749(05)80041-7; JUNIPER EF, 1981, THORAX, V36, P575, DOI 10.1136/thx.36.8.575; LEE TH, 1983, NEW ENGL J MED, V308, P1502, DOI 10.1056/NEJM198306233082504; MCFADDEN ER, 1987, NEW ENGL J MED, V317, P502, DOI 10.1056/NEJM198708203170809; MUSSAFFI H, 1986, J ALLERGY CLIN IMMUN, V77, P48, DOI 10.1016/0091-6749(86)90321-0; OBYRNE PM, 1987, AM REV RESPIR DIS, V136, P740, DOI 10.1164/ajrccm/136.3.740; PAIK YH, 1991, J KOREAN MED ASSOC, V34, P69; RENZI PM, 1992, AM REV RESPIR DIS, V146, P163, DOI 10.1164/ajrccm/146.1.163; RUBINSTEIN I, 1987, NEW ENGL J MED, V317, P482, DOI 10.1056/NEJM198708203170805; RUFFIN RE, 1978, J ALLERGY CLIN IMMUN, V61, P42, DOI 10.1016/0091-6749(78)90472-4; SILVERMAN M, 1972, ARCH DIS CHILD, V47, P882, DOI 10.1136/adc.47.256.882; SOTOMAYOR H, 1984, AM REV RESPIR DIS, V130, P56; SPEELBERG B, 1991, J ALLERGY CLIN IMMUN, V87, P1128, DOI 10.1016/0091-6749(91)92159-X; SPEELBERG B, 1989, EUR RESPIR J, V2, P402; SUZUKI S, 1985, ANN ALLERGY, V54, P136; THORPE JE, 1987, CHEST, V91, P21, DOI 10.1378/chest.91.1.21; VERHOEFF NPLG, 1990, CHEST, V98, P1194, DOI 10.1378/chest.98.5.1194; WEILERRAVELL D, 1981, J ALLERGY CLIN IMMUN, V67, P391, DOI 10.1016/0091-6749(81)90085-3; YOON KA, 1993, J KOREAN PEDIATR ASS, V36, P25; ZAWADSKI DK, 1988, AM REV RESPIR DIS, V137, P837, DOI 10.1164/ajrccm/137.4.837; ZAWADSKI DK, 1988, J APPL PHYSIOL, V64, P812, DOI 10.1152/jappl.1988.64.2.812	42	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1994	94	3	1				507	516		10.1016/0091-6749(94)90207-0	http://dx.doi.org/10.1016/0091-6749(94)90207-0			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PG907	8083456				2022-12-18	WOS:A1994PG90700010
J	MAYUMI, M; ISHIGAMI, T; KANAZASHI, SI; YAMAOKA, K; SUMIMOTO, SI; HEIKE, T; KATAMURA, K; HATA, D; KIM, KM				MAYUMI, M; ISHIGAMI, T; KANAZASHI, SI; YAMAOKA, K; SUMIMOTO, SI; HEIKE, T; KATAMURA, K; HATA, D; KIM, KM			POSITIVE AND NEGATIVE SIGNALS TRANSDUCED THROUGH SURFACE IMMUNOGLOBULINS IN HUMAN B-CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	New Trends in Immunopharmacology 1993 Conference	JUL   17, 1993	TOKYO, JAPAN			B CELL; SIGNALING; ANTIGEN RECEPTOR; TYROSINE KINASE; APOPTOSIS	PROTEIN-TYROSINE KINASE; ANTIGEN RECEPTOR COMPLEX; IGM CROSS-LINKING; HUMAN-LYMPHOCYTES; CYCLOSPORINE-A; DNA DAMAGE; APOPTOSIS; LINE; PHOSPHORYLATION; ANTIBODIES	Cross-linking of surface IgM and surface IgD by anti-IgM antibodies and anti-IgD antibodies, respectively, showed different effects on the growth of normal human peripheral blood B cells and the human B lymphoma cell line, B104. Only cross-linking of surface IgM transduced signals that inhibited cell division of peripheral blood B cells and B104 cells at the G(2)/M interphase. In B104 cells, the inhibition of cell division was followed by rapid B104 cell death. The negative signals were inhibited by cyclosporin A and FK-506 at lower concentrations than those that inhibited proliferation of the B cells. Anti-IgM antibody-induced B104 cell death was dependent on CA(2+) influx and macromolecular synthesis. B104 cells treated with anti-IgM antibodies showed neither DNA fragmentation or morphology of apoptosis but showed DNA single-strand breaks and morphology of necrosis. Nicotinamide inhibited anti-IgM antibody-induced B104 cell death and the involvement of poly(adenosine diphosphate-ribosyl)ation was suggested in the process of the B104 cell death. With regard to the intracellular mechanisms responsible for the different signals, however no qualitative difference was detected in putative signal transducers, including tyrosine phosphorylated protein, phosphatidyl inositol turnover, Ca2+ influx, activation of protein kinase C, and messenger ribonucleic acid expression of c-fos and Egr-1 when surface IgM and surface IgD were crosslinked. Further investigations of the mechanisms responsible for the different signals transduced through surface IgM and surface IgD will provide better understanding of immunodeficiencies and autoimmune diseases.			MAYUMI, M (corresponding author), KYOTO UNIV HOSP,DEPT PEDIAT,SAKYO KU,SHOGOIN KAWAHARACHO 54,KYOTO 606,JAPAN.							AGARWAL S, 1988, J IMMUNOL, V140, P4187; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; BERGER NA, 1979, J CLIN INVEST, V63, P1164, DOI 10.1172/JCI109410; BERNOFSKY C, 1973, ANAL BIOCHEM, V53, P452, DOI 10.1016/0003-2697(73)90094-8; BROWN DG, 1993, J BIOL CHEM, V268, P3037; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; CAMPBELL KS, 1991, P NATL ACAD SCI USA, V88, P3982, DOI 10.1073/pnas.88.9.3982; GOLD MR, 1991, P NATL ACAD SCI USA, V88, P3436, DOI 10.1073/pnas.88.8.3436; HASBOLD J, 1990, EUR J IMMUNOL, V20, P1685, DOI 10.1002/eji.1830200810; HATA D, 1994, IMMUNOL LETT, V40, P65, DOI 10.1016/0165-2478(94)90208-9; HATA D, 1992, INT IMMUNOL, V4, P797, DOI 10.1093/intimm/4.7.797; HOMBACH J, 1990, EUR J IMMUNOL, V20, P2795, DOI 10.1002/eji.1830201239; HUTCHCROFT JE, 1991, J BIOL CHEM, V266, P14846; ISHIGAMI T, 1992, J IMMUNOL, V148, P360; IWABUCHI N, 1992, EUR J IMMUNOL, V22, P2507, DOI 10.1002/eji.1830221007; KANAZASHI S, 1994, MOL IMMUNOL, V31, P21; KIM KM, 1991, J IMMUNOL, V146, P819; KIM KM, 1992, J IMMUNOL, V148, P29; KIM KM, 1992, J IMMUNOL, V148, P1797; LIN JJ, 1992, J IMMUNOL, V149, P1548; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; REDEGELD FA, 1992, J IMMUNOL, V149, P3509; SARTHOU P, 1989, EUR J IMMUNOL, V19, P1247, DOI 10.1002/eji.1830190715; SETO S, 1985, J CLIN INVEST, V75, P377, DOI 10.1172/JCI111710; SEYFERT VL, 1989, MOL CELL BIOL, V9, P2083, DOI 10.1128/MCB.9.5.2083; SUMIMOTO SI, 1994, CELL IMMUNOL, V153, P184, DOI 10.1006/cimm.1994.1016; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; TOMEI LD, 1993, P NATL ACAD SCI USA, V90, P853, DOI 10.1073/pnas.90.3.853; TSUBATA T, 1993, NATURE, V364, P645, DOI 10.1038/364645a0; VALENTINE MA, 1992, EUR J IMMUNOL, V22, P3141, DOI 10.1002/eji.1830221217; VENKITARAMAN AR, 1991, NATURE, V352, P777, DOI 10.1038/352777a0; YAMANASHI Y, 1991, SCIENCE, V251, P192, DOI 10.1126/science.1702903; YAMANASHI Y, 1993, P NATL ACAD SCI USA, V90, P3631, DOI 10.1073/pnas.90.8.3631; YAMAOKA K, 1993, IMMUNOL LETT, V36, P203, DOI 10.1016/0165-2478(93)90053-5	34	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1994	94	3	2	S			612	619		10.1016/0091-6749(94)90137-6	http://dx.doi.org/10.1016/0091-6749(94)90137-6			8	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PH235	8083469				2022-12-18	WOS:A1994PH23500006
J	SALARI, H; HOWARD, S; CHAN, H; DRYDEN, P; CHANYEUNG, M				SALARI, H; HOWARD, S; CHAN, H; DRYDEN, P; CHANYEUNG, M			INVOLVEMENT OF IMMUNOLOGICAL MECHANISMS IN A GUINEA-PIG MODEL OF WESTERN RED CEDAR ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						OCCUPATIONAL ASTHMA; GUINEA PIG; PLICATIC ACID; HISTAMINE LEUKOTRIENES; PROSTAGLANDIN; IGG(1)	OCCUPATIONAL ASTHMA; IGE ANTIBODIES; ACID; CHROMATOGRAPHY; LEUKOTRIENES; HISTAMINE	Western red cedar asthma is the most common form of occupational asthma in the Pacific Northwest. Plicatic acid (PA) is the chemical component of western red cedar that causes asthma. The role of immunologic processes involved in the PA-induced asthmatic reaction has not been established. To characterize the mechanisms of PA-induced asthmatic reaction, guinea pigs were sensitized to PA through biweekly injection of PA-ovalbumin conjugate with aluminum hydroxide as an adjuvant for a period of 6 months. Specific IgG(1) antibodies to PA were detected in the blood 3 months after sensitization of animals. The level of specific IgG(1) antibodies to ovalbumin after 6 months was about two times the level of specific IgG(1) to PA. At 6 months, tracheal tissue from PA-ovalbumin-sensitized guinea pigs contracted after exposure to either PA or ovalbumin in vitro. The degree of contraction induced by PA was two to three times less than the contraction induced by ovalbumin. PA caused histamine prostaglandin D-2 and leukotriene D-4 release from both lung mast cells and blood basophils. The amount of histamine and eicosanoids released by PA was also two to three times less than the amount of mediators released by ovalbumin. When the trachea of normal guinea pigs was passively sensitized with serum from PA-ovalbumin-sensitized guinea pigs, it contracted in response to PA or ovalbumin in an organ bath. When the serum of PA-ovalbumin-sensitized guinea pigs was depleted of immunoglobulins and then used for passive sensitization of normal trachea, no contraction was observed when challenged with PA, suggesting that IgG(1) antibodies mediate the tracheal reaction to PA. The results demonstrated that PA-induced reaction in guinea pigs is an immunologic process that involves IgG(1) antibodies.	UNIV BRITISH COLUMBIA, DEPT MED, VANCOUVER, BC, CANADA	University of British Columbia								Bernstein David I., 1993, P373; BERSTEIN DI, 1984, J ALLERGY CLIN IMMUN, V74, P794; Butcher Brian T., 1993, P415; CHAN H, 1987, J ALLERGY CLIN IMMUN, V79, P762, DOI 10.1016/0091-6749(87)90208-9; CHANYEUNG M, 1990, CHEST, V98, pS148, DOI 10.1378/chest.98.5.148S; CHANYEUNG M, 1973, AM REV RESPIR DIS, V108, P1094; LAM S, 1983, J ALLERGY CLIN IMMUN, V72, P134, DOI 10.1016/0091-6749(83)90520-1; MOIRA CY, 1989, J ALLERGY CLIN IMMUN, V84, P762, DOI 10.1016/0091-6749(89)90306-0; SALARI H, 1987, ANAL BIOCHEM, V165, P220, DOI 10.1016/0003-2697(87)90223-5; SALARI H, 1989, J IMMUNOL, V142, P2821; SALARI H, 1985, J EXP MED, V162, P1904, DOI 10.1084/jem.162.6.1904; SCHLEIMER RP, 1985, J ALLERGY CLIN IMMUN, V76, P369, DOI 10.1016/0091-6749(85)90656-6; STEFFENRUD S, 1988, J CHROMATOGR-BIOMED, V427, P1, DOI 10.1016/0378-4347(88)80099-9; TSE KS, 1982, CLIN ALLERGY, V12, P249, DOI 10.1111/j.1365-2222.1982.tb02525.x; VERBURG KM, 1983, LIFE SCI, V32, P2855, DOI 10.1016/0024-3205(83)90322-3	15	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1994	93	5					877	884		10.1016/0091-6749(94)90381-6	http://dx.doi.org/10.1016/0091-6749(94)90381-6			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NL919	8182231	Bronze			2022-12-18	WOS:A1994NL91900012
J	POPP, W; BOCK, A; HERKNER, K; WAGNER, C; ZWICK, H; SERTL, K				POPP, W; BOCK, A; HERKNER, K; WAGNER, C; ZWICK, H; SERTL, K			FACTORS CONTRIBUTING TO THE OCCURRENCE AND PREDICTABILITY OF BRONCHIAL HYPERRESPONSIVENESS TO METHACHOLINE IN CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						BRONCHIAL HYPERRESPONSIVENESS; SPIROMETRY; ALLERGY; IMMUNE SYSTEM		Using a stepwise logistic regression analysis, we investigated clinical data, allergologic findings, spirometric data, and the cellular and humoral immune system in order to gain new insights into the role these parameters play in bronchial hyperresponsiveness to methacholine in children and to create a model for the prediction thereof. Bronchial hyperresponsiveness, which was found in 124 of 462 children (26.8%), was observed to have been influenced by an increased level of eosinophils, the positivity of the skin prick test for any of the allergens tested a decreased baseline forced expiratory volume in 1 second (FEI(1)) (percent predicted), a decreased maximum expiratory flow at 50% expiration as a percent of forced vital capacity, and a decreased level of kappa-chain-assembled immunoglobulins. Logit analysis disclosed that the influence of all other parameters on the occurrence of bronchial hyperresponsiveness was of no further statistical significance. The degree of bronchial hyperresponsiveness (provocative dose causing a 20% fall in FEV(1)) showed a statistically significant correlation with the eosinophil count (Spearman's r = -0.198) and FEI(1) (percent predicted) (Speaman's r = 0.203). Our findings suggest that allergic sensitization and eosinophilic reaction in children are major factors in contributing to the occurrence of bronchial hyperresponsiveness to methacholine.	UNIV VIENNA, PEDIAT CLIN, LUDWIG BOLTZMANN INST PEDIAT ENDOCRINOL & IMMUNOL, VIENNA, AUSTRIA; GESUNDE LUNGE, VIENNA, AUSTRIA	Ludwig Boltzmann Institute; University of Vienna	POPP, W (corresponding author), KRANKENHAUS LAINZ, DEPT PULM, WOLKERSBERGENSTR 1, A-1130 VIENNA, AUSTRIA.							[Anonymous], 1989, ALLERGY S10, V10, P1; AQUILINA AT, 1980, AM REV RESPIR DIS, V122, P3; BACKER V, 1989, ALLERGY, V44, P214, DOI 10.1111/j.1398-9995.1989.tb02265.x; BARNES PJ, 1989, J ALLERGY CLIN IMMUN, V83, P1013, DOI 10.1016/0091-6749(89)90441-7; BRITTON WJ, 1986, INT J EPIDEMIOL, V15, P202, DOI 10.1093/ije/15.2.202; BURNEY PGJ, 1987, THORAX, V42, P38, DOI 10.1136/thx.42.1.38; COCKCROFT DW, 1988, J ALLERGY CLIN IMMUN, V81, P111, DOI 10.1016/0091-6749(88)90229-1; COCKCROFT DW, 1984, ANN ALLERGY, V53, P26; Dixon W. J., 1990, BMDP STATISTICAL SOF; EMPEY DW, 1976, AM REV RESPIR DIS, V113, P131; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; FORCHE G, 1986, WIEN MED WOCHENSCHR, V136, P1; FORESI A, 1990, CHEST, V98, P528, DOI 10.1378/chest.98.3.528; FRIGAS E, 1986, J ALLERGY CLIN IMMUN, V77, P527, DOI 10.1016/0091-6749(86)90341-6; GERBLICH AA, 1984, NEW ENGL J MED, V310, P1349, DOI 10.1056/NEJM198405243102103; HARGREAVE FE, 1981, J ALLERGY CLIN IMMUN, V68, P347, DOI 10.1016/0091-6749(81)90132-9; HARGREAVE FE, 1986, J ALLERGY CLIN IMMUN, V78, P825, DOI 10.1016/0091-6749(86)90226-5; HOFFMAN RA, 1980, P NATL ACAD SCI-BIOL, V77, P4914, DOI 10.1073/pnas.77.8.4914; HOPP RJ, 1986, AM REV RESPIR DIS, V134, P994, DOI 10.1164/arrd.1986.134.5.994; HOPP RJ, 1984, J ALLERGY CLIN IMMUN, V74, P154, DOI 10.1016/0091-6749(84)90279-3; JOHANSSON SG, 1971, INT ARCH ALLER A IMM, V41, P443, DOI 10.1159/000230538; KREUKNIET J, 1973, RESPIRATION, V30, P345, DOI 10.1159/000193049; LAITINEN LA, 1985, AM REV RESPIR DIS, V131, P599, DOI 10.1164/arrd.1985.131.4.599; MARTINEZ FD, 1988, AM REV RESPIR DIS, V138, P518, DOI 10.1164/ajrccm/138.3.518; METZGER WJ, 1987, AM REV RESPIR DIS, V135, P433; MURANAKA M, 1974, J ALLERGY CLIN IMMUN, V54, P32, DOI 10.1016/S0091-6749(74)80006-0; NEIJENS HJ, 1990, LUNG, V168, P268, DOI 10.1007/BF02718142; OLLERENSHAW SL, 1992, AM REV RESPIR DIS, V145, P922, DOI 10.1164/ajrccm/145.4_Pt_1.922; PAGE CP, 1989, EUR RESPIR J S6, V2, P483; PATTEMORE PK, 1990, AM REV RESPIR DIS, V142, P549, DOI 10.1164/ajrccm/142.3.549; PEAT JK, 1987, CLIN ALLERGY, V17, P291, DOI 10.1111/j.1365-2222.1987.tb02017.x; PEAT JK, 1987, CLIN ALLERGY, V17, P283, DOI 10.1111/j.1365-2222.1987.tb02016.x; POPP W, 1989, ALLERGY, V44, P572, DOI 10.1111/j.1398-9995.1989.tb04202.x; PULLAN CR, 1982, BRIT MED J, V284, P1665, DOI 10.1136/bmj.284.6330.1665; SACHS L, 1984, ANGEWANDTE STATISTIK; SALOME CM, 1987, CLIN ALLERGY, V17, P271, DOI 10.1111/j.1365-2222.1987.tb02015.x; SCHEMBRI DA, 1990, MED J AUSTRALIA, V152, P578, DOI 10.5694/j.1326-5377.1990.tb125387.x; SCHWARTZ J, 1990, AM REV RESPIR DIS, V142, P555, DOI 10.1164/ajrccm/142.3.555; SEARS MR, 1986, THORAX, V41, P283, DOI 10.1136/thx.41.4.283; SEARS MR, 1989, CLIN EXP ALLERGY, V19, P419, DOI 10.1111/j.1365-2222.1989.tb02408.x; SEARS MR, 1993, J ALLERGY CLIN IMMUN, V91, P351; SHAPIRO GG, 1982, J ALLERGY CLIN IMMUN, V69, P365, DOI 10.1016/0091-6749(82)90147-6; SHERTER CB, 1981, CLIN CHEST MED, V2, P67; TATTERSFIELD AE, 1991, BRONCHIAL HYPERRESPO, P71; TOWNLEY RG, 1975, J ALLERGY CLIN IMMUN, V56, P427, DOI 10.1016/0091-6749(75)90061-5; WEISS ST, 1985, AM REV RESPIR DIS, V131, P573, DOI 10.1164/arrd.1985.131.4.573; WELTY C, 1984, AM REV RESPIR DIS, V130, P198; WITT C, 1986, J ALLERGY CLIN IMMUN, V77, P698, DOI 10.1016/0091-6749(86)90413-6; WOOLCOCK AJ, 1989, CLIN REV ALLERG, V7, P245; WOOLCOCK AJ, 1987, THORAX, V42, P361, DOI 10.1136/thx.42.5.361; ZETTERSTROM O, 1981, ALLERGY, V36, P537, DOI 10.1111/j.1398-9995.1981.tb01871.x	51	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1994	93	4					735	742		10.1016/0091-6749(94)90253-4	http://dx.doi.org/10.1016/0091-6749(94)90253-4			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NH497	8163783				2022-12-18	WOS:A1994NH49700006
J	SCHAUBSCHLAGER, WW; BECKER, WM; MAZUR, G; GODDE, M				SCHAUBSCHLAGER, WW; BECKER, WM; MAZUR, G; GODDE, M			OCCUPATIONAL SENSITIZATION TO PLASMOPARA-VITICOLA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						PLASMOPARA VITICOLA; PSEUDO MILDEW; OOMYCETES; OCCUPATIONAL ALLERGY; IGE; HISTAMINE RELEASE; IMMUNOBLOTTING	NITROCELLULOSE; BASIDIOMYCETE; ALLERGEN; EXTRACTS; SYMPTOMS; PROTEINS; ASTHMA	Molds of the class of Oomycetes are of allergologic importance in special cases. However, probes are not commercially available for diagnostic purposes. Our case report is based on the medical history of a greenhouse worker who had atopic syndrome. He handled pure cultures of defined fungi and plants. A sensitization to pseudo mildew growing on grapevine (Plasmopara viticola) was found. Skin prick test and histamine release test results were positive when extract of P. viticola was wed. Detection of IgE reactivities against pseudo mildew via binding tests, Western blot analysis, and isoelectric focusing immunoblot confirmed the diagnosis. To our knowledge these results demonstrate for the second time a sensitization to Oomycetes.	FORSCHUNGSINST BORSTEL,MED KLIN,BORSTEL,GERMANY; UNIV MUNICH,KLINIKUM GROSSHADERN,MED KLIN 1,PNEUMOL ABT,MUNICH,GERMANY	Forschungszentrum Borstel; University of Munich	SCHAUBSCHLAGER, WW (corresponding author), UNIV MUNICH,INST & POLIKLIN ARBEITSMED,ZIEMSSENSTR 1,D-80336 MUNICH,GERMANY.							COCKCROFT DW, 1990, ANN ALLERGY, V65, P169; DEMEULEMESTER C, 1987, ELECTROPHORESIS, V8, P71, DOI 10.1002/elps.1150080113; GIANNINI EH, 1975, ANN ALLERGY, V35, P372; HAAS H, 1986, INT ARCH ALLER A IMM, V79, P434, DOI 10.1159/000234014; HANCOCK K, 1983, ANAL BIOCHEM, V133, P157, DOI 10.1016/0003-2697(83)90237-3; HORNER WE, 1991, INT ARCH ALLER A IMM, V94, P359; IMWIDTHAYA P, 1989, MYCOPATHOLOGIA, V106, P109, DOI 10.1007/BF00437089; Klein G, 1991, Pneumologie, V45 Suppl 2, P679; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LEARY JJ, 1983, P NATL ACAD SCI-BIOL, V80, P4045, DOI 10.1073/pnas.80.13.4045; LEHRER SB, 1986, J ALLERGY CLIN IMMUN, V78, P478, DOI 10.1016/0091-6749(86)90036-9; LIEBESKIND A, 1969, ACTA ALLERGOL, V24, P362, DOI 10.1111/j.1398-9995.1969.tb03749.x; MENDOZA L, 1987, J CLIN MICROBIOL, V25, P2159, DOI 10.1128/JCM.25.11.2159-2162.1987; Neville D M Jr, 1974, Methods Enzymol, V32, P92; OHOLLAREN MT, 1991, NEW ENGL J MED, V324, P359, DOI 10.1056/NEJM199102073240602; ONEIL CE, 1990, CLIN EXP ALLERGY, V20, P533, DOI 10.1111/j.1365-2222.1990.tb03146.x; SALVAGGIO JE, 1981, CLIN IMMUNOL, V69, P327; SCHAUBSCHLAGER WW, 1991, INT ARCH ALLER A IMM, V96, P97, DOI 10.1159/000235478; SCHUBELER K, 1988, ALLERGY S7, V43, P71; Schwaiblmair M, 1991, Pneumologie, V45, P15; SRIDHARA S, 1990, ALLERGY, V45, P577, DOI 10.1111/j.1398-9995.1990.tb00943.x; STANGL A, 1990, IN VITRO DIAGNOSTICA, V1, P28; WAEGEMAEKERS M, 1989, ALLERGY, V44, P192, DOI 10.1111/j.1398-9995.1989.tb02261.x; 1992, CLIN EXP ALLERGY, V22, P103	24	7	7	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1994	93	2					457	463		10.1016/0091-6749(94)90354-9	http://dx.doi.org/10.1016/0091-6749(94)90354-9			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MY581	7509819				2022-12-18	WOS:A1994MY58100006
J	ANNE, S; AGARWAL, R; NAIR, MP; SCHWARTZ, SA; BALLOW, M; KANDASWAMI, C; MIDDLETON, E				ANNE, S; AGARWAL, R; NAIR, MP; SCHWARTZ, SA; BALLOW, M; KANDASWAMI, C; MIDDLETON, E			INHIBITION OF ENDOTOXIN-INDUCED EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 AND OF LEUKOCYTE ADHESION TO ENDOTHELIAL-CELLS BY THE PLANT FLAVONOL QUERCETIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	8	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				276	276						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700681
J	HEINO, M				HEINO, M			REGULARLY INHALED BETA-AGONISTS WITH STEROIDS ARE NOT HARMFUL IN STABLE ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ASTHMA; BETA-AGONIST; PEF; STEROID; SYMPTOMS		Regular use of inhaled beta-agonists with steroids was not harmful in stable asthma. Morning and evening peak expiratory flow (PEF) values were recorded daily for 1 week (week 1) before regular inhalation of beta-agonists and steroids. Then beta-agonists were withdrawn and used as needed for a 2-week washout period. The PEF values of the first week (week 1) were compared with the PEF values before treatment during a further 1-week period (week 4) of as-needed use of beta-agonists. The mean evening PEF values were significantly higher (difference = 9.55 L/min; p = 0.017; 95% confidence interval [CI], 1.80 to 17.30 L/min), and the mean morning PEF values were nearly significantly higher (difference = 6.49 L/min; p = 0.088, 95% CI, -0.99 to 14.00 L/min) during regular beta-agonist use. There were significantly more patients with more symptom days, including nights with awakening, during as-needed treatment (difference in ratio of patients = 40.74%; p = 0.0001; 95% CI, 20.21% to 61.27%). When nocturnal symptoms are considered separately, there were more patients with more nights with awakening during as-needed treatment with a nearly significant difference (difference in ratio of patients = 12.96%; p = 0.0654; 95% CI, 0.92 to 25.00%). PEF monitoring should be used to distinguish the majority of patients with asthma who have higher PEF values during regular treatment from those who do better with administration of beta-agonists as needed. To deny patients with asthma regular use of small doses of beta-agonists in general is to deny individual differences among patients with asthma.			HEINO, M (corresponding author), PEIJAS HOSP,DEPT PULM MED,PULM UNIT,SAIRAALAKATU 1,SF-01400 VANTAA,FINLAND.							BENNATI D, 1989, J ASTHMA, V26, P359, DOI 10.3109/02770908909073279; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; GORE SM, 1981, BRIT MED J, V283, P660, DOI 10.1136/bmj.283.6292.660; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; KOENIG JQ, 1992, LANCET, V340, P738, DOI 10.1016/0140-6736(92)92285-N; KUITERT LM, 1992, THORAX, V47, P568, DOI 10.1136/thx.47.7.568; LOFDAHL CG, 1991, EUR RESPIR J, V4, P1161; LOFDAHL CG, 1992, EUR RESPIR J, V5, P989; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; SHEPHERD GL, 1981, BRIT J DIS CHEST, V75, P215, DOI 10.1016/0007-0971(81)90057-7; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; 1992, CLIN EXP ALLERGY S1, V22, P1	12	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	1				80	84		10.1016/0091-6749(94)90235-6	http://dx.doi.org/10.1016/0091-6749(94)90235-6			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MT781	7905884				2022-12-18	WOS:A1994MT78100009
J	LU, G; KOCHOUMIAN, L; KING, TP				LU, G; KOCHOUMIAN, L; KING, TP			WHITE FACE HORNET VENOM ALLERGEN, HYALURONIDASE - CLONING AND ITS SEQUENCE SIMILARITY WITH OTHER PROTEINS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									ROCKEFELLER UNIV,NEW YORK,NY 10021	Rockefeller University									0	7	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				224	224						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700366
J	TURJANMAA, K; ALENIUS, H; MAKINENKILJUNEN, S; PALOSUO, T; REUNALA, T				TURJANMAA, K; ALENIUS, H; MAKINENKILJUNEN, S; PALOSUO, T; REUNALA, T			COMMERCIAL SKIN PRICK TEST PREPARATIONS IN THE DIAGNOSIS OF RUBBER LATEX ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				299	299						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700819
J	YUMIBE, N; HUIE, K; CHEN, KJ; CLEMENT, RP; CAYEN, MN				YUMIBE, N; HUIE, K; CHEN, KJ; CLEMENT, RP; CAYEN, MN			IDENTIFICATION OF HUMAN LIVER CYTOCHROME P450S INVOLVED IN THE MICROSOMAL METABOLISM OF THE ANTIHISTAMINIC DRUG LORATADINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									SCHERING PLOUGH RES INST,DEPT DRUG METAB & PHARMACOKINET,LAFAYETTE,NJ	Merck & Company; Schering-Plough Research Institute									0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				234	234						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700428
J	FUJIWARA, H; KURIHARA, N; HIRATA, K; OHTA, K; KANAZAWA, H; TAKEDA, T				FUJIWARA, H; KURIHARA, N; HIRATA, K; OHTA, K; KANAZAWA, H; TAKEDA, T			EFFECT OF NEUROPEPTIDE-Y ON HUMAN BRONCHUS AND ITS MODULATION OF NEUTRAL ENDOPEPTIDASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ACETYLCHOLINE RELEASE; ELECTRICAL FIELD STIMULATION; HUMAN BRONCHUS; NEUTRAL ENDOPEPTIDASE; NEUROPEPTIDE-Y	GUINEA-PIG TRACHEA; SUBSTANCE-P; RESPIRATORY-TRACT; CHOLINERGIC NEUROTRANSMISSION; AIRWAY HYPERRESPONSIVENESS; ENKEPHALINASE; NERVES; INHIBITION; PEPTIDE; NPY	Background:Neuropeptide Y (NPY) and neutral endopeptidase have been shown to regulate the response of airway smooth muscle. However, their interactions have not been studied. Methods: To determine the role of NPY and endogenous neutral endopeptidase in regulating the effects of NPY, we investigated the effects of NPY and a neutral endopeptidase inhibitor, phosphoramidon, on the contractile response of isolated human bronchial segments to electrical field stimulation (EFS). Results: Concentrations of up to 10(-6) mol/L of NPY did not change resting tension. NPY inhibited the cholinergic contractions induced by EFS at 5 Hz dose-dependently. Phosphoramidon (10(-5) mol/L) enhanced the inhibitory effect of NPY on EFS-induced contractions at 5 Hz. NPY (3 x 10(-7) mol/L) shifted the frequency-response curve for EFS (1 to 50 Hz) to the right and significantly increased the mean logarithm of frequency that produced 50% of maximal contraction (control: 0.54 +/- 0.07 versus NPY: 0.79 +/- 0.09, p < 0.05). Phosphoramidon (10(-5) mol/L) did not affect the frequency response to EFS, but enhanced the inhibitory effect of NPY (3 x 10(-7) mol/L) on frequency response to EFS, resulting in a significant increase in the mean logarithm of frequency that produced 50% of maximal contraction (NPY: 0.79 +/- 0.09 versus NPY plus phosphoramidon: 1.18 +/- 0.15, p < 0.05). NPY (3 x 10(-7) mol/L) did not affect the response of tissues to exogenously applied acetylcholine. Conclusions: These observations suggest that NPY inhibits the output of acetylcholine from nerve endings and that endogenous neutral endopeptidase modulates the effect of NPY in the human airway by inactivating this peptide.			FUJIWARA, H (corresponding author), OSAKA CITY UNIV,SCH MED,DEPT INTERNAL MED 1,1-5-7 ASAHIMACHI,ABENO KU,OSAKA 545,JAPAN.							ADRIAN TE, 1983, NATURE, V306, P584, DOI 10.1038/306584a0; BARANIUK JN, 1990, AM J RESP CELL MOL, V3, P165, DOI 10.1165/ajrcmb/3.2.165; BJORKLUND A, 1988, HDB CHEM NEUROANATOM, P391; DOIDGE JM, 1982, J AUTONOM NERV SYST, V5, P83, DOI 10.1016/0165-1838(82)90030-3; DUSSER DJ, 1989, J APPL PHYSIOL, V67, P1504, DOI 10.1152/jappl.1989.67.4.1504; DUSSER DJ, 1989, J CLIN INVEST, V84, P900, DOI 10.1172/JCI114251; FROSSARD N, 1991, NEUROPEPTIDES, V19, P157, DOI 10.1016/0143-4179(91)90113-W; GIULIANI S, 1989, BRIT J PHARMACOL, V98, P407, DOI 10.1111/j.1476-5381.1989.tb12611.x; GRUNDEMAR L, 1988, REGUL PEPTIDES, V23, P309, DOI 10.1016/0167-0115(88)90231-5; GRUNDEMAR L, 1990, BRIT J PHARMACOL, V99, P473, DOI 10.1111/j.1476-5381.1990.tb12952.x; HONDA I, 1991, AM REV RESPIR DIS, V143, P1416, DOI 10.1164/ajrccm/143.6.1416; HUDGIN RL, 1981, LIFE SCI, V29, P2593, DOI 10.1016/0024-3205(81)90632-9; JACOBY DB, 1988, J APPL PHYSIOL, V64, P2653, DOI 10.1152/jappl.1988.64.6.2653; JOHNSON AR, 1985, AM REV RESPIR DIS, V132, P564; LAITINEN A, 1985, EUR J RESPIR DIS, V67, P209; MARTLING CR, 1990, CELL TISSUE RES, V260, P223, DOI 10.1007/BF00318626; MATRAN R, 1989, EUR J PHARMACOL, V163, P15, DOI 10.1016/0014-2999(89)90390-7; MORRIS MJ, 1986, CLIN EXP PHARMACOL P, V13, P437, DOI 10.1111/j.1440-1681.1986.tb00923.x; NADEL JA, 1991, EUR RESPIR J, V4, P745; OHARE MMT, 1988, REGUL PEPTIDES, V20, P293, DOI 10.1016/0167-0115(88)90064-X; PERNOW J, 1986, ACTA PHYSIOL SCAND, V126, P239, DOI 10.1111/j.1748-1716.1986.tb07811.x; POLAK JM, 1984, PEPTIDES, V5, P79, DOI 10.1016/0196-9781(84)90267-5; RHODEN KJ, 1988, J APPL PHYSIOL, V65, P700, DOI 10.1152/jappl.1988.65.2.700; SEKIZAWA K, 1987, J APPL PHYSIOL, V63, P1401, DOI 10.1152/jappl.1987.63.4.1401; SHEPPARD MN, 1984, THORAX, V39, P326, DOI 10.1136/thx.39.5.326; STIMLERGERARD NP, 1987, J CLIN INVEST, V79, P1819, DOI 10.1172/JCI113023; STRETTON CD, 1988, BRIT J PHARMACOL, V93, P672, DOI 10.1111/j.1476-5381.1988.tb10325.x; TAM EK, 1990, AM J RESP CELL MOL, V2, P449, DOI 10.1165/ajrcmb/2.5.449; UDDMAN R, 1984, CELL TISSUE RES, V237, P321, DOI 10.1007/BF00217151; WAHLESTEDT C, 1986, REGUL PEPTIDES, V13, P307, DOI 10.1016/0167-0115(86)90048-0; WIDDICOMBE JG, 1991, AM REV RESPIR DIS, V143, P18	31	7	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1993	92	1	1				89	94		10.1016/0091-6749(93)90042-E	http://dx.doi.org/10.1016/0091-6749(93)90042-E			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LQ353	8335860	Bronze			2022-12-18	WOS:A1993LQ35300014
J	SCHWARTZ, HJ; KEMP, JP; BIANCO, S; BONE, M; BRUDERMAN, I; REBUCK, AS; BERGMANN, KC				SCHWARTZ, HJ; KEMP, JP; BIANCO, S; BONE, M; BRUDERMAN, I; REBUCK, AS; BERGMANN, KC			HIGHLIGHTS OF THE NEDOCROMIL SODIUM CLINICAL-STUDY PRESENTATIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							DOUBLE-BLIND; CHRONIC ASTHMA; PLACEBO; TRIAL; MULTICENTER; EFFICACY; THERAPY				SCHWARTZ, HJ (corresponding author), CASE WESTERN UNIV,1611 S GREEN RD,SUITE 265,CLEVELAND,OH 44121, USA.		Bergmann, Karl-Christian/AAA-4104-2019					BERGMANN KC, 1989, CURR MED RES OPIN, V11, P533, DOI 10.1185/03007998909110465; BIANCO S, 1989, RESPIRATION, V56, P204; BONE MF, 1989, THORAX, V44, P654, DOI 10.1136/thx.44.8.654; CALLAGHAN B, 1992, CHEST, V101, P787, DOI 10.1378/chest.101.3.787; CHERNIACK R M, 1990, Chest, V97, P1299; FOULDS RA, 1993, J ALLERGY CLIN IMMUN, V92, P202, DOI 10.1016/0091-6749(93)90109-S; GRIEF J, 1989, CHEST, V96, P583; HILLER EJ, 1975, BRIT J DIS CHEST, V69, P103; MATHISON DA, 1971, J AMER MED ASSOC, V216, P1454, DOI 10.1001/jama.216.9.1454; MITCHELL J, 1976, BRIT MED J, V2, P457; REBUCK AS, 1990, J ALLERGY CLIN IMMUN, V85, P612, DOI 10.1016/0091-6749(90)90101-9; SCHWARTZ H, DOUBLE BLIND MULTICE; TOOGOOD JH, 1981, J ALLERGY CLIN IMMUN, V67, P317, DOI 10.1016/0091-6749(81)90028-2; VANAS A, 1986, EUR J RESPIR DIS, V69, P143	14	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1993	92	1	2				204	209		10.1016/0091-6749(93)90110-2	http://dx.doi.org/10.1016/0091-6749(93)90110-2			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LQ354	8393032	Bronze			2022-12-18	WOS:A1993LQ35400016
J	WASSERMAN, SI				WASSERMAN, SI			A REVIEW OF SOME RECENT CLINICAL-STUDIES WITH NEDOCROMIL SODIUM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							DIOXIDE-INDUCED BRONCHOCONSTRICTION; ASTHMATIC SUBJECTS; BRONCHIAL HYPERRESPONSIVENESS; BECLOMETHASONE DIPROPIONATE; AIRWAYS DISEASE; CROMOGLYCATE; INHIBITION; RESPONSIVENESS; METABISULFITE; PATHOGENESIS				WASSERMAN, SI (corresponding author), UNIV CALIF SAN DIEGO,MED CTR,DEPT MED,DIV ALLERGY,402 W DICKINSON ST,SAN DIEGO,CA 92103, USA.							ALTOUNYAN REC, 1986, EUR J RESPIR DIS, V69, P274; BARNES PJ, 1989, J ALLERGY CLIN IMMUN, V83, P1013, DOI 10.1016/0091-6749(89)90441-7; BEL EH, 1990, AM REV RESPIR DIS, V141, P21, DOI 10.1164/ajrccm/141.1.21; BERGMANN KC, 1989, CURR MED RES OPIN, V11, P533, DOI 10.1185/03007998909110465; CALLAGHAN B, 1992, CHEST, V101, P787, DOI 10.1378/chest.101.3.787; CHERNIACK R M, 1990, Chest, V97, P1299; COCKCROFT DW, 1988, J ALLERGY CLIN IMMUN, V81, P111, DOI 10.1016/0091-6749(88)90229-1; CRIMI E, 1991, ALLERGY CLIN IMMUN S, V1, P328; CRIMI N, 1988, CLIN ALLERGY, V18, P367, DOI 10.1111/j.1365-2222.1988.tb02884.x; DELBONO L, 1986, EUR J RESPIR DIS, V69, P268; DIXON CMS, 1987, THORAX, V42, P462, DOI 10.1136/thx.42.6.462; DIXON CMS, 1989, BRIT J CLIN PHARMACO, V27, P831, DOI 10.1111/j.1365-2125.1989.tb03446.x; DIXON CMS, 1990, BRIT J CLIN PHARMACO, V30, P371, DOI 10.1111/j.1365-2125.1990.tb03786.x; FAIRFAX AJ, 1988, J INT MED RES, V16, P216, DOI 10.1177/030006058801600309; HARPER GD, 1990, RESP MED, V84, P463, DOI 10.1016/S0954-6111(08)80110-2; HOLGATE ST, 1987, CLIN SCI, V73, P561, DOI 10.1042/cs0730561; JUNIPER EF, 1987, CLIN ALLERGY, V17, P523, DOI 10.1111/j.1365-2222.1987.tb02048.x; KOETER GH, 1992, DOUBLE BLIND CROSSOV; LAL S, IN PRESS CHEST; MARCOUX JP, 1992, ANN ALLERGY, V68, P110; PHILLIPS GD, 1989, EUR RESPIR J, V2, P210; REED CE, 1988, CHEST, V94, P175, DOI 10.1378/chest.94.1.175; RICHARDS R, 1989, CLIN EXP ALLERGY, V19, P285, DOI 10.1111/j.1365-2222.1989.tb02385.x; ROCCHICCIOLI KMS, 1989, DRUGS, V37, P123, DOI 10.2165/00003495-198900371-00022; SCHWARTZ H, DOUBLE BLIND MULTICE; VANAS A, 1986, EUR J RESPIR DIS, V69, P143; WRIGHT W, 1990, AM REV RESPIR DIS, V141, P1400, DOI 10.1164/ajrccm/141.6.1400; 1992, NIH923091 PUBL; 1991, NIH913042 US DEP HLT	29	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1993	92	1	2				210	215		10.1016/0091-6749(93)90111-R	http://dx.doi.org/10.1016/0091-6749(93)90111-R			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LQ354	8101535	Bronze			2022-12-18	WOS:A1993LQ35400017
J	GEORGITIS, JW; DRUCE, HM; GOLDSTEIN, S; MELTZER, EO; OKUDA, M; SELNER, JC; SCHUMACHER, MJ				GEORGITIS, JW; DRUCE, HM; GOLDSTEIN, S; MELTZER, EO; OKUDA, M; SELNER, JC; SCHUMACHER, MJ			RHINOPHARYNGOLARYNGOSCOPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							RHINOLARYNGOSCOPY; LARYNGOSCOPY; DISORDERS		UNIV ARIZONA,ARIZONA HLTH SCI CTR,COLL MED,DEPT PEDIAT,1501 N CAMPBELL AVE,TUCSON,AZ 85724	University of Arizona; University of Arizona Health Sciences								CHRISTOPHER KL, 1983, NEW ENGL J MED, V308, P1566, DOI 10.1056/NEJM198306303082605; LANCER JM, 1985, J LARYNGOL OTOL, V99, P767, DOI 10.1017/S0022215100097632; LANCER JM, 1985, J LARYNGOL OTOL, V99, P771, DOI 10.1017/S0022215100097644; ROHR A, 1983, ANN ALLERGY, V50, P380; SCHUMACHER MJ, 1988, J ALLERGY CLIN IMMUN, V81, P960, DOI 10.1016/0091-6749(88)90160-1; SELNER JC, 1988, J ALLERGY CLIN IMMUN, V82, P909, DOI 10.1016/0091-6749(88)90033-4; SELNER JC, 1985, ANN ALLERGY, V54, P479; SHANMUGHAM MS, 1985, J LARYNGOL OTOL, V99, P779, DOI 10.1017/S0022215100097668; SILBERMAN HD, 1976, ANN OTO RHINOL LARYN, V85, P640, DOI 10.1177/000348947608500513; WELCH AR, 1982, J LARYNGOL OTOL, V96, P1125, DOI 10.1017/S0022215100093580; WILLIAMS GT, 1975, J LARYNGOL OTOL, V89, P299, DOI 10.1017/S0022215100080403; ZEDALIS D, 1989, J ALLERGY CLIN IMMUN, V83, P973, DOI 10.1016/0091-6749(89)90114-0	12	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1993	91	4					961	962		10.1016/0091-6749(93)90355-J	http://dx.doi.org/10.1016/0091-6749(93)90355-J			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KY251	8473685				2022-12-18	WOS:A1993KY25100018
J	ARRUDA, LK; VAILES, LD; CHAPMAN, MD				ARRUDA, LK; VAILES, LD; CHAPMAN, MD			MOLECULAR-CLONING OF COCKROACH (B-GERMANICA) ALLERGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Arruda, L. Karla/D-5845-2013	Arruda, L. Karla/0000-0002-7505-210X					0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				188	188						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100189
J	BER, DJ; MUNEMASA, KH; HAMILTON, RG; CORNISH, K; KLEIN, DE; SETTIPANE, GA				BER, DJ; MUNEMASA, KH; HAMILTON, RG; CORNISH, K; KLEIN, DE; SETTIPANE, GA			ALLERGY TO LATEX	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				271	271						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100521
J	COLAS, C; POLA, J; ZAPATA, C; DOMINGUEZ, A; GIMENO, A; DUCE, F				COLAS, C; POLA, J; ZAPATA, C; DOMINGUEZ, A; GIMENO, A; DUCE, F			QUINOLONES HYPERSENSITIVITY - CLINICAL AND IMMUNOLOGICAL ASPECTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract														Colas Sanz, Carlos/0000-0001-8959-6784					0	7	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				365	365						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100897
J	CRETICOS, PS; REED, CE; NORMAN, PS				CRETICOS, PS; REED, CE; NORMAN, PS			THE NIAID COOPERATIVE STUDY OF THE ROLE OF IMMUNOTHERAPY IN RAGWEED-INDUCED ADULT ASTHMA - 3RD YEAR CLINICAL END-POINTS - COST-EFFECTIVENESS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				227	227						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100344
J	DEMEESTER, IA; MERTENS, AV; DECLERCK, LS; SCHARPE, SL; BRIDTS, CH; STEVENS, WJ				DEMEESTER, IA; MERTENS, AV; DECLERCK, LS; SCHARPE, SL; BRIDTS, CH; STEVENS, WJ			CORRELATION BETWEEN DIPEPTIDYL PEPTIDASE-IV AND DISEASE-ACTIVITY OF RHEUMATOID-ARTHRITIS (RA)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													BRIDTS, Chris HM/M-7933-2016	BRIDTS, Chris HM/0000-0002-3324-7320					0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				228	228						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100351
J	DOAN, T; GRAMMER, LC; YARNOLD, P; PATTERSON, R				DOAN, T; GRAMMER, LC; YARNOLD, P; PATTERSON, R			AN INTERVENTION PROGRAM TO REDUCE COST OF ASTHMA CARE IN PATIENTS WHO HAVE REQUIRED INTUBATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				319	319						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100713
J	DONNELLY, A; GLASS, M; MULLER, B; SMART, S; HUTSON, J; MINKWITZ, MC; CASALE, TB				DONNELLY, A; GLASS, M; MULLER, B; SMART, S; HUTSON, J; MINKWITZ, MC; CASALE, TB			LEUKOTRIENE-D4 (LTD4) ANTAGONIST ICI-204, 219 RELIEVES RAGWEED ALLERGIC RHINITIS SYMPTOMS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Casale, Thomas B/K-4334-2013	Casale, Thomas B/0000-0002-3149-7377					0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				259	259						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100474
J	HAYDEL, R; ELDAHR, J; MCCANTS, M; HELBLING, A; MUSMAND, J; LEHRER, S				HAYDEL, R; ELDAHR, J; MCCANTS, M; HELBLING, A; MUSMAND, J; LEHRER, S			FOOD ALLERGY - CHALLENGE STUDIES OF FISH ALLERGIC SUBJECTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				344	344						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100812
J	HOFFMAN, DR				HOFFMAN, DR			THE COMPLETE AMINO-ACID-SEQUENCE OF A YELLOW JACKET VENOM PHOSPHOLIPASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				187	187						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100186
J	OKAYAMA, Y; QUINT, D; HUNT, TC; ELLATI, S; HEUSSER, CH; BULLOCK, G; MUELLER, R; BRADDING, P; HOWARTH, P; HOLGATE, ST; CHURCH, MK				OKAYAMA, Y; QUINT, D; HUNT, TC; ELLATI, S; HEUSSER, CH; BULLOCK, G; MUELLER, R; BRADDING, P; HOWARTH, P; HOLGATE, ST; CHURCH, MK			EXPRESSION OF IL-4 MESSENGER-RNA IN HUMAN DERMAL MAST-CELLS IN RESPONSE TO FC RECEPTOR CROSS-LINKAGE IN THE PRESENCE OF SCF	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV SOUTHAMPTON,IMMUNOPHARMACOL GRP,SOUTHAMPTON SO9 5NH,HANTS,ENGLAND; GLAXO GRP RES LTD,GREENFORD UB6 0HE,MIDDX,ENGLAND; CIBA GEIGY AG,CH-4002 BASEL,SWITZERLAND	University of Southampton; GlaxoSmithKline; Novartis									0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				256	256						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100461
J	VANHAGEHAMSTEN, M; BERGMAN, T; JOHANSSON, E; PERSSON, B; JORNVALL, H; HARFAST, B; JOHANSSON, SGO				VANHAGEHAMSTEN, M; BERGMAN, T; JOHANSSON, E; PERSSON, B; JORNVALL, H; HARFAST, B; JOHANSSON, SGO			N-TERMINAL AMINO-ACID-SEQUENCE OF MAJOR ALLERGEN OF THE MITE LEPIDOGLYPHUS DESTRUCTOR	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													van Hage, Marianne/A-9678-2017	van Hage, Marianne/0000-0003-3091-1596					0	7	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				353	353						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100849
J	VONTSCHIRSCHNITZ, M; VONESCHENBACH, CE; HERMANN, K; RING, J				VONTSCHIRSCHNITZ, M; VONESCHENBACH, CE; HERMANN, K; RING, J			PLASMA ANGIOTENSIN-II IN PATIENTS WITH HYMENOPTERA VENOM ALLERGY DURING HYPOSENSITIZATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Ring, Johannes/GLN-4341-2022	Ring, Johannes/0000-0001-8236-3152					0	7	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				283	283						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100571
J	NACLERIO, RM; BAROODY, FM				NACLERIO, RM; BAROODY, FM			RESPONSE OF NASAL-MUCOSA TO HISTAMINE OR METHACHOLINE CHALLENGE - USE OF A QUANTITATIVE METHOD TO EXAMINE THE MODULATORY EFFECTS OF ATROPINE AND IPRATROPIUM BROMIDE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	CONF ON INTRANASAL ANTICHOLINERGIC TREATMENT OF NASAL DISORDERS	MAR   06, 1991	SAN FRANCISCO, CA	BOEHRINGER INGELHEIM PHARM		NASAL MUCOSA; FILTER PAPER DISKS; METHACHOLINE; HISTAMINE; IPRATROPIUM BROMIDE	SECRETION	We have developed a new technique for the direct local administration of test solutions to the nasal mucosa and for quantification of nasal secretory responses. This technique, a variation on several published reports of filter paper use, allows simple and rapid determination of drug effects and facilitates the analysis of ipsilateral and contralateral responses to local challenge of the nasal mucosa. We have used this technique to investigate the secretory responses of the nasal mucosa to methacholine and histamine and to determine the effects of atropine and ipratropium bromide (Atrovent nasal spray) on these secretory responses.			NACLERIO, RM (corresponding author), JOHNS HOPKINS UNIV,SCH MED,CTR ASTHMA & ALLERGY,UNIT OFF 7,5501 HOPKINS BAYVIEW CIRCLE,BALTIMORE,MD 21224, USA.							BAROODY FM, 1992, J ALLERGY CLIN IMMUN, V89, P1065, DOI 10.1016/0091-6749(92)90290-I; BAROODY FM, UNPUB COMP SECRETORY; BORUM P, 1979, J ALLERGY CLIN IMMUN, V63, P253, DOI 10.1016/0091-6749(79)90109-X; BORUM P, 1979, ACTA OTOLARYNGOL S S, V360, P35; CAUNA N, 1972, J NEUROCYTOL, V1, P49, DOI 10.1007/BF01098645; CONNELL JT, 1968, J ALLERGY, V41, P123, DOI 10.1016/0021-8707(68)90053-1; KNOWLES GK, 1981, CLIN ALLERGY, V11, P287, DOI 10.1111/j.1365-2222.1981.tb01596.x; KRISTIANSEN BE, 1984, J IMMUNOL METHODS, V73, P251, DOI 10.1016/0022-1759(84)90399-5; LORIN MI, 1972, J LAB CLIN MED, V80, P275; MCLEAN JA, 1976, J ALLERGY CLIN IMMUN, V57, P153, DOI 10.1016/0091-6749(76)90034-8; MYGIND N, 1983, EUR J RESPIR DIS, V64, P167; MYGIND N, 1975, INT ARCH ALLER A IMM, V49, P99, DOI 10.1159/000231383; OKUDA M, 1989, AM J RHINOL, V3, P83; OSTBERG B, 1987, ARCH OTOLARYNGOL, V113, P160; PETERSSON G, 1989, ANN ALLERGY, V62, P39; TAYLOR G, 1971, Clinical Allergy, V1, P63, DOI 10.1111/j.1365-2222.1971.tb02448.x; WILDER WH, 1983, OTOLARYNG HEAD NECK, V91, P643, DOI 10.1177/019459988309100610	17	7	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1992	90	6	2	S			1051	1054		10.1016/0091-6749(92)90122-I	http://dx.doi.org/10.1016/0091-6749(92)90122-I			4	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KD635	1460207	Bronze			2022-12-18	WOS:A1992KD63500005
J	MCCOY, JP; HANLEYYANEZ, K; MCCASLIN, D; THARP, MD				MCCOY, JP; HANLEYYANEZ, K; MCCASLIN, D; THARP, MD			DETECTION OF DECREASED CYTOTOXIC EFFECTOR CD8+ LYMPHOCYTES-T IN ATOPIC-DERMATITIS BY FLOW-CYTOMETRY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									UNIV PITTSBURGH,DEPT DERMATOL,PITTSBURGH,PA 15260	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	MCCOY, JP (corresponding author), UNIV MED & DENT NEW JERSEY,COOPER HOSP,UNIV MED CTR,ROBERT WOOD JOHNSON MED SCH,DEPT PEDIAT,CAMDEN,NJ 08103, USA.		mccoy, john philip/ABD-9348-2021					EVANS EI, 1952, ANN SURG, V135, P804, DOI 10.1097/00000658-195206000-00006; HANIFIN JM, 1982, J AM ACAD DERMATOL, V236, P1; LEUNG DYM, 1983, J IMMUNOL, V130, P1678; LEUNG DYM, 1986, DERMATOLOGY GENERAL, P1385; MORIMOTO C, 1987, NATURE, V330, P479, DOI 10.1038/330479a0	5	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1992	90	4	1				688	690		10.1016/0091-6749(92)90145-R	http://dx.doi.org/10.1016/0091-6749(92)90145-R			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JT995	1401650				2022-12-18	WOS:A1992JT99500018
J	DJUKANOVIC, R; MANN, M; RIMMER, J; SPACKMAN, D; LAU, L; CHURCH, MK; HOLGATE, ST; HOWARTH, PH				DJUKANOVIC, R; MANN, M; RIMMER, J; SPACKMAN, D; LAU, L; CHURCH, MK; HOLGATE, ST; HOWARTH, PH			THE EFFECT OF INHALED ALLERGEN ON CIRCULATING BASOPHILS IN ATOPIC ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ASTHMA; BASOPHILS; HISTAMINE; BRONCHIAL PROVOCATION TESTS; ALLERGENS; METHACHOLINE CHLORIDE	HISTAMINE-RELEASING ACTIVITY; COLONY-STIMULATING FACTOR; MONONUCLEAR-CELLS; PLASMA HISTAMINE; INTERLEUKIN-3; EOSINOPHILS; CHALLENGE; IL-3; IGE	There is increasing evidence for the role of basophils in the allergen-induced late asthmatic response (LAR). To study the effect of inhaled allergen on basophil function in subjects with asthma, ex vivo basophil spontaneous histamine release (SHR) in peripheral blood and plasma histamine was measured before and 2, 5, 10, and 15 minutes, and 2, 4, 6, and 8 hours after allergen bronchial challenge (allergen study day) in six subjects with atopic asthma. Allergen inhalation induced an early response and LAR consisting of a mean (+/- SD) 32.5% (+/- 7.9%) and 28.8% (+/- 7.7%) fall in FEV1, respectively. As a control for the effects of bronchoconstriction, on another occasion, methacholine challenge was performed to produce a mean 33.4% (+/- 3.4%) fall in FEV1 during the early response and no LAR, and blood was obtained to measure basophil histamine release (HR) and plasma histamine. There was a small, but significant (p < 0.05), rise in median SHR from 4.6% to 6.1% of total basophil histamine after allergen but not after methacholine inhalation. HR remained high after allergen inhalation during the 8 hours of study, whereas it demonstrated a steady, significant, decrease between 4 to 8 hours after methacholine inhalation. No significant changes in plasma histamine were recorded on either allergen or methacholine study days. On a third occasion, SHR was measured after challenge with physiologic saline to control for any effects of methacholine on SHR, and a decrease in HR was recorded during the day similar to HR observed after methacholine challenge. These studies suggest an enhancing effect of inhaled allergen on SHR. The increase in SHR ev vivo is not necessarily associated with increased plasma histamine levels in vivo and may be more a reflection of basophil activation, possibly involving histamine-releasing factors and cytokines.			DJUKANOVIC, R (corresponding author), UNIV SOUTHAMPTON, SOUTHAMPTON GEN HOSP, IMMUNOPHARMACOL GRP, SOUTHAMPTON S09 4XY, ENGLAND.			Djukanovic, Ratko/0000-0001-6039-5612; Howarth, Peter/0000-0003-0619-7927				AKAGI K, 1989, J ALLERGY CLIN IMMUN, V83, P742, DOI 10.1016/0091-6749(89)90009-2; ALAM R, 1989, J IMMUNOL, V142, P3431; AZZAWI M, 1990, AM REV RESPIR DIS, V142, P1407, DOI 10.1164/ajrccm/142.6_Pt_1.1407; BARNES PJ, 1982, CLIN SCI, V62, P661, DOI 10.1042/cs0620661; BASCOM R, 1988, J ALLERGY CLIN IMMUN, V81, P570, DOI 10.1016/0091-6749(88)90198-4; BROIDE DH, 1991, AM REV RESPIR DIS, V143, P201; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; CONROY MC, 1977, J IMMUNOL, V118, P1317; CORRIGAN CJ, 1988, LANCET, V1, P1129; DENBURG JA, 1989, CLIN EXP ALLERGY, V19, P249, DOI 10.1111/j.1365-2222.1989.tb02379.x; DURHAM SR, 1984, NEW ENGL J MED, V311, P1398, DOI 10.1056/NEJM198411293112202; DURHAM SR, 1984, J ALLERGY CLIN IMMUN, V74, P49, DOI 10.1016/0091-6749(84)90086-1; GIBSON PG, 1991, AM REV RESPIR DIS, V143, P331, DOI 10.1164/ajrccm/143.2.331; GUO C-B, 1990, Journal of Allergy and Clinical Immunology, V85, P172; HAAKFRENDSCHO M, 1988, J CLIN INVEST, V82, P17, DOI 10.1172/JCI113567; HAAKFRENDSCHO M, 1988, J ALLERGY CLIN IMMUN, V82, P218, DOI 10.1016/0091-6749(88)91002-0; HOWARTH PH, 1984, J ALLERGY CLIN IMMUN, V73, P391, DOI 10.1016/0091-6749(84)90414-7; HOWARTH PH, 1987, J ALLERGY CLIN IMMUN, V80, P703, DOI 10.1016/0091-6749(87)90291-0; ISHIZAKA T, 1975, PROG ALLERGY, V19, P60, DOI 10.1159/000313384; KUNA P, 1989, J ALLERGY CLIN IMMUN, V83, P816, DOI 10.1016/0091-6749(89)90020-1; LIU MC, 1986, J IMMUNOL, V136, P2588; MACDONALD SM, 1989, J IMMUNOL, V142, P3527; MACDONALD SM, 1987, CLIN RES, V35, pA641; MACGLASHAN D, 1983, J IMMUNOL, V130, P2330; MARONE G, 1985, INT ARCH ALLER A IMM, V77, P103, DOI 10.1159/000233761; MERGET RD, 1990, INT ARCH ALLER A IMM, V92, P366, DOI 10.1159/000235167; NACLERIO RM, 1985, NEW ENGL J MED, V313, P65, DOI 10.1056/NEJM198507113130201; ORCHARD MA, 1986, J IMMUNOL, V136, P2240; THUESON DO, 1979, J IMMUNOL, V123, P626; TUNG R, 1982, J IMMUNOL, V128, P2067; WHITE MV, 1987, J IMMUNOL, V139, P1624; WILSON JW, 1992, AM REV RESPIR DIS, V145, P958, DOI 10.1164/ajrccm/145.4_Pt_1.958	32	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1992	90	2					175	183		10.1016/0091-6749(92)90069-E	http://dx.doi.org/10.1016/0091-6749(92)90069-E			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ423	1380018	Bronze			2022-12-18	WOS:A1992JJ42300006
J	EDWARDS, TB; TRUDEAU, WL; FERNANDEZCALDAS, E; LEE, DK; SELEZNICK, MJ; LOCKEY, RF				EDWARDS, TB; TRUDEAU, WL; FERNANDEZCALDAS, E; LEE, DK; SELEZNICK, MJ; LOCKEY, RF			PROTEINASES IN EXTRACTS OF THE STORAGE MITE, ALEUROGLYPHUS-OVATUS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							PROTEASES		JAMES A HALEY VET HOSP,DIV ALLERGY & IMMUNOL,VAR 111 D,13000 BRUCE B DOWNS BLVD,TAMPA,FL 33612; UNIV S FLORIDA,COLL MED,DIV ALLERGY & IMMUNOL,TAMPA,FL 33612	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida								CHAVIRA R, 1984, ANAL BIOCHEM, V136, P446, DOI 10.1016/0003-2697(84)90242-2; CHUA KY, 1988, J EXP MED, V167, P175, DOI 10.1084/jem.167.1.175; FERNANDEZCALDAS E, 1991, ALLERGEN IMMUNOTHERA, P69; INO Y, 1989, INT ARCH ALLER A IMM, V89, P321, DOI 10.1159/000234970; ROWAN AD, 1990, BIOCHEM J, V266, P869; SILTON RP, 1991, J ALLERGY CLIN IMMUN, V88, P595, DOI 10.1016/0091-6749(91)90153-F; STEWART GA, 1991, INT ARCH ALLER A IMM, V95, P248, DOI 10.1159/000235437	7	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1992	90	1					129	131		10.1016/S0091-6749(06)80021-7	http://dx.doi.org/10.1016/S0091-6749(06)80021-7			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JE255	1629500				2022-12-18	WOS:A1992JE25500017
J	SPIEGEL, W; MCGEADY, SJ; MANSMANN, HC				SPIEGEL, W; MCGEADY, SJ; MANSMANN, HC			CEREBRAL CORTICAL ATROPHY AND CENTRAL-NERVOUS-SYSTEM (CNS) SYMPTOMS IN A STEROID-TREATED CHILD WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									THOMAS JEFFERSON UNIV,CHILDRENS REHABIL HOSP,JEFFERSON MED COLL,PHILADELPHIA,PA 19107	Jefferson University								BENDER BG, 1988, J AM ACADEMY CHILD A, V6, P720; BENTSON J, 1978, J COMPUT ASSIST TOMO, V2, P16, DOI 10.1097/00004728-197801000-00003; LEWIS DA, 1983, J AFFECT DISORDERS, V5, P319, DOI 10.1016/0165-0327(83)90022-8; MOMOSE KJ, 1971, RADIOLOGY, V99, P341, DOI 10.1148/99.2.341; 1972, CLIN PHARM, V13, P694	5	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1992	89	4					918	919		10.1016/0091-6749(92)90449-C	http://dx.doi.org/10.1016/0091-6749(92)90449-C			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN860	1560173				2022-12-18	WOS:A1992HN86000019
J	SANDBERG, ET; SLATER, JE; ROTH, DR; ABRAMSON, SL				SANDBERG, ET; SLATER, JE; ROTH, DR; ABRAMSON, SL			RUBBER-SPECIFIC IGE IN CHILDREN ENROLLED IN A SPINA-BIFIDA CLINIC	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				223	223						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000268
J	VENGE, P; DAHL, R; KARLSTROM, R; PEDERSEN, B; PETERSON, CGB				VENGE, P; DAHL, R; KARLSTROM, R; PEDERSEN, B; PETERSON, CGB			EOSINOPHIL AND NEUTROPHIL ACTIVITY IN ASTHMA IN A ONE-YEAR DOUBLE-BLIND TRIAL WITH THEOPHYLLINE AND 2 DOSES OF INHALED BUDESONIDE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				190	190						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000133
J	WINDOM, HH; LIMMOMBAY, M; THOMPSON, M; NACLERIO, RM; TOGIAS, A				WINDOM, HH; LIMMOMBAY, M; THOMPSON, M; NACLERIO, RM; TOGIAS, A			THE EFFECT OF NASAL VERSUS BRONCHIAL ANTIGEN (AG) CHALLENGE ON THE ASTHMATIC AIRWAYS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				334	334						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000708
J	LEVINSON, AI; WHEATLEY, LM				LEVINSON, AI; WHEATLEY, LM			INTRAVENOUS IMMUNOGLOBULIN - A NEW THERAPEUTIC APPROACH IN STEROID-DEPENDENT ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							GAMMA-GLOBULIN; ANTIBODY-RESPONSE; IMMUNE GLOBULIN; AUTOANTIBODIES; SUPPRESSION; IDIOTYPE; DISEASE; IGG		VET ADM MED CTR,PHILADELPHIA,PA 19104	US Department of Veterans Affairs; Veterans Health Administration (VHA)	LEVINSON, AI (corresponding author), UNIV PENN,SCH MED,ALLERGY IMMUNOL SECT,ROOM 726,CLIN RES BLDG,422 CURIE BLVD,PHILADELPHIA,PA 19104, USA.							AMBROSINO DM, 1987, NEW ENGL J MED, V316, P790, DOI 10.1056/NEJM198703263161306; AMBROSINO DM, 1988, J ALLERGY CLIN IMMUN, V81, P1175, DOI 10.1016/0091-6749(88)90887-1; BLASER K, 1982, PROG ALLERGY, V32, P203; BOSE R, 1986, CLIN EXP IMMUNOL, V66, P231; BUSSEL J, 1983, BLOOD, V62, P398; BUSSEL JB, 1989, J ALLERGY CLIN IMMUN, V84, P566, DOI 10.1016/0091-6749(89)90193-0; COOK D, 1990, NEUROLOGY, V40, P212, DOI 10.1212/WNL.40.2.212; DIETRICH G, 1990, J CLIN INVEST, V85, P620, DOI 10.1172/JCI114483; HAHN BH, 1984, J IMMUNOL, V132, P187; HARGREAVE FE, 1986, J ALLERGY CLIN IMMUN, V78, P825, DOI 10.1016/0091-6749(86)90226-5; KAWADA K, 1987, EXP HEMATOL, V15, P133; LEUNG DYM, 1989, J ALLERGY CLIN IMMUN, V84, P588, DOI 10.1016/0091-6749(89)90195-4; MAZER BD, 1991, J ALLERGY CLIN IMMUN, V87, P976, DOI 10.1016/0091-6749(91)90420-S; NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601; PAGE R, 1988, J PEDIATR-US, V112, P127, DOI 10.1016/S0022-3476(88)80137-9; ROMAGNANI S, 1990, IMMUNOL TODAY, V11, P316, DOI 10.1016/S0167-5699(10)80004-0; ROSSI F, 1989, J IMMUNOL, V143, P4104; SAINTREMY JMR, 1988, EUR J IMMUNOL, V18, P83, DOI 10.1002/eji.1830180113; STOHL W, 1986, J IMMUNOL, V136, P4407; SULTAN Y, 1984, LANCET, V2, P765	20	7	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1991	88	4					552	554		10.1016/0091-6749(91)90147-G	http://dx.doi.org/10.1016/0091-6749(91)90147-G			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GL049	1717530				2022-12-18	WOS:A1991GL04900002
J	MADDOX, DE				MADDOX, DE			REGIONAL EXPRESSION OF COLD URTICARIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											MADDOX, DE (corresponding author), MAYO CLIN & MAYO GRAD SCH MED,INTERNAL MED,ROCHESTER,MN 55905, USA.							KURTZ AS, 1990, J ALLERGY CLIN IMMUN, V86, P272, DOI 10.1016/S0091-6749(05)80076-4	1	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1991	88	4					682	682		10.1016/0091-6749(91)90165-K	http://dx.doi.org/10.1016/0091-6749(91)90165-K			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GL049	1918735	Bronze			2022-12-18	WOS:A1991GL04900019
J	VALONE, FH				VALONE, FH			SYNTHESIS OF PLATELET-ACTIVATING-FACTOR BY HUMAN MONOCYTES STIMULATED BY PLATELET-ACTIVATING-FACTOR	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							TUMOR NECROSIS FACTOR; ENDOTHELIAL-CELLS; CYTO-TOXICITY; 1-ALKYL-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE; PHOSPHOLIPIDS; INTERLEUKIN-1; MACROPHAGES; GAMMA	The capacity of platelet-activating factor (PAF) to stimulate its own synthesis by human monocytes was examined. Adherent human monocytes of > 85% purity were incubated with 100 fM to 10 nM of PAF in the presence of 20-mu-Ci of [H-3]acetic acid to radiolabel newly synthesized PAF. After incubation for 15 minutes to 15 hours, PAF was purified by high-performance liquid chromatography, and newly synthesized PAF was quantified by its radioactivity. PAF stimulated its own synthesis in a dose-related manner with a maximal twofold to threefold increase in synthesis at 10 pM to 100 pM of PAF. Maximal PAF synthesis occurred after incubation for 6 to 8 hours. There was a good correlation (r = 0.95) between PAF quantified by [H-3]acetic acid incorporation and by rabbit platelet aggregation bioassay, indicating that the radioactive material is PAF. The protein synthesis inhibitor, cycloheximide, did not inhibit delayed PAF synthesis, indicating that delayed PAF synthesis does not require protein synthesis. PAF is metabolized rapidly in vivo. The capacity of PAF to stimulate its own synthesis would result in a prolonged effective half-life in vivo. This prolonged half-life could contribute to the capacity of PAF to induce prolonged inflammatory reactions in vivo.	UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	VALONE, FH (corresponding author), VET AFFAIRS MED CTR,HEMATOL ONCOL SECT,4150 CLEMENT ST,SAN FRANCISCO,CA 94121, USA.				NIAID NIH HHS [AI 22141] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022141] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARCHER CB, 1984, BRIT J DERMATOL, V110, P45, DOI 10.1111/j.1365-2133.1984.tb07310.x; BARTHELSON R, 1990, J ALLERGY CLIN IMMUN, V86, P193, DOI 10.1016/S0091-6749(05)80066-1; BARTHELSON RA, 1990, CELL IMMUNOL, V125, P142, DOI 10.1016/0008-8749(90)90069-4; BLANK ML, 1981, LIFE SCI, V29, P769, DOI 10.1016/0024-3205(81)90031-X; BLANK ML, 1983, J CHROMATOGR, V273, P415, DOI 10.1016/S0378-4347(00)80963-9; BONAVIDA B, 1989, INT ARCH ALLER A IMM, V88, P1157; CAMUSSI G, 1987, J EXP MED, V166, P1390, DOI 10.1084/jem.166.5.1390; CUSS FM, 1986, LANCET, V2, P189; DUBOIS C, 1989, J IMMUNOL, V143, P964; PHILIP R, 1986, NATURE, V323, P86, DOI 10.1038/323086a0; PIGNOL B, 1989, INT ARCH ALLER A IMM, V88, P161, DOI 10.1159/000234773; PRESCOTT SM, 1984, P NATL ACAD SCI-BIOL, V81, P3534, DOI 10.1073/pnas.81.11.3534; ROSE JK, 1990, J IMMUNOL, V144, P3513; RUIS N, IN PRESS LIPIDS; TESSNER TG, 1989, J BIOL CHEM, V264, P4794; VALONE FH, 1988, IMMUNOLOGY, V64, P715; VALONE FH, 1988, J IMMUNOL, V141, P3945; WARD S, 1988, PLATELET ACTIVATING, P6; WARNER SJC, 1987, J EXP MED, V165, P1316, DOI 10.1084/jem.165.5.1316; WOODARD DS, 1987, J BIOL CHEM, V262, P2520; WYKLE RL, 1980, J BIOL CHEM, V255, P256	21	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1991	87	3					715	720		10.1016/0091-6749(91)90394-4	http://dx.doi.org/10.1016/0091-6749(91)90394-4			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FB801	2005325				2022-12-18	WOS:A1991FB80100018
J	KEAHEY, TM; INDRISANO, J; WHITE, MV; KALINER, MA				KEAHEY, TM; INDRISANO, J; WHITE, MV; KALINER, MA			ANALYSES OF MICROVASCULAR PERMEABILITY IN RESPONSE TO MEDIATORS OF IMMEDIATE HYPERSENSITIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							VASCULAR-PERMEABILITY; HISTAMINE; SITES; RAT	Mediator-induced changes in microvascular permeability were studied in rodent skin. To monitor these changes, Evan's blue dye, iodinated rat albumin and IgG, and tritiated neutral dextran molecules having different molecular radii were used. After intradermal injections of serotonin, histamine, and bradykinin, the degree of radiolabeled tracer efflux was determined by measuring the extent of blueing and the level of radioactivity in skin biopsy specimens. Although the mediators varied in potency on a molar basis (serotonin > bradykinin > histamine), the efflux resulting from each was similar. Furthermore, kinetic studies revealed that each of these vasoactive agents caused a marked but transient increase in macromolecular permeability that lasted less than 30 minutes. To determine the pore size created and the effect of charge on the transudation of macromolecules into the interstitium, fractions of neutral [H-3]dextrans with a known molecular size (average radii, 12 and 4.4 nm, respectively) were infused either singly or in combination with I-125-labeled rat albumin and/or IgG before intradermal injection of serotonin, histamine, bradykinin, or compound 48/80. Regardless of the mediator used, no differences could be demonstrated in macromolecular efflux, as indicated by either the molecular size of the charge of the tracer used. Thus, all mediators of immediate hypersensitivity reactions that were studied produce venular gaps > 12 nm in addition to displaying similar vasopermeable characteristics.	NIAID,CLIN INVEST LAB,ALLERG DIS SECT,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)								BECKER CG, 1973, AM J PATHOL, V71, P1; BJORK J, 1981, INFLAMMATORY PROCESS, P103; CHANG RLS, 1975, BIOPHYS J, V15, P887, DOI 10.1016/S0006-3495(75)85863-2; DEEN WM, 1976, AM J PHYSIOL, V231, P283, DOI 10.1152/ajplegacy.1976.231.2.283; FOX J, 1980, MICROVASC RES, V19, P108, DOI 10.1016/0026-2862(80)90087-4; GREGA G J, 1981, Microcirculation, V1, P325; Haddy F J, 1976, Int Rev Physiol, V9, P63; HULSTROM D, 1980, J PATHOL, V129, P125; JORIS I, 1972, VIRCHOWS ARCH B, V12, P73; KEAHEY TM, 1989, J ALLERGY CLIN IMMUN, V83, P669, DOI 10.1016/0091-6749(89)90081-X; MAJNO G, 1969, J CELL BIOL, V42, P647, DOI 10.1083/jcb.42.3.647; MAJNO G, 1961, J BIOPHYS BIOCHEM CY, V11, P571, DOI 10.1083/jcb.11.3.571; MAJNO G, 1967, CIRC RES, V21, P833, DOI 10.1161/01.RES.21.6.833; MAJNO G, 1961, J BIOPHYS BIOCHEM CY, V11, P607, DOI 10.1083/jcb.11.3.607; SVENSJO E, 1984, MICROCIRC ENDOTH LYM, V1, P381; VEHASKARI VM, 1984, J CLIN INVEST, V73, P1053, DOI 10.1172/JCI111290; WAYLAND H, 1984, BIORHEOLOGY, V21, P104	17	7	7	1	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1991	87	2					586	594		10.1016/0091-6749(91)90019-K	http://dx.doi.org/10.1016/0091-6749(91)90019-K			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EX987	1993817	Bronze			2022-12-18	WOS:A1991EX98700018
J	WANDERER, AA				WANDERER, AA			SYSTEMIC COLD URTICARIA (ATYPICAL ACQUIRED COLD URTICARIA)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									ALLERGY & ASTHMA CONSULTANTS,ENGLEWOOD,CO 80110		WANDERER, AA (corresponding author), UNIV COLORADO,HLTH SCI CTR,DENVER,CO 80262, USA.							ILLIG L, 1980, ACTA DERM-VENEREOL, V60, P373; KAPLAN AP, 1984, J ALLERGY CLIN IMMUN, V73, P453, DOI 10.1016/0091-6749(84)90354-3; KIVITY S, 1990, J ALLERGY CLIN IMMUN, V85, P52, DOI 10.1016/0091-6749(90)90220-X; MATHEWS K P, 1970, Algerie Medicale, V72, P241; SARKANY I, 1977, BRIT J DERMATOL, V85, P46; SIBBALD RG, 1984, DERMATOL CLIN, V3, P62; WANDERER AA, 1986, J ALLERGY CLIN IMMUN, V78, P417, DOI 10.1016/0091-6749(86)90027-8; WANDERER AA, 1990, J ALLERGY CLIN IMMUN, V85, P965, DOI 10.1016/0091-6749(90)90037-5	8	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1991	87	1	1				137	138		10.1016/0091-6749(91)90231-C	http://dx.doi.org/10.1016/0091-6749(91)90231-C			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EX985	1991920				2022-12-18	WOS:A1991EX98500026
J	DACOSTA, PSG; DEMACEDO, MS; PERINI, A				DACOSTA, PSG; DEMACEDO, MS; PERINI, A			SUPPRESSION OF MOUSE IGE RESPONSE BY IMMUNE-COMPLEXES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									INST BUTANTAN,PAN AMER HLTH ORG,WHO CTR IMMUNOL RES & TRAINING,SAO PAULO,BRAZIL; UNIV SAO PAULO,INST BIOMED SCI,DEPT IMMUNOL,SAO PAULO,BRAZIL	Instituto Butantan; Pan American Health Organization; Universidade de Sao Paulo								BLASER K, 1982, PROG ALLERGY, V32, P203; CAULFIELD MJ, 1983, J EXP MED, V157, P1713, DOI 10.1084/jem.157.6.1713; CAULFIELD MJ, 1987, J IMMUNOL, V138, P3680; EISEN HN, 1953, J AM CHEM SOC, V75, P4583, DOI 10.1021/ja01114a507; FOX DA, 1976, J IMMUNOL, V177, P1622; GARB KS, 1982, J IMMUNOL, V129, P2752; HALL EP, 1987, IMMUNOLOGY, V61, P415; ISHIZAKA K, 1972, J IMMUNOL, V109, P84; ISHIZAKA K, 1988, ANNU REV IMMUNOL, V6, P513; ISHIZAKA K, 1976, ADV IMMUNOL, V23, P1, DOI 10.1016/S0065-2776(08)60318-1; ISHIZAKA K, 1976, J IMMUNOL, V117, P40; KLAUS GGB, 1978, NATURE, V272, P265, DOI 10.1038/272265a0; MALLEY A, 1983, IMMUNOL TODAY, V4, P163, DOI 10.1016/0167-5699(83)90004-X; MCDUFFIE FC, 1956, J IMMUNOL, V77, P193; MIYAMA M, 1979, CELL IMMUNOL, V44, P51, DOI 10.1016/0008-8749(79)90027-3; MOTA I, 1969, LIFE SCI PT 1 PHYSI, V8, P813, DOI 10.1016/0024-3205(69)90099-X; MURGITA RA, 1972, IMMUNOLOGY, V22, P319; NISONOFF A, 1960, ARCH BIOCHEM BIOPHYS, V89, P230, DOI 10.1016/0003-9861(60)90049-7; PARK Y, 1986, INT ARCH ALLER A IMM, V86, P156; PARK YH, 1984, CELL IMMUNOL, V83, P340, DOI 10.1016/0008-8749(84)90313-7; SAKAGUCHI M, 1989, J IMMUNOL METHODS, V116, P181, DOI 10.1016/0022-1759(89)90202-0; SINCLAIR NRS, 1987, IMMUNOL TODAY, V8, P76, DOI 10.1016/0167-5699(87)90849-8; SINCLAIR NRS, 1979, PHARMACOL THERAPEUT, V4, P355, DOI 10.1016/0163-7258(79)90142-6; SPIEGELB.HL, 1965, J EXP MED, V121, P323, DOI 10.1084/jem.121.3.323; STRANNEGARD O, 1971, CLIN EXP IMMUNOL, V8, P963; STRANNEGARD O, 1970, IMMUNOLOGY, V18, P775; TADA T, 1971, J IMMUNOL, V106, P1002; Theofilopoulos A N, 1982, Am J Pathol, V108, P319; TITE JP, 1982, IMMUNOLOGY, V46, P809; Uhr J W, 1968, Adv Immunol, V8, P81, DOI 10.1016/S0065-2776(08)60465-4; VIRGIN HW, 1985, J IMMUNOL, V135, P3744; VIRGIN HW, 1985, J IMMUNOL, V135, P3735; WASON WM, 1973, J IMMUNOL, V110, P1427	33	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1990	86	4	1				496	502						7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EG454	2229811				2022-12-18	WOS:A1990EG45400009
J	CHAPMAN, KR; BOUCHER, S; HYLAND, RH; DAY, A; KREISMAN, H; RIVINGTON, R; HODDER, RV; YORK, EL; ABBOUD, RT; PETERS, S; WOLKOVE, N; FREEMAN, D				CHAPMAN, KR; BOUCHER, S; HYLAND, RH; DAY, A; KREISMAN, H; RIVINGTON, R; HODDER, RV; YORK, EL; ABBOUD, RT; PETERS, S; WOLKOVE, N; FREEMAN, D			A COMPARISON OF ENPROFYLLINE AND THEOPHYLLINE IN THE MAINTENANCE THERAPY OF CHRONIC REVERSIBLE OBSTRUCTIVE AIRWAY DISEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									WELLESLEY COLL HOSP,TORONTO M4Y 1J3,ONTARIO,CANADA; MT SINAI HOSP,TORONTO M5G 1X5,ONTARIO,CANADA; HOP ST SACREMENT,QUEBEC CITY G1S 4L8,QUEBEC,CANADA; SIR MORTIMER B DAVIS JEWISH HOSP,MONTREAL H3T 1E2,QUEBEC,CANADA; OTTAWA CIVIC HOSP,OTTAWA K1Y 4E9,ONTARIO,CANADA; HLTH SCI CTR,EDMONTON,ALBERTA,CANADA; VANCOUVER GEN HOSP,VANCOUVER V5Z 1M9,BC,CANADA; HLTH SCI CTR,ST JOHN,NB,CANADA; UNIV WESTERN ONTARIO HOSP,LONDON N6A 5A5,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Laval University; McGill University; University of Ottawa; Ottawa Hospital Research Institute; University of Alberta; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of British Columbia; Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba; Western University (University of Western Ontario)	CHAPMAN, KR (corresponding author), TORONTO HOSP,CTR ASTHMA,399 BATHURST ST,TORONTO M5T 2S8,ONTARIO,CANADA.							AITKEN ML, 1987, CHEST, V91, P10, DOI 10.1378/chest.91.1.10; ANDERSSON KE, 1984, EUR J CLIN PHARMACOL, V26, P33, DOI 10.1007/BF00546705; ANDERSSON KE, 1980, EUR J RESPIR DIS, V61, P17; CHAPMAN KR, 1989, AM REV RESPIR DIS, V139, P688, DOI 10.1164/ajrccm/139.3.688; JOAD JP, 1986, J ALLERGY CLIN IMMUN, V78, P1147, DOI 10.1016/0091-6749(86)90264-2; JOHANNESSON N, 1985, AM REV RESPIR DIS, V131, P26; LEVY G, 1975, J PEDIATR-US, V86, P789, DOI 10.1016/S0022-3476(75)80374-X; LUNELL E, 1982, EUR J CLIN PHARMACOL, V22, P395, DOI 10.1007/BF00542541; LUNELL E, 1983, EUR J RESPIR DIS, V64, P333; LUNELL E, 1984, EUR J RESPIR DIS, V654, P28; MITENKO PA, 1973, NEW ENGL J MED, V289, P600, DOI 10.1056/NEJM197309202891202; PERSSON CGA, 1982, ARCH INT PHARMACOD T, V258, P267; PERSSON CGA, 1986, J ALLERGY CLIN IMMUN, V78, P817, DOI 10.1016/0091-6749(86)90067-9; PERSSON CGA, 1986, LIFE SCI, V38, P1057, DOI 10.1016/0024-3205(86)90241-9; PERSSON CGA, 1981, ACTA PHARMACOL TOX, V49, P313; PERSSON CGA, 1981, ACTA PHARMACOL TOX, V49, P317; RADULOVACKI M, 1982, BRAIN RES, V246, P178, DOI 10.1016/0006-8993(82)90161-5; ZWILLICH CW, 1975, ANN INTERN MED, V82, P784, DOI 10.7326/0003-4819-82-6-784	18	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1990	85	2					514	521		10.1016/0091-6749(90)90164-Y	http://dx.doi.org/10.1016/0091-6749(90)90164-Y			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CP511	2406328				2022-12-18	WOS:A1990CP51100015
J	MENON, P; MENON, V; HILMAN, BC; WOLF, R; BAIRNSFATHER, L				MENON, P; MENON, V; HILMAN, BC; WOLF, R; BAIRNSFATHER, L			ANTINUCLEAR ANTIBODIES AND ANTICYTOPLASMIC ANTIBODIES IN BRONCHIAL-ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									LOUISIANA STATE UNIV, MED CTR, DEPT PEDIAT, PULM ALLERGY SECT, POB 33932, NEW ORLEANS, LA 70112 USA; LOUISIANA STATE UNIV, MED CTR, DEPT BIOMETRY, SHREVEPORT, LA 71105 USA; LOUISIANA STATE UNIV, MED CTR, DEPT MED, RHEUMATOL SECT, SHREVEPORT, LA 71105 USA	Louisiana State University System; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport								BARTHOLOMEW BA, 1974, AM J CLIN PATHOL, V61, P495; BIBERFELD G, 1976, CLIN EXP IMMUNOL, V24, P287; BIGAZZI PE, 1980, MANUAL CLIN IMMUNOLO, P874; BRUIJNZEEL PLB, 1987, ANN ALLERGY, V58, P179; COCHRANE CG, 1968, J EXP MED, V127, P371, DOI 10.1084/jem.127.2.371; DICK E C, 1972, Clinical Research, V20, P799; Dinu I V, 1965, Rum Med Rev, V19, P26; EGESKJOLD EM, 1981, ALLERGY, V36, P573, DOI 10.1111/j.1398-9995.1981.tb01875.x; FRITZLER MJ, 1985, CLIN IMMUNOL IMMUNOP, V36, P120, DOI 10.1016/0090-1229(85)90045-5; GRANT JA, 1975, J IMMUNOL, V114, P1101; HSIEH KH, 1981, ANN ALLERGY, V47, P38; HSIEH KH, 1980, ANN ALLERGY, V44, P313; LI JTC, 1987, ANN ALLERGY, V59, P321; LIDOR Y, 1980, ANN ALLERGY, V44, P296; McCarty GA, 1984, ANTINUCLEAR ANTIBODI; MEEK F, 1980, CLIN EXP IMMUNOL, V41, P43; OSTER J, 1972, ACTA PAEDIATR SCAND, V61, P329, DOI 10.1111/j.1651-2227.1972.tb16108.x; Pepys J, 1967, J R Coll Physicians Lond, V2, P42; SALVAGGIO JE, 1964, J ALLERGY, V35, P62, DOI 10.1016/0021-8707(64)90050-4; SCOLOZZI R, 1984, B I SIEROTER MILAN, V63, P213; SCOTLAND SM, 1983, LANCET, V2, P216; SERAFINI U, 1965, LANCET, V2, P821; SMILEY JD, 1988, AM J MED SCI, V295, P478, DOI 10.1097/00000441-198805000-00014; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; TAN EM, 1982, ADV IMMUNOL, V33, P167, DOI 10.1016/S0065-2776(08)60836-6; TESSER JRP, 1983, J RHEUMATOL, V10, P227; TURNERWARWICK M, 1974, PROG IMMUNOL, V11, P283; VENTER JC, 1980, SCIENCE, V207, P1361, DOI 10.1126/science.6153472; WARWICK MT, 1970, CLIN EXP IMMUNOL, V7, P31; WILSON MR, 1981, OCCUPATIONAL LUNG DI, P125; 1962, AM REV RESPIR DIS, V58, P762	31	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1989	84	6	1				937	943		10.1016/0091-6749(89)90392-8	http://dx.doi.org/10.1016/0091-6749(89)90392-8			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CG293	2689497				2022-12-18	WOS:A1989CG29300013
J	WAHL, R; MEINEKE, D; OLIVER, J; SCHULTZEWERNINGHAUS, G; HAUCK, PR				WAHL, R; MEINEKE, D; OLIVER, J; SCHULTZEWERNINGHAUS, G; HAUCK, PR			COMPARISON OF IN-HOUSE ALLERGEN EXTRACTS OF PHLEUM-PRATENSE (TIMOTHY GRASS) POLLEN WITH THE INTERNATIONAL STANDARD AND INVESTIGATION OF IGE SPECIFICITIES OF A GRASS-POLLEN SERUM POOL FROM WEST-GERMANY AND OF THE ONE RECOMMENDED BY THE WORLD-HEALTH-ORGANIZATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CTR LABS,PORT WASHINGTON,NY; UNIV FRANKFURT,HAUTKLIN,D-6000 FRANKFURT 1,FED REP GER	Goethe University Frankfurt	WAHL, R (corresponding author), ALLERGOPHARMA JOACHIM GANZER KG,DEPT RES & DEV ALLERGEN EXTRACTS,HERMANN KORNER STR 52,D-2057 REINBEK,FED REP GER.							ANDERSON MC, 1981, RAST INHIBITION PROC; BAER H, 1970, J ALLERGY, V45, P347, DOI 10.1016/0021-8707(70)90043-2; BAER H, 1987, 4TH INT P EHRL SEM W, P167; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CESKA M, 1972, J ALLERGY CLIN IMMUN, V49, P1, DOI 10.1016/0091-6749(72)90117-0; Coca AF, 1922, J IMMUNOL, V7, P163; FORD A, 1985, J ALLERGY CLIN IMMUN, V75, P676, DOI 10.1016/0091-6749(85)90093-4; GJESING B, 1985, J ALLERGY CLIN IMMUN, V75, P258, DOI 10.1016/0091-6749(85)90055-7; GLEICH GJ, 1976, J ALLERGY CLIN IMMUN, V58, P31, DOI 10.1016/0091-6749(76)90104-4; GLEICH GJ, 1974, J ALLERGY CLIN IMMUN, V53, P158, DOI 10.1016/0091-6749(74)90004-9; GUERIN B, 1988, 5TH INT P EHRL SEM S, P51; HELM RM, 1984, J ALLERGY CLIN IMMUN, V73, P790, DOI 10.1016/0091-6749(84)90449-4; LOWENSTEIN H, 1980, ALLERGY, V35, P188, DOI 10.1111/j.1398-9995.1980.tb01739.x; LOWENSTEIN H, 1980, ADV ALLERGOLOGY CLIN, P505; LOWENSTEIN H, 1978, PROGR ALLERGY, P25; MAASCH HJ, 1987, INT ARCH ALLER A IMM, V84, P363, DOI 10.1159/000234451; MAASCH HJ, 1987, ANN ALLERGY, V58, P429; MAASCH HJ, 1987, ANN ALLERGY, V59, P29; MALLING HJ, 1988, ALLERGY S6, V43, P13; MARSH DG, 1988, INT ARCH ALLER A IMM, V85, P194; MEINEKE D, 1988, CHROMATOGRAPHIA, V25, P242, DOI 10.1007/BF02316452; PELTRE G, 1982, IMMUNOL LETT, V5, P127, DOI 10.1016/0165-2478(82)90096-7; TOVEY ER, 1987, J ALLERGY CLIN IMMUN, V79, P93, DOI 10.1016/S0091-6749(87)80022-2; TURKELTAUB PC, 1982, J ALLERGY CLIN IMMUN, V70, P343, DOI 10.1016/0091-6749(82)90023-9; VANDERZEE JS, 1988, J ALLERGY CLIN IMMUN, V81, P884, DOI 10.1016/0091-6749(88)90946-3; WAHL R, 1983, ANAL BIOCHEM, V134, P189, DOI 10.1016/0003-2697(83)90282-8; WAHL R, 1985, BIOL CHEM H-S, V366, P979, DOI 10.1515/bchm3.1985.366.2.979; WAHL R, 1985, J CHROMATOGR, V329, P153, DOI 10.1016/S0021-9673(01)81909-9; WAHL R, 1986, J CHROMATOGR, V351, P39, DOI 10.1016/S0021-9673(01)83470-1; WAHL R, 1988, INT ARCH ALLER A IMM, V87, P109, DOI 10.1159/000234659; WAHL R, 1987, NEW ENGL REG ALLERGY, V8, P237; WAHL R, 1987, INT ANAL, V7, P22; WEEKE B, 1973, SCAND J IMMUNOL, V2, P149, DOI 10.1111/j.1365-3083.1973.tb03796.x; Yman L, 1975, Dev Biol Stand, V29, P151; 1978, WHO TECH REP SER, V626, P15	35	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1989	84	4	1				448	456		10.1016/0091-6749(89)90357-6	http://dx.doi.org/10.1016/0091-6749(89)90357-6			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AW760	2794290				2022-12-18	WOS:A1989AW76000005
J	KUROSAWA, M; OKAYAMA, Y; KOBAYASHI, S				KUROSAWA, M; OKAYAMA, Y; KOBAYASHI, S			A DIPHOSPHOINOSITIDE KINASE IN RAT MAST-CELL GRANULES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											KUROSAWA, M (corresponding author), GUNMA UNIV,SCH MED,DEPT INTERNAL MED 1,3-39-15 SHYOWA MACHI,MAEBASHI,GUNMA 371,JAPAN.							ALLAN D, 1976, NATURE, V261, P58, DOI 10.1038/261058a0; BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DIAMANT B, 1975, INT ARCH ALLER A IMM, V49, P155, DOI 10.1159/000231391; GONZALEZ.F, 1968, J LIPID RES, V9, P532; HAWTHORNE JN, 1983, BIOSCIENCE REP, V3, P887, DOI 10.1007/BF01140658; HOKIN LE, 1964, BIOCHIM BIOPHYS ACTA, V84, P563, DOI 10.1016/0926-6542(64)90126-X; HOLGATE ST, 1980, J IMMUNOL, V124, P2093; IRVINE RF, 1982, CELL CALCIUM, V3, P295, DOI 10.1016/0143-4160(82)90018-5; IRVINE RF, 1984, BIOCHEM J, V218, P177, DOI 10.1042/bj2180177; ISHIZAKA T, 1981, J ALLERGY CLIN IMMUN, V67, P90, DOI 10.1016/0091-6749(81)90002-6; JOLLES J, 1981, BIOCHEM J, V194, P283, DOI 10.1042/bj1940283; KAI M, 1968, BIOCHEM J, V106, P791, DOI 10.1042/bj1060791; KAI M, 1966, BIOCHEM BIOPH RES CO, V22, P370, DOI 10.1016/0006-291X(66)90655-3; KAIBUCHI K, 1981, J BIOL CHEM, V256, P7146; KALINER M, 1974, J IMMUNOL, V112, P664; KENNERLY DA, 1979, J IMMUNOL, V122, P152; KENNERLY DA, 1979, J EXP MED, V150, P1039, DOI 10.1084/jem.150.4.1039; KENNERLY DA, 1979, J IMMUNOL, V123, P1519; KRUGER PG, 1980, EXP CELL RES, V129, P83, DOI 10.1016/0014-4827(80)90333-X; KUROSAWA M, 1989, BIOCHEM PHARMACOL, V38, P431; KUROSAWA M, 1986, J IMMUNOL, V136, P616; KUROSAWA M, IN PRESS CLIN ALLERG; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGUNOFF D, 1976, ARCH BIOCHEM BIOPHYS, V173, P554, DOI 10.1016/0003-9861(76)90292-7; LAGUNOFF D, 1984, CELL BIOL INFLAMMATI, P217; LUNDBERG GA, 1985, BIOCHIM BIOPHYS ACTA, V846, P379, DOI 10.1016/0167-4889(85)90009-6; MACARA IG, 1984, P NATL ACAD SCI-BIOL, V81, P2728, DOI 10.1073/pnas.81.9.2728; PARKER CW, 1984, FUNDAMENTAL IMMUNOLO, P697; PARSONS SJ, 1986, BIOCHEM BIOPH RES CO, V134, P736, DOI 10.1016/S0006-291X(86)80482-X; PERTOFT H, 1978, ANAL BIOCHEM, V88, P271, DOI 10.1016/0003-2697(78)90419-0; PHILLIPS JH, 1973, BIOCHEM J, V136, P579, DOI 10.1042/bj1360579; RADIN NS, 1969, METHOD ENZYMOL, V14, P245; ROHLICH P, 1971, J CELL BIOL, V51, P465, DOI 10.1083/jcb.51.2.465; SHORE PA, 1959, J PHARMACOL EXP THER, V127, P182; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; SUGIMOTO Y, 1984, P NATL ACAD SCI-BIOL, V81, P2117, DOI 10.1073/pnas.81.7.2117; TOU JS, 1970, ARCH BIOCHEM BIOPHYS, V140, P492, DOI 10.1016/0003-9861(70)90093-7; VANDONGEN CJ, 1984, BIOCHEM J, V223, P197, DOI 10.1042/bj2230197; VANROOIJEN LAA, 1985, BIOCHEM BIOPH RES CO, V126, P1506; WHITE JR, 1985, P NATL ACAD SCI USA, V82, P8193, DOI 10.1073/pnas.82.23.8193	43	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1989	84	1					118	128		10.1016/0091-6749(89)90185-1	http://dx.doi.org/10.1016/0091-6749(89)90185-1			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AG120	2546984				2022-12-18	WOS:A1989AG12000016
J	MALVEAUX, FJ				MALVEAUX, FJ			ASTHMA CARE FOR THE INDIGENT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											MALVEAUX, FJ (corresponding author), JOHNS HOPKINS UNIV,GOOD SAMARITAN HOSP,SCH MED,5601 LOCH RAVEN BLVD,BALTIMORE,MD 21239, USA.							BENATAR SR, 1986, NEW ENGL J MED, V314, P423, DOI 10.1056/NEJM198602133140706; BENATAR SR, 1986, S AFR MED J, V69, P669; CLARK NM, 1986, J ALLERGY CLIN IMMUN, V78, P108, DOI 10.1016/0091-6749(86)90122-3; DAVIS K, 1981, ANNU REV PUBL HEALTH, V2, P159, DOI 10.1146/annurev.pu.02.050181.001111; DUTTON DB, 1978, AM SOCIOL REV, V43, P348, DOI 10.2307/2094495; GERGEN PJ, 1988, PEDIATRICS, V81, P1; GERSTMAN BB, 1989, J ALLERGY CLIN IMMUN, V83, P1032, DOI 10.1016/0091-6749(89)90444-2; Kitagawa EM, 1973, DIFFERENTIAL MORTALI; MALVEAUX FJ, 1987, J ALLERGY CLIN IMMUN, V79, P183; MULLALLY DI, 1984, ANN ALLERGY, V53, P15; RIES P, 1987, DHHS PHS871250 PUBL; SEARS MR, 1985, NEW ZEAL MED J, V98, P271; SLY RM, 1988, J ALLERGY CLIN IMMUN, V82, P705, DOI 10.1016/0091-6749(88)90069-3; WISSOW LS, 1988, AM J PUBLIC HEALTH, V78, P777, DOI 10.2105/AJPH.78.7.777; 1985, REPORT SECRETARYS TA, V1, P3	15	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1989	83	6					1029	1031		10.1016/0091-6749(89)90443-0	http://dx.doi.org/10.1016/0091-6749(89)90443-0			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AC235	2732404				2022-12-18	WOS:A1989AC23500004
J	ZEDALIS, D; DOLEN, WK; GLOVER, GC; WIENER, MB; SELNER, JC; WEBER, RW				ZEDALIS, D; DOLEN, WK; GLOVER, GC; WIENER, MB; SELNER, JC; WEBER, RW			EVALUATION OF NASAL PATENCY BY FIBEROPTIC RHINOSCOPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									FITZSIMONS ARMY MED CTR,ALLERGY IMMUNOL SERV,AURORA,CO 80045; ALTON OCHSNER MED FDN & OCHSNER CLIN,ALLERGY & CLIN IMMUNOL SECT,NEW ORLEANS,LA 70121; ALLERGY RESP INST COLORADO,DENVER,CO	Ochsner Health System								BORUM P, 1979, J ALLERGY CLIN IMMUN, V63, P253, DOI 10.1016/0091-6749(79)90109-X; Clement P A, 1984, Rhinology, V22, P151; CLEMENT P A R, 1978, Rhinology (Utrecht), V16, P149; COLE P, 1984, AM REV RESPIR DIS, V129, P351; CONNELL JT, 1982, ANN ALLERGY, V49, P179; HASEGAWA M, 1977, MAYO CLIN PROC, V52, P28; LANCER JM, 1985, J LARYNGOL OTOL, V99, P771, DOI 10.1017/S0022215100097644; MYGIND N, 1986, EUR J RESPIR DIS, V68, P31; NOLTE D, 1973, RESPIRATION, V30, P31, DOI 10.1159/000192973; SELNER JC, 1985, ANN ALLERGY, V54, P479; SELNER JC, UNPUB ASSESSMENT NAS; TAYLOR G, 1973, J ALLERGY CLIN IMMUN, V52, P193, DOI 10.1016/0091-6749(73)90057-2; UNDRITZ W., 1930, ADA OTO LARYNGOL, V14, P513, DOI 10.3109/00016483009120137	13	7	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1989	83	5					973	978		10.1016/0091-6749(89)90114-0	http://dx.doi.org/10.1016/0091-6749(89)90114-0			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	U7161	2715554				2022-12-18	WOS:A1989U716100020
J	LIN, FL; VAUGHAN, TR; VANDEWALKER, ML; WEBER, RW				LIN, FL; VAUGHAN, TR; VANDEWALKER, ML; WEBER, RW			HYPEREOSINOPHILIA, NEUROLOGIC, AND GASTROINTESTINAL SYMPTOMS AFTER BEE-POLLEN INGESTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									FITZSIMONS ARMY MED CTR,ALLERGY IMMUNOL SERV,AURORA,CO 80045									BJORKSTEN B, 1986, ALLERGY, V41, P290, DOI 10.1111/j.1398-9995.1986.tb02031.x; COHEN SH, 1979, J ALLERGY CLIN IMMUN, V64, P270, DOI 10.1016/0091-6749(79)90143-X; COOPER PJ, 1984, CLIN ALLERGY, V14, P541, DOI 10.1111/j.1365-2222.1984.tb02242.x; DAVIES J, 1983, Q J MED, V52, P23; FAUCI AS, 1982, ANN INTERN MED, V97, P78, DOI 10.7326/0003-4819-97-1-78; JACKSON JL, 1983, INT J BIOSC RES, V5, P47; MANSFIELD LE, 1981, ANN ALLERGY, V47, P154; OTTESEN EA, 1979, J INFECT DIS, V139, P343, DOI 10.1093/infdis/139.3.343; PETERS MS, 1987, J AM ACAD DERMATOL, V16, P513, DOI 10.1016/S0190-9622(87)70067-X; PIERONI RE, 1982, J MED ASS STATE ALA, P11; SHIFMAN NR, 1988, ALLERGY PRINCIPLES P, P179; STANLEY RG, 1974, POLLEN BIOL BIOCH MA, P164; TAUDORF E, 1985, ALLERGY, V40, P321, DOI 10.1111/j.1398-9995.1985.tb00243.x	13	7	8	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1989	83	4					793	796		10.1016/0091-6749(89)90016-X	http://dx.doi.org/10.1016/0091-6749(89)90016-X			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	U3420	2708739				2022-12-18	WOS:A1989U342000013
J	LUSKIN, SS; FITZSIMMONS, WE; MACLEOD, CM; LUSKIN, AT				LUSKIN, SS; FITZSIMMONS, WE; MACLEOD, CM; LUSKIN, AT			PHARMACOKINETIC EVALUATION OF THE TERFENADINE-THEOPHYLLINE INTERACTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									RUSH PRESBYTERIAN ST LUKES MED CTR,DEPT PHARMACOL,CHICAGO,IL 60612; RUSH PRESBYTERIAN ST LUKES MED CTR,DEPT IMMUNOL MICROBIOL,CHICAGO,IL 60612	Rush University; Rush University	LUSKIN, SS (corresponding author), RUSH PRESBYTERIAN ST LUKES MED CTR,DEPT PHARM,165W W CONGRESS PKWY,CHICAGO,IL 60612, USA.							ANOLIK R, 1982, ANN ALLERGY, V49, P109; BROWN RD, 1978, J PHARM SCI, V67, P1687, DOI 10.1002/jps.2600671214; CHANG KC, 1978, LANCET, V1, P1132; CONRAD KA, 1980, CLIN PHARMACOL THER, V28, P463, DOI 10.1038/clpt.1980.189; CUSACK BJ, 1985, CLIN PHARMACOL THER, V37, P330, DOI 10.1038/clpt.1985.48; ELLIS EF, 1976, PEDIATRICS, V58, P542; FITZSIMMONS WE, IN PRESS ANN ALLERGY; GINCHANSKY E, 1977, J PEDIATR-US, V91, P655, DOI 10.1016/S0022-3476(77)80527-1; HENDELES L, 1978, AM REV RESPIR DIS, V118, P97; HENDELES L, 1981, DRUG INTEL CLIN PHAR, V15, P338, DOI 10.1177/106002808101500504; ISLES A, 1983, AM REV RESPIR DIS, V127, P417, DOI 10.1164/arrd.1983.127.4.417; JOLLEY ME, 1981, CLIN CHEM, V27, P1575; JUSKO WJ, 1978, CLIN PHARMACOL THER, V24, P406; LOUGHNAN PM, 1976, J PEDIATR-US, V88, P874, DOI 10.1016/S0022-3476(76)81136-5; MANGIONE A, 1978, CHEST, V73, P616, DOI 10.1378/chest.73.5.616; MILAVETZ G, 1987, J ALLERGY CLIN IMMUN, V80, P723, DOI 10.1016/0091-6749(87)90294-6; NAFZIGER AN, 1988, CLIN PHARMACOL THER, V43, P147; PATEL KR, 1984, BRIT MED J, V288, P1496, DOI 10.1136/bmj.288.6429.1496; PIAFSKY KM, 1977, CLIN PHARMACOL THER, V21, P310; PIAFSKY KM, 1977, NEW ENGL J MED, V296, P1495, DOI 10.1056/NEJM197706302962603; POWELL JR, 1977, AM REV RESPIR DIS, V116, P17; RICHER C, 1982, CLIN PHARMACOL THER, V31, P579, DOI 10.1038/clpt.1982.81; STAIB AH, 1980, INT J CLIN PHARM TH, V18, P500; UPTON RA, 1982, J PHARMACOKINET BIOP, V10, P123, DOI 10.1007/BF01062330; VICUNA N, 1979, BRIT J CLIN PHARMACO, V7, P33, DOI 10.1111/j.1365-2125.1979.tb00893.x; VOZEH S, 1978, JAMA-J AM MED ASSOC, V240, P1882, DOI 10.1001/jama.240.17.1882	26	7	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1989	83	2	1				406	411		10.1016/0091-6749(89)90126-7	http://dx.doi.org/10.1016/0091-6749(89)90126-7			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T4489	2493044				2022-12-18	WOS:A1989T448900007
J	DIETEMANN, A; HOYET, C; BESSOT, JC; DEBLAY, F; PAULI, G				DIETEMANN, A; HOYET, C; BESSOT, JC; DEBLAY, F; PAULI, G			EFFECTS OF ACARICIDE APPLICATION ON MITE ALLERGEN LEVELS AND ON SYMPTOMS OF DERMATOPHAGOIDES PTERONYSSINUS (DPT) ALLERGIC ASTHMATIC-PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					263	263						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900387
J	EBBELING, W; BUCKLEY, R				EBBELING, W; BUCKLEY, R			DOUBLE-BLIND, PLACEBO-CONTROLLED CHALLENGES WITH HEATED COW MILK WHEY-PROTEIN IN MILK SENSITIVE PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					238	238						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900288
J	LEIMGRUBER, A; PEITREQUIN, R; MOSIMANN, B; CLAEYS, M; SEPPEY, M; JACCARD, Y; PECOUD, A				LEIMGRUBER, A; PEITREQUIN, R; MOSIMANN, B; CLAEYS, M; SEPPEY, M; JACCARD, Y; PECOUD, A			THE PHARMACIA CAP SYSTEM - A NEW ASSAY FOR SPECIFIC IGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					176	176						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900040
J	MARSHALL, C; LIEBERMAN, P				MARSHALL, C; LIEBERMAN, P			ANALYSIS OF 3 PRETREATMENT PROCEDURES TO PREVENT ANAPHYLACTOID REACTIONS TO RADIOCONTRAST (RCM) IN PREVIOUS REACTORS (R)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					254	254						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900352
J	MULLER, U; STETTLER, R; HOTTINGER, S				MULLER, U; STETTLER, R; HOTTINGER, S			CARDIAC SYMPTOMS (CS) DURING ANAPHYLAXIS TO HYMENOPTERA STINGS (HA)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					230	230						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900256
J	SHIRLEY, LR; MARSH, WH				SHIRLEY, LR; MARSH, WH			CAMPYLOBACTER PYLORI GASTRITIS IN CHILDREN WITH X-LINKED AGAMMAGLOBULINEMIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					287	287						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900484
J	LORIA, RC; PRANGE, JO; WEDNER, HJ				LORIA, RC; PRANGE, JO; WEDNER, HJ			IMMUNOBLOTTING OF POLLEN PROTEINS - TWEEN-20 MEDIATES NONSPECIFIC-BINDING OF GAMMA-GLOBULINS TO IMMUNOBLOTS OF OAK-POLLEN PROTEINS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									WASHINGTON UNIV,SCH MED,DEPT MED,DIV ALLERGY & IMMUNOL,BOX 8122,660 S EUCLID,ST LOUIS,MO 63110	Washington University (WUSTL)								ASHANI Y, 1980, ANAL BIOCHEM, V109, P55, DOI 10.1016/0003-2697(80)90009-3; AVRAMEAS S, 1971, IMMUNOCHEMISTRY, V8, P1175, DOI 10.1016/0019-2791(71)90395-8; BENGTSSON A, 1985, INT ARCH ALLER A IMM, V78, P139, DOI 10.1159/000233876; BERS G, 1985, Biotechniques, V3, P276; CHANG HW, 1980, ANAL BIOCHEM, V104, P112, DOI 10.1016/0003-2697(80)90283-3; DEWAIR M, 1985, J ALLERGY CLIN IMMUN, V76, P537, DOI 10.1016/0091-6749(85)90772-9; EKRAMODDOULLAH AKM, 1986, MOL IMMUNOL, V23, P111, DOI 10.1016/0161-5890(86)90031-3; EKRAMODDOULLAH AKM, 1986, INT ARCH ALLER A IMM, V80, P100, DOI 10.1159/000234033; FLORVAAG E, 1986, INT ARCH ALLER A IMM, V80, P26, DOI 10.1159/000234021; FORD SA, 1987, J ALLERGY CLIN IMMUN, V79, P711, DOI 10.1016/0091-6749(87)90201-6; FORD SA, 1985, INT ARCH ALLER A IMM, V78, P15, DOI 10.1159/000233855; GERSHONI JM, 1983, ANAL BIOCHEM, V131, P1, DOI 10.1016/0003-2697(83)90128-8; GERSHONI JM, 1985, TRENDS BIOCHEM SCI, V10, P103, DOI 10.1016/0968-0004(85)90262-2; GUEVARA J, 1982, ELECTROPHORESIS, V3, P197, DOI 10.1002/elps.1150030404; HAAS H, 1986, INT ARCH ALLER A IMM, V79, P434, DOI 10.1159/000234014; ITO Y, 1981, INT ARCH ALLERGY APP, V1, P174; JACOBSON RS, 1986, J ALLERGY CLIN IMMUN, V77, P143; JACOBSON RS, 1985, J ALLERGY CLIN IMMUN, V75, P121, DOI 10.1016/0091-6749(85)90203-9; KENNA JG, 1985, J IMMUNOL METHODS, V85, P409, DOI 10.1016/0022-1759(85)90150-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; PERINI JM, 1986, CLIN CHEM, V32, P811; THEOBALD K, 1986, J ALLERGY CLIN IMMUN, V78, P470, DOI 10.1016/0091-6749(86)90035-7; TOVEY ER, 1984, INT ARCH ALLER A IMM, V75, P322, DOI 10.1159/000233641; TOWBIN H, 1984, J IMMUNOL METHODS, V72, P313, DOI 10.1016/0022-1759(84)90001-2; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WALSH BJ, 1984, J IMMUNOL METHODS, V66, P99, DOI 10.1016/0022-1759(84)90252-7	27	7	7	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1988	82	5	1				834	841		10.1016/0091-6749(88)90086-3	http://dx.doi.org/10.1016/0091-6749(88)90086-3			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	R1708	2461404				2022-12-18	WOS:A1988R170800018
J	CARPENTIERE, G; CASTELLO, F; MARINO, S				CARPENTIERE, G; CASTELLO, F; MARINO, S			INCREASED RESPONSIVENESS TO HISTAMINE AFTER PROPRANOLOL IN SUBJECTS WITH ASTHMA NONRESPONSIVE TO THE BRONCHOCONSTRICTIVE EFFECT OF PROPRANOLOL	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											CARPENTIERE, G (corresponding author), UNIV PALERMO,INST MED CLIN,PIAZZA CLINICHE 2,I-90127 PALERMO,ITALY.							ANKIN MG, 1979, AM REV RESPIR DIS, V119, P55; BENSON MK, 1975, BRIT J DIS CHEST, V69, P227, DOI 10.1016/0007-0971(75)90090-X; BENSON MK, 1977, POSTGRAD MED J, V53, P143; CAULD DR, 1979, MED J AUST, V11, P88; CHESTER EH, 1981, CHEST, V79, P540, DOI 10.1378/chest.79.5.540; COCKCROFT DW, 1983, THORAX, V38, P523, DOI 10.1136/thx.38.7.523; COLTART DJ, 1970, BRIT MED J, V3, P731, DOI 10.1136/bmj.3.5725.731; DOLOVICH M, 1981, CHEST, V80, P834; DRAZEN JM, 1978, J APPL PHYSIOL, V44, P340, DOI 10.1152/jappl.1978.44.3.340; JUNIPER EF, 1978, THORAX, V33, P705, DOI 10.1136/thx.33.6.705; MACONOCHIE JG, 1977, BRIT J CLIN PHARMACO, V4, P157, DOI 10.1111/j.1365-2125.1977.tb00688.x; MCFADDEN ER, 1968, J APPL PHYSIOL, V25, P365, DOI 10.1152/jappl.1968.25.4.365; MCNEILL RS, 1964, LANCET, V2, P1101; NEWHOUSE MT, 1978, CHEST, V735, P936; OREHEK J, 1975, J ALLERGY CLIN IMMUN, V55, P164, DOI 10.1016/0091-6749(75)90012-3; PIPER PJ, 1967, NATURE, V213, P838, DOI 10.1038/213838a0; RUFFIN RE, 1978, AM REV RESPIR DIS, V117, P485; SEIDLER A, 1987, AM REV RESPIR DIS, V4, pA478; WANNER A, 1985, AM REV RESPIR DIS, V131, P3; WIDDICOMBE JG, 1982, J EXP BIOL, V100, P41; [No title captured]	21	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1988	82	4					595	598		10.1016/0091-6749(88)90970-0	http://dx.doi.org/10.1016/0091-6749(88)90970-0			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	Q6399	3171001				2022-12-18	WOS:A1988Q639900010
J	ADVENIER, C; NALINE, E; MATRAN, R; TOTY, L; BAKDACH, H				ADVENIER, C; NALINE, E; MATRAN, R; TOTY, L; BAKDACH, H			INTERACTION BETWEEN FENOTEROL, IPRATROPIUM, AND ACETYLCHOLINE ON HUMAN ISOLATED BRONCHUS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									LAB PHARMACOL, PARIS, FRANCE; CTR CHIRURG VAL OR, ST CLOUD, FRANCE; HOP COCHIN, EXPLORAT FONCTIONNELLES RESPIRATOIRES LAB, F-75674 PARIS 14, FRANCE; CTR MED CHIRURG FOCH, F-92151 SURESNES, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite								ADVENIER C, 1986, BRIT J PHARMACOL, V88, P33, DOI 10.1111/j.1476-5381.1986.tb09468.x; BONGRANI S, 1981, ARZNEIMITTEL-FORSCH, V31-1, P970; BRINK C, 1980, BRIT J PHARMACOL, V69, P383, DOI 10.1111/j.1476-5381.1980.tb07026.x; BRUDERMAN I, 1983, CHEST, V83, P208, DOI 10.1378/chest.83.2.208; BUCKNER CK, 1975, J PHARMACOL EXP THER, V194, P565; CHAN CS, 1977, BR J CLIN PHARM, V17, P103; DOUGLAS NJ, 1979, THORAX, V34, P51, DOI 10.1136/thx.34.1.51; ELWOOD RK, 1982, J ALLERGY CLIN IMMUN, V69, P467, DOI 10.1016/0091-6749(82)90123-3; FURCHGOTT RF, 1967, ANN NY ACAD SCI, V144, P882, DOI 10.1111/j.1749-6632.1967.tb53817.x; GHELANI AM, 1980, BRIT J PHARMACOL, V71, P107, DOI 10.1111/j.1476-5381.1980.tb10915.x; GOLDIE RG, 1984, BRIT J PHARMACOL, V81, P611, DOI 10.1111/j.1476-5381.1984.tb16125.x; GROSS NJ, 1984, AM REV RESPIR DIS, V129, P856, DOI 10.1164/arrd.1984.129.5.856; GUILLOT C, 1984, J ALLERGY CLIN IMMUN, V74, P713, DOI 10.1016/0091-6749(84)90235-5; HERZOG H, 1975, POSTGRAD MED J S7, V51, P146; LANDRY Y, 1985, TRAITEMENT ASTHME, P166; LEFCOE NM, 1982, CHEST, V82, P300, DOI 10.1378/chest.82.3.300; LIN MT, 1978, ANN ALLERGY, V40, P326; NADEL JA, 1980, PHYSL PHARM AIRWAYS, P217; ODONNELL SR, 1977, BRIT J PHARMACOL, V60, P255, DOI 10.1111/j.1476-5381.1977.tb07748.x; OFFERMEIER J, 1980, WORKSHOP BAD REICHEN, P19; PETRIE GR, 1975, BRIT MED J, V1, P430, DOI 10.1136/bmj.1.5955.430; PIERCE RJ, 1979, THORAX, V34, P45, DOI 10.1136/thx.34.1.45; RUFFIN RE, 1982, J ALLERGY CLIN IMMUN, V69, P60, DOI 10.1016/0091-6749(82)90089-6; RUFFIN RE, 1977, J ALLERGY CLIN IMMUN, V59, P136, DOI 10.1016/0091-6749(77)90215-9; TORPHY TJ, 1985, J PHARMACOL EXP THER, V233, P409; TORPHY TJ, 1983, J PHARMACOL EXP THER, V227, P694; ULLAH MI, 1981, THORAX, V36, P523, DOI 10.1136/thx.36.7.523; VANDENBRINK FG, 1973, EUR J PHARMACOL, V22, P279, DOI 10.1016/0014-2999(73)90027-7; VANROSSUM JM, 1963, ARCH INT PHARMACOD T, V143, P240; VINCENC K, 1984, EUR J PHARMACOL, V98, P201, DOI 10.1016/0014-2999(84)90591-0; WAUD DR, 1969, J PHARMACOL EXP THER, V170, P117	31	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1988	82	1					40	46		10.1016/0091-6749(88)90049-8	http://dx.doi.org/10.1016/0091-6749(88)90049-8			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P4004	2969022				2022-12-18	WOS:A1988P400400008
J	ZWEIMAN, B; LEVINSON, AI				ZWEIMAN, B; LEVINSON, AI			IMMUNOLOGICAL ASPECTS OF NEUROLOGIC DISEASES .1. GENERAL RESPONSES AND DEMYELINATING DISEASES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											ZWEIMAN, B (corresponding author), UNIV PENN,SCH MED,ALLERGY & IMMUNOL SECT,PHILADELPHIA,PA 19104, USA.							ADAMS CWM, 1975, J NEUROL SCI, V25, P165, DOI 10.1016/0022-510X(75)90138-0; [Anonymous], 1986, JAMA, V256, P1333; ARNASON BGW, 1969, LAB INVEST, V21, P1; ARNASON BGW, 1984, PERIPHERAL NEUROPATH, P2050; ASBURY AK, 1981, ANN NEUROL, V9, P1, DOI 10.1002/ana.410090703; BARKER CF, 1977, ADV IMMUNOL, V25, P1; BIRNBAUM G, 1984, J CLIN INVEST, V74, P1307, DOI 10.1172/JCI111541; BORNSTEIN MB, 1984, ANN NY ACAD SCI, V436, P366, DOI 10.1111/j.1749-6632.1984.tb14807.x; BROOKS BR, 1983, CELLULAR HUMORAL IMM, P263; BURNET FM, 1959, CLONAL SELECTION THE, P60; BURNS J, 1984, J IMMUNOL, V132, P2690; CLARK RB, 1984, CELL IMMUNOL, V84, P409, DOI 10.1016/0008-8749(84)90113-8; COHEN IR, 1984, IMMUNOREGULATORY PRO, pCH3; DALAKAS MC, 1981, ANN NEUROL, V9, P134, DOI 10.1002/ana.410090719; DAY ED, 1986, J NEUROIMMUNOL, V10, P289, DOI 10.1016/S0165-5728(86)90014-7; DOREDUFFY P, 1981, CLIN IMMUNOL IMMUNOP, V19, P303, DOI 10.1016/0090-1229(81)90072-6; DOREDUFFY P, 1981, PROSTAG LEUKOTR ESS, V6, P299, DOI 10.1016/0161-4630(81)90153-1; EGGERS AE, 1981, J NEUROL SCI, V52, P385, DOI 10.1016/0022-510X(81)90019-8; GONATAS NK, 1986, IMMUNOL TODAY, V7, P121, DOI 10.1016/0167-5699(86)90072-1; HINRICHS D, 1984, IMMUNOREGULATORY PRO, pCH2; HUGHES RAC, 1981, J NEUROL NEUROSUR PS, V44, P565, DOI 10.1136/jnnp.44.7.565; ILYAS AA, 1984, P NATL ACAD SCI-BIOL, V81, P1225, DOI 10.1073/pnas.81.4.1225; KHATRI BO, 1984, ANN NY ACAD SCI, V436, P389, DOI 10.1111/j.1749-6632.1984.tb14810.x; KOSKI CL, 1985, P NATL ACAD SCI USA, V82, P905, DOI 10.1073/pnas.82.3.905; LEVINSON AI, 1983, NEUROLOGY, V33, P1305, DOI 10.1212/WNL.33.10.1305; LEVINSON AI, 1976, NEUROLOGY, V26, P693, DOI 10.1212/WNL.26.7.693; LISAK RP, 1977, NEW ENGL J MED, V297, P850, DOI 10.1056/NEJM197710202971602; MERRILL JE, 1983, J NEUROIMMUNOL, V4, P223, DOI 10.1016/0165-5728(83)90037-1; MORIMOTO C, 1987, NEW ENGL J MED, V316, P67, DOI 10.1056/NEJM198701083160202; NORONHA ABC, 1980, NEW ENGL J MED, V303, P713, DOI 10.1056/NEJM198009253031301; OGER J, 1982, NATURE, V295, P66, DOI 10.1038/295066a0; RAINE CS, 1984, LAB INVEST, V50, P608; REUNANEN M, 1983, J NEUROL SCI, V58, P211, DOI 10.1016/0022-510X(83)90218-6; RODRIGUEZ M, 1986, IMMUNOL TODAY, V7, P359, DOI 10.1016/0167-5699(86)90025-3; ROSTAMI A, 1985, CELL IMMUNOL, V91, P354, DOI 10.1016/0008-8749(85)90233-3; ROSTAMI A, 1984, ANN NEUROL; SAIDA T, 1978, NATURE, V272, P639, DOI 10.1038/272639a0; SAIDA T, 1982, ANN NEUROL, V11, P69, DOI 10.1002/ana.410110112; SANDBERGWOLLHEIM M, 1986, J NEUROIMMUNOL, V11, P205, DOI 10.1016/0165-5728(86)90004-4; SILBERBERG DH, 1984, ANN NY ACAD SCI, V436, P418, DOI 10.1111/j.1749-6632.1984.tb14813.x; SOBEL RA, 1984, J IMMUNOL, V132, P2402; STEINER I, 1985, SPRINGER SEMIN IMMUN, V8, P235; STERNBERGER NH, 1985, J NEUROIMMUNOL, V7, P355; STOHL W, 1978, J IMMUNOL, V120, P844; SUMNER A, 1982, NEUROLOGY, V32, pA106; TANDON DS, 1980, NEUROLOGY, V30, P362; TRAUGOTT U, 1985, CELL IMMUNOL, V91, P240, DOI 10.1016/0008-8749(85)90047-4; TRAUGOTT U, 1985, J NEUROIMMUNOL, V8, P1, DOI 10.1016/S0165-5728(85)80043-6; TRAUGOTT U, 1985, SPRINGER SEMIN IMMUN, V8, P71; VANDENBARK AA, 1985, J IMMUNOL, V135, P229; WEINER HL, 1985, ANN NY ACAD SCI, V436, P373; WEINER LP, 1984, J NEUROSURG, V61, P207, DOI 10.3171/jns.1984.61.2.0207; WEKERLE H, 1986, TRENDS NEUROSCI, V9, P271, DOI 10.1016/0166-2236(86)90077-9; WILLENBORG DO, 1986, J IMMUNOL, V136, P1676; ZAMVIL S, 1985, NATURE, V317, P355, DOI 10.1038/317355a0; ZEROMSKI J, 1970, CLIN EXP IMMUNOL, V6, P633; ZWEIMAN B, 1986, ANN NEUROL, V19, P588, DOI 10.1002/ana.410190611; ZWEIMAN B, 1986, HUM PATHOL, V17, P234, DOI 10.1016/S0046-8177(83)80216-0; ZWEIMAN B, 1983, NEUROLOGY, V33, P234, DOI 10.1212/WNL.33.2.234	59	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1988	81	6					1067	1077		10.1016/0091-6749(88)90868-8	http://dx.doi.org/10.1016/0091-6749(88)90868-8			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P0023	3288681				2022-12-18	WOS:A1988P002300001
J	SHEFFER, AL				SHEFFER, AL			ANAPHYLAXIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											SHEFFER, AL (corresponding author), HARVARD UNIV,SCH MED,110 FRANCIS ST,BOSTON,MA 02115, USA.							CAULFIELD JP, 1980, J CELL BIOL, V85, P229; JAMES LP, 1964, NEW ENGL J MED, V270, P597, DOI 10.1056/NEJM196403192701202; KIDD J, 1982, Journal of Allergy and Clinical Immunology, V69, P103; MAULITZ RM, 1979, J ALLERGY CLIN IMMUN, V63, P433, DOI 10.1016/0091-6749(79)90218-5; SHEFFER AL, 1985, J ALLERGY CLIN IMMUN, V75, P479, DOI 10.1016/S0091-6749(85)80021-X; SHEFFER AL, 1984, J ALLERGY CLIN IMMUN, V73, P699, DOI 10.1016/0091-6749(84)90309-9; SHEFFER AL, 1985, J ALLERGY CLIN IMMUN, V75, P227, DOI 10.1016/0091-6749(85)90048-X; SHEFFER AL, 1983, J ALLERGY CLIN IMMUN, V71, P311, DOI 10.1016/0091-6749(83)90085-4; SHEFFER AL, 1979, SCI PRACTICE MED, P468	9	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1988	81	5	2	S			1048	1050		10.1016/0091-6749(88)90178-9	http://dx.doi.org/10.1016/0091-6749(88)90178-9			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	N7037	3372913				2022-12-18	WOS:A1988N703700023
J	UPADRASHTA, B; CROOM, J; KOPP, WC; WITHERS, J; RICHERSON, HB				UPADRASHTA, B; CROOM, J; KOPP, WC; WITHERS, J; RICHERSON, HB			T-CELL LOCALIZATION IN RABBIT MODELS OF ACUTE AND CHRONIC EXPERIMENTAL HYPERSENSITIVITY PNEUMONITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV IOWA,DEPT INTERNAL MED,IOWA CITY,IA 52242	University of Iowa					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL019873, R01HL022676] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL19873, HL22676] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BIENENSTOCK J, 1985, INT ARCH ALLER A IMM, V76, P62, DOI 10.1159/000233736; BIENENSTOCK J, 1984, IMMUNOLOGY LUNG UPPE; BUTLER JE, 1983, INT ARCH ALLER A IMM, V71, P74, DOI 10.1159/000233365; CALVANICO NJ, 1984, IMMUNOLOGY LUNG UPPE, P365; CLANCY R, 1974, J IMMUNOL, V112, P1997; COSTABEL U, 1984, CHEST, V85, P514, DOI 10.1378/chest.85.4.514; HIEBERT CK, 1983, J MED CHEM, V26, P1729, DOI 10.1021/jm00366a014; HSU SM, 1981, AM J CLIN PATHOL, V75, P734, DOI 10.1093/ajcp/75.5.734; HUNTSBERGER D, 1970, STATISTICAL INFERENC, P213; JACKSON S, 1983, J EXP MED, V157, P34, DOI 10.1084/jem.157.1.34; KELLER RH, 1984, AM REV RESPIR DIS, V130, P766; KOPP WC, 1985, AM REV RESPIR DIS, V132, P1027; KRADIN RL, 1986, CLIN IMMUNOL IMMUNOP, V40, P224, DOI 10.1016/0090-1229(86)90025-5; LEATHERMAN JW, 1984, ANN INTERN MED, V100, P390, DOI 10.7326/0003-4819-100-3-390; MORNEX JF, 1984, J ALLERGY CLIN IMMUN, V74, P719, DOI 10.1016/0091-6749(84)90236-7; PEPYS J, 1969, MONOGRAPHS ALLERGY, V4, P132; Racz P, 1977, J Reticuloendothel Soc, V22, P59; RATAJCZAK HV, 1980, AM REV RESPIR DIS, V122, P761, DOI 10.1164/arrd.1980.122.5.761; RATAJCZAK HV, 1979, CELL IMMUNOL, V47, P390, DOI 10.1016/0008-8749(79)90348-4; REYNOLDS HY, 1977, J CLIN INVEST, V59, P165, DOI 10.1172/JCI108615; RICHERSON HB, 1971, AM REV RESPIR DIS, V104, P568; RICHERSON HB, 1981, J ALLERGY CLIN IMMUN, V68, P226, DOI 10.1016/0091-6749(81)90188-3; RICHERSON HB, 1984, SURV SYN PATHOL RES, V3, P281; RICHERSON HB, 1982, AM J PATHOL, V106, P409; RICHERSON HB, 1983, CLIN REV ALLERG, V1, P469; RICHERSON HB, 1974, ANN NY ACAD SCI, V221, P340, DOI 10.1111/j.1749-6632.1974.tb28236.x; RICHERSON HB, 1986, J ALLERGY CLIN IMM S, V77, P182; SAINTEMARIE G, 1962, J HISTOCHEM CYTOCHEM, V10, P250, DOI 10.1177/10.3.250; SELL S, 1980, DEV COMP IMMUNOL, V4, P355, DOI 10.1016/S0145-305X(80)80038-3; STANKUS RP, 1983, CLIN CHEST MED, V4, P55; UPADRASHTA BS, UNPUB EXP LUNG RES; WAKSMAN BH, 1976, PROG ALLERGY, V21, P1, DOI 10.1159/000313994; 1982, SAS USERS GUIDE STAT, P169	33	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1988	81	5	1				821	828		10.1016/0091-6749(88)90937-2	http://dx.doi.org/10.1016/0091-6749(88)90937-2			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	N7036	3259594				2022-12-18	WOS:A1988N703600009
J	FINKEL, MP; MALLARD, SP; THUESON, DO; CONROY, MC				FINKEL, MP; MALLARD, SP; THUESON, DO; CONROY, MC			THE INVIVO ANTI-ALLERGIC ACTIVITY OF CI-949, 5-METHOXY-3-(1-METHYLETHOXY)-1-PHENYL-N-1H-TETRAZOL-5-YL-1H-INDOLE-2-CARBOXAMIDE, ARGININE SALT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					313	313		10.1016/0091-6749(88)90816-0	http://dx.doi.org/10.1016/0091-6749(88)90816-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400603
J	GOURLEY, DS; WHISMAN, BA; MARTIN, ME; REID, MJ				GOURLEY, DS; WHISMAN, BA; MARTIN, ME; REID, MJ			CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF ALLERGIC FUNGAL SINUSITIS CAUSED BY BIPOLARIS-SPICIFERA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					285	285		10.1016/0091-6749(88)90701-4	http://dx.doi.org/10.1016/0091-6749(88)90701-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400488
J	LITTLE, M; ECKLUND, P; CASALE, T				LITTLE, M; ECKLUND, P; CASALE, T			AZELASTINE THERAPEUTIC ACTION IN ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					278	278		10.1016/0091-6749(88)90676-8	http://dx.doi.org/10.1016/0091-6749(88)90676-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274		Bronze			2022-12-18	WOS:A1988M027400463
J	NORMAN, PS; CRETICOS, PS; MARSH, DG; ADKINSON, NF; KAGEYSOBOTKA, A; LICHTENSTEIN, LM				NORMAN, PS; CRETICOS, PS; MARSH, DG; ADKINSON, NF; KAGEYSOBOTKA, A; LICHTENSTEIN, LM			2-YEAR STUDY OF CLINICAL-RESULTS AFTER DISCONTINUATION OF RAGWEED ALLERGOID IMMUNOTHERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					294	294		10.1016/0091-6749(88)90737-3	http://dx.doi.org/10.1016/0091-6749(88)90737-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400524
J	PIPKORN, U; KARLSSON, G; ENERBACK, L				PIPKORN, U; KARLSSON, G; ENERBACK, L			THE CELLULAR-RESPONSE OF THE HUMAN ALLERGIC MUCOSA TO NATURAL ALLERGEN EXPOSURE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	8	1	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					172	172		10.1016/0091-6749(88)90251-5	http://dx.doi.org/10.1016/0091-6749(88)90251-5			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274		Bronze			2022-12-18	WOS:A1988M027400038
J	STEINBERG, M; PAGE, R; WOLFSON, S; FRIDAY, G; FIREMAN, P				STEINBERG, M; PAGE, R; WOLFSON, S; FRIDAY, G; FIREMAN, P			FOOD INDUCED LATE PHASE HEADACHE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					185	185		10.1016/0091-6749(88)90303-X	http://dx.doi.org/10.1016/0091-6749(88)90303-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400090
J	CHAN, H; TSE, KS; VANOOSTDAM, J; MORENO, R; PARE, PD; CHANYEUNG, M				CHAN, H; TSE, KS; VANOOSTDAM, J; MORENO, R; PARE, PD; CHANYEUNG, M			A RABBIT MODEL OF HYPERSENSITIVITY TO PLICATIC ACID, THE AGENT RESPONSIBLE FOR RED CEDAR ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV BRITISH COLUMBIA, VANCOUVER GEN HOSP, DIV RESP, 2775 HEATHER ST, VANCOUVER V5Z 3J5, BC, CANADA	University of British Columbia			Pare, Peter D/C-7425-2011					Baur X, 1981, Chest, V80, P73; BERNSTEIN IL, 1981, CLIN CHEST MED, V2, P255; BERNSTEIN IL, 1982, J ALLERGY CLIN IMMUN, V70, P393, DOI 10.1016/0091-6749(82)90030-6; BUTCHER BT, 1976, J ALLERGY CLIN IMMUN, V58, P89, DOI 10.1016/0091-6749(76)90110-X; CHANYEUNG M, 1982, J ALLERGY CLIN IMMUN, V70, P32, DOI 10.1016/0091-6749(82)90198-1; CHANYEUNG M, 1973, AM REV RESPIR DIS, V108, P1094; CHEN SE, 1982, J ALLERGY CLIN IMMUN, V70, P383, DOI 10.1016/0091-6749(82)90029-X; DANKS JM, 1981, CLIN ALLERGY, V11, P161, DOI 10.1111/j.1365-2222.1981.tb01580.x; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; GARDNER JAF, 1959, CAN J CHEM, V37, P1703, DOI 10.1139/v59-246; KAROL MH, 1983, TOXICOL APPL PHARM, V68, P229, DOI 10.1016/0041-008X(83)90007-8; MCCORMACK GS, 1986, J APPL PHYSIOL, V60, P242, DOI 10.1152/jappl.1986.60.1.242; MOIRA CY, 1984, AM REV RESPIR DIS, V130, P1038; OUCHTERLONY O, 1962, PROG ALLERGY, V6, P30, DOI 10.1159/000313795; OVARY Z, 1964, IMMUNOLOGICAL METHOD, P259; PARE PD, 1976, J APPL PHYSIOL, V41, P668, DOI 10.1152/jappl.1976.41.5.668; PARE PD, 1979, J APPL PHYSIOL, V46, P346, DOI 10.1152/jappl.1979.46.2.346; PATTERSON R, 1974, INT ARCH ALLER A IMM, V46, P150, DOI 10.1159/000231119; PEPYS J, 1972, Clinical Allergy, V2, P225, DOI 10.1111/j.1365-2222.1972.tb01287.x; SHAMPAIN MP, 1982, AM REV RESPIR DIS, V126, P493; TSE KS, 1982, CLIN ALLERGY, V12, P249, DOI 10.1111/j.1365-2222.1982.tb02525.x; VONNEERGAARD K, 1927, Z KLIN MED, V105, P51; 1978, US DHEW NIOSH78215 P	23	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1987	79	5					762	767		10.1016/0091-6749(87)90208-9	http://dx.doi.org/10.1016/0091-6749(87)90208-9			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	H4349	3571767				2022-12-18	WOS:A1987H434900011
J	LAUFER, P; CHRYSSANTHOPOULOS, C; LAUFER, R; HAUSE, LL				LAUFER, P; CHRYSSANTHOPOULOS, C; LAUFER, R; HAUSE, LL			THE DETERMINATION OF THE EOSINOPHIL COUNT - COMPARISON OF 2 TECHNIQUES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MED COLL WISCONSIN, DEPT PATHOL, MILWAUKEE, WI 53226 USA	Medical College of Wisconsin	LAUFER, P (corresponding author), MED COLL WISCONSIN, DEPT PEDIAT, ALLERGY IMMUNOL SECT, MILWAUKEE, WI 53226 USA.							ANDERSEN V, 1969, CELL TISSUE KINET, V2, P139, DOI 10.1111/j.1365-2184.1969.tb01000.x; BEST WR, 1953, JAMA-J AM MED ASSOC, V151, P702; BURROWS B, 1980, AM REV RESPIR DIS, V122, P709, DOI 10.1164/arrd.1980.122.5.709; CONRAD ME, 1971, SEMIN HEMATOL, V8, P267; FAUCI AS, 1983, J ALLERGY CLIN IMMUN, V72, P211, DOI 10.1016/0091-6749(83)90021-0; FELARCA AB, 1967, J ALLERGY, V40, P16, DOI 10.1016/0021-8707(67)90055-X; HORN BR, 1975, NEW ENGL J MED, V292, P1152, DOI 10.1056/NEJM197505292922204; KOCHWESE.J, 1968, ARCH INTERN MED, V121, P255, DOI 10.1001/archinte.121.3.255; LOWELL F C, 1967, Journal of the American Medical Association, V202, P109; LOWELL FC, 1975, NEW ENGL J MED, V292, P1182, DOI 10.1056/NEJM197505292922210; MIALE JB, 1977, LABORATORY MED, P1001; RIMM AA, 1980, BASIC BIOSTATISTICS, P262; SCHATZ M, 1981, MED CLIN N AM, V65, P1055, DOI 10.1016/S0025-7125(16)31489-4; UHRBRAND H, 1958, ACTA MED SCAND, V160, P99; ZUSSMAN BM, 1978, ANN ALLERGY, V40, P195	15	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1987	79	3					438	441		10.1016/0091-6749(87)90360-5	http://dx.doi.org/10.1016/0091-6749(87)90360-5			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	G4795	3819226	Bronze			2022-12-18	WOS:A1987G479500005
J	MAHER, TJ				MAHER, TJ			NATURAL FOOD CONSTITUENTS AND FOOD-ADDITIVES - THE PHARMACOLOGICAL CONNECTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											MAHER, TJ (corresponding author), MASSACHUSETTS COLL PHARM & ALLIED HLTH SCI,DEPT PHARMACOL,179 LONGWOOD AVE,BOSTON,MA 02115, USA.							ALLWOOD MJ, 1963, BRIT MED BULL, V19, P132, DOI 10.1093/oxfordjournals.bmb.a070031; BARBEAU A, 1978, NEW ENGL J MED, V299, P200; BARBEAU A, 1978, CAN J NEUROL SCI, V5, P157, DOI 10.1017/S0317167100024963; BARBEAU A, 1982, CAN J NEUROL SCI, V9, P141, DOI 10.1017/S0317167100043845; BARRA MS, 1972, J NEUROCHEM, V19, P2287; BIERKAMPER GG, 1980, BRAIN RES, V202, P234, DOI 10.1016/S0006-8993(80)80052-7; Blau K, 1979, AROMATIC AMINO ACID, P77; Blundell J E, 1982, Rev Pure Appl Pharmacol Sci, V3, P381; BOGDUK N, 1981, CURRENT NEUROLOGY, V3, P377; BOWEN DM, 1976, BRAIN, V99, P459, DOI 10.1093/brain/99.3.459; BOYD WD, 1977, LANCET, V2, P711; BREMER J, 1960, BIOCHIM BIOPHYS ACTA, V37, P173, DOI 10.1016/0006-3002(60)90104-9; BRESHNAHAN MR, 1980, AM J PHYSIOL, V239, pH201; CHOUINARD G, 1979, ACTA PSYCHIAT SCAND, V59, P395, DOI 10.1111/j.1600-0447.1979.tb04482.x; CLOUTIER G, 1973, J PHARMACOL EXP THER, V186, P75; COHEN EL, 1976, SCIENCE, V191, P561, DOI 10.1126/science.1251187; COHEN EL, 1975, LIFE SCI, V16, P1095, DOI 10.1016/0024-3205(75)90194-0; CONLAY LA, 1983, J NEURAL TRANSM, V58, P69, DOI 10.1007/BF01249125; CONLAY LA, 1984, LIFE SCI, V35, P1207, DOI 10.1016/0024-3205(84)90192-9; CONLAY LA, 1981, SCIENCE, V212, P559, DOI 10.1126/science.7209553; COPPEN ALEC, 1967, BRIT J PSYCHIAT, V113, P1237, DOI 10.1192/bjp.113.504.1237; Costa E, 1974, Adv Biochem Psychopharmacol, V12, P161; CRANE GE, 1968, AM J PSYCHIAT, V124, P40, DOI 10.1176/ajp.124.8S.40; DAVIS JG, 1967, CHEM ADDITIVES FOODS; DAVIS KL, 1975, NEW ENGL J MED, V293, P152; DAVIS KL, 1976, LIFE SCI, V19, P1507, DOI 10.1016/0024-3205(76)90095-3; DAVIS KL, 1978, LIFE SCI, V22, P1865, DOI 10.1016/0024-3205(78)90472-1; de Jong W, 1975, Arch Int Pharmacodyn Ther, V213, P272; DELAHUERGA J, 1951, J CLIN INVEST, V30, P463, DOI 10.1172/JCI102463; DELEAN J, 1976, NEUROLOGY, V26, P863; DRACHMAN DA, 1977, NEUROLOGY, V27, P783, DOI 10.1212/WNL.27.8.783; DRACHMAN DB, 1981, ANNU REV NEUROSCI, V4, P195, DOI 10.1146/annurev.ne.04.030181.001211; FERNSTROM JD, 1979, AM J CLIN NUTR, V32, P1912, DOI 10.1093/ajcn/32.9.1912; FERNSTROM JD, 1971, SCIENCE, V173, P149, DOI 10.1126/science.173.3992.149; FERNSTROM JD, 1978, J NEUROCHEM, V30, P1531, DOI 10.1111/j.1471-4159.1978.tb10489.x; FERNSTROM JD, 1971, SCIENCE, V174, P1023, DOI 10.1126/science.174.4013.1023; FOVALL P, 1980, COMMUN PSYCHOPHARMAC, V4, P141; GELENBERG AJ, 1979, AM J PSYCHIAT, V136, P772; GELLIS SS, 1984, PEDIATRIC NOTES, V8, P19; GLAESER BS, 1983, J NEUROCHEM, V41, P1016, DOI 10.1111/j.1471-4159.1983.tb09045.x; GOLDMAN LEO, 1970, MED CLIN N AM, V54, P1339, DOI 10.1016/S0025-7125(16)32599-8; GOSSEL TA, 1984, US PHARM, V9, P26; GROWDON JH, 1978, NEW ENGL J MED, V298, P1029; GROWDON JH, 1977, NEW ENGL J MED, V297, P524, DOI 10.1056/NEJM197709082971002; HARTMANN E, 1977, AM J PSYCHIAT, V134, P366; HARTMANN E, 1977, WAKING SLEEPING, V1, P155; HAUBRICH DR, 1975, LIFE SCI, V17, P975, DOI 10.1016/0024-3205(75)90451-8; HIRSCH MJ, 1978, METABOLISM, V27, P953, DOI 10.1016/0026-0495(78)90139-7; HODGES R, 1980, NUTR MED PRACTICE RE, P323; HOSOBUCHI Y, 1978, LANCET, V2, P47; HU R, 1980, 33RD GER SOC AM SCI, P128; JACKSON IV, 1979, AM J PSYCHIAT, V136, P1458; JOHNS DR, 1986, NEW ENGL J MED, V315, P456; KILGORE WW, 1980, TOXICOLOGY BASIC SCI, P593; KIMURA H, 1980, SCIENCE, V208, P1057, DOI 10.1126/science.6990490; KING RB, 1980, J NEUROSURG, V53, P44, DOI 10.3171/jns.1980.53.1.0044; KLAWANS H, 1974, J NEUROL NEUROSUR PS, V27, P941; KRANZ H, 1980, J NEUROL NEUROSUR PS, V43, P483, DOI 10.1136/jnnp.43.6.483; KULCZYCKI A, 1986, ANN INTERN MED, V104, P207, DOI 10.7326/0003-4819-104-2-207; LEHNERT H, 1984, BRAIN RES, V303, P215, DOI 10.1016/0006-8993(84)91207-1; Lovenberg W, 1968, Adv Pharmacol, V6, P21; LOVENBERG W, 1975, P NATL ACAD SCI USA, V72, P2955, DOI 10.1073/pnas.72.8.2955; LOVENBERG W, 1974, LIFE SCI, V14, P2337, DOI 10.1016/0024-3205(74)90130-1; LUCKEY TD, 1968, HDB FOOD ADDITIVES; LYTLE LD, 1975, SCIENCE, V190, P692, DOI 10.1126/science.810890; MAHER TJ, 1986, NEUROTOXICOLOGY, V7, P183; MAHER TJ, 1980, LIFE SCI, V26, P1283, DOI 10.1016/0024-3205(80)90086-7; MAHER TJ, 1984, AM J CLIN NUTR, V39, P722, DOI 10.1093/ajcn/39.5.722; MAZUR RH, 1984, ASPARTAME PHYSL BIOC, P3; MCKEAN CM, 1972, BRAIN RES, V47, P469, DOI 10.1016/0006-8993(72)90653-1; MELAMED E, 1980, P NATL ACAD SCI-BIOL, V77, P4305, DOI 10.1073/pnas.77.7.4305; MENDELS J, 1975, ARCH GEN PSYCHIAT, V32, P22; MERVIS RF, 1981, J NEUROPATH EXP NEUR, V40, P313; MOLLER SE, 1976, PSYCHOPHARMACOLOGY, V49, P205, DOI 10.1007/BF00427292; NAUTA W, 1980, ASPARTAME DECISION P; NORUMA Y, 1979, J NEUROCHEM, V33, P803; NOVICK NL, 1986, ANN INTERN MED, V102, P206; PARDRIDGE W M, 1975, Critical Reviews in Toxicology, V3, P159, DOI 10.3109/10408447509079857; Pardridge W.M, 1977, NUTR BRAIN, V1, P141; PARDRIDGE WM, 1975, BIOCHIM BIOPHYS ACTA, V401, P128, DOI 10.1016/0005-2736(75)90347-8; PARDRIDGE WM, 1986, NUTR BRAIN, V7, P199; PARKER CW, 1972, PATHOBIOLOGIC ANN, P405; Patlak CS, 1975, FLUID ENV BRAIN, P47; PINTO JMB, 1986, NEUROCHEM INT, V9, P533, DOI 10.1016/0197-0186(86)90146-4; PINTO JMB, 1986, PHARMACOLOGIST, V28, P201; REINSTEIN DK, 1984, LIFE SCI, V34, P2225, DOI 10.1016/0024-3205(84)90209-1; REYNOLDS WA, 1980, ANAT RECORD, V198, P73, DOI 10.1002/ar.1091980106; ROE DA, 1976, DRUG INDUCED NUTRITI, P211; SCALLY MC, 1977, J NEURAL TRANSM, V43, P103; SCHWARTZ JC, 1972, J NEUROCHEM, V19, P801, DOI 10.1111/j.1471-4159.1972.tb01394.x; SCOTT NA, 1981, SCIENCE, V211, P727, DOI 10.1126/science.7455710; SHALITA B, 1977, EXPERIENTIA, V33, P1430, DOI 10.1007/BF01918786; SIGNORET JL, 1978, LANCET, V2, P837; SPILLER GA, 1980, AM J CLIN NUTR, V33, P1716; SVED AF, 1979, P NATL ACAD SCI USA, V76, P3511, DOI 10.1073/pnas.76.7.3511; SVED AF, 1979, LIFE SCI, V25, P1293, DOI 10.1016/0024-3205(79)90394-1; SWAIMAN KF, 1969, J NEUROCHEM, V16, P385, DOI 10.1111/j.1471-4159.1969.tb10378.x; TAMMINGA CA, 1977, AM J PSYCHIAT, V134, P769; THAL LJ, 1983, ANN NEUROL, V13, P491, DOI 10.1002/ana.410130504; VANPRAAG HM, 1974, INT PHARMACOPSYCHIAT, V9, P35, DOI 10.1159/000468114; WHITE HL, 1973, J NEUROCHEM, V20, P297, DOI 10.1111/j.1471-4159.1973.tb12129.x; WURTMAN JJ, 1979, LIFE SCI, V24, P895, DOI 10.1016/0024-3205(79)90339-4; WURTMAN JJ, 1979, NUTR BRAIN, V5, P73; WURTMAN RJ, 1985, LANCET, V2, P1060; WURTMAN RJ, 1984, FUND APPL TOXICOL, V4, pS318, DOI 10.1016/0272-0590(84)90258-6; WURTMAN RJ, 1986, ALZHEIMERS PARKINSON, P69; WURTMAN RJ, 1981, PHARMACOL REV, V32, P315; YELLOWLEES H, 1983, BR MED J, V287, P162; YOKOGOSHI H, 1984, AM J CLIN NUTR, V40, P1; 1984, EVALUATION CONSUMER	110	7	7	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1987	79	3					413	422		10.1016/0091-6749(87)90356-3	http://dx.doi.org/10.1016/0091-6749(87)90356-3			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	G4795	2880886				2022-12-18	WOS:A1987G479500001
J	DIAZ, P; GONZALEZ, C; GALLEGUILLOS, F; ANCIC, P; CROMWELL, O; KAY, AB				DIAZ, P; GONZALEZ, C; GALLEGUILLOS, F; ANCIC, P; CROMWELL, O; KAY, AB			LEUKOCYTES AND MEDIATORS IN BRONCHIAL MUCUS AND BRONCHOALVEOLAR LAVAGE DURING ALLERGEN-INDUCED LATE-PHASE ASTHMATIC REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									CARDIOTHORAC INST,LONDON SW3 6HP,ENGLAND										0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					256	256						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000547
J	GRANDGEORGE, S; VAUGHAN, L; MILAVETZ, G; HENDRICKER, C; AHRENS, R; WEINBERGER, M				GRANDGEORGE, S; VAUGHAN, L; MILAVETZ, G; HENDRICKER, C; AHRENS, R; WEINBERGER, M			SYSTEMIC AND TOPICAL DOSE-RESPONSE RELATIONSHIPS OF INHALED CORTICOSTEROID AEROSOLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					201	201						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000330
J	LEMANSKE, RF; ESSER, B; KOPP, D; ASPERHEIM, M; JUNK, P; TASHOFF, T				LEMANSKE, RF; ESSER, B; KOPP, D; ASPERHEIM, M; JUNK, P; TASHOFF, T			THE BIOLOGIC ACTIVITY OF MAST-CELL GRANULES .8. INVIVO AND INVITRO CHARACTERIZATION OF MAST-CELL GRANULE DERIVED INFLAMMATORY FACTORS INVOLVED IN RAT LATE-PHASE REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WISCONSIN,SCH MED,SCH MED,DEPT MED,MADISON,WI 53706; UNIV WISCONSIN,SCH MED,SCH MED,DEPT PEDIAT,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL001147] Funding Source: NIH RePORTER; NHLBI NIH HHS [1 K08 HL01147-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABRAHAM WM, 1983, AM REV RESPIR DIS, V128, P839; AKUJAMA K, 1984, J LAB CLIN MED, V104, P391; ATKINS PC, 1981, J ALLERGY CLIN IMMUN, V68, P286, DOI 10.1016/0091-6749(81)90153-6; CUNDELL DR, 1984, AGENTS ACTIONS, V14, P484, DOI 10.1007/BF01973855; FALK W, 1980, J IMMUNOL METHODS, V33, P239, DOI 10.1016/S0022-1759(80)80014-7; HUMMEL BCW, 1959, CAN J BIOCHEM PHYS, V37, P1393, DOI 10.1139/o59-157; JAQUES LB, 1967, CAN J PHYSIOL PHARM, V45, P787, DOI 10.1139/y67-093; KOPP DE, 1986, J ALLERGY CLIN IMMUN, V77, P302, DOI 10.1016/S0091-6749(86)80108-7; LEE TH, 1982, J CLIN INVEST, V69, P889, DOI 10.1172/JCI110528; LEMANSKE R, 1982, CRC CRIT REV IMMUNOL, V1, P547; LEMANSKE RF, 1983, J ALLERGY CLIN IMMUN, V72, P94, DOI 10.1016/0091-6749(83)90058-1; LEMANSKE RF, 1983, J IMMUNOL, V130, P1881; LEMANSKE RF, 1983, J IMMUNOL, V131, P929; LEMANSKE RF, 1983, J IMMUNOL, V130, P2837; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NACLERIO RM, 1985, NEW ENGL J MED, V313, P65, DOI 10.1056/NEJM198507113130201; OERTEL HL, 1981, J IMMUNOL, V127, P1398; RAPHAEL GD, 1978, EXP CELL RES, V115, P428, DOI 10.1016/0014-4827(78)90300-2; ROBERTSON DG, 1974, J ALLERGY CLIN IMMUN, V54, P54; SCHICK B, 1984, J IMMUNOL, V132, P2571; SCHWARTZ LB, 1980, J INVEST DERMATOL, V74, P349, DOI 10.1111/1523-1747.ep12543620; SEPPA H, 1980, INFLAMMATION, V4, P1, DOI 10.1007/BF00914098; SHAMPAIN MP, 1982, AM REV RESPIR DIS, V126, P493; SIRAGANIAN RP, 1976, MANUAL CLIN IMMUNOLO, P603; SOLLEY GO, 1976, J CLIN INVEST, V58, P408, DOI 10.1172/JCI108485; SOTTER NA, 1979, J INVEST DERM, V72, P282; SULLIVAN TJ, 1975, J IMMUNOL, V114, P1473; TANNENBAUM S, 1980, J IMMUNOL, V125, P325; VARTIO T, 1981, J BIOL CHEM, V256, P471; WASSERMAN SI, 1977, J CLIN INVEST, V60, P189, DOI 10.1172/JCI108756; WIESLANDER E, 1985, AGENTS ACTIONS, V16, P37, DOI 10.1007/BF01999639; WILKINSON PC, 1978, LEUKOCYTE CHEMOTAXIS, V1; ZIGMOND SH, 1973, J EXP MED, V137, P387, DOI 10.1084/jem.137.2.387	33	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					32	39		10.1016/S0091-6749(87)80013-1	http://dx.doi.org/10.1016/S0091-6749(87)80013-1			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810	3805545				2022-12-18	WOS:A1987F881000009
J	MOTOJIMA, S; DUNNETTE, SL; FRIGAS, E; GLEICH, GJ				MOTOJIMA, S; DUNNETTE, SL; FRIGAS, E; GLEICH, GJ			CREOLA BODIES AND EOSINOPHIL GRANULE PROTEINS IN SPUTA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					128	128						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000036
J	OEI, HD; VERHEIJ, E; SCHWAB, D; LHERMINIER, M; BRUYNZEEL, PLB				OEI, HD; VERHEIJ, E; SCHWAB, D; LHERMINIER, M; BRUYNZEEL, PLB			A COMPARATIVE-STUDY OF THE EFFICACY OF LORATADINE (L) AND ASTEMIZOLE (A)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					190	190						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000285
J	PROUD, D; REYNOLDS, CJ; LACAPRA, S; KAGEYSOBOTKA, A; LICHTENSTEIN, LM; NACLERIO, RM				PROUD, D; REYNOLDS, CJ; LACAPRA, S; KAGEYSOBOTKA, A; LICHTENSTEIN, LM; NACLERIO, RM			THE RESPONSE TO NASAL PROVOCATION WITH BRADYKININ	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					254	254						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000539
J	ZWEIMAN, B; KORNSTEIN, M; ATKINS, P				ZWEIMAN, B; KORNSTEIN, M; ATKINS, P			IMMUNOHISTOLOGIC STUDIES OF LATE CUTANEOUS ALLERGIC REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					169	169						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000201
J	ALLANSMITH, MR; CORNELLBELL, AH; BAIRD, RS; BLOCH, KJ; ASKENASE, PW				ALLANSMITH, MR; CORNELLBELL, AH; BAIRD, RS; BLOCH, KJ; ASKENASE, PW			CONJUNCTIVAL BASOPHIL HYPERSENSITIVITY IN THE GUINEA-PIG	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,EYE RES INST,IMMUNOL UNIT,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,CLIN IMMUNOL UNIT,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,ALLERGY UNIT,BOSTON,MA 02114; YALE UNIV,SCH MED,DEPT MED,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT PATHOL,NEW HAVEN,CT 06510	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Yale University; Yale University	ALLANSMITH, MR (corresponding author), HARVARD UNIV,SCH MED,DEPT OPHTHALMOL,BOSTON,MA 02115, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI012211, R37AI012211] Funding Source: NIH RePORTER; NEI NIH HHS [EY05263, EY05858] Funding Source: Medline; NIAID NIH HHS [AI-12211] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABELSON MB, 1980, OPHTHALMOLOGY, V87, P812; ALLANSMITH MR, 1981, IMMUNOLOGY, V44, P623; ALLANSMITH MR, 1979, AM J OPHTHALMOL, V87, P544, DOI 10.1016/0002-9394(79)90247-2; ALLANSMITH MR, 1977, AM J OPHTHALMOL, V83, P697, DOI 10.1016/0002-9394(77)90137-4; ALLANSMITH MR, 1979, IMMUNOLOGY IMMUNOPAT, P346; ALLANSMITH MR, 1982, CLIN OPHTHALMOLOGY, V4, pCH9; Askenase P W, 1977, Prog Allergy, V23, P199, DOI 10.1159/000314242; ASKENASE PW, 1976, J IMMUNOL, V117, P216; ASKENASE PW, 1976, J IMMUNOL, V117, P741; ASKENASE PW, 1978, IMMUNOLOGY, V35, P741; ASKENASE PW, 1976, J CLIN INVEST, V58, P1145, DOI 10.1172/JCI108567; COLLIN HB, 1977, INVEST OPHTH VIS SCI, V16, P858; COLVIN RB, 1973, J IMMUNOL, V110, P1279; CORNELLBELL AH, 1986, CELL IMMUNOL, V97, P1, DOI 10.1016/0008-8749(86)90369-2; DESAULES M, 1982, IMMUNOLOGY, V46, P381; DVORAK AM, 1976, LAB INVEST, V34, P179; DVORAK HF, 1971, J IMMUNOL, V107, P138; DVORAK HF, 1974, LAB INVEST, V31, P111; DVORAK HF, 1971, NEW ENGL J MED, V285, P54; DVORAK HF, 1970, J EXP MED, V132, P558, DOI 10.1084/jem.132.3.558; DVORAK HF, 1974, PROGR IMMUNOLOGY, V3, P171; FRIEDLAENDER MH, 1979, INVEST OPHTH VIS SCI, V18, P964; FRIEDLAENDER MH, 1977, J IMMUNOL, V118, P1558; KARNOVASKY MORRIS J., 1967, J CELL BIOL, V35, P213, DOI 10.1083/jcb.35.1.213; PUTT FA, 1972, MANUAL HISTOPATHOLOG, P15; ROITT I, 1980, ESSENTIAL IMMUNOLOGY, P232; STOCK EL, 1983, CURR EYE RES, V2, P887; UDELL IJ, 1981, AM J OPHTHALMOL, V92, P824, DOI 10.1016/S0002-9394(14)75637-5; WAKSMAN BH, 1960, AM J PATHOL, V37, P673	30	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1986	78	5	1				919	927		10.1016/0091-6749(86)90241-1	http://dx.doi.org/10.1016/0091-6749(86)90241-1			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E9713	3782659				2022-12-18	WOS:A1986E971300016
J	KATZ, DH				KATZ, DH			IMMUNOLOGICAL ALTERATIONS RELATED TO EXPRESSION OF THE ALLERGIC PHENOTYPE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									QUIDEL,LA JOLLA,CA		KATZ, DH (corresponding author), MED BIOL INST,DEPT IMMUNOL,11077 N TORREY PINES RD,LA JOLLA,CA 92037, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019476, R01AI019477] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-19477, AI-19476] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHEN SS, 1981, J IMMUNOL, V127, P166; FRITSCHE R, 1978, J IMMUNOL, V121, P471; GONZALEZMOLINA A, 1977, J CLIN INVEST, V59, P616, DOI 10.1172/JCI108679; HOOVER RG, 1981, IMMUNOL REV, V56, P115, DOI 10.1111/j.1600-065X.1981.tb01049.x; ISHIZAKA K, 1984, PROGR IMMUNOLOGY, V5, P455; Katz D H, 1980, Prog Clin Immunol, V4, P127; KATZ DH, 1979, J IMMUNOL, V122, P2184; KATZ DH, 1980, IMMUNOLOGY, V41, P1; KATZ DH, 1979, J IMMUNOL, V122, P2191; KATZ DH, 1984, ALLERGY, V39, P81, DOI 10.1111/j.1398-9995.1984.tb01940.x; KATZ DH, 1982, PROG ALLERGY, V32, P105; KATZ DH, 1984, J MOL CELL IMMUNOL, V1, P157; KATZ DH, 1977, LYMPHOCYTE DIFFERENT, P382; KATZ DH, 1983, PROG IMMUNOL P INT C, V5, P465; KATZ DH, 1982, HUMAN B LYMPHOCYTE F, P181; LIU FT, 1980, J IMMUNOL, V124, P2728; MARCELLETTI JF, 1984, J IMMUNOL, V133, P2837; MARCELLETTI JF, 1984, J IMMUNOL, V133, P2845; MARCELLETTI JF, 1984, J IMMUNOL, V133, P2829; MARCELLETTI JF, 1984, J IMMUNOL, V133, P2821; NONAKA M, 1981, J EXP MED, V153, P1574, DOI 10.1084/jem.153.6.1574; NONAKA N, 1984, CLIN RES, V32, pA507; YODOI J, 1979, J IMMUNOL, V122, P2577; YODOI J, 1979, J IMMUNOL, V123, P455; ZURAW BL, 1981, J IMMUNOL, V127, P1169	25	7	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1986	78	5	2	S			980	987		10.1016/0091-6749(86)90289-7	http://dx.doi.org/10.1016/0091-6749(86)90289-7			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E9719	2946754				2022-12-18	WOS:A1986E971900010
J	LESTER, LA; ROTHBERG, RM; KRANTMAN, HJ; SHERMETA, DW				LESTER, LA; ROTHBERG, RM; KRANTMAN, HJ; SHERMETA, DW			INTESTINAL LYMPHANGIECTASIA AND BILATERAL PLEURAL EFFUSIONS - EFFECT OF DIETARY THERAPY AND SURGICAL INTERVENTION ON IMMUNOLOGICAL AND PULMONARY PARAMETERS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											LESTER, LA (corresponding author), UNIV CHICAGO,DEPT PEDIAT,5841 SO MARYLAND AVE,BOX 133,CHICAGO,IL 60637, USA.							AIUTI F, 1975, CLIN IMMUNOL IMMUNOP, V3, P584, DOI 10.1016/0090-1229(75)90083-5; BRIGHAM KL, 1979, PULMONARY EDEMA, P161; FERNANDEZ B, 1976, ANN NY ACAD SCI, V278, P86; GRAY H, 1954, ANATOMY HUMAN BODY, P768; HOLT PR, 1964, PEDIATRICS, V33, P629; HSU KHK, 1979, J PEDIATR-US, V95, P14, DOI 10.1016/S0022-3476(79)80075-X; LINDSTEN T, 1982, J IMMUNOL, V129, P2536; MISTILIS SP, 1965, LANCET, V1, P77; NELSON LA, 1978, PEDIATRICS, V61, P703; Polgar G, 1971, PULMONARY FUNCTION T; ROSS JD, 1971, THORAX, V26, P119, DOI 10.1136/thx.26.1.119; STROBER W, 1984, TXB GASTROENTEROLOGY, P606; TIFT WL, 1975, ARCH DIS CHILD, V50, P26; VARDY PA, 1975, PEDIATRICS, V55, P842; VREIM CE, 1976, AM J PHYSIOL, V230, P1650, DOI 10.1152/ajplegacy.1976.230.6.1650; WALDMANN TA, 1965, J CLIN INVEST, V44, P1523, DOI 10.1172/JCI105259; WEIDEN PL, 1972, J CLIN INVEST, V51, P1319, DOI 10.1172/JCI106928; WEIDNER WA, 1971, RADIOLOGY, V100, P533, DOI 10.1148/100.3.533	18	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1986	78	5	1				891	897		10.1016/0091-6749(86)90236-8	http://dx.doi.org/10.1016/0091-6749(86)90236-8			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E9713	3782656				2022-12-18	WOS:A1986E971300011
J	PEPYS, J				PEPYS, J			OCCUPATIONAL ALLERGIC LUNG-DISEASE CAUSED BY ORGANIC-AGENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV LONDON IMPERIAL COLL SCI & TECHNOL,DEPT CLIN IMMUNOL,LONDON SW7 2AZ,ENGLAND	Imperial College London								BOROS DL, 1973, IMMUNOLOGY, V24, P511; BRYANT DH, 1973, BRIT MED J, V4, P589, DOI 10.1136/bmj.4.5892.589; BURGE PS, 1980, CLIN ALLERGY, V10, P355, DOI 10.1111/j.1365-2222.1980.tb02119.x; BURGE PS, 1984, CLIN IMMUNOL ALLERGY, P55; CHANYEUNG M, 1982, AM J MED, V72, P411, DOI 10.1016/0002-9343(82)90497-1; CHANYEUNG M, 1982, J ALLERGY CLIN IMMUN, V70, P32, DOI 10.1016/0091-6749(82)90198-1; CHANYEUNG M, 1980, J ALLERGY CLIN IMMUN, V65, P333, DOI 10.1016/0091-6749(80)90209-2; CHAPMAN MD, 1983, 11TH P INT C ALL CLI, P531; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P503, DOI 10.1111/j.1365-2222.1977.tb01481.x; CUTHBERT OD, 1984, CLIN ALLERGY, V14, P197, DOI 10.1111/j.1365-2222.1984.tb02653.x; CUTHBERT OD, 1979, CLIN ALLERGY, V9, P229, DOI 10.1111/j.1365-2222.1979.tb01547.x; CUTHBERT OD, 1981, CLIN ALLERGY, V11, P217, DOI 10.1111/j.1365-2222.1981.tb01587.x; DAVIES RJ, 1976, AM REV RESPIR DIS, V114, P1011; DAVIES RJ, 1983, ALLERGY PRINCIPLES P, P1037; DAVIES RJ, 1975, J ALLERGY CLIN IMMUN, V56, P417; EDWARDS JH, 1976, CLIN ALLERGY, V6, P19, DOI 10.1111/j.1365-2222.1976.tb01408.x; EDWARDS JH, 1980, BRIT J IND MED, V37, P55; EDWARDS JH, 1981, CLIN ALLERGY, V11, P227, DOI 10.1111/j.1365-2222.1981.tb01588.x; EDWARDS JH, 1976, NATURE, V264, P438, DOI 10.1038/264438a0; EVANS E, 1974, BRIT J IND MED, V31, P28; FINK JN, 1971, ANN INTERN MED, V74, P80, DOI 10.7326/0003-4819-74-1-80; FRIEND JAR, 1977, LANCET, V1, P297; GRANT IWB, 1972, BRIT MED J, V1, P530, DOI 10.1136/bmj.1.5799.530; GWYNN CM, 1982, LANCET, V1, P254; GWYNN CM, 1982, CLIN ALLERGY, V12, P459, DOI 10.1111/j.1365-2222.1982.tb01644.x; HARGREAVE FE, 1974, CAN MED ASSOC J, V110, P415; HENDRICK DJ, 1984, CLIN IMMUNOL ALLERGY, P37; JONES RN, 1982, AM REV RESPIR DIS, V125, P199; KESKINEN H, 1983, 11TH P INT C ALL CLI, P403; LACEY J, 1972, SAFETY MICROBIOLOGY, P151; LONGBOTTOM JL, 1984, CLIN IMMUNOL ALLERGY, P23; McCarthy D S, 1971, Clin Allergy, V1, P415, DOI 10.1111/j.1365-2222.1971.tb00793.x; McCarthy DS, 1971, CLIN ALLERGY, V1, P261, DOI DOI 10.1111/J.1365-2222.1971.TB; MOLINA C, 1984, CLIN IMMUNOLOGY ALLE, P173; NEWMANTAYLOR A, 1977, LANCET, V2, P847; NEWMANTAYLOR AJ, 1979, CLIN ALLERGY, V9, P213; PEPYS J, 1973, CLIN ALLERGY, V3, P491, DOI 10.1111/j.1365-2222.1973.tb03057.x; PEPYS J, 1975, AM REV RESPIR DIS, V112, P829; PEPYS J, 1963, LANCET, V2, P607; PEPYS J, 1965, THORAX, V20, P21, DOI 10.1136/thx.20.1.21; PEPYS J, 1979, CLIN ALLERGY, V9, P99, DOI 10.1111/j.1365-2222.1979.tb01528.x; PEPYS J, 1969, MONOGR ALLERGY, V4, P71; PICKERING CAC, 1976, CLIN ALLERGY, V6, P109, DOI 10.1111/j.1365-2222.1976.tb01888.x; SPECTOR WG, 1969, J PATHOL, V98, P31, DOI 10.1002/path.1710980105; WARREN CPW, 1977, CLIN ALLERGY, V7, P303, DOI 10.1111/j.1365-2222.1977.tb01458.x	45	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1986	78	5	2	S			1058	1062		10.1016/0091-6749(86)90305-2	http://dx.doi.org/10.1016/0091-6749(86)90305-2			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E9719	3782667	Bronze			2022-12-18	WOS:A1986E971900026
J	GRANT, JA; ELLIS, EF				GRANT, JA; ELLIS, EF			SYMPOSIUM PROCEEDINGS - UPDATE ON THEOPHYLLINE, SEPTEMBER 4-6, 1985 BETHESDA, MARYLAND - OPENING REMARKS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									SUNY BUFFALO,PEDIAT,BUFFALO,NY 14260	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	GRANT, JA (corresponding author), UNIV TEXAS,MED BRANCH,DIV ALLERGY,GALVESTON,TX 77550, USA.								0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1986	78	4	2				669	669		10.1016/0091-6749(86)90043-6	http://dx.doi.org/10.1016/0091-6749(86)90043-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E5684					2022-12-18	WOS:A1986E568400001
J	SPECTOR, SL; LEWIS, CE				SPECTOR, SL; LEWIS, CE			WORKSHOP 6 - COMPLIANCE FACTORS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											SPECTOR, SL (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,LOS ANGELES,CA 90024, USA.			Haynes, Robert Brian/0000-0002-1453-3196				AYD FJ, 1974, JAMA-J AM MED ASSOC, V230, P263, DOI 10.1001/jama.230.2.263; CLARK NM, 1981, HEALTH EDUC QUART, V8, P166, DOI 10.1177/109019818100800203; COLCHER IS, 1972, J AMER MED ASSOC, V222, P657, DOI 10.1001/jama.222.6.657; CREER TL, 1985, BIOL BARRIERS BEHAVI, P37; DAVIS MS, 1968, MED CARE, V6, P115, DOI 10.1097/00005650-196803000-00003; DIRKS JF, 1982, CLIN PHARMACOL THER, V31, P413, DOI 10.1038/clpt.1982.53; ENEY RD, 1976, PEDIATRICS, V57, P513; FOX W, 1961, B INT UNION TUBERC, V32, P307; Gatley M S, 1968, J R Coll Gen Pract, V16, P39; GORDIS L, 1969, PEDIATRICS, V43, P173; HAYNES RB, 1985, B NY ACAD MED, V16, P123; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; KINSMAN RA, 1980, J PSYCHOSOM RES, V24, P97, DOI 10.1016/0022-3999(80)90059-8; KLEIGER JH, 1979, J ASTHMA RES, V16, P93, DOI 10.3109/02770907909106618; LEWIS CE, 1984, PEDIATRICS, V74, P478; MARSTON MV, 1970, NURS RES, V19, P312; MATTHEWS D, 1977, MED CLIN N AM, V61, P879, DOI 10.1016/S0025-7125(16)31304-9; MILLER KA, 1982, J ADOLESC HLTH CARE, V3, P117; RADIUS SM, 1978, J ASTHMA RES, V15, P133, DOI 10.3109/02770907809106598; SMITH NA, 1984, AUST PAEDIATR J, V20, P47; SPECTOR SL, 1986, J ALLERGY CLIN IMMUN, V77, P65, DOI 10.1016/0091-6749(86)90325-8; SUBLETT JL, 1979, ANN ALLERGY, V43, P95; TINKELMAN DG, 1980, ANN ALLERGY, V44, P283; 1981, JUN C CTR INT RES IM, V1; 1984, PRESCRIPTION DRUGS S	25	7	7	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1986	78	3	2				529	533		10.1016/0091-6749(86)90100-4	http://dx.doi.org/10.1016/0091-6749(86)90100-4			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E1151					2022-12-18	WOS:A1986E115100008
J	STRICKER, WE; LAYTON, JE; HOMBURGER, HA; KATZMANN, JA; SWANSON, MC; HYATT, RE; REED, CE				STRICKER, WE; LAYTON, JE; HOMBURGER, HA; KATZMANN, JA; SWANSON, MC; HYATT, RE; REED, CE			IMMUNOLOGICAL RESPONSE TO AEROSOLS OF AFFINITY-PURIFIED ANTIGEN IN HYPERSENSITIVITY PNEUMONITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MAYO CLIN & MAYO FDN,ALLERG DIS & INTERNAL MED SECT,200 1ST ST SW,ROCHESTER,MN 55905	Mayo Clinic								ALTSHULER B, 1967, INHALED PARTICLES VA; BANASZAK EF, 1970, NEW ENGL J MED, V283, P271, DOI 10.1056/NEJM197008062830601; BERNARDO J, 1979, AM REV RESPIR DIS, V120, P985; CALVANICO NJ, 1980, J LAB CLIN MED, V96, P129; COSTABEL U, 1984, CHEST, V85, P514, DOI 10.1378/chest.85.4.514; EDWARDS JH, 1976, NATURE, V264, P438, DOI 10.1038/264438a0; FINK JN, 1975, INT ARCH ALLER A IMM, V49, P831, DOI 10.1159/000231466; FLAHERTY DK, 1984, INFECT IMMUN, V43, P206, DOI 10.1128/IAI.43.1.206-212.1984; FLAHERTY DK, 1984, INFECT IMMUN, V43, P213, DOI 10.1128/IAI.43.1.213-216.1984; FLAHERTY DK, 1976, AM REV RESPIR DIS, V114, P1093; HANSEN PJ, 1974, INT ARCH ALLER A IMM, V47, P498, DOI 10.1159/000231244; HARGREAVE F, 1972, Clinical Radiology, V23, P1, DOI 10.1016/S0009-9260(72)80126-0; KOHLER PF, 1976, CHEST, V69, P294; LEATHERMAN JW, 1984, ANN INTERN MED, V100, P390, DOI 10.7326/0003-4819-100-3-390; MARX JJ, 1978, J ALLERGY CLIN IMMUN, V62, P185, DOI 10.1016/0091-6749(78)90105-7; McCarthy DS, 1971, CLIN ALLERGY, V1, P261, DOI DOI 10.1111/J.1365-2222.1971.TB; MOORE V, 1978, J ALLERGY CLIN IMMUN, V61, P210, DOI 10.1016/0091-6749(78)90182-3; MOORE VL, 1980, J ALLERGY CLIN IMMUN, V65, P365, DOI 10.1016/0091-6749(80)90214-6; MOORE VL, 1974, J ALLERGY CLIN IMMUN, V53, P319, DOI 10.1016/0091-6749(74)90115-8; MORELL F, 1982, J ALLERGY CLIN IMMUN, V69, P405, DOI 10.1016/0091-6749(82)90114-2; PATTERSON R, 1979, AM REV RESPIR DIS, V120, P1113; PICKERING CAC, 1982, EUR J RESPIR DIS, V63, P104; RAMAZZINI B, 1940, MORBUS ARTIFICUM DIA; RANKIN J, 1967, MED CLIN N AM, V51, P495; REED CE, 1965, J AMER MED ASSOC, V193, P261, DOI 10.1001/jama.1965.03090040005001; REED CE, 1983, J OCCUP ENVIRON MED, V25, P207, DOI 10.1097/00043764-198303000-00014; REED CE, 1974, PROG IMMUNOL, V4, P271; REYNOLDS HY, 1982, CLIN CHEST MED, V3, P503; SCHLUETER DP, 1969, ANN INTERN MED, V70, P457, DOI 10.7326/0003-4819-70-3-457; SOLOMON WR, 1974, J ALLERGY CLIN IMMUN, V54, P222, DOI 10.1016/0091-6749(74)90064-5; UNGER JD, 1968, RADIOLOGY, V90, P683, DOI 10.1148/90.4.683	31	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1986	78	3	1				411	416		10.1016/0091-6749(86)90026-6	http://dx.doi.org/10.1016/0091-6749(86)90026-6			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E1148	3760400	Bronze			2022-12-18	WOS:A1986E114800007
J	GRANT, JA; LETTBROWN, MA				GRANT, JA; LETTBROWN, MA			BRONCHIAL-ASTHMA, LEUKOCYTE SYNTHESIS OF SLOW-REACTING SUBSTANCE OF ANAPHYLAXIS, AND OTHER EVIDENCE FOR ACTIVATION OF BLOOD-CELLS IN ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											GRANT, JA (corresponding author), UNIV TEXAS,MED BRANCH,DEPT MED,DIV ALLERGY,GALVESTON,TX 77550, USA.							ALAM R, 1985, ALLERGY, V40, P124, DOI 10.1111/j.1398-9995.1985.tb02671.x; ALAM R, 1984, ANN ALLERGY, V53, P66; ATKINS PC, 1985, J ALLERGY CLIN IMMUN, V75, P239, DOI 10.1016/0091-6749(85)90052-1; BLEECKER ER, 1985, J ALLERGY CLIN IMMUN, V75, P21, DOI 10.1016/0091-6749(85)90006-5; BOOIJNOORD H, 1971, J ALLERGY CLIN IMMUN, V48, P344, DOI 10.1016/0091-6749(71)90080-7; BROCKLEHURST WE, 1960, J PHYSIOL-LONDON, V151, P416, DOI 10.1113/jphysiol.1960.sp006449; CONROY MC, 1976, J IMMUNOL, V116, P1677; DAHLEN SE, 1983, P NATL ACAD SCI-BIOL, V80, P1712, DOI 10.1073/pnas.80.6.1712; DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373; DUNNILL MS, 1971, IDENTIFICATION ASTHM, P35; EZEAMUZIE IC, 1983, AGENTS ACTIONS, V13, P222, DOI 10.1007/BF01967337; EZEAMUZIE IC, 1985, AGENTS ACTIONS, V7, P533; Feldberg W, 1938, J PHYSIOL-LONDON, V94, P187, DOI 10.1113/jphysiol.1938.sp003674; FINDLAY SR, 1980, J IMMUNOL, V124, P238; FINDLAY SR, 1980, AM REV RESPIR DIS, V122, P53; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; GERBLICH AA, 1984, NEW ENGL J MED, V310, P1349, DOI 10.1056/NEJM198405243102103; GIN W, 1985, J ALLERGY CLIN IMMUN, V76, P675, DOI 10.1016/0091-6749(85)90670-0; GLEICH GJ, 1982, J ALLERGY CLIN IMMUN, V70, P160, DOI 10.1016/0091-6749(82)90037-9; GLEICH GJ, 1985, CHEST S, V87, P10; GOETZL EJ, 1984, IMMUNOLOGY, V53, P227; GOSSET P, 1984, J ALLERGY CLIN IMMUN, V74, P827, DOI 10.1016/0091-6749(84)90186-6; GRANT JA, 1974, J IMMUNOL, V112, P897; HAYES EC, 1983, J IMMUNOL, V131, P429; HOLTZMAN MJ, 1983, BIOCHEM BIOPH RES CO, V114, P1071, DOI 10.1016/0006-291X(83)90671-X; HOWARTH PH, 1984, J ALLERGY CLIN IMMUN, V73, P391, DOI 10.1016/0091-6749(84)90414-7; ISONO T, 1985, BIOCHEM BIOPH RES CO, V130, P486, DOI 10.1016/0006-291X(85)90443-7; KALINER MM, 1984, J ALLERGY CLIN IMMUN, V73, P311, DOI 10.1016/0091-6749(84)90401-9; KAPLAN AP, 1985, J IMMUNOL, V135, P2027; LARSEN GL, 1985, J ALLERGY CLIN IMMUN, V76, P665, DOI 10.1016/0091-6749(85)90668-2; LETTBROWN MA, 1984, CELL IMMUNOL, V87, P434, DOI 10.1016/0008-8749(84)90012-1; LETTBROWN MA, 1984, CELL IMMUNOL, V87, P445, DOI 10.1016/0008-8749(84)90013-3; LEWIS RA, 1975, J IMMUNOL, V114, P87; LEWIS RA, 1984, J CLIN INVEST, V73, P889, DOI 10.1172/JCI111312; LEWIS RA, 1985, J ALLERGY CLIN IMMUN, V76, P259, DOI 10.1016/0091-6749(85)90639-6; MACGLASHAN DW, 1982, J CLIN INVEST, V70, P747, DOI 10.1172/JCI110670; MACGLASHAN DW, J IMMUNOL; MARONE G, 1985, INT ARCH ALLER A IMM, V76, P70, DOI 10.1159/000233737; MATHEWS WR, 1981, ANAL BIOCHEM, V118, P96, DOI 10.1016/0003-2697(81)90162-7; MCGETTIGAN MC, 1985, J ALLERGY CLIN IMMUN, V75, P110, DOI 10.1016/0091-6749(85)90156-3; METZGER WJ, 1985, CHEST, V87, P16; MITA H, 1985, LIFE SCI, V37, P907, DOI 10.1016/0024-3205(85)90526-0; NACLERIO RM, 1985, NEW ENGL J MED, V313, P65, DOI 10.1056/NEJM198507113130201; NAGY L, 1982, NEW ENGL J MED, V306, P497, DOI 10.1056/NEJM198203043060901; PEPYS J, 1975, AM REV RESPIR DIS, V112, P829; PETERS SP, 1986, HIGHLIGHTS ASTHMOLOG; ROBINSON C, 1985, J ALLERGY CLIN IMMUN, V76, P140, DOI 10.1016/0091-6749(85)90691-8; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; SANO Y, 1983, J ALLERGY CLIN IMMUN, V72, P495, DOI 10.1016/0091-6749(83)90587-0; SCHULMAN ES, 1985, AM REV RESPIR DIS, V131, P230; SEDGWICK JD, 1981, CLIN EXP IMMUNOL, V45, P409; SHAW JO, 1981, J IMMUNOL, V127, P1250; SHEFFER AL, 1985, J ALLERGY CLIN IMMUN, V76, P249, DOI 10.1016/0091-6749(85)90637-2; THUESON DO, 1979, J IMMUNOL, V123, P633; THUESON DO, 1979, J IMMUNOL, V123, P626; THUESON DO, 1982, HUMAN LYMPHOKINES BI, P229; TOMIOKA M, 1984, AM REV RESPIR DIS, V129, P1000; WANG SR, 1986, J ALLERGY CLIN IMMUN, V77, P465, DOI 10.1016/0091-6749(86)90181-8; WARNER J, 1985, FED PROC, V44, P1682; WELLER PF, 1983, P NATL ACAD SCI-BIOL, V80, P7626, DOI 10.1073/pnas.80.24.7626; WILLIAMS JD, 1984, J IMMUNOL, V132, P3034	61	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1986	77	3					407	410		10.1016/0091-6749(86)90174-0	http://dx.doi.org/10.1016/0091-6749(86)90174-0			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	A5367	2419381	Bronze			2022-12-18	WOS:A1986A536700003
J	KEMP, JP; PINNAS, JL; TINKELMAN, DG; MELTZER, EO; CAMPBELL, SC; ORGEL, HA; WELCH, MJ; MINGO, TS				KEMP, JP; PINNAS, JL; TINKELMAN, DG; MELTZER, EO; CAMPBELL, SC; ORGEL, HA; WELCH, MJ; MINGO, TS			COMPARISON OF BRONCHODILATOR RESPONSES WITH BITOLTEROL MESYLATE SOLUTION WITH THE USE OF 2 DIFFERENT NEBULIZER SYSTEMS IN ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									ALLERGY & ASTHMA MED GRP,SAN DIEGO,CA									BACON, 1978, LANCET, V1, P158; CUSHLEY MJ, 1981, THORAX, V36, P714; GODFREY S, 1981, ANN ALLERGY, V47, P423; GRIMWOOD K, 1981, BRIT MED J, V282, P105, DOI 10.1136/bmj.282.6258.105; KEMP JP, 1984, J ALLERGY CLIN IMMUN, V73, P32, DOI 10.1016/0091-6749(84)90481-0; KJELLMAN B, 1980, ALLERGY, V35, P605, DOI 10.1111/j.1398-9995.1980.tb01811.x; KONIG P, 1978, ANN ALLERGY, V40, P185; KONIG P, 1983, ARCH INTERN MED, V143, P1361, DOI 10.1001/archinte.143.7.1361; KRADJAN WA, 1985, CHEST, V87, P512, DOI 10.1378/chest.87.4.512; LAWFORD P, 1978, BRIT MED J, V1, P84, DOI 10.1136/bmj.1.6105.84; MILNER AD, 1971, ARCH DIS CHILD, V46, P502, DOI 10.1136/adc.46.248.502; PEERLESS AG, 1983, J ALLERGY CLIN IMMUN, V72, P702, DOI 10.1016/0091-6749(83)90633-4; PIERCE RJ, 1981, CHEST, V79, P506, DOI 10.1378/chest.79.5.506; PINNAS J L, 1984, Journal of Allergy and Clinical Immunology, V73, P132; REILLY PA, 1983, J PEDIATR-US, V103, P121, DOI 10.1016/S0022-3476(83)80797-5; ROSSING TH, 1977, AM REV RESPIR DIS, V116, P861; SHIM CS, 1984, J ALLERGY CLIN IMMUN, V73, P387, DOI 10.1016/0091-6749(84)90413-5; STAINFORTH JN, 1983, THORAX, V38, P751, DOI 10.1136/thx.38.10.751; TARALA RA, 1980, BRIT J CLIN PHARMACO, V10, P393; TATTERSFIELD AE, 1983, ASTHMA, P301; WALTERS EH, 1981, THORAX, V36, P625, DOI 10.1136/thx.36.8.625; WEBBER BA, 1982, BRIT J DIS CHEST, V76, P69, DOI 10.1016/0007-0971(82)90010-9; WEBBER BA, 1974, AM REV RESPIR DIS, V109, P293; WEBER RW, 1979, J ALLERGY CLIN IMMUN, V63, P116, DOI 10.1016/0091-6749(79)90201-X	24	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1986	77	3					509	515		10.1016/0091-6749(86)90187-9	http://dx.doi.org/10.1016/0091-6749(86)90187-9			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	A5367	3950254				2022-12-18	WOS:A1986A536700016
J	DAUL, CB; DESHAZO, RD; ANDES, WA; PANKEY, GA				DAUL, CB; DESHAZO, RD; ANDES, WA; PANKEY, GA			IMMUNOLOGICAL STUDIES IN HOMOSEXUAL AND HEMOPHILIAC SUBJECTS WITH PERSISTENT GENERALIZED LYMPHADENOPATHY - A COMPARATIVE-ANALYSIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									TULANE UNIV,SCH MED,DEPT PEDIAT,HEMATOL ONCOL SECT,NEW ORLEANS,LA 70112; OSCHNER MED INST,NEW ORLEANS,LA	Tulane University	DAUL, CB (corresponding author), TULANE UNIV,SCH MED,DEPT MED,HERBERT F HARVEY LAB,CLIN IMMUNOL SECT,1700 PERDIDO ST,NEW ORLEANS,LA 70112, USA.				NCI NIH HHS [CA34977] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA034977] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BENVENISTE E, 1983, J CLIN IMMUNOL, V3, P359, DOI 10.1007/BF00915797; BIGGAR RJ, 1984, JAMA-J AM MED ASSOC, V251, P1441, DOI 10.1001/jama.251.11.1441; BOX GEP, 1978, STATISTICS EXPERIMEN, P204; DAUL CB, 1983, ANN ALLERGY, V51, P351; DESHAZO RD, 1983, ANN INTERN MED, V99, P159, DOI 10.7326/0003-4819-99-2-159; DESHAZO RD, 1984, ARCH INTERN MED, V144, P1153, DOI 10.1001/archinte.144.6.1153; FAHEY JL, 1983, NEW ENGL J MED, V308, P842; FAHEY JL, 1984, AM J MED, V76, P95, DOI 10.1016/0002-9343(84)90756-3; GOLDSMITH JC, 1983, ANN INTERN MED, V98, P294, DOI 10.7326/0003-4819-98-3-294; HURTENBACH U, 1982, J EXP MED, V155, P1719, DOI 10.1084/jem.155.6.1719; JENNRICH R, 1981, BMDP 81 STATISTICAL, P540; KLOSTER BE, 1984, CLIN IMMUNOL IMMUNOP, V30, P330, DOI 10.1016/0090-1229(84)90066-7; KORNFELD H, 1982, NEW ENGL J MED, V307, P729, DOI 10.1056/NEJM198209163071206; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; LEDERMAN MM, 1983, NEW ENGL J MED, V308, P79, DOI 10.1056/NEJM198301133080205; MAVLIGIT GM, 1984, JAMA-J AM MED ASSOC, V251, P237, DOI 10.1001/jama.251.2.237; MENITOVE JE, 1983, NEW ENGL J MED, V308, P83, DOI 10.1056/NEJM198301133080206; METROKA CE, 1983, ANN INTERN MED, V99, P585, DOI 10.7326/0003-4819-99-5-585; MILLER B, 1984, JAMA-J AM MED ASSOC, V251, P242, DOI 10.1001/jama.251.2.242; MORRIS L, 1982, ANN INTERN MED, V96, P714, DOI 10.7326/0003-4819-96-6-714; MORRISON D, 1976, MULTIVARIATE STATIST, P134; REINHERZ EL, 1980, J IMMUNOL, V125, P1269; REINHERZ EL, 1979, P NATL ACAD SCI USA, V76, P4061, DOI 10.1073/pnas.76.8.4061; REMINGTON RD, 1970, STATISTICS APPLICATI, P253; RINALDO CR, 1980, J INFECT DIS, V141, P488, DOI 10.1093/infdis/141.4.488; SAIDI P, 1983, NEW ENGL J MED, V308, P1291; SHEARER GM, 1983, NEW ENGL J MED, V308, P223, DOI 10.1056/NEJM198301273080415; STAHL RE, 1982, AM J MED, V73, P171, DOI 10.1016/0002-9343(82)90174-7; WALLACE JI, 1982, LANCET, V1, P908; [No title captured]; 1982, MMWR, V31, P249	31	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1986	77	2					295	301		10.1016/S0091-6749(86)80107-5	http://dx.doi.org/10.1016/S0091-6749(86)80107-5			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	A0899	3484760				2022-12-18	WOS:A1986A089900005
J	HARRIS, JB; AHRENS, RC; MILAVETZ, G; RIES, RA; ANNIS, L; EDDY, ME				HARRIS, JB; AHRENS, RC; MILAVETZ, G; RIES, RA; ANNIS, L; EDDY, ME			RELATIVE POTENCIES AND RATES OF DECLINE IN EFFECT OF INHALED ALBUTEROL(A) AND TERBUTALINE(T)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			147	147						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800104
J	IRANI, AA; SCHECHTER, NM; CRAIG, S; DEBLOIS, G; SCHWARTZ, LB				IRANI, AA; SCHECHTER, NM; CRAIG, S; DEBLOIS, G; SCHWARTZ, LB			2 HUMAN MAST-CELL SUBSETS WITH DIFFERENT NEUTRAL PROTEASE COMPOSITIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			247	247						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800504
J	KAGEN, SL; YUNGINGER, JW; WYNN, SR				KAGEN, SL; YUNGINGER, JW; WYNN, SR			OCCUPATIONAL RESPIRATORY ALLERGY DUE TO CADDIS FLY AEROALLERGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			168	168						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800188
J	KEMP, JP; MELTZER, EO; ORGEL, HA; WELCH, MJ; LOCKEY, RF; MIDDLETON, E; SPECTOR, SL; PERHACH, JL; NEWTON, JJ				KEMP, JP; MELTZER, EO; ORGEL, HA; WELCH, MJ; LOCKEY, RF; MIDDLETON, E; SPECTOR, SL; PERHACH, JL; NEWTON, JJ			A DOSE-RESPONSE STUDY OF THE BRONCHODILATOR ACTION OF AZELASTINE (AZEL) IN ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			249	249						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800510
J	SPECTOR, S; ROHR, A; RACHELEFSKY, G; KATZ, R; SIEGEL, S; PERHACH, J; NEWTON, J				SPECTOR, S; ROHR, A; RACHELEFSKY, G; KATZ, R; SIEGEL, S; PERHACH, J; NEWTON, J			PHARMACODYNAMIC EVALUATION OF AZELASTINE IN ASTHMATICS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			249	249						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800509
J	SPRENGER, JD; ALTMAN, LC; ONEIL, CE; LEHRER, SB; AYARS, GH				SPRENGER, JD; ALTMAN, LC; ONEIL, CE; LEHRER, SB; AYARS, GH			SKIN-TEST REACTIVITY TO BASIDIOSPORES (BS) IN ADULTS IN SEATTLE WITH RESPIRATORY ALLERGIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			200	200						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800316
J	WEILER, JM; RHODES, BJ; IWAMOTO, PKL; DONNELLY, AL; PERHACH, JL				WEILER, JM; RHODES, BJ; IWAMOTO, PKL; DONNELLY, AL; PERHACH, JL			EFFECTIVENESS AND SAFETY OF AZELASTINE IN A CHRONIC STUDY IN PATIENTS WITH ALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			180	180						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800234
J	WHITE, MV; KALINER, MA; BAER, H				WHITE, MV; KALINER, MA; BAER, H			STIMULATED NEUTROPHILS RELEASE A HISTAMINE RELEASING-FACTOR	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			132	132						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800046
J	BROWN, JS; LEDOUX, R; NELSON, HS				BROWN, JS; LEDOUX, R; NELSON, HS			AN INVESTIGATION OF POSSIBLE IMMUNOLOGICAL REACTIONS TO HUMAN-SERUM ALBUMIN USED AS A STABILIZER IN ALLERGY EXTRACTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									FITZSIMONS ARMY MED CTR,ALLERGY IMMUNOL SERV,AURORA,CO 80045									EILAT D, 1981, SCAND J IMMUNOL, V14, P77, DOI 10.1111/j.1365-3083.1981.tb00186.x; FOUCARD T, 1973, Clinical Allergy, V3, P91, DOI 10.1111/j.1365-2222.1973.tb01313.x; LINDSTROM P, 1978, SCAND J IMMUNOL, V7, P419, DOI 10.1111/j.1365-3083.1978.tb00472.x; NAYLOR DH, 1982, TRANSFUSION, V22, P128, DOI 10.1046/j.1537-2995.1982.22282177119.x; NELSON HS, 1979, J ALLERGY CLIN IMMUN, V63, P417, DOI 10.1016/0091-6749(79)90216-1; NELSON HS, 1981, J ALLERGY CLIN IMMUN, V67, P64, DOI 10.1016/0091-6749(81)90047-6; NORMAN PS, 1978, J ALLERGY CLIN IMMUN, V62, P314, DOI 10.1016/0091-6749(78)90164-1; RING J, 1979, CLIN ALLERGY, V9, P89, DOI 10.1111/j.1365-2222.1979.tb01527.x; Tamura N, 1982, Gastroenterol Jpn, V17, P469; WEITKAMP LR, 1969, HUM HERED, V19, P159, DOI 10.1159/000152212	10	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1985	76	6					808	812		10.1016/0091-6749(85)90753-5	http://dx.doi.org/10.1016/0091-6749(85)90753-5			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AWX93	4067129				2022-12-18	WOS:A1985AWX9300009
J	MORGAN, J; WARING, NP; DAUL, CB; OHENEFREMPONG, K; DESHAZO, RD				MORGAN, J; WARING, NP; DAUL, CB; OHENEFREMPONG, K; DESHAZO, RD			PERSISTENT LYMPHADENOPATHY ASSOCIATED WITH HYPER-TRANSFUSION IN SICKLE-CELL DISEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									TULANE UNIV,DEPT PEDIAT,NEW ORLEANS,LA 70118; TULANE UNIV,HERBERT F HARVEY LAB,NEW ORLEANS,LA 70118; TULANE UNIV,DEPT MED,NEW ORLEANS,LA 70118	Tulane University; Tulane University; Tulane University					ONCHIT HHS [OC 34977] Funding Source: Medline	ONCHIT HHS		AARLI JA, 1976, ACTA NEUROL SCAND, V54, P423, DOI 10.1111/j.1600-0404.1976.tb04374.x; ADES EW, 1980, CLIN IMMUNOL IMMUNOP, V17, P459, DOI 10.1016/0090-1229(80)90117-8; ALLEN JI, 1981, ANN INTERN MED, V95, P154, DOI 10.7326/0003-4819-95-2-154; AMMANN AJ, 1983, LANCET, V1, P956; ANTHONY JJ, 1970, ARCH NEUROL-CHICAGO, V22, P450, DOI 10.1001/archneur.1970.00480230068008; Bedros A A, 1981, Adv Pediatr, V28, P341; BRYAN CF, 1983, CELL IMMUNOL, V75, P71, DOI 10.1016/0008-8749(83)90306-4; CHARLESWORTH EN, 1977, ARCH DERMATOL, V113, P477, DOI 10.1001/archderm.113.4.477; CREMER NE, 1978, J CLIN MICROBIOL, V8, P153; CURRAN JW, 1984, NEW ENGL J MED, V310, P69, DOI 10.1056/NEJM198401123100201; DESHAZO R, BLOOD; DESHAZO RD, 1983, ANN INTERN MED, V99, P159, DOI 10.7326/0003-4819-99-2-159; DIXON J, 1977, BMDPP77 BIOMEDICAL C, P540; DOSCH HM, 1982, NEW ENGL J MED, V306, P406, DOI 10.1056/NEJM198202183060707; DWYER JM, 1982, CLIN EXP IMMUNOL, V50, P406; EVATT BL, 1984, ANN INTERN MED, V100, P499, DOI 10.7326/0003-4819-100-4-499; FAUCI AS, 1984, ANN INTERN MED, V100, P92, DOI 10.7326/0003-4819-100-1-92; FONTANA A, 1976, LANCET, V2, P228; GAMS RA, 1968, ANN INTERN MED, V69, P557, DOI 10.7326/0003-4819-69-3-557; GASCON P, 1984, ANN INTERN MED, V100, P173, DOI 10.7326/0003-4819-100-2-173; GLASSMAN AB, 1980, ANN CLIN LAB SCI, V10, P9; GROOPMAN JE, 1984, NEW ENGL J MED, V311, P1419, DOI 10.1056/NEJM198411293112206; HYMAN GA, 1966, BLOOD-J HEMATOL, V28, P416, DOI 10.1182/blood.V28.3.416.416; JOSEPHS SH, 1980, J ALLERGY CLIN IMMUN, V66, P166, DOI 10.1016/0091-6749(80)90065-2; KAPLAN J, 1984, BLOOD, V64, P308; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; LANIER LL, 1983, J IMMUNOL, V131, P1789; MORRISON D, 1976, MULTIVARIATE STATIST, P134; MUNN CG, 1981, THYMUS, V3, P119; NISHIYA K, 1980, CELL IMMUNOL, V53, P71, DOI 10.1016/0008-8749(80)90427-X; OLESKE JM, 1979, AM J DIS CHILD, V133, P915, DOI 10.1001/archpedi.1979.02130090043007; PRASAD AS, 1975, CLIN CHEM, V21, P582; PURTILO DT, 1983, IMMUNOL TODAY, V4, P291, DOI 10.1016/0167-5699(83)90139-1; REINHERZ EL, 1979, P NATL ACAD SCI USA, V76, P4061, DOI 10.1073/pnas.76.8.4061; RUSSELL MO, 1976, J PEDIATR-US, V88, P382, DOI 10.1016/S0022-3476(76)80251-X; SARNGADHARAN MG, 1984, SCIENCE, V224, P506, DOI 10.1126/science.6324345; SEAGER J, 1975, LANCET, V2, P632; SPITLER LE, 1976, MANUAL CLIN IMMUNOLO, P53; STASHENKO P, 1980, J IMMUNOL, V125, P1678; STIEHM ER, 1966, PEDIATRICS, V37, P715; SULLIVAN JL, 1983, J CLIN INVEST, V71, P1765, DOI 10.1172/JCI110932; [No title captured]	42	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1985	76	6					869	875		10.1016/0091-6749(85)90762-6	http://dx.doi.org/10.1016/0091-6749(85)90762-6			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AWX93	3877748				2022-12-18	WOS:A1985AWX9300018
J	ALLANSMITH, MR; BAIRD, RS; BLOCH, KJ				ALLANSMITH, MR; BAIRD, RS; BLOCH, KJ			EFFECT OF ANAPHYLAXIS ON CONJUNCTIVAL GOBLET CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,GEN MED SERV,CLIN IMMUNOL UNIT,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,ALLERGY UNIT,BOSTON,MA 02114; RETINA FDN,DEPT CORNEA RES,BOSTON,MA 02114	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	ALLANSMITH, MR (corresponding author), HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DEPT OPHTHALMOL,BOSTON,MA 02215, USA.				NEI NIH HHS [EY-02099] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002099] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABELSON MB, 1980, OPHTHALMOLOGY, V87, P812; ALLANSMITH M, 1963, J ALLERGY, V34, P535, DOI 10.1016/0021-8707(63)90095-9; ALLANSMITH M, 1983, INVEST OPHTHALMOL S, V24, P101; ALLANSMITH MR, 1981, IMMUNOLOGY, V44, P623; ALLANSMITH MR, 1979, INVEST OPHTH VIS SCI, V18, P863; ALLANSMITH MR, 1980, INVEST OPHTH VIS SCI, V19, P690; ALLANSMITH MR, 1984, J ALLERGY CLIN IMMUN, V73, P49, DOI 10.1016/0091-6749(84)90483-4; ALLANSMITH MR, 1979, AM J OPHTHALMOL, V87, P544, DOI 10.1016/0002-9394(79)90247-2; ALLANSMITH MR, 1978, CLIN OPHTHALMOLOGY, V4, pCH9; ALLANSMITH R, 1980, INVEST OPHTH VIS SCI, V19, P1521; ALLEN M, 1972, ARCH OPHTHALMOL-CHIC, V88, P493, DOI 10.1001/archopht.1972.01000030495005; BLOCH KJ, 1973, J IMMUNOL, V110, P194; DUKEELDER S, 1965, SYSTEM OPHTHALMOLO 1, V8, P475; DUKEELDER S, 1965, SYSTEM OPHTHALMOLOGY, V8, P59; FLOREY HW, 1962, GASTROENTEROLOGY, V43, P326; GARCIAAROCHA H, 1961, CAN J BIOCHEM PHYS, V39, P403, DOI 10.1139/o61-039; GREINER JV, 1980, ARCH OPHTHALMOL-CHIC, V98, P1843; HOLLANDER M, 1973, NONPARAMETRIC STAT, P71; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; KULEMANNKLOENE H, 1982, SCIENCE, V217, P736, DOI 10.1126/science.6285469; LAKE AM, 1979, J IMMUNOL, V122, P834; MAROM Z, 1981, J CLIN INVEST, V67, P1695, DOI 10.1172/JCI110207; MAROM Z, 1982, FED PROC, V41, P558; MORAN NC, 1962, ACTA PHYSIOL SCAND, V56, P26, DOI 10.1111/j.1748-1716.1962.tb02479.x; NEUTRA MR, 1982, AM J PHYSIOL, V242, pG380, DOI 10.1152/ajpgi.1982.242.4.G380; SHELHAMER J, 1979, J ALLERGY CLIN IMMUN, V63, P141; SHELHAMER JH, 1982, CHEST, V81, pS36, DOI 10.1378/chest.81.5_Supplement.36S; SPECIAN RD, 1982, AM J PHYSIOL, V242, pG370, DOI 10.1152/ajpgi.1982.242.4.G370; SPECIAN RD, 1980, J CELL BIOL, V85, P626, DOI 10.1083/jcb.85.3.626; Takakusaki I, 1969, Arch Histol Jpn, V30, P247; WALKER WA, 1977, SCIENCE, V197, P370, DOI 10.1126/science.877559; WHITMORE PV, 1980, CLIN OPHTHALMOLOGY, V5, pCH27	32	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	2					200	206		10.1016/0091-6749(85)90702-X	http://dx.doi.org/10.1016/0091-6749(85)90702-X			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	APE88	4019952	Bronze			2022-12-18	WOS:A1985APE8800014
J	DOLOVICH, J; KENNEDY, L; KAZIM, F; VICKERSON, F				DOLOVICH, J; KENNEDY, L; KAZIM, F; VICKERSON, F			IPRATROPIUM BROMIDE (ATROVENT) NASAL SPRAY IN VASOMOTOR RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					160	160		10.1016/0091-6749(85)90357-4	http://dx.doi.org/10.1016/0091-6749(85)90357-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200222
J	EGGLESTON, PA; ADKINSON, NF; KAGEYSOBOTKA, A; LICHTENSTEIN, LM				EGGLESTON, PA; ADKINSON, NF; KAGEYSOBOTKA, A; LICHTENSTEIN, LM			OSMOTICALLY ACTIVATED HUMAN-LUNG MAST-CELLS (MC) AND BASOPHILS RELEASE HISTAMINE BUT NOT ARACHIDONIC-ACID METABOLITES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		1981, JCI, V67, P1604	1	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					125	125		10.1016/0091-6749(85)90218-0	http://dx.doi.org/10.1016/0091-6749(85)90218-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200083
J	HOLGATE, ST; HOWARTH, PH; LEE, TH; DURHAM, SR; NAGAKURA, T; KAY, AB				HOLGATE, ST; HOWARTH, PH; LEE, TH; DURHAM, SR; NAGAKURA, T; KAY, AB			AIRWAY HYPERREACTIVITY AND MEDIATOR RELEASE IN CLINICAL-MODELS OF ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract														Lee, Tak/0000-0002-7554-4059					0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					140	140		10.1016/0091-6749(85)90279-9	http://dx.doi.org/10.1016/0091-6749(85)90279-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200144
J	HOWLAND, WC; SIMON, RA				HOWLAND, WC; SIMON, RA			RESTAURANT-PROVOKED ASTHMA - SULFITE SENSITIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					145	145		10.1016/0091-6749(85)90296-9	http://dx.doi.org/10.1016/0091-6749(85)90296-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200161
J	SONIN, L; GRAMMER, LC; PATTERSON, R				SONIN, L; GRAMMER, LC; PATTERSON, R			THE OCCURRENCE OF MULTIPLE PHYSICAL ALLERGIES IN THE SAME PATIENT - REPORT OF 3 CASES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY & IMMUNOL SECT,CHICAGO,IL 60611	Northwestern University				Grammer, Leslie/0000-0001-6860-2014	NIAID NIH HHS [AI 11403] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011403] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BACAL E, 1978, CLIN ALLERGY, V8, P295, DOI 10.1111/j.1365-2222.1978.tb03227.x; BARBIER F, 1958, Acta Rheumatol Scand, V4, P218; BIANCHI FA, 1966, J CHRON DIS, V19, P953, DOI 10.1016/0021-9681(66)90030-0; Horton BT, 1936, J AMER MED ASSOC, V107, P1263, DOI 10.1001/jama.1936.02770420001001; KAPLAN AP, 1981, J ALLERGY CLIN IMMUN, V68, P319, DOI 10.1016/0091-6749(81)90158-5; KAPLAN AP, 1975, J ALLERGY CLIN IMMUN, V55, P394, DOI 10.1016/0091-6749(75)90078-0; KID JM, 1983, J ALLERGY CLIN IMMUN, V71, P407; LIEBERMAN P, 1979, ARCH INTERN MED, V139, P1032, DOI 10.1001/archinte.139.9.1032; MYERS G, 1981, J ALLERGY CLIN IMMUN, V67, P305, DOI 10.1016/0091-6749(81)90026-9; NOVEY HS, 1983, J ALLERGY CLIN IMMUN, V71, P498, DOI 10.1016/0091-6749(83)90468-2; SHEFFER A L, 1984, Journal of Allergy and Clinical Immunology, V73, P112; SHEFFER AL, 1980, J ALLERGY CLIN IMMUN, V66, P106, DOI 10.1016/0091-6749(80)90056-1; SHEFFER AL, 1983, J ALLERGY CLIN IMMUN, V71, P311, DOI 10.1016/0091-6749(83)90085-4; SONIN L, 1985, J ALLERGY CLIN IMMUN, V75, P67, DOI 10.1016/0091-6749(85)90014-4; SONIN L, 1983, ANN INTERN MED, V99, P634, DOI 10.7326/0003-4819-99-5-634; SOTER NA, 1980, NEW ENGL J MED, V302, P604, DOI 10.1056/NEJM198003133021104	16	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	6					705	708		10.1016/0091-6749(85)90097-1	http://dx.doi.org/10.1016/0091-6749(85)90097-1			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ALA84	4008799				2022-12-18	WOS:A1985ALA8400012
J	STALENHEIM, G; MACHADO, L				STALENHEIM, G; MACHADO, L			LATE ALLERGIC BRONCHIAL REACTIONS AND THE EFFECT OF ALLERGEN PROVOCATION ON THE COMPLEMENT-SYSTEM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV UPPSALA,DEPT MED & PHYSIOL CHEM,S-75105 UPPSALA,SWEDEN	Uppsala University	STALENHEIM, G (corresponding author), UPPSALA UNIV HOSP,DEPT LUNG MED,S-75185 UPPSALA,SWEDEN.							ARROYAVE CM, 1977, CLIN ALLERGY, V7, P173, DOI 10.1111/j.1365-2222.1977.tb01439.x; BAUR X, 1980, ALLERGY, V35, P383, DOI 10.1111/j.1398-9995.1980.tb01783.x; CARTIER A, 1982, J ALLERGY CLIN IMMUN, V70, P170, DOI 10.1016/0091-6749(82)90038-0; COOPER NR, 1970, IMMUNOCHEMISTRY, V7, P341, DOI 10.1016/0019-2791(70)90237-5; HARGREAVE FE, 1974, CAN MED ASSOC J, V110, P415; HSIEH KH, 1978, ANN ALLERGY, V41, P182; HUTCHCROFT BJ, 1978, CLIN ALLERGY, V8, P59, DOI 10.1111/j.1365-2222.1978.tb00448.x; MACHADO L, UNPUB CLIN ALLERGY; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; Mayer M.M., 1967, EXPT IMMUNOCHEMISTRY, P133; MULLEREBERHARD HJ, 1966, ARCH PATHOL, V82, P205; PEPYS J, 1969, MONOGR ALLERGY, V4, P19; PRICE JF, 1982, CLIN EXP IMMUNOL, V47, P587; PRYJMA JR, 1982, J ALLERGY CLIN IMMUN, V70, P306, DOI 10.1016/0091-6749(82)90067-7; SOLLEY GO, 1976, J CLIN INVEST, V58, P408, DOI 10.1172/JCI108485; STALENHE.G, 1971, FEBS LETT, V14, P79, DOI 10.1016/0014-5793(71)80104-7; Stalenheim G, 1979, Monogr Allergy, V14, P264; UMEMOTO L, 1976, J ALLERGY CLIN IMMUN, V58, P60, DOI 10.1016/0091-6749(76)90107-X; WARNER JO, 1976, ARCH DIS CHILD, V51, P905, DOI 10.1136/adc.51.12.905; WUEPPER KD, 1972, CLIN EXP IMMUNOL, V11, P13	20	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	4					508	512						5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AFY44	3980885				2022-12-18	WOS:A1985AFY4400012
J	WANNER, A; RUSSI, E; BRODNAN, JM; DANTA, I; GAZEROGLU, H				WANNER, A; RUSSI, E; BRODNAN, JM; DANTA, I; GAZEROGLU, H			PROLONGED BRONCHIAL OBSTRUCTION AFTER A SINGLE ANTIGEN CHALLENGE IN RAGWEED ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											WANNER, A (corresponding author), UNIV MIAMI,MT SINAI MED CTR,DEPT MED,DIV PULM DIS,4300 ALTON RD,MIAMI BEACH,FL 33140, USA.							BANDOUVAKIS J, 1981, BRIT J DIS CHEST, V75, P295, DOI 10.1016/0007-0971(81)90009-7; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; CONNOLLY CK, 1979, BRIT J DIS CHEST, V73, P357, DOI 10.1016/S0007-0971(79)80173-4; FEINBERG SM, 1952, J ALLERGY, V23, P387, DOI 10.1016/0021-8707(52)90001-4; GANDEVIA B, 1970, BRIT J IND MED, V27, P235; GRAHAM WGB, 1967, AM REV RESPIR DIS, V96, P266; HETZEL MR, 1977, THORAX, V32, P418, DOI 10.1136/thx.32.4.418; HETZEL MR, 1981, THORAX, V36, P481, DOI 10.1136/thx.36.7.481; MITCHELL C, 1970, MED J AUSTRALIA, V2, P233, DOI 10.5694/j.1326-5377.1970.tb49952.x; PEPYS J, 1977, AM REV RESPIR DIS, V116, P573, DOI 10.1164/arrd.1977.116.4.573; PEPYS J, 1975, NEW ENGL J MED, V293, P758; PEPYS J, 1975, AM REV RESPIR DIS, V112, P829; REINBERG A, 1972, B PHYSIO-PATHOL RESP, V8, P663; SPICER WS, 1966, ARCH ENVIRON HEALTH, V12, P217, DOI 10.1080/00039896.1966.10664360; TAYLOR AJN, 1979, CLIN ALLERGY, V9, P213, DOI 10.1111/j.1365-2222.1979.tb01544.x; THOMSON NC, 1983, J ALLERGY CLIN IMMUN, V71, P357, DOI 10.1016/0091-6749(83)90062-3; WANNER A, 1980, DIAGNOSTIC TECHNIQUE, V16, P353	17	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	2					177	181		10.1016/0091-6749(85)90698-0	http://dx.doi.org/10.1016/0091-6749(85)90698-0			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	APE88	4019950				2022-12-18	WOS:A1985APE8800010
J	APPEL, DW				APPEL, DW			EFFECT OF AMINOPHYLLINE WHEN ADDED TO METAPROTERENOL SULFATE AND BECLOMETHASONE DIPROPIONATE AEROSOL	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MONTEFIORE HOSP & MED CTR,DEPT MED,BRONX,NY 10467; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MED,DIV PULM,BRONX,NY 10461	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine								APPEL D, 1981, LUNG, V159, P243, DOI 10.1007/BF02713922; APPEL D, 1982, J FAM PRACTICE, V14, P1135; BESWICK K, 1975, PRACTITIONER, V214, P561; CONNOLLY CK, 1979, BRIT J DIS CHEST, V73, P357, DOI 10.1016/S0007-0971(79)80173-4; FREARS J, 1976, J ALLERGY CLIN IMMUN, V57, P391, DOI 10.1016/0091-6749(76)90053-1; HEIMER D, 1980, J ALLERGY CLIN IMMUN, V66, P75, DOI 10.1016/0091-6749(80)90141-4; JOSEPHSON GW, 1979, JAMA-J AM MED ASSOC, V242, P639, DOI 10.1001/jama.242.7.639; KOUP JR, 1978, AM REV RESPIR DIS, V117, P1135; LAL S, 1972, BMJ-BRIT MED J, V3, P314, DOI 10.1136/bmj.3.5822.314; OREHEK J, 1976, BRIT MED J, V1, P76, DOI 10.1136/bmj.1.6001.76; Paterson J W, 1974, BTTA Rev, V4, P61; PATERSON JW, 1974, BTTA REV BRIT THO TU, V4, P25; ROSSING TH, 1980, AM REV RESPIR DIS, V122, P365; RUBENSTEIN KE, 1972, BIOCHEM BIOPH RES CO, V47, P846, DOI 10.1016/0006-291X(72)90570-0; SAUNDERS KB, 1965, BRIT MED J, V1, P1037, DOI 10.1136/bmj.1.5441.1037; SHIM C, 1980, ANN INTERN MED, V93, P428; SHIM C, 1981, AM J MED, V71, P452, DOI 10.1016/0002-9343(81)90181-9; SMITH JA, 1980, CHEST, V78, P816, DOI 10.1378/chest.78.6.816; SVEDMYR K, 1977, Scandinavian Journal of Respiratory Diseases Supplementum, V101, P139; WILLIAMS MH, 1975, AM REV RESPIR DIS, V111, P321; WINER BJ, 1971, STATISTICAL PRINCIPL, P267; WOLFE JD, 1978, NEW ENGL J MED, V298, P363, DOI 10.1056/NEJM197802162980703; 1962, AM REV RESPIR DIS, V85, P762	23	7	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	73	2					291	297		10.1016/S0091-6749(84)80022-6	http://dx.doi.org/10.1016/S0091-6749(84)80022-6			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SF020	6699312	Bronze			2022-12-18	WOS:A1984SF02000012
J	CLARKE, KS				CLARKE, KS			SPORTS MEDICINE AND DRUG-CONTROL PROGRAMS OF THE UNITED-STATES OLYMPIC COMMITTEE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											CLARKE, KS (corresponding author), US OLYMP COMM,SPORTS MED PROGRAM,COLORADO SPRINGS,CO 80901, USA.								0	7	7	0	5	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	73	5					740	744		10.1016/0091-6749(84)90317-8	http://dx.doi.org/10.1016/0091-6749(84)90317-8			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SS046	6715739				2022-12-18	WOS:A1984SS04600024
J	PIPER, PJ				PIPER, PJ			THE EVOLUTION AND FUTURE HORIZONS OF RESEARCH ON THE METABOLISM OF ARACHIDONIC-ACID BY 5-LIPOXYGENASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											PIPER, PJ (corresponding author), ROYAL COLL SURG ENGLAND,DEPT PHARMACOL,LONDON WC2A 3PN,ENGLAND.							ANDERSON ME, 1982, P NATL ACAD SCI-BIOL, V79, P1088, DOI 10.1073/pnas.79.4.1088; BACH MK, 1984, J ALLERGY CLIN IMMUN, V74, P353, DOI 10.1016/0091-6749(84)90129-5; BARNES NC, THORAX; BORGEAT P, 1979, P NATL ACAD SCI USA, V76, P3213, DOI 10.1073/pnas.76.7.3213; BORGEAT P, 1979, J BIOL CHEM, V254, P7865; BORGEAT P, 1984, J ALLERGY CLIN IMMUN, V74, P310, DOI 10.1016/0091-6749(84)90122-2; BRAIN SD, 1984, BRIT J CLIN PHARMACO, V17, pP650; BRASH AR, 1984, J ALLERGY CLIN IMMUN, V74, P316, DOI 10.1016/0091-6749(84)90123-4; CRAMER EB, 1984, J ALLERGY CLIN IMMUN, V74, P386, DOI 10.1016/0091-6749(84)90136-2; Feldberg W, 1938, J PHYSIOL-LONDON, V94, P187, DOI 10.1113/jphysiol.1938.sp003674; FORDHUTCHINSON AW, 1984, J ALLERGY CLIN IMMUN, V74, P437, DOI 10.1016/0091-6749(84)90144-1; FORDHUTCHINSON AW, 1982, BRIT J PHARMACOL, V76, P215, DOI 10.1111/j.1476-5381.1982.tb09209.x; GOLDMAN DW, 1984, J ALLERGY CLIN IMMUN, V74, P373, DOI 10.1016/0091-6749(84)90133-7; GRIFFIN M, 1983, NEW ENGL J MED, V308, P436, DOI 10.1056/NEJM198302243080807; HAYES EC, 1983, J IMMUNOL, V131, P429; HOLROYDE MC, 1981, LANCET, V2, P17; KUEHL FA, 1984, J ALLERGY CLIN IMMUN, V74, P378, DOI 10.1016/0091-6749(84)90134-9; MARCUS AJ, 1984, J ALLERGY CLIN IMMUN, V74, P338, DOI 10.1016/0091-6749(84)90126-X; MCLEOD LJ, BR J PHARM; MONCADA S, 1977, THROMB RES, V11, P323, DOI 10.1016/0049-3848(77)90185-2; MORRIS HR, 1978, FEBS LETT, V87, P203, DOI 10.1016/0014-5793(78)80332-9; PAYAN DG, 1984, J ALLERGY CLIN IMMUN, V74, P403, DOI 10.1016/0091-6749(84)90138-6; Piper P. J., 1981, SRS LEUKOTRIENES; PIPER PJ, 1983, PROSTAGLANDINS, V25, P591, DOI 10.1016/0090-6980(83)90031-X; PIPER PJ, 1983, BRIT MED BULL, V39, P255, DOI 10.1093/oxfordjournals.bmb.a071829; SALMON JA, 1982, PROSTAGLANDINS, V24, P225, DOI 10.1016/0090-6980(82)90148-4; SAMHOUN MN, 1984, PROSTA LEUKOTR MED, V13, P79, DOI 10.1016/0262-1746(84)90106-9; SAMUELSSON B, 1980, PROSTAGLANDINS, V19, P645, DOI 10.1016/0090-6980(80)90099-4; SEAMAN WE, 1984, J ALLERGY CLIN IMMUN, V74, P407, DOI 10.1016/0091-6749(84)90139-8; STENMARK KR, 1983, NEW ENGL J MED, V309, P77, DOI 10.1056/NEJM198307143090204; WEDMORE CV, 1981, NATURE, V289, P646, DOI 10.1038/289646a0; WEISS JW, 1982, SCIENCE, V216, P196, DOI 10.1126/science.7063880; WEISS JW, 1983, JAMA-J AM MED ASSOC, V249, P2814, DOI 10.1001/jama.249.20.2814; WESTCOTT JY, 1984, J ALLERGY CLIN IMMUN, V74, P363, DOI 10.1016/0091-6749(84)90131-3; WOLBLING RH, 1983, PROSTAG OTH LIPID M, V25, P823, DOI 10.1016/0090-6980(83)90006-0; YAMAMOTO S, 1984, J ALLERGY CLIN IMMUN, V74, P349, DOI 10.1016/0091-6749(84)90128-3	36	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	3					441	444		10.1016/0091-6749(84)90145-3	http://dx.doi.org/10.1016/0091-6749(84)90145-3			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TQ633	6088618				2022-12-18	WOS:A1984TQ63300025
J	RASMUSSEN, JE				RASMUSSEN, JE			RECENT DEVELOPMENTS IN THE MANAGEMENT OF PATIENTS WITH ATOPIC-DERMATITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review											RASMUSSEN, JE (corresponding author), UNIV MICHIGAN, MED CTR, DEPT DERMATOL & PEDIAT, ANN ARBOR, MI 48109 USA.							ABRAMSON JS, 1982, J AM ACAD DERMATOL, V7, P105, DOI 10.1016/S0190-9622(82)80017-0; ANDERSON TF, 1983, PEDIATR CLIN N AM, V30, P701; ATHERTON DJ, 1978, LANCET, V1, P401; ATHERTON DJ, 1983, CLIN EXP DERMATOL, V8, P227, DOI 10.1111/j.1365-2230.1983.tb01775.x; BOCK SA, 1982, J ALLERGY CLIN IMMUN, V69, P173, DOI 10.1016/0091-6749(82)90096-3; DAHL MV, 1983, ARCH DERMATOL, V119, P840, DOI 10.1001/archderm.119.10.840; DANNAEUS A, 1979, ACTA PAEDIATR SCAND, V68, P377, DOI 10.1111/j.1651-2227.1979.tb05023.x; FORD RPK, 1982, ARCH DIS CHILD, V57, P649, DOI 10.1136/adc.57.9.649; Grulee CG, 1936, J PEDIATR-US, V9, P223, DOI 10.1016/S0022-3476(36)80058-4; GRUSKAY FL, 1982, CLIN PEDIATR, V21, P486, DOI 10.1177/000992288202100807; HALPERN SR, 1973, J ALLERGY CLIN IMMUN, V51, P139, DOI 10.1016/0091-6749(73)90019-5; HATHAWAY MJ, 1983, ARCH DIS CHILD, V58, P463, DOI 10.1136/adc.58.6.463; KAJOSAARI M, 1982, ACTA PAEDIATR SCAND, V71, P815, DOI 10.1111/j.1651-2227.1982.tb09525.x; KAJOSAARI M, 1983, ACTA PAEDIATR SCAND, V72, P411, DOI 10.1111/j.1651-2227.1983.tb09738.x; KJELLMAN NIM, 1979, CLIN ALLERGY, V9, P347, DOI 10.1111/j.1365-2222.1979.tb02493.x; KRAMER MS, 1981, J PEDIATR-US, V98, P546, DOI 10.1016/S0022-3476(81)80757-3; LEYDEN JJ, 1974, BRIT J DERMATOL, V90, P525, DOI 10.1111/j.1365-2133.1974.tb06447.x; POLANO M K, 1960, Dermatologica, V120, P191; SAMPSON HA, 1983, J ALLERGY CLIN IMMUN, V71, P473, DOI 10.1016/0091-6749(83)90464-5; SOLOMON AR, 1984, JAMA-J AM MED ASSOC, V251, P633, DOI 10.1001/jama.251.5.633; TZANCK A, 1947, ANN DERMATOL SYPHIL, V7, P68; WACHS GN, 1976, BRIT J DERMATOL, V95, P323, DOI 10.1111/j.1365-2133.1976.tb07021.x; WHITE I, 1983, BRIT J CLIN PRACT, V37, P215; WRIGHT S, 1982, LANCET, V2, P1120; 1980, J INFECT DIS JID, V75, P1	25	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	6					771	776		10.1016/0091-6749(84)90176-3	http://dx.doi.org/10.1016/0091-6749(84)90176-3			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TW418	6501746				2022-12-18	WOS:A1984TW41800002
J	WASSERMAN, SJ				WASSERMAN, SJ			CILIARY FUNCTION AND DISEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											WASSERMAN, SJ (corresponding author), UNIV CALIF SAN DIEGO, DIV RHEUMAT DIS, LA JOLLA, CA 92093 USA.							AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Afzelius B A, 1979, Int Rev Exp Pathol, V19, P1; AFZELIUS BA, 1975, J CELL BIOL, V66, P225, DOI 10.1083/jcb.66.2.225; AHMED T, 1981, AM REV RESPIR DIS, V124, P110; AHONEN A, 1983, EUR J RESPIR DIS, V64, P460; COLLIER AM, 1971, INFECT IMMUN, V3, P694, DOI 10.1128/IAI.3.5.694-701.1971; ELIASSON R, 1977, NEW ENGL J MED, V297, P1, DOI 10.1056/NEJM197707072970101; FORREST JB, 1979, AM REV RESPIR DIS, V120, P511; GIBBONS IR, 1965, SCIENCE, V149, P424, DOI 10.1126/science.149.3682.424; GREENSTONE M, 1983, EUR J RESPIR DIS, V64, P449; JEFFERY PK, 1977, RESPIRATORY DEFENS 1, P193; MEZEY RJ, 1978, AM REV RESPIR DIS, V117, P156; MOHRI H, 1968, NATURE, V217, P1053, DOI 10.1038/2171053a0; MOSSBERG B, 1978, SCAND J RESPIR DIS, V59, P55; MYGIND N, 1973, ACTA ALLERGOL, V28, P9, DOI 10.1111/j.1398-9995.1973.tb02562.x; RUTLAND J, 1983, EUR J RESPIR DIS, V64, P451; Sleigh M., 1977, RESP DEFENSE MECH PA, V1, P247; SPOCK A, 1967, PEDIATR RES, V1, P173, DOI 10.1203/00006450-196705000-00003; STUARTHARRIS CH, 1979, REV INFECT DIS, V1, P592; STURGESS JM, 1979, NEW ENGL J MED, V300, P53, DOI 10.1056/NEJM197901113000201; STURGESS JM, 1980, NEW ENGL J MED, V303, P318, DOI 10.1056/NEJM198008073030606; TURNER JAP, 1981, PEDIATRICS, V67, P805; VANIRVANI J, 1972, J PATHOL, V106, P81; WANNER A, 1983, J ALLERGY CLIN IMMUN, V72, P663, DOI 10.1016/0091-6749(83)90626-7; WARNER F, 1974, CILIA FLAGELLA; WARNER FD, 1974, J CELL BIOL, V63, P35, DOI 10.1083/jcb.63.1.35; [No title captured]	27	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	73	1					17	19		10.1016/0091-6749(84)90478-0	http://dx.doi.org/10.1016/0091-6749(84)90478-0			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SB990	6693663				2022-12-18	WOS:A1984SB99000002
J	BJORK, J; SMEDEGARD, G				BJORK, J; SMEDEGARD, G			MICROVASCULAR RESPONSE TO PLATELET ACTIVATING FACTOR (PAF-ACETHER)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					145	145		10.1016/0091-6749(83)90352-4	http://dx.doi.org/10.1016/0091-6749(83)90352-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200229
J	EGGLESTON, PA; SOBOTKA, AK; SCHLEIMER, R; LICHTENSTEIN, LM				EGGLESTON, PA; SOBOTKA, AK; SCHLEIMER, R; LICHTENSTEIN, LM			INTERACTION BETWEEN HYPEROSMOLAR AND IGE INDUCED HISTAMINE-RELEASE FROM BASOPHILS AND MAST-CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		JCI, V67, P1604	1	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					93	93		10.1016/0091-6749(83)90143-4	http://dx.doi.org/10.1016/0091-6749(83)90143-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200020
J	GALLAGHER, JS; RIEHM, JG; VALANIS, B; BERNSTEIN, IL				GALLAGHER, JS; RIEHM, JG; VALANIS, B; BERNSTEIN, IL			CROSS-SECTIONAL SURVEY OF THE INCIDENCE OF ADVERSE FOOD SYMPTOMS IN ADULTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					113	113		10.1016/0091-6749(83)90221-X	http://dx.doi.org/10.1016/0091-6749(83)90221-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200098
J	HOWICK, J; KELLY, HW; MENENDEZ, R; MURPHY, S				HOWICK, J; KELLY, HW; MENENDEZ, R; MURPHY, S			ABSORPTION CHARACTERISTICS OF A NEW SUSTAINED-RELEASE THEOPHYLLINE (SRT) SPRINKLE FOR INFANTS AND YOUNG-CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					130	130		10.1016/0091-6749(83)90291-9	http://dx.doi.org/10.1016/0091-6749(83)90291-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200168
J	SIMON, R; PLESKOW, W; KALINER, M; WASSERMAN, S; CURD, J; STEVENSON, D				SIMON, R; PLESKOW, W; KALINER, M; WASSERMAN, S; CURD, J; STEVENSON, D			PLASMA MEDIATOR STUDIES IN ASPIRIN SENSITIVE ASTHMA - LACK OF A ROLE FOR THE MAST-CELL	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					146	146		10.1016/0091-6749(83)90356-1	http://dx.doi.org/10.1016/0091-6749(83)90356-1			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200233
J	ARVAY, G; SZATHMARY, G; REUTER, M				ARVAY, G; SZATHMARY, G; REUTER, M			CHANGES IN ANGIOTENSIN-CONVERTING ENZYME-ACTIVITY AND ANGIOTENSIN-I LEVEL IN ASTHMATIC AND HEALTHY-CHILDREN AFTER SUBMAXIMAL PHYSICAL WORK	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									STATE SANATORIUM,DEPT PEDIAT,H-9400 SOPRON,HUNGARY		ARVAY, G (corresponding author), STATE SANATORIUM,CENT LAB,VARISI 2,H-9400 SOPRON,HUNGARY.							ABE K, 1976, EXPERIENTIA, V23, P626; ASHUTOSH K, 1976, THORAX, V31, P552, DOI 10.1136/thx.31.5.552; CHRYSSANTHOPOULOS C, 1978, J ALLERGY CLIN IMMUN, V61, P17, DOI 10.1016/0091-6749(78)90468-2; DAS M, 1975, J BIOL CHEM, V250, P6762; DORER FE, 1974, CIRC RES, V34, P824, DOI 10.1161/01.RES.34.6.824; ERDOS EG, 1979, FED PROC, V38, P2774; ERDOS EG, 1977, FED PROC, V36, P1760; FROHLICH ED, 1967, CIRCULATION, V36, P387, DOI 10.1161/01.CIR.36.3.387; GOULD AB, 1970, LAB INVEST, V22, P443; HUGGINS CG, 1974, CIRC RES S, V1, P93; LIEBERMAN J, 1976, NEW ENGL J MED, V294, P1442, DOI 10.1056/NEJM197606242942609; LIEBERMAN J, 1977, ANN INTERN MED, V87, P422, DOI 10.7326/0003-4819-87-4-422; LIEBERMAN J, 1976, ANN NY ACAD SCI, V278, P488, DOI 10.1111/j.1749-6632.1976.tb47061.x; MATTIOLI L, 1975, J PEDIATR-US, V87, P97, DOI 10.1016/S0022-3476(75)80081-3; SCHWEISFURTH H, 1980, KLIN WOCHENSCHR, V58, P1361, DOI 10.1007/BF01477734; SCHWEISFURTH J, 1979, ACTA HEPATOGASTROENT, V26, P207; SUETSUGU M, 1978, ANN ALLERGY, V40, P51; TAKAHASHI M, 1977, TOHOKU J EXP MED, V121, P195, DOI 10.1620/tjem.121.195	18	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1982	69	2					178	180						3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NC581	6276459				2022-12-18	WOS:A1982NC58100003
J	DESHAZO, RD; HASE, T; WRIGHT, DG; DIEM, JE				DESHAZO, RD; HASE, T; WRIGHT, DG; DIEM, JE			EVIDENCE FOR HISTAMINE-MEDIATED INHIBITION OF MONOCYTE CHEMOTAXIS IN ATOPIC-DERMATITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									TULANE UNIV,SCH MED,DEPT PEDIAT,BIOSTAT SECT,NEW ORLEANS,LA 70112; WALTER REED ARMY MED CTR,WASHINGTON,DC 20012	Tulane University; United States Department of Defense; United States Army; Walter Reed National Military Medical Center	DESHAZO, RD (corresponding author), TULANE UNIV,SCH MED,DEPT MED,CLIN IMMUNOL SECT,NEW ORLEANS,LA 70112, USA.							ALY R, 1980, ACTA DERM-VENEREOL, V92, P16; BROSTOFF J, 1980, CLIN EXP IMMUNOL, V39, P739; BUCKLEY RH, 1972, PEDIATRICS, V49, P59; CIANCIOLO GJ, 1981, J CLIN INVEST, V67, P60, DOI 10.1172/JCI110033; CLARK RAF, 1978, LEUKOCYTE CHEMOTAXIS, P205; CRUCHAUD A, 1977, INT ARCH ALLER A IMM, V54, P529, DOI 10.1159/000231873; DAHL MV, 1978, ARCH DERMATOL, V114, P544, DOI 10.1001/archderm.114.4.544; DIXON WJ, 1969, INTRO STATISTICAL AN, P116; DIXON WJ, 1969, INTRO STATISTICAL AN, P202; DIXON WJ, 1977, BMDPP 77 BIOMEDICAL, P540; FALK W, 1980, J IMMUNOL METHODS, V33, P239, DOI 10.1016/S0022-1759(80)80014-7; FISCHER TJ, 1980, PEDIATR RES, V14, P242, DOI 10.1203/00006450-198003000-00013; FURUKAWA CT, 1978, J ALLERGY CLIN IMMUN, V61, P288, DOI 10.1016/0091-6749(78)90049-0; GALLIN JI, 1973, J IMMUNOL, V110, P233; GALLIN JI, 1975, BLOOD, V45, P863; GALLIN JI, 1978, LEUKOCYTE CHEMOTAXIS, P79; GOETZL EJ, 1978, LEUKOCYTE CHEMOTAXIS, P161; HANIFIN JM, 1977, ARCH DERMATOL, V113, P1383, DOI 10.1001/archderm.113.10.1383; HERLIN T, 1980, ALLERGY, V35, P647, DOI 10.1111/j.1398-9995.1980.tb02017.x; HILL HR, 1974, LANCET, V1, P183; JUHLIN L, 1969, ARCH DERMATOL, V100, P12, DOI 10.1001/archderm.100.1.12; JUHLIN L, 1967, ACTA DERM-VENEREOL, V47, P383; LEYDEN JJ, 1974, BRIT J DERMATOL, V90, P525, DOI 10.1111/j.1365-2133.1974.tb06447.x; MCGEADY SJ, 1975, J ALLERGY CLIN IMMUN, V56, P393, DOI 10.1016/0091-6749(75)90133-5; MORRISON D, 1976, MULTIVARIATE STATIST, P134; MORRISON DF, 1976, MULTIVARIATE STATIST, P136; OGDEN BE, 1980, IMMUNOLOGY, V41, P107; OHMAN S, 1974, ACTA DERM-VENEREOL, V54, P283; RADERMECKER M, 1981, INT ARCH ALLER A IMM, V65, P144, DOI 10.1159/000232750; RASMUSSEN JE, 1978, ATOPIC DERMATITIS AL, P1039; RIVKIN I, 1972, Federation Proceedings, V31, P657; SELIGMAN B, 1981, CLIN RES, V29, P172; SNYDERMAN R, 1977, J ALLERGY CLIN IMMUN, V60, P121, DOI 10.1016/0091-6749(77)90037-9; SNYDERMAN R, 1978, LEUKOCYTE CHEMOTAXIS, P73; STRANNEGARD IL, 1977, SCAND J IMMUNOL, V6, P1225	35	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1982	69	5					429	434		10.1016/0091-6749(82)90117-8	http://dx.doi.org/10.1016/0091-6749(82)90117-8			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NP934	7076982				2022-12-18	WOS:A1982NP93400004
J	FORTNER, BR; DANZIGER, RE; RABINOWITZ, PS; NELSON, HS				FORTNER, BR; DANZIGER, RE; RABINOWITZ, PS; NELSON, HS			THE EFFECT OF ASCORBIC-ACID ON CUTANEOUS AND NASAL RESPONSE TO HISTAMINE AND ALLERGEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									USA,FITZSIMONS ARMY MED CTR,ALLERGY IMMUNOL SERV,AURORA,CO 80045									ANDERSON R, 1979, S AFR MED J, V56, P394; ANDERSON R, 1979, S AFR MED J, V56, P476; BARNESS LA, 1975, ANN NY ACAD SCI, V258, P523, DOI 10.1111/j.1749-6632.1975.tb29311.x; BOXER LA, 1976, NEW ENGL J MED, V295, P1041, DOI 10.1056/NEJM197611042951904; BRIGGS MH, 1973, LANCET, V2, P677; BROWN E A, 1949, Ann Allergy, V7, P65; BROWN RG, 1973, JAMA-J AM MED ASSOC, V224, P1529, DOI 10.1001/jama.1973.03220250051020; CAMPBELL GD, 1975, ANN INTERN MED, V82, P810, DOI 10.7326/0003-4819-82-6-810_1; CLEMETSON CAB, 1980, J NUTR, V110, P662, DOI 10.1093/jn/110.4.662; COCCHI P, 1980, PEDIATRICS, V65, P862; Engelsher DL, 1944, J AMER MED ASSOC, V126, P318, DOI 10.1001/jama.1944.02850400050022; FOX MRS, 1975, ANN NY ACAD SCI, V258, P144, DOI 10.1111/j.1749-6632.1975.tb29274.x; FRIEDLAENDER S, 1945, J ALLERGY, V16, P140, DOI 10.1016/0021-8707(45)90353-4; GINTER E, 1969, J NUTR, V99, P261, DOI 10.1093/jn/99.3.261; HEBALD S, 1944, J ALLERGY, V15, P236; HOFFER A, 1973, LANCET, V2, P1146; Holmes HN, 1942, SCIENCE, V96, P497, DOI 10.1126/science.96.2500.497; HORROBIN DF, 1973, LANCET, V2, P317; Hunt AH, 1941, BRIT J SURG, V28, P436, DOI 10.1002/bjs.18002811112; KING CG, 1975, ANN NY ACAD SCI, V258, P540, DOI 10.1111/j.1749-6632.1975.tb29313.x; KREISMAN H, 1977, LUNG, V154, P223; MENGEL CE, 1976, ANN INTERN MED, V84, P490, DOI 10.7326/0003-4819-84-4-490_1; Pathak J D, 1976, Indian J Med Sci, V30, P257; Pauling L., 1970, VITAMIN C COMMON COL; PONTE L, 1980, READERS DIGEST   OCT, P94; RAINERI R, 1975, ANN NY ACAD SCI, V258, P181, DOI 10.1111/j.1749-6632.1975.tb29278.x; RAMP WK, 1971, J DENT RES, V50, P1504; ROE JH, 1961, STANDARD METHODS CLI, V3; Ruskin Simon L., 1945, AMER JOUR DIGEST DIS, V12, P281, DOI 10.1007/BF02998596; SCHOEPFLIN GS, 1977, J CYCLIC NUCL PROT, V3, P355; SCHRAUZER GN, 1973, INT J VITAM NUTR RES, V43, P201; SUBRAMANIAN N, 1978, AGENTS ACTIONS, V8, P484, DOI 10.1007/BF02111433; THORNTON PA, 1969, P SOC EXP BIOL MED, V132, P618, DOI 10.3181/00379727-132-34272; Vickery R E, 1973, Int Surg, V58, P422; WALTA DC, 1976, GASTROENTEROLOGY, V70, P766; ZUSKIN E, 1973, J ALLERGY CLIN IMMUN, V51, P218, DOI 10.1016/0091-6749(73)90141-3	36	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1982	69	6					484	488		10.1016/0091-6749(82)90171-3	http://dx.doi.org/10.1016/0091-6749(82)90171-3			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NT025	7076989				2022-12-18	WOS:A1982NT02500002
J	FRICK, OL				FRICK, OL			THE NATURAL-HISTORY OF FOOD SENSITIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											FRICK, OL (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143, USA.							ASHKENAZI A, 1980, PEDIATRICS, V66, P399; CHANG TT, 1981, 37TH P ANN M AM AC A; CUNNINGHAMRUNDLES C, 1981, CLIN EXP IMMUNOL, V45, P299; GOLDMAN AS, 1963, PEDIATRICS, V32, P425; HIPPOCRATES, 1957, ENCYCL BRITANNICA, V11, P584; MAY CD, 1978, ALLERGY, V33, P166, DOI 10.1111/j.1398-9995.1978.tb01532.x; MINOR JD, 1980, J ALLERGY CLIN IMMUN, V66, P314, DOI 10.1016/0091-6749(80)90027-5; PAGANELLI R, 1979, LANCET, V1, P1270; RATNER B, 1958, PEDIATRICS, V22, P449; Rowe A., 1944, ELIMINATION DIETS PA; Schloss OM, 1916, AM J DIS CHILD, V11, P342	11	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1982	69	2					171	172		10.1016/0091-6749(82)90095-1	http://dx.doi.org/10.1016/0091-6749(82)90095-1			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NC581		Bronze			2022-12-18	WOS:A1982NC58100001
J	BOLIN, JF; DAHMS, TE; SLAVIN, RG				BOLIN, JF; DAHMS, TE; SLAVIN, RG			EFFECT OF DISCONTINUING SMOKING ON MECHOLYL SENSITIVITY IN ASTHMATIC SMOKERS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					207	208						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000143
J	CARPENTER, GB; BUNKER, AL; NELSON, HS				CARPENTER, GB; BUNKER, AL; NELSON, HS			EVALUATION OF COMBINED H-1 AND H-2 ANTAGONISTS IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					187	187						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000079
J	GREENBERGER, P; PATTERSON, R; STEVENSON, D; SIMON, R; LIEBERMAN, P				GREENBERGER, P; PATTERSON, R; STEVENSON, D; SIMON, R; LIEBERMAN, P			PRETREATMENT OF HIGH-RISK PATIENTS RECEIVING RADIOGRAPHIC CONTRAST-MEDIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Greenberger, Paul/L-2770-2019	Greenberger, Paul/0000-0003-3882-8498					0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					220	220						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000183
J	LIU, FT; BARGATZE, RF; KATZ, DH				LIU, FT; BARGATZE, RF; KATZ, DH			INDUCTION OF IMMUNOLOGICAL-TOLERANCE TO THE TRIMELLITATE HAPTENIC GROUP IN MICE - MODEL FOR A THERAPEUTIC APPROACH TO TRIMELLITIC ANHYDRIDE-INDUCED HYPERSENSITIVITY SYNDROMES IN HUMANS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SCRIPPS CLIN & RES FDN,DEPT CELLULAR & DEV IMMUNOL,10666 N TORREY PINES RD,LA JOLLA,CA 92037	Scripps Research Institute			Liu, FU-TONG/A-5749-2019	Liu, FU-TONG/0000-0002-3354-1001				AULT KA, 1974, P NATL ACAD SCI USA, V71, P3111, DOI 10.1073/pnas.71.8.3111; CHIORAZZI N, 1977, J EXP MED, V146, P302, DOI 10.1084/jem.146.1.302; CHIORAZZI N, 1976, P NATL ACAD SCI USA, V73, P2091, DOI 10.1073/pnas.73.6.2091; DAVIE JM, 1972, J EXP MED, V136, P426, DOI 10.1084/jem.136.3.426; ESHHAR Z, 1975, J IMMUNOL, V114, P872; HAMAOKA T, 1974, J IMMUNOL, V113, P958; HAMAOKA T, 1974, J EXP MED, V139, P1446, DOI 10.1084/jem.139.6.1446; HAMAOKA T, 1977, J EXP MED, V146, P91, DOI 10.1084/jem.146.1.91; KATZ DH, 1972, J EXP MED, V136, P1404, DOI 10.1084/jem.136.6.1404; KATZ DH, 1975, J ALLERGY CLIN IMMUN, V55, P403, DOI 10.1016/0091-6749(75)90079-2; KATZ DH, 1973, P NATL ACAD SCI USA, V70, P2776, DOI 10.1073/pnas.70.10.2776; KATZ DH, 1971, J EXP MED, V134, P201, DOI 10.1084/jem.134.1.201; KATZ DH, 1974, IMMUNOLOGICAL TOLERA, P189; LIU FT, 1979, P NATL ACAD SCI USA, V76, P1430, DOI 10.1073/pnas.76.3.1430; LIU FT, 1979, J IMMUNOL, V123, P2456; NOSSAL GJV, 1973, J EXP MED, V138, P312, DOI 10.1084/jem.138.1.312; PATTERSON, 1978, J CLIN INV, V62, P971; PIERCE SK, 1976, J EXP MED, V144, P1254, DOI 10.1084/jem.144.5.1254; ZEISS CR, 1977, J ALLERGY CLIN IMMUN, V60, P96, DOI 10.1016/0091-6749(77)90033-1	19	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	66	4					322	326		10.1016/0091-6749(80)90028-7	http://dx.doi.org/10.1016/0091-6749(80)90028-7			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KM254	6775023				2022-12-18	WOS:A1980KM25400010
J	SULLIVAN, TJ; WEDNER, HJ; PARKER, CW				SULLIVAN, TJ; WEDNER, HJ; PARKER, CW			DESENSITIZATION OF PATIENTS ALLERGIC TO PENICILLIN USING ORAL PENICILLIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					195	196						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000105
J	BURGE, HA; SOLOMON, WR; WILLIAMS, P				BURGE, HA; SOLOMON, WR; WILLIAMS, P			FUNGUS EXPOSURE RISKS ASSOCIATED WITH ANIMAL CARE UNITS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											BURGE, HA (corresponding author), UNIV MICHIGAN,DEPT INTERNAL MED,ALLERGY SECT,ANN ARBOR,MI 48109, USA.							ANDERSEN AA, 1958, J BACTERIOL, V76, P471, DOI 10.1128/JB.76.5.471-484.1958; BURGE HP, 1977, J ALLERGY CLIN IMMUN, V60, P199, DOI 10.1016/0091-6749(77)90124-5; ELLIS M B, 1971, P608; SOLOMON WR, 1976, J ALLERGY CLIN IMMUN, V57, P46, DOI 10.1016/0091-6749(76)90078-6; SOLOMON WR, 1970, J ALLERGY, V45, P1, DOI 10.1016/0021-8707(70)90012-2	5	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	1					29	31		10.1016/0091-6749(79)90079-4	http://dx.doi.org/10.1016/0091-6749(79)90079-4			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HC424	109485				2022-12-18	WOS:A1979HC42400007
J	GUPTA, S; FIKRIG, S; GOOD, R				GUPTA, S; FIKRIG, S; GOOD, R			EFFECTS OF AGENTS MODULATING CYCLIC-NUCLEOTIDES ON T-CELL SUBSETS AND LOCOMOTION OF T-CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					143	143						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400028
J	JENNE, JW				JENNE, JW			BETA-ADRENERGIC AGENTS - HOW MUCH IS ENOUGH	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											JENNE, JW (corresponding author), HINES VET ADM MED CTR,HINES,IL 60141, USA.							AVNER BP, 1977, P W PHARMACOL SOC, V20, P25; AVNER BP, 1978, J PHARMACOL EXP THER, V207, P23; CONOLLY ME, 1971, BRIT J PHARMACOL, V43, P389; DOUGLAS JS, 1977, EUR J PHARMACOL, V42, P195, DOI 10.1016/0014-2999(77)90285-0; ELLULMIC.R, 1974, CLIN SCI MOL MED, V47, P105, DOI 10.1042/cs0470105; ELLULMICALLEF R, 1975, LANCET, V2, P1269; GALANT SP, 1978, NEW ENGL J MED, V299, P933, DOI 10.1056/NEJM197810262991707; HOLGATE ST, 1977, LANCET, V2, P375; JENNE JW, 1977, J ALLERGY CLIN IMMUN, V59, P383, DOI 10.1016/0091-6749(77)90023-9; KEIGHLEY JF, 1966, ANN INTERN MED, V65, P985, DOI 10.7326/0003-4819-65-5-985; LIN CS, 1977, J PHARMACOL EXP THER, V203, P12; NELSON HS, 1977, AM REV RESPIR DIS, V116, P871; PATERSON J W, 1971, British Journal of Diseases of the Chest, V65, P21, DOI 10.1016/S0007-0971(71)80015-3; REISMAN RE, 1970, J ALLERGY, V46, P162, DOI 10.1016/0021-8707(70)90095-X; SIMS JA, 1978, J ALLERGY CLIN IMMUN, V62, P15, DOI 10.1016/0091-6749(78)90066-0; STEPHAN W, 1978, AM REV RESPIR DIS, V117, P182; TATTERSFIELD AE, 1976, LANCET, V1, P422; TRAUTLEIN J, 1976, J CLIN PHARMACOL, V16, P361, DOI 10.1002/j.1552-4604.1976.tb01533.x; Van Metre T E Jr, 1967, Trans Am Clin Climatol Assoc, V78, P58; WEBER RW, 1979, J ALLERGY CLIN IMMUN, V63; WEINBERG.MM, 1974, J PEDIATR-US, V84, P421; WILSON AF, 1976, J ALLERGY CLIN IMMUN, V58, P204, DOI 10.1016/0091-6749(76)90156-1; WOLFE JD, 1978, NEW ENGL J MED, V298, P363, DOI 10.1056/NEJM197802162980703	23	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	2					74	76		10.1016/0091-6749(79)90194-5	http://dx.doi.org/10.1016/0091-6749(79)90194-5			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GJ748	32195	Bronze			2022-12-18	WOS:A1979GJ74800002
J	JOHNSON, JD				JOHNSON, JD			STATISTICAL CONSIDERATIONS IN STUDIES OF EXERCISE-INDUCED BRONCHOSPASM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											JOHNSON, JD (corresponding author), SYNTEX RES,3401 HILLVIEW AVE,PALO ALTO,CA 94304, USA.							GRIZZLE JE, 1965, BIOMETRICS, V21, P467, DOI 10.2307/2528104; KOCH GG, 1972, BIOMETRICS, V28, P577, DOI 10.2307/2556170; MOOD AM, 1963, INTRO THEORY STATIST; ROSENTHAL R, 1977, TIXANOX BRONCHIAL CH; SPRENKLE A, 1975, INT S EXERCISE ASTHM; Winer BJ., 1971, STAT PRINCIPLES EXPT, V2nd ed	6	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	6					634	641		10.1016/0091-6749(79)90027-7	http://dx.doi.org/10.1016/0091-6749(79)90027-7			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HX843	389991				2022-12-18	WOS:A1979HX84300015
J	MARONE, G; PLAUT, M; LICHTENSTEIN, LM				MARONE, G; PLAUT, M; LICHTENSTEIN, LM			HYDROCORTISONE AND HUMAN LYMPHOCYTES - INCREASES IN CYCLIC ADENOSINE-MONOPHOSPHATE AND POTENTIATION OF ADENYLATE CYCLASE-ACTIVATING AGENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					217	218						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400285
J	PAULL, BR; GLEICH, GJ; ATASSI, MZ				PAULL, BR; GLEICH, GJ; ATASSI, MZ			STRUCTURE AND ACTIVITY OF RAGWEED ANTIGEN-E .2. ALLERGENIC CROSSREACTIVITY OF THE SUBUNITS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MAYO CLIN & MAYO FDN,SCH MED,DEPT IMMUNOL,ROCHESTER,MN 55901; MAYO CLIN & MAYO FDN,SCH MED,DEPT PEDIAT,ROCHESTER,MN 55901; MAYO CLIN & MAYO FDN,SCH MED,DEPT INTERNAL MED,ROCHESTER,MN 55901	Mayo Clinic; Mayo Clinic; Mayo Clinic								ACKERS GK, 1964, BIOCHEMISTRY-US, V3, P723, DOI 10.1021/bi00893a021; ADOLPHSON C, 1978, J ALLERGY CLIN IMMUN, V62, P197, DOI 10.1016/0091-6749(78)90208-7; Atassi M Z, 1972, Methods Enzymol, V25, P546, DOI 10.1016/S0076-6879(72)25053-4; ATASSI MZ, 1979, BIOCHEM J, V179, P327, DOI 10.1042/bj1790327; ATASSI MZ, 1968, BIOCHEMISTRY-US, V7, P699, DOI 10.1021/bi00842a027; GLEICH GJ, 1976, MANUAL CLIN IMMUNOLO, P575; GRIFFITHS BW, 1972, J CHROMATOGR, V69, P391, DOI 10.1016/S0021-9673(00)92916-9; HABEEB AFSA, 1970, BIOCHEMISTRY-US, V9, P4939, DOI 10.1021/bi00827a016; KAZIM AL, 1977, BIOCHEM J, V167, P275, DOI 10.1042/bj1670275; KING TP, 1974, IMMUNOCHEMISTRY, V11, P83, DOI 10.1016/0019-2791(74)90321-8; KING TP, 1964, BIOCHEMISTRY-US, V3, P458, DOI 10.1021/bi00891a026; KING TP, 1967, BIOCHEMISTRY-US, V6, P1992, DOI 10.1021/bi00859a017; KING TP, 1967, ANN ALLERGY, V25, P541; LICHTENSTEIN LM, 1966, J ALLERGY, V38, P174, DOI 10.1016/0021-8707(66)90040-2; PAULL BR, 1978, IMMUNOCHEMISTRY, V15, P199, DOI 10.1016/0161-5890(78)90149-9; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SINGHAL RP, 1971, BIOCHEMISTRY-US, V10, P1756; TAKATSU K, 1975, J IMMUNOL, V115, P1469; WELSH PW, 1977, J ALLERGY CLIN IMMUN, V60, P104, DOI 10.1016/0091-6749(77)90034-3; WIDE L, 1967, LANCET, V2, P1105	20	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	6					539	545		10.1016/0091-6749(79)90065-4	http://dx.doi.org/10.1016/0091-6749(79)90065-4			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HX840	92489				2022-12-18	WOS:A1979HX84000011
J	REED, CE; BHANSALI, PV; IRVIN, C; POLCYN, RE				REED, CE; BHANSALI, PV; IRVIN, C; POLCYN, RE			SITE OF DEPOSITION OF AEROSOLS DELIVERED BY 2 METHODS USING THE DOSIMETER	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					164	165						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400100
J	SHERMAN, NA; MORRIS, HG; ARROYAVE, CM; SELNER, JC				SHERMAN, NA; MORRIS, HG; ARROYAVE, CM; SELNER, JC			CHANGES IN PLASMA CYCLIC ADENOSINE MONOPHOSPHATE, CYCLIC GUANOSINE MONOPHOSPHATE, HISTAMINE, AND PROSTAGLANDINS DURING EXERCISE-INDUCED ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					154	154						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400064
J	YUNGINGER, JW; SANTRACH, PJ				YUNGINGER, JW; SANTRACH, PJ			TREATMENT FAILURES FOLLOWING HONEYBEE VENOM IMMUNOTHERAPY - USE OF PASSIVE-IMMUNIZATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					179	179						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400152
J	KRANTMAN, HJ; RACHELEFSKY, GS; LIPSON, M; FONKALSRUD, EW				KRANTMAN, HJ; RACHELEFSKY, GS; LIPSON, M; FONKALSRUD, EW			RECURRENT PULMONARY INFILTRATES, DIGITAL CLUBBING, AND FAILURE TO THRIVE IN A 4-YEAR-OLD BOY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CALIF LOS ANGELES,CTR HLTH SCI,SCH MED,DEPT PEDIAT,DIV PEDIAT SURG,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,CTR HLTH SCI,SCH MED,DEPT SURG,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	KRANTMAN, HJ (corresponding author), UNIV CALIF LOS ANGELES,CTR HLTH SCI,SCH MED,DEPT PEDIAT,DIV ALLERGY IMMUNOL,LOS ANGELES,CA 90024, USA.							CARCASSONNE M, 1973, J PEDIATR SURG, V8, P575, DOI 10.1016/0022-3468(73)90394-1; CARRE IJ, 1959, ARCH DIS CHILD, V34, P344, DOI 10.1136/adc.34.176.344; CARRE IJ, 1960, ARCH DIS CHILD, V35, P569, DOI 10.1136/adc.35.184.569; DANUS O, 1976, J PEDIATR-US, V89, P220, DOI 10.1016/S0022-3476(76)80452-0; DEES SC, 1974, N C MED J, V35, P230; Donahue P E, 1977, Rev Surg, V34, P223; Euler A R, 1976, Pediatr Ann, V5, P678; EULER AR, 1977, PEDIATRICS, V59, P58; EULER AR, 1977, PEDIATRICS, V60, P65; FERGUSON AC, 1974, J PEDIATR-US, V85, P717, DOI 10.1016/S0022-3476(74)80527-5; FOLLETTE D, 1976, J PEDIATR SURG, V11, P757, DOI 10.1016/0022-3468(76)90100-7; HERBST JJ, 1976, AM J DIS CHILD, V130, P1256, DOI 10.1001/archpedi.1976.02120120090017; JOHNSON DG, 1977, PEDIATRICS, V59, P62; KULAPONGS P, 1974, LANCET, V2, P689; LENSMAN JF, 1965, AM J ROENTGENOL, V94, P325; MASAWE AEJ, 1974, LANCET, V2, P314; MAYS EE, 1976, JAMA-J AM MED ASSOC, V236, P2626, DOI 10.1001/jama.236.23.2626; MCNAMARA JJ, 1969, PEDIATRICS, V43, P527; MOALLEM S, 1973, NEW YORK STATE J MED, V73, P279; NEWMAN CG, 1977, MALNUTRITION IMMUNE, V7, P77; NISSEN R, 1961, AM J DIG DIS, V6, P954, DOI 10.1007/BF02231426; POPE CE, 1976, GASTROENTEROLOGY, V70, P445; RANDOLPH JG, 1974, ANN SURG, V180, P479, DOI 10.1097/00000658-197410000-00013; STROBER W, 1967, J CLIN INVEST, V46, P1643, DOI 10.1172/JCI105656; [No title captured]; 1968, WHO405 TECHN REP SER, P13	26	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	6					403	407						5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FC593	659732				2022-12-18	WOS:A1978FC59300010
J	RING, J; ARROYAVE, CM; FRITZLER, MJ; TAN, EM				RING, J; ARROYAVE, CM; FRITZLER, MJ; TAN, EM			INVITRO HISTAMINE AND SEROTONIN RELEASE BY RADIOGRAPHIC CONTRAST-MEDIA (RCM) IN MAN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Ring, Johannes/GLN-4341-2022	Ring, Johannes/0000-0001-8236-3152					0	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					145	145		10.1016/0091-6749(78)90296-8	http://dx.doi.org/10.1016/0091-6749(78)90296-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173		Bronze			2022-12-18	WOS:A1978ES17300057
J	ROCKLIN, RE; GREINEDER, D				ROCKLIN, RE; GREINEDER, D			HISTAMINE-INDUCED SUPPRESSOR FACTOR (HSF) - NATURE OF STIMULUS AND EFFECT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					144	144		10.1016/0091-6749(78)90293-2	http://dx.doi.org/10.1016/0091-6749(78)90293-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300054
J	SHAPIRO, GG; CHRISTIE, DL; PIERSON, WE; BIERMAN, CW; FURUKAWA, CT				SHAPIRO, GG; CHRISTIE, DL; PIERSON, WE; BIERMAN, CW; FURUKAWA, CT			GASTROESOPHAGEAL REFLUX (GER) IN ASTHMATIC-CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					137	137		10.1016/0091-6749(78)90269-5	http://dx.doi.org/10.1016/0091-6749(78)90269-5			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300030
J	DAVIES, RJ; BUTCHER, BT; SALVAGGIO, JE				DAVIES, RJ; BUTCHER, BT; SALVAGGIO, JE			OCCUPATIONAL ASTHMA CAUSED BY LOW-MOLECULAR WEIGHT CHEMICAL AGENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									TULANE UNIV,DEPT MED,NEW ORLEANS,LA 70112	Tulane University								Bernton HS, 1923, AM J MED SCI, V165, P196; BUTCHER BT, 1976, J ALLERGY CLIN IMMUN, V58, P89, DOI 10.1016/0091-6749(76)90110-X; BUTCHER BT, IN PRESS; DAVIES R J, 1977, American Review of Respiratory Disease, V115, P209; DAVIES RJ, 1974, CLIN ALLERGY, V4, P227; DOLOVICH J, 1977, ANN ALLERGY, V38, P382; FREEDMAN SO, 1968, J ALLERGY, V42, P233, DOI 10.1016/S0021-8707(68)90118-4; HUNTER D, 1945, BRIT J IND MED, V2, P92; LEHRER SB, COMMUNICATION; MACCIA CA, 1976, AM REV RESPIR DIS, V113, P701; MCCONNELL LH, 1973, ANN INTERN MED, V78, P888, DOI 10.7326/0003-4819-78-6-888; NEWHOUSE ML, 1970, LANCET, V1, P689; PARROT JL, 1969, ARCH ENVIRON HEALTH, V19, P685, DOI 10.1080/00039896.1969.10666910; PEPYS J, 1973, CLIN ALLERGY, V3, P491, DOI 10.1111/j.1365-2222.1973.tb03057.x; PEPYS J, 1973, Clinical Allergy, V3, P143, DOI 10.1111/j.1365-2222.1973.tb01318.x	15	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1977	60	2					93	95		10.1016/0091-6749(77)90032-X	http://dx.doi.org/10.1016/0091-6749(77)90032-X			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DR448	194937				2022-12-18	WOS:A1977DR44800001
J	SPECTOR, SL; HUDSON, L; PETTY, TL				SPECTOR, SL; HUDSON, L; PETTY, TL			EFFECT OF BRONKOSOL AND ITS COMPONENTS ON CARDIOPULMONARY PARAMETERS IN ASTHMATIC-PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NATL JEWISH HOSP & RES CTR,DEPT MED,ALLERGY & CLIN IMMUNOL SECT,DENVER,CO 80206; HARBORVIEW MED CTR,DEPT MED RESP DIS,SEATTLE,WA 98104; UNIV COLORADO,MED CTR,DEPT MED,DIV PULM SCI,DENVER,CO 80220	National Jewish Health; Harborview Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver								ALLIOTT RJ, 1972, BMJ-BRIT MED J, V1, P539, DOI 10.1136/bmj.1.5799.539; BASS BH, 1969, LANCET, V2, P438; COHEN AA, 1965, AM J MED SCI, V249, P309, DOI 10.1097/00000441-196503000-00010; ELSHABOURY H, 1964, BRIT MED J, V2, P1037; FREEDMAN BJ, 1968, THORAX, V23, P590, DOI 10.1136/thx.23.6.590; GOLDFARB AA, 1962, ANN ALLERGY, V20, P307; GROSS GN, 1974, CHEST, V66, P397, DOI 10.1378/chest.66.4.397; HARRIS L, 1972, J ALLERGY CLIN IMMUN, V49, P43; HUME KM, 1970, BRIT MED J, V1, P173, DOI 10.1136/bmj.1.5689.173-c; KALINER M, 1972, J EXP MED, V136, P556, DOI 10.1084/jem.136.3.556; KALLOS P, 1963, INT ARCH ALLERGY APP, V24, P17; KEIGHLEY JF, 1966, ANN INTERN MED, V65, P985, DOI 10.7326/0003-4819-65-5-985; MATTILA M, 1966, ACTA MED SCAND, V180, P421; OLSON CR, 1968, AM REV RESPIR DIS, V98, P301; PALMER KNV, 1969, BRIT MED J, V1, P31, DOI 10.1136/bmj.1.5635.31; PALMER KNV, 1970, BRIT MED J, V1, P23; PATEL KR, 1973, CLIN ALLERGY, V3, P439, DOI 10.1111/j.1365-2222.1973.tb01351.x; RIDING WD, 1971, AM REV RESPIR DIS, V104, P688; SAUNDERS NA, 1976, AM REV RESPIR DIS, V113, P745; SIEGEL S, 1956, NONPARAMETRIC STAT, P63; SPECTOR S, 1976, AM REV RESPIR DIS, V113, P43; SPECTOR S, COMMUNICATION; WINER BJ, 1971, STATISTICAL PRINCIPL, P518; 1962, AM REV RESPIR DIS, V85, P762	24	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1977	59	5					371	376		10.1016/0091-6749(77)90021-5	http://dx.doi.org/10.1016/0091-6749(77)90021-5			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DF215	323326				2022-12-18	WOS:A1977DF21500007
J	RATNOFF, OD				RATNOFF, OD			MEDIATORS OF INFLAMMATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review									CASE WESTERN RESERVE UNIV, SCH MED, DEPT MED, CLEVELAND, OH 44106 USA; UNIV HOSP CLEVELAND, DEPT MED, CLEVELAND, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland								ABE K, 1967, EXPERIENTIA, V23, P626, DOI 10.1007/BF02144161; Abelous JE, 1909, CR SOC BIOL, V66, P511; ARMSTRONG D, 1954, NATURE, V174, P791, DOI 10.1038/174791a0; Bordet J., 1901, ANN I PASTEUR PARIS, V15, P129; BROCKLEHURST WE, 1962, J PHYSIOL-LONDON, V160, pP15; COCHRANE CG, 1972, INFLAMMATION MECHANI, P119; COLLAGEN S, 1975, FED PROC, V34, P860; COLMAN RW, 1975, J CLIN INVEST, V56, P1650, DOI 10.1172/JCI108247; DELAUS FV, 1968, ARCH DERMATOL, V98, P67, DOI 10.1001/archderm.98.1.67; DOLOVICH J, 1968, J ALLERGY, V41, P103; DONALDSON VH, 1963, AM J MED, V35, P37, DOI 10.1016/0002-9343(63)90162-1; DONALDSON VH, 1964, J CLIN INVEST, V43, P2204, DOI 10.1172/JCI105094; DONALDSON VH, 1969, J CLIN INVEST, V48, P642, DOI 10.1172/JCI106022; DONALDSON VH, 1976, J LAB CLIN MED, V87, P327; DONALDSON VH, 1968, J EXP MED, V127, P411, DOI 10.1084/jem.127.3.411; FREY EK, 1930, ARCH EXP PATHOL PH, V158, P334; GOODWIN LG, 1963, BRIT J EXP PATHOL, V44, P551; HATHAWAY WE, 1965, BLOOD-J HEMATOL, V26, P521, DOI 10.1182/blood.V26.5.521.521; IATRIDIS SG, 1962, J CLIN INVEST, V41, P1277, DOI 10.1172/JCI104590; JACOBSEN S, 1967, BRIT J PHARM CHEMOTH, V29, P25, DOI 10.1111/j.1476-5381.1967.tb01935.x; KAGEN LJ, 1963, FED PROC, V22, P613; KELLERMEYER WF, 1969, P SOC EXP BIOL MED, V130, P1310; KRAUT H, 1928, Z PHYSL CHEM, V175, P97; LANDERMAN NS, 1962, J ALLERGY, V33, P330, DOI 10.1016/0021-8707(62)90032-1; LEPOW IH, 1954, J IMMUNOL, V73, P146; LEWIS GP, 1958, J PHYSIOL-LONDON, V140, P285, DOI 10.1113/jphysiol.1958.sp005934; Lewis T., 1927, BLOOD VESSELS HUMAN; Lister J., 1863, P R SOC LOND, V12, P580; MARGOLIS J, 1958, J PHYSIOL-LONDON, V144, P1; MCMILLIN CR, 1974, J CLIN INVEST, V54, P1312, DOI 10.1172/JCI107877; MICHEL B, 1968, J CLIN INVEST, V47, pA68; MORRISON DC, 1974, J EXP MED, V140, P797, DOI 10.1084/jem.140.3.797; MOSKOWITZ RW, 1970, J LAB CLIN MED, V76, P790; NIEWIAROWSKI S, 1959, THROMB DIATH HAEMOST, V3, P593; OATES JA, 1964, LANCET, V1, P514; OGSTON D, 1969, J CLIN INVEST, V48, P1786, DOI 10.1172/JCI106145; OGSTON D, 1969, J LAB CLIN MED, V73, P70; OSLER W, 1888, AM J MED SCI, V95, P363; Ratnoff O D, 1969, Adv Immunol, V10, P145, DOI 10.1016/S0065-2776(08)60417-4; RATNOFF OD, 1963, J EXP MED, V118, P681, DOI 10.1084/jem.118.5.681; RATNOFF OD, 1955, J CLIN INVEST, V34, P602, DOI 10.1172/JCI103109; RATNOFF OD, 1964, J LAB CLIN MED, V63, P359; RATNOFF OD, 1957, J EXP MED, V106, P327, DOI 10.1084/jem.106.2.327; RATNOFF OD, 1958, AM J MED, V25, P160, DOI 10.1016/0002-9343(58)90023-8; RATNOFF OD, 1975, P SOC EXP BIOL MED, V148, P177; RATNOFF OD, 1971, THROMB DIATH HAEMO, V45, P109; RATNOFF OD, UNPUBLISHED STUDIES; RATNOFF OSCAR D., 1966, PROGR HEMATOL, V5, P204; SAITO H, 1975, J CLIN INVEST, V55, P1082, DOI 10.1172/JCI108009; SCHWARTZ HJ, 1971, J IMMUNOL, V106, P450; SCHWARTZ HJ, 1969, P SOC EXP BIOL MED, V132, P1021; SILVA MRE, 1949, AM J PHYSIOL, V156, P261, DOI 10.1152/ajplegacy.1949.156.2.261; SOULIER JP, 1958, REV FR ETUD CLIN BIO, V3, P263; VOGT W, 1964, J PHYSIOL-LONDON, V170, P153, DOI 10.1113/jphysiol.1964.sp007320; WALSH PN, 1972, BRIT J HAEMATOL, V22, P237, DOI 10.1111/j.1365-2141.1972.tb08803.x; WEBSTER ME, 1961, NATURE, V192, P180, DOI 10.1038/192180a0; WERLE E, 1955, POLYPEPTIDES STIMULA, P20; WILNER GD, 1968, J CLIN INVEST, V47, P2608, DOI 10.1172/JCI105943; WUEPPER KD, 1975, J CLIN INVEST, V56, P1663, DOI 10.1172/JCI108248; WUEPPER KD, 1972, INFLAMMATION MECHANI, P93; ZACHARSKI LR, 1975, THROMB RES, V7, P929, DOI 10.1016/0049-3848(75)90097-3	61	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	58	3					438	446		10.1016/0091-6749(76)90125-1	http://dx.doi.org/10.1016/0091-6749(76)90125-1			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CD454	135010	Bronze			2022-12-18	WOS:A1976CD45400011
J	SCHWARTZ, HJ; TRAUTLEIN, JJ; GOLDSTEIN, AR				SCHWARTZ, HJ; TRAUTLEIN, JJ; GOLDSTEIN, AR			ACUTE EFFECTS OF TERBUTALINE AND EPINEPHRINE ON ASTHMA - DOUBLE-BLIND CROSSOVER PLACEBO STUDY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									CASE WESTERN RESERVE UNIV,DEPT MED,DIV ALLERGY,CLEVELAND,OH 44106; VET ADM HOSP,PULM SECT B,CLEVELAND,OH	Case Western Reserve University								BRECHTER C, 1973, SCAND J RESPIR DIS, V54, P78; DACOSTA J, 1970, SCAND J RESPIR DIS, V51, P212; DULFANO MJ, 1973, CURR THER RES, V15, P141; ELGEFORS B, 1971, EUR J CLIN PHARMACOL, V3, P209, DOI 10.1007/BF00565008; FORMGREN H, 1971, ACTA ALLERGOL, V26, P81, DOI 10.1111/j.1398-9995.1971.tb01283.x; GLASS P, 1973, CURR THER RES CLIN E, V15, P141; LINEHAN WD, 1973, IRISH J MED SCI, V142, P115, DOI 10.1007/BF02949998; MAGNUSSON G, 1973, CARDIOLOGY, V58, P174, DOI 10.1159/000169631; MANICATIDE M A, 1973, Revue Roumaine de Medecine Interne, V10, P49; MARANETRA N, 1973, MED J AUSTRALIA, V1, P988, DOI 10.5694/j.1326-5377.1973.tb110855.x; NOU E, 1971, SCAND J RESPIR DIS, V52, P192; OLSSON T, 1971, ACT ALLERG, V26, P448	12	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	58	4					516	522		10.1016/0091-6749(76)90195-0	http://dx.doi.org/10.1016/0091-6749(76)90195-0			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CH210	787050				2022-12-18	WOS:A1976CH21000008
J	STORMS, WW; DICK, EC; BUSSE, WW				STORMS, WW; DICK, EC; BUSSE, WW			INTRANASAL IMMUNIZATION WITH ATTENUATED LIVE INFLUENZA VACCINE IN ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WISCONSIN,DEPT MED,MADISON,WI 53706; UNIV WISCONSIN,DEPT PREVENT MED,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison								BERGOVICH S, 1970, ANN ALLERGY, V28, P42; DALESSIO DJ, 1969, J AMER MED ASSOC, V210, P485, DOI 10.1001/jama.210.3.485; Davies J E, 1972, Br J Clin Pract, V26, P469; DESPAS PJ, 1972, J CLIN INVEST, V51, P3235, DOI 10.1172/JCI107150; FRIDY WW, 1974, ANN INTERN MED, V80, P150, DOI 10.7326/0003-4819-80-2-150; HOWELLS CHL, 1975, LANCET, V1, P381; HUTCHEON M, 1974, AM REV RESPIR DIS, V110, P458; MINOR TE, 1975, J CLIN MICROBIOL, V2, P403; MINOR TE, 1974, J PEDIATR-US, V85, P472, DOI 10.1016/S0022-3476(74)80447-6; OUELLETTE JJ, 1965, J ALLERGY, V36, P558, DOI 10.1016/0021-8707(65)90193-0; PICKEN JJ, 1972, AM J MED, V52, P738, DOI 10.1016/0002-9343(72)90079-4; PODOSIN RL, 1958, NEW ENGL J MED, V258, P778, DOI 10.1056/NEJM195804172581603; REBHAN A W, 1957, Can Med Assoc J, V77, P797; ROSENZWEIG DY, 1975, AM REV RESPIR DIS, V111, P399; SHOPE RE, 1958, PUBLIC HEALTH REP, V73, P165, DOI 10.2307/4590072; VANUFFORD WJQ, 1959, INT ARCH ALLER A IMM, V15, P189; WALDMAN RH, 1973, J IMMUNOL, V111, P38	17	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	58	2					284	290		10.1016/0091-6749(76)90133-0	http://dx.doi.org/10.1016/0091-6749(76)90133-0			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CA661	947980				2022-12-18	WOS:A1976CA66100005
J	GORDON, HH				GORDON, HH			EPISODIC URTICARIA DUE TO SACCHARIN INGESTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									KAISER FDN HOSP,DEPT DERMATOL,FONTANA,CA	Kaiser Permanente								Gordon H.H., 1972, CUTIS, V10, P77; KENNEDY BARRETT, 1961, JOUR LOUISIANA STATE MED SOC, V113, P365; MILLER R, 1974, J ALLERG CL, V53; PATIALA R, 1951, ANN MED EXP BIOL FEN, V29, P191; PITKIN RM, 1971, AM J OBSTET GYNECOL, V111, P280, DOI 10.1016/0002-9378(71)90903-3; THOMPSON MM, 1959, AM J CLIN NUTR, V7, P80, DOI 10.1093/ajcn/7.1.80; VALENSTEIN ES, 1965, J COMP PHYSIOL PSYCH, V60, P443, DOI 10.1037/h0022560	7	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	56	1					78	79		10.1016/0091-6749(75)90036-6	http://dx.doi.org/10.1016/0091-6749(75)90036-6			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AH615					2022-12-18	WOS:A1975AH61500008
J	HOFFMAN, DR; SHIPMAN, WH				HOFFMAN, DR; SHIPMAN, WH			ALLERGENIC ANALYSIS OF BEE VENOM FRACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					73	73						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800011
J	OKAZAKI, T; OKAZAKI, A; REISMAN, RE; ARBESMAN, CE				OKAZAKI, T; OKAZAKI, A; REISMAN, RE; ARBESMAN, CE			GLYCOGENOLYSIS AND CONTROL OF ANAPHYLACTIC HISTAMINE-RELEASE BY CYCLIC ADENOSINE MONOPHOSPHATE-RELATED AGENTS .1. ROLE OF GLYCOGEN AND GLUCOSE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SUNY, DEPT MED, BUFFALO, NY USA; SUNY, DEPT MICROBIOL, BUFFALO, NY USA; BUFFALO GEN HOSP, ALLERGY RES LAB, 100 HIGH ST, BUFFALO, NY 14203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; SUNY Maritime College; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; SUNY Maritime College; Buffalo General Medical Center								ASSEM ESK, 1969, NATURE, V224, P1028, DOI 10.1038/2241028a0; AUSTEN KF, 1963, ADV IMMUNOL, V3, P1, DOI 10.1016/S0065-2776(08)60810-X; BING OHL, 1972, J MOL CELL CARDIOL, V4, P319, DOI 10.1016/0022-2828(72)90078-8; BOURNE HR, 1971, SCIENCE, V173, P743, DOI 10.1126/science.173.3998.743; BOURNE HR, 1972, J IMMUNOL, V108, P695; BUEDING E, 1964, ANAL BIOCHEM, V7, P26, DOI 10.1016/0003-2697(64)90116-2; BUELBRING E, 1960, ADRENERGIC MECHANISM, P275; BURTON SD, 1965, AM J PHYSIOL, V209, P1145, DOI 10.1152/ajplegacy.1965.209.6.1145; CHAPLER CK, 1972, BRAIN RES, V45, P321, DOI 10.1016/0006-8993(72)90246-6; CHAPLER CK, 1972, CAN J PHYSIOL PHARM, V50, P471, DOI 10.1139/y72-072; De Zwaan A., 1972, Comparative Biochem Physiol (B), V43, P47, DOI 10.1016/0305-0491(72)90200-3; FREDHOLM B, 1969, Acta Physiologica Scandinavica, V76, P446, DOI 10.1111/j.1748-1716.1969.tb04491.x; GABBE SG, 1972, AM J OBSTET GYNECOL, V114, P540, DOI 10.1016/0002-9378(72)90217-7; GLINSMANN WH, 1969, ENDOCRINOLOGY, V85, P711, DOI 10.1210/endo-85-4-711; HALL MT, 1972, BRIT J PHARMACOL, V45, P378, DOI 10.1111/j.1476-5381.1972.tb08093.x; Hegnauer AH, 1934, J BIOL CHEM, V105, P691; HESS ME, 1962, BIOCHEM PHARMACOL, V11, P1031, DOI 10.1016/0006-2952(62)90161-2; ISHIZAKA T, 1971, J IMMUNOL, V106, P1267; KALINER M, 1972, J EXP MED, V136, P556, DOI 10.1084/jem.136.3.556; LICHTENS.LM, 1968, SCIENCE, V161, P902, DOI 10.1126/science.161.3844.902; MALAMUD D, 1968, EXP CELL RES, V50, P581, DOI 10.1016/0014-4827(68)90420-5; MANSOUR TE, 1972, J BIOL CHEM, V247, P6059; MONGAR JL, 1962, PHYSIOL REV, V42, P226, DOI 10.1152/physrev.1962.42.2.226; MONTGOMERY R, 1957, ARCH BIOCHEM BIOPHYS, V67, P378, DOI 10.1016/0003-9861(57)90292-8; MRSULJA BB, 1972, EXPERIENTIA, V28, P1067; ORANGE RP, 1971, J EXP MED, V134, P1365; Parker C, COMMUNICATION; PASTAN I, 1971, NATURE-NEW BIOL, V229, P5, DOI 10.1038/newbio229005a0; SCHILD H., 1936, QUART JOUR EXP PHYSIOL, V26, P165; SCHILD HO, 1968, BIOCHEMISTRY ACUTE A, P99; SHERLINE P, 1972, ENDOCRINOLOGY, V91, P680, DOI 10.1210/endo-91-3-680; SHORE PA, 1959, J PHARMACOL EXP THER, V127, P182; YAMAMOTO S, 1973, IMMUNOLOGY, V24, P77	33	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	56	4					243	252		10.1016/0091-6749(75)90098-6	http://dx.doi.org/10.1016/0091-6749(75)90098-6			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AS523	51861				2022-12-18	WOS:A1975AS52300001
J	RODRIGUEZ, GE; BRANCH, LB; COTTON, EK				RODRIGUEZ, GE; BRANCH, LB; COTTON, EK			USE OF HUMIDITY IN ASTHMATIC-CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV COLORADO,MED CTR,DENVER,CO; NATL JEWISH HOSP & RES CTR,3800 E COLFAX AVE,DENVER,CO 80206	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health								ALLEN GW, 1971, AM REV RESPIR DIS, V104, P61; AVERY ME, 1967, PEDIATRICS, V39, P160; BAKER R, 1972, J PEDIATR, V80, P396; BAU SK, 1971, PEDIATRICS, V48, P605; BRISCOE WA, 1958, J CLIN INVEST, V37, P1279, DOI 10.1172/JCI103715; CHENEY FW, 1965, ANESTHESIOLOGY, V29, P1099; DAVIES RR, 1969, ACTA ALLERGOL, V24, P396, DOI 10.1111/j.1398-9995.1969.tb03754.x; Dixon WE, 1903, J PHYSIOL-LONDON, V29, P97; DOERSHUK CF, 1968, PEDIATRICS, V41, P723; DUBOIS AB, 1956, J CLIN INVEST, V35, P327, DOI 10.1172/JCI103282; Farr RS, 1973, CHEST, V63, p64S; FORD R M, 1969, Medical Journal of Australia, V56-1, P628; JOSENHANS WT, 1969, RESPIRATION, V26, P435, DOI 10.1159/000192624; MACKLEM PT, 1967, J APPL PHYSIOL, V22, P395, DOI 10.1152/jappl.1967.22.3.395; MATTHEWS LW, 1967, PEDIATRICS, V39, P176; MEAD J, 1960, J APPL PHYSIOL, V15, P736, DOI 10.1152/jappl.1960.15.4.736; MELVILLE GN, 1970, CAN J PHYSIOL PHARM, V48, P592, DOI 10.1139/y70-090; MERCER TT, 1968, ANN ALLERGY, V26, P18; MITCHELL RI, 1960, AM REV RESPIR DIS, V82, P627; MOFFET HL, 1967, AM J DIS CHILD, V114, P21, DOI 10.1001/archpedi.1967.02090220027004; MOORE RB, 1972, J ALLERGY CLIN IMMUN, V49, P137, DOI 10.1016/0091-6749(72)90107-8; MOTOYAMA EK, 1972, PEDIATRICS, V50, P299; NADEL JA, 1961, J APPL PHYSIOL, V16, P717, DOI 10.1152/jappl.1961.16.4.717; NADEL JA, 1968, ARCH ENVIRON HEALTH, V16, P171, DOI 10.1080/00039896.1968.10665039; SLONIM NB, 1971, RESPIRATORY PHYSIOLO; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; TOWNLEY RG, 1965, J ALLERGY, V36, P121, DOI 10.1016/0021-8707(65)90161-9; WELLS RE, 1960, NEW ENGL J MED, V263, P268, DOI 10.1056/NEJM196008112630602; WIDCHCOMBE JG, 1962, J APPL PHYSIOL, V17, P613; WOLFSDORF J, 1969, PEDIATRICS, V43, P799; ZAPLETAL A, 1971, PEDIATRICS, V48, P64	31	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	56	2					133	140		10.1016/0091-6749(75)90118-9	http://dx.doi.org/10.1016/0091-6749(75)90118-9			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AM325	1151009				2022-12-18	WOS:A1975AM32500007
J	SOLLEY, GO; LARSON, JB; JORDON, RE; GLEICH, GJ				SOLLEY, GO; LARSON, JB; JORDON, RE; GLEICH, GJ			LATE CUTANEOUS REACTIONS DUE TO IGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					112	112						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800108
J	WEBB, DR; PEARSALL, HR; SUMIDA, SE				WEBB, DR; PEARSALL, HR; SUMIDA, SE			DEPRESSION OF THIRD COMPONENT OF COMPLEMENT (C3) IN CHRONIC ANGIOEDEMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					106	106						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800093
J	COLEMAN, M; BARNARD, J; BARR, S; BROWN, H; LEVINE, M; MUELLER, H				COLEMAN, M; BARNARD, J; BARR, S; BROWN, H; LEVINE, M; MUELLER, H			PROLONGED INTERVAL THERAPY IN HYMENOPTERA-SENSITIVE PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					111	112						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000116
J	MIKLICH, DR; CHAI, H; PURCELL, K; WEISS, JH; BRADY, K				MIKLICH, DR; CHAI, H; PURCELL, K; WEISS, JH; BRADY, K			NATURALISTIC OBSERVATION OF EMOTIONS PRECEDING LOW PULMONARY FLOW-RATES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					102	102						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000093
J	MITCHELL, RG; THOM, H; RICHARDSON, JE				MITCHELL, RG; THOM, H; RICHARDSON, JE			HISTAMINE METABOLISM IN ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV ABERDEEN, DEPT CHILD HLTH, MED BLDG, FORESTERHILL, ABERDEEN AB9 2ZD, SCOTLAND	University of Aberdeen								BERG B, 1971, SCAND J HAEMATOL, V8, P63; DOWELL RC, 1966, J ALLERGY, V38, P290, DOI 10.1016/0021-8707(66)90025-6; FRAM DH, 1965, J BIOL CHEM, V240, P2036; GRANERUS G, 1968, SCAND J CLIN LAB INV, VS 22, P39; GRANERUS G, 1968, SCAND J CLIN LAB INV, VS 22, P59, DOI 10.1080/00365516809168041; HELANDER E, 1962, ACTA ALLERGOL, V17, P86, DOI 10.1111/j.1398-9995.1962.tb02930.x; HUFF JA, 1966, J LAB CLIN MED, V67, P1044; KELVIN AS, 1970, BRIT J PHARMACOL, V38, pP466; KERR JW, 1964, BMJ-BRIT MED J, V2, P606, DOI 10.1136/bmj.2.5409.606; OATES JA, 1962, CLIN CHIM ACTA, V7, P488; WHITE T, 1966, BRIT J PHARM CHEMOTH, V26, P494, DOI 10.1111/j.1476-5381.1966.tb01930.x	11	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	54	2					111	114		10.1016/0091-6749(74)90039-6	http://dx.doi.org/10.1016/0091-6749(74)90039-6			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T7816	4852274				2022-12-18	WOS:A1974T781600006
J	SUTNICK, AI				SUTNICK, AI			AUSTRALIA-ANTIGEN AND IMMUNE-RESPONSE IN HUMAN DISEASES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									FOX CHASE CTR CANC & MED SCI,INST CANC RES,7701 BURHOLME AVE,PHILADELPHIA,PA 19111	Fox Chase Cancer Center								ALEXANDER P, 1972, ANN I PASTEUR PARIS, V122, P645; BANCROFT WH, 1972, J IMMUNOL, V109, P843; Blumberg B S, 1971, CRC Crit Rev Clin Lab Sci, V2, P473, DOI 10.3109/10408367109151315; BLUMBERG BARUCH S., 1964, BULL N Y ACAD MED, V40, P377; BLUMBERG BS, 1966, AM J HUM GENET, V18, P594; BLUMBERG BS, 1971, POSTGRAD MED, V50, P70, DOI 10.1080/00325481.1971.11697697; BLUMBERG BS, 1969, P NATL ACAD SCI USA, V62, P1108, DOI 10.1073/pnas.62.4.1108; BLUMBERG BS, 1972, ARCH INTERN MED, V130, P227, DOI 10.1001/archinte.130.2.227; BLUMBERG BS, 1972, HEPATITIS BLOOD TRAN, pCH10; CEPPELLINI R, 1970, HIGH FREQUENCY FAMIL; CHIURCO AA, 1973, RES COMMUN CHEM PATH, V6, P273; DENISON GK, 1971, ANN INTERN MED, V74, P391; DOLL R, 1970, CANCER INCIDENCE 5 C, V2; DUDLEY FJ, 1972, LANCET, V1, P723; FRAUMENI JF, 1971, J NATL CANCER I, V46, P461; FRAUMENI JF, 1964, PUBLIC HEALTH REP, V79, P1093, DOI 10.2307/4592331; HAMPERS CL, 1964, NEW ENGL J MED, V271, P747, DOI 10.1056/NEJM196410082711501; HANN HWL, 1973, P AM ASSOC CANC RES, V14, P9; HIBBS JB, 1972, SCIENCE, V177, P998, DOI 10.1126/science.177.4053.998; IRWIN GR, 1972, J INFECT DIS, V125, P73, DOI 10.1093/infdis/125.1.73; KIM CY, 1971, J INFECT DIS, V123, P618, DOI 10.1093/infdis/123.6.618; LEBOUVIER GL, 1971, J INFECT DIS, V123, P671, DOI 10.1093/infdis/123.6.671; LEVENE C, 1969, NATURE, V221, P195, DOI 10.1038/221195a0; MAZZUR S, TO BE PUBLISHED; MAZZUR S, PERSONAL COMMUNICATI; OHBAYASHI A, 1972, GASTROENTEROLOGY, V62, P618; RAUNIO VK, 1970, P SOC EXP BIOL MED, V134, P548, DOI 10.3181/00379727-134-34833; SENIOR JR, 1971, GASTROENTEROLOGY, V60, P752; SIMONE JV, 1971, PERSONAL COMMUNICATI; SUTNICK AI, 1972, AM J DIS CHILD, V123, P392, DOI 10.1001/archpedi.1972.02110100124047; SUTNICK AI, 1971, LANCET, V1, P1200; SUTNICK AI, 1971, JNCI-J NATL CANCER I, V47, P923; SUTNICK AI, 1972, GASTROENTEROLOGY, V62, P819; SUTNICK AI, 1973, J LAB CLIN MED, V82, P79; SUTNICK AI, 1973, PROGR REPORT MED CLI, V57, P1029; VERMYLEN C, 1972, LANCET, V1, P1119; YEUNGLAIWAH AAC, 1971, LANCET, V2, P470	37	7	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	1					42	51		10.1016/0091-6749(74)90098-0	http://dx.doi.org/10.1016/0091-6749(74)90098-0			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	R8075	4271677	Bronze			2022-12-18	WOS:A1974R807500006
J	VALENTIN.MD; SOBOTKA, A; LICHTENS.LM				VALENTIN.MD; SOBOTKA, A; LICHTENS.LM			BLOCKING ANTIBODY TO BEE VENOM - INDUCTION BY VENOM AND NOT BY WHOLE-BODY EXTRACTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					105	105						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000101
J	HUBSCHER, T; EISEN, AH				HUBSCHER, T; EISEN, AH			EOSINOPHIL DERIVED INHIBITOR (EDI) OF HISTAMINE-RELEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	2					83	84		10.1016/S0091-6749(73)80015-6	http://dx.doi.org/10.1016/S0091-6749(73)80015-6			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O7913		Bronze			2022-12-18	WOS:A1973O791300015
J	MATHISON, DA; STEVENSON, DD; TAN, EM; VAUGHAN, JH				MATHISON, DA; STEVENSON, DD; TAN, EM; VAUGHAN, JH			METHACHOLINE CHALLENGE AND DIAGNOSIS OF BRONCHIAL-ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	2					94	95		10.1016/S0091-6749(73)80037-5	http://dx.doi.org/10.1016/S0091-6749(73)80037-5			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O7913					2022-12-18	WOS:A1973O791300037
J	RANCOUR, JM; STIER, RA				RANCOUR, JM; STIER, RA			STABILITY OF ANTIGEN-E IN AQUEOUS AND GLYCERINATED SHORT RAGWEED EXTRACTS STORED AT VARIOUS TEMPERATURES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	2					114	115		10.1016/S0091-6749(73)80078-8	http://dx.doi.org/10.1016/S0091-6749(73)80078-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O7913					2022-12-18	WOS:A1973O791300078
J	TOWNLEY, RG; KANG, B; LEE, CK; KOLOTKIN, B				TOWNLEY, RG; KANG, B; LEE, CK; KOLOTKIN, B			EFFECTS OF DISODIUM CHROMOGLYCATE ON INTRAVENOUS INFUSION OF HISTAMINE IN ASTHMATICS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		KERR, 1970, BRIT MED J, V2, P139; 1971, J ALLERGY CLIN IMMUN, V47, P96	2	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	2					121	122		10.1016/S0091-6749(73)80092-2	http://dx.doi.org/10.1016/S0091-6749(73)80092-2			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O7913					2022-12-18	WOS:A1973O791300092
J	VANHOUTEN, PD; HASHIMOTO, B; WILSON, AF				VANHOUTEN, PD; HASHIMOTO, B; WILSON, AF			TECHNIQUE FOR INTENSE RADIOLABELING OF POLLEN AND POLLEN EXTRACT WITH TC-99M	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CALIF, DEPT MED, IRVINE, CA 92664 USA	University of California System; University of California Irvine								[Anonymous], 1972, ADV INORGANIC CHEMIS; BROOKS J, 1968, NATURE, V219, P532, DOI 10.1038/219532a0; ECKELMAN W, 1971, J NUCL MED, V12, P596; ECKELMAN W, 1970, J NUCL MED, V11, P761; ECKELMAN WC, 1971, J NUCL MED, V12, P707; ECKELMAN WC, 1972, J NUCL MED, V13, P202; Freeman H C, 1967, Adv Protein Chem, V22, P257, DOI 10.1016/S0065-3233(08)60043-1; HESLOPHARRISON J, 1968, SCIENCE, V161, P230, DOI 10.1126/science.161.3838.230; KNOX RB, 1971, J CELL SCI, V9, P209; KOTEGOV KV, 1968, ADV INORG CHEM RAD, V11, P11; LIN MS, 1971, J NUCL MED, V12, P204; MELLOR JW, 1927, COMPREHENSIVE TREATI, V7; NOLLER CR, 1965, CHEMISTRY ORGANIC CO; Willard H. H., 1965, INSTRUMENTAL METHODS	14	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	52	2					115	121		10.1016/0091-6749(73)90083-3	http://dx.doi.org/10.1016/0091-6749(73)90083-3			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	Q4190	4723888	Bronze			2022-12-18	WOS:A1973Q419000006
J	KALINER, M; AUSTEN, KF; ORANGE, RP; LARAIA, PJ				KALINER, M; AUSTEN, KF; ORANGE, RP; LARAIA, PJ			CHOLINERGIC ENHANCEMENT OF IMMUNOLOGICAL RELEASE OF HISTAMINE AND SLOW-REACTING SUBSTANCE OF ANAPHYLAXIS (SRS-A) FROM HUMAN LUNG TISSUE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		GRIECO, 1971, J ALLERG CL, V48, P143; ITKIN IH, 1970, J ALLERGY, V45, P178, DOI 10.1016/0021-8707(70)90126-7; SIMONSSON BG, 1967, J CLIN INVEST, V46, P1812, DOI 10.1172/JCI105671; TOWNLEY RG, 1965, J ALLERGY, V36, P121, DOI 10.1016/0021-8707(65)90161-9	4	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					88	&						0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997					2022-12-18	WOS:A1972L599700008
J	MILLER, JR; MELTZER, EO				MILLER, JR; MELTZER, EO			USE OF EGG-CONTAINING VACCINES IN EGG-SENSITIVE PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					109	&						0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997					2022-12-18	WOS:A1972L599700052
J	VIJAYANAGAR, HM; SEHON, AH; ATTALLAH, NA; DAVID, MF				VIJAYANAGAR, HM; SEHON, AH; ATTALLAH, NA; DAVID, MF			IN-VITRO DETECTION OF HUMAN REAGINS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					119	+						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997					2022-12-18	WOS:A1972L599700072
J	BULLOCK, JD; BODENBENDER, JG; DEAMER, WC; FRICK, OL				BULLOCK, JD; BODENBENDER, JG; DEAMER, WC; FRICK, OL			SKIN WINDOW EOSINOPHIL RESPONSE IN HOUSE DUST ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		ARCHER RK, 1959, J PATHOL BACTERIOL, V78, P95, DOI 10.1002/path.1700780111; ARCHER RK, 1963, EOSINOPHIL LEUKOCYTE; BULLOCK JD, 1970, ANN ALLERGY, V28, P127; BULLOCK JD, 1968, ANN ALLERGY, V26, P177; COHEN SG, 1965, J ALLERGY, V36, P415, DOI 10.1016/0021-8707(65)90135-8; Cooke RA, 1922, J IMMUNOL, V7, P147; Cooke RA, 1935, J EXP MED, V62, P733, DOI 10.1084/jem.62.6.733; FELARCA AB, 1968, J ALLERGY, V41, P82, DOI 10.1016/0021-8707(68)90016-6; FOWLER JW, 1966, J ALLERGY, V37, P19, DOI 10.1016/0021-8707(66)90106-7; ISHIZAKA K, 1968, J ALLERGY, V42, P330, DOI 10.1016/0021-8707(68)90095-6; ISHIZAKA K, 1970, J IMMUNOL, V105, P1459; ISHIZAKA T, 1970, J IMMUNOL, V104, P854; KAY AB, 1970, CLIN EXP IMMUNOL, V6, P75; KAY AB, 1971, J EXP MED, V133, P602, DOI 10.1084/jem.133.3.602; KAY AB, 1971, FED PROC, V30, pA682; KERN A, 1921, MED CLIN N AM, V5, P751; LITT M, 1964, J CELL BIOL, V23, P355, DOI 10.1083/jcb.23.2.355; MITCHELL WF, 1969, ANN ALLERGY, V27, P93; MIYAMOTO T, 1969, J ALLERGY, V44, P228, DOI 10.1016/0021-8707(69)90089-6; MIYAMOTO T, 1968, J ALLERGY, V42, P14, DOI 10.1016/0021-8707(68)90128-7; PEPYS J, 1968, LANCET, V1, P1270; REBUCK JW, 1955, ANN NY ACAD SCI, V59, P757, DOI 10.1111/j.1749-6632.1955.tb45983.x; SADAN N, 1969, NEW ENGL J MED, V280, P623, DOI 10.1056/NEJM196903202801201; TOMIOKA H, 1971, FED PROC, V30, pA654; VOORHORS.R, 1967, J ALLERGY, V39, P325, DOI 10.1016/0021-8707(67)90045-7; Voorhorst R., 1964, Allergie Asthma, V10, P329	26	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1971	48	3					153	+		10.1016/0091-6749(71)90010-8	http://dx.doi.org/10.1016/0091-6749(71)90010-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K3234	4105535				2022-12-18	WOS:A1971K323400004
J	Fu, LH; Zhao, J; Huang, JY; Li, N; Dong, X; He, Y; Wang, WY; Wang, Y; Qiu, J; Guo, XH				Fu, Liuhui; Zhao, Jie; Huang, Jiaoyan; Li, Na; Dong, Xin; He, Yao; Wang, Wenyan; Wang, Yu; Qiu, Ju; Guo, Xiaohuan			A mitochondrial STAT3-methionine metabolism axis promotes ILC2-driven allergic lung inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergic lung inflammation; ILC2; STAT3; mitochon-dria; methionine metabolism; histone methylation	INNATE LYMPHOID-CELLS; TYPE-2 IMMUNITY; STAT3; PROLIFERATION; MECHANISMS; PROTECTION; DYNAMICS; ASTHMA; HSP90; FATE	Background: Group 2 innate lymphoid cells (ILC2s), the innate counterpart of TH2 cells, play a critical role in type 2 immune responses. However, the molecular regulatory mechanisms of ILC2s are still unclear. Objective: The aim of this study was to explore the importance of signal transducer and activator of transcription 3 (STAT3) to ILC2 function in allergic lung inflammation. Methods: Acute and chronic asthma models were established by intranasal administration of the protease allergen papain in Vav(icre)Stat3(fl/fl), Il5(tdtomato-cre)Stat3(fl/fl), and Rorc(cre)Stat3(fl/fl) mice to verify the necessity of functional STAT3 for ILC2 allergic response. The intrinsic role of STAT3 in regulating ILC2 function was examined by generation of bone marrow chimera mice. The underlying mechanism was studied through confocal imaging, metabolomics analysis, and chromatin immunoprecipitation quantitative PCR. Results: STAT3 is essential for ILC2 effector function and promotes ILC2-driven allergic inflammation in the lung. Mechanistically, the alarmin cytokine IL-33 induces a noncanonical STAT3 phosphorylation at serine 727 in ILC2s, leading to translocation of STAT3 into the mitochondria. Mitochondrial STAT3 further facilitates adenosine triphosphate synthesis to fuel the methionine cycle and generation of S-adenosylmethionine, which supports the epigenetic reprogramming of type 2 cytokines in ILC2s. STAT3 deficiency, inhibition of STAT3 mitochondrial translocation, or blockade of methionine metabolism markedly dampened the ILC2 allergic response and ameliorated allergic lung inflammation. Conclusion: The mitochondrial STAT3-methionine metabolism pathway is a key regulator that shapes ILC2 effector function through epigenetic regulation, and the related proteins or metabolites represent potential therapeutic targets for allergic lung inflammation.	[Fu, Liuhui; Zhao, Jie; Huang, Jiaoyan; Li, Na; Dong, Xin; He, Yao; Wang, Wenyan; Guo, Xiaohuan] Tsinghua Univ, Inst Immunol, Med Sci Bldg,Room D317, Beijing 100084, Peoples R China; [Fu, Liuhui; Zhao, Jie; Huang, Jiaoyan; Li, Na; Dong, Xin; He, Yao; Wang, Wenyan; Guo, Xiaohuan] Tsinghua Univ, Dept Basic Med Sci, Sch Med, Beijing, Peoples R China; [Fu, Liuhui; Zhao, Jie; Huang, Jiaoyan; Li, Na; Dong, Xin; He, Yao; Wang, Wenyan; Guo, Xiaohuan] Tsinghua Univ, Beijing Key Lab Immunol Res Chron Dis, Beijing, Peoples R China; [Wang, Yu] Tianjin Univ Tradit Chinese Med, State Key Lab Component Based Chinese Med, Tianjin, Peoples R China; [Qiu, Ju] Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Tissue Microenvironm & Tumor, Shanghai, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tianjin University of Traditional Chinese Medicine; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS	Guo, XH (corresponding author), Tsinghua Univ, Inst Immunol, Med Sci Bldg,Room D317, Beijing 100084, Peoples R China.	guoxiaohuan@tsinghua.edu.cn	Guo, Xiaohuan/I-3710-2017	Guo, Xiaohuan/0000-0001-5152-3010	National Natural Science Foundation of China [32170872, 82122030, 31821003]; Tsinghua University Spring Breeze Fund; Tsinghua University (School ofMedicine)-Xiamen Changgeng Hospital Co Ltd Joint Research Center for Anaphylactic Disease; National Key R&D Program of China [2017YFA0103602, 2021YFE0200300]; Tsinghua-Peking Center for Life Sciences at Tsinghua University; Institute for Immunology at Tsinghua University; School of Medicine at Tsinghua University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University Spring Breeze Fund; Tsinghua University (School ofMedicine)-Xiamen Changgeng Hospital Co Ltd Joint Research Center for Anaphylactic Disease; National Key R&D Program of China; Tsinghua-Peking Center for Life Sciences at Tsinghua University; Institute for Immunology at Tsinghua University; School of Medicine at Tsinghua University	This work was supported by the National Natural Science Foundation of China (32170872, 82122030, and 31821003 to X.G.), the Tsinghua University Spring Breeze Fund, the Tsinghua University (School ofMedicine)-Xiamen Changgeng Hospital Co Ltd Joint Research Center for Anaphylactic Disease, and the National Key R&D Program of China (2017YFA0103602 and 2021YFE0200300). The Guo laboratory was also supported by the Tsinghua-Peking Center for Life Sciences, the Institute for Immunology, and the School of Medicine at Tsinghua University.	Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Califano D, 2015, IMMUNITY, V43, P354, DOI 10.1016/j.immuni.2015.07.005; Doherty TA, 2012, AM J PHYSIOL-LUNG C, V303, pL577, DOI 10.1152/ajplung.00174.2012; Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009; Duerr CU, 2016, CYTOKINE, V87, P1, DOI 10.1016/j.cyto.2016.01.018; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Erlich TH, 2018, ALLERGY, V73, P2160, DOI 10.1111/all.13467; Gao X, 2019, NATURE, V572, P397, DOI 10.1038/s41586-019-1437-3; Gavino AC, 2016, ALLERGY, V71, P1684, DOI 10.1111/all.12937; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Guo XH, 2014, IMMUNITY, V40, P25, DOI 10.1016/j.immuni.2013.10.021; Halim TYF, 2018, IMMUNITY, V48, P1195, DOI 10.1016/j.immuni.2018.05.003; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hussein YM, 2011, ANN ALLERG ASTHMA IM, V106, P474, DOI 10.1016/j.anai.2011.02.021; Jaeger AM, 2019, ANNU REV CANC BIOL, V3, P275, DOI 10.1146/annurev-cancerbio-030518-055533; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Kubo M, 2017, IMMUNOL REV, V278, P162, DOI 10.1111/imr.12557; Li Q, 2018, IMMUNITY, V48, P258, DOI 10.1016/j.immuni.2017.12.013; Lim AI, 2017, CURR OPIN IMMUNOL, V44, P61, DOI 10.1016/j.coi.2017.03.010; Litonjua AA, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-52; Mentch SJ, 2015, CELL METAB, V22, P861, DOI 10.1016/j.cmet.2015.08.024; Monticelli LA, 2016, NAT IMMUNOL, V17, P656, DOI 10.1038/ni.3421; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Rambold AS, 2018, TRENDS IMMUNOL, V39, P6, DOI 10.1016/j.it.2017.08.006; Rincon M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061656; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Ron-Harel N, 2016, CELL METAB, V24, P104, DOI 10.1016/j.cmet.2016.06.007; Roy DG, 2020, CELL METAB, V31, P250, DOI 10.1016/j.cmet.2020.01.006; Sanderson SM, 2019, NAT REV CANCER, V19, P625, DOI 10.1038/s41568-019-0187-8; Stritesky GL, 2011, IMMUNITY, V34, P39, DOI 10.1016/j.immuni.2010.12.013; Takeda K, 1998, J IMMUNOL, V161, P4652; Villarino AV, 2015, J IMMUNOL, V194, P21, DOI 10.4049/jimmunol.1401867; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; Wilhelm C, 2016, J EXP MED, V213, P1409, DOI 10.1084/jem.20151448; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Yang R, 2016, INT J BIOL SCI, V12, P532, DOI 10.7150/ijbs.15153; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3	42	6	6	13	14	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2022	149	6					2091	2104		10.1016/j.jaci.2021.12.783	http://dx.doi.org/10.1016/j.jaci.2021.12.783			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	2E6QP	34974065				2022-12-18	WOS:000812351900004
J	Kolkhir, P; Pyatilova, P; Ashry, T; Jiao, QQ; Abad-Perez, AT; Altrichter, S; Ayala, CEV; Church, MK; He, JJ; Lohse, K; Metz, M; Scheffel, J; Turk, M; Frischbutter, S; Maurer, M				Kolkhir, Pavel; Pyatilova, Polina; Ashry, Tameem; Jiao, Qingqing; Abad-Perez, Angela Teresa; Altrichter, Sabine; Ayala, Carolina Elisa Vera; Church, Martin K.; He, Jiajun; Lohse, Katharina; Metz, Martin; Scheffel, Joerg; Tuerk, Murat; Frischbutter, Stefan; Maurer, Marcus			Mast cells, cortistatin, and its receptor, MRGPRX2, are linked to the pathogenesis of chronic prurigo	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Chronic prurigo; cortistatin; mast cell; degranulation; MRGPRX2; severity	NERVE GROWTH-FACTOR; SUBSTANCE-P; IMMUNOREACTIVE NERVES; ATOPIC-DERMATITIS; GENE X2; NODULARIS; ACTIVATION; EXPRESSION; PEPTIDE; HISTAMINE	Background: Chronic prurigo (CPG) is characterized by intensive itch and interactions among nerves, neuropeptides, and mast cells (MCs). The role of some neuropeptides such as cortistatin (CST) and its receptor, Mas-related G protein-coupled receptor X2 (MRGPRX2), in CPG remains poorly investigated. Objectives: We evaluated first whether CST activates human skin MCs, and second whether CST and MRGPRX2 are expressed in the skin of CPG patients, and by which cells. Methods: Skin prick tests and microdialysis with CST were performed in 6 and 1 healthy volunteers, respectively. Degranulation of human skin MCs was assessed using beta-hexosaminidase and histamine release assays. Skin samples from 10 patients with CPG and 10 control subjects were stained for CST, MCs, and MRGPRX2 (protein and mRNA) using immunohistochemistry, immunofluorescence, and/or in situ hybridization. Flow cytometry was used to assess CST in human skin MCs. MRGPRX2 levels were measured in serum by ELISA. Results: CST induced concentration-dependent degranulation of human skin MCs in vivo and ex vivo. Skin lesions of CPG patients exhibited markedly higher numbers of CST-expressing cells, CST-expressing MCs, MRGPRX2-expressing cells, and MRGPRX2 mRNA-expressing cells than nonlesional skin. MCs were the main MRGPRX2 mRNA-expressing cells in the lesions of most CPG patients (70%). Stimulation of human skin MCs with anti-IgE led to a release of CST. The number of MRGPRX2-expressing cells correlated with disease severity (r = 0.649, P = .04). MRGPRX2 serum levels in CPG patients correlated with disease severity (r = 0.704, P = .023) and quality-of-life impairment (r = 0.687, P = .028). Conclusions: CST and MRGPRX2 may contribute to the pathogenesis of CPG and should be evaluated in further studies as potential biomarkers and novel therapeutic targets.	[Kolkhir, Pavel; Pyatilova, Polina; Ashry, Tameem; Jiao, Qingqing; Abad-Perez, Angela Teresa; Altrichter, Sabine; Ayala, Carolina Elisa Vera; Church, Martin K.; He, Jiajun; Lohse, Katharina; Metz, Martin; Scheffel, Joerg; Frischbutter, Stefan; Maurer, Marcus] Charite Univ Med Berlin, Inst Allergol, Charitepl 1, D-10117 Berlin, Germany; [Kolkhir, Pavel; Pyatilova, Polina; Ashry, Tameem; Jiao, Qingqing; Abad-Perez, Angela Teresa; Altrichter, Sabine; Ayala, Carolina Elisa Vera; Church, Martin K.; He, Jiajun; Lohse, Katharina; Metz, Martin; Scheffel, Joerg; Frischbutter, Stefan; Maurer, Marcus] Free Univ Berlin, Berlin, Germany; [Kolkhir, Pavel; Pyatilova, Polina; Ashry, Tameem; Jiao, Qingqing; Abad-Perez, Angela Teresa; Altrichter, Sabine; Ayala, Carolina Elisa Vera; Church, Martin K.; He, Jiajun; Lohse, Katharina; Metz, Martin; Scheffel, Joerg; Frischbutter, Stefan; Maurer, Marcus] Humboldt Univ, Berlin, Germany; [Kolkhir, Pavel; Pyatilova, Polina; Ashry, Tameem; Jiao, Qingqing; Altrichter, Sabine; Ayala, Carolina Elisa Vera; Church, Martin K.; He, Jiajun; Lohse, Katharina; Metz, Martin; Scheffel, Joerg; Frischbutter, Stefan; Maurer, Marcus] Fraunhofer Inst Translat Med & Pharmacol ITMP All, Berlin, Germany; [Kolkhir, Pavel] IM Sechenov First Moscow State Med Univ, Sechenov Univ, Div Immune Mediated Skin Dis, Moscow, Russia; [Ashry, Tameem] King Saud Univ, Coll Med, Dept Pathol, Riyadh, Saudi Arabia; [Jiao, Qingqing] Soochow Univ, Dept Dermatol, Affiliated Hosp 1, Suzhou, Peoples R China; [Altrichter, Sabine] Kepler Univ Hosp Linz, Comprehens Allergy Ctr, Dept Dermatol & Venerol, Linz, Austria; [He, Jiajun] Southwest Med Univ, Dept Dermatol, Affiliated Hosp, Luzhou, Peoples R China; [Tuerk, Murat] Kayseri City Educ & Res Hosp, Clin Immunol & Allerg Dis, Kayseri, Turkey	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Sechenov First Moscow State Medical University; King Saud University; Soochow University - China; Kepler University Hospital; Southwest Medical University	Maurer, M (corresponding author), Charite Univ Med Berlin, Inst Allergol, Charitepl 1, D-10117 Berlin, Germany.	marcus.maurer@charite.de	Türk, Murat/ADX-4459-2022; Frischbutter, Stefan/AAM-9487-2021; Maurer, Marcus/ABG-2174-2020; Metz, Martin/B-8799-2009	Frischbutter, Stefan/0000-0003-3971-7343; Maurer, Marcus/0000-0002-4121-481X; Metz, Martin/0000-0002-4070-9976; Pyatilova, Polina/0000-0001-5520-2900	AstraZeneca, Germany; GA2LEN stipend	AstraZeneca, Germany(AstraZeneca); GA2LEN stipend	Funded in part by a research grant from AstraZeneca, Germany (ROBERTIS study). P.K. and P.P. were supported by a GA<SUP>2</SUP>LEN stipend.	Aggarwal P, 2021, CLIN EXP DERMATOL, V46, P1277, DOI 10.1111/ced.14722; Babina M, 2018, ALLERGY, V73, P256, DOI 10.1111/all.13301; Baumann KY, 2019, CLIN TRANSL ALLERGY, V9, DOI 10.1186/s13601-019-0262-y; Boozalis E, 2018, J AM ACAD DERMATOL, V79, P714, DOI 10.1016/j.jaad.2018.04.047; Cao C, 2021, NATURE, V600, P170, DOI 10.1038/s41586-021-04126-6; Cao TBT, 2021, ALLERGY ASTHMA IMMUN, V13, P498, DOI 10.4168/aair.2021.13.3.498; COULSON IH, 1990, BRIT J DERMATOL, V122, P343, DOI 10.1111/j.1365-2133.1990.tb08282.x; Criado JR, 1999, J NEUROSCI RES, V56, P611, DOI 10.1002/(SICI)1097-4547(19990615)56:6<611::AID-JNR7>3.3.CO;2-7; Dalm VASH, 2004, CLIN ENDOCRINOL, V60, P625, DOI 10.1111/j.1365-2265.2004.02024.x; Delgado M, 2017, FRONT HORM RES, V48, P110, DOI 10.1159/000452910; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Elmariah S, 2021, J AM ACAD DERMATOL, V84, P747, DOI 10.1016/j.jaad.2020.07.025; Fujisawa D, 2014, J ALLERGY CLIN IMMUN, V134, P622, DOI 10.1016/j.jaci.2014.05.004; Godbole GB, 2007, REPRODUCTION, V134, P513, DOI 10.1530/REP-07-0234; Gonzalez-Rey E, 2006, P NATL ACAD SCI USA, V103, P4228, DOI 10.1073/pnas.0508997103; Gonzalez-Rey E, 2006, J EXP MED, V203, P563, DOI 10.1084/jem.20052017; Gonzalez-Rey E, 2007, ANN RHEUM DIS, V66, P582, DOI 10.1136/ard.2006.062703; Guhl S, 2011, BIOSCI BIOTECH BIOCH, V75, P382, DOI 10.1271/bbb.100745; HAMMARLUND A, 1991, CLIN EXP ALLERGY, V21, P333, DOI 10.1111/j.1365-2222.1991.tb01665.x; Hashimoto T, 2021, EXP DERMATOL, V30, P804, DOI 10.1111/exd.14279; Hirayama T, 2010, PEPTIDES, V31, P2109, DOI 10.1016/j.peptides.2010.07.010; Jarvikallio A, 2003, ARCH DERMATOL RES, V295, P2, DOI 10.1007/s00403-002-0378-z; Kempuraj D, 2004, ENDOCRINOLOGY, V145, P43, DOI 10.1210/en.2003-0805; Kim DK, 2018, P NATL ACAD SCI USA, V115, pE10692, DOI 10.1073/pnas.1809938115; Kim HO, 2009, INT J DERMATOL, V48, P431, DOI 10.1111/j.1365-4632.2009.03968.x; Kuhn H, 2021, J ALLERGY CLIN IMMUN, V147, P456, DOI 10.1016/j.jaci.2020.08.027; Lansu K, 2017, NAT CHEM BIOL, V13, P529, DOI [10.1038/NCHEMBIO.2334, 10.1038/nchembio.2334]; Leis Maria, 2021, Skin Therapy Lett, V26, P5; Li D, 2015, INT J DERMATOL, V54, pE309, DOI 10.1111/ijd.12836; Liang Y, 1998, J CUTAN PATHOL, V25, P189, DOI 10.1111/j.1600-0560.1998.tb01718.x; Liang Y, 2000, J CUTAN PATHOL, V27, P359, DOI 10.1034/j.1600-0560.2000.027007359.x; Liang Y, 1999, EUR J DERMATOL, V9, P297; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Meixiong J, 2019, IMMUNITY, V50, P1163, DOI 10.1016/j.immuni.2019.03.013; Mittal A, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00110; Morell M, 2014, NEUROBIOL DIS, V63, P141, DOI 10.1016/j.nbd.2013.11.022; Navines-Ferrer A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29965-8; Ohanyan T, 2018, ACTA DERM-VENEREOL, V98, P26, DOI 10.2340/00015555-2780; Pereira MP, 2018, J EUR ACAD DERMATOL, V32, P1059, DOI 10.1111/jdv.14570; Pereira MP, 2021, ACTA DERM-VENEREOL, V101, DOI 10.2340/00015555-3726; Robas N, 2003, J BIOL CHEM, V278, P44400, DOI 10.1074/jbc.M302456200; Rol A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22076-5; Schneider G, 2006, CLIN EXP DERMATOL, V31, P762, DOI 10.1111/j.1365-2230.2006.02211.x; Schuhknecht B, 2011, BRIT J DERMATOL, V165, P85, DOI 10.1111/j.1365-2133.2011.10306.x; Souza-Moreira L, 2013, J IMMUNOL, V191, P2144, DOI 10.4049/jimmunol.1300384; Stander S, 2020, ACTA DERM-VENEREOL, V100, DOI 10.2340/00015555-3655; Stander S, 2020, NEW ENGL J MED, V382, P706, DOI 10.1056/NEJMoa1908316; Subramanian H, 2011, J BIOL CHEM, V286, P44739, DOI 10.1074/jbc.M111.277152; Teresiak-Mikolajczak E, 2013, POSTEP DERM ALERGOL, V30, P286, DOI 10.5114/pdia.2013.38357; Terhorst D, 2018, CLIN EXP DERMATOL, V43, P131, DOI 10.1111/ced.13254; Toffoli L, 2022, J DERMATOL TREAT, V33, P1306, DOI 10.1080/09546634.2021.1886232; Toyoda M, 2002, BRIT J DERMATOL, V147, P71, DOI 10.1046/j.1365-2133.2002.04803.x; Tsianakas A, 2019, ACTA DERM-VENEREOL, V99, P379, DOI 10.2340/00015555-3120; van Hagen PM, 2008, MOL CELL ENDOCRINOL, V286, P141, DOI 10.1016/j.mce.2008.03.007; Varricchi G, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00299; Vincent L, 2013, BLOOD, V122, P1853, DOI 10.1182/blood-2013-04-498105; WALLENGREN J, 1987, ARCH DERMATOL RES, V279, P512, DOI 10.1007/BF00413281; Weber A, 2003, BRIT J DERMATOL, V148, P224, DOI 10.1046/j.1365-2133.2003.05090.x; Zeidler C, 2016, EUR J PAIN, V20, P37, DOI 10.1002/ejp.767; Zeidler C, 2021, ACTA DERM-VENEREOL, V101, DOI 10.2340/00015555-3701; Zeidler C, 2018, DERMATOL CLIN, V36, P189, DOI 10.1016/j.det.2018.02.003; Zirbs M, 2013, EUR J DERMATOL, V23, P812, DOI 10.1684/ejd.2013.2191	62	6	6	4	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2022	149	6					1998	+		10.1016/j.jaci.2022.02.021	http://dx.doi.org/10.1016/j.jaci.2022.02.021			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3J6SZ	35283140				2022-12-18	WOS:000833525500023
J	Morgenstern, NB; Ballaban, AY; Wen, T; Shoda, T; Caldwell, JM; Kliewer, K; Felton, JM; Abonia, JP; Mukkada, VA; Putnam, PE; Bolton, SM; Dwyer, DF; Barrett, NA; Rothenberg, ME				Morgenstern, Netali Ben-Baruch; Ballaban, Adina Y.; Wen, Ting; Shoda, Tetsuo; Caldwell, Julie M.; Kliewer, Kara; Felton, Jennifer M.; Abonia, J. Pablo; Mukkada, Vincent A.; Putnam, Philip E.; Bolton, Scott M.; Dwyer, Daniel F.; Barrett, Nora A.; Rothenberg, Marc E.			Single-cell RNA sequencing of mast cells in eosinophilic esophagitis reveals heterogeneity, local proliferation, and activation that persists in remission	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Eosinophilic esophagitis; mast cells; single-cell RNA sequencing; IL-13; proliferation	NECROSIS-FACTOR-ALPHA; C-KIT LIGAND; CONNECTIVE-TISSUE; GROWTH-FACTOR; EXPRESSION; RECEPTOR; INNATE; DIAGNOSIS; ALLERGY; MICE	Background: Mast cells (MCs) are pleiotropic cells that accumulate in the esophagus of patients with eosinophilic esophagitis (EoE) and are thought to contribute to disease pathogenesis, yet their properties and functions in this organ are largely unknown. Objectives: This study aimed to perform a comprehensive molecular and spatial characterization of esophageal MCs in EoE. Methods: Esophageal biopsies obtained from patients with active EoE, patients with EoE in histologic remission, and individuals with histologically normal esophageal biopsies and no history of esophageal disease (ie, control individuals) were subject to single-cell RNA sequencing, flow cytometry, and immunofluorescence analyses. Results: This study probed 39,562 single esophageal cells by single-cell RNA sequencing; approximately 5% of these cells were MCs. Dynamic MC expansion was identified across disease states. During homeostasis, TPSAB1(high)AREG(high) resident MCs were mainly detected in the lamina propria and exhibited a quiescent phenotype. In patients with active EoE, resident MCs assumed an activated phenotype, and 2 additional proinflammatory MC populations emerged in the intraepithelial compartment, each linked to a proliferating MKI67(high) cluster. One proinflammatory activated MC population, marked as KIT(high)IL1RL1(high)FCER1A(low), was not detected in disease remission (termed "transient MC "), whereas the other population, marked as CMA1(high)CTSG(high), was detected in disease remission where it maintained an activated state (termed "persistent MC "). MCs were prominent producers of esophageal IL-13 mRNA and protein, a key therapeutic target in EoE. Conclusions: Esophageal MCs comprise heterogeneous populations with transcriptional signatures associated with distinct spatial compartmentalization and EoE disease status. In active EoE, they assume a proinflammatory state and locally proliferate, and they remain activated and poised to reinitiate inflammation even during disease remission.	[Morgenstern, Netali Ben-Baruch; Ballaban, Adina Y.; Wen, Ting; Shoda, Tetsuo; Caldwell, Julie M.; Kliewer, Kara; Felton, Jennifer M.; Abonia, J. Pablo; Rothenberg, Marc E.] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, 3333 Burnet Ave,MLC 7028, Cincinnati, OH 45229 USA; [Mukkada, Vincent A.; Putnam, Philip E.; Bolton, Scott M.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Mukkada, Vincent A.; Putnam, Philip E.; Bolton, Scott M.; Rothenberg, Marc E.] Univ Cincinnati, Dept Pediat, Coll Med, Cincinnati, OH USA; [Dwyer, Daniel F.; Barrett, Nora A.] Brigham & Womens Hosp, Jeff & Penny Vinik Ctr Translat Immunol Res, Div Allergy & Clin Immunol, Boston, MA USA; [Barrett, Nora A.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Wen, Ting] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA; [Wen, Ting] Univ Utah, Sch Med, Associated Reg & Univ Pathol Labs, Salt Lake City, UT USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Rothenberg, ME (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, 3333 Burnet Ave,MLC 7028, Cincinnati, OH 45229 USA.	Rothenberg@cchmc.org		Shoda, Tetsuo/0000-0001-8337-5438	National Institutes of Health [R01 AI24355, R01 AI045898-21]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by National Institutes of Health grants R01 AI24355 and R01 AI045898-21.	Abonia JP, 2010, J ALLERGY CLIN IMMUN, V126, P140, DOI 10.1016/j.jaci.2010.04.009; Aceves SS, 2010, J ALLERGY CLIN IMMUN, V126, P1198, DOI 10.1016/j.jaci.2010.08.050; Acharya KR, 2014, J BIOL CHEM, V289, P17406, DOI 10.1074/jbc.R113.546218; Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Austen KF, 2001, LEUKEMIA RES, V25, P511, DOI 10.1016/S0145-2126(01)00030-3; Balzar S, 2011, AM J RESP CRIT CARE, V183, P299, DOI 10.1164/rccm.201002-0295OC; Bieber T, 2007, IMMUNOBIOLOGY, V212, P499, DOI 10.1016/j.imbio.2007.03.001; Bischoff SC, 1999, GUT, V44, P643, DOI 10.1136/gut.44.5.643; Boesiger J, 1998, J EXP MED, V188, P1135, DOI 10.1084/jem.188.6.1135; Bolton SM, 2020, AM J GASTROENTEROL, V115, P224, DOI 10.14309/ajg.0000000000000474; Braga FAV, 2019, NAT MED, V25, P1153, DOI 10.1038/s41591-019-0468-5; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chen CW, 2013, STEM CELLS, V31, P305, DOI 10.1002/stem.1285; Cildir G, 2019, IMMUNITY, V51, P949, DOI 10.1016/j.immuni.2019.09.021; Clark RAF, 1997, J CELL PHYSIOL, V170, P69; Clayton F, 2014, GASTROENTEROLOGY, V147, P602, DOI 10.1053/j.gastro.2014.05.036; Collins MH, 2014, DIGEST DIS, V32, P68, DOI 10.1159/000357012; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; CRAPPER RM, 1983, J IMMUNOL, V131, P923; Davis BP, 2016, ANNU REV PATHOL-MECH, V11, P365, DOI 10.1146/annurev-pathol-012615-044241; Dellon ES, 2020, NEW ENGL J MED, V383, P1624, DOI 10.1056/NEJMoa2012047; Doherty TA, 2015, J ALLERGY CLIN IMMUN, V136, P792, DOI 10.1016/j.jaci.2015.05.048; Doherty TA, 2015, J LEUKOCYTE BIOL, V97, P455, DOI 10.1189/jlb.5BT0814-374R; Duah E, 2013, SCI REP-UK, V3, DOI 10.1038/srep03274; Dwyer DF, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abb7221; Dwyer DF, 2016, NAT IMMUNOL, V17, P878, DOI 10.1038/ni.3445; Emanuele MJ, 2011, P NATL ACAD SCI USA, V108, P9845, DOI 10.1073/pnas.1106136108; Foroughi S, 2007, J ALLERGY CLIN IMMUN, V120, P594, DOI 10.1016/j.jaci.2007.06.015; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; Friend DS, 1998, J IMMUNOL, V160, P5537; Furuta GT, 2015, NEW ENGL J MED, V373, P1640, DOI 10.1056/NEJMra1502863; Galli SJ, 2016, AM J PATHOL, V186, P212, DOI 10.1016/j.ajpath.2015.07.025; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Gann PH, 2020, J ALLERGY CLIN IMMUN, V146, P367, DOI 10.1016/j.jaci.2020.03.045; Rojas-Zuleta WG, 2017, METHODS MOL BIOL, V1585, P21, DOI 10.1007/978-1-4939-6877-0_2; Gonsalves NP, 2020, J ALLERGY CLIN IMMUN, V145, P1, DOI 10.1016/j.jaci.2019.11.011; GORDON JR, 1991, J EXP MED, V174, P103, DOI 10.1084/jem.174.1.103; Gounni AS, 2000, J ALLERGY CLIN IMMUN, V106, P460, DOI 10.1067/mai.2000.109172; Groschwitz KR, 2009, P NATL ACAD SCI USA, V106, P22381, DOI 10.1073/pnas.0906372106; Herring CA, 2018, CELL MOL GASTROENTER, V5, P539, DOI 10.1016/j.jcmgh.2018.01.023; Hirano I, 2019, GASTROENTEROLOGY, V156, P592, DOI 10.1053/j.gastro.2018.10.051; Holgate Stephen T., 2003, Journal of Allergy and Clinical Immunology, V111, pS18, DOI 10.1067/mai.2003.25; IEMURA A, 1994, AM J PATHOL, V144, P321; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; Jacobsen EA, 2012, BLOOD, V120, P3882, DOI 10.1182/blood-2012-06-330845; Jones CV, 2013, ORGANOGENESIS, V9, P249, DOI 10.4161/org.25676; Jones JT, 1999, FEBS LETT, V447, P227, DOI 10.1016/S0014-5793(99)00283-5; Kambe N, 2002, J DERMATOL, V29, P1; Kawakami T, 2009, CURR OPIN IMMUNOL, V21, P666, DOI 10.1016/j.coi.2009.09.006; KITAMURA Y, 1989, ANNU REV IMMUNOL, V7, P59, DOI 10.1146/annurev.iy.07.040189.000423; Kubota Y, 2008, J CLIN INVEST, V118, P2393, DOI 10.1172/JCI34882; Li HM, 1996, J IMMUNOL, V156, P4833; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Loizou D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113483; MacDonald KPA, 2005, J IMMUNOL, V175, P1399, DOI 10.4049/jimmunol.175.3.1399; Macdonald-Obermann JL, 2014, J BIOL CHEM, V289, P26178, DOI 10.1074/jbc.M114.586826; Martin LJ, 2015, J ALLERGY CLIN IMMUN, V135, P1519, DOI 10.1016/j.jaci.2015.03.004; Matsuzawa S, 2003, J IMMUNOL, V170, P3461, DOI 10.4049/jimmunol.170.7.3461; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Metcalfe DD, 2006, J ALLERGY CLIN IMMUN, V117, P1227, DOI 10.1016/j.jaci.2006.03.031; Metz M., ALLERGOL SELECT, V5, P89; MILLER JS, 1989, CURR OPIN IMMUNOL, V1, P637, DOI 10.1016/0952-7915(89)90033-2; Morgan DM., SCI IMMUNOL, V6; Morgenstern NB, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abj1366; Mukai K, 2018, IMMUNOL REV, V282, P121, DOI 10.1111/imr.12634; Nicola NA, 2015, CYTOKINE GROWTH F R, V26, P533, DOI 10.1016/j.cytogfr.2015.07.001; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Otani IM, 2013, J ALLERGY CLIN IMMUN, V131, P1576, DOI 10.1016/j.jaci.2013.02.042; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Richter Joel E, 2018, Gastrointest Endosc Clin N Am, V28, P97, DOI 10.1016/j.giec.2017.07.009; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Rothenberg ME, 2015, J ALLERGY CLIN IMMUN, V135, P500, DOI 10.1016/j.jaci.2014.07.049; Saelens W, 2019, NAT BIOTECHNOL, V37, P547, DOI 10.1038/s41587-019-0071-9; Schmid-Grendelmeier P, 2002, J IMMUNOL, V169, P1021, DOI 10.4049/jimmunol.169.2.1021; Schoepfer Alain M, 2018, Gastrointest Endosc Clin N Am, V28, P77, DOI 10.1016/j.giec.2017.07.007; Schoepfer AM, 2010, AM J GASTROENTEROL, V105, P1062, DOI 10.1038/ajg.2009.657; Sewell WA, 1998, CLIN DIAGN LAB IMMUN, V5, P18, DOI 10.1128/CDLI.5.1.18-23.1998; SHEFFER AL, 1995, INT ARCH ALLERGY IMM, V107, P11, DOI 10.1159/000236917; Sherrill JD, 2014, GENES IMMUN, V15, P361, DOI 10.1038/gene.2014.27; Sherrill JD, 2014, GASTROENTEROL CLIN N, V43, P269, DOI 10.1016/j.gtc.2014.02.003; Shoda T, 2018, LANCET GASTROENTEROL, V3, P477, DOI 10.1016/S2468-1253(18)30096-7; Siddhuraj P, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10020309; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Stratton R, 2010, J CELL COMMUN SIGNAL, V4, P75, DOI 10.1007/s12079-010-0089-8; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Travaglini KJ, 2020, NATURE, V587, DOI 10.1038/s41586-020-2922-4; TSAI M, 1991, J EXP MED, V174, P125, DOI 10.1084/jem.174.1.125; Wei JY, 2019, COMPUT BIOL CHEM, V80, P111, DOI 10.1016/j.compbiolchem.2019.03.013; Wen T, 2019, J CLIN INVEST, V129, P2014, DOI 10.1172/JCI125917; Wen T, 2017, J ALLERGY CLIN IMMUN, V140, P1736, DOI 10.1016/j.jaci.2017.07.022; Wen T, 2013, GASTROENTEROLOGY, V145, P1289, DOI 10.1053/j.gastro.2013.08.046; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Wheeler JC, 2019, J ALLERGY CLIN IMMUN, V143, P2131, DOI 10.1016/j.jaci.2018.10.070; Xing W, 2011, P NATL ACAD SCI USA, V108, P14210, DOI 10.1073/pnas.1111048108	94	6	6	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2022	149	6					2062	2077		10.1016/j.jaci.2022.02.025	http://dx.doi.org/10.1016/j.jaci.2022.02.025			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	2E6QP	35304158				2022-12-18	WOS:000812351900002
J	Valent, P; Akin, C; Hartmann, K; Reiter, A; Gotlib, J; Sotlar, K; Sperr, WR; Degenfeld-Schonburg, L; Smiljkovic, D; Triggiani, M; Horny, HP; Arock, M; Galli, SJ; Metcalfe, DD				Valent, Peter; Akin, Cem; Hartmann, Karin; Reiter, Andreas; Gotlib, Jason; Sotlar, Karl; Sperr, Wolfgang R.; Degenfeld-Schonburg, Lina; Smiljkovic, Dubravka; Triggiani, Massimo; Horny, Hans-Peter; Arock, Michel; Galli, Stephen J.; Metcalfe, Dean D.			Drug-induced mast cell eradication: A novel approach to treat mast cell activation disorders?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Mast cells; KIT; Mast cell activation syndrome; tyrosine kinase inhibitor; midostaurin; avapritinib	TYROSINE KINASE INHIBITOR; FACTOR KIT-LIGAND; SYSTEMIC MASTOCYTOSIS; C-KIT; BONE-MARROW; MEDIATOR RELEASE; DEPENDENT ACTIVATION; IMATINIB MESYLATE; I EXPRESSION; STEM-CELLS	Mast cell (MC) activation is a key event in allergic reactions, other inflammatory states, and MC activation syndromes. MC-stabilizing agents, mediator-targeting drugs, and drugs interfering with mediator effects are often prescribed for these patients. However, the clinical efficacy of these drugs varies depending on the numbers of involved MCs and the underlying pathology. One straightforward approach would be to eradicate the primary target cell. To date however, no MC-eradicating treatment approach has been developed for patients with MC activation disorders. Nevertheless, recent data suggest that long-term treatment with agents effectively inhibiting KIT function results in the virtual eradication of tissue MCs and a sustained decrease in serum tryptase levels. In many of these patients, MC depletion is associated with a substantial improvement in mediator-induced symptoms. In patients with an underlying KIT D816V-positive mastocytosis, such MC eradication requires an effective inhibitor of KIT D816V, such as avapritinib. However, the use of KIT inhibitors must be balanced against their potential side effects. Here we discuss MC-eradicating strategies in various disease models, the feasibility of this approach, available clinical data, and future prospects for the use of KIT-targeting drugs in MC activation disorders.	[Valent, Peter; Sperr, Wolfgang R.; Degenfeld-Schonburg, Lina; Smiljkovic, Dubravka] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Waehringer Guertel 18-20, A-1090 Vienna, Austria; [Valent, Peter; Sperr, Wolfgang R.; Degenfeld-Schonburg, Lina; Smiljkovic, Dubravka] Med Univ Vienna, Ludwig Boltzmann Inst Hematol & Oncol, Waehringer Guertel 18-20, A-1090 Vienna, Austria; [Akin, Cem] Univ Michigan, Div Allergy & Clin Immunol, Ann Arbor, MI USA; [Hartmann, Karin] Univ Hosp Basel, Dept Dermatol, Div Allergy, Basel, Switzerland; [Hartmann, Karin] Univ Basel, Basel, Switzerland; [Hartmann, Karin] Univ Hosp Basel, Dept Biomed, Basel, Switzerland; [Reiter, Andreas] Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany; [Gotlib, Jason] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA USA; [Sotlar, Karl] Paracelsus Med Univ Salzburg, Inst Pathol, Salzburg, Austria; [Triggiani, Massimo] Univ Salerno, Div Allergy & Clin Immunol, Salerno, Italy; [Horny, Hans-Peter] Ludwig Maximilians Univ Munchen, Inst Pathol, Munich, Germany; [Arock, Michel] Sorbonne Univ, Pitie Salpetriere Charles Foix Hosp, AP HP, Dept Hematol Biol, Paris, France; [Galli, Stephen J.] Stanford Univ, Sch Med, Dept Pathol, Dept Microbiol & Immunol, Stanford, CA USA; [Galli, Stephen J.] Stanford Univ, Sch Med, Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA USA; [Metcalfe, Dean D.] NIAID, Mast Cell Biol Sect, Lab Allerg Dis, NH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Medical University of Vienna; Ludwig Boltzmann Institute; Medical University of Vienna; University of Michigan System; University of Michigan; University of Basel; University of Basel; University of Basel; Ruprecht Karls University Heidelberg; Stanford Cancer Institute; Stanford University; Paracelsus Private Medical University; University of Salerno; University of Munich; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Valent, P (corresponding author), Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Waehringer Guertel 18-20, A-1090 Vienna, Austria.; Valent, P (corresponding author), Med Univ Vienna, Ludwig Boltzmann Inst Hematol & Oncol, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	peter.valent@meduniwien.ac.at	Hartmann, Karin/N-4865-2015	Hartmann, Karin/0000-0002-4595-8226; Valent, Peter/0000-0003-0456-5095; Sperr, Wolfgang/0000-0003-3288-8027	Austrian Science Fund (FWF) [P32470-B, F4704-B20]; Charles and Ann Johnson Foundation; Division of Intramural Research, NIAID, NIH	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Charles and Ann Johnson Foundation; Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support: P.V. was supported by the Austrian Science Fund (FWF), projects P32470-B and F4704-B20. J.G. was supported by the Charles and Ann Johnson Foundation. D.D.M. was supported by the Division of Intramural Research, NIAID, NIH. The content is solely the responsibility of the authors and does not represent the official views of the NIH.	Akin C, 2004, BLOOD, V103, P3222, DOI 10.1182/blood-2003-11-3816; Akin C, 2004, J ALLERGY CLIN IMMUN, V114, P13, DOI 10.1016/j.jaci.2004.04.046; Akin C, 2010, J ALLERGY CLIN IMMUN, V126, P1099, DOI 10.1016/j.jaci.2010.08.035; Alvarado D, 2022, ALLERGY, V77, P2393, DOI 10.1111/all.15262; Alvarez-Twose I, 2017, ONCOTARGET, V8, P68950, DOI 10.18632/oncotarget.10711; Arock M, 2015, LEUKEMIA, V29, P1223, DOI 10.1038/leu.2015.24; Baird JH, 2018, CURR HEMATOL MALIG R, V13, P407, DOI 10.1007/s11899-018-0469-3; Belle L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052564; BISCHOFF SC, 1992, J EXP MED, V175, P237, DOI 10.1084/jem.175.1.237; Bonadonna P, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-015-0582-5; Bonadonna P, 2013, J ALLER CL IMM-PRACT, V1, P474, DOI 10.1016/j.jaip.2013.06.014; Broesby-Olsen S, 2018, ALLERGY, V73, P230, DOI 10.1111/all.13237; Cahill KN, 2017, NEW ENGL J MED, V376, P1911, DOI 10.1056/NEJMoa1613125; Carter MC, 2021, J ALLERGY CLIN IMMUN, V147, P1004, DOI 10.1016/j.jaci.2020.11.005; Castells M, 2019, J ALLER CL IMM-PRACT, V7, P1097, DOI 10.1016/j.jaip.2019.02.002; Cerny-Reiterer S, 2015, ONCOTARGET, V6, P3071, DOI 10.18632/oncotarget.3074; Chandesris MO, 2016, NEW ENGL J MED, V374, P2605, DOI 10.1056/NEJMc1515403; COLUMBO M, 1992, J IMMUNOL, V149, P599; Costa JJ, 1996, J EXP MED, V183, P2681, DOI 10.1084/jem.183.6.2681; da Silva AL, 2016, BRIT J PHARMACOL, V173, P1236, DOI 10.1111/bph.13430; Da Silva CA, 2005, CHEM IMMUNOL ALLERGY, V87, P154, DOI 10.1159/000087642; Campos PD, 2014, LEUKEMIA RES, V38, P1245, DOI 10.1016/j.leukres.2014.07.010; DeAngelo DJ, 2021, NAT MED, V27, P2183, DOI 10.1038/s41591-021-01538-9; Droogendijk HJ, 2006, CANCER, V107, P345, DOI 10.1002/cncr.21996; Dubreuil P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007258; FODINGER M, 1994, BLOOD, V84, P2954; FURITSU T, 1993, J CLIN INVEST, V92, P1736, DOI 10.1172/JCI116761; GALLI SJ, 1990, LAB INVEST, V62, P5; GALLI SJ, 1993, AM J PATHOL, V142, P965; Galli SJ, 2020, ANNU REV IMMUNOL, V38, P49, DOI 10.1146/annurev-immunol-071719-094903; Galli SJ, 2017, NEW ENGL J MED, V376, P1983, DOI 10.1056/NEJMe1702653; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Gleixner KV, 2007, HAEMATOLOGICA, V92, P1451, DOI 10.3324/haematol.11339; Gleixner KV, 2006, BLOOD, V107, P752, DOI 10.1182/blood-2005-07-3022; Gotlib J, 2021, NAT MED, V27, P2192, DOI 10.1038/s41591-021-01539-8; Gotlib J, 2016, NEW ENGL J MED, V374, P2530, DOI 10.1056/NEJMoa1513098; Guarnieri A, 2021, BLOOD, V138, DOI 10.1182/blood-2021-152770; Gulen T, 2022, IMMUNOL ALLERGY CLIN, V42, P45, DOI 10.1016/j.iac.2021.09.007; Hartmann K, 2020, J ALLERGY CLIN IMMUN, V146, P356, DOI 10.1016/j.jaci.2020.03.044; Hernandez JD, 2020, LAB INVEST, V100, P516, DOI 10.1038/s41374-019-0354-2; Hochhaus A, 2015, J CANCER RES CLIN, V141, P2047, DOI 10.1007/s00432-015-1988-0; Humbert M, 2009, ALLERGY, V64, P1194, DOI 10.1111/j.1398-9995.2009.02122.x; IRANI AMA, 1992, BLOOD, V80, P3009; Jendoubi F, 2020, CLIN EXP ALLERGY, V50, P654, DOI 10.1111/cea.13592; Jung SH, 2013, BRIT J DERMATOL, V168, P112, DOI 10.1111/bjd.12069; Kanbe T, 2001, BRIT J DERMATOL, V144, P1148, DOI 10.1046/j.1365-2133.2001.04224.x; Kempuraj D, 1999, BLOOD, V93, P3338, DOI 10.1182/blood.V93.10.3338.410k05_3338_3346; Kirshenbaum AS, 1999, BLOOD, V94, P2333, DOI 10.1182/blood.V94.7.2333.419k30_2333_2342; KIRSHENBAUM AS, 1992, J IMMUNOL, V148, P772; KITAMURA Y, 1978, BLOOD, V52, P447; KITAMURA Y, 1979, NATURE, V281, P154, DOI 10.1038/281154a0; Kneidinger M, 2008, BLOOD, V111, P3097, DOI 10.1182/blood-2007-08-104372; Krauth MT, 2009, CLIN EXP ALLERGY, V39, P1711, DOI 10.1111/j.1365-2222.2009.03353.x; Kudlaty E, 2021, J ALLER CL IMM-PRACT, V9, P2534, DOI 10.1016/j.jaip.2021.02.040; Lee D, 2020, BIOMOL THER, V28, P456, DOI 10.4062/biomolther.2020.013; Lee-Fowler TM, 2012, INT ARCH ALLERGY IMM, V158, P369, DOI 10.1159/000335122; Lei Z, 2008, ALLERGY, V63, P327, DOI 10.1111/j.1398-9995.2007.01566.x; Lemal R, 2019, J ALLER CL IMM-PRACT, V7, P2387, DOI 10.1016/j.jaip.2019.03.039; Lubke J, 2019, LEUKEMIA, V33, P1195, DOI 10.1038/s41375-019-0450-8; Ma YS, 2002, BLOOD, V99, P1741, DOI 10.1182/blood.V99.5.1741; Maaninka K, 2013, J ALLERGY CLIN IMMUN, V132, P463, DOI 10.1016/j.jaci.2013.02.011; Manley PW, 2018, BIOCHEMISTRY-US, V57, P5576, DOI 10.1021/acs.biochem.8b00727; MARTIN TR, 1989, J CLIN INVEST, V83, P1375, DOI 10.1172/JCI114025; McHugh K, 2022, EMERG MED CLIN N AM, V40, P19, DOI 10.1016/j.emc.2021.08.004; Metcalfe DD, 2008, BLOOD, V112, P946, DOI 10.1182/blood-2007-11-078097; Miettinen M, 2005, APPL IMMUNOHISTO M M, V13, P205, DOI 10.1097/01.pai.0000173054.83414.22; Nakahata T, 2002, INT J HEMATOL, V75, P350, DOI 10.1007/BF02982123; Niedoszytko M, 2009, ALLERGY, V64, P1237, DOI 10.1111/j.1398-9995.2009.02118.x; NILSSON G, 1994, J IMMUNOL, V153, P3717; Ochi H, 1999, J EXP MED, V190, P267, DOI 10.1084/jem.190.2.267; Peter B, 2016, LEUKEMIA, V30, P464, DOI 10.1038/leu.2015.242; Reber LL, 2017, J ALLERGY CLIN IMMUN, V140, P335, DOI 10.1016/j.jaci.2017.06.003; Reber LL, 2013, J ALLERGY CLIN IMMUN, V132, P881, DOI 10.1016/j.jaci.2013.06.008; Reiter A, 2020, BLOOD, V135, P1365, DOI 10.1182/blood.2019000932; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; Saito H, 1996, J IMMUNOL, V157, P343; Savage JH, 2012, J ALLERGY CLIN IMMUN, V130, P1123, DOI 10.1016/j.jaci.2012.05.039; Schneeweiss M, 2018, HAEMATOLOGICA, V103, P799, DOI 10.3324/haematol.2017.179895; Sheikh A, 2013, CURR OPIN ALLERGY CL, V13, P263, DOI 10.1097/ACI.0b013e32836097f4; SPERR WR, 1993, INT ARCH ALLERGY IMM, V102, P170, DOI 10.1159/000236568; Takeuchi K, 2003, J LEUKOCYTE BIOL, V74, P1026, DOI 10.1189/jlb.0602284; Tayel SI, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0504-2; Theoharides TC, 2015, NEW ENGL J MED, V373, P163, DOI 10.1056/NEJMra1409760; Toledo MAS, 2021, BLOOD, V137, P2070, DOI 10.1182/blood.2019004509; Toru H, 1998, BLOOD, V91, P187, DOI 10.1182/blood.V91.1.187.187_187_195; Toru H, 1996, INT IMMUNOL, V8, P1367; Tsai M, 2005, CHEM IMMUNOL ALLERGY, V87, P179, DOI 10.1159/000087644; Ustun C, 2011, LEUKEMIA RES, V35, P1143, DOI 10.1016/j.leukres.2011.05.006; Vaali K, 2012, NEUROGASTROENT MOTIL, V24, pe325, DOI 10.1111/j.1365-2982.2012.01941.x; Valent P, 2017, ANN ONCOL, V28, P2367, DOI 10.1093/annonc/mdx290; Valent P, 2014, CLIN EXP ALLERGY, V44, P914, DOI 10.1111/cea.12318; VALENT P, 1992, BLOOD, V80, P2237; Valent P, 2013, ALLERGY, V68, P417, DOI 10.1111/all.12126; VALENT P, 1994, IMMUNOL TODAY, V15, P111, DOI 10.1016/0167-5699(94)90153-8; Valent P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21239030; Valent P, 2020, THERANOSTICS, V10, P10743, DOI 10.7150/thno.46719; Valent P, 2019, J ALLER CL IMM-PRACT, V7, P1125, DOI 10.1016/j.jaip.2019.01.006; Valent P, 2014, AM J BLOOD RES, V4, P93; Valent P, 2012, INT ARCH ALLERGY IMM, V157, P215, DOI 10.1159/000328760; van Anrooij B, 2018, J ALLERGY CLIN IMMUN, V142, P1006, DOI 10.1016/j.jaci.2018.06.003; Vega-Ruiz A, 2009, LEUKEMIA RES, V33, P1481, DOI [10.1016/j.leukres.2009.05.005, 10.1016/j.leukres.2008.12.020]; Verstovsek S, 2008, CLIN CANCER RES, V14, P3906, DOI 10.1158/1078-0432.CCR-08-0366; Wyatt R, 1996, POSTGRAD MED, V100, P87, DOI 10.3810/pgm.1996.08.51; Xia HZ, 1997, J IMMUNOL, V159, P2911; Yamaguchi M, 1999, J IMMUNOL, V162, P5455; Zhang LY, 2006, LEUKEMIA RES, V30, P373, DOI 10.1016/j.leukres.2005.08.015	106	6	6	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2022	149	6					1866	1874		10.1016/j.jaci.2022.04.003	http://dx.doi.org/10.1016/j.jaci.2022.04.003			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3J6SZ	35421448	hybrid			2022-12-18	WOS:000833525500006
J	Kumar, D; Rostad, CA; Jaggi, P; Nunez, DSV; Prince, C; Lu, A; Hussaini, L; Nguyen, TH; Malik, S; Ponder, LA; Shenoy, SPV; Anderson, EJ; Briones, M; Sanz, I; Prahalad, S; Chandrakasan, S				Kumar, Deepak; Rostad, Christina A.; Jaggi, Preeti; Nunez, D. Sofia Villacis; Prince, Chengyu; Lu, Austin; Hussaini, Laila; Nguyen, Thinh H.; Malik, Sakshi; Ponder, Lori A.; Shenoy, Sreekala P., V; Anderson, Evan J.; Briones, Michael; Sanz, Ignacio; Prahalad, Sampath; Chandrakasan, Shanmuganathan			Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						MIS-C; COVID-19; HLH; T-cell activation; hyperin-flammation; cardiac dysfunction	ENDOTHELIAL GROWTH-FACTOR; ANGIOTENSIN-II; CD57 DEFINES; DISEASE; EXPRESSION; PLATELET; CELLS	Background: Multisystem inflammatory syndrome in children (MIS-C) is a potentially life-threatening sequela of severe acute respiratory syndrome coronavirus 2 infection characterized by hyperinflammation and multiorgan dysfunction. Although hyperinflammation is a prominent manifestation of MIS-C, there is limited understanding of how the inflammatory state of MIS-C differs from that of well-characterized hyperinflammatory syndromes such as hemophagocytic lymphohistiocytosis (HLH). Objectives: We sought to compare the qualitative and quantitative inflammatory profile differences between patients with MIS-C, coronavirus disease 2019, and HLH. Methods: Clinical data abstraction from patient charts, T-cell immunophenotyping, and multiplex cytokine and chemokine profiling were performed for patients with MIS-C, patients with coronavirus disease 2019, and patients with HLH. Results: We found that both patients with MIS-C and patients with HLH showed robust T-cell activation, markers of senescence, and exhaustion along with elevated T(H)1 and proinflammatory cytokines such as IFN-gamma, C-X-C motif chemokine ligand 9, and C-X-C motif chemokine ligand 10. In comparison, the amplitude of T-cell activation and the levels of cytokines/chemokines were higher in patients with HLH when compared with patients with MIS-C. Distinguishing inflammatory features of MIS-C included elevation in T(H)2 inflammatory cytokines such as IL-4 and IL-13 and cytokine mediators of angiogenesis, vascular injury, and tissue repair such as vascular endothelial growth factor A and platelet-derived growth factor. Immune activation and hypercytokinemia in MIS-C resolved at follow-up. In addition, when these immune parameters were correlated with clinical parameters, CD8(+) T-cell activation correlated with cardiac dysfunction parameters such as B-type natriuretic peptide and troponin and inversely correlated with platelet count. Conclusions: Overall, this study characterizes unique and overlapping immunologic features that help to define the hyperinflammation associated with MIS-C versus HLH.	[Kumar, Deepak; Prince, Chengyu; Nguyen, Thinh H.; Briones, Michael; Chandrakasan, Shanmuganathan] Emory Univ, Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Dept Pediat,Sch Med, Atlanta, GA 30322 USA; [Rostad, Christina A.; Jaggi, Preeti; Lu, Austin; Hussaini, Laila; Anderson, Evan J.] Emory Univ, Childrens Healthcare Atlanta, Ctr Childhood Infect & Vaccines, Sch Med, Atlanta, GA 30322 USA; [Nunez, D. Sofia Villacis; Shenoy, Sreekala P., V; Prahalad, Sampath] Emory Univ, Childrens Healthcare Atlanta, Div Pediat Rheumatol, Sch Med,Dept Pediat, Atlanta, GA 30322 USA; [Malik, Sakshi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Malik, Sakshi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Ponder, Lori A.] Emory Univ, Sch Med, Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Anderson, Evan J.] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA; [Sanz, Ignacio] Emory Univ, Sch Med, Div Rheumatol, Dept Med, Atlanta, GA 30322 USA; [Sanz, Ignacio] Emory Univ, Lowance Ctr Human Immunol, Atlanta, GA 30322 USA; [Prahalad, Sampath] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Children's Healthcare of Atlanta (CHOA); Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; Emory University; Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; Emory University; Emory University; Emory University; Emory University	Chandrakasan, S (corresponding author), Emory Univ, Immune Dysregulat & Immunohematol Program, Aflac Canc & Blood Disorders Ctr, Childrens Healthcare Atlanta,Sch Med, 2015 Uppergate Dr,ECC Rm 434A, Atlanta, GA 30322 USA.	Shanmuganathan.chandrakasan@emory.edu	Villacis Nunez, Diana Sofia/ABG-4099-2021; Malik, Sakshi/AFM-0302-2022; Kumar, Deepak/AGN-7477-2022	Villacis Nunez, Diana Sofia/0000-0001-9182-6067; Rostad, Christina/0000-0001-8439-0592; Malik, Sakshi/0000-0002-9586-0892	National Heart, Lung, and Blood Institute [1K08HL141635-01A1]; Atlanta Pediatric Scholars Program K12 Scholar [K12HD072245, U54AI082973]; National Institute of Allergy and Infectious Diseases [3U19AI110483-07S1]; Marcus Foundation, Inc, Atlanta	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Atlanta Pediatric Scholars Program K12 Scholar; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Marcus Foundation, Inc, Atlanta	This work was supported by the National Heart, Lung, and Blood Institute (grant no. 1K08HL141635-01A1), Atlanta Pediatric Scholars Program K12 Scholar (grant nos. K12HD072245 and U54AI082973 to S.C.), and the National Institute of Allergy and Infectious Diseases 3U19AI110483-07S1 to I.S. (PI) and S.C. (Co-I) and S.P. (Co-I). S.P. is supported in part by the Marcus Foundation, Inc, Atlanta.	Abdel-Haq N, 2021, EUR J PEDIATR, V180, P1581, DOI 10.1007/s00431-021-03935-1; Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Ahmed A, 2019, LANCET HAEMATOL, V6, pE630, DOI 10.1016/S2352-3026(19)30156-5; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Brodin P, 2020, ACTA PAEDIATR, V109, P1082, DOI 10.1111/apa.15271; Bronte V, 2020, J CLIN INVEST, V130, P6409, DOI 10.1172/JCI141772; Canna SW, 2020, BLOOD, V135, P1332, DOI 10.1182/blood.2019000936; Canzano P, 2021, JACC-BASIC TRANSL SC, V6, P202, DOI 10.1016/j.jacbts.2020.12.009; Carter MJ, 2020, NAT MED, V26, P1701, DOI 10.1038/s41591-020-1054-6; Castelnovo L, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000023582; Centers for Disease Control and Prevention, 2020, COR DIS 2019 COVID 1; Chandrakasan S, 2013, J PEDIATR-US, V163, P1253, DOI 10.1016/j.jpeds.2013.06.053; Chaturvedi V, 2021, BLOOD, V137, P2337, DOI 10.1182/blood.2020009499; Cho ML, 2006, IMMUNOL LETT, V103, P159, DOI 10.1016/j.imlet.2005.10.020; Consiglio CR, 2020, CELL, V183, P968, DOI 10.1016/j.cell.2020.09.016; Daball PC, 2018, IMMUNOL CELL BIOL, V96, P1060, DOI 10.1111/imcb.12169; de Jesus AA, 2020, J CLIN INVEST, V130, P1669, DOI 10.1172/JCI129301; Della Paolera S, 2021, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.624248; Dinarello CA, 2018, IMMUNOL REV, V281, P8, DOI 10.1111/imr.12621; Diorio C, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-27544-6; Diorio C, 2020, BLOOD ADV, V4, P6051, DOI 10.1182/bloodadvances.2020003471; Diorio C, 2020, J CLIN INVEST, V130, P5967, DOI 10.1172/JCI140970; Dolinger MT, 2020, J PEDIATR GASTR NUTR, V71, P153, DOI 10.1097/MPG.0000000000002809; Dove ML, 2021, J PEDIATR-US, V229, P33, DOI 10.1016/j.jpeds.2020.10.026; Dufort EM, 2020, NEW ENGL J MED, V383, P347, DOI 10.1056/NEJMoa2021756; Esteve-Sole A, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI144554; Feldmann M, 2020, LANCET, V395, P1407, DOI 10.1016/S0140-6736(20)30858-8; Feldstein LR, 2021, JAMA-J AM MED ASSOC, V325, P1074, DOI 10.1001/jama.2021.2091; Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680; Focosi D, 2010, J LEUKOCYTE BIOL, V87, P107, DOI 10.1189/jlb.0809566; Funatsu H, 2002, BRIT J OPHTHALMOL, V86, P311, DOI 10.1136/bjo.86.3.311; Gloude NJ, 2020, J CLIN IMMUNOL, V40, P699, DOI 10.1007/s10875-020-00789-4; Godfred-Cato S, 2020, MMWR-MORBID MORTAL W, V69, P1074, DOI 10.15585/mmwr.mm6932e2; Gruber CN, 2020, CELL, V183, P982, DOI 10.1016/j.cell.2020.09.034; Han JH, 2017, SCI REP-UK, V7, DOI 10.1038/srep46652; Hennon TR., PROG PEDIATR CARDIOL, V62; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Jiang L, 2020, LANCET INFECT DIS, V20, pE276, DOI 10.1016/S1473-3099(20)30651-4; Kalil AC, 2021, NEW ENGL J MED, V384, P795, DOI 10.1056/NEJMoa2031994; Kaushik S, 2020, J PEDIATR-US, V224, P24, DOI 10.1016/j.jpeds.2020.06.045; Khandelwal P, 2020, BIOL BLOOD MARROW TR, V26, P1, DOI 10.1016/j.bbmt.2019.08.008; Khandelwal P, 2015, BIOL BLOOD MARROW TR, V21, P1215, DOI 10.1016/j.bbmt.2015.04.010; Kim TS, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0316-1; Kucukardali Y, 2008, CARDIOVASC REVASCULA, V9, P66, DOI 10.1016/j.carrev.2007.11.005; Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114; Lee H, 2020, BLOOD, V136, DOI 10.1182/blood-2020-137338; Lee HG, 2020, EXP MOL MED, V52, P1255, DOI 10.1038/s12276-020-00486-7; Lee MS, 2021, FRONT PEDIATR, V9, DOI 10.3389/fped.2021.640118; Lin H, 2021, BLOOD ADV, V5, P3457, DOI 10.1182/bloodadvances.2021004287; Locatelli F, 2020, NEW ENGL J MED, V382, P1811, DOI 10.1056/NEJMoa1911326; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Ma L, BIORXIV; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Miller J, 2020, GASTROENTEROLOGY, V159, P1571, DOI 10.1053/j.gastro.2020.05.079; Morris SB, 2020, MMWR-MORBID MORTAL W, V69, P1450, DOI 10.15585/mmwr.mm6940e1; Nakra NA, 2020, CHILDREN-BASEL, V7, DOI 10.3390/children7070069; Otani A, 2000, INVEST OPHTH VIS SCI, V41, P1192; Ouldali N, 2021, JAMA-J AM MED ASSOC, V325, P855, DOI 10.1001/jama.2021.0694; Patoulias D, 2021, CLIN RHEUMATOL, V40, P4671, DOI 10.1007/s10067-021-05884-4; Payne AB, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.16420; Qian L, 2019, PANCREATOLOGY, V19, P340, DOI 10.1016/j.pan.2019.01.015; Reiff DD, 2021, ACR OPEN RHEUMATOL, V3, P820, DOI 10.1002/acr2.11331; Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/50140-6736(20)31094-1, 10.1016/S0140-6736(20)31094-1]; Robinson PC, 2020, LANCET RHEUMATOL, V2, pE653, DOI 10.1016/S2665-9913(20)30309-X; Selheim F, 2000, BIOCHEM J, V350, P469, DOI 10.1042/0264-6021:3500469; Shaigany S, 2020, LANCET, V396, pE8, DOI 10.1016/S0140-6736(20)31526-9; Son MBF, 2021, NEW ENGL J MED, V385, P23, DOI 10.1056/NEJMoa2102605; Song CY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72718-9; Sperotto F, 2021, EUR J PEDIATR, V180, P307, DOI 10.1007/s00431-020-03766-6; Sun PP, 2020, NEPHROLOGY, V25, P125, DOI 10.1111/nep.13630; Tacke CE, 2014, PEDIATR INFECT DIS J, V33, P793, DOI 10.1097/INF.0000000000000271; Valverde I, 2021, CIRCULATION, V143, P21, DOI 10.1161/CIRCULATIONAHA.120.050065; Vannucchi AM, 2021, LEUKEMIA, V35, P1121, DOI 10.1038/s41375-020-01018-y; Vella LA, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abf7570; Weatherhead JE, 2020, J CLIN INVEST, V130, P6194, DOI 10.1172/JCI145301; Weiss ES, 2018, BLOOD, V131, P1442, DOI 10.1182/blood-2017-12-820852; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369; Yonker LM, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI149633; Zhao Y, 2021, AM J EMERG MED, V49, P62, DOI 10.1016/j.ajem.2021.05.044	84	6	6	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2022	149	5					1592	+		10.1016/j.jaci.2022.02.028	http://dx.doi.org/10.1016/j.jaci.2022.02.028			31	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3W0TR	35304157	Bronze, Green Published			2022-12-18	WOS:000842068800011
J	Poposki, JA; Klingler, AI; Stevens, WW; Suh, LA; Tan, BK; Peters, AT; Abdala-Valencia, H; Grammer, LC; Welch, KC; Smith, SS; Conley, DB; Kern, RC; Schleimer, RP; Kato, A				Poposki, Julie A.; Klingler, Aiko, I; Stevens, Whitney W.; Suh, Lydia A.; Tan, Bruce K.; Peters, Anju T.; Abdala-Valencia, Hiam; Grammer, Leslie C.; Welch, Kevin C.; Smith, Stephanie S.; Conley, David B.; Kern, Robert C.; Schleimer, Robert P.; Kato, Atsushi			Elevation of activated neutrophils in chronic rhinosinusitis with nasal polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Neutrophils; nasal polyps; chronic rhinosinusitis; endotype; type 2 inflammation	ONCOSTATIN M; EXPRESSION; ASTHMA; INFLAMMATION; EOSINOPHILS; LUNG	Background: Chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) is well characterized by type 2 (T2) inflammation characterized by eosinophilia in Western countries. However, the presence and roles of neutrophils in T2 CRSwNP are poorly understood. Objective: We sought to clarify accumulation and inflammatory roles of neutrophils in CRSwNP in a Western population. Methods: Sinonasal tissues and nasal lavage fluids were obtained from control patients and patients with CRS, and neutrophil markers were determined by ELISA. The presence of neutrophils in tissue was determined by flow cytometry. The gene expression profiles in neutrophils were determined by RNA sequencing. Results: A neutrophil marker elastase was selectively elevated in nasal polyp (NP) tissue, whereas eosinophilic cationic protein (an eosinophil marker) was elevated in both uncinate and NP tissues of CRSwNP patients. Nasal lavage fluid myeloperoxidase (another neutrophil marker) was also significantly elevated in CRSwNP compared to control patients. Neutrophil markers were more greatly elevated in CRSwNP patients with recurrent disease. Flow cytometric analysis confirmed that neutrophil numbers were significantly elevated in NPs compared to control tissues. RNA sequencing analysis found that 344 genes were >3-fold and significantly elevated in NP neutrophils compared to peripheral blood neutrophils. Gene Ontology analysis suggested that the elevated genes in NP neutrophils were significantly associated with activation. Results suggest that neutrophils are accumulated in T2 NP tissues and that accumulated neutrophils are highly activated and contribute to inflammation in NPs. Conclusions: Neutrophils may play a heretofore unrecognized meaningful role in the pathogenesis of CRSwNP in Western countries and may be a potentially important therapeutic target in T2 CRSwNP.	[Poposki, Julie A.; Klingler, Aiko, I; Stevens, Whitney W.; Suh, Lydia A.; Peters, Anju T.; Grammer, Leslie C.; Kern, Robert C.; Schleimer, Robert P.; Kato, Atsushi] Northwestern Univ, Feinberg Sch Med, Div Allergy & Immunol, Dept Med, 240 E Huron,Room M304, Chicago, IL 60611 USA; [Tan, Bruce K.; Welch, Kevin C.; Smith, Stephanie S.; Conley, David B.; Kern, Robert C.; Schleimer, Robert P.; Kato, Atsushi] Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol, Chicago, IL 60611 USA; [Abdala-Valencia, Hiam] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care, Dept Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Kato, A (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Allergy & Immunol, Dept Med, 240 E Huron,Room M304, Chicago, IL 60611 USA.	a-kato@northwestern.edu			National Institutes of Health [R01 AI104733, R01 AI137174, U19 AI106683, P01 AI145818]; Ernest S. Bazley Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ernest S. Bazley Foundation	This research was supported in part by National Institutes of Health grants R01 AI104733, R01 AI137174, U19 AI106683, and P01 AI145818 and by a grant from the Ernest S. Bazley Foundation.	Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Cavallo-Medved Dora, 2011, AFCS Nat Mol Pages, V2011; Delemarre T, 2021, J ALLERGY CLIN IMMUN, V148, P327, DOI 10.1016/j.jaci.2021.03.024; Delemarre T, 2021, J ALLERGY CLIN IMMUN, V147, P179, DOI 10.1016/j.jaci.2020.08.036; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gelfand EW, 2017, SEMIN IMMUNOL, V33, P44, DOI 10.1016/j.smim.2017.08.005; GEORAS SN, 1992, AM J RESP CELL MOL, V7, P261, DOI 10.1165/ajrcmb/7.3.261; Hamilos DL, 2016, J ALLER CL IMM-PRACT, V4, P605, DOI 10.1016/j.jaip.2016.04.013; Hook G, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00178; Ikeda K, 2013, LARYNGOSCOPE, V123, pE1, DOI 10.1002/lary.24154; Kamp VM, 2012, J LEUKOCYTE BIOL, V92, P1011, DOI 10.1189/jlb.0612273; Klingler AI, 2021, J ALLERGY CLIN IMMUN, V147, P1306, DOI 10.1016/j.jaci.2020.11.037; Ley K, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat4579; Lou HF, 2018, INT FORUM ALLERGY RH, V8, P1218, DOI 10.1002/alr.22214; Lou HF, 2015, AM J RHINOL ALLERGY, V29, P350, DOI 10.2500/ajra.2015.29.4231; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Orlandi RR, 2016, INT FORUM ALLERGY RH, V6, pS22, DOI 10.1002/alr.21695; Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105; Pothoven KL, 2017, J ALLERGY CLIN IMMUN, V139, P1966, DOI 10.1016/j.jaci.2016.10.039; Pothoven KL, 2015, J ALLERGY CLIN IMMUN, V136, P737, DOI 10.1016/j.jaci.2015.01.043; Radermecker C, 2018, CURR OPIN IMMUNOL, V54, P28, DOI 10.1016/j.coi.2018.05.006; Ray A, 2017, TRENDS IMMUNOL, V38, P942, DOI 10.1016/j.it.2017.07.003; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Smith KA, 2015, LARYNGOSCOPE, V125, P1547, DOI 10.1002/lary.25180; Stevens WW, 2021, J ALLERGY CLIN IMMUN, V147, P600, DOI 10.1016/j.jaci.2020.04.031; Stevens WW, 2019, J ALLER CL IMM-PRACT, V7, P2812, DOI 10.1016/j.jaip.2019.05.009; Succar EF, 2020, ALLERGY, V75, P713, DOI 10.1111/all.14071; Tak T, 2015, CLIN EXP IMMUNOL, V182, P204, DOI 10.1111/cei.12676; Tan BK, 2017, J ALLERGY CLIN IMMUN, V139, P699, DOI 10.1016/j.jaci.2016.06.063; Thomas CJ, 2013, TRENDS IMMUNOL, V34, P317, DOI 10.1016/j.it.2013.02.008; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; Torsteinsdottir I, 1999, SCAND J IMMUNOL, V50, P433, DOI 10.1046/j.1365-3083.1999.00602.x; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Wang XD, 2016, J ALLERGY CLIN IMMUN, V138, P1344, DOI 10.1016/j.jaci.2016.05.041; Weiss E, 2018, TRENDS IMMUNOL, V39, P815, DOI 10.1016/j.it.2018.08.005; Wu W, 2014, J ALLERGY CLIN IMMUN, V133, P1280, DOI 10.1016/j.jaci.2013.11.042; Zhang XQ, 2004, J LEUKOCYTE BIOL, V75, P358, DOI 10.1189/jlb.0903412; Zhao LS, 2004, J IMMUNOL METHODS, V293, P207, DOI 10.1016/j.jim.2004.08.009; Zheng DP, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0167-x	40	6	6	4	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2022	149	5					1666	1674		10.1016/j.jaci.2021.11.023	http://dx.doi.org/10.1016/j.jaci.2021.11.023			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3W0TR	34953792				2022-12-18	WOS:000842068800016
J	Tian, GX; Peng, KP; Liu, MH; Tian, DF; Xie, HQ; Wang, LW; Guo, YY; Zhou, S; Mo, LH; Yang, PC				Tian, Gui-Xiang; Peng, Ke-Ping; Liu, Ming-Hui; Tian, Dao-Fa; Xie, Hai-Qing; Wang, Li-Wen; Guo, Yu-Yang; Zhou, Shan; Mo, Li-Hua; Yang, Ping-Chang			CD38(+) B cells affect immunotherapy for allergic rhinitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergy; immunotherapy; CD38; B cell; regulatory T cell	REGULATORY T; MECHANISMS; INHIBITION; UPDATE; IGE	Background: Allergen-specific immunotherapy (AIT) is the mainstay in the treatment of allergic diseases, but the therapeutic effects of AIT need to be improved. CD38(+) B cells are an immune cell fraction involved in the pathogenesis of allergic diseases as well as in immune regulation. Objective: We sought to elucidate the role of antigen-specific CD38(+) B cells in AIT. Methods: An analysis was carried out on AIT results of 48 patients with perennial allergic rhinitis (AR), among which peripheral blood immune cells were analyzed by flow cytometry; serum cytokine levels were determined by ELISA. An AR murine model was developed to test the role of CD38(+) B cells in AIT. Results: A fraction of antigen-specific CD38(+) B cell was detected in AR patients. CD38(+) B-cell frequency was negatively correlated with the therapeutic effects of AIT. A negative correlation was detected between the CD381 B-cell frequency and regulatory Tcell frequency in AR patients treated with AIT. Exposure to specific antigens induced CD38(+) B cells to produce IL-6, that converted Treg cells to TH17 cells. Coadministration of anti-CD38 antibody significantly promoted the therapeutic effects of AIT. Conclusions: Antigen-specific CD38(+) B cells compromise AIT effects by producing IL-6 to convert regulatory T cells to TH17 cells. Inhibition of CD38(+) B cells promotes the effects of AIT.	[Tian, Gui-Xiang; Liu, Ming-Hui; Xie, Hai-Qing; Wang, Li-Wen; Guo, Yu-Yang; Zhou, Shan] Cent South Univ, Xiangya Hosp 2, Dept Ultrasound, Changsha, Peoples R China; [Tian, Gui-Xiang; Liu, Ming-Hui] Cent South Univ, Xiangya Hosp 2, Res Ctr Ultrasonog, Changsha, Peoples R China; [Peng, Ke-Ping; Tian, Dao-Fa] Hunan Univ Chinese Med, Hosp 1, Dept Otorhinolaryngol Head & Neck Surg, Changsha 410007, Hunan, Peoples R China; [Mo, Li-Hua; Yang, Ping-Chang] Guangdong Prov Key Lab Reg Immun & Dis, Shenzhen, Peoples R China; [Mo, Li-Hua; Yang, Ping-Chang] Shenzhen Univ, Inst Allergy & Immunol, Sch Med, State Key Lab Resp Dis,Allergy Div, Shenzhen, Peoples R China; [Yang, Ping-Chang] Longgang ENT Hosp, Shenzhen, Peoples R China; [Yang, Ping-Chang] Shenzhen ENT Inst, Shenzhen, Peoples R China	Central South University; Central South University; Hunan University of Chinese Medicine; Shenzhen University	Peng, KP (corresponding author), Hunan Univ Chinese Med, Hosp 1, Dept Otorhinolaryngol Head & Neck Surg, Changsha 410007, Hunan, Peoples R China.; Yang, PC (corresponding author), Shenzhen Univ, Sch Med, Room A7-509,Lihu Campus,1066 Xueyuan Blvd, Shenzhen 518055, Peoples R China.	499192561@qq.com; pcy2356@163.com		Tian, Gui Xiang/0000-0001-6282-269X	National Nature and Science Foundation of China [32090052, 81900914]; Guangdong Provincial Key Laboratory of Regional Immunity and Diseases [2019B030301009]	National Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Key Laboratory of Regional Immunity and Diseases	Supported by grants from the National Nature and Science Foundation of China (32090052 and 81900914) and the Guangdong Provincial Key Laboratory of Regional Immunity and Diseases (2019B030301009).	Akatsuka T, 2018, EUR J DERMATOL, V28, P314, DOI 10.1684/ejd.2018.3319; Blacher E, 2015, INT J CANCER, V136, P1422, DOI 10.1002/ijc.29095; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Boonpiyathad T, 2019, ALLERGY, V74, P976, DOI 10.1111/all.13684; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Chen QB, 2020, MEDIAT INFLAMM, V2020, DOI 10.1155/2020/3019378; Chini CCS, 2020, NAT METAB, V2, DOI 10.1038/s42255-020-00298-z; Cole S, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1578-z; Dahanayake JM, 2020, TRIALS, V21, DOI 10.1186/s13063-019-4004-1; Dong X, 2016, ALLERGY ASTHMA IMMUN, V8, P421, DOI 10.4168/aair.2016.8.5.421; Hogan KA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01187; Jutel M, 2015, J ALLERGY CLIN IMMUN, V136, P556, DOI 10.1016/j.jaci.2015.04.047; Kar A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071716; Kucuksezer UC, 2020, ALLERGOL INT, V69, P549, DOI 10.1016/j.alit.2020.08.002; Lam HY, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20200256; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Ma XM, 2020, HUM IMMUNOL, V81, P452, DOI 10.1016/j.humimm.2020.05.008; Nurmatov U, 2017, ALLERGY, V72, P1133, DOI 10.1111/all.13124; Ogura Y, 2020, AGING-US, V12, P11325, DOI 10.18632/aging.103410; Ostendorf L, 2020, NEW ENGL J MED, V383, P1149, DOI 10.1056/NEJMoa2023325; Palomares O, 2017, IMMUNOL REV, V278, P219, DOI 10.1111/imr.12555; Passalacqua G, 2001, BIODRUGS, V15, P509, DOI 10.2165/00063030-200115080-00003; Platts-Mills TAE, 2016, J ALLERGY CLIN IMMUN, V137, P1662, DOI 10.1016/j.jaci.2016.04.010; Rosser EC, 2014, NAT MED, V20, P1334, DOI 10.1038/nm.3680; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Shamji MH, 2017, J ALLERGY CLIN IMMUN, V140, P1485, DOI 10.1016/j.jaci.2017.10.010; Theodoropoulos DS, 2000, ALLERGY ASTHMA PROC, V21, P159, DOI 10.2500/108854100778149007; Yao Y, 2020, ALLERGY, V75, P2599, DOI 10.1111/all.14288; Yao Y, 2019, J ALLERGY CLIN IMMUN, V144, P118, DOI 10.1016/j.jaci.2019.02.008; Yao Y, 2018, J ALLERGY CLIN IMMUN, V142, P321, DOI 10.1016/j.jaci.2018.03.008; Zhao MJ, 2019, AUTOIMMUNITY, V52, P12, DOI 10.1080/08916934.2019.1576644	31	6	6	3	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2022	149	5					1691	+		10.1016/j.jaci.2022.01.012	http://dx.doi.org/10.1016/j.jaci.2022.01.012			20	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3I4PN	35093485				2022-12-18	WOS:000832701000001
J	Blom, M; Zetterstrom, RH; Stray-Pedersen, A; Gilmour, K; Gennery, AR; Puck, JM; van der Burg, M				Blom, Maartje; Zetterstrom, Rolf H.; Stray-Pedersen, Asbjorg; Gilmour, Kimberly; Gennery, Andrew R.; Puck, Jennifer M.; van der Burg, Mirjam			Recommendations for uniform definitions used in newborn screening for severe combined immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Newborn screening; neonatal screening; severe combined immunodeficiency terminology; case definitions; T-cell receptor excisions circles	RECEPTOR EXCISION CIRCLES; TANDEM MASS-SPECTROMETRY; THYMUS TRANSPLANTATION; GUIDELINES; EXPERIENCE; DIAGNOSIS; TREC; MANAGEMENT; DISEASES; OUTCOMES	Background: Public health newborn screening (NBS) programs continuously evolve, taking advantage of international shared learning. NBS for severe combined immunodeficiency (SCID) has recently been introduced in many countries. However, comparison of screening outcomes has been hampered by use of disparate terminology and imprecise or variable case definitions for non-SCID conditions with T-cell lymphopenia. Objectives: This study sought to determine whether standardized screening terminology could overcome a Babylonian confusion and whether improved case definitions would promote international exchange of knowledge. Methods: A systematic literature review highlighted the diverse terminology in SCID NBS programs internationally. While, as expected, individual screening strategies and tests were tailored to each program, we found uniform terminology to be lacking in definitions of disease targets, sensitivity, and specificity required for comparisons across programs. Results: The study's recommendations reflect current evidence from literature and existing guidelines coupled with opinion of experts in public health screening and immunology. Terminologies were aligned. The distinction between actionable and nonactionable T-cell lymphopenia among non-SCID cases was clarified, the former being infants with T-cell lymphopenia who could benefit from interventions such as protection from infections, antibiotic prophylaxis, and live-attenuated vaccine avoidance. Conclusions: By bringing together the previously unconnected public health screening community and clinical immunology community, these SCID NBS deliberations bridged the gaps in language and perspective between these disciplines. This study proposes that international specialists in each disorder for which NBS is performed join forces to hone their definitions and recommend uniform registration of outcomes of NBS. Standardization of terminology will promote international exchange of knowledge and optimize each phase of NBS and follow-up care, advancing health outcomes for children worldwide.	[Blom, Maartje; van der Burg, Mirjam] Leiden Univ, Med Ctr, Dept Pediat, Lab Pediat Immunol, Leiden, Netherlands; [Zetterstrom, Rolf H.] Karolinska Univ Hosp, Ctr Inherited Metab Dis, Stockholm, Sweden; [Zetterstrom, Rolf H.] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Stray-Pedersen, Asbjorg] Oslo Univ Hosp, Norwegian Natl Unit Newborn Screening, Oslo, Norway; [Stray-Pedersen, Asbjorg] Oslo Univ Hosp, Dept Pediat, Div Pediat & Adolescent Med, Oslo, Norway; [Gilmour, Kimberly] UCL, Great Ormond St Inst Child Hlth, London, England; [Gilmour, Kimberly] Great Ormond St Hosp Children Natl Hlth Serv Fdn, London, England; [Gilmour, Kimberly] Great Ormond St Hosp Biomed Res Ctr, Natl Inst Hlth Res, London, England; [Gennery, Andrew R.] Newcastle Univ, Childrens Bone Marrow Transplant Unit, Great North Childrens Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Gennery, Andrew R.] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Puck, Jennifer M.] Univ Calif San Francisco, Dept Pediat, Sch Med, Div Allergy Immunol & Blood & Marrow Transplantat, San Francisco, CA 94143 USA; [Puck, Jennifer M.] Univ Calif San Francisco, Benioff Childrens Hosp San Francisco, San Francisco, CA 94143 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Oslo; University of Oslo; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Newcastle University - UK; Newcastle University - UK; University of California System; University of California San Francisco; University of California System; University of California San Francisco	van der Burg, M (corresponding author), Leiden Univ, Willem Alexander Childrens Hosp, Dept Pediat, Lab Pediat Immunol,Med Ctr, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	m.van_der_burg@lumc.nl		Zetterstrom, Rolf/0000-0002-3016-0019; van der Burg, Mirjam/0000-0002-1510-3104	Netherlands Organisation for Health Research and Development ZonMw [543002002]	Netherlands Organisation for Health Research and Development ZonMw(Netherlands Organization for Health Research and Development)	Supported by the Netherlands Organisation for Health Research (M.B.) and Development ZonMw (SONNET study, project 543002002 [M.B.]).	Adams SP, 2014, J CLIN IMMUNOL, V34, P323, DOI 10.1007/s10875-014-0007-6; Al-Mousa H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00782; Amatuni GS, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-2300; APHL, CAS DEF NEWB SCREEN; Argudo-Ramirez A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02406; Audrain M, 2014, CLIN IMMUNOL, V150, P137, DOI 10.1016/j.clim.2013.11.012; Audrain MAP, 2018, J CLIN IMMUNOL, V38, P778, DOI 10.1007/s10875-018-0550-7; Baker MW, 2010, PUBLIC HEALTH REP, V125, P88, DOI 10.1177/00333549101250S211; Barbaro M, 2017, J CLIN IMMUNOL, V37, P51, DOI 10.1007/s10875-016-0347-5; Blom M, 2021, J CLIN IMMUNOL, V41, P99, DOI 10.1007/s10875-020-00886-4; Blom M, 2017, CLIN IMMUNOL, V180, P106, DOI 10.1016/j.clim.2017.05.007; Borte S, 2012, BLOOD, V119, P2552, DOI 10.1182/blood-2011-08-371021; Bousfiha A, 2020, J CLIN IMMUNOL, V40, P66, DOI 10.1007/s10875-020-00758-x; Buchbinder D, 2021, J CLIN IMMUNOL, V41, P294, DOI 10.1007/s10875-020-00931-2; Chan K, 2005, J ALLERGY CLIN IMMUN, V115, P391, DOI 10.1016/j.jaci.2004.10.012; Chien Y-H, 2017, INT J NEONAT SCREEN, V3, P16, DOI [DOI 10.3390/IJNS3030016, 10.3390/ijns3030016]; Chien YH, 2015, J FORMOS MED ASSOC, V114, P12, DOI 10.1016/j.jfma.2012.10.020; Collins C, 2021, J CLIN IMMUNOL, V41, P881, DOI 10.1007/s10875-021-01059-7; Comeau AM, 2010, J INHERIT METAB DIS, V33, pS273, DOI 10.1007/s10545-010-9103-9; De Felipe B, 2017, INT J NEONATAL SCREE, V3, P27; de Felipe B, 2016, PEDIAT ALLERG IMM-UK, V27, P70, DOI 10.1111/pai.12501; Dorsey MJ, 2017, J ALLERGY CLIN IMMUN, V139, P733, DOI 10.1016/j.jaci.2017.01.005; EURORDIS, KEY PRINC NEWB SCREE; Ford G, 2014, BEST PRACT RES CL EN, V28, P175, DOI 10.1016/j.beem.2013.05.008; Gizewska M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01948; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; Heimall J, 2017, BLOOD, V130, P2718, DOI 10.1182/blood-2017-05-781849; IDF, 2015, IMMUNE DEFICIENCY FD; Kanegae Marilia Pyles P., 2017, Rev. paul. pediatr., V35, P25, DOI 10.1590/1984-0462/;2017;35;1;00013; King J, 2017, INT J NEONATAL SCREE, V3, P19; Kobrynski LJ, 2019, ANN ALLERG ASTHMA IM, V123, P424, DOI 10.1016/j.anai.2019.08.006; Kreins AY, 2020, AM J TRANSPLANT, V20, P1447, DOI 10.1111/ajt.15668; Kwan A, 2015, CLIN IMMUNOL, V158, P29, DOI 10.1016/j.clim.2015.02.015; Kwan A, 2014, JAMA-J AM MED ASSOC, V312, P729, DOI 10.1001/jama.2014.9132; Kwan A, 2013, J ALLERGY CLIN IMMUN, V132, P140, DOI 10.1016/j.jaci.2013.04.024; la Marca G, 2014, J ALLERGY CLIN IMMUN, V134, P155, DOI 10.1016/j.jaci.2014.01.040; la Marca G, 2013, J ALLERGY CLIN IMMUN, V131, P1604, DOI 10.1016/j.jaci.2012.08.054; Madkaikar M, 2016, INDIAN J PEDIATR, V83, P455, DOI 10.1007/s12098-016-2059-5; Markert ML, 2011, BLOOD, V117, P688, DOI 10.1182/blood-2010-06-292490; Markert ML, 2009, IMMUNOL RES, V44, P61, DOI 10.1007/s12026-008-8082-5; Mauracher AA, 2017, J ALLER CL IMM-PRACT, V5, P1457, DOI 10.1016/j.jaip.2017.02.009; Nourizadeh M, 2018, SCAND J IMMUNOL, V88, DOI 10.1111/sji.12699; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177; Kanegae MPP, 2016, J PEDIAT-BRAZIL, V92, P374, DOI 10.1016/j.jped.2015.10.006; Puck JM, 2019, IMMUNOL REV, V287, P241, DOI 10.1111/imr.12729; Rechavi E, 2017, INT J NEONAT SCREEN, V3, P13, DOI DOI 10.3390/IJNS3020013; Rechavi E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01448; Richards S, 2020, J PAEDIATR CHILD H, V56, P1508, DOI 10.1111/jpc.15158; Routes J, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0783-9; Routes JM, 2009, JAMA-J AM MED ASSOC, V302, P2465, DOI 10.1001/jama.2009.1806; Schmidt JL, 2012, GENET MED, V14, P76, DOI 10.1038/gim.2011.5; Shearer WT, 2014, J ALLERGY CLIN IMMUN, V133, P1092, DOI 10.1016/j.jaci.2013.09.044; Son Sohee, 2017, Pediatric Infection and Vaccine, V24, P134, DOI 10.14776/piv.2017.24.3.134; Strand J, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01417; Tagliaferri L, 2017, CLIN IMMUNOL, V175, P51, DOI 10.1016/j.clim.2016.11.016; Tangye SG, 2021, J CLIN IMMUNOL, V41, P666, DOI 10.1007/s10875-021-00980-1; Tangye SG, 2020, J CLIN IMMUNOL, V40, P24, DOI 10.1007/s10875-019-00737-x; Thomas C, 2019, CLIN IMMUNOL, V202, P33, DOI 10.1016/j.clim.2019.03.012; Thorsen J, 2021, J CLIN IMMUNOL, V41, P595, DOI 10.1007/s10875-020-00956-7; van der Burg M, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00373; Verbsky JW, 2012, J CLIN IMMUNOL, V32, P82, DOI 10.1007/s10875-011-9609-4; Vogel BH, 2014, J CLIN IMMUNOL, V34, P289, DOI 10.1007/s10875-014-0006-7; Waisbren SE, 2003, JAMA-J AM MED ASSOC, V290, P2564, DOI 10.1001/jama.290.19.2564; Zetterstr_om RH, 2017, INT J NEONAT SCREEN, V3, P11, DOI DOI 10.3390/IJNS3020011	66	6	6	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2022	149	4					1428	1436		10.1016/j.jaci.2021.08.026	http://dx.doi.org/10.1016/j.jaci.2021.08.026			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	2R0DI	34537207	hybrid, Green Published			2022-12-18	WOS:000820784100009
J	Lafon, E; Jager, M; Bauer, A; Reindl, M; Bellmann-Weiler, R; Wilflingseder, D; Lass-Florl, C; Posch, W				Lafon, Eliott; Jaeger, Michael; Bauer, Angelika; Reindl, Markus; Bellmann-Weiler, Rosa; Wilflingseder, Doris; Lass-Floerl, Cornelia; Posch, Wilfried			Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concern	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						SARS-CoV-2; variants of concern; vaccines; IgG and IgA antibodies; virus neutralization	SARS-COV-2	Background: Few studies have directly compared virus-specific antibodies and their neutralizing capacity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) wild type (WT) and circulating variants of concern despite the reported high efficacy of messenger RNA (mRNA)-and vector-based vaccines. Objective: We assessed SARS-CoV-2 spike protein region 1 (S1)-specific antibodies of BNT162b2, mRNA-1273, and ChAdOx1 vaccinated as well as convalescent coronavirus disease 2019 (COVID-19) patients. We also determined the neutralization ability against SARS-CoV-2 WT and B.1.1.7 (Alpha), B1.1.7 E484K (Alpha-E484K), B.1.351 (Beta), and B.1.617.2 (Delta) variants. Methods: Serum samples of 107 fully vaccinated or convalescent individuals were analyzed for anti-SARS-CoV-2-S1 IgG and IgA as well as for total anti-SARS-CoV-2 receptor binding domain Ig. Furthermore, neutralization capacity as 50% and 90% neutralization titer values against SARS-CoV-2 WT virus and circulating variants were determined. Results: We observed a robust IgG response in all participants; however, the highest titers were detected in mRNA-based vaccine recipients. In case of serum IgA responses, the-difference between mRNA-and vector-based vaccines or convalescent patients was even more pronounced. Interestingly, all 3 vaccines could neutralize all tested variants of concern in addition to WT virus, but in some individuals, only low or no neutralization, especially against Alpha-E484K and the Delta variant, was detected. Conclusion: Our study of the efficacy of various COVID-19 vaccines found that mRNA-1273 had the highest neutralization abilities compared to BNT162b2 and ChAdOx1. COVID-19 convalescent patients demonstrated the most heterogeneous range of antibody titers and neutralization abilities, making it hard to assess protection. Furthermore, a significant positive relation between antibodies and the 50% neutralization titer values for immunized and convalescent individuals was determined.	[Lafon, Eliott; Jaeger, Michael; Wilflingseder, Doris; Lass-Floerl, Cornelia; Posch, Wilfried] Med Univ Innsbruck, Inst Hyg & Med Microbiol, Schopfstr 41,R311, A-6020 Innsbruck, Austria; [Bauer, Angelika; Reindl, Markus] Med Univ Innsbruck, Clin Dept Neurol, Innsbruck, Austria; [Bellmann-Weiler, Rosa] Med Univ Innsbruck, Dept Internal Med 2, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Posch, W (corresponding author), Med Univ Innsbruck, Inst Hyg & Med Microbiol, Schopfstr 41,R311, A-6020 Innsbruck, Austria.	wilfried.posch@i-med.ac.at	Reindl, Markus/ABE-5880-2020; Posch, Wilfried/AAH-6845-2019	Posch, Wilfried/0000-0001-8955-7654; Jager, Michael/0000-0002-8692-1657; Bauer, Angelika/0000-0003-2413-3425	Austrian Science Fund (FWF) [P34070-B, P33510-B]; Anniversary Fund of the Austrian National Bank (OeNB) [P17614, P17633]; state of Tyrol [70454]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Anniversary Fund of the Austrian National Bank (OeNB); state of Tyrol	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA (NIBSC 19/304) was obtained from the National Institute for Biological Standards and Control, United Kingdom. The following reagents were deposited by the US Centers for Disease Control and Prevention and obtained through BEI Resources, National Institute of Allergy and Infectious Diseases, US National Institutes of Health: SARS-related coronavirus 2, isolate USA-WA1/2020 NR-52281; SARS-related coronavirus 2, isolate hCoV-19/England/204820464/2020, NR-54000, contributed by Bassam Hallis; and SARS-related coronavirus 2, isolate hCoV-19/South Africa/KRISP-K005325/2020, NR-54009, contributed by Alex Sigal and Tulio de Oliveira. The authors were supported by the Austrian Science Fund (FWF; P34070-B to W.P. and P33510-B to D.W.), the Anniversary Fund of the Austrian National Bank (OeNB; P17614 to W.P., P17633 to D.W.), and the state of Tyrol (70454 to W.P.).	Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Bosnjak B, 2021, CELL MOL IMMUNOL, V18, P936, DOI 10.1038/s41423-020-00573-9; Cervia C, 2021, J ALLERGY CLIN IMMUN, V147, P545, DOI 10.1016/j.jaci.2020.10.040; Colkesen F, 2022, JPN J INFECT DIS, V75, P228, DOI 10.7883/yoken.JJID.2021.281; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; European Medicines Agency, 2020, EMA CONS COVID 19 VA; Firestone MJ, 2021, MMWR-MORBID MORTAL W, V70, P346, DOI 10.15585/mmwr.mm7010e1; Fisman DN, MEDRXIV; Food and Drug Administration, 2020, DEV LIC VACC PREV CO; Giles B, 2021, LANCET INFECT DIS, V21, P1213, DOI 10.1016/S1473-3099(21)00356-X; Heath PT, 2021, NEW ENGL J MED, V385, P1172, DOI 10.1056/NEJMoa2107659; Ketas TJ, BIORXIV; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Klasse PJ, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe8065; Krammer F, 2020, NATURE, V586, P516, DOI 10.1038/s41586-020-2798-3; Lafon E, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.684014; Lavelle EC, 2021, NAT REV IMMUNOL; LavelleEC WardRW, 2021, NAT REV IMMUNOL; Logunov DY, 2021, LANCET, V397, P671, DOI 10.1016/S0140-6736(21)00234-8; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Puranik A, MEDRXIV; Rubio-Acero R, 2021, INFECT DIS THER, V10, P1505, DOI 10.1007/s40121-021-00475-x; Russell MW, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.611337; Sadoff J, 2021, NEW ENGL J MED, V384, P2187, DOI 10.1056/NEJMoa2101544; Sahin U, 2021, NATURE, V595, P572, DOI 10.1038/s41586-021-03653-6; Sanmarchi F, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.17359; Sette A, 2021, CELL, V184, P861, DOI 10.1016/j.cell.2021.01.007; Sheikh A, 2021, LANCET, V397, P2461, DOI 10.1016/S0140-6736(21)01358-1; Sheikh-Mohamed S., MEDRXIV, DOI 10.1101/2021.08.01.21261297; Shen Xiaoying, 2021, bioRxiv, DOI [10.1016/j.chom.2021.03.002, 10.1101/2021.01.27.428516]; Steensels D, 2021, JAMA-J AM MED ASSOC, V326, P1533, DOI 10.1001/jama.2021.15125; Sterlin D, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd2223; Supasa P, 2021, CELL, V184, P2201, DOI 10.1016/j.cell.2021.02.033; Tang P, MEDRXIV; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Wang Zijun, 2021, bioRxiv, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Wei J, 2021, NAT MICROBIOL, V6, P1140, DOI 10.1038/s41564-021-00947-3; Wise J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n359; Wu K., 2021, BIORXIV, DOI [DOI 10.1101/2021.01.25.427948, 10.1101/2021.01.25.427948]; Xie XP, 2021, NAT MED, V27, DOI [10.1101/2021.01.27.427998, 10.1038/s41591-021-01270-4]; Zhou DM, 2021, CELL, V184, P2348, DOI 10.1016/j.cell.2021.02.037	44	6	6	8	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2022	149	4					1242	+		10.1016/j.jaci.2022.01.013	http://dx.doi.org/10.1016/j.jaci.2022.01.013			23	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3T5RO	35093484	hybrid, Green Published			2022-12-18	WOS:000840331500018
J	Marsh, RA; Hebert, K; Kim, S; Dvorak, CC; Aquino, VM; Baker, KS; Chellapandian, D; Saldana, BD; Duncan, CN; Eckrich, MJ; Georges, GE; Olson, TS; Pulsipher, MA; Shenoy, S; Stenger, E; Vander Lugt, M; Yu, LC; Gennery, AR; Eapen, M				Marsh, Rebecca A.; Hebert, Kyle; Kim, Soyoung; Dvorak, Christopher C.; Aquino, Victor M.; Baker, K. Scott; Chellapandian, Deepak; Saldana, Blachy Davila; Duncan, Christine N.; Eckrich, Michael J.; Georges, George E.; Olson, Timothy S.; Pulsipher, Michael A.; Shenoy, Shalini; Stenger, Elizabeth; Vander Lugt, Mark; Yu, Lolie C.; Gennery, Andrew R.; Eapen, Mary			Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disorders	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Hemophagocytic lymphohistiocytosis; HLH; allogeneic hematopoietic cell transplantation; HCT; hematopoietic stem cell transplantation; HSCT; bone marrow transplantation; BMT	CORD BLOOD TRANSPLANTATION; SURVIVAL; CONSENSUS; CHILDREN	Background: Allogeneic hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis (HLH) disorders is associated with substantial morbidity and mortality. Objective: The effect of conditioning regimen groups of varying intensity on outcomes after transplantation was examined to identify an optimal regimen or regimens for HLH disorders. Methods: We studied 261 patients with HLH disorders transplanted between 2005 and 2018. Risk factors for transplantation outcomes by conditioning regimen groups were studied by Cox regression models. Results: Four regimen groups were studied: (1) fludarabine (Flu) and melphalan (Mel) in 123 subjects; (2) Flu, Mel, and thiotepa (TT) in 28 subjects; (3) Flu and busulfan (Bu) in 14 subjects; and (4) Bu and cyclophosphamide (Cy) in 96 subjects. The day 100 incidence of veno-occlusive disease was lower with Flu/Mel (4%) and Flu/Mel/TT (0%) compared to Flu/Bu (14%) and Bu/Cy (22%) (P < .001). The 6-month incidence of viral infections was highest after Flu/Mel (72%) and Flu/Mel/TT (64%) compared to Flu/Bu (39%) and Bu/Cy (38%) (P < .001). Five-year event-free survival (alive and engrafted without additional cell product administration) was lower with Flu/Mel (44%) compared to Flu/Mel/TT (70%), Flu/Bu (79%), and Bu/ Cy (61%) (P = .002). The corresponding 5-year overall survival values were 68%, 75%, 86%, and 64%, and did not differ by conditioning regimen (P = .19). Low event-free survival with Flu/Mel is attributed to high graft failure (42%) compared to Flu/Mel/TT (15%), Flu/Bu (7%), and Bu/Cy (18%) (P < .001). Conclusions: Given the high rate of graft failure with Flu/Mel and the high rate of veno-occlusive disease with Bu/Cy and Flu/Bu, Flu/Mel/TT may be preferred for HLH disorders. Prospective studies are warranted.	[Marsh, Rebecca A.] Univ Cincinnati, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Marsh, Rebecca A.] Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplantat & Immune Deficiency, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Hebert, Kyle; Kim, Soyoung; Eapen, Mary] Med Coll Wisconsin, Dept Med, Div Hematol Oncol, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA; [Dvorak, Christopher C.] Univ Calif San Francisco, Benioff Childrens Hosp, Div Pediat Allergy Immunol & Bone Marrow Transpla, San Francisco, CA USA; [Aquino, Victor M.] UT Southwestern Med Ctr, Dallas, TX USA; [Baker, K. Scott; Georges, George E.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Chellapandian, Deepak] Johns Hopkins All Childrens Hosp, Ctr Cell & Gene Therapy Nonmalignant Condit, St Petersburg, FL USA; [Saldana, Blachy Davila] Childrens Natl Hosp, Div Bone Marrow Transplant, Washington, DC USA; [Duncan, Christine N.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Eckrich, Michael J.] Methodist Childrens Hosp, Sarah Cannon Pediat Transplant & Cellular Therapy, San Antonio, TX USA; [Olson, Timothy S.] Childrens Hosp Philadelphia, Dept Pediat, Div Oncol, Philadelphia, PA USA; [Pulsipher, Michael A.] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Shenoy, Shalini] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Stenger, Elizabeth] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Vander Lugt, Mark] Univ Michigan, Ann Arbor, MI 48109 USA; [Yu, Lolie C.] Childrens Hosp, New Orleans, LA USA; [Gennery, Andrew R.] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Center for International Blood & Marrow Transplant Research; Medical College of Wisconsin; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; Fred Hutchinson Cancer Center; Johns Hopkins University; Johns Hopkins Medicine; Children's National Health System; Harvard University; Dana-Farber Cancer Institute; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's Hospital Los Angeles; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; Children's Hospital of New Orleans; Newcastle University - UK	Marsh, RA (corresponding author), Univ Cincinnati, 3333 Burnet Ave, Cincinnati, OH 45229 USA.; Marsh, RA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplantat & Immune Deficiency, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Rebecca.marsh@cchmc.org		Eapen, Mary/0000-0001-6193-4243; Dvorak, Christopher/0000-0002-6146-3952	National Cancer Institute (NCI), the National Heart, Lung, and Blood Institute (NHLBI) [5U24-CA076518]; National Institute of Allergy and Infectious Diseases (NIAID); Health Resources and Services Administration (HRSA/DHHS) [HHSH250201200016C]	National Cancer Institute (NCI), the National Heart, Lung, and Blood Institute (NHLBI); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Health Resources and Services Administration (HRSA/DHHS)(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	The CIBMTR is supported primarily by Public Health Service grant agreement 5U24-CA076518 from the National Cancer Institute (NCI), the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute of Allergy and Infectious Diseases (NIAID), and contract HHSH250201200016C with Health Resources and Services Administration (HRSA/DHHS). The views expressed in this article do not reflect the official policy or position of the National Institute of Health, Health Resources and Services Administration, or any other agency of the US government.	Allen CE, 2018, BLOOD, V132, P1438, DOI 10.1182/blood-2018-01-828277; Amrolia P, 2000, BLOOD, V96, P1239, DOI 10.1182/blood.V96.4.1239.h8001239_1239_1246; Andersen PK, 1999, STAT MED, V18, P1489, DOI 10.1002/(SICI)1097-0258(19990630)18:12<1489::AID-SIM140>3.0.CO;2-#; ATKINSON K, 1989, BONE MARROW TRANSPL, V4, P247; Baker KS, 2008, BONE MARROW TRANSPL, V42, P175, DOI 10.1038/bmt.2008.133; Bergsten E, 2020, BLOOD ADV, V4, P3754, DOI 10.1182/bloodadvances.2020002101; Canna SW, 2020, BLOOD, V135, P1332, DOI 10.1182/blood.2019000936; Chandra S, 2021, J CLIN IMMUNOL, V41, P89, DOI 10.1007/s10875-020-00888-2; Contreras CF, 2020, BIOL BLOOD MARROW TR, V26, P1646, DOI 10.1016/j.bbmt.2020.06.004; Cooper N, 2006, BLOOD, V107, P1233, DOI 10.1182/blood-2005-05-1819; COX DR, 1972, J R STAT SOC B, V34, P187; Eapen M, 2017, LANCET HAEMATOL, V4, pE325, DOI 10.1016/S2352-3026(17)30104-7; Felber M, 2020, BLOOD ADV, V4, P1998, DOI 10.1182/bloodadvances.2020001748; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gloude NJ, 2020, J CLIN IMMUNOL, V40, P699, DOI 10.1007/s10875-020-00789-4; GOURIEROUX C, 1981, J ECONOMETRICS, V17, P83, DOI 10.1016/0304-4076(81)90060-9; Horan J, 2012, BLOOD, V120, P2918, DOI 10.1182/blood-2012-03-417758; Khandelwal P, 2016, BIOL BLOOD MARROW TR, V22, P2011, DOI 10.1016/j.bbmt.2016.08.013; Lin DY, 1997, STAT MED, V16, P901, DOI 10.1002/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO;2-M; Marsh RA, 2018, J ALLERGY CLIN IMMUN, V142, P2004, DOI 10.1016/j.jaci.2018.08.010; Marsh RA, 2010, BLOOD, V116, P5824, DOI 10.1182/blood-2010-04-282392; Naik S, 2020, BRIT J HAEMATOL, V188, pE84, DOI 10.1111/bjh.16370; Nishi M, 2012, AM J HEMATOL, V87, P637, DOI 10.1002/ajh.23190; Olsson R, 2013, BONE MARROW TRANSPL, V48, P537, DOI 10.1038/bmt.2012.239; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Shenoy S, 2005, BONE MARROW TRANSPL, V35, P345, DOI 10.1038/sj.bmt.1704795; Slatter MA, 2005, BONE MARROW TRANSPL, V35, P683, DOI 10.1038/sj.bmt.1704872; Vrooman LM, 2017, BIOL BLOOD MARROW TR, V23, P1327, DOI 10.1016/j.bbmt.2017.04.017; Zhang X, 2007, COMPUT METH PROG BIO, V88, P95, DOI 10.1016/j.cmpb.2007.07.010	29	6	6	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2022	149	3					1097	+		10.1016/j.jaci.2021.07.031	http://dx.doi.org/10.1016/j.jaci.2021.07.031			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZO6CI	34375618				2022-12-18	WOS:000765811400007
J	Verhoeven, D; Schonenberg-Meinema, D; Ebstein, F; Papendorf, JJ; Baars, PA; van Leeuwen, EMM; Jansen, MH; Lankester, AC; van der Burg, M; Florquin, S; Maas, SM; van Koningsbruggen, S; Kruger, E; van den Berg, JM; Kuijpers, TW				Verhoeven, Dorit; Schonenberg-Meinema, Dieneke; Ebstein, Frederic; Papendorf, Jonas J.; Baars, Paul A.; van Leeuwen, Ester M. M.; Jansen, Machiel H.; Lankester, Arjan C.; van der Burg, Mirjam; Florquin, Sandrine; Maas, Saskia M.; van Koningsbruggen, Silvana; Krueger, Elke; van den Berg, J. Merlijn; Kuijpers, Taco W.			Hematopoietic stem cell transplantation in a patient with proteasome-associated autoinflammatory syndrome (PRAAS)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Autoinflammation; autoinflammatory syndrome; inter-feron; immunoproteasome; HSCT; PRAAS; proteasome; PSMB4	SUBUNIT; LIPODYSTROPHY; PANNICULITIS; MUTATION; DISEASE	Background: Proteasome-associated autoinflammatory syndromes (PRAASs) form a family of recently described rare autosomal recessive disorders of disturbed proteasome assembly and proteolytic activity caused by mutations in genes coding for proteasome subunits. The treatment options for these proteasome disorders consist of lifelong immunosuppressive drugs or Janus kinase inhibitors, which may have partial efficacy and noticeable side effects. Because proteasomes are ubiquitously expressed, it is unknown whether hematopoietic stem cell transplantation (HSCT) may be a sufficient treatment option. Objective: Our aim was to report the case of a young boy with a treatment-resistant cutaneous vasculitis that was initially suspected to be associated with a gene variant in SH2D1A. Methods: Whole-exome sequencing was performed to identify the genetic defect. Molecular and functional analyses were performed to assess the impact of variants on proteasomal function. The immune characterization led to the decision to perform HSCT on our patient and conduct follow-up over the 7-year period after the transplant. Because loss of myeloid chimerism after the first HSCT was associated with relapse of autoinflammation, a second HSCT was performed. Results: After the successful second HSCT, the patient developed mild symptoms of lipodystrophy, which raised the suspicion of a PRAAS. Genetic analysis revealed 2 novel heterozygous variants in PSMB4 (encoding proteasomal subunit beta 7). Retrospective analysis of patient cells stored before the first HSCT and patient cells obtained after the second HSCT demonstrated that HSCT successfully rescued proteasome function, restored protein homeostasis, and resolved the interferon-stimulated gene signature. Furthermore, successful HSCT alleviated the autoinflammatory manifestations in our patient. Conclusion: Patients with treatment-resistant PRAAS can be cured by HSCT.	[Verhoeven, Dorit; Schonenberg-Meinema, Dieneke; van den Berg, J. Merlijn; Kuijpers, Taco W.] Emma Childrens Hosp, Dept Pediat Immunol Rheumatol & Infect Dis, Amsterdam, Netherlands; [Verhoeven, Dorit; Baars, Paul A.; van Leeuwen, Ester M. M.; Jansen, Machiel H.; Kuijpers, Taco W.] Amsterdam Inst Infect & Immun, Dept Expt Immunol, Amsterdam, Netherlands; [Florquin, Sandrine] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Maas, Saskia M.; van Koningsbruggen, Silvana] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Ebstein, Frederic; Papendorf, Jonas J.; Krueger, Elke] Univ Med Greifswald, Inst Med Biochem & Mol Biol, Greifswald, Germany; [Lankester, Arjan C.] Leiden Univ, Leiden Univ Med Ctr, Willem Alexander Childrens Hosp, Dept Pediat,Pediat Stem Cell Transplantat Program, Leiden, Netherlands; [van der Burg, Mirjam] Leiden Univ, Leiden Univ Med Ctr, Willem Alexander Childrens Hosp, Dept Pediat,Lab Pediat Immunol, Leiden, Netherlands	Emma Children's Hospital; University of Amsterdam; University of Amsterdam; University of Amsterdam; Greifswald Medical School; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kuijpers, TW (corresponding author), Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.w.kuijpers@amsterdamumc.nl	Krueger, Elke/B-1462-2012	Krueger, Elke/0000-0002-2551-242X; Verhoeven, Dorit/0000-0001-5837-6068	German Research Foundation [SFB-TR167 A04]	German Research Foundation(German Research Foundation (DFG))	Supported by the German Research Foundation (grant SFB-TR167 A04 [to E.K.]).	Agarwal AK, 2010, AM J HUM GENET, V87, P866, DOI 10.1016/j.ajhg.2010.10.031; AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; Booth C, 2011, BLOOD, V117, P53, DOI 10.1182/blood-2010-06-284935; Brehm A, 2015, J CLIN INVEST, V125, P4196, DOI 10.1172/JCI81260; Brehm A, 2015, SEMIN IMMUNOPATHOL, V37, P323, DOI 10.1007/s00281-015-0486-4; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; de Jager W, 2005, J IMMUNOL METHODS, V300, P124, DOI 10.1016/j.jim.2005.03.009; de Jesus AA, 2019, J ALLERGY CLIN IMMUN, V143, P1939, DOI 10.1016/j.jaci.2018.12.1012; Ebstein F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02756; Fonteneau JF, 2001, J IMMUNOL METHODS, V258, P111, DOI 10.1016/S0022-1759(01)00477-X; Hill DA, 2018, P NATL ACAD SCI USA, V115, pE5096, DOI 10.1073/pnas.1802611115; Jegalian AG, 2009, ADV ANAT PATHOL, V16, P392, DOI 10.1097/PAP.0b013e3181bb6bc2; Kitamura A, 2011, J CLIN INVEST, V121, P4150, DOI 10.1172/JCI58414; Kuijpers TW, 2013, HAEMATOLOGICA, V98, P1030, DOI 10.3324/haematol.2012.077511; McDermott A, 2015, INT J DERMATOL, V54, P121, DOI 10.1111/ijd.12695; Mostafavi S, 2016, CELL, V164, P564, DOI 10.1016/j.cell.2015.12.032; Poli MC, 2018, AM J HUM GENET, V102, P1126, DOI 10.1016/j.ajhg.2018.04.010; Rice GI, 2017, J CLIN IMMUNOL, V37, P123, DOI 10.1007/s10875-016-0359-1; Sanchez GAM, 2018, J CLIN INVEST, V128, P3041, DOI 10.1172/JCI98814; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Sijts EJAM, 2011, CELL MOL LIFE SCI, V68, P1491, DOI 10.1007/s00018-011-0657-y; Torrelo A, 2017, J EUR ACAD DERMATOL, V31, P536, DOI 10.1111/jdv.13858; Torrelo A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00927; Torrelo A, 2015, AM J DERMATOPATH, V37, P517, DOI 10.1097/DAD.0000000000000340; Torrelo A, 2010, J AM ACAD DERMATOL, V62, P489, DOI 10.1016/j.jaad.2009.04.046; Weise G, 2012, J CLIN NEUROSCI, V19, P1312, DOI 10.1016/j.jocn.2011.11.026; Weiss ES, 2018, BLOOD, V131, P1442, DOI 10.1182/blood-2017-12-820852	28	6	6	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2022	149	3					1120	+		10.1016/j.jaci.2021.07.039	http://dx.doi.org/10.1016/j.jaci.2021.07.039			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZO6CI	34416217	hybrid			2022-12-18	WOS:000765811400010
J	Wang, ZC; Yao, Y; Chen, CL; Guo, CL; Ding, HX; Song, J; Wang, ZZ; Wang, N; Li, XL; Liao, B; Yang, Y; Yu, D; Liu, Z				Wang, Zhi-Chao; Yao, Yin; Chen, Cai-Ling; Guo, Cui-Lian; Ding, Hong-Xia; Song, Jia; Wang, Zhe-Zheng; Wang, Nan; Li, Xue-Li; Liao, Bo; Yang, Yang; Yu, Di; Liu, Zheng			Extrafollicular PD-1(high)CXCR5(-)CD4(+) T cells participate in local immunoglobulin production in nasal polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Nasal polyps; immunoglobulin; T cell; programmed cell death protein 1; programmed death ligand	CHRONIC RHINOSINUSITIS; B-CELLS; ACTIVATION; PROMOTE; ALLERGY	Background: Local immunoglobulin hyperproduction is observed in nasal polyps (NPs) with and without ectopic lymphoid tissues (eLTs). Objective: Our aim was to identify the T-cell subsets involved in local immunoglobulin production independent of eLTs in NPs. Methods: The localization, abundance, and phenotype of CD4(+) T-cell subsets were studied by immunofluorescence, flow cytometry, and single cell RNA sequencing. Purified nasal T-cell subsets were cultured with autologous peripheral naive B cells to explore their function. Programmed death ligand 1 and programmed death ligand 2 expression in NPs was investigated by immunofluorescence staining and flow cytometry. Results: Accumulation of PD-1(high) CXCR5(-)CD4(+) T cells outside lymphoid aggregates was found in NPs. Nasal PD-1(high) CXCR5(-)CD4(+) T cells were characterized by a unique phenotype that was related to B-cell help and tissue residency and distinct from PD-1(high)CXCR5(+) and CXCR5(+) CD4(+) T cells in NPs as well as PD-1(high) CXCR5(high) CD4(+) follicular helper T cells in tonsils. Compared with the frequencies of PD-1(high) CXCR5(-)CD4(+) T cells and their IFN-gamma(+), IL-17A(+), and IL-21(+) subsets in the control inferior turbinate tissues, the frequencies of these cells and their subsets were increased in both eosinophilic and noneosinophilic NPs, whereas the frequencies of the IL-4(+) and IL-4(+), IL-21(+) subsets were increased only in eosinophilic NPs. Nasal PD-1(high) CXCR5(-)CD4(+) T cells induced immunoglobulin production from B cells in a potency comparable to that induced by tonsillar follicular helper T cells. PD-1(high) CXCR5(-)CD4(+) T-cell frequencies were correlated with IgE levels in eosinophilic NPs. PD-L1 and PD-L2 suppressed the function of PD-1(high) CXCR5(-)CD4(+) T cells, and their levels were reduced in NPs. PD-1(high) CXCR5(-)CD4(+) T-cell abundance was associated with the postsurgical relapse of NPs. Conclusion: PD-1(high) CXCR5(-)CD4(+) T cells participate in local immunoglobulin production independent of eLTs in NPs.	[Wang, Zhi-Chao; Yao, Yin; Chen, Cai-Ling; Guo, Cui-Lian; Ding, Hong-Xia; Song, Jia; Wang, Zhe-Zheng; Wang, Nan; Li, Xue-Li; Liao, Bo; Liu, Zheng] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Otolaryngol Head & Neck Surg, 1095 Jiefang Ave, Wuhan 430030, Peoples R China; [Yang, Yang; Yu, Di] Univ Queensland, Diamantina Inst, Fac Med, Brisbane, Qld, Australia	Huazhong University of Science & Technology; University of Queensland	Liu, Z (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Otolaryngol Head & Neck Surg, 1095 Jiefang Ave, Wuhan 430030, Peoples R China.	zhengliuent@hotmail.com		Yu, Di/0000-0003-1721-8922; Yin, Yao/0000-0002-5833-5263	National Natural Science Foundation of China [81920108011, 81630024, 82000964, 81900925, 81800891]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Supported by the National Natural Science Foundation of China (grants 81920108011 and 81630024 [to Z.L.], 82000964 [to Z.C.W.], 81900925 [to J.S.], and 81800891 [to N.W.]).	Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Bachert C, 2016, JAMA-J AM MED ASSOC, V315, P469, DOI 10.1001/jama.2015.19330; Caielli S, 2019, NAT MED, V25, P75, DOI 10.1038/s41591-018-0254-9; Cao PP, 2014, CLIN EXP ALLERGY, V44, P690, DOI 10.1111/cea.12304; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Chen WJ, 2016, ATHEROSCLEROSIS, V244, P108, DOI 10.1016/j.atherosclerosis.2015.11.002; Coquet JM, 2015, IMMUNITY, V43, P318, DOI 10.1016/j.immuni.2015.07.015; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; de Loos DAED, 2013, CURR ALLERGY ASTHM R, V13, P162, DOI 10.1007/s11882-012-0334-8; De Schryver E, 2015, ALLERGY ASTHMA IMMUN, V7, P321, DOI 10.4168/aair.2015.7.4.321; Deng J, 2019, NAT REV RHEUMATOL, V15, P475, DOI 10.1038/s41584-019-0254-2; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gevaert P, 2020, J ALLERGY CLIN IMMUN, V146, P595, DOI 10.1016/j.jaci.2020.05.032; Jia XY, 2019, CLIN IMMUNOL, V198, P89, DOI 10.1016/j.clim.2018.11.015; Kim D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16115-w; Kobayashi S, 2016, EUR J IMMUNOL, V46, P360, DOI 10.1002/eji.201546043; Krohn IK, 2017, ALLERGY, V72, P985, DOI 10.1111/all.13136; Lau A, 2017, J ALLERGY CLIN IMMUN, V139, P1371, DOI 10.1016/j.jaci.2016.08.052; Liao B, 2018, ALLERGY, V73, P1459, DOI 10.1111/all.13411; Lim WC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00565; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Nakayama T, 2011, RHINOLOGY, V49, P392, DOI 10.4193/Rhino10.261; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Orlandi RR, 2016, INT FORUM ALLERGY RH, V6, pS3, DOI 10.1002/alr.21694; Paramasivan S, 2018, J ALLERGY CLIN IMMUN, V142, P1673, DOI 10.1016/j.jaci.2018.07.024; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; Sakthivel P, 2012, REV RECENT CLIN TRIA, V7, P10, DOI 10.2174/157488712799363262; Shi JB, 2015, ALLERGY, V70, P533, DOI 10.1111/all.12577; Shi JW, 2018, IMMUNITY, V49, P264, DOI 10.1016/j.immuni.2018.06.012; Shi LL, 2014, AM J RESP CRIT CARE, V190, P628, DOI 10.1164/rccm.201402-0234OC; Song J, 2018, J ALLERGY CLIN IMMUN, V141, P927, DOI 10.1016/j.jaci.2017.10.014; Tan BK, 2018, J ALLERGY CLIN IMMUN, V141, P1553, DOI 10.1016/j.jaci.2018.03.002; Tan BK, 2011, J ALLERGY CLIN IMMUN, V128, P1198, DOI 10.1016/j.jaci.2011.08.037; Van Roey GA, 2017, J ALLERGY CLIN IMMUN, V140, P89, DOI 10.1016/j.jaci.2016.11.015; Wang H, 2018, J ALLERGY CLIN IMMUN, V141, P1646, DOI 10.1016/j.jaci.2017.12.972; Xiao L, 2015, SCI REP-UK, V5, DOI 10.1038/srep12781; Yao Y, 2019, J ALLERGY CLIN IMMUN, V144, P118, DOI 10.1016/j.jaci.2019.02.008; Yao Y, 2018, J ALLERGY CLIN IMMUN, V142, P321, DOI 10.1016/j.jaci.2018.03.008; Zhai GT, 2018, J ALLERGY CLIN IMMUN, V142, P1489, DOI 10.1016/j.jaci.2018.07.025; Zhang YN, 2016, J ALLERGY CLIN IMMUN, V137, P462, DOI 10.1016/j.jaci.2015.07.025	40	6	6	5	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2022	149	2					610	623		10.1016/j.jaci.2021.06.023	http://dx.doi.org/10.1016/j.jaci.2021.06.023			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YV3IA	34224786				2022-12-18	WOS:000752623200020
J	Xie, Y; Abel, PW; Casale, TB; Tu, YP				Xie, Yan; Abel, Peter W.; Casale, Thomas B.; Tu, Yaping			T(H)17 cells and corticosteroid insensitivity in severe asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						T(H)17 cells; corticosteroid insensitivity; severe asthma; type 2 asthma; non-type 2 asthma; airway neutrophilia; IL-17; IL-6; RhoA; Rho-associated kinase	ROR-GAMMA-T; AIRWAY SMOOTH-MUSCLE; GROWTH-FACTOR-BETA; GLUCOCORTICOID-RECEPTOR GENE; DOUBLE-BLIND; TGF-BETA; IN-VIVO; BRONCHIAL THERMOPLASTY; SMOKING-CESSATION; RESISTANT ASTHMA	Asthma is classically described as having either a type 2 (T2) eosinophilic phenotype or a non-T2 neutrophilic phenotype. T2 asthma usually responds to classical bronchodilation therapy and corticosteroid treatment. Non-T2 neutrophilic asthma is often more severe. Patients with non-T2 asthma or late-onset T2 asthma show poor response to the currently available anti-inflammatory therapies. These therapeutic failures result in increased morbidity and cost associated with asthma and pose a major health care problem. Recent evidence suggests that some non-T2 asthma is associated with elevated T(H)17 cell immune responses. T(H)17 cells producing Il-17A and IL-17F are involved in the neutrophilic inflammation and airway remodeling processes in severe asthma and have been suggested to contribute to the development of subsets of corticosteroid-insensitive asthma. This review explores the pathologic role of T(H)17 cells in corticosteroid insensitivity of severe asthma and potential targets to treat this endotype of asthma.	[Xie, Yan; Abel, Peter W.; Tu, Yaping] Creighton Univ, Sch Med, Dept Pharmacol & Neurosci, 2500 Calif Plaza, Omaha, NE 68178 USA; [Casale, Thomas B.] Univ S Florida, Sch Med, Dept Internal Med, Tampa, FL 33612 USA	Creighton University; State University System of Florida; University of South Florida	Tu, YP (corresponding author), Creighton Univ, Sch Med, Dept Pharmacol & Neurosci, 2500 Calif Plaza, Omaha, NE 68178 USA.; Casale, TB (corresponding author), Univ S Florida, Sch Med, Dept Internal Med, Tampa, FL 33612 USA.	Yat60399@creighton.edu			National Institutes of Health [R01HL116849, 5R21ES029566]; Nebraska State LB595 Research Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska State LB595 Research Program	Supported in part by the National Institutes of Health (grants R01HL116849 [to Y. Tu and T.B. Casale] and 5R21ES029566 [to Y. Tu and P.W. Abel]) and the Nebraska State LB595 Research Program (to Y. Tu and P.W. Abel).	Agache I, 2010, RESP MED, V104, P1131, DOI 10.1016/j.rmed.2010.02.018; Al-Hajjaj M, 2020, ANN THORAC MED, V15, P47, DOI 10.4103/atm.ATM_38_20; Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Albano GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058892; Allan SE, 2005, J CLIN INVEST, V115, P3276, DOI 10.1172/JCI24685; Altenburg J, 2011, RESPIRATION, V81, P75, DOI 10.1159/000320320; Ano S, 2013, J IMMUNOL, V190, P1056, DOI 10.4049/jimmunol.1202386; [Anonymous], 2021, GLOBAL INITIATIVE AS; [Anonymous], 2021, 2021 GLOBAL INITIATI; Anticevich SZ, 1996, CLIN EXP ALLERGY, V26, P549, DOI 10.1046/j.1365-2222.1996.d01-341.x; Arron JR, 2014, EUR RESPIR J, V43, P627, DOI 10.1183/09031936.00117013; Baines KJ, 2011, THORAX, V66, P942, DOI 10.1136/thx.2010.157719; Barczyk A, 2003, RESP MED, V97, P726, DOI 10.1053/rmed.2003.1507; Basu R, 2015, NAT IMMUNOL, V16, P286, DOI 10.1038/ni.3099; Berry M, 2007, THORAX, V62, P1043, DOI 10.1136/thx.2006.073429; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Bonta PI, 2018, RESPIRATION, V95, P289, DOI 10.1159/000488291; BORISH L, 1992, J IMMUNOL, V149, P3078; Brightling CE, 2021, NEW ENGL J MED, V385, P1669, DOI 10.1056/NEJMoa2030880; Brusselle GG, 2013, THORAX, V68, P322, DOI 10.1136/thoraxjnl-2012-202698; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Bullone M, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00068-2019; Bush A, 2011, CURR OPIN ALLERGY CL, V11, P115, DOI 10.1097/ACI.0b013e32834487ae; Busse PJ, 2017, J ALLERGY CLIN IMMUN, V139, P1808, DOI 10.1016/j.jaci.2016.09.015; Busse WW, 2013, AM J RESP CRIT CARE, V188, P1294, DOI 10.1164/rccm.201212-2318OC; Camargo LD, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01835; Castro M, 2010, AM J RESP CRIT CARE, V181, P116, DOI 10.1164/rccm.200903-0354OC; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Chambers ES, 2015, J ALLERGY CLIN IMMUN, V136, P628, DOI 10.1016/j.jaci.2015.01.026; Chan MTS, 1998, J ALLERGY CLIN IMMUN, V101, P594, DOI 10.1016/S0091-6749(98)70165-4; Chang Y, 2012, FASEB J, V26, P5152, DOI 10.1096/fj.12-208033; Chang Y, 2011, J ALLERGY CLIN IMMUN, V127, P1046, DOI 10.1016/j.jaci.2010.12.1117; Charmandari E, 2011, HORM RES PAEDIAT, V76, P145, DOI 10.1159/000330759; Chaudhuri R, 2006, AM J RESP CRIT CARE, V174, P127, DOI 10.1164/rccm.200510-1589OC; Chen SY, 2022, ALLERGOL INT, V71, P73, DOI 10.1016/j.alit.2021.07.004; Chesne J, 2014, AM J RESP CRIT CARE, V190, P1094, DOI 10.1164/rccm.201405-0859PP; Chiarella SE, 2015, J ALLERGY CLIN IMMUN, V135, P290, DOI 10.1016/j.jaci.2014.09.037; Chiba Y, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-4; Chien JW, 2013, CLIN EXP ALLERGY, V43, P1018, DOI 10.1111/cea.12119; Choy DF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3142; Chu DK, 2015, ALLERGY ASTHMA CL IM, V11, DOI 10.1186/s13223-015-0081-1; Chu HW, 2000, J ALLERGY CLIN IMMUN, V106, P1115; Chung KF, 1999, EUR RESPIR J, V13, P1198; Chung KF, 2016, J INTERN MED, V279, P192, DOI 10.1111/joim.12382; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Ciprandi G, 2012, INT ARCH ALLERGY IMM, V159, P183, DOI 10.1159/000336418; Cloutier MM, 2020, J ALLERGY CLIN IMMUN, V146, P1217, DOI 10.1016/j.jaci.2020.10.003; Cook Donald N, 2015, Nucl Receptor Res, V2; Corren J, 2020, J ALLER CL IMM-PRACT, V8, P516, DOI 10.1016/j.jaip.2019.08.050; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Coverstone AM, 2020, J ALLER CL IMM-PRACT, V8, P442, DOI 10.1016/j.jaip.2019.11.020; Cowan DC, 2010, THORAX, V65, P384, DOI 10.1136/thx.2009.126722; COX G, 1995, J IMMUNOL, V154, P4719; Crisford H, 2021, THORAX, V76, P835, DOI 10.1136/thoraxjnl-2020-215986; Cundall M, 2003, J ALLERGY CLIN IMMUN, V112, P1064, DOI 10.1016/j.jaci.2003.08.013; Demarche S, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0208-2; DENNIS M, 1964, J ALLERGY, V35, P70, DOI 10.1016/0021-8707(64)90051-6; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Domvri K, 2019, RESP MED, V151, P102, DOI 10.1016/j.rmed.2019.03.017; Ducharme ME, 2011, RESP MED, V105, P1284, DOI 10.1016/j.rmed.2011.04.006; Esty B, 2019, J ALLER CL IMM-PRACT, V7, P1639, DOI 10.1016/j.jaip.2019.02.043; Evans MD, 2018, J ALLERGY CLIN IMMUN, V142, P415, DOI 10.1016/j.jaci.2017.09.035; Facciolongo N, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-017-0554-8; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Floss DM, 2015, CYTOKINE GROWTH F R, V26, P569, DOI 10.1016/j.cytogfr.2015.07.005; Foley SC, 2007, J ALLERGY CLIN IMMUN, V119, P1282, DOI 10.1016/j.jaci.2007.02.006; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Foster PS, 2017, IMMUNOL REV, V278, P20, DOI 10.1111/imr.12549; Fukakusa M, 2005, J ALLERGY CLIN IMMUN, V115, P280, DOI 10.1016/j.jaci.2004.10.036; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gibson PG, 2017, LANCET, V390, P659, DOI 10.1016/S0140-6736(17)31281-3; Golebski K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09883-7; Green BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100645; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; Guntermann C, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91127; Hahmann C, 2010, CELL MOL LIFE SCI, V67, P171, DOI 10.1007/s00018-009-0189-x; Hakonarson H, 2002, J ALLERGY CLIN IMMUN, V110, P624, DOI 10.1067/mai.2002.128529; Hakonarson H, 1997, J CLIN INVEST, V99, P117, DOI 10.1172/JCI119122; Halwani R, 2017, J ASTHMA, V54, P893, DOI 10.1080/02770903.2017.1283696; Hamzaoui A, 2011, J INFLAMM RES, V4, P139, DOI 10.2147/JIR.S25314; Hansbro PM, 2017, IMMUNOL REV, V278, P41, DOI 10.1111/imr.12543; Hawkins GA, 2012, J ALLERGY CLIN IMMUN, V130, P510, DOI 10.1016/j.jaci.2012.03.018; Heaney LG, 2003, THORAX, V58, P561, DOI 10.1136/thorax.58.7.561; Henderson I, 2020, PHARMACOL RES, V160, DOI 10.1016/j.phrs.2020.105189; Hernandez ML, 2015, J ALLERGY CLIN IMMUN, V135, P379, DOI 10.1016/j.jaci.2014.07.039; Hirahara K, 2010, CYTOKINE GROWTH F R, V21, P425, DOI 10.1016/j.cytogfr.2010.10.006; Hirst SJ, 1998, AM J RESP CRIT CARE, V158, pS201, DOI 10.1164/ajrccm.158.supplement_2.13tac190; Hizawa N, 2006, CLIN EXP ALLERGY, V36, P1109, DOI 10.1111/j.1365-2222.2006.02550.x; Huang JL, 2021, IMMUNITY, V54, P673, DOI 10.1016/j.immuni.2021.03.018; Hynes GM, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00364-2019; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; IRWIN RS, 1993, CHEST, V103, P1662, DOI 10.1378/chest.103.6.1662; Israel E, 2017, NEW ENGL J MED, V377, P965, DOI 10.1056/NEJMra1608969; Ito K, 2006, J ALLERGY CLIN IMMUN, V117, P522, DOI 10.1016/j.jaci.2006.01.032; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jetten Anton M, 2013, Front Endocrinol (Lausanne), V4, P1, DOI 10.3389/fendo.2013.00001; Jevnikar Z, 2019, J ALLERGY CLIN IMMUN, V143, P577, DOI 10.1016/j.jaci.2018.05.026; Johnston A, 2013, J IMMUNOL, V190, P2252, DOI 10.4049/jimmunol.1201505; Kamath AV, 2005, THORAX, V60, P529, DOI 10.1136/thx.2005.043182; Kawaguchi M, 2006, J ALLERGY CLIN IMMUN, V117, P795, DOI 10.1016/j.jaci.2005.12.1346; Kawaguchi M, 2001, J IMMUNOL, V167, P4430, DOI 10.4049/jimmunol.167.8.4430; Ke X, 2019, J ALLERGY CLIN IMMUN, V143, P1560, DOI 10.1016/j.jaci.2018.08.023; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Kim RY, 2017, AM J RESP CRIT CARE, V196, P283, DOI 10.1164/rccm.201609-1830OC; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Krishnamoorthy N, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao4747; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Kusam S, 2003, J IMMUNOL, V170, P2435, DOI 10.4049/jimmunol.170.5.2435; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Lamb D, 2021, RESP RES, V22, DOI 10.1186/s12931-021-01743-7; Lamblin C, 1998, AM J RESP CRIT CARE, V157, P394, DOI 10.1164/ajrccm.157.2.97-02099; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lazarus SC, 2007, AM J RESP CRIT CARE, V175, P783, DOI 10.1164/rccm.200511-1746OC; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liao SY, 2019, ERJ OPEN RES, V5, DOI 10.1183/23120541.00123-2018; Liu WM, 2017, J ALLERGY CLIN IMMUN, V139, P1548, DOI 10.1016/j.jaci.2016.08.032; Llanos JP, 2020, J ASTHMA ALLERGY, V13, P77, DOI 10.2147/JAA.S236609; Louis R, 2006, CLIN EXP ALLERGY, V36, P563, DOI 10.1111/j.1365-2222.2006.02493.x; Louis R, 2000, AM J RESP CRIT CARE, V161, P9, DOI 10.1164/ajrccm.161.1.9802048; Loza MJ, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0482-9; Mailer RKW, 2015, SCI REP-UK, V5, DOI 10.1038/srep14674; Mailer RKW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006104; Malmhall C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040012; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Manni ML, 2014, MUCOSAL IMMUNOL, V7, P1186, DOI 10.1038/mi.2014.8; Manni ML, 2016, J IMMUNOL, V196, P963, DOI 10.4049/jimmunol.1501531; Martinez FD, 2013, LANCET, V382, P1360, DOI 10.1016/S0140-6736(13)61536-6; Mattos MS, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.566953; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGrath KW, 2012, AM J RESP CRIT CARE, V185, P612, DOI 10.1164/rccm.201109-1640OC; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Mersha TB, 2021, CLIN REV ALLERG IMMU, V60, P200, DOI 10.1007/s12016-020-08787-5; Mincham KT, 2021, IMMUNOLOGY, V164, P701, DOI 10.1111/imm.13419; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Monteseirin J, 2009, J INVEST ALLERG CLIN, V19, P340; Moore WC, 2014, J ALLERGY CLIN IMMUN, V133, P1557, DOI 10.1016/j.jaci.2013.10.011; Murphy RC, 2021, J ALLER CL IMM-PRACT, V9, P2588, DOI 10.1016/j.jaip.2021.04.033; Na H, 2018, J ALLERGY CLIN IMMUN, V141, P2061, DOI 10.1016/j.jaci.2017.07.050; Nabe T, 2011, LIFE SCI, V88, P1127, DOI 10.1016/j.lfs.2011.04.003; Nagasaki T, 2014, J ALLERGY CLIN IMMUN, V133, P1474, DOI 10.1016/j.jaci.2013.12.1084; Nair P, 2021, LANCET RESP MED, V9, P441, DOI 10.1016/S2213-2600(21)00023-0; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Nembrini C, 2009, J ALLERGY CLIN IMMUN, V123, P986, DOI 10.1016/j.jaci.2009.03.033; Newcomb DC, 2013, CURR OPIN IMMUNOL, V25, P755, DOI 10.1016/j.coi.2013.08.002; Ntontsi P, 2020, CURR OPIN ALLERGY CL, V20, P202, DOI 10.1097/ACI.0000000000000623; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Byrne PM, 2016, LANCET RESP MED, V4, P797, DOI 10.1016/S2213-2600(16)30227-2; Oakley RH, 1999, J BIOL CHEM, V274, P27857, DOI 10.1074/jbc.274.39.27857; OBYRNE PM, 1984, AM REV RESPIR DIS, V130, P214; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Okada S, 2015, SCIENCE, V349, P606, DOI 10.1126/science.aaa4282; Ortega H, 2014, EUR RESPIR J, V44, P239, DOI 10.1183/09031936.00220413; Osei ET, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00563-2019; Ouyang SD, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.132836; Pascoe S., 2006, ANN C 2006 NOVEL TRE; Perret JL, 2016, J ASTHMA ALLERGY, V9, P117, DOI 10.2147/JAA.S85615; Peters MC, 2020, AM J RESP CRIT CARE, V202, P973, DOI 10.1164/rccm.201909-1813OC; Peters MC, 2019, AM J RESP CRIT CARE, V199, P465, DOI 10.1164/rccm.201807-1291OC; Peters MC, 2016, LANCET RESP MED, V4, P574, DOI 10.1016/S2213-2600(16)30048-0; Pothoven KL, 2017, J ALLERGY CLIN IMMUN, V139, P1966, DOI 10.1016/j.jaci.2016.10.039; Pretolani M, 2014, AM J RESP CRIT CARE, V190, P1452, DOI 10.1164/rccm.201407-1374LE; PUJOL JL, 1990, INT ARCH ALLER A IMM, V91, P207, DOI 10.1159/000235117; Qin HW, 2009, J IMMUNOL, V183, P97, DOI 10.4049/jimmunol.0801986; Ramamoorthy S, 2013, MOL CELL BIOL, V33, P1711, DOI 10.1128/MCB.01151-12; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Ray A, 2017, TRENDS IMMUNOL, V38, P942, DOI 10.1016/j.it.2017.07.003; Ricciardolo FLM, 2017, J ALLERGY CLIN IMMUN, V140, P395, DOI 10.1016/j.jaci.2016.10.034; Robinson MB, 2015, AM J PHYSIOL-LUNG C, V309, pL129, DOI 10.1152/ajplung.00288.2014; Saffar AS, 2011, CURR DRUG TARGETS, V12, P556; Saoudi Abdelhadi, 2014, Small GTPases, V5, DOI 10.4161/sgtp.28208; Scapini P, 2016, IMMUNOL REV, V273, P48, DOI 10.1111/imr.12448; Schaafsma D, 2008, EUR J PHARMACOL, V585, P398, DOI 10.1016/j.ejphar.2008.01.056; Schleich F, 2014, RESP MED, V108, P1723, DOI 10.1016/j.rmed.2014.10.007; Schwarzenberger P, 1998, J IMMUNOL, V161, P6383; Schwiebert LA, 1996, J ALLERGY CLIN IMMUN, V97, P143, DOI 10.1016/S0091-6749(96)80214-4; Shukla SD, 2021, THORAX, V76, P733, DOI 10.1136/thoraxjnl-2020-216331; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x; Simpson JL, 2008, AM J RESP CRIT CARE, V177, P148, DOI 10.1164/rccm.200707-1134OC; Skepner J, 2015, IMMUNOLOGY, V145, P347, DOI 10.1111/imm.12444; Skepner J, 2014, J IMMUNOL, V192, P2564, DOI 10.4049/jimmunol.1302190; Soehnlein O, 2009, TRENDS IMMUNOL, V30, P546, DOI 10.1016/j.it.2009.06.006; Sorbello V, 2015, ALLERGY, V70, P236, DOI 10.1111/all.12547; Stanescu D, 1996, THORAX, V51, P267, DOI 10.1136/thx.51.3.267; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Stokes JR, 2016, ANN ALLERG ASTHMA IM, V117, P121, DOI 10.1016/j.anai.2016.05.016; Sun WJ, 2021, CAN RESPIR J, V2021, DOI 10.1155/2021/9999122; Sun YC, 2005, CHINESE MED J-PEKING, V118, P953; Svenningsen S, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00158; Sze E, 2020, ALLERGY, V75, P311, DOI 10.1111/all.13985; Taylor SL, 2018, J ALLERGY CLIN IMMUN, V141, P94, DOI 10.1016/j.jaci.2017.03.044; Telenga ED, 2012, ALLERGY, V67, P1060, DOI 10.1111/j.1398-9995.2012.02855.x; Thomas RA, 2004, CHEST, V126, P1811, DOI 10.1016/S0012-3692(15)31427-6; Thomson NC, 2004, EUR RESPIR J, V24, P822, DOI 10.1183/09031936.04.00039004; Tliba O, 2019, J ALLERGY CLIN IMMUN, V143, P1287, DOI 10.1016/j.jaci.2018.06.008; Trivedi A, 2016, LANCET RESP MED, V4, P585, DOI 10.1016/S2213-2600(16)30018-2; Tsitoura DC, 2004, J CLIN INVEST, V113, P619, DOI 10.1172/JCI200418975; Tsokos M, 2002, VIRCHOWS ARCH, V441, P494, DOI 10.1007/s00428-002-0666-1; van Rossum EFC, 2003, CLIN ENDOCRINOL, V59, P585, DOI 10.1046/j.1365-2265.2003.01888.x; Vargas A, 2016, AM J RESP CELL MOL, V55, P450, DOI 10.1165/rcmb.2016-0033OC; Vazquez-Tello A, 2013, J CLIN IMMUNOL, V33, P466, DOI 10.1007/s10875-012-9828-3; Vignola AM, 1998, AM J RESP CRIT CARE, V157, P505, DOI 10.1164/ajrccm.157.2.9703070; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Wang C, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.068; Wang YH, 2010, J EXP MED, V207, P2479, DOI 10.1084/jem.20101376; Weigel NL, 2007, MOL ENDOCRINOL, V21, P2311, DOI 10.1210/me.2007-0101; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Westergaard CG, 2014, CLIN EXP ALLERGY, V44, P353, DOI 10.1111/cea.12243; Whitehead GS, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125528; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Wright JF, 2008, J IMMUNOL, V181, P2799, DOI 10.4049/jimmunol.181.4.2799; Wright JF, 2007, J BIOL CHEM, V282, P13447, DOI 10.1074/jbc.M700499200; Wu SZ, 2017, IMMUNOL LETT, V192, P20, DOI 10.1016/j.imlet.2017.10.006; Xiao S, 2014, IMMUNITY, V40, P477, DOI 10.1016/j.immuni.2014.04.004; Xue XH, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90497-9; Yang JQ, 2019, J LEUKOCYTE BIOL, V106, P1139, DOI 10.1002/JLB.3A0119-025RRR; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Yoon JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8600; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zanin-Zhorov A, 2014, P NATL ACAD SCI USA, V111, P16814, DOI 10.1073/pnas.1414189111; Zhang H, 2014, GENET MOL RES, V13, P8320, DOI [10.4238/2014.October.20.8, 10.4238/2014.January.22.2]; Zhang Y, 2020, CLIN TRANSL IMMUNOL, V9, DOI 10.1002/cti2.1134; Zhang YL, 2020, MEDIAT INFLAMM, V2020, DOI 10.1155/2020/1719467; Zhao J, 2013, MUCOSAL IMMUNOL, V6, P335, DOI 10.1038/mi.2012.76; Zhao Y, 2010, INT ARCH ALLERGY IMM, V151, P297, DOI 10.1159/000250438; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zijlstra GJ, 2012, EUR RESPIR J, V39, P439, DOI 10.1183/09031936.00017911	237	6	6	2	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2022	149	2					467	479		10.1016/j.jaci.2021.12.769	http://dx.doi.org/10.1016/j.jaci.2021.12.769			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YV3IA	34953791				2022-12-18	WOS:000752623200002
J	Badi, YE; Pavel, AB; Pavlidis, S; Riley, JH; Bates, S; Kermani, NZ; Knowles, R; Kolmert, J; Wheelock, CE; Worsley, S; Uddin, M; Alving, K; Bakke, PS; Behndig, A; Caruso, M; Chanez, P; Fleming, LJ; Fowler, SJ; Frey, U; Howarth, P; Horvath, I; Krug, N; Maitland-Van der Zee, AH; Montuschi, P; Roberts, G; Sanak, M; Shaw, DE; Singer, F; Sterk, PJ; Djukanovic, R; Dahlen, SE; Guo, YK; Chung, AF; Guttman-Yassky, E; Adcock, IM				Badi, Yusef Eamon; Pavel, Ana B.; Pavlidis, Stelios; Riley, John H.; Bates, Stewart; Kermani, Nazanin Zounemat; Knowles, Richard; Kolmert, Johan; Wheelock, Craig E.; Worsley, Sally; Uddin, Mohib; Alving, Kjell; Bakke, Per S.; Behndig, Annelie; Caruso, Massimo; Chanez, Pascal; Fleming, Louise J.; Fowler, Stephen J.; Frey, Urs; Howarth, Peter; Horvath, Ildiko; Krug, Norbert; Maitland-van der Zee, Anke H.; Montuschi, Paolo; Roberts, Graham; Sanak, Marek; Shaw, Dominick E.; Singer, Florian; Sterk, Peter J.; Djukanovic, Ratko; Dahlen, Sven-Eric; Guo, Yi-Ke; Chung, Kian Fan; Guttman-Yassky, Emma; Adcock, Ian M.		U-BIOPRED Study Grp	Mapping atopic dermatitis and anti-IL-22 response signatures to type 2-low severe neutrophilic asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Fezakinumab; atopic dermatitis; gene set variation analysis; IL-22; severe asthma	EXPRESSION; INFLAMMATION; CYTOKINES; PACKAGE	Background: Transcriptomic changes in patients who respond clinically to biological therapies may identify responses in other tissues or diseases. Objective: We sought to determine whether a disease signature identified in atopic dermatitis (AD) is seen in adults with severe asthma and whether a transcriptomic signature for patients with AD who respond clinically to anti-IL-22 (fezakinumab [FZ]) is enriched in severe asthma. Methods: An AD disease signature was obtained from analysis of differentially expressed genes between AD lesional and nonlesional skin biopsies. Differentially expressed genes from lesional skin from therapeutic superresponders before and after 12 weeks of FZ treatment defined the FZ-response signature. Gene set variation analysis was used to produce enrichment scores of AD and FZ-response signatures in the Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes asthma cohort. Results: The AD disease signature (112 upregulated genes) encompassing inflammatory, T-cell, T(H)2, and T(H)17/T(H)22 pathways was enriched in the blood and sputum of patients with asthma with increasing severity. Patients with asthma with sputum neutrophilia and mixed granulocyte phenotypes were the most enriched (P < .05). The FZ-response signature (296 downregulated genes) was enriched in asthmatic blood (P < .05) and particularly in neutrophilic and mixed granulocytic sputum (P < .05). These data were confirmed in sputum of the Airway Disease Endotyping for Personalized Therapeutics cohort. IL-22 mRNA across tissues did not correlate with FZ-response enrichment scores, but this response signature correlated with T(H)22/IL-22 pathways. Conclusions: The FZ-response signature in AD identifies severe neutrophilic asthmatic patients as potential responders to FZ therapy. This approach will help identify patients for future asthma clinical trials of drugs used successfully in other chronic diseases.	[Badi, Yusef Eamon; Fleming, Louise J.; Chung, Kian Fan; Adcock, Ian M.] Imperial Coll London, Natl Heart & Lung Inst, Dovehouse St, London SW3 6LY, England; [Badi, Yusef Eamon; Fleming, Louise J.; Chung, Kian Fan; Adcock, Ian M.] NIHR Imperial Biomed Res Ctr, London, England; [Badi, Yusef Eamon; Pavlidis, Stelios; Kermani, Nazanin Zounemat; Guo, Yi-Ke] Imperial Coll London, Data Sci Inst, London, England; [Pavel, Ana B.; Guttman-Yassky, Emma] Icahn Sch Med Mt Sinai, Dept Dermatol, Lab Inflammatory Skin Dis, New York, NY 10029 USA; [Pavel, Ana B.] Univ Mississippi, Dept Biomed Engn, Oxford, MS USA; [Riley, John H.; Bates, Stewart] GSK Resp Therapeut Area Unit, Stevenage, Herts, England; [Knowles, Richard] Knowles Consulting, Stevenage, Herts, England; [Kolmert, Johan; Dahlen, Sven-Eric] Karolinska Inst, Inst Environm Med, Ctr Allergy Res, Stockholm, Sweden; [Kolmert, Johan; Wheelock, Craig E.] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, Stockholm, Sweden; [Worsley, Sally] GSK Value Evidence & Outcomes, Brentford, England; [Uddin, Mohib] AstraZeneca, Resp Global Med Dev, Gothenburg, Sweden; [Alving, Kjell] Uppsala Univ, Dept Womens & Childrens Hlth Paediat Res, Uppsala, Sweden; [Bakke, Per S.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Behndig, Annelie] Umea Univ, Dept Publ Hlth & Clin Med, Div Med Resp Med, Umea, Sweden; [Caruso, Massimo] Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy; [Chanez, Pascal] Aix Marseille Univ, AP HM, Clin Bronches Allergies & Sommeil, Marseille, France; [Fowler, Stephen J.] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Infect Immun & Resp Med, Manchester, Lancs, England; [Fowler, Stephen J.] Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Fowler, Stephen J.] Manchester Univ Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, Manchester, Lancs, England; [Frey, Urs] Univ Basel, Univ Childrens Hosp Basel, Basel, Switzerland; [Howarth, Peter; Roberts, Graham; Djukanovic, Ratko] Univ Southampton, Clin & Expt Sci & Human Dev Hlth, Fac Med, Southampton, Hants, England; [Howarth, Peter; Roberts, Graham; Djukanovic, Ratko] Univ Hosp Southampton NHS Fdn Trust, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Howarth, Peter; Roberts, Graham; Djukanovic, Ratko] St Marys Hosp, David Hide Asthma & Allergy Res Ctr, Newport, Wight, England; [Horvath, Ildiko] Semmelweis Univ, Dept Publ Hlth, Budapest, Hungary; [Krug, Norbert] Fraunhofer ITEM, Hannover, Germany; [Maitland-van der Zee, Anke H.; Sterk, Peter J.] Univ Amsterdam, Dept Resp Med, Amsterdam UMC, Amsterdam, Netherlands; [Montuschi, Paolo] Univ Cattolica Sacro Cuore, Agostino Gemelli Univ Hosp Fdn, Pharmacol, Rome, Italy; [Sanak, Marek] Jagiellonian Univ Med Coll, Dept Internal Med, Krakow, Poland; [Shaw, Dominick E.] Univ Nottingham, NIHR Biomed Res Ctr, Nottingham, England; [Singer, Florian] Univ Bern, Dept Paediat, Div Resp Med, Inselspital, Bern, Switzerland; [Pavlidis, Stelios] Janssen Res & Dev Ltd, High Wycombe, Bucks, England	Imperial College London; Imperial College London; Icahn School of Medicine at Mount Sinai; University of Mississippi; Karolinska Institutet; Karolinska Institutet; AstraZeneca; Uppsala University; University of Bergen; Umea University; University of Catania; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Manchester; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital NHS Foundation Trust; University of Basel; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Semmelweis University; University of Amsterdam; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Nottingham; University of Bern	Adcock, IM (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Dovehouse St, London SW3 6LY, England.	ian.adcock@imperial.ac.uk	郭, 伊可/GYD-3212-2022; kermani, nazanin/HGA-6347-2022; Horváth, Ildikó/GPP-6088-2022; Maitland-van der Zee, Anke/I-9572-2016	Maitland-van der Zee, Anke/0000-0002-0414-3442; Singer, Florian/0000-0003-3471-5664; Howarth, Peter/0000-0003-0619-7927; Zounemat Kermani, Nazanin/0000-0003-2479-3861; Djukanovic, Ratko/0000-0001-6039-5612; chanez, pascal/0000-0003-4059-0917	Biotechnology and Biological Sciences Research Council Studentship (BBSRC-NPIF) [BIDS3000032503]; Innovative Medicines Initiative Joint Undertaking from the European Union's Seventh Framework Programme (FP7/2007-2013) [115010]; 3TR (Taxonomy, Treatment, Targets and Remission) project - Innovative Medicines Initiative 2 Joint Undertaking [831434]; European Federation of Pharmaceutical Industries and Associations	Biotechnology and Biological Sciences Research Council Studentship (BBSRC-NPIF); Innovative Medicines Initiative Joint Undertaking from the European Union's Seventh Framework Programme (FP7/2007-2013); 3TR (Taxonomy, Treatment, Targets and Remission) project - Innovative Medicines Initiative 2 Joint Undertaking; European Federation of Pharmaceutical Industries and Associations	This study was supported by the Biotechnology and Biological Sciences Research Council Studentship (BBSRC-NPIF studentship/BIDS3000032503) to Y.E.B. Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes (U-BIOPRED) was supported by an Innovative Medicines Initiative Joint Undertaking (no. 115010), resources from the European Union's Seventh Framework Programme (FP7/2007-2013), and The European Federation of Pharmaceutical Industries and Associations companies' in-kind contribution (www.imi.europa.eu).We acknowledge the contribution of the whole U-BIOPRED team. S.-E.D. and I.M.A. are supported by the 3TR (Taxonomy, Treatment, Targets and Remission) project funded by the Innovative Medicines Initiative 2 Joint Undertaking (grant agreement no. 831434).	Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Aguilar D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179125; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Araujo AC, 2018, ANTIOXID REDOX SIGN, V29, P275, DOI 10.1089/ars.2017.7332; Athey Brian D, 2013, AMIA Jt Summits Transl Sci Proc, V2013, P6; Aw M, 2020, INT ARCH ALLERGY IMM, V181, P1, DOI 10.1159/000502958; Benjamini Y., 1995, J R STAT SOC B, V57, P289; Besnard AG, 2011, AM J RESP CRIT CARE, V183, P1153, DOI 10.1164/rccm.201008-1383OC; Bhakta NR, 2018, AM J RESP CRIT CARE, V197, P313, DOI 10.1164/rccm.201706-1070OC; Brunner PM, 2019, J ALLERGY CLIN IMMUN, V143, P142, DOI 10.1016/j.jaci.2018.07.028; Bullone M, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00068-2019; Chang Y, 2012, FASEB J, V26, P5152, DOI 10.1096/fj.12-208033; Chang Y, 2011, J ALLERGY CLIN IMMUN, V127, P1046, DOI 10.1016/j.jaci.2010.12.1117; Choy DF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3142; Choy DF, 2012, J ALLERGY CLIN IMMUN, V130, P1335, DOI 10.1016/j.jaci.2012.06.044; Davidson WF, 2019, J ALLERGY CLIN IMMUN, V143, P894, DOI 10.1016/j.jaci.2019.01.003; Dhingra N, 2013, J ALLERGY CLIN IMMUN, V132, P498, DOI 10.1016/j.jaci.2013.04.043; Edqvist PHD, 2015, J HISTOCHEM CYTOCHEM, V63, P129, DOI 10.1369/0022155414562646; Ewald DA, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0133-x; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Gabrijelcic J, 2003, EUR RESPIR J, V22, P290, DOI 10.1183/09031936.03.00098102; Gauthier M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94580; Guttman-Yassky E, 2018, J AM ACAD DERMATOL, V78, P872, DOI 10.1016/j.jaad.2018.01.016; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hay SB, 2018, EXP HEMATOL, V68, P51, DOI 10.1016/j.exphem.2018.09.004; He H, 2021, J ALLERGY CLIN IMMUN, V147, P1369, DOI 10.1016/j.jaci.2020.08.041; He HL, 2020, J ALLERGY CLIN IMMUN, V145, P1615, DOI 10.1016/j.jaci.2020.01.042; Hekking PP, 2018, J ALLERGY CLIN IMMUN, V141, P1280, DOI 10.1016/j.jaci.2017.06.037; Holguin F, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00588-2019; Kolmert J, 2021, AM J RESP CRIT CARE, V203, P37, DOI 10.1164/rccm.201909-1869OC; Kuo CHS, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02135-2016; Kuruvilla ME, 2019, CLIN REV ALLERG IMMU, V56, P219, DOI 10.1007/s12016-018-8712-1; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Leyva-Castillo JM, 2019, J ALLERGY CLIN IMMUN, V143, P619, DOI 10.1016/j.jaci.2018.05.032; Ostling J, 2019, J ALLERGY CLIN IMMUN, V144, P1198, DOI 10.1016/j.jaci.2019.03.027; Ogawa Y, 2008, CURR MOL MED, V8, P437, DOI 10.2174/156652408785160907; Papi A, 2018, LANCET, V391, P783, DOI 10.1016/S0140-6736(17)33311-1; Pavel AB, 2020, J AM ACAD DERMATOL, V82, P690, DOI 10.1016/j.jaad.2019.10.039; Pennino D, 2013, J ALLERGY CLIN IMMUN, V131, P562, DOI 10.1016/j.jaci.2012.09.036; R Core Team, 2021, R LANG ENV STAT COMP; Renert-Yuval Y, 2021, J ALLERGY CLIN IMMUN, V13, P00007; Ricciardolo FLM, 2017, J ALLERGY CLIN IMMUN, V140, P395, DOI 10.1016/j.jaci.2016.10.034; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rossios C, 2018, J ALLERGY CLIN IMMUN, V141, P560, DOI 10.1016/j.jaci.2017.02.045; Shaw DE, 2015, EUR RESPIR J, V46, P1308, DOI 10.1183/13993003.00779-2015; Sherkat R, 2014, ASIA PAC ALLERGY, V4, P212, DOI 10.5415/apallergy.2014.4.4.212; Silkoff PE, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0299-y; Takahashi K, 2011, J ALLERGY CLIN IMMUN, V128, P1067, DOI 10.1016/j.jaci.2011.06.018; Uddin M, 2010, THORAX, V65, P684, DOI 10.1136/thx.2009.120741; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e; Zenewicz Lauren A, 2018, Immunohorizons, V2, P198, DOI 10.4049/immunohorizons.1800006; Zhou LS, 2019, J ALLERGY CLIN IMMUN, V144, P144, DOI 10.1016/j.jaci.2019.01.015	54	6	6	1	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					89	101		10.1016/j.jaci.2021.04.010	http://dx.doi.org/10.1016/j.jaci.2021.04.010			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YJ5AM	33891981	Green Published, Green Submitted			2022-12-18	WOS:000744544500019
J	Gertie, JA; Zhang, BY; Liu, EG; Hoyt, LR; Yin, XY; Xu, L; Long, LL; Soldatenko, A; Gowthaman, U; Williams, A; Eisenbarth, SC				Gertie, Jake A.; Zhang, Biyan; Liu, Elise G.; Hoyt, Laura R.; Yin, Xiangyun; Xu, Lan; Long, Lauren L.; Soldatenko, Arielle; Gowthaman, Uthaman; Williams, Adam; Eisenbarth, Stephanie C.			Oral anaphylaxis to peanut in a mouse model is associated with gut permeability but not with Tlr4 or Dock8 mutations	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						C3H; HeJ; food allergy; anaphylaxis; peanut; TLR4; DOCK8; gut permeability	FOOD ALLERGY; INTESTINAL PERMEABILITY; SENSITIZATION; IGE; RESPONSES; SUSCEPTIBILITY; EPIDEMIOLOGY; PATHOGENESIS; PREVENTION; MICROBIOTA	Objective: We aimed to determine the mechanism underlying the unique susceptibility to anaphylaxis in C3H/HeJ mice. We tested the role of deleterious Toll-like receptor 4 (Tlr4) or dedicator of cytokinesis 8 (Dock8) mutations in this strain because both genes have been associated with food allergy. Methods: We generated C3H/HeJ mice with corrected Dock8 or Tlr4 alleles and sensitized and challenged them with peanut. We then characterized the antibody response to sensitization, anaphylaxis response to both oral and systemic peanut challenge, gut microbiome, and biomarkers of gut permeability. Results: In contrast to C3H/HeJ mice, C57BL/6 mice were resistant to anaphylaxis after oral peanut challenge; however, both strains undergo anaphylaxis with intraperitoneal challenge. Restoring Tlr4 or Dock8 function in C3H/HeJ mice did not protect from anaphylaxis. Instead, we discovered enhanced gut permeability resulting in ingested allergens in the bloodstream in C3H/HeJ mice compared to C57BL/6 mice, which correlated with an increased number of goblet cells in the small intestine. Conclusions: Our work highlights the potential importance of gut permeability in driving anaphylaxis to ingested food allergens; it also indicates that genetic loci outside of Tlr4 and Dock8 are responsible for the oral anaphylactic susceptibility of C3H/HeJ mice. (J Allergy Clin Immunol 2022;149:262-74.)	[Gertie, Jake A.; Zhang, Biyan; Liu, Elise G.; Hoyt, Laura R.; Yin, Xiangyun; Xu, Lan; Soldatenko, Arielle; Gowthaman, Uthaman; Eisenbarth, Stephanie C.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Gertie, Jake A.; Zhang, Biyan; Liu, Elise G.; Hoyt, Laura R.; Yin, Xiangyun; Xu, Lan; Soldatenko, Arielle; Gowthaman, Uthaman; Eisenbarth, Stephanie C.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Liu, Elise G.; Eisenbarth, Stephanie C.] Yale Univ, Sch Med, Sect Rheumatol Allergy & Immunol, New Haven, CT USA; [Zhang, Biyan] Singapore Immunol Network SIgN, Singapore, Singapore; [Long, Lauren L.; Williams, Adam] Jackson Lab Genom Med, Farmington, CT USA; [Williams, Adam] Univ Connecticut, Hlth Ctr, Dept Genet & Genome Sci, Farmington, CT 06032 USA; [Gowthaman, Uthaman] Univ Massachusetts, Med Sch, Dept Pathol, Worcester, MA 01605 USA	Yale University; Yale University; Yale University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Jackson Laboratory; University of Connecticut; University of Massachusetts System; University of Massachusetts Worcester	Eisenbarth, SC (corresponding author), Yale Sch Med, 330 Cedar St,Clin Bldg 407, New Haven, CT 06520 USA.; Williams, A (corresponding author), Univ Connecticut, Jackson Lab Genom Med, Dept Genet & Genome Sci, Hlth Ctr, 10 Discovery Dr, Farmington, CT 06032 USA.	adam.williams@jax.org; stephanie.eisenbarth@yale.edu		Gertie, Jake/0000-0002-3867-1884; Zhang, Biyan/0000-0003-0329-2451; , UTHAMAN GOWTHAMAN/0000-0002-5484-7851	Food Allergy Research Education; Ira & Diana Riklis Family Research Award in Food Allergy; National Institute of Allergy and Infectious Diseases [AI136942]; Colton Foundation [5T32AR007107]; NCATS [UL1TR001863]; National Science Scholarship from Agency for Science, Technology and Research, Singapore	Food Allergy Research Education; Ira & Diana Riklis Family Research Award in Food Allergy; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Colton Foundation; NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Science Scholarship from Agency for Science, Technology and Research, Singapore	Funding for this study was provided by Food Allergy Research & Education, The Ira & Diana Riklis Family Research Award in Food Allergy (to S.C.E.) , National Institute of Allergy and Infectious Diseases grant AI136942 (to S.C.E.) , a gift from the Colton Foundation (to S.C.E.) , 5T32AR007107 (to E.G.L.) , NCATS grant UL1TR001863 (to E.G.L.) , National Science Scholarship from Agency for Science, Technology and Research, Singapore (to B.Z.) , and a generous philanthropic gift from Francoise Haasch-Jones and Rhett Jones (to A.W.) .	Abdel-Gadir A, 2019, NAT MED, V25, P1164, DOI 10.1038/s41591-019-0461-z; Azad MB, 2015, CLIN EXP ALLERGY, V45, P632, DOI 10.1111/cea.12487; Bashir MEH, 2004, J IMMUNOL, V172, P6978, DOI 10.4049/jimmunol.172.11.6978; Benede S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190453; Berin MC, 2006, ALLERGY, V61, P64, DOI 10.1111/j.1398-9995.2006.01012.x; Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7; Boos AC, 2014, ALLERGY, V69, P943, DOI 10.1111/all.12416; Capobianco F, 2008, INT IMMUNOL, V20, P1077, DOI 10.1093/intimm/dxn065; Chen JS, 2021, J ALLERGY CLIN IMMUN, V147, P470, DOI 10.1016/j.jaci.2020.04.063; Engelhardt KR, 2015, J ALLERGY CLIN IMMUN, V136, P402, DOI 10.1016/j.jaci.2014.12.1945; Feehley T, 2019, NAT MED, V25, P448, DOI 10.1038/s41591-018-0324-z; Finkelman FD, 2005, J ALLERGY CLIN IMMUN, V115, P449, DOI 10.1016/j.jaci.2004.12.1125; Gowthaman U, 2019, SCIENCE, V365, P883, DOI 10.1126/science.aaw6433; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; Kearney CJ, 2017, CELL MOL IMMUNOL, V14, P406, DOI 10.1038/cmi.2017.9; Krishnaswamy JK, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam9169; Krishnaswamy JK, 2015, P NATL ACAD SCI USA, V112, P3056, DOI 10.1073/pnas.1501554112; LEHRER SB, 1977, IMMUNOLOGY, V32, P507; Li XM, 2000, J ALLERGY CLIN IMMUN, V106, P150, DOI 10.1067/mai.2000.107395; Liu TG, 2016, MOL IMMUNOL, V70, P104, DOI 10.1016/j.molimm.2015.11.011; Lopez-Exposito I, 2012, J DAIRY SCI, V95, P541, DOI 10.3168/jds.2011-4646; Menard S, 2010, MUCOSAL IMMUNOL, V3, P247, DOI 10.1038/mi.2010.5; Morafo V, 2003, J ALLERGY CLIN IMMUN, V111, P1122, DOI 10.1067/mai.2003.1463; Noah TK, 2019, J ALLERGY CLIN IMMUN, V144, P1058, DOI 10.1016/j.jaci.2019.04.030; Orgel K, 2019, J ALLERGY CLIN IMMUN, V143, P1027, DOI 10.1016/j.jaci.2018.10.009; OVARY Z, 1958, J IMMUNOL, V81, P355; Peters A, 2019, P NATL ACAD SCI USA, V116, P14788, DOI 10.1073/pnas.1909224116; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rachid R, 2016, CURR OPIN PEDIATR, V28, P748, DOI 10.1097/MOP.0000000000000427; Schulke S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060546; Sicherer SH, 2018, J ALLERGY CLIN IMMUN, V141, P41, DOI 10.1016/j.jaci.2017.11.003; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Singh AK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94275; Smarr CB, 2011, J IMMUNOL, V187, P5090, DOI 10.4049/jimmunol.1100608; Smeekens JM, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.599637; Smit JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028917; Sodhi CP, 2012, GASTROENTEROLOGY, V143, P708, DOI 10.1053/j.gastro.2012.05.053; Stefka AT, 2014, P NATL ACAD SCI USA, V111, P13145, DOI 10.1073/pnas.1412008111; Su HC, 2019, IMMUNOL REV, V287, P9, DOI 10.1111/imr.12723; Su HC, 2011, ANN NY ACAD SCI, V1246, P26, DOI 10.1111/j.1749-6632.2011.06295.x; Venkataraman D, 2014, J ALLERGY CLIN IMMUN, V134, P876, DOI 10.1016/j.jaci.2014.07.033; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Wesemann DR, 2016, IMMUNITY, V44, P728, DOI 10.1016/j.immuni.2016.02.002; Xiong HZ, 2012, J EXP MED, V209, P353, DOI 10.1084/jem.20111941	44	6	6	4	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					262	274		10.1016/j.jaci.2021.05.015	http://dx.doi.org/10.1016/j.jaci.2021.05.015			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YE9QV	34051223				2022-12-18	WOS:000741453800008
J	Tjalvin, G; Svanes, O; Igland, J; Bertelsen, RJ; Benediktsdottir, B; Dharmage, S; Forsberg, B; Holm, M; Janson, C; Jogi, NO; Johannessen, A; Malinovschi, A; Pape, K; Real, FG; Sigsgaard, T; Toren, K; Vindenes, HK; Zock, JP; Schlunssen, V; Svanes, C				Tjalvin, Gro; Svanes, Oistein; Igland, Jannicke; Jacobsen Bertelsen, Randi; Benediktsdottir, Bryndis; Dharmage, Shyamali; Forsberg, Bertil; Holm, Mathias; Janson, Christer; Oskar Jogi, Nils; Johannessen, Ane; Malinovschi, Andrei; Pape, Kathrine; Gomez Real, Francisco; Sigsgaard, Torben; Toren, Kjell; Kristin Vindenes, Hilde; Zock, Jan-Paul; Schlunssen, Vivi; Svanes, Cecilie			Maternal preconception occupational exposure to cleaning products and disinfectants and offspring asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Occupational exposures; preconception exposures; Job-Exposure Matrix (JEM); disinfectants; cleaning products; mother; childhood asthma; generation study; RHINESSA	PARENTAL OCCUPATION; ONSET ASTHMA; RISK; INHERITANCE; ENVIRONMENT; CHILDREN; ALLERGY	Background: Emerging research suggests health effects in offspring after parental chemical exposures before conception. Many future mothers are exposed to potent chemicals at work, but potential offspring health effects are hardly investigated. Objective: We sought to investigate childhood asthma in relation to mother's occupational exposure to cleaning products and disinfectants before conception. Methods: The multicenter Respiratory Health In Northern Europe/Respiratory Health In Northern Europe, Spain and Australia generation study investigated asthma and wheeze starting at age less than 10 years in 3318 mother-offspring pairs. From an asthma-specific Job-Exposure Matrix and mothers' occupational history, we defined maternal occupational exposure to indoor cleaning agents (cleaning products/detergents and disinfectants) starting before conception, in the 2-year period around conception and pregnancy, or after birth. Never-employed mothers were excluded. Exposed groups include cleaners, health care workers, cooks, and so forth. Associations were analyzed using mixed-effects logistic regression and ordinary logistic regression with clustered robust SEs and adjustment for maternal education. Results: Maternal occupational exposure to indoor cleaning starting preconception and continuing (n = 610) was associated with offspring's childhood asthma: odds ratio 1.56 (95% CI, 1.05-2.31), childhood asthma with nasal allergies: 1.77 (1.13-2.77), and childhood wheeze and/or asthma: 1.71 (95% CI, 1.19-2.44). Exposure starting around conception and pregnancy (n = 77) was associated with increased childhood wheeze and/or asthma: 2.25 (95% CI, 1.03-4.91). Exposure starting after birth was not associated with asthma outcomes (1.13 [95% CI, 0.71-1.80], 1.15 [95% CI, 0.67-1.97], 1.08 [95% CI, 0.69-1.67]). Conclusions: Mother's occupational exposure to indoor cleaning agents starting before conception, or around conception and pregnancy, was associated with more childhood asthma and wheeze in offspring. Considering potential implications for vast numbers of women in childbearing age using cleaning agents, and their children, further research is imperative.	[Tjalvin, Gro; Igland, Jannicke; Johannessen, Ane] Univ Bergen, Dept Global Publ Hlth & Primary Care, POB 7804, N-5020 Bergen, Norway; [Tjalvin, Gro; Svanes, Oistein; Oskar Jogi, Nils; Kristin Vindenes, Hilde; Svanes, Cecilie] Haukeland Hosp, Dept Occupat Med, Bergen, Norway; [Svanes, Oistein; Jacobsen Bertelsen, Randi; Oskar Jogi, Nils; Gomez Real, Francisco; Kristin Vindenes, Hilde] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Igland, Jannicke] Western Norway Univ Appl Sci, Fac Hlth & Social Sci, Dept Hlth & Caring Sci, Bergen, Norway; [Jacobsen Bertelsen, Randi] Oral Hlth Ctr Expertise Western Norway, Bergen, Norway; [Benediktsdottir, Bryndis] Univ Iceland, Med Fac, Reykjavik, Iceland; [Benediktsdottir, Bryndis] Landspitali Univ Hosp Reykjavik, Dept Sleep, Reykjavik, Iceland; [Dharmage, Shyamali] Univ Melbourne, Allergy & Lung Hlth Unit, Melbourne, Vic, Australia; [Forsberg, Bertil] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Holm, Mathias; Toren, Kjell] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Occupat & Environm Med,Sch Publ Hlth & Community, Gothenburg, Sweden; [Janson, Christer] Uppsala Univ, Dept Med Sci Resp Allergy & Sleep Res, Uppsala, Sweden; [Oskar Jogi, Nils] Tartu Univ, Lung Clin, Tartu, Estonia; [Malinovschi, Andrei] Uppsala Univ, Dept Med Sci Clin Physiol, Uppsala, Sweden; [Pape, Kathrine; Schlunssen, Vivi] Natl Res Ctr Working Environm, Aarhus, Denmark; [Pape, Kathrine; Sigsgaard, Torben; Schlunssen, Vivi] Aarhus Univ, Dept Publ Hlth, Environm Work & Hlth, Danish Ramazzini Ctr, Aarhus, Denmark; [Gomez Real, Francisco] Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway; [Zock, Jan-Paul] ISGlobal, Barcelona, Spain; [Zock, Jan-Paul] Univ Pompeu Fabra UPF, Barcelona, Spain; [Zock, Jan-Paul] GIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Svanes, Cecilie] Univ Bergen, Dept Global Publ Hlth & Primary Care, Ctr Int Hlth, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Western Norway University of Applied Sciences; University of Iceland; Landspitali National University Hospital; University of Melbourne; Umea University; University of Gothenburg; University of Tartu; Uppsala University; National Research Centre for the Working Environment; Aarhus University; University of Bergen; Haukeland University Hospital; ISGlobal; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Bergen	Tjalvin, G (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, POB 7804, N-5020 Bergen, Norway.	gro.tjalvin@uib.no		Schlunssen, Vivi/0000-0003-4915-1734; Gomez Real, Francisco/0000-0001-5407-3270; Sigsgaard, Torben/0000-0002-2043-7571; Jogi, Nils Oskar/0000-0002-9600-1950	Research Council of Norway [214123, 228174]; Bergen Medical Research Foundation; Western Norwegian Regional Health Authorities [912011, 911892, 911631]; Norwegian Labour Inspection; Norwegian Asthma and Allergy Association; Danish Wood Foundation [444508795]; Danish Working Environment Authority [20150067134]; Swedish Heart and Lung Foundation; Swedish Asthma and Allergy Association; Estonian Research Council [PUT562]; Norwegian Research Council; Danish Lung Association; Vardal Foundation for Health Care Science and Allergy Research; Swedish Association Against Asthma and Allergy; Swedish Association Against Heart and Lung Disease; Swedish Council for Working Life and Social Research; Icelandic Research Council; Estonian Science Foundation	Research Council of Norway(Research Council of Norway); Bergen Medical Research Foundation; Western Norwegian Regional Health Authorities; Norwegian Labour Inspection; Norwegian Asthma and Allergy Association; Danish Wood Foundation; Danish Working Environment Authority; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Asthma and Allergy Association; Estonian Research Council(Estonian Research Council); Norwegian Research Council(Research Council of NorwayEuropean Commission); Danish Lung Association; Vardal Foundation for Health Care Science and Allergy Research; Swedish Association Against Asthma and Allergy; Swedish Association Against Heart and Lung Disease; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Icelandic Research Council; Estonian Science Foundation	The RHINESSA generation study received funding by the Research Council of Norway (grants nos. 214123 and 228174), the Bergen Medical Research Foundation, theWestern Norwegian Regional Health Authorities (grant nos. 912011, 911892, and 911631), the Norwegian Labour Inspection, the Norwegian Asthma and Allergy Association, the Danish Wood Foundation (grant no. 444508795), the Danish Working Environment Authority (grant no. 20150067134), the Swedish Heart and Lung Foundation, the Swedish Asthma and Allergy Association, and the Estonian Research Council (grant no. PUT562). The Respiratory Health In Northern Europe study received funding by the Norwegian Research Council, the Norwegian Asthma and Allergy Association, the Danish Lung Association, the Swedish Heart and Lung Foundation, the Vardal Foundation for Health Care Science and Allergy Research, the Swedish Association Against Asthma and Allergy, the Swedish Association Against Heart and Lung Disease, the Swedish Council for Working Life and Social Research, the Icelandic Research Council, and the Estonian Science Foundation. The funding agencies had no direct role in the conduct of the study, the collection, management, statistical analysis, and interpretation of the data, or preparation/approval of the manuscript.	Accordini S, 2021, EUR RESPIR J, V58, DOI 10.1183/13993003.02791-2020; Accordini S, 2018, INT J EPIDEMIOL, V47, P1106, DOI 10.1093/ije/dyy031; [Anonymous], 2018, CHALLENGES MDPI; Armstrong BG, 1998, OCCUP ENVIRON MED, V55, P651, DOI 10.1136/oem.55.10.651; Bobolea I, 2019, J INVEST ALLERG CLIN, V29, P168, DOI 10.18176/jiaci.0361; Capra L, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-7; Carder M, 2019, OCCUP ENVIRON MED, V76, P530, DOI 10.1136/oemed-2018-105646; Casas L, 2013, INT J PUBLIC HEALTH, V58, P757, DOI 10.1007/s00038-012-0417-2; Christensen BH, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002401; Clausen PA, 2020, INT J HYG ENVIR HEAL, V229, DOI 10.1016/j.ijheh.2020.113592; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Fedak KM, 2015, EMERG THEMES EPIDEMI, V12, DOI 10.1186/s12982-015-0037-4; Folletti I, 2017, CURR OPIN ALLERGY CL, V17, P90, DOI 10.1097/ACI.0000000000000349; Folletti I, 2014, J ASTHMA, V51, P18, DOI 10.3109/02770903.2013.833217; Godfrey KM, 2015, J DEV ORIG HLTH DIS, V6, P399, DOI 10.1017/S204017441500121X; Griffiths SK, 2015, BJA EDUC, V15, P84, DOI 10.1093/bjaceaccp/mku013; Hammer B, 2021, INT J OBESITY, V45, P1623, DOI 10.1038/s41366-021-00798-2; Hammer B, 2018, CLIN EXP ALLERGY, V48, P1378, DOI 10.1111/cea.13283; Holt PG, 2012, CURR OPIN ALLERGY CL, V12, P151, DOI 10.1097/ACI.0b013e3283520166; ILO, 1988, INT STANDARD CLASSIF; Johannessen A, 2020, J ALLERGY CLIN IMMUN, V145, P791, DOI 10.1016/j.jaci.2019.08.030; Knudsen GTM, 2019, ENVIRON EPIGENETICS, V5, DOI 10.1093/eep/dvz023; Knudsen TM, 2018, J ALLERGY CLIN IMMUN, V142, P765, DOI [10.1016/j.jaci..2018.07.007, 10.1016/j.jaci.2018.07.007]; Kuiper IN, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0687-4; Kuiper IN, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165828; La Merrill M, 2013, ENVIRON HEALTH PERSP, V121, P162, DOI 10.1289/ehp.1205485; Le Moual N, 2018, OCCUP ENVIRON MED, V75, P507, DOI 10.1136/oemed-2017-104866; Lederer DJ, 2019, ANN AM THORAC SOC, V16, P22, DOI 10.1513/AnnalsATS.201808-564PS; Lewis KM, 2017, EUR J EPIDEMIOL, V32, P797, DOI 10.1007/s10654-017-0309-0; Li XJ, 2009, J ASTHMA, V46, P815, DOI 10.3109/02770900903141260; Lillienberg L, 2013, ANN OCCUP HYG, V57, P482, DOI 10.1093/annhyg/mes083; Martin EM, 2018, ANNU REV PUBL HEALTH, V39, P309, DOI 10.1146/annurev-publhealth-040617-014629; Midodzi WK, 2010, J ASTHMA, V47, P7, DOI 10.3109/02770900903380996; Nilsson EE, 2015, TRANSL RES, V165, P12, DOI 10.1016/j.trsl.2014.02.003; Pape K, 2020, INT J EPIDEMIOL, V49, P1856, DOI 10.1093/ije/dyaa085; Parsons MA, 2017, J ASTHMA, V54, P239, DOI 10.1080/02770903.2016.1206564; Pembrey M, 2014, J MED GENET, V51, P563, DOI 10.1136/jmedgenet-2014-102577; Rava M, 2017, ENVIRON HEALTH PERSP, V125, P207, DOI 10.1289/EHP376; Siracusa A, 2013, ALLERGY, V68, P1532, DOI 10.1111/all.12279; Soubry A, 2014, BIOESSAYS, V36, P359, DOI 10.1002/bies.201300113; Strina A, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-5; Svanes C, 2017, INT J EPIDEMIOL, V46, P235, DOI 10.1093/ije/dyw151; Svanes O, 2018, AM J RESP CRIT CARE, V197, P1157, DOI 10.1164/rccm.201706-1311OC; Svanes O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131959; Tagiyeva N, 2010, EUR RESPIR J, V35, P987, DOI 10.1183/09031936.00050009; Textor J, 2016, INT J EPIDEMIOL, V45, P1887, DOI 10.1093/ije/dyw341; Timm S, 2020, INT J EPIDEMIOL, V49, P1874, DOI 10.1093/ije/dyaa091; Tun MH, 2018, CAN MED ASSOC J, V190, pE1097, DOI 10.1503/cmaj.170809; Zock JP, 2007, AM J RESP CRIT CARE, V176, P735, DOI 10.1164/rccm.200612-1793OC	49	6	6	2	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					422	+		10.1016/j.jaci.2021.08.025	http://dx.doi.org/10.1016/j.jaci.2021.08.025			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YO4PH	34674855	Green Published, hybrid			2022-12-18	WOS:000747922700011
J	Miller, RL; Grayson, MH; Strothman, K				Miller, Rachel L.; Grayson, Mitchell H.; Strothman, Kasey			Advances in asthma: New understandings of asthma's natural history, risk factors, underlying mechanisms, and clinical management	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; biomarkers; genetics; microbiome; viral infec-tions; cytokines; tryptase; T cells; innate lymphoid cells; macro-phages; epithelium; scoring systems; airway physiology; biologics	RHINOVIRUS; CHILDREN; ASSOCIATION; EXPOSURE; INDUCE; ADULTS	The last 2 years yielded a proliferation of high-quality asthma research. These include new understandings of the incidence and natural history of asthma, findings on the effects of exposure to air pollution, allergens, and intake of acetaminophen, soy isoflavones, and polyunsaturated fatty acids, and exposure to microbial products. The past 2 years have benefited from great strides in determining potential mechanisms of asthma development and asthma exacerbations. These novel understandings led to identification and development of exciting new avenues for potential therapeutic intervention. Finally, there has been significant progress made in the development of tools to facilitate the diagnosis of asthma and measurement of airway physiology and in precision diagnostic approaches. Asthma guidelines were updated and new insights into the pharmacologic management of patients, including biologics, were reported. We review the most notable advances in the natural history of asthma, risk factors for the development of asthma, underlying mechanisms, diagnostic approaches, and treatments. Although greater knowledge of the mechanisms underlying responses and nonresponses to novel therapeutics and across asthma phenotypes would be beneficial, the progress over just the past 2 years has been immense and impactful.	[Miller, Rachel L.] Icahn Sch Med Mt Sinai, Div Clin Immunol, Dept Med, New York, NY 10029 USA; [Grayson, Mitchell H.; Strothman, Kasey] Ohio State Univ, Coll Med, Div Allergy & Immunol, Dept Pediat,Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Grayson, Mitchell H.] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Clin & Translat Res, Columbus, OH USA	Icahn School of Medicine at Mount Sinai; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Miller, RL (corresponding author), Icahn Sch Med Mt Sinai, Div Clin Immunol, One Gustave L Levy Pl, New York, NY 10029 USA.	Rachel.miller2@mssm.edu						Abdel-Aziz MI, 2020, J ALLERGY CLIN IMMUN, V146, P1045, DOI 10.1016/j.jaci.2020.05.038; Ahmed A, 2020, J ALLER CL IMM-PRACT, V8, P596, DOI 10.1016/j.jaip.2019.08.044; Bell AJ, 2019, J ALLERGY CLIN IMMUN, V144, P83, DOI 10.1016/j.jaci.2019.01.014; Biagini Myers JM, 2019, J ALLERGY CLIN IMMUN, V143, P1803, DOI 10.1016/j.jaci.2018.09.037; Branchett WJ, 2020, J ALLERGY CLIN IMMUN, V145, P666, DOI 10.1016/j.jaci.2019.08.006; Brightling CE, 2021, LANCET RESP MED, V9, P43, DOI 10.1016/S2213-2600(20)30412-4; Brinkman P, 2019, J ALLERGY CLIN IMMUN, V143, P1811, DOI 10.1016/j.jaci.2018.10.058; Bui DS, 2020, LANCET RESP MED, V9, P387, DOI 10.1016/S2213-2600(20)30413-6; Busse WW, 2021, J ALLERGY CLIN IMMUN, V148, P266, DOI 10.1016/j.jaci.2021.02.009; Busse WW, 2019, LANCET RESP MED, V7, P46, DOI 10.1016/S2213-2600(18)30406-5; Chaudhuri R, 2021, LANCET RESP MED, V9, P457, DOI 10.1016/S2213-2600(20)30408-2; Chen X, 2019, J ALLERGY CLIN IMMUN, V143, P2038, DOI 10.1016/j.jaci.2018.12.999; Chhiba KD, 2020, J ALLERGY CLIN IMMUN, V146, P307, DOI 10.1016/j.jaci.2020.06.010; Chuang YT, 2019, J ALLERGY CLIN IMMUN, V143, P565, DOI 10.1016/j.jaci.2018.03.022; Cloutier MM, 2020, J ALLERGY CLIN IMMUN, V146, P1217, DOI 10.1016/j.jaci.2020.10.003; Dai X, 2020, J ALLERGY CLIN IMMUN, V146, P1035, DOI 10.1016/j.jaci.2020.03.027; Durack J, 2020, J ALLERGY CLIN IMMUN, V146, P1016, DOI 10.1016/j.jaci.2020.03.028; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Fitzpatrick AM, 2020, J ALLERGY CLIN IMMUN, V145, P127, DOI 10.1016/j.jaci.2019.09.018; Galle-Treger L, 2020, J ALLERGY CLIN IMMUN, V145, P502, DOI 10.1016/j.jaci.2019.10.035; Gordon EM, 2019, J ALLERGY CLIN IMMUN, V144, P426, DOI 10.1016/j.jaci.2019.02.027; Grant T, 2020, J ALLERGY CLIN IMMUN, V145, P646, DOI 10.1016/j.jaci.2019.08.043; Grossman NL, 2019, J ALLERGY CLIN IMMUN, V144, P1524, DOI 10.1016/j.jaci.2019.08.033; Hallmark B, 2021, AM J RESP CRIT CARE, V203, P864, DOI 10.1164/rccm.202003-0820OC; Hauptman M, 2020, J ALLERGY CLIN IMMUN, V145, P119, DOI 10.1016/j.jaci.2019.08.038; Heymann PW, 2020, J ALLERGY CLIN IMMUN, V146, P545, DOI 10.1016/j.jaci.2020.01.035; Inoue H, 2019, J ALLERGY CLIN IMMUN, V143, P2075, DOI 10.1016/j.jaci.2018.11.046; Jevnikar Z, 2019, J ALLERGY CLIN IMMUN, V143, P577, DOI 10.1016/j.jaci.2018.05.026; Johannessen A, 2020, J ALLERGY CLIN IMMUN, V145, P791, DOI 10.1016/j.jaci.2019.08.030; Johnson CC, 2021, J ALLERGY CLIN IMMUN, V148, P1270, DOI 10.1016/j.jaci.2021.04.027; Ketelaar ME, 2021, J ALLERGY CLIN IMMUN, V147, P144, DOI 10.1016/j.jaci.2020.04.051; Khatri S, 2019, J ALLERGY CLIN IMMUN, V143, P1742, DOI 10.1016/j.jaci.2018.09.033; Kicic A, 2020, J ALLERGY CLIN IMMUN, V145, P1562, DOI 10.1016/j.jaci.2020.02.018; Kim J, 2019, J ALLERGY CLIN IMMUN, V143, P1769, DOI 10.1016/j.jaci.2018.10.040; Korde A, 2020, J ALLERGY CLIN IMMUN, V145, P550, DOI 10.1016/j.jaci.2019.10.031; Kumar R, 2020, J ALLERGY CLIN IMMUN, V146, DOI 10.1016/j.jaci.2020.04.019; Kyogoku Y, 2019, J ALLERGY CLIN IMMUN, V144, P972, DOI 10.1016/j.jaci.2019.04.023; Lee SW, 2019, J ALLERGY CLIN IMMUN, V144, P1542, DOI 10.1016/j.jaci.2019.08.037; Lee-Sarwar KA, 2019, J ALLERGY CLIN IMMUN, V144, P442, DOI 10.1016/j.jaci.2019.02.032; Levin AM, 2019, J ALLERGY CLIN IMMUN, V143, P1791, DOI 10.1016/j.jaci.2018.09.034; Lovinsky-Desir S, 2020, J ALLERGY CLIN IMMUN, V146, P1027, DOI 10.1016/j.jaci.2020.07.026; Ma M, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.718779; Manson ML, 2020, J ALLERGY CLIN IMMUN, V145, P808, DOI 10.1016/j.jaci.2019.10.037; Maun HR, 2019, CELL, V179, P417, DOI 10.1016/j.cell.2019.09.009; McCauley K, 2019, J ALLERGY CLIN IMMUN, V144, P1187, DOI 10.1016/j.jaci.2019.05.035; Menzies-Gow A, 2021, NEW ENGL J MED, V384, P1800, DOI 10.1056/NEJMoa2034975; Muehling LM, 2020, J ALLERGY CLIN IMMUN, V146, P555, DOI 10.1016/j.jaci.2020.03.037; Namazy JA, 2020, J ALLERGY CLIN IMMUN, V145, P528, DOI 10.1016/j.jaci.2019.05.019; Ning FK, 2019, J ALLERGY CLIN IMMUN, V143, P2026, DOI 10.1016/j.jaci.2018.11.049; O'Byrne PM, 2021, LANCET RESP MED, V9, P149, DOI 10.1016/S2213-2600(20)30416-1; Ober C, 2020, LANCET RESP MED, V8, P482, DOI 10.1016/S2213-2600(20)30011-4; Patrick DM, 2020, LANCET RESP MED, V8, P1094, DOI 10.1016/S2213-2600(20)30052-7; Permaul P, 2020, J ALLERGY CLIN IMMUN, V146, P813, DOI 10.1016/j.jaci.2020.03.003; Persson EK, 2019, SCIENCE, V364, P751, DOI 10.1126/science.aaw4295; Pividori M, 2019, LANCET RESP MED, V7, P509, DOI 10.1016/S2213-2600(19)30055-4; Pomes A, 2019, J ALLERGY CLIN IMMUN, V144, P935, DOI 10.1016/j.jaci.2019.05.036; Qi CC, 2020, J ALLERGY CLIN IMMUN, V145, P1655, DOI [10.1016/j.jaci.2020.12.911, 10.1016/j.jaci.2019.12.911]; Rajput C, 2020, J ALLERGY CLIN IMMUN, V146, P571, DOI 10.1016/j.jaci.2020.03.039; Ravanetti L, 2019, J ALLERGY CLIN IMMUN, V143, P1355, DOI 10.1016/j.jaci.2018.08.051; Reese SE, 2019, J ALLERGY CLIN IMMUN, V143, P2062, DOI 10.1016/j.jaci.2018.11.043; Rosa MJ, 2020, J ALLERGY CLIN IMMUN, V145, P800, DOI 10.1016/j.jaci.2019.10.039; Ross KR, 2020, J ALLERGY CLIN IMMUN, V145, P140, DOI 10.1016/j.jaci.2019.09.030; Saku A, 2019, J ALLERGY CLIN IMMUN, V144, P698, DOI 10.1016/j.jaci.2019.05.010; Schofield JPR, 2019, J ALLERGY CLIN IMMUN, V144, P70, DOI 10.1016/j.jaci.2019.03.013; Sharma A, 2019, J ALLERGY CLIN IMMUN, V144, P1214, DOI 10.1016/j.jaci.2019.06.025; Shrine N, 2019, LANCET RESP MED, V7, P20, DOI 10.1016/S2213-2600(18)30389-8; Sordillo JE, 2020, J ALLERGY CLIN IMMUN, V145, P716, DOI 10.1016/j.jaci.2019.10.026; Sordillo JE, 2019, J ALLERGY CLIN IMMUN, V144, P1534, DOI 10.1016/j.jaci.2019.07.044; Tam JS, 2013, J ALLERGY CLIN IMMUN, V132, P1241, DOI 10.1016/j.jaci.2013.07.011; Tang HHF, 2021, J ALLERGY CLIN IMMUN, V147, P1683, DOI 10.1016/j.jaci.2020.10.009; Thio CLP, 2019, J ALLERGY CLIN IMMUN, V144, P682, DOI 10.1016/j.jaci.2019.03.008; van Zyl-Smit RN, 2020, LANCET RESP MED, V8, P987, DOI 10.1016/S2213-2600(20)30178-8; Vince N, 2020, J ALLERGY CLIN IMMUN, V146, P147, DOI 10.1016/j.jaci.2020.01.011; Visness CM, 2019, J ALLERGY CLIN IMMUN, V144, P866, DOI 10.1016/j.jaci.2019.05.025; Wang AL, 2019, J ALLERGY CLIN IMMUN, V143, P1752, DOI 10.1016/j.jaci.2018.09.038; Wechsler ME, 2019, NEW ENGL J MED, V381, P1227, DOI 10.1056/NEJMoa1905560; Weinstein CLJ, 2019, J ALLERGY CLIN IMMUN, V143, P1395, DOI 10.1016/j.jaci.2018.10.065; Winkler C, 2019, J ALLERGY CLIN IMMUN, V144, P61, DOI 10.1016/j.jaci.2019.01.027; Yu SH, 2019, J ALLERGY CLIN IMMUN, V144, P94, DOI 10.1016/j.jaci.2018.12.1022; Zhu J, 2019, J ALLERGY CLIN IMMUN, V143, P114, DOI 10.1016/j.jaci.2018.04.003; Zhu ZZ, 2020, J ALLERGY CLIN IMMUN, V145, P537, DOI 10.1016/j.jaci.2019.09.035	81	6	7	8	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2021	148	6					1430	1441		10.1016/j.jaci.2021.10.001	http://dx.doi.org/10.1016/j.jaci.2021.10.001		DEC 2021	12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XM1ZO	34655640				2022-12-18	WOS:000728634000007
J	Fang, L; Li, JL; Papakonstantinou, E; Karakioulaki, M; Sun, QZ; Schumann, D; Tamm, M; Stolz, D; Roth, M				Fang, Lei; Li, Junling; Papakonstantinou, Eleni; Karakioulaki, Meropi; Sun, Qingzhu; Schumann, Desiree; Tamm, Michael; Stolz, Daiana; Roth, Michael			Secreted heat shock proteins control airway remodeling: Evidence from bronchial thermoplasty	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; airway wall remodeling; bronchial thermoplasty; HSP70; HSP90; epithelial cells; airway smooth muscle cells	EXTRACELLULAR HSP70; SMOOTH-MUSCLE; EPITHELIAL-CELLS; MOUSE MODEL; ASTHMA; HEAT-SHOCK-PROTEIN-70; RECEPTOR; MODERATE; HSP90; MILD	Background: Increased airway smooth muscle mass is a key pathology in asthma. Bronchial thermoplasty is a treatment for severe asthma based on selective heating of the airways that aims to reduce the mass of airway smooth muscle cells (ASMCs), and thereby bronchoconstriction. However, short heat exposure is insufficient to explain the long-lasting effect, and heat shock proteins (HSPs) have been suggested to play a role. Objective: We sought to determine the role of HSP70 and HSP90 in the control of airway wall remodeling by bronchial thermoplasty. Methods: Bronchoalveolar lavage fluid and endobronchial biopsies of 20 patients with severe asthma were obtained before and after thermoplasty. Isolated epithelial cells and ASMCs were exposed to 65 degrees C for 10 seconds, mimicking thermoplasty. Proteins were determined by immunohistochemistry, Western blotting, immunofluorescence, and ELISA; proliferation by cell counts and antigen Ki67 (MKI67) expression. Results: Thermoplasty significantly increased the expression of HSP70 and HSP90 in the epithelium and bronchoalveolar lavage fluid. In ASMCs, thermoplasty reduced both HSPs. These cell-type-specific effects were detectable even 1 month after thermoplasty in tissue sections. In epithelial cells, ex vivo exposure to heat (65 degrees C, 10 seconds) increased the expression and secretion of HSP70 and HSP90. In addition, epithelial cell proliferation was upregulated by heat or treatment with human recombinant HSP70 or HSP90. In ASMCs, heat exposure or exogenous HSPs reduced proliferation and differentiation. In both cell types, HSP70 and HSP90 activated the signaling cascade of serine/threonine-protein kinase -> mammalian target of rapamycin -> ribosomal protein S6 kinase 1 and CCAAT/enhancer binding protein-beta -> protein arginine methyltransferase 1 -> mitochondria activity. Conclusions: Epithelial cell-derived HSP70 and HSP90 improve the function of epithelial cells, but block ASMC remodeling.	[Fang, Lei; Li, Junling; Papakonstantinou, Eleni; Karakioulaki, Meropi; Schumann, Desiree; Tamm, Michael; Stolz, Daiana; Roth, Michael] Univ Basel, Dept Biomed, Pulm Cell Res & Clin Resp Med, CH-4031 Basel, Switzerland; [Fang, Lei; Li, Junling; Papakonstantinou, Eleni; Karakioulaki, Meropi; Schumann, Desiree; Tamm, Michael; Stolz, Daiana; Roth, Michael] Univ Hosp Basel, CH-4031 Basel, Switzerland; [Li, Junling] Southern Med Univ, Affiliated Dongguan Shilong Peoples Hosp, Guangzhou, Guangdong, Peoples R China; [Sun, Qingzhu] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China	University of Basel; University of Basel; Southern Medical University - China; Northwest A&F University - China	Roth, M (corresponding author), Univ Basel, Dept Biomed, Pulm Cell Res & Clin Resp Med, CH-4031 Basel, Switzerland.; Roth, M (corresponding author), Univ Hosp Basel, CH-4031 Basel, Switzerland.	michael.roth@usb.ch	Roth, Michael/H-8657-2019	Roth, Michael/0000-0002-8139-2821; Stolz, Daiana/0000-0003-0099-882X	Swiss National Science Foundation [SNF 310030_192470]; Lungenliga Schweiz [2017-02_Roth]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Lungenliga Schweiz	This study was funded by a Swiss National Science Foundation grant to M.R. (grant no. SNF 310030_192470) and the Lungenliga Schweiz (grant no. 2017-02_Roth) .	Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Barreca MM, 2017, J CELL PHYSIOL, V232, P1845, DOI 10.1002/jcp.25722; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Bhardwaj M, 2015, LIFE SCI, V142, P36, DOI 10.1016/j.lfs.2015.10.012; Bhatia A, 2016, ADV WOUND CARE, V5, P176, DOI 10.1089/wound.2014.0620; Bonato M, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081180; Borges TJ, 2013, INT J HYPERTHER, V29, P455, DOI 10.3109/02656736.2013.798037; Burn J, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026742; Chakir J, 2015, ANN AM THORAC SOC, V12, P1612, DOI 10.1513/AnnalsATS.201504-208OC; Chernyavsky IL, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01680-2017; d'Hooghe JNS, 2019, CLIN EXP ALLERGY, V49, P541, DOI 10.1111/cea.13365; Donovan GM, 2018, AM J RESP CELL MOL, V59, P355, DOI 10.1165/rcmb.2018-0011OC; Duhamel David R, 2010, J Vis Exp, DOI 10.3791/2428; Eisenmann S, 2019, LUNG, V197, P493, DOI 10.1007/s00408-019-00240-5; Fang L, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040875; Goswami S, 2003, INVEST OPHTH VIS SCI, V44, P2084, DOI 10.1167/iovs.02-0882; Gross C, 2003, CELL STRESS CHAPERON, V8, P348, DOI 10.1379/1466-1268(2003)008<0348:HSPRIA>2.0.CO;2; Gusev NB, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1112, DOI 10.1023/A:1012480829618; Hosseini SA, 2018, RESP MED, V145, P28, DOI 10.1016/j.rmed.2018.10.016; Hou CC, 2011, CELL STRESS CHAPERON, V16, P663, DOI 10.1007/s12192-011-0271-9; Hulina-Tomaskovic A, 2018, EXP PHYSIOL, V103, P1704, DOI 10.1113/EP087180; Ichikawa T, 2019, RESP MED, V150, P165, DOI 10.1016/j.rmed.2019.03.005; Kikuchi K, 2013, J INVEST MED, V61, P708, DOI 10.2310/JIM.0b013e3182857d6c; Kong FZ, 2016, IN VITRO CELL DEV-AN, V52, P568, DOI 10.1007/s11626-016-0005-5; Lambers C, 2015, PHARMACOL RES, V102, P310, DOI 10.1016/j.phrs.2015.09.010; Langton D, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1132-9; Liao SY, 2019, ERJ OPEN RES, V5, DOI 10.1183/23120541.00123-2018; Liu LL, 2019, ENVIRON TOXICOL, V34, P495, DOI 10.1002/tox.22703; Loffredo LF, 2017, ALLERGY, V72, P1988, DOI 10.1111/all.13222; Loxham M, 2017, J ALLERGY CLIN IMMUN, V139, P1736, DOI 10.1016/j.jaci.2017.04.005; Maile R, 2015, AM J PHYSIOL-LUNG C, V308, pL855, DOI 10.1152/ajplung.00321.2014; Nasr MA, 2019, BIOESSAYS, V41, DOI 10.1002/bies.201900055; Persson C, 2019, J ALLERGY CLIN IMMUN, V143, P1271, DOI 10.1016/j.jaci.2018.07.037; Prakash YS, 2017, AM J RESP CRIT CARE, V195, P247, DOI 10.1164/rccm.201611-2248ST; Pretolani M, 2017, J ALLERGY CLIN IMMUN, V139, P1176, DOI 10.1016/j.jaci.2016.08.009; Raiford KL, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-118; Roth M, 2004, NEW ENGL J MED, V351, P560, DOI 10.1056/NEJMoa021660; Roth M, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/451084; Saglani S, 2017, PAEDIATR RESPIR REV, V24, P11, DOI 10.1016/j.prrv.2017.06.001; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Seeley EJ, 2019, RESPIRATION, V98, P165, DOI 10.1159/000499404; Shevchenko MA, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1384, DOI 10.1134/S0006297916110158; Steelant B, 2019, J ALLERGY CLIN IMMUN, V144, P1242, DOI 10.1016/j.jaci.2019.04.027; Sun QZ, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.003OO-2019; Sun QZ, 2019, J IMMUNOL, V202, P37, DOI 10.4049/jimmunol.1800782; Sun QZ, 2017, J ALLERGY CLIN IMMUN, V140, P510, DOI 10.1016/j.jaci.2016.11.013; Tamaki K, 2011, DIGEST DIS SCI, V56, P1954, DOI 10.1007/s10620-010-1558-x; Yang M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-18; Yombo DJK, 2019, J BIOL CHEM, V294, P15082, DOI 10.1074/jbc.RA119.009145; Zanon M, 2017, AM J ROENTGENOL, V209, P752, DOI 10.2214/AJR.17.18027; Zhang GH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00726-x; Zininga T, 2018, MOLECULES, V23, DOI 10.3390/molecules23112846	52	6	6	2	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2021	148	5					1249	+		10.1016/j.jaci.2021.02.022	http://dx.doi.org/10.1016/j.jaci.2021.02.022		NOV 2021	21	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WV7LX	33675818				2022-12-18	WOS:000717415000023
J	Lee, GC; Restrepo, MI; Harper, N; Manoharan, MS; Smith, AM; Meunier, JA; Sanchez-Reilly, S; Ehsan, A; Branum, AP; Winter, C; Winter, L; Jimenez, F; Pandranki, L; Carrillo, A; Perez, GL; Anzueto, A; Trinh, H; Lee, M; Hecht, JM; Martinez-Vargas, C; Sehgal, RT; Cadena, J; Walter, EA; Oakman, K; Benavides, R; Pugh, JA; Letendre, S; Steri, M; Orru, V; Fiorillo, E; Cucca, F; Moreira, AG; Zhang, N; Leadbetter, E; Agan, BK; Richman, DD; He, WJ; Clark, RA; Okulicz, JF; Ahuja, SK				Lee, Grace C.; Restrepo, Marcos I.; Harper, Nathan; Manoharan, Muthu Saravanan; Smith, Alisha M.; Meunier, Justin A.; Sanchez-Reilly, Sandra; Ehsan, Aamir; Branum, Anne P.; Winter, Caitlyn; Winter, Lauryn; Jimenez, Fabio; Pandranki, Lavanya; Carrillo, Andrew; Perez, Graciela L.; Anzueto, Antonio; Trinh, Hanh; Lee, Monica; Hecht, Joan M.; Martinez-Vargas, Celida; Sehgal, Raj T.; Cadena, Jose; Walter, Elizabeth A.; Oakman, Kimberly; Benavides, Raymond; Pugh, Jacqueline A.; Letendre, Scott; Steri, Maristella; Orru, Valeria; Fiorillo, Edoardo; Cucca, Francesco; Moreira, Alvaro G.; Zhang, Nu; Leadbetter, Elizabeth; Agan, Brian K.; Richman, Douglas D.; He, Weijing; Clark, Robert A.; Okulicz, Jason F.; Ahuja, Sunil K.		South Texas Vet Hlth Care Syst	Immunologic resilience and COVID-19 survival advantage	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Aging; AIDS; biomarkers; COVID-19; HIV; immune; inflammation; influenza; SARS-CoV-2	SYSTEMIC-LUPUS-ERYTHEMATOSUS; SEX-DIFFERENCES; DISEASE; IMMUNITY; UPDATE; BLOOD; MODEL; LIFE	Background: The risk of severe coronavirus disease 2019 (COVID-19) varies significantly among persons of similar age and is higher in males. Age-independent, sex-biased differences in susceptibility to severe COVID-19 may be ascribable to deficits in a sexually dimorphic protective attribute that we termed immunologic resilience (IR). Objective: We sought to examine whether deficits in IR that antedate or are induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection independently predict COVID-19 mortality. Methods: IR levels were quantified with 2 novel metrics: immune health grades (IHG-I [best] to IHG-IV) to gauge CD8(+) and CD4(+) T-cell count equilibrium, and blood gene expression signatures. IR metrics were examined in a prospective COVID-19 cohort (n = 522); primary outcome was 30-day mortality. Associations of IR metrics with outcomes in non-COVID-19 cohorts (n = 13,461) provided the framework for linking pre-COVID-19 IR status to IR during COVID-19, as well as to COVID-19 outcomes. Results: IHG-I, tracking high-grade equilibrium between CD8(+) and CD4(+) T-cell counts, was the most common grade (73%) among healthy adults, particularly in females. SARS-CoV-2 infection was associated with underrepresentation of IHG-I (21%) versus overrepresentation (77%) of IHG-II or IHG-IV, especially in males versus females (P < .01). Presentation with IHG-I was associated with 88% lower mortality, after controlling for age and sex; reduced risk of hospitalization and respiratory failure; lower plasma IL-6 levels; rapid clearance of nasopharyngeal SARS-CoV-2 burden; and gene expression signatures correlating with survival that signify immunocompetence and controlled inflammation. In non-COVID-19 cohorts, IR-preserving metrics were associated with resistance to progressive influenza or HIV infection, as well as lower 9-year mortality in the Framingham Heart Study, especially in females. Conclusions: Preservation of immunocompetence with controlled inflammation during antigenic challenges is a hallmark of IR and associates with longevity and AIDS resistance. Independent of age, a male-biased proclivity to degrade IR before and/or during SARS-CoV-2 infection predisposes to severe COVID-19.	[Lee, Grace C.; Restrepo, Marcos I.; Harper, Nathan; Manoharan, Muthu Saravanan; Smith, Alisha M.; Meunier, Justin A.; Branum, Anne P.; Winter, Caitlyn; Winter, Lauryn; Jimenez, Fabio; Pandranki, Lavanya; Carrillo, Andrew; Perez, Graciela L.; Walter, Elizabeth A.; Pugh, Jacqueline A.; Moreira, Alvaro G.; Zhang, Nu; Leadbetter, Elizabeth; He, Weijing; Clark, Robert A.; Ahuja, Sunil K.] South Texas Vet Hlth Care Syst, Vet Adm Res Ctr AIDS & HIV 1 Infect, San Antonio, TX USA; [Lee, Grace C.; Restrepo, Marcos I.; Harper, Nathan; Manoharan, Muthu Saravanan; Smith, Alisha M.; Meunier, Justin A.; Branum, Anne P.; Winter, Caitlyn; Winter, Lauryn; Jimenez, Fabio; Pandranki, Lavanya; Carrillo, Andrew; Perez, Graciela L.; Walter, Elizabeth A.; Pugh, Jacqueline A.; Moreira, Alvaro G.; Zhang, Nu; Leadbetter, Elizabeth; He, Weijing; Clark, Robert A.; Ahuja, Sunil K.] South Texas Vet Hlth Care Syst, Ctr Personalized Med, San Antonio, TX USA; [Lee, Grace C.; Benavides, Raymond] Univ Texas Hlth Sci Ctr San Antonio, Sch Med, Pharmacotherapy Educ & Res Ctr, San Antonio, TX 78229 USA; [Lee, Grace C.; Benavides, Raymond] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA; [Restrepo, Marcos I.; Sanchez-Reilly, Sandra; Ehsan, Aamir; Anzueto, Antonio; Trinh, Hanh; Lee, Monica; Hecht, Joan M.; Martinez-Vargas, Celida; Sehgal, Raj T.; Cadena, Jose; Walter, Elizabeth A.; Oakman, Kimberly; Pugh, Jacqueline A.; Clark, Robert A.; Ahuja, Sunil K.; South Texas Vet Hlth Care Syst] South Texas Vet Hlth Care Syst, 7400 Merton Minter, San Antonio, TX 78229 USA; [Restrepo, Marcos I.; Manoharan, Muthu Saravanan; Sanchez-Reilly, Sandra; Pandranki, Lavanya; Anzueto, Antonio; Sehgal, Raj T.; Cadena, Jose; Walter, Elizabeth A.; Pugh, Jacqueline A.; Clark, Robert A.; Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Harper, Nathan; Smith, Alisha M.; Meunier, Justin A.; Branum, Anne P.; Jimenez, Fabio; Carrillo, Andrew; Perez, Graciela L.; Hecht, Joan M.; He, Weijing] Fdn Adv Vet Hlth Res, San Antonio, TX USA; [Smith, Alisha M.; Zhang, Nu; Leadbetter, Elizabeth; Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol Immunol & Mol Genet, San Antonio, TX 78229 USA; [Winter, Caitlyn; Winter, Lauryn; Moreira, Alvaro G.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, San Antonio, TX 78229 USA; [Letendre, Scott; Richman, Douglas D.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Letendre, Scott] Univ Calif San Diego, HIV Neurobehav Res Ctr, Antiviral Res Ctr, San Diego, CA 92103 USA; [Steri, Maristella; Orru, Valeria; Fiorillo, Edoardo; Cucca, Francesco] Natl Res Council CNR, Inst Genet & Biomed Res, Sardinia, Italy; [Cucca, Francesco] Univ Sassari, Dept Biomed Sci, Sassari, Italy; [Agan, Brian K.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Agan, Brian K.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Okulicz, Jason F.] San Antonio Mil Med Ctr, Infect Dis Serv, San Antonio, TX USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Austin; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of California System; University of California San Diego; University of California System; University of California San Diego; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Sassari; Uniformed Services University of the Health Sciences - USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; San Antonio Military Medical Center	Ahuja, SK (corresponding author), South Texas Vet Hlth Care Syst, 7400 Merton Minter, San Antonio, TX 78229 USA.; Ahuja, SK (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	ahujas@uthscsa.edu	Pandranki, Lavanya/GZL-7371-2022; Letendre, Scott L./GLU-6874-2022; Steri, Maristella/AAX-8760-2020; Nambiar, Anoop M./P-5319-2017; Pascual-Guardia, Sergi/L-7652-2014	Steri, Maristella/0000-0001-5869-3872; Nambiar, Anoop M./0000-0003-2778-0433; Agan, Brian/0000-0002-5114-1669; Marin-Corral, Judith/0000-0003-1320-4427; Branum, Anne/0000-0001-9725-8419; Pascual-Guardia, Sergi/0000-0002-6567-0916	Veterans Affairs (VA) (VA Center for Personalized Medicine) [IP1 CX000875-01A1]; National Institutes of Health (NIH) MERIT award [R37AI046326]; Doris Duke Distinguished Clinical Scientist Award; Burroughs Wellcome Clinical Scientist Award in Translational Research; Elizabeth Glaser Pediatric AIDS Foundation; National Institute of Allergy and Infectious Diseases (NIAID) /NIH [AAI20042-001]; Department of Veterans Affairs [COVID19-8100-01]; US Air Force (US Air Force 59th Medical Wing Intramural Award) [FA8650-17-2-6816]; Infectious Disease Clinical Research Program [IDCRP-000-03]; Department of Defense program by the Uniformed Services University of the Health Sciences; Henry M. Jackson Foundation; Advancement of Military Medicine, Inc.; NIAID/NIH [Y1-AI-5072]; Defense Health Program; US Department of Defense [HU0001190002]; Intramural Research Program of the NIH, National Institute on Aging [N01-AG-1-2109, HHSN271201100005C]; Italian grants [FISM 2011/R/13, FaReBio2011]; European Union's Horizon 2020 Research and Innovation Programme [633964]; NIH [K23-AG066933, T32DE014318]; Clinical and Translational Science Award [1UL1 TR002645]; San Antonio Claude D. Pepper Older Americans Independence Center [P30 AG044271]; Long School of Medicine, UTHSCA	Veterans Affairs (VA) (VA Center for Personalized Medicine); National Institutes of Health (NIH) MERIT award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); Elizabeth Glaser Pediatric AIDS Foundation; National Institute of Allergy and Infectious Diseases (NIAID) /NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Veterans Affairs(US Department of Veterans Affairs); US Air Force (US Air Force 59th Medical Wing Intramural Award); Infectious Disease Clinical Research Program; Department of Defense program by the Uniformed Services University of the Health Sciences(United States Department of Defense); Henry M. Jackson Foundation; Advancement of Military Medicine, Inc.; NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Defense Health Program; US Department of Defense(United States Department of Defense); Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Italian grants; European Union's Horizon 2020 Research and Innovation Programme; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Award; San Antonio Claude D. Pepper Older Americans Independence Center; Long School of Medicine, UTHSCA	The main sources of funding for the data presented herein are those awarded to S.K.A., M.I.R., and J.F.O. S.K.A. was supported by grants from the Veterans Affairs (VA) (VA Center for Personalized Medicine, grant no. IP1 CX000875-01A1) , by the National Institutes of Health (NIH) MERIT award (grant no. R37AI046326) , by the Doris Duke Distinguished Clinical Scientist Award, by the Burroughs Wellcome Clinical Scientist Award in Translational Research, and by the Elizabeth Glaser Pediatric AIDS Foundation. The work was also supported, in part, by an award jointly funded by the National Institute of Allergy and Infectious Diseases (NIAID) /NIH (grant no. AAI20042-001) and the Department of Veterans Affairs (grant no. COVID19-8100-01) awarded to S.K.A. and M.I.R. A portion of the material presented is based on research sponsored by the US Air Force under agreement number FA8650-17-2-6816 (US Air Force 59th Medical Wing Intramural Award to J.F.O.) . The HIV cohort was supported by the Infectious Disease Clinical Research Program (grant no. IDCRP-000-03) , a Department of Defense program executed by the Uniformed Services University of the Health Sciences through a cooperative agreement with The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. The latter project has been supported with federal funds from the NIAID/NIH (under Inter-Agency Agreement no. Y1-AI-5072) and from the Defense Health Program, US Department of Defense (under award no. HU0001190002) . The SardiNIA study was supported in part by the Intramural Research Program of the NIH, National Institute on Aging (with contract nos. N01-AG-1-2109 and HHSN271201100005C) ; by Italian grants (grant no. FISM 2011/R/13, grant no. FaReBio2011, Funds MIUR/CNR for Rare Diseases and Molecular Screening, CNR/DSB flagship INTEROMICS, PNR/CNR Aging Program 2012-2014) ; European Union's Horizon 2020 Research and Innovation Programme (under grant agreement no. 633964) ; Giovani Ricercatori 2007 (D.lgs 502/92) ; and Legge Regionale 30 giugno 2011 n.12, articolo 3, comma 3 (FC) . G.C.L. wassupported by the NIH (grant no. K23-AG066933) . A.M.S. was supported by the NIH (grant no. T32DE014318 COSTAR) institutional research training grant. This work was also supported by pilot project funding to S.K.A. (from 1UL1 TR002645 Clinical and Translational Science Award, San Antonio Claude D. Pepper Older Americans Independence Center grant no. P30 AG044271, and Long School of Medicine, UTHSCA) .	Ahuja SK, 2017, J ALLERGY CLIN IMMUN, V139, P844, DOI 10.1016/j.jaci.2016.08.019; Alpert A, 2019, NAT MED, V25, P487, DOI 10.1038/s41591-019-0381-y; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson MR, 2020, ANN INTERN MED, V173, P782, DOI 10.7326/M20-3214; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 1987, MMWR-MORBID MORTAL W, V36, p1S; Austad SN, 2016, CELL METAB, V23, P1022, DOI 10.1016/j.cmet.2016.05.019; Aydillo T, 2020, NEW ENGL J MED, V383, P2586, DOI 10.1056/NEJMc2031670; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Brodin P, 2021, NAT MED, V27, P28, DOI 10.1038/s41591-020-01202-8; Carter MJ, 2020, NAT MED, V26, P1701, DOI 10.1038/s41591-020-1054-6; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI 10.15585/mmwr.mm6915e4; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Chiche L, 2014, ARTHRITIS RHEUMATOL, V66, P1583, DOI 10.1002/art.38628; Choi B, 2020, NEW ENGL J MED, V383, P2291, DOI 10.1056/NEJMc2031364; Cunningham JW, 2021, JAMA INTERN MED, V181, P379, DOI 10.1001/jamainternmed.2020.5313; Dunning J, 2018, NAT IMMUNOL, V19, P625, DOI 10.1038/s41590-018-0111-5; Effros RB, 2016, MECH AGEING DEV, V158, P46, DOI 10.1016/j.mad.2015.09.003; Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Gabriel G, 2014, J INFECT DIS, V209, pS93, DOI 10.1093/infdis/jiu020; Grasselli G, 2020, JAMA INTERN MED, V180, P1345, DOI 10.1001/jamainternmed.2020.3539; Gupta S, 2020, JAMA INTERN MED, V180, P1436, DOI 10.1001/jamainternmed.2020.3596; Hall VG, 2021, NEW ENGL J MED, V385, P1244, DOI 10.1056/NEJMc2111462; Huang YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002234; Hue S, 2020, AM J RESP CRIT CARE, V202, P1509, DOI 10.1164/rccm.202005-1885OC; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Laguna-Goya R, 2020, J ALLERGY CLIN IMMUN, V146, P799, DOI 10.1016/j.jaci.2020.07.009; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006; Liu MF, 2004, SCAND J IMMUNOL, V59, P198, DOI 10.1111/j.0300-9475.2004.01370.x; Mahmood SS, 2014, LANCET, V383, P999, DOI 10.1016/S0140-6736(13)61752-3; Marconi VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017956; Marconi VC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-14; Marshall JC, 2020, LANCET INFECT DIS, V20, pE192, DOI 10.1016/S1473-3099(20)30483-7; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Nhamoyebonde S, 2014, J INFECT DIS, V209, pS100, DOI 10.1093/infdis/jiu147; Okulicz JF, 2015, JAMA INTERN MED, V175, P88, DOI 10.1001/jamainternmed.2014.4010; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Pawelec G, 2014, EXP GERONTOL, V54, P1, DOI 10.1016/j.exger.2013.11.010; Peckham H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19741-6; Puzianowska-Kuznicka M, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0076-x; Scully EP, 2020, NAT REV IMMUNOL, V20, P442, DOI 10.1038/s41577-020-0348-8; Smith AM, 2021, J ALLERGY CLIN IMMUN, V148, P533, DOI 10.1016/j.jaci.2021.01.008; Takahashi T, 2021, SCIENCE, V371, P347, DOI 10.1126/science.abe7199; Takahashi Takehiro, 2020, medRxiv, DOI 10.1101/2020.06.06.20123414; Tartof SY, 2020, ANN INTERN MED, V173, P773, DOI 10.7326/M20-3742; TAYLOR JMG, 1989, J ACQ IMMUN DEF SYND, V2, P114; Tu WJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02111; Urra JM, 2020, CLIN IMMUNOL, V217, DOI 10.1016/j.clim.2020.108486; Utrero-Rico A, 2021, J ALLERGY CLIN IMMUN, V147, P1652, DOI 10.1016/j.jaci.2021.02.021; Vila LM, 2006, ARTHRIT RHEUM-ARTHR, V55, P799, DOI 10.1002/art.22224; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wang F, 2020, J INFECT DIS, V221, P1762, DOI 10.1093/infdis/jiaa150; Wang F, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.137799; Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556; Yen YF, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020142; Zarulli V, 2018, P NATL ACAD SCI USA, V115, pE832, DOI 10.1073/pnas.1701535115; Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9	62	6	6	2	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2021	148	5					1176	1191		10.1016/j.jaci.2021.08.021	http://dx.doi.org/10.1016/j.jaci.2021.08.021		NOV 2021	16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WV7LX	34508765	hybrid, Green Published			2022-12-18	WOS:000717415000017
J	Mersha, TB; Qin, K; Beck, AF; Ding, LL; Huang, B; Kahn, RS				Mersha, Tesfaye B.; Qin, Ke; Beck, Andrew F.; Ding, Lili; Huang, Bin; Kahn, Robert S.			Genetic ancestry differences in pediatric asthma readmission are mediated by socioenvironmental factors	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; readmission; social factors; environmental exposure risk; genetic ancestry; mediation analysis	GENOME-WIDE ASSOCIATION; ALLERGEN SENSITIZATION; SOCIOECONOMIC-STATUS; AIR-POLLUTION; UNITED-STATES; LUNG-FUNCTION; GALA II; CHILDREN; RISK; EXPOSURE	Background: Social and financial hardships, combined with disease managment and environmental factors explain approximately 80% of the observed disparity in asthma-related readmissions between Black and White children. Objective: We sought to determine whether asthma-related readmissions differed by degree of African ancestry and the extent to which such an association would also be explained by socioenvironmental risk factors. Methods: This study used data from a prospective cohort study of 695 Black and White children aged 1 to 16 years with an asthma-related admission. The primary outcome was a similar readmission within 12 months. Each subject's African ancestry was determined by single nucleotide polymorphisms on a continuous scale ranging from 0 to 1 (0 = no African ancestry; 1 = 100% African ancestry). We also assessed 37 social, environmental, and clinical variables that we clustered into 6 domains (for example, hardship, disease management). Survival and mediation analyses were conducted. Results: A total of 134 children (19.3%) were readmitted within 12 months. Higher African ancestry was associated with asthma readmission (odds ratio 1.11, 95% confidence interval 1.05-1.18 for every 10% increase in African ancestry) with adjustment for age and gender. The association between African ancestry and readmission was mediated by hardship (sI3 = 3.42, P <.001) and disease management (sI3= 0.046, P = .001), accounting for >50% of African ancestry's effect on readmission. African ancestry was no longer significantly associated with readmission (sI3 = 0.035, P = .388) after accounting for these mediators. Conclusions: African ancestry was strongly associated with readmission, and the association was mediated by family hardship and disease management. These results are consistent with the notion that asthma-related racial disparities are driven by factors like structural racism and social adversity. (J Allergy Clin Immunol 2021;148:1210-8.)	[Mersha, Tesfaye B.; Qin, Ke] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Coll Med, Div Asthma Res, Cincinnati, OH USA; [Beck, Andrew F.; Kahn, Robert S.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Coll Med, Div Gen & Community Pediat, Cincinnati, OH USA; [Beck, Andrew F.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Coll Med, Div Hosp Med, Cincinnati, OH USA; [Ding, Lili; Huang, Bin] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Coll Med, Div Biostat & Epidemiol, Cincinnati, OH USA; [Mersha, Tesfaye B.; Qin, Ke; Beck, Andrew F.; Ding, Lili; Huang, Bin; Kahn, Robert S.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Coll Med, Dept Pediat, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Mersha, TB (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pedia Allergy Asthma, 3333 Burnet Ave, Cincinnati, OH 45255 USA.	tesfaye.mersha@cchmc.org			National Institutes of Health (NIH) [R01HL132344, R01A188116]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (NIH) grant R01HL132344 (Mersha) and R01A188116 (Kahn).	Adejare AA, 2022, J ASTHMA, V59, P79, DOI 10.1080/02770903.2020.1838539; Akinbami LJ, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2354; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Archer DN, 2020, VANDERBILT LAW REV, V73, P1259; Auger KA, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-1720; Auger KA, 2013, PEDIATRICS, V131, P64, DOI 10.1542/peds.2012-1055; Balavarca Y, 2020, INT J CANCER, V146, P627, DOI 10.1002/ijc.32272; Bang HJ, 2009, ANN INTERN MED, V151, P775, DOI 10.7326/0003-4819-151-11-200912010-00005; Baye TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016522; Beck AF, 2016, JAMA PEDIATR, V170, P695, DOI 10.1001/jamapediatrics.2016.0269; Beck AF, 2015, ANN AM THORAC SOC, V12, P376, DOI 10.1513/AnnalsATS.201408-376OC; Beck AF, 2014, PEDIATRICS, V133, P431, DOI 10.1542/peds.2013-2437; Beck AF, 2013, J PEDIATR-US, V163, P574, DOI 10.1016/j.jpeds.2013.01.064; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Biagini Myers JM, 2019, J ALLERGY CLIN IMMUN, V143, P1803, DOI 10.1016/j.jaci.2018.09.037; Brokamp C, 2019, ANN EPIDEMIOL, V30, P37, DOI 10.1016/j.annepidem.2018.11.008; Brokamp C, 2018, ENVIRON SCI TECHNOL, V52, P4173, DOI 10.1021/acs.est.7b05381; Brokamp C, 2016, J EXPO SCI ENV EPID, V26, P428, DOI 10.1038/jes.2016.10; Choudhry S, 2006, AM J RESP CRIT CARE, V174, P1086, DOI [10.1164/RCCM.200605-596OC, 10.1164/rccm.200605-596OC]; DeWan AT, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-95; Forno E, 2009, CURR OPIN ALLERGY CL, V9, P154, DOI 10.1097/ACI.0b013e3283292207; Gautam Y, 2019, GENET EPIDEMIOL, V43, P831, DOI 10.1002/gepi.22216; Gruchalla RS, 2005, J ALLERGY CLIN IMMUN, V115, P478, DOI 10.1016/j.jaci.2004.12.006; Howrylak JA, 2014, PEDIATRICS, V133, pE355, DOI 10.1542/peds.2013-2422; Karlsen S, 2002, AM J PUBLIC HEALTH, V92, P624, DOI 10.2105/AJPH.92.4.624; Kline, 2016, PRINCIPLES PRACTICE; Klinnert MD, 2008, FAM PROCESS, V47, P41, DOI 10.1111/j.1545-5300.2008.00238.x; Kumar R, 2010, NEW ENGL J MED, V363, P321, DOI 10.1056/NEJMoa0907897; Litonjua AA, 1999, PEDIATR PULM, V28, P394, DOI 10.1002/(SICI)1099-0496(199912)28:6<394::AID-PPUL2>3.0.CO;2-6; Luria CJ, 2020, ALLERGY ASTHMA PROC, V41, P210, DOI 10.2500/aap.2020.41.200017; MacKinnon D. P., 2008, INTRO STAT MEDIATION; Margolis HG, 2009, INT J ENVIRON HEAL R, V19, P139, DOI 10.1080/09603120802415792; Mersha TB, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00292; Mersha TB, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-014-0023-x; Moncrief T, 2014, J COMMUN HEALTH, V39, P1209, DOI 10.1007/s10900-014-9880-4; Neophytou AM, 2016, AM J RESP CRIT CARE, V193, P1271, DOI 10.1164/rccm.201508-1706OC; Newman NC, 2014, J PEDIATR-US, V164, P1396, DOI 10.1016/j.jpeds.2014.02.017; Nurmagambetov T, 2018, ANN AM THORAC SOC, V15, P348, DOI 10.1513/AnnalsATS.201703-259OC; Nyenhuis SM, 2017, J ALLERGY CLIN IMMUN, V140, P257, DOI 10.1016/j.jaci.2016.10.024; Pacheco CM, 2014, ALLERGY ASTHMA PROC, V35, P467, DOI 10.2500/aap.2014.35.3792; Park SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098632; Piccolo RS, 2016, DIABETES CARE, V39, P1208, DOI 10.2337/dc15-2255; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Ryan PH, 2007, ENVIRON HEALTH PERSP, V115, P278, DOI 10.1289/ehp.9480; Sills MR, 2016, JAMA PEDIATR, V170, P350, DOI 10.1001/jamapediatrics.2015.4440; Spanier AJ, 2015, PEDIATRICS, V135, pE416, DOI 10.1542/peds.2014-1748; Spira-Cohen A, 2010, J EXPO SCI ENV EPID, V20, P446, DOI 10.1038/jes.2009.34; Thakur N, 2014, J ASTHMA, V51, P720, DOI 10.3109/02770903.2014.905593; Thakur N, 2013, AM J RESP CRIT CARE, V188, P1202, DOI 10.1164/rccm.201306-1016OC; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; VanderWeele TJ, 2016, ANNU REV PUBL HEALTH, V37, P17, DOI 10.1146/annurev-publhealth-032315-021402; Wang J, 2009, CLIN EXP ALLERGY, V39, P1381, DOI 10.1111/j.1365-2222.2009.03225.x; Weiss ST, 1998, CLIN EXP ALLERGY, V28, P29; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zahran HS, 2018, MMWR-MORBID MORTAL W, V67, P149, DOI 10.15585/mmwr.mm6705e1	57	6	6	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2021	148	5					1210	+		10.1016/j.jaci.2021.05.046	http://dx.doi.org/10.1016/j.jaci.2021.05.046		NOV 2021	13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	WV7LX	34217757	Green Accepted			2022-12-18	WOS:000717415000020
J	Winkler, T; Frey, U				Winkler, Tilo; Frey, Urs			Airway remodeling: Shifting the trigger point for exacerbations in asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; bronchoconstriction; asthma exacerbations; lung function decline; computed tomography; airway remodeling; airway wall area; computational modeling; ventilation defects; fluctuation analysis	HETEROGENEITY		[Winkler, Tilo] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, 55 Fruit St, Boston, MA 02114 USA; [Winkler, Tilo] Harvard Med Sch, Boston, MA USA; [Frey, Urs] Univ Basel, Univ Childrens Hosp, Basel, Switzerland	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Basel	Winkler, T (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, 55 Fruit St, Boston, MA 02114 USA.	twinkler@mgh.harvard.edu	Winkler, Tilo/B-5337-2009	Winkler, Tilo/0000-0002-7276-5550; Frey, Urs/0000-0003-3773-2822				Bui DS, 2018, LANCET RESP MED, V6, P535, DOI 10.1016/S2213-2600(18)30100-0; Delgado-Eckert E, 2021, J ALLERGY CLIN IMMUN, V148, P407, DOI 10.1016/j.jaci.2020.12.652; Fabienne D, 2020, SEMIN IMMUNOPATHOL, V42, P17, DOI 10.1007/s00281-020-00784-2; Krings JG, 2021, J ALLERGY CLIN IMMUN, V148, P752, DOI 10.1016/j.jaci.2021.01.029; Pascoe CD, 2017, AM J PHYSIOL-LUNG C, V312, pL425, DOI 10.1152/ajplung.00421.2016; Suki B, 2003, J APPL PHYSIOL, V95, P2122, DOI 10.1152/japplphysiol.00636.2003; Thamrin C, 2011, J ALLERGY CLIN IMMUN, V127, P1494, DOI 10.1016/j.jaci.2011.01.018; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Winkler T, 2016, AM J RESP CRIT CARE, V193; Winkler T, 2007, J APPL PHYSIOL, V103, P655, DOI 10.1152/japplphysiol.00041.2007	10	6	6	2	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2021	148	3					710	712		10.1016/j.jaci.2021.07.010	http://dx.doi.org/10.1016/j.jaci.2021.07.010		SEP 2021	3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UP2VR	34310927	Bronze			2022-12-18	WOS:000695242900014
J	Hsieh, LY; Chiang, AWT; Duong, LD; Kuo, CC; Dong, SX; Dohil, R; Kurten, R; Lewis, NE; Aceves, SS				Hsieh, Lance Y.; Chiang, Austin W. T.; Duong, Loan D.; Kuo, Chih-Chung; Dong, Stephanie X.; Dohil, Ranjan; Kurten, Richard; Lewis, Nathan E.; Aceves, Seema S.			A unique esophageal extracellular matrix proteome alters normal fibroblast function in severe eosinophilic esophagitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Eosinophil; esophagus; fibrosis; interactome; remodeling; thrombospondin-1	TGF-BETA; THROMBOSPONDIN-1; NETWORKS	Background: Eosinophilic esophagitis (EoE) is a chronic T(H)2 disorder complicated by tissue fibrosis and loss of esophageal luminal patency. The fibrostenotic esophagus does not respond well to therapy, but profibrotic therapeutic targets are largely unclear. Objective: Our aim was to utilize proteomics and primary cells as a novel approach to determine relevant profibrotic factors. Methods: We utilized primary esophageal EoE and normal fibroblasts, their derivative extracellular matrixes (ECMs), an approach of fibroblast culture on autologous versus nonautologous ECM, and proteomics to elucidate EoE ECM proteins that dysregulate cellular function. Results: We cultured esophageal fibroblasts from normal esophagi and esophagi from patients with severe EoE on autologous versus nonautologous ECM. The EoE ECM proteome shifted normal esophageal fibroblast protein expression. Proteomic analysis demonstrated that thrombospondin-1 is detected only in the EoE ECM, is central in the EoE ECM protein-protein interactome, is found at significantly elevated levels in biopsy specimens from patients with active EoE, and induces fibroblast collagen I production. Conclusion: Fibroblasts from patients with EoE secrete a unique ECM proteome that reflects their in vivo state and induces collagen I and alpha-smooth muscle actin protein expression from normal fibroblasts. Thrombospondin-1 is a previously unappreciated profibrotic molecule in EoE.	[Hsieh, Lance Y.; Chiang, Austin W. T.; Duong, Loan D.; Dong, Stephanie X.; Dohil, Ranjan; Lewis, Nathan E.; Aceves, Seema S.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Hsieh, Lance Y.; Duong, Loan D.; Dong, Stephanie X.; Aceves, Seema S.] Univ Calif San Diego, Div Allergy Immunol, 9500 Gilman Dr,MC-0760, La Jolla, CA 92093 USA; [Chiang, Austin W. T.; Kuo, Chih-Chung; Lewis, Nathan E.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Dohil, Ranjan] Univ Calif San Diego, Div Gastroenterol, La Jolla, CA 92093 USA; [Aceves, Seema S.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Dohil, Ranjan; Aceves, Seema S.] Rady Childrens Hosp San Diego, San Diego, CA USA; [Kurten, Richard] Univ Arkansas Med Sci, Dept Physiol & Biophys, Arkansas Childrens Hosp, Res Inst, Little Rock, AR 72205 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Arkansas Children's Hospital; University of Arkansas System; University of Arkansas Medical Sciences	Aceves, SS (corresponding author), Univ Calif San Diego, Div Allergy Immunol, 9500 Gilman Dr,MC-0760, La Jolla, CA 92093 USA.	saceves@health.ucsd.edu	Kuo, Chihchung/X-4576-2019; Chiang, Austin W.T./AAF-8376-2019	Chiang, Austin W.T./0000-0001-6514-5612; Hsieh, Lance/0000-0002-1478-2643	National Institutes of Health/National Institute of Allergy and Infectious Diseases/National Institute of Diabetes and Digestive and Kidney Dis-eases [R01AI092135, K24AI135034, R21AI154353, R01DK114457]; Novo Nordisk Foundation [NNF10CC1016517, R35 GM119850]	National Institutes of Health/National Institute of Allergy and Infectious Diseases/National Institute of Diabetes and Digestive and Kidney Dis-eases; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	Supported by grants from the National Institutes of Health/National Institute of Allergy and Infectious Diseases/National Institute of Diabetes and Digestive and Kidney Dis-eases (grants R01AI092135 [to S.S.A.] , K24AI135034 [to S.S.A.] , R21AI154353 [to S.S.A.] , and R01DK114457 [to S.S.A.] ) . In addition, the Novo Nordisk Foundation provided funding to the Center for Biosustainability at the Technical University of Denmark (grants NNF10CC1016517 [to A.W.T.C.] and R35 GM119850 [to N.E.L.] ) .	Abonia JP, 2013, J ALLERGY CLIN IMMUN, V132, P378, DOI 10.1016/j.jaci.2013.02.030; Aceves SS, 2007, J ALLERGY CLIN IMMUN, V119, P206, DOI 10.1016/j.jaci.2006.10.016; Adams JC, 2008, J CELL SCI, V121, P784, DOI 10.1242/jcs.021006; Azouz NP, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9736; Banerjee I, 2015, J MOL CELL CARDIOL, V79, P133, DOI 10.1016/j.yjmcc.2014.11.003; Belotti D, 2016, MATRIX BIOL, V55, P106, DOI 10.1016/j.matbio.2016.03.003; Beppu L, 2015, J PEDIATR GASTR NUTR, V61, P194, DOI 10.1097/MPG.0000000000000668; Blanchard C, 2008, MUCOSAL IMMUNOL, V1, P289, DOI 10.1038/mi.2008.15; Carlson DA, 2017, CLIN TRANSL GASTROEN, V8, DOI 10.1038/ctg.2017.47; Chen CX, 2020, J PROTEOMICS, V211, DOI 10.1016/j.jprot.2019.103558; Dellon ES, 2018, GASTROENTEROLOGY, V155, P1022, DOI 10.1053/j.gastro.2018.07.009; Dellon ES, 2014, GASTROINTEST ENDOSC, V79, P577, DOI 10.1016/j.gie.2013.10.027; Dunn J, 2019, EBIOMEDICINE, V40, P77, DOI 10.1016/j.ebiom.2018.12.048; Duong LD, 2020, MUCOSAL IMMUNOL, V13, P110, DOI 10.1038/s41385-019-0214-9; Eluri S, 2017, CLIN TRANSL GASTROEN, V8, DOI 10.1038/ctg.2017.27; Eluri S, 2016, GASTROINTEST ENDOSC, V83, P1142, DOI 10.1016/j.gie.2015.11.019; Feizi A, 2017, NPJ SYST BIOL APPL, V3, DOI 10.1038/s41540-017-0021-4; Frischmeyer-Guerrerio PA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006448; Hassan M, 2019, J PEDIATR GASTR NUTR, V68, P559, DOI 10.1097/MPG.0000000000002202; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JK, 2018, CELL SYST, V6, P484, DOI 10.1016/j.cels.2018.03.001; Kasagi Y, 2018, J ALLERGY CLIN IMMUN; Kwiatek MA, 2011, GASTROENTEROLOGY, V140, P82, DOI 10.1053/j.gastro.2010.09.037; Menard-Katcher C, 2017, AM J GASTROENTEROL, V112, P1466, DOI 10.1038/ajg.2017.131; Min-DeBartolo J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226854; Muir AB, 2016, J PEDIATR GASTR NUTR, V63, P200, DOI 10.1097/MPG.0000000000001100; Murphy-Ullrich JE, 2019, J HISTOCHEM CYTOCHEM, V67, P683, DOI 10.1369/0022155419851103; Nhu QM, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00128; Parker MW, 2014, J CLIN INVEST, V124, P1622, DOI 10.1172/JCI71386; Rawson R, 2016, J ALLERGY CLIN IMMUN, V138, P791, DOI 10.1016/j.jaci.2016.02.028; Resovi A, 2014, MATRIX BIOL, V37, P83, DOI 10.1016/j.matbio.2014.01.012; Schoepfer AM, 2013, GASTROENTEROLOGY, V145, P1230, DOI 10.1053/j.gastro.2013.08.015; Sherrill JD, 2014, MUCOSAL IMMUNOL, V7, P718, DOI 10.1038/mi.2013.90; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tkachenko E, 2016, J ALLERGY CLIN IMMUN, V137, P1270, DOI 10.1016/j.jaci.2015.09.020; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Walker C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103028	37	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2021	148	2					486	494		10.1016/j.jaci.2021.01.023	http://dx.doi.org/10.1016/j.jaci.2021.01.023		AUG 2021	9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TZ7BX	33556465	Green Accepted			2022-12-18	WOS:000684625700025
J	Habener, A; Happle, C; Grychtol, R; Skuljec, J; Busse, M; Daluge, K; Obernolte, H; Sewald, K; Braun, A; Meyer-Bahlburg, A; Hansen, G				Habener, Anika; Happle, Christine; Grychtol, Ruth; Skuljec, Jelena; Busse, Mandy; Daluge, Kathleen; Obernolte, Helena; Sewald, Katherina; Braun, Armin; Meyer-Bahlburg, Almut; Hansen, Gesine			Regulatory B cells control airway hyperreactivity and lung remodeling in a murine asthma model	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Experimental asthma; allergy; house dust mite; airway hyperreactivity; lung remodeling; regulatory B cells; IL-10; B-cell transfer; precision-cut lung slices	T-CELLS; RESPIRATORY TOLERANCE; DEFICIENT MICE; IMMUNOTHERAPY; INFLAMMATION; AUTOIMMUNE; INDUCTION; INTERLEUKIN-10; SUPPRESSION; SUBSET	Background: Asthma is a widespread, multifactorial chronic airway disease. The influence of regulatory B cells on airway hyperreactivity (AHR) and remodeling in asthma is poorly understood. Objective: Our aim was to analyze the role of B cells in a house dust mite (HDM)-based murine asthma model. Methods: The influence of B cells on lung function, tissue remodeling, and the immune response were analyzed by using wild-type and B-cell-deficient (& micro;MT) mice and transfer of IL-10-proficient and IL-10-deficient B cells to & micro;MT mice. Results: After HDM-sensitization, both wild-type and & micro;MT mice developed AHR, but the AHR was significantly stronger in & micro;MT mice, as confirmed by 2 independent techniques: invasive lung function measurement in vivo and examination of precision-cut lung slices ex vivo. Moreover, airway remodeling was significantly increased in allergic & micro;MT mice, as shown by enhanced collagen deposition in the airways, whereas the numbers of FoxP3+ and FoxP3- IL-10-secreting regulatory T cells were reduced. Adoptive transfer of IL-10-proficient but not IL-10-deficient B cells into & micro;MT mice before HDM-sensitization attenuated AHR and lung remodeling. In contrast, FoxP3+ regulatory T cells were equally upregulated by transfer of IL-10-proficient and IL-10-deficient B cells. Conclusion: Our data in a murine asthma model illustrate a central role of regulatory B cells in the control of lung function and airway remodeling and may support future concepts for B-cell-targeted prevention and treatment strategies for allergic asthma. (J Allergy Clin Immunol 2021;147:2281-94.)	[Habener, Anika; Happle, Christine; Grychtol, Ruth; Skuljec, Jelena; Busse, Mandy; Daluge, Kathleen; Meyer-Bahlburg, Almut; Hansen, Gesine] Hannover Med Sch, Dept Paediat Pneumol Allergol & Neonatol, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Habener, Anika; Happle, Christine; Grychtol, Ruth; Obernolte, Helena; Sewald, Katherina; Braun, Armin; Meyer-Bahlburg, Almut; Hansen, Gesine] Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Habener, Anika; Happle, Christine; Grychtol, Ruth; Obernolte, Helena; Sewald, Katherina; Braun, Armin; Meyer-Bahlburg, Almut; Hansen, Gesine] German Ctr Lung Res, Hannover, Germany; [Skuljec, Jelena] Univ Med Essen, Dept Neurol, Essen, Germany; [Busse, Mandy] Otto von Guericke Univ, Med Fac, Expt Obstet & Gynecol, Magdeburg, Germany; [Obernolte, Helena; Sewald, Katherina; Braun, Armin] Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany; [Meyer-Bahlburg, Almut] Univ Med Greifswald, Dept Pediat, Greifswald, Germany; [Hansen, Gesine] Hannover Med Sch, Cluster Excellence RESIST EXC 2155, Hannover, Germany	Hannover Medical School; Otto von Guericke University; Fraunhofer Gesellschaft; Greifswald Medical School; Hannover Medical School	Hansen, G (corresponding author), Hannover Med Sch, Dept Paediat Pneumol Allergol & Neonatol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	hansen.gesine@mh-hannover.de		Skuljec, Jelena/0000-0001-8509-6563; Braun, Armin/0000-0002-1142-1463	German Center for Lung Research (DZL/BREATH, BMBF, Federal Ministry of Education and Research); Cluster of Excellence RESIST (DFG, German Research Foundation) at Hannover Medical School, Hannover, Germany [EXC 2155]; Dorenkamp Foundation	German Center for Lung Research (DZL/BREATH, BMBF, Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Cluster of Excellence RESIST (DFG, German Research Foundation) at Hannover Medical School, Hannover, Germany(German Research Foundation (DFG)); Dorenkamp Foundation	Supported by the German Center for Lung Research (DZL/BREATH, BMBF, Federal Ministry of Education and Research), Cluster of Excellence RESIST (EXC 2155, DFG, German Research Foundation) at Hannover Medical School, Hannover, Germany and by the D_orenkamp Foundation.	Agrawal DK, 2010, CURR ALLERGY ASTHM R, V10, P39, DOI 10.1007/s11882-009-0081-7; Akdis CA, 1998, J CLIN INVEST, V102, P98, DOI 10.1172/JCI2250; Alhabbab RY, 2019, IMMUNOL REV, V292, P164, DOI 10.1111/imr.12800; Arras M, 2006, AM J RESP CELL MOL, V34, P573, DOI 10.1165/rcmb.2004-0383OC; Ayasoufi K, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125489; Barnes PJ, 2017, CLIN SCI, V131, P1541, DOI 10.1042/CS20160487; Behrendt AK, 2012, CLIN EXP IMMUNOL, V168, P308, DOI 10.1111/j.1365-2249.2012.04572.x; Behrendt AK, 2010, IMMUNOL LETT, V133, P19, DOI 10.1016/j.imlet.2010.06.004; Bohm L, 2015, J IMMUNOL, V194, P887, DOI 10.4049/jimmunol.1401612; Bonnardel E, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1177-9; Boulet LP, 2009, CURR ALLERGY ASTHM R, V9, P168, DOI 10.1007/s11882-009-0025-2; Braza F, 2015, ALLERGY, V70, P1421, DOI 10.1111/all.12697; Busse M, 2012, J IMMUNOL, V189, P1975, DOI 10.4049/jimmunol.1103581; Carter NA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3736; Carter NA, 2011, J IMMUNOL, V186, P5569, DOI 10.4049/jimmunol.1100284; Chu KH, 2015, CLIN EXP IMMUNOL, V180, P316, DOI 10.1111/cei.12583; Cui YB, 2018, CLIN TRANSL ALLERGY, V8, DOI 10.1186/s13601-018-0200-4; Dong J, 2015, ALLERGY, V70, P921, DOI 10.1111/all.12631; Drake LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121660; Ferru I, 1998, SCAND J IMMUNOL, V48, P233; Geginat J, 2016, CYTOKINE GROWTH F R, V30, P87, DOI 10.1016/j.cytogfr.2016.02.003; Ghosh S, 2012, J IMMUNOL, V189, P1322, DOI 10.4049/jimmunol.1200138; Gingele S, 2020, J NEUROIMMUNOL, V342, DOI 10.1016/j.jneuroim.2020.577216; Habener A, 2016, EUR J IMMUNOL; Happle C, 2018, J ALLERGY CLIN IMMUN, V141, P685, DOI 10.1016/j.jaci.2017.03.051; Hess A, 2016, TOXICOL IN VITRO, V32, P347, DOI 10.1016/j.tiv.2016.01.006; Hsu LH, 2015, CELL MOL IMMUNOL, V12, P354, DOI 10.1038/cmi.2014.56; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Jirmo AC, 2016, J IMMUNOL, V197, P4219, DOI 10.4049/jimmunol.1601094; Karaulov AV, 2018, INT ARCH ALLERGY IMM, V175, P189, DOI 10.1159/000486856; Kim HS, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005861; Kim HS, 2015, BMB REP, V48, P54, DOI 10.5483/BMBRep.2015.48.1.213; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Liang BT, 2008, J IMMUNOL, V180, P5916, DOI 10.4049/jimmunol.180.9.5916; Limjunyawong N, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.249; Lin Adora A, 2018, Immunohorizons, V2, P398, DOI 10.4049/immunohorizons.1800076; Lindell DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003129; Lino AC, 2018, IMMUNITY, V49, P120, DOI 10.1016/j.immuni.2018.06.007; Liu Q, 2007, J IMMUNOL, V179, P3821, DOI 10.4049/jimmunol.179.6.3821; Liu ZQ, 2013, ALLERGY, V68, P1241, DOI 10.1111/all.12218; Lloyd CM, 2019, TRENDS IMMUNOL, V40, P786, DOI 10.1016/j.it.2019.07.004; Matsuda M, 2019, J PHARMACOL SCI, V141, P139, DOI 10.1016/j.jphs.2019.10.004; Matsumoto M, 2014, IMMUNITY, V41, P1040, DOI 10.1016/j.immuni.2014.10.016; Matsushita T, 2010, J IMMUNOL, V185, P2240, DOI 10.4049/jimmunol.1001307; Mobs C, 2010, J IMMUNOL, V184, P2194, DOI 10.4049/jimmunol.0901379; Moreau A, 2015, EUR J IMMUNOL, V45, P843, DOI 10.1002/eji.201445082; Muehling LM, 2017, J ALLERGY CLIN IMMUN, V140, P1523, DOI 10.1016/j.jaci.2017.02.025; Natarajan P, 2012, MUCOSAL IMMUNOL, V5, P691, DOI 10.1038/mi.2012.42; Oleinika K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02911-y; Polte T, 2006, J CLIN INVEST, V116, P1025, DOI 10.1172/JCI23792; Poojary KV, 2010, AM J PATHOL, V177, P525, DOI 10.2353/ajpath.2010.090936; Ray A, 2012, J IMMUNOL, V188, P3188, DOI 10.4049/jimmunol.1103354; Reithofer M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071368; Renauld JC, 2001, J CLIN PATHOL, V54, P577, DOI 10.1136/jcp.54.8.577; Rivas MN, 2016, J ALLERGY CLIN IMMUN, V138, P639, DOI 10.1016/j.jaci.2016.06.003; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Satitsuksanoa P, 2019, CURR OPIN ALLERGY CL, V19, P632, DOI 10.1097/ACI.0000000000000580; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shamji MH, 2017, J ALLERGY CLIN IMMUN, V140, P1485, DOI 10.1016/j.jaci.2017.10.010; Shamskhou EA, 2019, BIOMATERIALS, V203, P52, DOI 10.1016/j.biomaterials.2019.02.017; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Skuljec J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01125; Stanic B, 2015, J ALLERGY CLIN IMMUN, V135, P771, DOI 10.1016/j.jaci.2014.07.041; Sun CM, 2005, IMMUNITY, V22, P467, DOI 10.1016/j.immuni.2005.02.008; van de Veen W, 2017, CURR OPIN ALLERGY CL, V17, P447, DOI 10.1097/ACI.0000000000000400; van de Veen W, 2016, J ALLERGY CLIN IMMUN, V138, P654, DOI 10.1016/j.jaci.2016.07.006; van der Vlugt LEPM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030883; Wang RX, 2014, NAT MED, V20, P633, DOI 10.1038/nm.3554; Yong L, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007474; Zhang HP, 2013, SCI REP-UK, V3, DOI 10.1038/srep03345; Zhang JF, 2019, IMMUNOLOGY, V157, P13, DOI 10.1111/imm.13044	71	6	6	2	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					2281	+		10.1016/j.jaci.2020.09.041	http://dx.doi.org/10.1016/j.jaci.2020.09.041		JUN 2021	21	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7MD	33249168				2022-12-18	WOS:000657783800008
J	Sukseree, S; Bakiri, L; Palomo-Irigoyen, M; Uluckan, O; Petzelbauer, P; Wagner, EF				Sukseree, Supawadee; Bakiri, Latifa; Palomo-Irigoyen, Marta; Uluckan, Oezge; Petzelbauer, Peter; Wagner, Erwin F.			Sequestosome 1/p62 enhances chronic skin inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; psoriasis; skin inflammation; sequestosome 1/p62; AP-1; disease model; NF-kappa B; mTOR	SIGNALING ADAPTER; P62; ACTIVATION; MECHANISMS; SQSTM1/P62; DEFICIENT; PSORIASIS; DISEASE	Background: The molecular control of inflammation and epidermal thickening in skin lesions of patients with atopic dermatitis (AD) is not known. Sequestosome 1/p62 is a multifunctional adapter protein implicated in the control of key regulators of cellular homeostasis, such as proinflammatory and mechanistic target of rapamycin signaling. Objective: We sought to determine whether p62 plays a role in the cutaneous and systemic manifestations of an AD-like mouse model. Methods: AD-like skin lesions were induced by deletion of JunB/AP-1, specifically in epidermal keratinocytes (JunB(Delta ep)). The contribution of p62 to pathological changes was determined by inactivation of p62 in JunB(Delta ep) p62(-/-) double knockout mice. Results: Expression of p62 was elevated in skin lesions of JunB(Delta ep) mice, resembling upregulation of p62 in AD and psoriasis. When p62 was inactivated, JunB(Delta ep)-associated defects in the differentiation of keratinocytes, epidermal thickening, skin infiltration by mast cells and neutrophils, and the development of macroscopic skin lesions were significantly reduced. p62 inactivation had little effect on circulating cytokines, but decreased serum IgE. Signaling through mechanistic target of rapamycin and natural factor kappa B was increased in JunB(Delta ep) but not in JunB(Delta ep) p62(-/-) double knockout skin, indicating an important role of p62 in enhancing these signaling pathways in the skin during AD-like inflammation. Conclusions: Our results provide the first in vivo evidence for a proinflammatory role of p62 in skin and suggest that p62-dependent signaling pathways may be promising therapeutic targets to ameliorate the skin manifestations of AD and possibly psoriasis.	[Sukseree, Supawadee; Palomo-Irigoyen, Marta; Wagner, Erwin F.] Med Univ Vienna, Dept Dermatol, Genes & Dis Lab, Vienna, Austria; [Bakiri, Latifa; Wagner, Erwin F.] Med Univ Vienna, Dept Lab Med KILM, Genes & Dis Lab, Vienna, Austria; [Uluckan, Oezge] CNIO, Genes Dev & Dis Grp, Madrid, Spain; [Petzelbauer, Peter] Med Univ Vienna, Dept Dermatol, Skin & Endothelium Res Div, Vienna, Austria; [Uluckan, Oezge] Novartis Inst Biomed Res, Autoimmun Transplantat Inflammat Dis Area ATI, Basel, Switzerland	Medical University of Vienna; Medical University of Vienna; Centro Nacional de Investigaciones Oncologicas (CNIO); Medical University of Vienna; Novartis	Wagner, EF (corresponding author), Med Univ Vienna, Dept Dermatol, Lazarettgasse 14, A-1090 Vienna, Austria.; Wagner, EF (corresponding author), Med Univ Vienna, Dept Lab Med, Lazarettgasse 14, A-1090 Vienna, Austria.	erwin.wagner@meduniwien.ac.at	petzelbauer, peter/GLU-3941-2022	Palomo Irigoyen, Marta/0000-0003-2447-8343; bakiri, latifa/0000-0002-6300-2420; Sukseree, Supawadee/0000-0002-7011-9352	European Research Council [ERC-AdG 2016 CSI-Fun-741888]; Medical University of Vienna	European Research Council(European Research Council (ERC)European Commission); Medical University of Vienna	This work was supported by the European Research Council (grant no. ERC-AdG 2016 CSI-Fun-741888) and the Medical University of Vienna. The funders did not play any role in the study design, data collection and analysis, and decision to publish.	Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Egawa G, 2016, J ALLERGY CLIN IMMUN, V138, P350, DOI 10.1016/j.jaci.2016.06.002; Huang JF, 2018, CELL CYCLE, V17, P2110, DOI 10.1080/15384101.2018.1520566; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Kim D, 2019, J INVEST DERMATOL, V139, P984, DOI 10.1016/j.jid.2019.02.014; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Laurin N, 2002, AM J HUM GENET, V70, P1582, DOI 10.1086/340731; Lee HM, 2011, J IMMUNOL, V186, P1248, DOI 10.4049/jimmunol.1001954; Linares JF, 2013, MOL CELL, V51, P283, DOI 10.1016/j.molcel.2013.06.020; Meixner A, 2008, NAT CELL BIOL, V10, P1003, DOI 10.1038/ncb1761; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Moscat J, 2016, CELL, V167, P606, DOI 10.1016/j.cell.2016.09.030; Nakajima S, 2019, J ALLERGY CLIN IMMUN, V143, P13, DOI 10.1016/j.jaci.2018.11.014; Patrick GJ, 2021, J INVEST DERMATOL, V141, P274, DOI 10.1016/j.jid.2020.07.006; Pflegerl P, 2009, P NATL ACAD SCI USA, V106, P20423, DOI 10.1073/pnas.0910371106; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Sanchez-Martin P, 2018, J CELL SCI, V131, DOI 10.1242/jcs.222836; Sukseree S, 2020, AUTOPHAGY, V16, P1851, DOI 10.1080/15548627.2019.1709764; Taniguchi K, 2016, FEBS LETT, V590, P2375, DOI 10.1002/1873-3468.12301; Uluckan O, 2019, CELL REP, V29, P844, DOI 10.1016/j.celrep.2019.09.042; Umemura A, 2016, CANCER CELL, V29, P935, DOI 10.1016/j.ccell.2016.04.006; Wagner EF, 2010, NAT REV RHEUMATOL, V6, P704, DOI 10.1038/nrrheum.2010.157; Weidinger S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0001-z; Werfel T, 2016, J ALLERGY CLIN IMMUN, V138, P336, DOI 10.1016/j.jaci.2016.06.010; Wooten MW, 2005, J BIOL CHEM, V280, P35625, DOI 10.1074/jbc.C500237200; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zhang XL, 2015, J INVEST DERMATOL, V135, P1016, DOI 10.1038/jid.2014.519	27	6	6	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					2386	+		10.1016/j.jaci.2021.02.028	http://dx.doi.org/10.1016/j.jaci.2021.02.028		JUN 2021	12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7ID	33675820				2022-12-18	WOS:000657773400005
J	Tiwari, A; Li, J; Kho, AT; Sun, MY; Lu, Q; Weiss, ST; Tantisira, KG; McGeachie, MJ				Tiwari, Anshul; Li, Jiang; Kho, Alvin T.; Sun, Maoyun; Lu, Quan; Weiss, Scott T.; Tantisira, Kelan G.; McGeachie, Michael J.			Developing and evaluating a pediatric asthma severity computable phenotype derived from electronic health records	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; electronic health records; big data; respiratory function tests; selection bias; health care disparities; delivery of health care; observer variation; National Heart; Lung; and Blood Institute (US); pediatrics	AIRWAY SMOOTH-MUSCLE; CHILDHOOD ASTHMA; LUNG-FUNCTION; MICRORNA; KINASE; DIFFERENTIATION; EXACERBATION; EXPRESSION; PREDICTION; PATTERNS	Background: Extensive data available in electronic health records (EHRs) have the potential to improve asthma care and understanding of factors influencing asthma outcomes. However, this work can be accomplished only when the EHR data allow for accurate measures of severity, which at present are complex and inconsistent. Objective: Our aims were to create and evaluate a standardized pediatric asthma severity phenotype based in clinical asthma guidelines for use in EHR-based health initiatives and studies and also to examine the presence and absence of these data in relation to patient characteristics. Methods: We developed an asthma severity computable phenotype and compared the concordance of different severity components contributing to the phenotype to trends in the literature. We used multivariable logistic regression to assess the presence of EHR data relevant to asthma severity. Results: The asthma severity computable phenotype performs as expected in comparison with national statistics and the literature. Severity classification for a child is maximized when based on the long-term medication regimen component and minimized when based only on the symptom data component. Use of the severity phenotype results in better, clinically grounded classification. Children for whom severity could be ascertained from these EHR data were more likely to be seen for asthma in the outpatient setting and less likely to be older or Hispanic. Black children were less likely to have lung function testing data present. Conclusion: We developed a pragmatic computable phenotype for pediatric asthma severity that is transportable to other EHRs. (J Allergy Clin Immunol 2021;147:2162-70.)	[Tiwari, Anshul; Li, Jiang; Kho, Alvin T.; Weiss, Scott T.; Tantisira, Kelan G.; McGeachie, Michael J.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Tiwari, Anshul; Li, Jiang; Kho, Alvin T.; Weiss, Scott T.; Tantisira, Kelan G.; McGeachie, Michael J.] Harvard Med Sch, Boston, MA 02115 USA; [Kho, Alvin T.] Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA USA; [Sun, Maoyun; Lu, Quan] Harvard TH Chan Sch Publ Hlth, Mol & Integrat Physiol Sci, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	McGeachie, MJ (corresponding author), Harvard Med Sch, Channing Div Network Med, 181 Longwood Ave,Room 539, Boston, MA 02115 USA.	remmg@channing.harvard.edu	Li, Jiang/AAG-1722-2021	Li, Jiang/0000-0002-9791-2553; Tiwari, Anshul/0000-0003-2647-8144	National Heart, Lung, and Blood Institute [R01 HL139634, R01 HL127332, R01 HL129935, P01 HL132825]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by National Heart, Lung, and Blood Institute grants R01 HL139634, R01 HL127332, R01 HL129935, and P01 HL132825.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Al-Muhsen S, 2011, J ALLERGY CLIN IMMUN, V128, P451, DOI 10.1016/j.jaci.2011.04.047; Baarsma HA, 2017, J EXP MED, V214, P143, DOI 10.1084/jem.20160675; Balzano F, 2015, MOLECULES, V20, P19030, DOI 10.3390/molecules201019030; Barnes PJ, 2016, PHARMACOL REV, V68, P788, DOI 10.1124/pr.116.012518; Brown Derek, 2014, Ann Am Thorac Soc, V11, P1277, DOI 10.1513/AnnalsATS.201404-179FR; Bui DS, 2018, LANCET RESP MED, V6, P535, DOI 10.1016/S2213-2600(18)30100-0; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; CLEVELAND WS, 1981, AM STAT, V35, P54, DOI 10.2307/2683591; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dougherty RH, 2009, CLIN EXP ALLERGY, V39, P193, DOI 10.1111/j.1365-2222.2008.03157.x; Dubitzyk W, 2013, ENCY SYSTEM BIOL, P2367; Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004; Feng ZH, 2011, J MOL CELL BIOL, V3, P44, DOI 10.1093/jmcb/mjq040; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Gays D, 2017, DEVELOPMENT, V144, P464, DOI 10.1242/dev.133926; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hobbs BD, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.00515-2019; Howrylak JA, 2014, J ALLERGY CLIN IMMUN, V133, P1289, DOI 10.1016/j.jaci.2014.02.006; Hsin JP, 2018, NAT IMMUNOL, V19, P1137, DOI 10.1038/s41590-018-0208-x; Hu RX, 2014, FASEB J, V28, P2347, DOI 10.1096/fj.13-247247; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Karagkouni D, 2018, NUCLEIC ACIDS RES, V46, pD239, DOI 10.1093/nar/gkx1141; Kerkhof M, 2014, J ALLERGY CLIN IMMUN, V133, P68, DOI 10.1016/j.jaci.2013.06.004; Kho AT, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0828-6; Koppelman GH, 2009, AM J RESP CRIT CARE, V180, P929, DOI 10.1164/rccm.200810-1621OC; Lazaar AL, 2005, J ALLERGY CLIN IMMUN, V116, P488, DOI 10.1016/j.jaci.2005.06.030; Liu X, 2018, INT J CHRONIC OBSTR, V13, P1217, DOI 10.2147/COPD.S163459; Liu XJ, 2012, J MOL CELL CARDIOL, V52, P245, DOI 10.1016/j.yjmcc.2011.11.008; Liu Y, 2015, MOL CELL BIOCHEM, V409, P135, DOI 10.1007/s11010-015-2519-7; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; Maitre JL, 2013, CURR BIOL, V23, pR626, DOI 10.1016/j.cub.2013.06.019; Matias-Garcia PR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227648; McCall MN, 2017, GENOME RES, V27, P1769, DOI 10.1101/gr.222067.117; McGeachie MJ, 2016, NEW ENGL J MED, V374, P1842, DOI 10.1056/NEJMoa1513737; McGeachie MJ, 2017, J ALLERGY CLIN IMMUN, V140, P598, DOI 10.1016/j.jaci.2017.01.023; McGeachie MJ, 2017, CURR OPIN ALLERGY CL, V17, P104, DOI 10.1097/ACI.0000000000000348; McGeachie MJ, 2016, AM J RESP CRIT CARE, V194, P1465, DOI 10.1164/rccm.201602-0250OC; McGeachie MJ, 2016, IMMUN INFLAMM DIS, V4, P487, DOI 10.1002/iid3.133; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; O'Brien J, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00402; O'Leary L, 2016, FEBS LETT, V590, P1324, DOI 10.1002/1873-3468.12168; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Post S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31500-8; Provost F, 2001, MACH LEARN, V42, P203, DOI 10.1023/A:1007601015854; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Reese SE, 2013, BIOINFORMATICS, V29, P2877, DOI 10.1093/bioinformatics/btt480; Rozowsky J, 2019, CELL SYST, V8, P352, DOI 10.1016/j.cels.2019.03.004; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sharma S, 2010, AM J RESP CRIT CARE, V181, P328, DOI 10.1164/rccm.200907-1009OC; Skronska-Wasek W, 2017, AM J RESP CRIT CARE, V196, P172, DOI 10.1164/rccm.201605-0904OC; Sticht C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206239; Sun ZX, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01598; Tahamtan A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01377; Vengrenyuk Y, 2015, ARTERIOSCL THROM VAS, V35, P535, DOI 10.1161/ATVBAHA.114.304029; Vijayan VK, 2013, INDIAN J MED RES, V137, P251; WANG DS, 1994, BIOCHEM BIOPH RES CO, V203, P29, DOI 10.1006/bbrc.1994.2144; Wang J, 2019, MOL MED REP, V19, P3403, DOI 10.3892/mmr.2019.10015; Wang MY, 2016, CLIN RESPIR J, V10, P104, DOI 10.1111/crj.12194; Wu KH, 2014, AM J RESP CRIT CARE, V190, P619, DOI 10.1164/rccm.201403-0460OC; Xia C., 2020, ROLE P53 INDUCED MIR; Xiong T, 2019, J INT MED RES, V47, P3307, DOI 10.1177/0300060518789819; Yang SZ, 2013, FASEB J, V27, P2382, DOI 10.1096/fj.12-219493; Yao LB, 1997, J BIOL CHEM, V272, P13033, DOI 10.1074/jbc.272.20.13033; Yeh YT, 2019, BIOMATERIALS, V204, P59, DOI 10.1016/j.biomaterials.2019.03.003; Zhang WX, 2017, J ALLERGY CLIN IMMUN, V139, pAB3, DOI 10.1016/j.jaci.2016.12.065	69	6	6	2	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					2181	2190		10.1016/j.jaci.2020.11.048	http://dx.doi.org/10.1016/j.jaci.2020.11.048		JUN 2021	10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7YB	33385444	Green Accepted, hybrid			2022-12-18	WOS:000657814800023
J	de las Vecillas, L; Castells, M				de las Vecillas, Leticia; Castells, Mariana			Non-IgE adverse reactions to biologics	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Biologics; non-IgE-mediated reactions; antidrug antibodies; adverse reactions; phenotype; endotype; biomarkers; desensitization	HYPERSENSITIVITY REACTIONS; INFLIXIMAB; ANTIBODIES		[de las Vecillas, Leticia] Marques de Valdecilla Univ Hosp, Inst Invest Marques de Valdecilla IDIVAL, Dept Allergy, Santander, Spain; [Castells, Mariana] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Allergy & Clin Immunol, 60 Fenwood Rd, Boston, MA 02115 USA	Hospital Universitario Marques de Valdecilla (HUMV); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Castells, M (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Allergy & Clin Immunol, 60 Fenwood Rd, Boston, MA 02115 USA.	mcastells@bwh.harvard.edu	de las Vecillas Sanchez, Leticia/ABF-5180-2021	de las Vecillas Sanchez, Leticia/0000-0003-4969-5678				Isabwe GAC, 2018, J ALLERGY CLIN IMMUN, V142, P159, DOI 10.1016/j.jaci.2018.02.018; Jonsson F, 2011, J CLIN INVEST, V121, P1484, DOI 10.1172/JCI45232; Matucci A, 2013, CLIN EXP ALLERGY, V43, P659, DOI 10.1111/cea.12098; Nencini F, 2018, J ALLER CL IMM-PRACT, V6, P2065, DOI 10.1016/j.jaip.2018.04.007; Picard M, 2017, J ALLER CL IMM-PRACT, V5, P600, DOI 10.1016/j.jaip.2016.12.001; Succaria F, 2016, AM J DERMATOPATH, V38, P321, DOI 10.1097/DAD.0000000000000356; Vultaggio A, 2016, CLIN EXP IMMUNOL, V186, P364, DOI 10.1111/cei.12858; Vultaggio A, 2010, ALLERGY, V65, P657, DOI 10.1111/j.1398-9995.2009.02280.x; Vultaggio A, 2020, J ALLER CL IMM-PRACT, V8, P1764, DOI 10.1016/j.jaip.2019.12.040; Yildizhan E, 2018, J ONCOLOGICAL SCI, V4, P134	10	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2021	147	4					1204	1206		10.1016/j.jaci.2020.11.012	http://dx.doi.org/10.1016/j.jaci.2020.11.012		APR 2021	3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RJ1NP	33227316	Bronze			2022-12-18	WOS:000637368900007
J	Li, L; Chang, YC; Song, S; Losina, E; Costenbader, KH; Laidlaw, TM				Li, Lily; Chang, Yuchiao; Song, Shuang; Losina, Elena; Costenbader, Karen H.; Laidlaw, Tanya M.			Impact of reported NSAID ?allergies?on opioid use disorder in back pain	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Aspirin; nonsteroidal anti-inflammatory drug (NSAID); hypersensitivity; drug allergy; adverse drug reaction; opioid use dis-order; analgesics; outpatient; utilization; electronic health record	UNITED-STATES; PRESCRIBING PATTERNS; OVERDOSE DEATHS; ANALGESIC USE; PRESCRIPTION; DRUG; HYPERSENSITIVITY; TRENDS; OSTEOARTHRITIS; ASSOCIATION	Background: It is crucial to identify patients at highest risk for opioid use disorder (OUD) and to address challenges in reducing opioid use. Reported nonsteroidal anti-inflammatory drug (NSAID) allergies may predispose to use of stronger pain medications and potentially to OUD. Objective: We sought to investigate the clinical impact of reported NSAID allergy on OUD in patients with chronic back pain. Methods: We conducted a retrospective study of adults receiving care at a tertiary health care system from January 1, 2013, to December 31, 2018. Back pain and OUD were identified using administrative data algorithms. We used propensity score matching and logistic regression to estimate the impact of self-reported NSAID adverse drug reactions (ADRs) on risk of OUD, adjusting for other relevant clinical information. Results: Of 47,114 patients with chronic back pain, 3,620 (7.7%) had a reported NSAID ADR. In an adjusted propensity score-matched analysis, patients with NSAID ADRs had higher odds (odds ratio, 1.34; 95% CI, 1.07-1.67) of developing OUD as compared with those without NSAID ADRs. Additional risk factors for OUD included younger age, male sex, Medicaid insurance, Medicare insurance, higher number of inpatient and outpatient visits in the previous year, and comorbid anxiety and depression. Patients with listed NSAID ADRs also had higher odds of a documented opioid prescription during the study period (odds ratio, 1.22; 95% CI, 1.11-1.34). Conclusions: Adults with chronic back pain and reported NSAID ADRs are at a higher risk of developing OUD and receiving opioid analgesics, even after accounting for comorbidities and health care utilization. Allergy evaluation is critical for potential delabeling of patients with reported NSAID allergies and chronic pain. (J Allergy Clin Immunol 2021;147:1413-9.)	[Li, Lily; Laidlaw, Tanya M.] Brigham & Womens Hosp, Dept Med, Div Allergy & Clin Immunol, 75 Francis St, Boston, MA 02115 USA; [Chang, Yuchiao] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Song, Shuang; Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, 75 Francis St, Boston, MA 02115 USA; [Losina, Elena; Costenbader, Karen H.; Laidlaw, Tanya M.] Harvard Med Sch, Boston, MA 02115 USA; [Costenbader, Karen H.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Inflammat & Immun, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Li, L (corresponding author), Brigham & Womens Hosp, Div Allergy & Clin Immunol, 60 Fenwood Rd,5002D, Boston, MA 02115 USA.	lli39@bwh.harvard.edu		Li, Lily/0000-0002-9794-8468	National Institutes of Health [T32 AI007306, P30 AR072577, K24 AR057827, R01 AR074290, K24 AR066109, R01 HL128241, U19 AI095219]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study is supported by the National Institutes of Health (award nos. T32 AI007306 and P30 AR072577 to L.L., award nos. K24 AR057827 and R01 AR074290 to E.L., award no. K24 AR066109 to K.H.C., and award nos. R01 HL128241 and U19 AI095219 to T.M.L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], CASE STUDY EXPLORING; Asero R, 2013, EUR ANN ALLERGY CLIN, V45, P3; Atlas SJ, 2007, SPINE, V32, P2019, DOI 10.1097/BRS.0b013e318133d69b; Becker WC, 2008, DRUG ALCOHOL DEPEN, V94, P207, DOI 10.1016/j.drugalcdep.2007.11.018; Blumenthal KG, 2017, J ALLER CL IMM-PRACT, V5, P737, DOI 10.1016/j.jaip.2016.12.006; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Boudreau D, 2009, PHARMACOEPIDEM DR S, V18, P1166, DOI 10.1002/pds.1833; Campbell CI, 2010, AM J PUBLIC HEALTH, V100, P2541, DOI 10.2105/AJPH.2009.180646; Carnide N, 2018, J OCCUP ENVIRON MED, V60, P644, DOI 10.1097/JOM.0000000000001311; Chalana H., 2016, J ADDICT, V2016, DOI [10.1155/2016/7620860, DOI 10.1155/2016/7620860]; Cragg A, 2019, ANN EMERG MED, V74, P634, DOI 10.1016/j.annemergmed.2019.04.019; Deyo RA, 2017, J GEN INTERN MED, V32, P21, DOI 10.1007/s11606-016-3810-3; Dufour R, 2014, AM J PHARM BENEFIST, V6, P208; Edlund MJ, 2014, CLIN J PAIN, V30, P557, DOI 10.1097/AJP.0000000000000021; Gomes ER, 2005, CURR OPIN ALLERGY CL, V5, P309, DOI 10.1097/01.all.0000173785.81024.33; Gupta A, 2018, ANESTHESIOLOGY, V128, P880, DOI 10.1097/ALN.0000000000002136; Guy GP, 2017, MMWR-MORBID MORTAL W, V66, P697, DOI 10.15585/mmwr.mm6626a4; HCUP/AHRQ, DAT INN ICD 10 CM PC; Hedegaard Holly, 2020, NCHS Data Brief, P1; Heslin KC, 2017, MED CARE, V55, P918, DOI 10.1097/MLR.0000000000000805; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Hser YI, 2015, HARVARD REV PSYCHIAT, V23, P76, DOI 10.1097/HRP.0000000000000052; Hulin J, 2020, ADDICTION, V115, P832, DOI 10.1111/add.14870; Krebs EE, 2018, JAMA-J AM MED ASSOC, V319, P872, DOI 10.1001/jama.2018.0899; Kuperman Gilad J, 2003, AMIA Annu Symp Proc, P376; Laidlaw TM, 2017, J ALLER CL IMM-PRACT, V5, P537, DOI 10.1016/j.jaip.2016.10.021; Lankenau SE, 2012, INT J DRUG POLICY, V23, P37, DOI 10.1016/j.drugpo.2011.05.014; Larochelle MR, 2015, PHARMACOEPIDEM DR S, V24, P885, DOI 10.1002/pds.3776; Li L, 2019, J ALLER CL IMM-PRACT, V7, P2891, DOI 10.1016/j.jaip.2019.04.042; Licciardone John C, 2018, Tex Med, V114, pe1; Morden NE, 2014, MED CARE, V52, P852, DOI 10.1097/MLR.0000000000000183; Naik R, 2018, J ALLERGY CLIN IMMUN, V141, pAB218, DOI 10.1016/j.jaci.2017.12.690; Owens PL, 2006, HOSP INPATIENT UTILI; Peavy KM, 2012, J PSYCHOACTIVE DRUGS, V44, P259, DOI 10.1080/02791072.2012.704591; Reardon JM, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0075-4; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Shah A, 2017, MMWR-MORBID MORTAL W, V66, P265, DOI 10.15585/mmwr.mm6610a1; Shrestha S, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0319-y; Sinnott PL, 2012, SPINE, V37, P860, DOI 10.1097/BRS.0b013e3182376508; Stone CA, 2020, ALLERGY, V75, P273, DOI 10.1111/all.13848; Viola M, 2005, INT ARCH ALLERGY IMM, V137, P145, DOI 10.1159/000085794; Volkow ND, 2019, JAMA PSYCHIAT, V76, P208, DOI 10.1001/jamapsychiatry.2018.3126; Ward EN, 2018, ANESTH ANALG, V127, P539, DOI 10.1213/ANE.0000000000003477; Weberschock TB, 2007, ARCH DERMATOL RES, V299, P169, DOI 10.1007/s00403-007-0757-6; White PF, 2011, ANESTH ANALG, V112, P323, DOI 10.1213/ANE.0b013e3182025a8a; Wilson N, 2020, MMWR-MORBID MORTAL W, V69, P290, DOI 10.15585/mmwr.mm6911a4; Zhan M, 2017, CLIN J AM SOC NEPHRO, V12, P1778, DOI 10.2215/CJN.12311216; Zhou L, 2016, ALLERGY, V71, P1305, DOI 10.1111/all.12881	48	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2021	147	4					1413	1419		10.1016/j.jaci.2020.08.025	http://dx.doi.org/10.1016/j.jaci.2020.08.025		APR 2021	7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	RX3VK	32916184	Green Accepted			2022-12-18	WOS:000647154500006
J	Chen, JS; Grassmann, JDS; Gowthaman, U; Olyha, SJ; Simoneau, T; Berin, MC; Eisenbarth, SC; Williams, A				Chen, Jennifer S.; Grassmann, Jessica D. S.; Gowthaman, Uthaman; Olyha, Sam J.; Simoneau, Tregony; Berin, M. Cecilia; Eisenbarth, Stephanie C.; Williams, Adam			Flow cytometric identification of T(FH)13 cells in mouse and human	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						T follicular helper cells; T(FH)13 cells; intracellular cytokine staining; IL-4; IL-5; IL-13; allergy; IgE	HELPER T-CELLS; ANAPHYLAXIS; IL-4	Anaphylaxis is a life-threatening allergic reaction caused by cross-linking of high-affinity IgE antibodies on the surface of mast cells and basophils. Understanding the cellular mechanisms that lead to high-affinity IgE production is required to develop better therapeutics for preventing this severe reaction. A recently discovered population of T follicular helper T(FH)13 cells regulates the production of high-affinity IgE in mouse models of allergy and can also be found in patients with allergies with IgE antibodies against food or aeroallergens. Here we describe optimized protocols for identifying T(FH)13 cells in both mice and humans.	[Chen, Jennifer S.; Gowthaman, Uthaman; Olyha, Sam J.; Eisenbarth, Stephanie C.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Chen, Jennifer S.; Gowthaman, Uthaman; Olyha, Sam J.; Eisenbarth, Stephanie C.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Grassmann, Jessica D. S.; Williams, Adam] Jackson Lab Genom Med, Farmington, CT USA; [Simoneau, Tregony] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Simoneau, Tregony] Boston Childrens Hosp, Div Resp Dis, Boston, MA USA; [Berin, M. Cecilia] Icahn Sch Med Mt Sinai, Inst Immunol, Jaffe Food Allergy Inst, New York, NY 10029 USA; [Williams, Adam] Univ Connecticut, Ctr Hlth, Dept Genet & Genome Sci, Farmington, CT 06032 USA	Yale University; Yale University; Jackson Laboratory; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Icahn School of Medicine at Mount Sinai; University of Connecticut	Williams, A (corresponding author), Univ Connecticut, Ctr Hlth, Jackson Lab Genom Med, Dept Genet & Genome Sci, 10 Discovery Dr, Farmington, CT 06032 USA.	adam.williams@jax.org		Chen, Jennifer/0000-0002-7808-2670; Olyha, Sam/0000-0002-6915-3721; berin, cecilia/0000-0002-9051-9249; , UTHAMAN GOWTHAMAN/0000-0002-5484-7851; Grassmann, Jessica/0000-0001-9076-452X	National Institutes of Health (NIH) [T32GM007205]; Gershon/Trudeau Fellowship from Immunobiology at Yale University; Robert E. Leet and Clara Guthrie Patterson Trust Mentored Research Award; NIH [U24AI118644, R01 AI136942, R01 AI108829, R21 AI135221, R21 AI133440, R01 AI141609]; Food Allergy Research and Education; Ira and Diana Riklis Family Research Award in Food Allergy	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gershon/Trudeau Fellowship from Immunobiology at Yale University; Robert E. Leet and Clara Guthrie Patterson Trust Mentored Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Food Allergy Research and Education; Ira and Diana Riklis Family Research Award in Food Allergy	This work was supported by National Institutes of Health (NIH) grant T32GM007205 (to J.S.C. and S.J.O.), Gershon/Trudeau Fellowship from Immunobiology at Yale University (to U.G.), Robert E. Leet and Clara Guthrie Patterson Trust Mentored Research Award (to T.S.), NIH U24AI118644 (to M.C.B.), Food Allergy Research and Education (to S.C.E.), Ira and Diana Riklis Family Research Award in Food Allergy (to S.C.E.), NIH R01 AI136942 (to S.C.E.), NIH R01 AI108829 (to S.C.E.), NIH R21 AI135221 (to A.W.), NIH R21 AI133440 (to A.W.), and NIH R01 AI141609 (to A.W.).	ADORINI L, 1990, NATURE, V346, P63, DOI 10.1038/346063a0; Beyer KB, 2001, J ALLERGY CLIN IMMUN, V107, P1077, DOI 10.1067/mai.2001.115480; Byford E, 2019, JOVE-J VIS EXP, DOI 10.3791/58431; Chiang D, 2018, J ALLERGY CLIN IMMUN, V141, P2107, DOI 10.1016/j.jaci.2017.11.060; Dolence JJ, 2018, J ALLERGY CLIN IMMUN, V142, P1144, DOI 10.1016/j.jaci.2017.11.020; Gowthaman U, 2020, J LEUKOCYTE BIOL, V107, P409, DOI 10.1002/JLB.3RI1219-425R; Gowthaman U, 2019, SCIENCE, V365, P883, DOI 10.1126/science.aaw6433; Jandl C, 2017, METHODS MOL BIOL, V1623, P95, DOI 10.1007/978-1-4939-7095-7_8; Kobayashi T, 2017, J ALLERGY CLIN IMMUN, V139, P300, DOI 10.1016/j.jaci.2016.04.021; Ma L, 2014, J ALLERGY CLIN IMMUN, V133, P1075, DOI 10.1016/j.jaci.2013.10.029; Meli AP, 2017, J IMMUNOL, V199, P244, DOI 10.4049/jimmunol.1700141; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Mullins RJ, 2016, CLIN EXP ALLERGY, V46, P1099, DOI 10.1111/cea.12748; Noble A, 2016, CLIN EXP ALLERGY, V46, P1075, DOI 10.1111/cea.12750; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Wu H, 2015, J IMMUNOL, V195, P2080, DOI 10.4049/jimmunol.1500335; Zimmermann J, 2015, EUR J IMMUNOL, V45, P1270, DOI 10.1002/eji.201445247	17	6	6	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2021	147	2					470	483		10.1016/j.jaci.2020.04.063	http://dx.doi.org/10.1016/j.jaci.2020.04.063		FEB 2021	14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QF1NF	32709424	Green Accepted, Bronze			2022-12-18	WOS:000616665800005
J	Goel, RR; Nakabo, S; Dizon, BLP; Urban, A; Waldman, M; Howard, L; Darnell, D; Buhaya, M; Carmona-Rivera, C; Hasni, S; Kaplan, MJ; Freeman, AF; Gupta, S				Goel, Rishi R.; Nakabo, Shuichiro; Dizon, Brian L. P.; Urban, Amanda; Waldman, Meryl; Howard, Lillian; Darnell, Dirk; Buhaya, Munir; Carmona-Rivera, Carmelo; Hasni, Sarfaraz; Kaplan, Mariana J.; Freeman, Alexandra F.; Gupta, Sarthak			Lupus-like autoimmunity and increased interferon response in patients with STAT3-deficient hyper-IgE syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							MUTATIONS		[Goel, Rishi R.; Nakabo, Shuichiro; Carmona-Rivera, Carmelo; Hasni, Sarfaraz; Kaplan, Mariana J.; Gupta, Sarthak] NIAMSD, System Autoimmun Branch, NIH, Bethesda, MD 20892 USA; [Dizon, Brian L. P.] NIAMSD, Rheumatol Training Program, NIH, Bethesda, MD 20892 USA; [Urban, Amanda; Darnell, Dirk; Buhaya, Munir; Freeman, Alexandra F.] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Waldman, Meryl; Howard, Lillian] NIDDK, Kidney Dis Branch, NIH, Bethesda, MD 20892 USA; [Goel, Rishi R.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Pennsylvania; Pennsylvania Medicine	Freeman, AF (corresponding author), NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	freemaal@mail.nih.gov; sarthak.gupta@nih.gov			Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases of the National Institutes of Health; National Cancer Institute, National Institutes of Health [HHSN261200800001E]	Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Ahmed S, 2016, CEN CASE REP, V5, P61, DOI 10.1007/s13730-015-0191-0; Crow MK, 2014, J IMMUNOL, V192, P5459, DOI 10.4049/jimmunol.1002795; Flanagan SE, 2014, NAT GENET, V46, P812, DOI 10.1038/ng.3040; Goel RR, 2020, CURR OPIN RHEUMATOL, V32, P64, DOI 10.1097/BOR.0000000000000667; Goyal R, 2009, CURR OPIN RHEUMATOL, V21, P78, DOI 10.1097/BOR.0b013e32831cb939; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Leffler J, 2012, J IMMUNOL, V188, P3522, DOI 10.4049/jimmunol.1102404; Yoshida N, 2019, LUPUS, V28, P1468, DOI 10.1177/0961203319877242; Zhang Y, 2017, J EXP MED, V214, P2523, DOI 10.1084/jem.20161427	9	6	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2021	147	2					746	749		10.1016/j.jaci.2020.07.024	http://dx.doi.org/10.1016/j.jaci.2020.07.024		FEB 2021	4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QF1NF	32768442	Bronze, Green Accepted			2022-12-18	WOS:000616665800040
J	Nakajima, M; Matsuyama, M; Arai, N; Yamada, H; Hyodo, K; Nonaka, M; Kitazawa, H; Yoshida, K; Shigemasa, R; Morishima, Y; Kiwamoto, T; Masuko, H; Ishii, Y; Muratani, M; Saito, T; Hizawa, N				Nakajima, Masayuki; Matsuyama, Masashi; Arai, Naoki; Yamada, Hideyasu; Hyodo, Kentaro; Nonaka, Mizu; Kitazawa, Haruna; Yoshida, Kazufumi; Shigemasa, Rie; Morishima, Yuko; Kiwamoto, Takumi; Masuko, Hironori; Ishii, Yukio; Muratani, Masafumi; Saito, Takefumi; Hizawa, Nobuyuki			Identification of whole blood gene expressions correlated with responsiveness to benralizumab	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ASTHMA; STANDARDIZATION; EQUATIONS; RECEPTOR		[Nakajima, Masayuki; Matsuyama, Masashi; Kitazawa, Haruna; Yoshida, Kazufumi; Shigemasa, Rie; Morishima, Yuko; Kiwamoto, Takumi; Masuko, Hironori; Ishii, Yukio; Hizawa, Nobuyuki] Univ Tsukuba, Fac Med, Dept Pulm Med, Tsukuba, Ibaraki, Japan; [Arai, Naoki; Hyodo, Kentaro; Nonaka, Mizu; Saito, Takefumi] Natl Hosp Org Ibarakihigashi Natl Hosp, Tsukuba, Ibaraki, Japan; [Yamada, Hideyasu] Univ Tsukuba, Fac Med, Div Resp Med, Tsukuba, Ibaraki, Japan; [Yamada, Hideyasu] Hitachi Hitachinaka Gen Hosp, Div Resp Med, Tsukuba, Ibaraki, Japan; [Muratani, Masafumi] Univ Tsukuba, Fac Med, Dept Genome Biol, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba	Matsuyama, M (corresponding author), Univ Tsukuba, Fac Med, Dept Pulm Med, Tsukuba, Ibaraki, Japan.	mmatsuyama@md.tsukuba.ac.jp; mmatsuyama@md.tsukuba.ac.jp	Kiwamoto, Takumi/AAX-8140-2021	Kiwamoto, Takumi/0000-0003-3918-9878; Kitazawa, Haruna/0000-0001-7234-1275; Nakajima, Masayuki/0000-0002-5866-5588	Japan Society for the Promotion of Science and Clinical Research Support Program from the Japanese Society of Allergology [19H03663]	Japan Society for the Promotion of Science and Clinical Research Support Program from the Japanese Society of Allergology	This study was supported by a Grant-in-Aid for Scientific Research B (19H03663) from the Japan Society for the Promotion of Science and Clinical Research Support Program from the Japanese Society of Allergology.	Bauer M, 2019, BIOMARKERS, V24, P217, DOI 10.1080/1354750X.2018.1539769; Bleecker ER, 2016, LANCET, V388, P2115, DOI 10.1016/S0140-6736(16)31324-1; Ciccone G, 1997, EUR RESPIR J, V10, P1780; DALES RE, 1988, AM REV RESPIR DIS, V138, P317, DOI 10.1164/ajrccm/138.2.317; FitzGerald JM, 2016, LANCET, V388, P2128, DOI [10.1016/s0140-6736(16)31322-8, 10.1016/S0140-6736(16)31322-8]; Graham BL, 2019, AM J RESP CRIT CARE, V200, pE70, DOI 10.1164/rccm.201908-1590ST; Jalali A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225253; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Muggeo V.M, 2008, R NEWS, V8, P20, DOI DOI 10.1159/000323281; Nair P, 2017, NEW ENGL J MED, V376, P2448, DOI 10.1056/NEJMoa1703501; Nguyen LP, 2015, NAT IMMUNOL, V16, P207, DOI 10.1038/ni.3079; Quanjer PH, 2013, EUR RESPIR J, V42, P1046, DOI 10.1183/09031936.00195512; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rossios C, 2018, J ALLERGY CLIN IMMUN, V141, P560, DOI 10.1016/j.jaci.2017.02.045; Tan LD, 2016, J ASTHMA ALLERGY, V9, P71, DOI 10.2147/JAA.S78049; van Buuren S, 2011, J STAT SOFTW, V45, P1	16	6	6	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2021	147	2					772	+		10.1016/j.jaci.2020.08.004	http://dx.doi.org/10.1016/j.jaci.2020.08.004		FEB 2021	14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QF1NF	32795588	Bronze			2022-12-18	WOS:000616665800048
J	Petry, J; Rahmoller, J; Duhring, L; Lilienthal, GM; Lehrian, S; Buhre, JS; Bartsch, YC; Epp, A; Lunding, HB; Moremen, KW; Leliavski, A; Ehlers, M				Petry, Janina; Rahmoeller, Johann; Duehring, Lara; Lilienthal, Gina-Maria; Lehrian, Selina; Buhre, Jana Sophia; Bartsch, Yannic C.; Epp, Alexandra; Lunding, Hanna B.; Moremen, Kelley W.; Leliavski, Alexei; Ehlers, Marc			Enriched blood IgG sialylation attenuates IgG-mediated and IgG-controlled-IgE-mediated allergic reactions	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							DELTA-T CELLS; LYMPHOID-CELLS; CCR10; INFLAMMATION; EXPRESSION; PSORIASIS; RECEPTOR		[Petry, Janina; Rahmoeller, Johann; Duehring, Lara; Lilienthal, Gina-Maria; Lehrian, Selina; Buhre, Jana Sophia; Bartsch, Yannic C.; Epp, Alexandra; Lunding, Hanna B.; Leliavski, Alexei; Ehlers, Marc] Univ Lubeck, Labs Immunol & Antibody Glycan Anal, Inst Nutr Med, Lubeck, Germany; [Petry, Janina; Rahmoeller, Johann; Duehring, Lara; Lilienthal, Gina-Maria; Lehrian, Selina; Buhre, Jana Sophia; Bartsch, Yannic C.; Epp, Alexandra; Lunding, Hanna B.; Leliavski, Alexei; Ehlers, Marc] Univ Med Ctr Schleswig Holstein, Lubeck, Germany; [Rahmoeller, Johann] Univ Lubeck, Dept Anesthesiol & Intens Care, Lubeck, Germany; [Moremen, Kelley W.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Ehlers, Marc] Univ Lubeck, Airway Res Ctr North, German Ctr Lung Res DZL, Lubeck, Germany	University of Lubeck; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University System of Georgia; University of Georgia; University of Lubeck	Ehlers, M (corresponding author), Univ Lubeck, Labs Immunol & Antibody Glycan Anal, Inst Nutr Med, Lubeck, Germany.; Ehlers, M (corresponding author), Univ Med Ctr Schleswig Holstein, Lubeck, Germany.; Ehlers, M (corresponding author), Univ Lubeck, Airway Res Ctr North, German Ctr Lung Res DZL, Lubeck, Germany.	marc.ehlers@uksh.de	Ehlers, Marc/C-9441-2011	Ehlers, Marc/0000-0002-5383-8603	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [257739680 (EH 221/8-1), 398859914 (EH 221/10-1), 222374435, 49701054, 390884018]; VolkswagenStiftung [97301]; University of Lubeck;  [EXC 306]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); VolkswagenStiftung(Volkswagen); University of Lubeck; 	M.E. was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-grant numbers 257739680 (EH 221/8-1), 398859914 (EH 221/10-1), 222374435 (international Research Training Group - iRTG 1911), 49701054 (Germany's Excellence Strategies -EXC 306) and 390884018 (EXC 2167, Precision Medicine in Chronic Inflammation [PMI])-and the VolkswagenStiftung (grant no. 97301). A.L. received junior grants from the University of L_ubeck and the EXC 306. Y.C.B. and H.B.L. were members and J.P., L.D., S.L., and G.-M.L. were associated members of the RTG 1727. A.E. and J.R. were members of the iRTG 1911.	Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Berings M, 2017, J ALLERGY CLIN IMMUN, V140, P1250, DOI 10.1016/j.jaci.2017.08.025; Bernink JH, 2019, NAT IMMUNOL, V20, P992, DOI 10.1038/s41590-019-0423-0; Beutier H, 2017, J ALLERGY CLIN IMMUN, V139, P269, DOI 10.1016/j.jaci.2016.03.028; Coyne J, 2017, ACS BIOMATER SCI ENG, V3, P3395, DOI 10.1021/acsbiomaterials.7b00718; Duchene J, 2002, J BIOL CHEM, V277, P40375, DOI 10.1074/jbc.M202744200; Epp A, 2018, J ALLERGY CLIN IMMUN, V141, P399, DOI 10.1016/j.jaci.2017.06.021; Finkelman FD, 2016, J ALLERGY CLIN IMMUN, V137, P1674, DOI 10.1016/j.jaci.2016.02.015; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1829, DOI 10.1038/jid.2010.36; Hess C, 2013, J CLIN INVEST, V123, P3788, DOI 10.1172/JCI65938; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Hu SM, 2013, J IMMUNOL, V190, P3267, DOI 10.4049/jimmunol.1202261; Hudak S, 2002, J IMMUNOL, V169, P1189, DOI 10.4049/jimmunol.169.3.1189; Jin Y, 2010, J IMMUNOL, V185, P5723, DOI 10.4049/jimmunol.1001612; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kimple ME, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.40; Maddur MS, 2017, TRENDS IMMUNOL, V38, P789, DOI 10.1016/j.it.2017.08.008; McCully ML, 2012, BLOOD, V120, P4591, DOI 10.1182/blood-2012-05-433037; Oefner CM, 2012, J ALLERGY CLIN IMMUN, V129, P1647, DOI 10.1016/j.jaci.2012.02.037; Quaranta M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008946; Riis JL, 2011, EXP DERMATOL, V20, P789, DOI 10.1111/j.1600-0625.2011.01323.x; Sahmatova L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07975-2; Salimi M, 2016, CLIN EXP DERMATOL, V41, P552, DOI 10.1111/ced.12802; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Soler D, 2003, BLOOD, V101, P1677, DOI 10.1182/blood-2002-07-2348; Stockenhuber K, 2018, J EXP MED, V215, P1987, DOI 10.1084/jem.20172094; Swindell WR, 2017, J INVEST DERMATOL, V137, pS111, DOI 10.1186/s13073-017-0415-3; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Xia MC, 2014, J ALLERGY CLIN IMMUN, V134, P634, DOI 10.1016/j.jaci.2014.03.010; Xiong N, 2012, PROTEIN CELL, V3, P571, DOI 10.1007/s13238-012-2927-3; Yang J, 2016, NAT IMMUNOL, V17, P48, DOI 10.1038/ni.3312	31	6	6	1	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2021	147	2					763	+		10.1016/j.jaci.2020.05.056	http://dx.doi.org/10.1016/j.jaci.2020.05.056		FEB 2021	14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QF1NF	32603664	Green Accepted, hybrid			2022-12-18	WOS:000616665800045
J	Berdyshev, E; Goleva, E; Bronova, I; Bronoff, AS; Hoffman, BC; Ramirez-Gama, MA; Garcia, SL; Crumrine, D; Elias, PM; Cho, CB; Leung, DYM				Berdyshev, Evgeny; Goleva, Elena; Bronova, Irina; Bronoff, Anna-Sofia; Hoffman, Bryce C.; Ramirez-Gama, Marco A.; Garcia, Shannon L.; Crumrine, Debra; Elias, Peter M.; Cho, Christine B.; Leung, Donald Y. M.			Unique skin abnormality in patients with peanut allergy but no atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; food allergy; skin barrier; peanut allergy	CIS-UROCANIC ACID; IMMUNE SUPPRESSION; BARRIER FUNCTION; ECZEMA; ENVELOPE	Background: The nonlesional skin of children with atopic dermatitis (AD) with peanut allergy (PA) is associated with increased transepidermal water loss; low urocanic acid (UCA) and pyrrolidone carboxylic acid (PCA), both of which are filaggrin breakdown products; anda reduced ratio of esterified co-hydroxy fatty acid sphingosine ceramides (EOS-CERs) to nonhydroxy fatty acid sphingosine ceramides (NS-CERs) in the skin. The skin barrier of subjects with PA without AD (AD(-)PA(+)) has not been studied. Objective: Our aim was to explore whether AD-PA+ is associated with skin barrier abnormalities. Methods: A total of 33 participants were enrolled, including 13 AD-PA(+), 9 AD(+)PA(+), and 11 nonatopic (NA) participants. Results: The PCA content in the stratum corneum of AD(-)PA(+) subjects was significantly reduced versus that in NA subjects (median level, 67 vs 97 mu g/mg protein [P = .028]). The ratio between cisand trans-UCA decreased significantly from being highest in the NA group (1.62) to lowest in AD(+)PA(+) group (0.07 [P <.001 vs in the NA group; P = .006 vs in the AD(-)PA(+) group]), with the AD-PA(+) group having an intermediate cis/trans-UCA ratio (1.17 [P = .024 vs in the NA group]). The TEWL in AD(-)PA(+) subjects did not differ from that in the group with NA skin. Interestingly, AD-PA(+) subjects had an increased EOS/NS-CER ratio versus that in the group of subjects with NA skin (1.9 vs 1.3 [P = .008]), whereas the AD(+)PA(+) group had a decreased proportion of EOS-CERs (0.8 [P = .001] vs in the AD-PA(+) group). Conclusion: Our data demonstrate that irrespective of AD, PA is associated with decreased skin cis-UCA and PCA content. An increase in skin EOS-CER/NS-CER ratio separates the AD-PA(+) group from the AD(+)PA(+) and NA groups.	[Berdyshev, Evgeny; Bronova, Irina] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Goleva, Elena; Bronoff, Anna-Sofia; Hoffman, Bryce C.; Ramirez-Gama, Marco A.; Garcia, Shannon L.; Cho, Christine B.; Leung, Donald Y. M.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Crumrine, Debra; Elias, Peter M.] Univ Calif San Francisco, Dept Dermatol, VA Med Ctr, San Francisco, CA 94143 USA; [Cho, Christine B.; Leung, Donald Y. M.] Univ Colorado, Dept Pediat, Denver, CO 80202 USA	National Jewish Health; National Jewish Health; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Denver	Leung, DYM (corresponding author), Natl Jewish Hlth, 1400 Jackson St,K801a, Denver, CO 80206 USA.	Leungd@njhealth.org			National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Award [UL1 TR002535]; Atopic Dermatitis Research Network Leadership Center [1UM1AI151958-01]; Atopic Dermatitis Research Network Clinical Research Center [1U01AI152037-01]; Edelstein Family Chair for Pediatric Allergy at National Jewish Health	National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Award; Atopic Dermatitis Research Network Leadership Center; Atopic Dermatitis Research Network Clinical Research Center; Edelstein Family Chair for Pediatric Allergy at National Jewish Health	Supported by the National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Award (grant UL1 TR002535), the Atopic Dermatitis Research Network Leadership Center (grant 1UM1AI151958-01), the Atopic Dermatitis Research Network Clinical Research Center (grant 1U01AI152037-01), and the Edelstein Family Chair for Pediatric Allergy at National Jewish Health.	[Anonymous], 2019, MMWR Morb Mortal Wkly Rep, V68, P831, DOI 10.15585/mmwr.mm6838a6; Berdyshev E, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98006; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; DEFABO EC, 1983, J EXP MED, V158, P84, DOI 10.1084/jem.158.1.84; Elias PM, 2014, BBA-MOL CELL BIOL L, V1841, P314, DOI 10.1016/j.bbalip.2013.09.011; Gibbs NK, 2011, J INVEST DERMATOL, V131, P14, DOI 10.1038/jid.2010.276; Goleva E, 2019, J CLIN INVEST, V129, P1463, DOI 10.1172/JCI124608; Ishikawa J, 2010, J INVEST DERMATOL, V130, P2511, DOI 10.1038/jid.2010.161; Janssens M, 2012, J LIPID RES, V53, P2755, DOI 10.1194/jlr.P030338; Joensen UN, 2014, ENVIRON HEALTH PERSP, V122, P345, DOI 10.1289/ehp.1306720; Kezic S, 2011, ALLERGY, V66, P934, DOI 10.1111/j.1398-9995.2010.02540.x; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Lappin MB, 1995, ADV EXP MED BIOL, V378, P211; Leung DYM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav2685; Martin PE, 2015, CLIN EXP ALLERGY, V45, P255, DOI 10.1111/cea.12406; Miyaji Y, 2020, J ALLER CL IMM-PRACT, V8, P1721, DOI 10.1016/j.jaip.2019.11.036; Oyoshi MK, 2009, J ALLERGY CLIN IMMUN, V124, P485, DOI 10.1016/j.jaci.2009.05.042; Rueter K, 2019, J ALLERGY CLIN IMMUN, V143, P1012, DOI 10.1016/j.jaci.2018.08.037; Samady W, 2019, ANN ALLERG ASTHMA IM, V122, P656, DOI 10.1016/j.anai.2019.03.019; Smith AR, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0674-5; Tordesillas L, 2014, J CLIN INVEST, V124, P4965, DOI 10.1172/JCI75660; van Smeden J, 2014, EXP DERMATOL, V23, P45, DOI 10.1111/exd.12293; Walker MT, 2018, J ALLERGY CLIN IMMUN, V141, P1711, DOI 10.1016/j.jaci.2018.02.003; Walterscheid JP, 2006, P NATL ACAD SCI USA, V103, P17420, DOI 10.1073/pnas.0603119103	25	6	6	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2021	147	1					361	+		10.1016/j.jaci.2020.06.015	http://dx.doi.org/10.1016/j.jaci.2020.06.015		JAN 2021	8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PS2UA	32615171	Green Accepted			2022-12-18	WOS:000607781700009
J	Satitsuksanoa, P; van de Veen, W; Akdis, M				Satitsuksanoa, Pattraporn; van de Veen, Willem; Akdis, Mubeccel			B cells in food allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Allergen-specific IgE; IgE plus B cells; IgG(1); IgG(4); oral immunotherapy	IGG(4)		[Satitsuksanoa, Pattraporn; van de Veen, Willem; Akdis, Mubeccel] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Herman Burchard Str 9, CH-7265 Davos, Switzerland; [van de Veen, Willem] Christine Kuhne Ctr Allergy Res & Educ CK CARE, Davos, Switzerland	Swiss Institute of Allergy & Asthma Research; University of Zurich	Akdis, M (corresponding author), Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Herman Burchard Str 9, CH-7265 Davos, Switzerland.	akdism@siaf.uzh.ch	Satitsuksanoa, Pattraporn/AAS-3435-2021		Swiss National Science Foundation [310030-179428]; Sean Parker Asthma and Allergy Center, Stanford University	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Sean Parker Asthma and Allergy Center, Stanford University	The authors' laboratories are supported by the Swiss National Science Foundation (grant no. 310030-179428), Sean Parker Asthma and Allergy Center, Stanford University.	Croote D, 2018, SCIENCE, V362, P1306, DOI 10.1126/science.aau2599; Hoh RA, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay4209; Hoh RA, 2016, J ALLERGY CLIN IMMUN, V137, P157, DOI 10.1016/j.jaci.2015.05.029; Jimenez-Saiz R, 2019, ALLERGY, V74, P165, DOI 10.1111/all.13481; Neeland MR, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14919-4; Neeland MR, 2019, ALLERGY, V74, P1022, DOI 10.1111/all.13707; Noh J, 2010, CELL IMMUNOL, V264, P143, DOI 10.1016/j.cellimm.2010.05.013; Santos AF, 2015, J ALLERGY CLIN IMMUN, V135, P1249, DOI 10.1016/j.jaci.2015.01.012; Satitsuksanoa P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02939; Schwarz A, 2016, J ALLERGY CLIN IMMUN, V138, P1426, DOI 10.1016/j.jaci.2016.01.057	10	6	6	2	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2021	147	1					49	51		10.1016/j.jaci.2020.11.014	http://dx.doi.org/10.1016/j.jaci.2020.11.014		JAN 2021	3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QA7UA	33242492	Bronze			2022-12-18	WOS:000613645900005
J	Simard, M; Madore, AM; Girard, S; Waserman, S; Duan, QL; Subbarao, P; Sears, MR; Moraes, TJ; Becker, AB; Turvey, SE; Mandhane, PJ; Morin, C; Begin, P; Laprise, C				Simard, Mathieu; Madore, Anne-Marie; Girard, Simon; Waserman, Susan; Duan, Qingling; Subbarao, Padmaja; Sears, Malcolm R.; Moraes, Theo J.; Becker, Allan B.; Turvey, Stuart E.; Mandhane, Piushkumar J.; Morin, Charles; Begin, Philippe; Laprise, Catherine			Polygenic risk score for atopic dermatitis in the Canadian population	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Simard, Mathieu; Madore, Anne-Marie; Girard, Simon; Morin, Charles; Laprise, Catherine] Univ Quebec Chicoutimi, Dept Sci Fondamentales, Saguenay, PQ, Canada; [Simard, Mathieu; Girard, Simon; Laprise, Catherine] Univ Quebec Chicoutimi, Ctr Intersectoriel Sante Durable, Saguenay, PQ, Canada; [Waserman, Susan] McMaster Univ, Div Clin Immunol & Allergy, Hamilton, ON, Canada; [Duan, Qingling] Queens Univ, Sch Comp, Kingston, ON, Canada; [Duan, Qingling] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Subbarao, Padmaja; Moraes, Theo J.] Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON, Canada; [Sears, Malcolm R.] McMaster Univ, Div Respirol, Hamilton, ON, Canada; [Becker, Allan B.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Turvey, Stuart E.] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada; [Mandhane, Piushkumar J.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Morin, Charles; Laprise, Catherine] Ctr Integre Univ Sante & Serv Sociaux Saguenay La, Dept Pediat, Saguenay, PQ, Canada; [Begin, Philippe] Ctr Hosp Univ Montreal, Dept Med, Montreal, PQ, Canada; [Begin, Philippe] CHU St Justine, Dept Pediat, Montreal, PQ, Canada	University of Quebec; University of Quebec Chicoutimi; University of Quebec; University of Quebec Chicoutimi; McMaster University; Queens University - Canada; Queens University - Canada; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; University of Manitoba; University of British Columbia; University of Alberta; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Laprise, C (corresponding author), Univ Quebec Chicoutimi, Dept Sci Fondamentales, Saguenay, PQ, Canada.; Laprise, C (corresponding author), Univ Quebec Chicoutimi, Ctr Intersectoriel Sante Durable, Saguenay, PQ, Canada.; Laprise, C (corresponding author), Ctr Integre Univ Sante & Serv Sociaux Saguenay La, Dept Pediat, Saguenay, PQ, Canada.	catherine.laprise@uqac.ca	Bégin, Philippe/AAU-9126-2021; Moraes, Theo/CAJ-3254-2022; Turvey, Stuart/HGV-1191-2022	Moraes, Theo/0000-0001-9968-6601; Turvey, Stuart/0000-0003-1599-1065	Fonds de recherche du Quebec -Sante (FRQS) Master's Training Award; Quebec Respiratory Health Network (RHN); Canada Research Chair in the Environment and Genetics of Respiratory Disorders and Allergy; European Commission as part of GABRIEL (A multidisciplinary study to identify the genetic and environmental causes of asthma in the European Community) [018996, LSH-2004-1.2.5-1]; Wellcome Trust [WT091310]	Fonds de recherche du Quebec -Sante (FRQS) Master's Training Award; Quebec Respiratory Health Network (RHN); Canada Research Chair in the Environment and Genetics of Respiratory Disorders and Allergy; European Commission as part of GABRIEL (A multidisciplinary study to identify the genetic and environmental causes of asthma in the European Community); Wellcome Trust(Wellcome TrustEuropean Commission)	M.S. is supported by a Fonds de recherche du Quebec -Sante (FRQS) Master's Training Award. This study had support from the Quebec Respiratory Health Network (RHN; https://rsr-qc.ca/en/) pilot project grants and by the Canada Research Chair in the Environment and Genetics of Respiratory Disorders and Allergy. The Canadian Institutes of Health Research (CIHR), and the Allergy, Genes and Environment (AllerGen) Network of Centres of Excellence provided core support for the CHILD study. C.L. is part of the Quebec RHN, the investigator of the CHILD study, the director of the Centre intersectoriel en sante durable de l'UQAC and the chairholder of the Canada Research Chair in the Environment and Genetics of Respiratory Disorders and Allergy (http://www.chairs.gc.ca).The GWAS data were made available by the European Commission as part of GABRIEL (A multidisciplinary study to identify the genetic and environmental causes of asthma in the European Community) contract number 018996 under the Integrated Program LSH-2004-1.2.5-1 (Post genomic approaches to understand the molecular basis of asthma aiming at a preventive or therapeutic control). This study makes use of data generated by the UK10K Consortium. A full list of the investigators who contributed to the generation of the data is available from www.UK10K.org.Funding for UK10K was provided by the Wellcome Trust under award WT091310.	Do CB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002973; Du Toit G, 2016, NEW ENGL J MED, V374, P1435, DOI 10.1056/NEJMoa1514209; Fahmideh MA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54701-1; Horimukai K, 2014, J ALLERGY CLIN IMMUN, V134, P824, DOI 10.1016/j.jaci.2014.07.060; Huls A, 2018, PEDIAT ALLERG IMM-UK, V29, P596, DOI 10.1111/pai.12903; Natsume O, 2017, LANCET, V389, P276, DOI 10.1016/S0140-6736(16)31418-0; Pedersen ESL, 2019, J ALLER CL IMM-PRACT, V7, P943, DOI 10.1016/j.jaip.2018.09.032; Simpson EL, 2014, J ALLERGY CLIN IMMUN, V134, P818, DOI 10.1016/j.jaci.2014.08.005; Tran MM, 2018, J ALLERGY CLIN IMMUN, V141, P601, DOI 10.1016/j.jaci.2017.08.024	9	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2021	147	1					406	+		10.1016/j.jaci.2020.04.057	http://dx.doi.org/10.1016/j.jaci.2020.04.057		JAN 2021	4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PS2UA	32439431	Green Accepted, hybrid			2022-12-18	WOS:000607781700019
J	Israel, E				Israel, Elliot			Implementing the guidelines: What do you do when the rubber hits the road?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; guidelines; inhaled corticosteroids; SMART; immunotherapy; exhaled nitric oxide; bronchial thermoplasty	BUDESONIDE-FORMOTEROL	The National Asthma Education and Prevention Program Coordinating Committee Expert Panel Report 4 Working Group has issued a selected update to the 2007 National Asthma Education and Prevention Program guidelines based on predetermined questions. This rostrum provides an overview of the clinically important recommendations and a guide to practical issues that clinicians may face as they implement the working group's updated guidance. It also draws attention to areas in which the recommendations differ from those of the Global INitiative for Asthma. Factors that clinicians may wish to consider as they step up therapy in the continuum of care are elaborated, especially in areas in which the update does not provide sufficient information to make a recommendation.	[Israel, Elliot] Harvard Med Sch, Gloria M & Anthony C Simboli Distinguished Chair, Boston, MA 02115 USA; [Israel, Elliot] Brigham & Womens Hosp, Div Pulm & Crit Care Med & Allergy & Immunol, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Israel, E (corresponding author), Brigham & Womens Hosp, 15 Francis St,Clin 3, Boston, MA 02115 USA.	eisrael@partners.org						Barnes CB, 2015, RESP CARE, V60, P455, DOI 10.4187/respcare.03200; Bateman ED, 2018, NEW ENGL J MED, V378, P1877, DOI 10.1056/NEJMoa1715275; Expert Panel Working Group of the National Heart Lung and Blood Institute (NHLBI) administered and coordinated National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC), 2020, J ALLERGY CLIN IMMUN, V146, P1217; Global Initiative for Asthma, GLOB STRAT ASTHM MAN; Jackson DJ, 2018, NEW ENGL J MED, V378, P891, DOI 10.1056/NEJMoa1710988; McKeever T, 2018, NEW ENGL J MED, V378, P902, DOI 10.1056/NEJMoa1714257; O'Byrne PM, 2018, NEW ENGL J MED, V378, P1865, DOI 10.1056/NEJMoa1715274	7	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2020	146	6					1271	1274		10.1016/j.jaci.2020.10.010	http://dx.doi.org/10.1016/j.jaci.2020.10.010			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PC3XH	33280710				2022-12-18	WOS:000596937900003
J	Camoretti-Mercado, B; Lockey, RF				Camoretti-Mercado, Blanca; Lockey, Richard F.			Bitter taste receptors in the treatment of asthma: Opportunities and challenges	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; bitter taste receptor; bronchodilation; contraction; obstructive lung disease; inflammation; airway smooth muscle; airway remodeling; bitter tastants; chloroquine; quinine; denatonium; GPCR; toxicity; adrenergic			[Camoretti-Mercado, Blanca; Lockey, Richard F.] Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy & Immunol, Tampa, FL 33612 USA	State University System of Florida; University of South Florida	Camoretti-Mercado, B (corresponding author), Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy & Immunol, Tampa, FL 33612 USA.	bcamoret@usf.edu			Joy McCann Culverhouse Endowment	Joy McCann Culverhouse Endowment	We thank the Joy McCann Culverhouse Endowment for funding support.	Camoretti-Mercado B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131582; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Pulkkinen V, 2012, AM J PHYSIOL-LUNG C, V303, pL956, DOI 10.1152/ajplung.00205.2012; Robinett KS, 2014, AM J RESP CELL MOL, V50, P678, DOI 10.1165/rcmb.2013-0439RC; Talmon M, 2019, J BIOL CHEM, V294, P12472, DOI 10.1074/jbc.RA119.007763; Tan XH, 2014, BRIT J PHARMACOL, V171, P646, DOI 10.1111/bph.12460; Triantafillou V, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00064; Zhang CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001501	9	6	7	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2020	146	4					776	779		10.1016/j.jaci.2020.04.036	http://dx.doi.org/10.1016/j.jaci.2020.04.036			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OH2JO	32407838	Bronze			2022-12-18	WOS:000582395800005
J	Johnson, JL; Gupta, RS; Bilaver, LA; Hu, JW; Martin, J; Jiang, JL; Bozen, A; Davis, MM; Reese, J; Cooper, S; Togias, A; Arbes, SJ				Johnson, Jacqueline L.; Gupta, Ruchi S.; Bilaver, Lucy A.; Hu, Jack W.; Martin, Jennifer; Jiang, Jialing; Bozen, Alexandria; Davis, Matthew M.; Reese, Jamie; Cooper, Susan; Togias, Alkis; Arbes, Samuel J.			Implementation of the Addendum Guidelines for Peanut Allergy Prevention by US allergists, a survey conducted by the NIAID, in collaboration with the AAAAI	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Peanut allergy; food allergy; prevention guidelines; clinical practice; survey	ANAPHYLACTIC REACTIONS; FATALITIES; FOOD	Background: In 2017, the Addendum Guidelines for the Prevention of Peanut Allergy were published with recommendations on early introduction of peanut-containing foods based on infants' clinical history. Objective: We sought to conduct a nationwide US survey to assess Guidelines implementation among allergists and immunologists who manage infants for food allergy. Methods: Survey invitations were delivered to 3281 nonretired, US members of the American Academy of Asthma, Allergy & Immunology, board certified in allergy and immunology. The survey assessed awareness and implementation of the Guidelines and barriers to implementation. Descriptive statistics were generated. Results: Twenty-nine percent (946 of 3281) of surveyed allergists/immunologists responded, and 87.1% (825 of 946) of responders met eligibility criteria. Among eligible responders, 97.1% were aware of the Guidelines. Of these, 64.5% reported full implementation of the Guidelines as published, 34.4% reported partial implementation, and 1.1% reported using none of the Guidelines. Barriers to Guidelines use included parental (47.6%) and self (21.8%) concerns about allergic reactions, lack of referrals (33.6%), parents uninterested in early feeding (28.2%), and lack of clinic time (20.9%). The 2 most common deviations from the Guidelines were considering additional factors not specified in the Guidelines such as family history (50.2%) and conducting skin prick testing in non-high-risk children (43.9%). Of respondents using the Guidelines, 45.7% indicated they needed more education or training. Conclusions: Essentially all allergists/immunologists who responded to the survey reported full or partial Guidelines implementation. Parental concerns and lack of referrals are major identifiable barriers. Improved Guidelines messaging to parents and referring physicians is warranted.	[Johnson, Jacqueline L.; Hu, Jack W.; Martin, Jennifer; Reese, Jamie; Arbes, Samuel J.] Rho Inc, 2635 East NC Highway 55, Durham, NC 27713 USA; [Gupta, Ruchi S.; Davis, Matthew M.] Ann & Robert H Lurie Childrens Hosp, Chicago, IL USA; [Gupta, Ruchi S.; Bilaver, Lucy A.; Jiang, Jialing; Bozen, Alexandria; Davis, Matthew M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Cooper, Susan; Togias, Alkis] NIAID, Div Allergy Immunol & Transplantat, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Rho; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Johnson, JL (corresponding author), Rho Inc, 2635 East NC Highway 55, Durham, NC 27713 USA.	Jacqueline_Johnson@rhoworld.com			National Institute of Allergy and Infectious Diseases [1UM2AI117870-04]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the National Institute of Allergy and Infectious Diseases (grant no. 1UM2AI117870-04).	[Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; [Anonymous], CENS BUR REG DIV STA; Bock SA, 2007, J ALLERGY CLIN IMMUN, V119, P1016, DOI 10.1016/j.jaci.2006.12.622; Bock SA, 2001, J ALLERGY CLIN IMMUN, V107, P191, DOI 10.1067/mai.2001.112031; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Greenhawt M, 2018, ANN ALLERG ASTHMA IM, V120, P620, DOI 10.1016/j.anai.2018.03.001; Gupta RS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10511; Gupta RS, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.5630; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Lai M, 2019, ANN ALLERG ASTHMA IM, V122, P647, DOI 10.1016/j.anai.2019.03.034; Motosue MS, 2018, PEDIAT ALLERG IMM-UK, V29, P538, DOI 10.1111/pai.12908; Togias A, 2017, J ALLERGY CLIN IMMUN, V139, P29, DOI 10.1016/j.jaci.2016.10.010	12	6	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2020	146	4					875	883		10.1016/j.jaci.2020.07.020	http://dx.doi.org/10.1016/j.jaci.2020.07.020			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OH2JO	32745556	Green Accepted			2022-12-18	WOS:000582395800018
J	Portales-Cervantes, L; Crump, OM; Dada, S; Liwski, CR; Gotovina, J; Haidl, ID; Marshall, JS				Portales-Cervantes, Liliana; Crump, Owen M.; Dada, Sarah; Liwski, Christopher R.; Gotovina, Jelena; Haidl, Ian D.; Marshall, Jean S.			IL-4 enhances interferon production by virus-infected human mast cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							RHINOVIRUS		[Portales-Cervantes, Liliana; Crump, Owen M.; Dada, Sarah; Liwski, Christopher R.; Haidl, Ian D.; Marshall, Jean S.] Dalhousie Univ, Dept Microbiol & Immunol, Dalhousie Human Immunol & Inflammat Grp, Halifax, NS, Canada; [Gotovina, Jelena] Med Univ Vienna, Univ Vienna Med, Interuniv Messerli Res Inst, Comparat Med, Vienna, Austria; [Gotovina, Jelena] Univ Vienna, Vienna, Austria; [Gotovina, Jelena] Med Univ Vienna, Inst Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria	Dalhousie University; Medical University of Vienna; University of Vienna; Medical University of Vienna	Marshall, JS (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Dalhousie Human Immunol & Inflammat Grp, Halifax, NS, Canada.	jean.marshall@dal.ca		Marshall, Jean S./0000-0002-5642-1379	CIHR [MOP93517] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		Akoto C, 2017, CLIN EXP ALLERGY, V47, P351, DOI 10.1111/cea.12879; Al-Afif A, 2015, J ALLERGY CLIN IMMUN, V136, P1346, DOI 10.1016/j.jaci.2015.01.042; Cheung DS, 2012, CURR ALLERGY ASTHM R, V12, P613, DOI 10.1007/s11882-012-0295-y; Contoli M, 2015, ALLERGY, V70, P910, DOI 10.1111/all.12627; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Portales-Cervantes L, 2017, J INNATE IMMUN, V9, P94, DOI 10.1159/000450576; Tel J, 2011, J INVEST DERMATOL, V131, P900, DOI 10.1038/jid.2010.410; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wollenberg A, 2003, J ALLERGY CLIN IMMUN, V112, P667, DOI 10.1016/j.jaci.2003.07.001	9	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2020	146	3					675	+		10.1016/j.jaci.2020.02.011	http://dx.doi.org/10.1016/j.jaci.2020.02.011			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NN7PN	32112794	hybrid			2022-12-18	WOS:000568978400005
J	Chirumbolo, S; Bjorklund, G				Chirumbolo, Salvatore; Bjorklund, Geir			The bimodal SARS-CoV-2 outbreak in Italy as an effect of environmental and allergic causes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ASTHMA		[Chirumbolo, Salvatore] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Chirumbolo, Salvatore; Bjorklund, Geir] Council Nutr & Environm Med CONEM, Mo I Rana, Norway	University of Verona	Chirumbolo, S (corresponding author), Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy.; Chirumbolo, S (corresponding author), Council Nutr & Environm Med CONEM, Mo I Rana, Norway.	salvatore.chirumbolo@univr.it	Chirumbolo, Salvatore/L-6865-2016	Chirumbolo, Salvatore/0000-0003-1789-8307				AlGhatrif M, 2020, JAMA CARDIOL, V5, P747, DOI 10.1001/jamacardio.2020.1329; Chiambaretta Navel V, 2020, J ALLERGY CLIN IMMUN, DOI 10.1016/j.jaci.2020.04.026.; Conticini E, 2020, ENVIRON POLLUT, V261, DOI 10.1016/j.envpol.2020.114465; Dhawale VS, 2016, TOXICOL APPL PHARM, V306, P17, DOI 10.1016/j.taap.2016.06.026; Li X, 2019, SCI TOTAL ENVIRON, V691, P549, DOI 10.1016/j.scitotenv.2019.06.382; Panza F, 2007, ATHEROSCLEROSIS, V193, P455, DOI 10.1016/j.atherosclerosis.2006.08.040; Pesce G, 2016, SCI TOTAL ENVIRON, V544, P645, DOI 10.1016/j.scitotenv.2015.12.015	7	6	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2020	146	2					331	332		10.1016/j.jaci.2020.05.011	http://dx.doi.org/10.1016/j.jaci.2020.05.011			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MZ0TA	32507495	Bronze, Green Published			2022-12-18	WOS:000558835000047
J	van Leersum, FS; Nagtzaam, IF; van Oosterhoud, CN; Ghesquiere, SAI; Brandts, RRHFJ; Gostynski, A; Steijlen, PM; van Geel, M				van Leersum, Frank S.; Nagtzaam, Ivo F.; van Oosterhoud, Carolien N.; Ghesquiere, Stijn A. I.; Brandts, Roel R. H. F. J.; Gostynski, Antoni; Steijlen, Peter M.; van Geel, Michel			Improving the diagnostic yield for filaggrin: Concealed mutations in the Dutch population	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ATOPIC-DERMATITIS; GENE		[van Leersum, Frank S.; Nagtzaam, Ivo F.; Gostynski, Antoni; Steijlen, Peter M.; van Geel, Michel] Maastricht Univ, Med Ctr, Dept Dermatol, Maastricht, Netherlands; [van Leersum, Frank S.; Nagtzaam, Ivo F.; Gostynski, Antoni; Steijlen, Peter M.; van Geel, Michel] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [van Oosterhoud, Carolien N.; Ghesquiere, Stijn A. I.; Brandts, Roel R. H. F. J.; van Geel, Michel] Maastricht Univ, Med Ctr, Dept Clin Genet, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	van Leersum, FS (corresponding author), Maastricht Univ, Med Ctr, Dept Dermatol, Maastricht, Netherlands.; van Leersum, FS (corresponding author), Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands.	frank.van.leersum@mumc.nl						Chen H, 2011, BRIT J DERMATOL, V165, P106, DOI 10.1111/j.1365-2133.2011.10331.x; Eijkelenboom A, 2016, J MOL DIAGN, V18, P851, DOI 10.1016/j.jmoldx.2016.06.010; Gruber R, 2007, EUR J HUM GENET, V15, P179, DOI 10.1038/sj.ejhg.5201742; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Margolis DJ, 2020, ARCH DERMATOL RES, V312, P155, DOI 10.1007/s00403-019-01956-3; Margolis DJ, 2018, J INVEST DERMATOL, V138, P1501, DOI 10.1016/j.jid.2018.01.029; Margolis DJ, 2014, J INVEST DERMATOL, V134, P2272, DOI 10.1038/jid.2014.126; Margolis DJ, 2013, J DERMATOL SCI, V70, P67, DOI 10.1016/j.jdermsci.2012.11.594; Margolis DJ, 2012, J ALLERGY CLIN IMMUN, V130, P912, DOI 10.1016/j.jaci.2012.07.008; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pigors M, 2018, J INVEST DERMATOL, V138, P2674, DOI 10.1016/j.jid.2018.05.013; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Wong XFCC, 2018, J ALLERGY CLIN IMMUN, V141, P814, DOI 10.1016/j.jaci.2017.10.001	14	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2020	145	6					1704	+		10.1016/j.jaci.2020.01.033	http://dx.doi.org/10.1016/j.jaci.2020.01.033			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LW4ZZ	32018027	Bronze			2022-12-18	WOS:000539157800030
J	Akenroye, A; McCormack, M; Keet, C				Akenroye, Ayobami; McCormack, Meredith; Keet, Corinne			Severe asthma in the US population and eligibility for mAb therapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Akenroye, Ayobami; Keet, Corinne] Johns Hopkins Univ, Sch Med, Dept Pediat Allergy & Immunol, Baltimore, MD 21218 USA; [McCormack, Meredith] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Akenroye, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat Allergy & Immunol, Baltimore, MD 21218 USA.	aakenroye@jhmi.edu		Pham, Hewlett/0000-0003-0330-6104; akenroye, ayobami/0000-0002-1909-1470; Koehl, Rachelle/0000-0002-7797-7456	National Institutes of Health (NIH)-National Institute of Allergy and Infectious Diseases (NIAID) [U19AI066738, U01AI066560]; National Center for Research Resources (a component of the NIH) [UL1 TR-000067, UL1 TR-000039, UL1 TR-000083, UL1 TR-000424, UL1 RR-025780]	National Institutes of Health (NIH)-National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources (a component of the NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by the National Institutes of Health (NIH)-National Institute of Allergy and Infectious Diseases (NIAID) (grants U19AI066738 and U01AI066560). The project was also supported by grants UL1 RR-025780 (University of Colorado Denver), UL1 TR-000067 (Icahn School of Medicine at Mount Sinai), UL1 TR-000039 (University of Arkansas for Medical Sciences), UL1 TR-000083 (University of North Carolina at Chapel Hill), and UL1 TR-000424 (Johns Hopkins University) from the National Center for Research Resources (a component of the NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the National Center for Research Resources or the NIH.	Albers FC, 2018, J ASTHMA, V55, P152, DOI 10.1080/02770903.2017.1322611; Centers for Disease Control and Prevention, ASTHM SURV DAT; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Comberiati P, 2019, J ALLER CL IMM-PRACT, V7, P2689, DOI 10.1016/j.jaip.2019.05.053; Hambly N, 2014, CURR OPIN PULM MED, V20, P87, DOI 10.1097/MCP.0000000000000007; Hekking PPW, 2015, J ALLERGY CLIN IMMUN, V135, P896, DOI 10.1016/j.jaci.2014.08.042; Lee J, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01836-2017; Mauger D, 2019, J ALLERGY CLIN IMMUN, V143, P84, DOI 10.1016/j.jaci.2018.11.005; Tran TN, 2016, ANN ALLERG ASTHMA IM, V116, P37, DOI 10.1016/j.anai.2015.10.027	9	6	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2020	145	4					1295	+		10.1016/j.jaci.2019.12.009	http://dx.doi.org/10.1016/j.jaci.2019.12.009			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LA0FR	31866437	Bronze			2022-12-18	WOS:000523633400027
J	Arkwright, PD; Mughal, MZ				Arkwright, Peter D.; Mughal, M. Zulf			Vertebral, pelvic, and hip fracture risk in adults with severe atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Atopic dermatitis; osteoporosis; fractures; peak bone mass; corticosteroids	BONE-MINERAL DENSITY; MODERATE; OSTEOPOROSIS		[Arkwright, Peter D.] Univ Manchester, Lydia Becker Inst Immunol & Inflammat, 48 Grafton St, Manchester M13 9XX, Lancs, England; [Mughal, M. Zulf] Royal Manchester Childrens Hosp, Dept Paediat Endocrinol, Manchester, Lancs, England	University of Manchester; Royal Manchester Children's Hospital	Arkwright, PD (corresponding author), Univ Manchester, Lydia Becker Inst Immunol & Inflammat, 48 Grafton St, Manchester M13 9XX, Lancs, England.	peter.arkwright@manchester.ac.uk	MUGHAL, Zulf/AAA-1230-2021					Garg NK, 2015, J ALLERGY CLIN IMMUN, V135, P1085, DOI 10.1016/j.jaci.2014.10.043; Haeck IM, 2009, BRIT J DERMATOL, V161, P1248, DOI 10.1111/j.1365-2133.2009.09327.x; Li AW, 2017, JAMA DERMATOL, V153, P1036, DOI 10.1001/jamadermatol.2017.2437; Loke YK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008554; Lowe KE, 2020, J ALLERGY CLIN IMMUN, V145, P563, DOI 10.1016/j.jaci.2019.09.015; Shaheen MS, 2019, J AM ACAD DERMATOL, V80, P550, DOI 10.1016/j.jaad.2018.05.026; Srivastava RK, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00657; van Velsen SGA, 2012, J AM ACAD DERMATOL, V66, P691, DOI 10.1016/j.jaad.2011.09.004; van Velsen SGA, 2010, J AM ACAD DERMATOL, V63, P824, DOI 10.1016/j.jaad.2009.12.015; Wu CY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171667	10	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2020	145	2					487	488		10.1016/j.jaci.2019.10.029	http://dx.doi.org/10.1016/j.jaci.2019.10.029			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK6ZG	31704284	Bronze, Green Submitted			2022-12-18	WOS:000512887400008
J	Hirano, I; Peterson, K; Murray, J; Dellon, E; Falk, G; Gonsalves, N; Chehade, M; Leung, J; Genta, R; Khoury, P; Bledsoe, A; Shaw, C; Rasmussen, H; Singh, B; Chang, A; Kamboj, A; Rothenberg, M				Hirano, Ikuo; Peterson, Kathryn; Murray, Joseph; Dellon, Evan; Falk, Gary; Gonsalves, Nirmala; Chehade, Mirna; Leung, John; Genta, Robert; Khoury, Paneez; Bledsoe, Adam; Shaw, Camilla; Rasmussen, Henrik; Singh, Bhupinder; Chang, Alan; Kamboj, Amol; Rothenberg, Marc			AK002, an Anti-Siglec-8 Antibody, Depletes Tissue Eosinophils and Improves Dysphagia Symptoms in Patients with Eosinophilic Esophagitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 13-16, 2020	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Hirano, Ikuo; Gonsalves, Nirmala] Northwestern Univ, Evanston, IL USA; [Peterson, Kathryn] Univ Utah, Salt Lake City, UT USA; [Murray, Joseph; Bledsoe, Adam] Mayo Clin, Rochester, MN USA; [Dellon, Evan] Univ N Carolina, Chapel Hill, NC 27515 USA; [Falk, Gary] Univ Penn, Philadelphia, PA 19104 USA; [Chehade, Mirna] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Leung, John] Tufts Univ, Medford, MA 02155 USA; [Genta, Robert] Baylor Coll Med, Houston, TX 77030 USA; [Khoury, Paneez] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Shaw, Camilla; Rasmussen, Henrik; Singh, Bhupinder; Chang, Alan; Kamboj, Amol] Allakos Inc, Redwood City, CA USA	Northwestern University; Utah System of Higher Education; University of Utah; Mayo Clinic; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; Icahn School of Medicine at Mount Sinai; Tufts University; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)			Khoury, Paneez/ABH-1951-2020	Khoury, Paneez/0000-0003-1800-0079					0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2020	145	2		S		539	AB167	AB167						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	KQ7IJ					2022-12-18	WOS:000517092700537
J	Pien, LC; Colbert, CY				Pien, Lily C.; Colbert, Colleen Y.			Time to develop more clinician-educators in allergy and immunology	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Allergy and immunology; clinician-educator; community of practice; educator development; faculty development; professional development; professional identity; scholarship; teaching	MEDICAL-EDUCATION; TEACH; COMPETENCES; PROGRAM; FLEXNER	Clinician-educators in the field of allergy and immunology (A/I) in the United States teach and assess trainees (medical students, residents, and fellows), provide professional development to primary care physicians and advance practice providers, and are essential in developing a pipeline of academic A/I specialists. According to data from Doximity and the Association of American Medical Colleges, the United States appears to be facing a shortage of clinician-educators and academic allergists in A/I. Without adequate numbers of A/I specialists focused on medical education, institutions will find it difficult to train fellows and introduce the field of A/I to medical students and residents. It is now imperative that the field focus on empowering more A/I specialists to become clinical teachers and clinician-educators. There are specific strategies that individuals, as active agents in their own development, can take in planning for this rewarding and fulfilling career. Individuals can pursue professional development opportunities, join medical education communities of practice, seek education mentors, and join in scholarship activities. It is also essential that systems-level support be provided for clinician-educators, given the increasing business pressures in medicine. Academic institutions, national organizations, and professional societies can provide resources, including structured programs in medical education, protected time, and grants. This article outlines strategies for individuals, institutions, and professional organizations that will promote the development of the next generation of A/I clinician-educators.	[Pien, Lily C.; Colbert, Colleen Y.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Pien, Lily C.] Cleveland Clin, Dept Allergy & Clin Immunol, Cleveland, OH 44106 USA; [Pien, Lily C.; Colbert, Colleen Y.] Cleveland Clin, Educ Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Pien, LC (corresponding author), Cleveland Clin, 9500 Euclid Ave,Desk A90, Cleveland, OH 44195 USA.	pienl@ccf.org		Colbert, Colleen/0000-0002-2608-7218				Accreditation Council for Graduate Medical Education, 2016, GEN SURG MIL; Accreditation Council for Graduate Medical Education; American Board of Internal Medicine, 2015, INT MED MIL PROJ; Ahn J, 2018, ACAD MED, V93, P214, DOI 10.1097/ACM.0000000000001815; Association of American Medical Colleges, ACT PHYS LARG SPEC; Austen KF, 2018, J ALLERGY CLIN IMMUN, V141, P880, DOI 10.1016/j.jaci.2018.01.004; Bartle E, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-110; BICKEL J, 1991, ACAD MED, V66, P249, DOI 10.1097/00001888-199105000-00002; Blumenthal KG, 2019, J ALLERGY CLIN IMMUN, V144, P1697, DOI 10.1016/j.jaci.2019.06.026; Blumenthal KG, 2014, J ALLER CL IMM-PRACT, V2, P407, DOI 10.1016/j.jaip.2014.02.003; Budden CR, 2017, MED TEACH, V39, P188, DOI 10.1080/0142159X.2016.1248384; Chen BY, 2019, ACAD MED, V94, P678, DOI 10.1097/ACM.0000000000002580; Dallaghan GLB, 2017, ACAD MED, V92, P1168, DOI 10.1097/ACM.0000000000001667; Friedman K, 2019, ACAD MED, V94, P1599, DOI 10.1097/ACM.0000000000002814; Goldberg LR, 2017, ADV MED EDUC PRACT, V8, P603, DOI 10.2147/AMEP.S115321; Goldie J, 2012, MED TEACH, V34, pE641, DOI 10.3109/0142159X.2012.687476; Gruppen LD, 2006, ACAD MED, V81, P990, DOI 10.1097/01.ACM.0000242572.60942.97; Gusic ME, 2014, ACAD MED, V89, P1006, DOI 10.1097/ACM.0000000000000233; JACOBS MB, 1993, ACAD MED, V68, P126, DOI 10.1097/00001888-199302000-00004; Jippes E, 2013, ACAD MED, V88, P398, DOI 10.1097/ACM.0b013e318280d9db; Knight CL, 2017, J GEN INTERN MED, V32, P948, DOI 10.1007/s11606-017-4053-7; Lave J., 1991, SITUATED LEARNING LE; Lilley P, 2018, 8 ROLES MED TEACHER; Lockyer JM, 2016, MED TEACH, V38, P815, DOI 10.3109/0142159X.2015.1112895; Ludmerer KM, 2010, ACAD MED, V85, P193, DOI 10.1097/ACM.0b013e3181c8f1e7; Markel H, 2010, JAMA-J AM MED ASSOC, V303, P888, DOI 10.1001/jama.2010.225; Metcalfe DD, 2019, J ALLERGY CLIN IMMUN, V143, P548, DOI 10.1016/j.jaci.2018.10.002; Murray H, 2018, CAN J EMERG MED, V20, P162, DOI 10.1017/cem.2018.21; Nelson Michael R, 2014, J Grad Med Educ, V6, P1, DOI 10.4300/JGME-06-01s1-02; Pien LC, 2018, PERSPECT MED EDUC, V7, P214, DOI 10.1007/s40037-018-0418-9; Rougas Steven, 2019, J Grad Med Educ, V11, P263, DOI 10.4300/JGME-D-18-00985.1; Scherzer R, 2018, ANN ALLERG ASTHMA IM, V121, P657, DOI 10.1016/j.anai.2018.09.457; Shanafelt TD, 2017, JAMA-J AM MED ASSOC, V317, P901, DOI 10.1001/jama.2017.0076; Sherbino J, 2014, ACAD MED, V89, P783, DOI 10.1097/ACM.0000000000000217; Simpson Deborah, 2018, J Grad Med Educ, V10, P243, DOI 10.4300/JGME-D-18-00253.1; Srinivasan M, 2011, ACAD MED, V86, P1211, DOI 10.1097/ACM.0b013e31822c5b9a; Steinert Y, 2015, MED EDUC, V49, P773, DOI 10.1111/medu.12782; Stoddard HA, 2016, ACAD MED, V91, P921, DOI 10.1097/ACM.0000000000001210; Sullivan Gail M, 2015, J Grad Med Educ, V7, P153, DOI 10.4300/JGME-D-15-00098.1; Tekian A, 2012, MED TEACH, V34, P52, DOI 10.3109/0142159X.2011.599895; The Accreditation Council for Graduate Medical Education and The American Board of Pediatrics, 2017, PEDIAT MILESTONES PR; Wright AA, 2018, NEW ENGL J MED, V378, P309, DOI 10.1056/NEJMp1716845; Wright S, 1997, J GEN INTERN MED, V12, P53, DOI 10.1007/s11606-006-0007-1	42	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2020	145	2					456	462		10.1016/j.jaci.2019.12.008	http://dx.doi.org/10.1016/j.jaci.2019.12.008			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK6ZG	31863807				2022-12-18	WOS:000512887400002
J	Bertoni, A; Carta, S; Baldovini, C; Penco, F; Balza, E; Borghini, S; Di Duca, M; Ognio, E; Signori, A; Nozza, P; Schena, F; Castellani, P; Pastorino, C; Perrone, C; Obici, L; Martini, A; Ceccherini, I; Gattorno, M; Rubartelli, A; Chiesa, S				Bertoni, Arinna; Carta, Sonia; Baldovini, Chiara; Penco, Federica; Balza, Enrica; Borghini, Silvia; Di Duca, Marco; Ognio, Emanuela; Signori, Alessio; Nozza, Paolo; Schena, Francesca; Castellani, Patrizia; Pastorino, Claudia; Perrone, Carola; Obici, Laura; Martini, Alberto; Ceccherini, Isabella; Gattorno, Marco; Rubartelli, Anna; Chiesa, Sabrina			A novel knock-in mouse model of cryopyrin-associated periodic syndromes with development of amyloidosis: Therapeutic efficacy of proton pump inhibitors	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Cryopyrin-associated periodic syndromes; NOD-like receptor family; pyrin domain containing 3; Nlrp3N(475K/+) mice; IL-1 beta; proton pump inhibitor	NLRP3 INFLAMMASOME; AUTOINFLAMMATORY DISEASES; DENDRITIC CELLS; INTERLEUKIN-1-BETA SECRETION; OXIDATIVE STRESS; OMEPRAZOLE; REDOX; ATP; ESOMEPRAZOLE; IL-1-BETA	Background: Cryopyrin-associated periodic syndromes (CAPS) are a group of autoinflammatory diseases linked to gain-of-function mutations in the NOD-like receptor family, pyrin domain containing 3 (NLRP3) gene, which cause uncontrolled IL-1 beta secretion. Proton pump inhibitors (PPIs), which are commonly used as inhibitors of gastric acid production, also have anti-inflammatory properties, protect mice from sepsis, and prevent IL-1 beta secretion by monocytes from patients with CAPS. Objective: We sought to develop a novel Nlrp3 knock-in (KI) mouse model of CAPS to study amyloidosis, a severe CAPS complication, and test novel therapeutic approaches. Methods: We generated KI mice by engineering the N475K mutation, which is associated with the CAPS phenotype, into the mouse Nlrp3 gene. KI and wild-type mice received PPIs or PBS intraperitoneally and were analyzed for survival, inflammation, cytokine secretion, and amyloidosis development. Results: Mutant Nlrp3 KI mice displayed features that recapitulate the immunologic and clinical phenotype of CAPS. They showed systemic inflammation with high levels of serum proinflammatory cytokines, inflammatory infiltrates in various organs, and amyloid deposits in the spleen, liver, and kidneys. Toll-like receptor stimulated macrophages from KI mice secreted high levels of IL-1 beta, IL-18, and IL-1 alpha but low amounts of IL-1 receptor antagonist. Treatment of KI mice with PPIs had a clear clinical effect, showing a reduction in inflammatory manifestations, regression of amyloid deposits, and normalization of proinflammatory and anti-inflammatory cytokine production by macrophages. Conclusion: Nlrp3 KI mice displayed a CAPS phenotype with many characteristics of autoinflammation, including amyloidosis. The therapeutic effectiveness of PPIs associated with a lack of toxicity indicates that these drugs could represent relevant adjuvants to the anti-IL-1 drugs in patients with CAPS and other IL-1-driven diseases.	[Bertoni, Arinna; Penco, Federica; Schena, Francesca; Pastorino, Claudia; Perrone, Carola; Gattorno, Marco; Chiesa, Sabrina] IRCCS Ist G Gaslini, UOSD Ctr Malattie Autoinfiammatorie & Immunodefic, Via G Gaslini 5, I-16147 Genoa, Italy; [Baldovini, Chiara; Nozza, Paolo] IRCCS Ist G Gaslini, Anat Patol, Genoa, Italy; [Borghini, Silvia; Ceccherini, Isabella] IRCCS Ist G Gaslini, Genet Med, Genoa, Italy; [Di Duca, Marco] IRCCS Ist G Gaslini, Lab Fisiopatol Uremia, Genoa, Italy; [Martini, Alberto] IRCCS Ist G Gaslini, Direz Sci, Genoa, Italy; [Gattorno, Marco] IRCCS Ist G Gaslini, UOC Clin Pediat & Reumatol, Genoa, Italy; [Carta, Sonia; Balza, Enrica; Castellani, Patrizia; Rubartelli, Anna] IRCCS Osped Policlin San Martino, Unita Biol Cellulare, Genoa, Italy; [Ognio, Emanuela] IRCCS Osped Policlin San Martino, SS Anim Facil, Genoa, Italy; [Signori, Alessio] Univ Genoa, DISSAL, Dipartimento Sci Salute, Sez Biostat, Genoa, Italy; [Obici, Laura] Fdn IRCCS Policlin San Matteo, Ctr Studio & Cura Amiloidosi Sistem, Pavia, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Fondazione San Matteo	Gattorno, M; Chiesa, S (corresponding author), IRCCS Ist G Gaslini, UOSD Ctr Malattie Autoinfiammatorie & Immunodefic, Via G Gaslini 5, I-16147 Genoa, Italy.	marcogattorno@gaslini.org; sabrinachiesa@gaslini.org	Penco, Federica/L-1013-2016; Schena, Francesca/AAA-9214-2020; Nozza, Paolo/AAC-5901-2022; Gattorno, Marco/AAL-2974-2020; Rubartelli, Anna/AAA-1259-2021; Bertoni, Arinna/AAB-3394-2019; Chiesa, Sabrina/AAN-7877-2020; Castellani, Patrizia/J-7333-2018; Di Duca, Marco/AAB-4531-2021; Ceccherini, Isabella/P-8195-2014; carta, sonia/AAB-3799-2020; Signori, Alessio/L-3081-2016	Penco, Federica/0000-0002-8437-3466; Schena, Francesca/0000-0002-5868-7699; Gattorno, Marco/0000-0003-0704-1916; Bertoni, Arinna/0000-0001-8317-9584; Castellani, Patrizia/0000-0002-6326-5853; Di Duca, Marco/0000-0001-8456-7706; Ceccherini, Isabella/0000-0001-8732-1955; carta, sonia/0000-0002-1278-9761; Chiesa, Sabrina/0000-0002-0392-1927; Signori, Alessio/0000-0001-6289-9144; MARTINI, Alberto/0000-0001-7642-1459; Perrone, Carola/0000-0001-5174-6978	Telethon Foundation [GGP09127, GGP14144]; Associazione Italiana per la Ricerca sul Cancro [IG15434]; Italian Ministry of Health [GR-2010-2309622, GR-2016-02363630]	Telethon Foundation(Fondazione Telethon); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy)	Supported by the Telethon Foundation (grants GGP09127 and GGP14144), Associazione Italiana per la Ricerca sul Cancro (grant IG15434), and the Italian Ministry of Health ("Young Investigators'' grants GR-2010-2309622 and GR-2016-02363630).	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Balza E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.218; Balza E, 2017, ONCOTARGET, V8, P67482, DOI 10.18632/oncotarget.18713; Bardou M, 2009, DRUGS, V69, P435, DOI 10.2165/00003495-200969040-00004; Biswas K, 2003, J BIOL CHEM, V278, P10993, DOI 10.1074/jbc.M210328200; Brydges SD, 2013, J CLIN INVEST, V123, P4695, DOI 10.1172/JCI71543; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Carta Sonia, 2017, Front Immunol, V8, P345, DOI 10.3389/fimmu.2017.00345; Carta S, 2015, P NATL ACAD SCI USA, V112, P2835, DOI 10.1073/pnas.1424741112; Carta S, 2012, ANN RHEUM DIS, V71, P1577, DOI 10.1136/annrheumdis-2012-201340; Carta S, 2011, J BIOL CHEM, V286, P27069, DOI 10.1074/jbc.M110.203398; Chiesa S, 2011, P NATL ACAD SCI USA, V108, P17384, DOI 10.1073/pnas.1103650108; Church LD, 2010, EXPERT REV CLIN IMMU, V6, P831, DOI [10.1586/eci.10.66, 10.1586/ECI.10.66]; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Cortes JR, 2009, J ALLERGY CLIN IMMUN, V124, P607, DOI 10.1016/j.jaci.2009.06.023; De Milito A, 2010, INT J CANCER, V127, P207, DOI 10.1002/ijc.25009; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Gattorno M, 2013, ARTHRITIS RHEUM-US, V65, P1137, DOI 10.1002/art.37882; Girardin SE, 2009, IMMUNITY, V30, P761, DOI 10.1016/j.immuni.2009.06.001; Goldbach-Mansky R, 2011, CURR RHEUMATOL REP, V13, P123, DOI 10.1007/s11926-011-0165-y; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Hinton A, 2009, PFLUG ARCH EUR J PHY, V457, P589, DOI 10.1007/s00424-007-0382-4; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jiang H, 2017, J EXP MED, V214, P3219, DOI 10.1084/jem.20171419; Kedika RR, 2009, DIGEST DIS SCI, V54, P2312, DOI 10.1007/s10620-009-0951-9; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kone-Paut I, 2015, EXPERT REV CLIN IMMU, V11, P1083, DOI 10.1586/1744666X.2015.1077702; Kuemmerle-Deschner JB, 2015, SEMIN IMMUNOPATHOL, V37, P377, DOI 10.1007/s00281-015-0491-7; Lasiglie D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020014; Lavieri R, 2014, J IMMUNOL, V192, P5373, DOI 10.4049/jimmunol.1303480; Levy R, 2015, ANN RHEUM DIS, V74, P2043, DOI 10.1136/annrheumdis-2013-204991; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Manthiram K, 2017, NAT IMMUNOL, V18, P832, DOI 10.1038/ni.3777; Marchetti C, 2018, P NATL ACAD SCI USA, V115, pE1530, DOI 10.1073/pnas.1716095115; McGeough MD, 2017, J CLIN INVEST, V127, P4488, DOI 10.1172/JCI90699; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; MORIYAMA Y, 1993, BIOCHEM BIOPH RES CO, V196, P699, DOI 10.1006/bbrc.1993.2306; Parikh N, 2010, GASTROENTEROL CLIN N, V39, P529, DOI 10.1016/j.gtc.2010.08.009; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Rohss K, 2007, INT J CLIN PHARM TH, V45, P345; Semino C, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1121-9; Shin Jai Moo, 2008, Curr Gastroenterol Rep, V10, P528, DOI 10.1007/s11894-008-0098-4; Sibley CH, 2015, ANN RHEUM DIS, V74, P1714, DOI 10.1136/annrheumdis-2013-204877; Tassi S, 2010, P NATL ACAD SCI USA, V107, P9789, DOI 10.1073/pnas.1000779107; ter Haar N, 2013, ANN RHEUM DIS, V72, P678, DOI 10.1136/annrheumdis-2011-201268; Xiao JQ, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.3000047	49	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2020	145	1					368	+		10.1016/j.jaci.2019.05.034	http://dx.doi.org/10.1016/j.jaci.2019.05.034			24	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KA1WZ	31194989	Bronze			2022-12-18	WOS:000505590800040
J	Dunlop, JH; Keet, CA				Dunlop, Joan H.; Keet, Corinne A.			Allergic diseases among Asian children in the United States	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ASTHMA; RISK		[Dunlop, Joan H.; Keet, Corinne A.] Johns Hopkins Univ, Sch Med, Div Pediat Allergy & Immunol, Baltimore, MD 21218 USA	Johns Hopkins University	Keet, CA (corresponding author), Johns Hopkins Univ, Sch Med, Div Pediat Allergy & Immunol, Baltimore, MD 21218 USA.	ckeet1@jhmi.edu						[Anonymous], 2017, 2016 NHIS QUEST SAMP; Glick AF, 2016, ACAD PEDIATR, V16, P430, DOI 10.1016/j.acap.2015.12.014; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Keet CA, 2012, J ALLERGY CLIN IMMUN, V129, pe1; Keet CA, 2012, J ALLERGY CLIN IMMUN, V129, P169, DOI 10.1016/j.jaci.2011.10.002; Koplin JJ, 2014, ALLERGY, V69, P1639, DOI 10.1111/all.12487; Larsen LJW, 2013, COMMERCE; LEUNG RC, 1994, MED J AUSTRALIA, V161, P418, DOI 10.5694/j.1326-5377.1994.tb127522.x; Parsons Van L, 2014, Vital Health Stat 2, P1; Prescott SL, 2013, WORLD ALLERGY ORGAN, V6, DOI 10.1186/1939-4551-6-21; Wang YC, 2018, CLIN EXP ALLERGY, V48, P1317, DOI 10.1111/cea.13235; Zablotsky B, 2019, J ASTHMA, V56, P285, DOI 10.1080/02770903.2018.1455854	12	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2019	144	6					1727	+		10.1016/j.jaci.2019.08.009	http://dx.doi.org/10.1016/j.jaci.2019.08.009			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JT0NR	31449913	Bronze, Green Accepted			2022-12-18	WOS:000500694900031
J	Camoretti-Mercado, B; Lockey, RF				Camoretti-Mercado, Blanca; Lockey, Richard F.			The beta-adrenergic theory of bronchial asthma: 50 years later	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Airway smooth muscle; allergy; asthma; beta-adrenergic receptor; bitter taste receptor	SMOOTH-MUSCLE		[Camoretti-Mercado, Blanca; Lockey, Richard F.] Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy & Immunol, Tampa, FL 33612 USA	State University System of Florida; University of South Florida	Camoretti-Mercado, B (corresponding author), Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy & Immunol, Tampa, FL 33612 USA.	bcamoret@health.usf.edu			Joy McCann Culverhouse Endowment	Joy McCann Culverhouse Endowment	Supported by the Joy McCann Culverhouse Endowment.	BAI TR, 1990, AM REV RESPIR DIS, V141, P552, DOI 10.1164/ajrccm/141.3.552; Camoretti-Mercado B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131582; Chin LYM, 2012, EUR RESPIR J, V40, P45, DOI 10.1183/09031936.00065411; Ijpma G, 2015, AM J RESP CRIT CARE, V191, P884, DOI 10.1164/rccm.201407-1296OC; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Ortega VE, 2014, LANCET RESP MED, V2, P204, DOI 10.1016/S2213-2600(13)70289-3; Peters SP, 2016, NEW ENGL J MED, V375, P850, DOI 10.1056/NEJMoa1511190; Stempel DA, 2016, NEW ENGL J MED, V375, P840, DOI 10.1056/NEJMoa1606356; Stempel DA, 2016, NEW ENGL J MED, V374, P1822, DOI 10.1056/NEJMoa1511049; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2	10	6	7	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2019	144	5					1166	1168		10.1016/j.jaci.2019.07.010	http://dx.doi.org/10.1016/j.jaci.2019.07.010			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JK7EU	31344383	Bronze			2022-12-18	WOS:000495004700006
J	Ogando, JCB; Gaytan, AP; Becerra, JCA; Cardona, AA; Bezrodnik, L; Borzutzky, A; Galicia, LB; Cabanillas, D; Condino-Neto, A; Ranero, AD; Padilla, SE; Fernandes, JF; Campos, JAG; Tello, HG; Serrano, MEG; Hernandez, AG; Bautista, VMH; Escoto, GI; King, A; Mazzucchelli, JL; Guillen, BAL; Reyes, SOL; Espinosa, SM; Oleastro, M; Mendoza, FO; Harlowe, MCP; Porras, O; Uribe, NR; Regairaz, L; Larrauri, FR; Weber, FJS; Grumach, AS; Boone, TS; Costa-Carvalho, BT; Nakashimada, MAY; Rosales, FJE				Bustamante Ogando, Juan Carlos; Partida Gaytan, Armando; Aldave Becerra, Juan Carlos; Alvarez Cardona, Aristoteles; Bezrodnik, Liliana; Borzutzky, Arturo; Galicia, Lizbeth Blancas; Cabanillas, Diana; Condino-Neto, Antonio; Ranero, Agustin De Colsa; Padilla, Sara Espinosa; Fernandes, Juliana Folloni; Garcia Campos, Jorge Alberto; Tello, Hector Gomez; Gonzalez Serrano, Maria Edith; Gutierrez Hernandez, Alonso; Hernandez Bautista, Victor Manuel; Escoto, Gabriele Ivankovich; King, Alejandra; Mazzucchelli, Juliana Lessa; Llamas Guillen, Beatriz Adriana; Lugo Reyes, Saul Oswaldo; Moreno Espinosa, Sarbelio; Oleastro, Matias; Mendoza, Francisco Otero; Poli Harlowe, Maria Cecilia; Porras, Oscar; Ramirez Uribe, Nideshda; Regairaz, Lorean; Larrauri, Francisco Rivas; Saracho Weber, Federico Jose; Grumach, Anete S.; Boone, Tamara Staines; Costa-Carvalho, Beatriz Tavares; Yamazaki Nakashimada, Marco Antonio; Espinosa Rosales, Francisco Javier			Latin American consensus on the supportive management of patients with severe combined immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Severe combined immunodeficiency; consensus; transplantation; supportive measures; treatment; immunodeficiency; primary immunodeficiency	HISTORY; DIAGNOSIS	Severe combined immunodeficiency (SCID) represents the most lethal form of primary immunodeficiency, with mortality rates of greater than 90% within the first year of life without treatment. Hematopoietic stem cell transplantation and gene therapy are the only curative treatments available, and the best-known prognostic factors for success are age at diagnosis, age at hematopoietic stem cell transplantation, and the comorbidities that develop in between. There are no evidence-based guidelines for standardized clinical care for patients with SCID during the time between diagnosis and definitive treatment, and we aim to generate a consensus management strategy on the supportive care of patients with SCID. First, we gathered available information about SCID diagnostic and therapeutic guidelines, then we developed a document including diagnostic and therapeutic interventions, and finally we submitted the interventions for expert consensus through a modified Delphi technique. Interventions are grouped in 10 topic domains, including 123 "agreed'' and 38 "nonagreed'' statements. This document intends to standardize supportive clinical care of patients with SCID from diagnosis to definitive treatment, reduce disease burden, and ultimately improve prognosis, particularly in countries where newborn screening for SCID is not universally available and delayed diagnosis is the rule. Our work intends to provide a tool not only for immunologists but also for primary care physicians and other specialists involved in the care of patients with SCID.	[Bustamante Ogando, Juan Carlos; Partida Gaytan, Armando; Galicia, Lizbeth Blancas; Padilla, Sara Espinosa; Gonzalez Serrano, Maria Edith; Lugo Reyes, Saul Oswaldo] Inst Nacl Pediat, Immunodeficiencies Res Unit, Mexico City, DF, Mexico; [Ranero, Agustin De Colsa; Mendoza, Francisco Otero] Inst Nacl Pediat, Dept Infect Dis, Mexico City, DF, Mexico; [Gutierrez Hernandez, Alonso; Hernandez Bautista, Victor Manuel; Larrauri, Francisco Rivas; Yamazaki Nakashimada, Marco Antonio] Inst Nacl Pediat, Dept Clin Immunol, Mexico City, DF, Mexico; [Ramirez Uribe, Nideshda] Inst Nacl Pediat, Hematopoiet Stem Cell Transplantat Unit, Mexico City, DF, Mexico; [Aldave Becerra, Juan Carlos] Hosp Nacl Edgardo Rebagliati Martins Lima, Div Allergy & Immunol, Lima, Peru; [Alvarez Cardona, Aristoteles] Hosp Ninos Dr Ricardo Gutierrez, Unidad Invest Inmunol Clin & Alergia Aguascalient, Buenos Aires, DF, Argentina; [Bezrodnik, Liliana] Hosp Ninos Dr Ricardo Gutierrez, Immunol Dept, Buenos Aires, DF, Argentina; [Bezrodnik, Liliana] Ctr Inmunol Clin Dra Bezrodnik, Buenos Aires, DF, Argentina; [Borzutzky, Arturo] Pontificia Univ Catolica Chile, Sch Med, Dept Pediat Infect Dis & Immunol, Santiago, Chile; [Cabanillas, Diana; Regairaz, Lorean] Childrens Hosp Superiora Sor Maria Ludov, Immunol Unit, La Plata, Buenos Aires, Argentina; [Condino-Neto, Antonio] Univ Sao Paulo, Dept Immunol, Inst Biomed Sci, Sao Paulo, Brazil; [Fernandes, Juliana Folloni] Hosp Israelita Albert Einstein, Dept Hematol & Transplante Medula Ossea, Sao Paulo, Brazil; [Garcia Campos, Jorge Alberto] Hosp Especialidades Ctr Med La Raza, Infect Dis Dept, Monterrey, Mexico; [Boone, Tamara Staines] Hosp Especialidades Ctr Med La Raza, Clin Immunol Dept, Monterrey, Mexico; [Tello, Hector Gomez] Hosp Nino Poblano, Immunol Dept, Puebla, Mexico; [Escoto, Gabriele Ivankovich] Univ Costa Rica, Sch Med, San Jose, Costa Rica; [King, Alejandra] Hosp Ninos Luis Calvo Mackenna, Div Pediat Immunol, Santiago, Chile; [Mazzucchelli, Juliana Lessa] Univ Fed Sao Paulo, Dept Pediat, Sao Paulo, Brazil; [Llamas Guillen, Beatriz Adriana] Hosp Nino Morelense, Immunol Dept, Cuernavaca, Morelos, Mexico; [Moreno Espinosa, Sarbelio] Hosp Infantil Mexico Dr Federico Gomez, Dept Infect Dis, Mexico City, DF, Mexico; [Oleastro, Matias] Hosp Pediat JP Garrahan, Dept Immunol & Rheumatol, Buenos Aires, DF, Argentina; [Poli Harlowe, Maria Cecilia] Univ Desarrollo Clin, Inst Ciencias & Innovac Med, Santiago, Chile; [Escoto, Gabriele Ivankovich; Porras, Oscar] Hosp Nacl Ninos Dr Carlos Saenz Herrera, Pediat Immunol & Rheumatol, San Jose, Costa Rica; [Saracho Weber, Federico Jose] Hosp Infantil Especialidades, Chihuahua, Mexico; [Grumach, Anete S.] Fac Med ABC, Div Clin Immunol, Sao Paulo, Brazil; [Costa-Carvalho, Beatriz Tavares] Univ Fed Sao Paulo, Dept Pediat, Allergy & Immunol Unit, Santo Andre, SP, Brazil; [Espinosa Rosales, Francisco Javier] Fdn Mexicana Ninas & Ninos Inmunodeficiencias Pri, Mexico City, DF, Mexico	Seguro Social de Salud del Peru; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; Pontificia Universidad Catolica de Chile; Universidade de Sao Paulo; Hospital Israelita Albert Einstein; Universidad Costa Rica; Universidad de Chile; Universidade Federal de Sao Paulo (UNIFESP); Hospital Infantil de Mexico Federico Gomez; Hospital de Pediatria Doctor Juan Garrahan; University of Buenos Aires; Faculdade de Medicina do ABC; Universidade Federal de Sao Paulo (UNIFESP)	Ogando, JCB (corresponding author), Av Insurgentes Sur 3700-C, Mexico City 04530, DF, Mexico.	drbustamante_inp@hotmail.com	Reyes, Saul O Lugo/AAP-7951-2021; Yamazaki-Nakashimada, Marco Antonio/Y-7129-2019; Partida-Gaytan, Armando/AAE-6483-2022; Reyes, Saul O Lugo/AAS-7621-2021; Grumach, Anete S/I-3430-2014; Condino-Neto, Antonio/D-4762-2012	Reyes, Saul O Lugo/0000-0002-3730-4150; Yamazaki-Nakashimada, Marco Antonio/0000-0002-7609-3923; Partida-Gaytan, Armando/0000-0002-8868-9257; Reyes, Saul O Lugo/0000-0002-3730-4150; Condino-Neto, Antonio/0000-0002-1069-3117; Aldave, Juan/0000-0003-3548-0385; Ivankovich-Escoto, Gabriela/0000-0001-9675-3143; GUTIERREZ-HERNANDEZ, JOSE ALONSO/0000-0003-1648-8648	Fundacion Mexicana para Ninas y Ninos con Inmunodeficiencias Primarias (FUMENI).	Fundacion Mexicana para Ninas y Ninos con Inmunodeficiencias Primarias (FUMENI).	This work was partially funded by Fundacion Mexicana para Ninas y Ninos con Inmunodeficiencias Primarias (FUMENI).	Chan A, 2011, CLIN IMMUNOL, V138, P3, DOI 10.1016/j.clim.2010.09.010; Chinn IK, 2015, IMMUNOL ALLERGY CLIN, V35, P671, DOI 10.1016/j.iac.2015.07.002; Dorsey MJ, 2017, J ALLERGY CLIN IMMUN, V139, P733, DOI 10.1016/j.jaci.2017.01.005; Dvorak CC, 2013, J CLIN IMMUNOL, V33, P1156, DOI 10.1007/s10875-013-9917-y; Espinosa-Rosales FJ, 2016, J CLIN IMMUNOL, V36, P415, DOI 10.1007/s10875-016-0277-2; Fernandes JF, 2018, J CLIN IMMUNOL, V38, P917, DOI 10.1007/s10875-018-0564-1; Fischer A, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.61; Gardulf A, 2017, J ALLERGY CLIN IMMUN, V139, P1713, DOI 10.1016/j.jaci.2016.10.043; Gaspar HB, 2013, BLOOD, V122, P3749, DOI 10.1182/blood-2013-02-380105; Griffith LM, 2009, J ALLERGY CLIN IMMUN, V124, P1152, DOI 10.1016/j.jaci.2009.10.022; Heimall J, 2018, J CLIN IMMUNOL, V38, P330; Ktuan A, 2015, SEMIN PERINATOL, V39, P194, DOI 10.1053/j.semperi.2015.03.004; Kwan A, 2014, JAMA-J AM MED ASSOC, V312, P729, DOI 10.1001/jama.2014.9132; Marciano BE, 2014, J ALLERGY CLIN IMMUN, V133, P1134, DOI 10.1016/j.jaci.2014.02.028; McWilliams LM, 2015, J ALLER CL IMM-PRACT, V3, P585, DOI 10.1016/j.jaip.2015.01.026; Nicholas S, 2011, CLIN IMMUNOL, V139, P360, DOI 10.1016/j.clim.2011.03.010; Pai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177; Picard C, 2018, J CLIN IMMUNOL, V38, P96, DOI 10.1007/s10875-017-0464-9; Puck JM, 2019, IMMUNOL REV, V287, P241, DOI 10.1111/imr.12729; Rivers L, 2015, ARCH DIS CHILD, V100, P667, DOI 10.1136/archdischild-2014-306425; Trevelyan EG, 2015, EUR J INTEGR MED, V7, P423, DOI 10.1016/j.eujim.2015.07.002	21	6	7	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2019	144	4					897	905		10.1016/j.jaci.2019.08.002	http://dx.doi.org/10.1016/j.jaci.2019.08.002			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JB8FZ	31419546	Bronze			2022-12-18	WOS:000488803900003
J	Fischer, A				Fischer, Alain			Platelets are the Achilles' heel of Wiskott-Aldrich syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Wiskott-Aldrich syndrome; platelets; gene therapy			[Fischer, Alain] Coll France, Paris, France; [Fischer, Alain] AP HP, Immunol & Pediat Hematol Dept, Paris, France; [Fischer, Alain] Inst Imagine, INSERM, UMR 1163, Paris, France	UDICE-French Research Universities; PSL Research University Paris; College de France; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Fischer, A (corresponding author), Hop Necker Enfants Malad, Pediat Immunol Hematol Dept, Inserm, Unit 768, 149 Rue Sevres, F-75015 Paris, France.	alain.fischer@aphp.fr						Abina SHB, 2015, JAMA-J AM MED ASSOC, V313, P1550, DOI 10.1001/jama.2015.3253; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Carrelha J, 2018, NATURE, V554, P106, DOI 10.1038/nature25455; Ferrua F, 2019, LANCET HAEMATOL, V6, pE239, DOI 10.1016/S2352-3026(19)30021-3; Moratto D, 2011, BLOOD, V118, P1675, DOI 10.1182/blood-2010-11-319376; PARKMAN R, 1978, NEW ENGL J MED, V298, P922, DOI 10.1056/NEJM197804272981701; Sabri S, 2006, BLOOD, V108, P134, DOI 10.1182/blood-2005-03-1219; Sereni L, 2019, J ALLERGY CLIN IMMUN, V144, P825, DOI 10.1016/j.jaci.2019.03.012; Sereni L, 2018, J LEUKOCYTE BIOL, V103, P577, DOI 10.1189/jlb.5MR0617-257R; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724	10	6	7	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2019	144	3					668	670		10.1016/j.jaci.2019.06.039	http://dx.doi.org/10.1016/j.jaci.2019.06.039			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IW8CV	31310756	Bronze			2022-12-18	WOS:000485222300012
J	Sharma, A; McCann, K; Tripathi, JK; Chauhan, P; Zerbe, C; Mishra, BB; Holland, SM; Sharma, J				Sharma, Atul; McCann, Katelyn; Tripathi, Jitendra Kumar; Chauhan, Pooja; Zerbe, Christa; Mishra, Bibhuti B.; Holland, Steven M.; Sharma, Jyotika			Tamoxifen restores extracellular trap formation in neutrophils from patients with chronic granulomatous disease in a reactive oxygen species-independent manner	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							HIGH-DOSE TAMOXIFEN; METABOLISM; AUTOPHAGY; EFFICACY; THERAPY; CANCER		[Sharma, Atul; Tripathi, Jitendra Kumar; Chauhan, Pooja; Mishra, Bibhuti B.; Sharma, Jyotika] Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58201 USA; [McCann, Katelyn; Zerbe, Christa; Holland, Steven M.] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	University of North Dakota Grand Forks; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sharma, J (corresponding author), Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58201 USA.	jyotika.sharma@med.und.edu	Sharma, Atul/W-6085-2019; Tripathi, Jitendra Kumar/N-2631-2013	Sharma, Atul/0000-0002-0189-1920; Tripathi, Jitendra Kumar/0000-0001-9246-8388	National Institutes of Health (NIH) [R01AI121804, P20GM113123]; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000647, R01AI121804, ZIAAI000646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113123] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health (NIH) grants R01AI121804 and P20GM113123 (to J.S.). B.B.M. is supported by P20GM113123. S.M.H. is supported by intramural funding from NIH.	Akin D, 2014, AUTOPHAGY, V10, P2021, DOI 10.4161/auto.32229; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; Cheong H, 2012, NAT BIOTECHNOL, V30, P671, DOI 10.1038/nbt.2285; Holland SM, 2013, HEMATOL ONCOL CLIN N, V27, P89, DOI 10.1016/j.hoc.2012.11.002; Leignadier J, 2017, BIOCHEM PHARMACOL, V144, P18, DOI 10.1016/j.bcp.2017.06.120; Liu S, 2019, INFLAMMATION, V42, P387, DOI 10.1007/s10753-018-0903-7; Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105; Robins HI, 2006, NEURO-ONCOLOGY, V8, P47, DOI 10.1215/S1522851705000311; Sharma A, 2017, J INFECT DIS, V215, P1040, DOI 10.1093/infdis/jix072; Skapek SX, 2013, PEDIATR BLOOD CANCER, V60, P1108, DOI 10.1002/pbc.24457; Talaei A, 2016, J CLIN PSYCHOPHARM, V36, P272, DOI 10.1097/JCP.0000000000000492; van de Veerdonk FL, 2014, AUTOPHAGY, V10, P1141, DOI 10.4161/auto.28638; Yang G, 2013, PHARMACOL THERAPEUT, V139, P392, DOI 10.1016/j.pharmthera.2013.05.005	13	6	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2019	144	2					597	+		10.1016/j.jaci.2019.04.014	http://dx.doi.org/10.1016/j.jaci.2019.04.014			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IN6LC	31039377	Green Accepted, Bronze			2022-12-18	WOS:000478789300027
J	Progatzky, F; Jha, A; Wane, M; Thwaites, RS; Makris, S; Shattock, RJ; Johansson, C; Openshaw, PJ; Bugeon, L; Hansel, TT; Dallman, MJ				Progatzky, Franze; Jha, Akhilesh; Wane, Madina; Thwaites, Ryan S.; Makris, Spyridon; Shattock, Robin J.; Johansson, Cecilia; Openshaw, Peter J.; Bugeon, Laurence; Hansel, Trevor T.; Dallman, Margaret J.			Induction of innate cytokine responses by respiratory mucosal challenge with R848 in zebrafish, mice, and humans	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							IN-VIVO; NASAL; INFLAMMATION; INFECTION; ASTHMA; CELLS		[Progatzky, Franze; Wane, Madina; Bugeon, Laurence; Dallman, Margaret J.] Imperial Coll London, Dept Life Sci, London, England; [Shattock, Robin J.] Imperial Coll London, Dept Infect Dis, Div Med, London, England; [Jha, Akhilesh; Thwaites, Ryan S.; Makris, Spyridon; Johansson, Cecilia; Openshaw, Peter J.; Hansel, Trevor T.] Imperial Coll London, St Marys Hosp, Natl Heart & Lung Inst, ICRRU, London, England; [Jha, Akhilesh; Thwaites, Ryan S.; Makris, Spyridon; Johansson, Cecilia; Openshaw, Peter J.; Hansel, Trevor T.] Imperial Coll London, St Marys Hosp, Resp Infect, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London	Hansel, TT (corresponding author), Imperial Coll London, St Marys Hosp, Natl Heart & Lung Inst, ICRRU, London, England.; Hansel, TT (corresponding author), Imperial Coll London, St Marys Hosp, Resp Infect, London, England.	t.hansel@imperial.ac.uk; m.dallman@imperial.ac.uk	Johansson, Cecilia/ABF-6337-2021; Openshaw, Peter/AAL-9442-2020	Johansson, Cecilia/0000-0002-6607-5000; Openshaw, Peter/0000-0002-7220-2555; Thwaites, Ryan/0000-0003-3052-2793; Jha, Akhilesh/0000-0002-8413-7738; Bugeon, Laurence/0000-0002-6978-2878; Makris, Spyridon/0000-0001-9243-2369; Progatzky, Franze/0000-0003-0784-1323	NC3Rs Strategic Award [NC/M001512/1]; Wellcome Trust PhD studentship; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Respiratory Infections at Imperial College London; Public Health England (PHE); Imperial College Healthcare Trust NIHR Biomedical Research Centre [P45058]; Rosetrees Trust [M370]; MRC [MR/R005982/1] Funding Source: UKRI	NC3Rs Strategic Award; Wellcome Trust PhD studentship(Wellcome Trust); National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Respiratory Infections at Imperial College London; Public Health England (PHE); Imperial College Healthcare Trust NIHR Biomedical Research Centre; Rosetrees Trust(Rosetrees Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Work in the Dallman laboratory was supported by an NC3Rs Strategic Award (NC/M001512/1). M.W. was supported by a Wellcome Trust PhD studentship. Human challenge studies were funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Respiratory Infections at Imperial College London in partnership with Public Health England (PHE) and the Imperial College Healthcare Trust NIHR Biomedical Research Centre (Grant ID P45058). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England. The mouse studies were supported by a grant from the Rosetrees Trust (M370; to C.J.).	Brandelius A, 2014, RESP MED, V108, P1816, DOI 10.1016/j.rmed.2014.10.010; Del Vecchio AM, 2015, PULM PHARMACOL THER, V30, P32, DOI 10.1016/j.pupt.2014.10.005; Dhariwal J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135363; Goritzka M, 2014, J VIROL, V88, P6128, DOI 10.1128/JVI.00333-14; Guiducci C, 2013, J EXP MED, V210, P2903, DOI 10.1084/jem.20131044; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Hansel TT, 2017, EBIOMEDICINE, V19, P128, DOI 10.1016/j.ebiom.2017.03.033; Langenau DM, 2004, P NATL ACAD SCI USA, V101, P7369, DOI 10.1073/pnas.0402248101; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lundberg AM, 2007, BLOOD, V110, P3245, DOI 10.1182/blood-2007-02-072934; Margine I, 2014, PATHOGENS, V3, P845, DOI 10.3390/pathogens3040845; McKay PF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148984; Progatzky F, 2016, AM J PHYSIOL-LUNG C, V310, pL551, DOI 10.1152/ajplung.00323.2015; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Scadding GW, 2015, ALLERGY, V70, P689, DOI 10.1111/all.12608; Skold AE, 2012, BLOOD, V120, P768, DOI 10.1182/blood-2011-12-397778	16	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2019	144	1					342	+		10.1016/j.jaci.2019.04.003	http://dx.doi.org/10.1016/j.jaci.2019.04.003			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IF9SM	31002833	Green Published, hybrid			2022-12-18	WOS:000473432800044
J	Yu, SH; Leung, KM; Kim, HY; Umetsu, SE; Xiao, YP; Albacker, LA; Lee, HJ; Umetsu, DT; Freeman, GJ; DeKruyff, RH				Yu, Sanhong; Leung, Krystle M.; Kim, Hye-Young; Umetsu, Sarah E.; Xiao, Yanping; Albacker, Lee A.; Lee, Hyun-Jun; Umetsu, Dale T.; Freeman, Gordon J.; DeKruyff, Rosemarie H.			Blockade of RGMb inhibits allergen-induced airways disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; airway hyperreactivity; macrophages; repulsive guidance molecule b; neogenin; IL-17RB; allergy	INNATE LYMPHOID-CELLS; REPULSIVE GUIDANCE MOLECULE; CD4(+) T-CELLS; IL-25; LUNG; RECEPTOR; NEOGENIN; FAMILY; IL-13; EXPRESSION	Background: Allergic asthma causes morbidity in many subjects, and novel precision-directed treatments would be valuable. Objective: We sought to examine the role of a novel innate molecule, repulsive guidance molecule b (RGMb), in murine models of allergic asthma. Methods: In models of allergic asthma using ovalbumin or cockroach allergen, mice were treated with anti-RGMb or control mAb and examined for airway inflammation and airway hyperreactivity (AHR), a cardinal feature of asthma. The mechanisms by which RGMb causes airways disease were also examined. Results: We found that blockade of RGMb by treatment with anti-RGMb mAb effectively blocked the development of airway inflammation and AHR. Importantly, blockade of RGMb completely blocked the development of airway inflammation and AHR, even if treatment occurred only during the challenge (effector) phase. IL-25 played an important role in these models of asthma because IL-25 receptor-deficient mice did not develop disease after sensitization and challenge with allergen. RGMb was expressed primarily by innate cells in the lungs, including bronchial epithelial cells (known producers of IL-25), activated eosinophils, and interstitial macrophages, which in the inflamed lung expressed the IL-25 receptor and produced IL-5 and IL-13. We also found that neogenin, the canonical receptor for RGMb, was expressed by interstitial macrophages and bronchial epithelial cells in the inflamed lung, suggesting that an innate RGMb-neogenin axis might modulate allergic asthma. Conclusions: These results demonstrate an important role for a novel innate pathway in regulating type 2 inflammation in patients with allergic asthma involving RGMb and RGMb-expressing cells, such as interstitial macrophages and bronchial epithelial cells. Moreover, targeting this previously unappreciated innate pathway might provide an important treatment option for allergic asthma.	[Yu, Sanhong; Xiao, Yanping; Freeman, Gordon J.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Dept Med, Boston, MA 02115 USA; [Albacker, Lee A.] Harvard Med Sch, Program Immunol, Boston, MA 02115 USA; [Yu, Sanhong; Leung, Krystle M.; Kim, Hye-Young; Albacker, Lee A.; Lee, Hyun-Jun; Umetsu, Dale T.; DeKruyff, Rosemarie H.] Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA; [Umetsu, Sarah E.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [DeKruyff, Rosemarie H.] Stanford Univ, Dept Med, Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA 94305 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California San Francisco; Stanford University	DeKruyff, RH (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.	rdk@stanford.edu	Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616; Kim, Hye Young/0000-0001-5978-512X	National Institutes of Health [PO1 AI-054456, R01 AI089955]; Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine	Supported by National Institutes of Health grants PO1 AI-054456 (to G.J.F., R.H.D., and D.T.U.) and R01 AI089955 (to G.J.F. and R.H.D.) and by the Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine (to R.H.D.).	Akbari O, 2010, MUCOSAL IMMUNOL, V3, P81, DOI 10.1038/mi.2009.112; Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Bankova LG, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat9453; Barlow JL, 2013, J ALLERGY CLIN IMMUN, V132, P933, DOI 10.1016/j.jaci.2013.05.012; Beale J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009124; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Bell CH, 2013, SCIENCE, V341, P77, DOI 10.1126/science.1232322; Bellusci S, 1996, DEVELOPMENT, V122, P1693; Borthwick LA, 2016, MUCOSAL IMMUNOL, V9, P38, DOI 10.1038/mi.2015.34; Bredo G, 2015, IMMUN INFLAMM DIS, V3, P455, DOI 10.1002/iid3.87; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chesne J, 2019, MUCOSAL IMMUNOL, V12, P10, DOI 10.1038/s41385-018-0063-y; Conrad S, 2010, MOL CELL NEUROSCI, V43, P222, DOI 10.1016/j.mcn.2009.11.003; Corrigan CJ, 2011, J ALLERGY CLIN IMMUN, V128, P116, DOI 10.1016/j.jaci.2011.03.043; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dolgachev V, 2009, J IMMUNOL, V183, P5705, DOI 10.4049/jimmunol.0901666; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gold MJ, 2014, J ALLERGY CLIN IMMUN, V133, P1142, DOI 10.1016/j.jaci.2014.02.033; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Harris N, 2016, SCIENCE, V351, P1265, DOI 10.1126/science.aaf5215; Healey EG, 2015, NAT STRUCT MOL BIOL, V22, P458, DOI 10.1038/nsmb.3016; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jung JS, 2009, CHEST, V135, P1173, DOI 10.1378/chest.08-1595; Kim HY, 2012, J ALLERGY CLIN IMMUN, V129, P216, DOI 10.1016/j.jaci.2011.10.036; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Kohanski MA, 2018, J ALLERGY CLIN IMMUN, V142, P460, DOI 10.1016/j.jaci.2018.03.019; Lambrecht BN, 2014, J ALLERGY CLIN IMMUN, V134, P499, DOI 10.1016/j.jaci.2014.06.036; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Mirakaj V, 2012, FASEB J, V26, P1549, DOI 10.1096/fj.11-200063; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Muehling LM, 2017, J ALLERGY CLIN IMMUN, V140, P1523, DOI 10.1016/j.jaci.2017.02.025; Nie XX, 2018, CELL MOL IMMUNOL, V15, P888, DOI 10.1038/cmi.2017.17; Petersen BC, 2014, J LEUKOCYTE BIOL, V95, P809, DOI 10.1189/jlb.0913482; Petersen BC, 2012, NAT MED, V18, P751, DOI 10.1038/nm.2735; Pope SM, 2001, J ALLERGY CLIN IMMUN, V108, P594, DOI 10.1067/mai.2001.118600; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Rosendahl A, 2002, AM J RESP CELL MOL, V27, P160, DOI 10.1165/ajrcmb.27.2.4779; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Samad TA, 2004, J NEUROSCI, V24, P2027, DOI 10.1523/JNEUROSCI.4115-03.2004; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sheih A, 2017, MUCOSAL IMMUNOL, V10, P705, DOI 10.1038/mi.2016.90; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sountoulidis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041460; Stier MT, 2016, J ALLERGY CLIN IMMUN, V138, P814, DOI 10.1016/j.jaci.2016.01.050; Sui P., 2018, SCIENCE, V360; Suzukawa M, 2012, J IMMUNOL, V189, P3641, DOI 10.4049/jimmunol.1200461; Van Dyken SJ, 2016, NAT IMMUNOL, V17, P1381, DOI 10.1038/ni.3582; Walter DM, 2001, J IMMUNOL, V167, P4668, DOI 10.4049/jimmunol.167.8.4668; Weathington NM, 2017, AM J RESP CELL MOL, V57, P346, DOI 10.1165/rcmb.2016-0316OC; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Xia Y, 2010, J AM SOC NEPHROL, V21, P666, DOI 10.1681/ASN.2009050511; Xiao YP, 2014, J EXP MED, V211, P943, DOI 10.1084/jem.20130790; Yoon BS, 2004, J CELL BIOCHEM, V93, P93, DOI 10.1002/jcb.20211; Yoon BS, 2006, DEVELOPMENT, V133, P4667, DOI 10.1242/dev.02680; Zhou Z, 2010, DEV CELL, V19, P90, DOI 10.1016/j.devcel.2010.06.016	64	6	7	2	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2019	144	1					94	+		10.1016/j.jaci.2018.12.1022	http://dx.doi.org/10.1016/j.jaci.2018.12.1022			26	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IF9SM	30703386	Green Accepted, hybrid			2022-12-18	WOS:000473432800013
J	Haspeslagh, E; Vanheerswynghels, M; Deswarte, K; Van Moorleghem, J; Jacquet, A; Lambrecht, BN; Hammad, H				Haspeslagh, Eline; Vanheerswynghels, Manon; Deswarte, Kim; Van Moorleghem, Justine; Jacquet, Alain; Lambrecht, Bart N.; Hammad, Hamida			Prophylactic allergen immunotherapy with Der p 2 prevents murine asthma by regulating lung GM-CSF	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							RESPONSES; EXPOSURE; CHILDREN; RISK		[Haspeslagh, Eline; Vanheerswynghels, Manon; Deswarte, Kim; Van Moorleghem, Justine; Lambrecht, Bart N.; Hammad, Hamida] VIB Ctr Inflammat Res, Lab Immunoregulat & Mucosal Immunol, Ghent, Belgium; [Haspeslagh, Eline; Vanheerswynghels, Manon; Deswarte, Kim; Van Moorleghem, Justine; Lambrecht, Bart N.; Hammad, Hamida] Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium; [Jacquet, Alain] Chulalongkorn Univ, Dept Med, Fac Med, Bangkok, Thailand; [Lambrecht, Bart N.] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Chulalongkorn University; Erasmus University Rotterdam; Erasmus MC	Hammad, H (corresponding author), VIB Ctr Inflammat Res, Lab Immunoregulat & Mucosal Immunol, Ghent, Belgium.; Hammad, H (corresponding author), Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium.	Hamida.hammad@ugent.be	Hammad, Hamida/J-9391-2015; Jacquet, Alain/GQI-0546-2022; Jacquet, Alain/T-8611-2019; Lambrecht, Bart N/K-2484-2014	Hammad, Hamida/0000-0003-3762-8603; Jacquet, Alain/0000-0002-0980-9741; Jacquet, Alain/0000-0002-0980-9741; Lambrecht, Bart N/0000-0003-4376-6834; Deswarte, Kim/0000-0002-9761-6973	Flanders Research Foundation [FWO13/ASP/138]; ERC; Ghent University [GOA 01G02817]; FWO	Flanders Research Foundation(FWO); ERC(European Research Council (ERC)European Commission); Ghent University(Ghent University); FWO(FWO)	Supported by the Flanders Research Foundation (grant no. FWO13/ASP/138 to E.H.), an ERC advanced grant (AsthmaCrystalClear to B.N.L.), several FWO project grants (to B.N.L. and H. H.), and a Ghent University grant (GOA 01G02817).	Baird D., 2017, INTRO GENSTAT WINDOW, V19; Coquet JM, 2015, IMMUNITY, V43, P318, DOI 10.1016/j.immuni.2015.07.015; Cullinan P, 2004, THORAX, V59, P855, DOI 10.1136/thx.2003.019877; Dhami S, 2017, ALLERGY, V72, P1825, DOI 10.1111/all.13208; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Holt PG, 2013, J ALLERGY CLIN IMMUN, V132, P991, DOI 10.1016/j.jaci.2013.04.049; James LK, 2011, J ALLERGY CLIN IMMUN, V127, P509, DOI 10.1016/j.jaci.2010.12.1080; Jeal H, 2006, AM J RESP CRIT CARE, V174, P21, DOI 10.1164/rccm.200506-964OC; Swirski FK, 2002, J IMMUNOL, V169, P3499, DOI 10.4049/jimmunol.169.7.3499	11	6	6	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2019	143	6					2307	2311		10.1016/j.jaci.2019.02.007	http://dx.doi.org/10.1016/j.jaci.2019.02.007			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IB2QG	30796980	Bronze, Green Published, Green Accepted			2022-12-18	WOS:000470113200041
J	Kelly, KJ; Poole, JA				Kelly, Kevin J.; Poole, Jill A.			Pollutants in the workplace: Effect on occupational asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Occupational; allergy; asthma; latex; agriculture; farm	RISK		[Kelly, Kevin J.] Univ N Carolina, Dept Pediat, Div Allergy Immunol Rheumatol, Chapel Hill, NC 27515 USA; [Poole, Jill A.] Univ Nebraska Med Ctr, Sect Allergy, Dept Med, Div Pulm Crit Care Sleep & Allergy, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Poole, JA (corresponding author), Univ Nebraska Med Ctr, Dept Pulm & Crit Care, Sleep & Allergy Div, 985990 Nebraska Med Ctr, Omaha, NE 68198 USA.	japoole@unmc.edu			National Institutes of Health [ES-019325]; National Institute for Occupational Safety and Health [U54OH010162]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U54OH010162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	J.A.P. is funded by the National Institutes of Health (ES-019325) and the National Institute for Occupational Safety and Health (U54OH010162).	Agache I, 2019, ALLERGY, V74, P449, DOI 10.1111/all.13690; Berger M, 2015, ALLERGY, V70, P257, DOI 10.1111/all.12544; Kelly KJ, 2017, J ALLER CL IMM-PRACT, V5, P1212, DOI 10.1016/j.jaip.2017.05.029; Mazurek JM, 2015, J AGROMEDICINE, V20, P31, DOI 10.1080/1059924X.2014.976729; Pedersen DJA, 2012, ANN ALLERG ASTHMA IM, V108, P94, DOI 10.1016/j.anai.2011.11.009; Shaffo FC, 2018, AM J PHYSIOL-LUNG C, V315, pL485, DOI 10.1152/ajplung.00211.2018; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Tarlo SM, 2014, NEW ENGL J MED, V370, P640, DOI 10.1056/NEJMra1301758; Vandenplas O, 2016, ALLERGY, V71, P840, DOI 10.1111/all.12872; Wunschel J, 2016, J ASTHMA, V53, P471, DOI 10.3109/02770903.2015.1116089	10	6	6	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2019	143	6					2014	2015		10.1016/j.jaci.2019.04.013	http://dx.doi.org/10.1016/j.jaci.2019.04.013			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IB2QG	31029774				2022-12-18	WOS:000470113200005
J	DiTommaso, LA; Rosenberg, CE; Eby, MD; Tasco, A; Collins, MH; Lyles, JL; Putnam, PE; Mukkada, VA; Rothenberg, ME				DiTommaso, Lauren A.; Rosenberg, Chen E.; Eby, Michael D.; Tasco, Amy; Collins, Margaret H.; Lyles, John L.; Putnam, Philip E.; Mukkada, Vincent A.; Rothenberg, Marc E.			Prevalence of eosinophilic colitis and the diagnoses associated with colonic eosinophilia	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							GASTROENTERITIS		[DiTommaso, Lauren A.; Rosenberg, Chen E.; Eby, Michael D.; Tasco, Amy; Rothenberg, Marc E.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Pediat,Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Collins, Margaret H.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Pediat,Div Pathol, Cincinnati, OH USA; [Lyles, John L.; Putnam, Philip E.; Mukkada, Vincent A.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Pediat,Div Gastroenterol Hepatol & Nutr, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Rothenberg, ME (corresponding author), Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Pediat,Div Allergy & Immunol, Cincinnati, OH 45229 USA.	rothenberg@cchmc.org	Mukkada, Vincent/AAF-6995-2019	Mukkada, Vincent/0000-0003-4225-5506	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060515, U54AI117804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI060515, U54 AI117804] Funding Source: Medline; NIDDK NIH HHS [P30 DK078392] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Collins MH, 2018, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00261; DeBrosse CW, 2006, PEDIATR DEVEL PATHOL, V9, P210, DOI 10.2350/11-05-0130.1; Egan M, 2018, ANN ALLERG ASTHMA IM, V121, P162, DOI 10.1016/j.anai.2018.06.013; Jensen ET, 2016, J PEDIATR GASTR NUTR, V62, P36, DOI 10.1097/MPG.0000000000000865; Mansoor E, 2017, CLIN GASTROENTEROL H, V15, P1733, DOI 10.1016/j.cgh.2017.05.050; Mark J, 2018, J PEDIATR GASTR NUTR, V66, P760, DOI 10.1097/MPG.0000000000001784; TALLEY NJ, 1990, GUT, V31, P54, DOI 10.1136/gut.31.1.54; Turner KO, 2017, AM J SURG PATHOL, V41, P225, DOI 10.1097/PAS.0000000000000760; 2018, PATHOL RES PRACT, V214, P100, DOI DOI 10.1016/J.PRP.2017.09.029	9	6	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2019	143	5					1928	+		10.1016/j.jaci.2018.12.1002	http://dx.doi.org/10.1016/j.jaci.2018.12.1002			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HW6FP	30654053	Green Accepted, Bronze			2022-12-18	WOS:000466784600029
J	Schmidt, F; Hose, AJ; Mueller-Rompa, S; Brick, T; Hamalainen, AM; Peet, A; Tillmann, V; Niemela, O; Siljander, H; Knip, M; Weber, J; von Mutius, E; Ege, MJ				Schmidt, Felicitas; Hose, Alexander J.; Mueller-Rompa, Susanne; Brick, Tabea; Hamalainen, Anu-Maaria; Peet, Aleksandr; Tillmann, Vallo; Niemela, Onni; Siljander, Heli; Knip, Mikael; Weber, Juliane; von Mutius, Erika; Ege, Markus J.		DIABIMMUNE Study Grp	Development of atopic sensitization in Finnish and Estonian children: A latent class analysis in a multicenter cohort	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Latent class analysis; unsupervised clustering; IgE; atopy; allergy; diabetes type 1 risk; wheezing; Finland; Estonia; severe atopy	BETA-CELL AUTOIMMUNITY; SERUM IGE LEVELS; ALLERGIC SENSITIZATION; ENVIRONMENTAL-FACTORS; INHALANT ALLERGENS; RUSSIAN KARELIA; ASTHMA; CHILDHOOD; DISEASE; ASSOCIATION	Background: The prevalence of atopy is associated with a Western lifestyle, as shown by studies comparing neighboring regions with different socioeconomic backgrounds. Atopy might reflect various conditions differing in their susceptibility to environmental factors. Objective: We sought to define phenotypes of atopic sensitization in early childhood and examine their association with allergic diseases and hereditary background in Finland and Estonia. Methods: The analysis included 1603 Finnish and 1657 Estonian children from the DIABIMMUNE multicenter young children cohort. Specific IgE levels were measured at age 3, 4, and 5 years, respectively, and categorized into 3 CAP classes. Latent class analysis was performed with the statistical software package poLCA in R software. Results: Both populations differed in terms of socioeconomic status and environmental determinants, such as pet ownership, farm-related exposure, time spent playing outdoors, and prevalence of allergic diseases (all P <.001). Nevertheless, we found similar latent classes in both populations: an unsensitized class, a food class, 2 inhalant classes differentiating between seasonal and perennial aeroallergens, and a severe atopy class. The latter was characterized by high total and specific IgE levels and strongly associated with wheeze (odds ratio [OR], 5.64 [95% CI, 3.07-10.52] and 4.56 [95% CI, 2.35-8.52]), allergic rhinitis (OR, 22.4 [95% CI, 11.67-44.54] and 13.97 [95% CI, 7.33-26.4]), and atopic eczema (OR, 9.39 [95% CI, 4.9-19.3] and 9.5 [95% CI, 5.2-17.5] for Finland and Estonia, respectively). Environmental differences were reflected in the larger seasonal inhalant atopy class in Finland, although composition of classes was comparable between countries. Conclusion: Despite profound differences in environmental exposures, there might exist genuine patterns of atopic sensitization. The distribution of these patterns might determine the contribution of atopic sensitization to disease onset.	[Schmidt, Felicitas; Mueller-Rompa, Susanne; Brick, Tabea; von Mutius, Erika; Ege, Markus J.] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Munich, Germany; [Hose, Alexander J.] German Res Ctr Environm Hlth, Inst Asthma & Allergy Prevent IAP, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Hamalainen, Anu-Maaria] Jorvi Hosp, Dept Pediat, Espoo, Finland; [Peet, Aleksandr; Tillmann, Vallo] Univ Tartu, Dept Pediat, Tartu, Estonia; [Peet, Aleksandr; Tillmann, Vallo] Tartu Univ Hosp, Tartu, Estonia; [Niemela, Onni] Seinajoki Cent Hosp, Dept Lab Med, Helsinki, Finland; [Niemela, Onni] Seinajoki Cent Hosp, Med Res Unit, Helsinki, Finland; [Niemela, Onni] Univ Tampere, Tampere, Finland; [Siljander, Heli; Knip, Mikael] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Siljander, Heli; Knip, Mikael] Helsinki Univ Hosp, Helsinki, Finland; [Siljander, Heli; Knip, Mikael] Univ Helsinki, Res Programs Unit, Diabet & Obes, Helsinki, Finland; [Knip, Mikael] Folkhalsan Res Ctr, Helsinki, Finland; [Knip, Mikael] Tampere Univ Hosp, Dept Pediat, Tampere, Finland; [Weber, Juliane] Landesamt Gesundheit & Lebensmittelsicherheit, Erlangen, Germany; [von Mutius, Erika; Ege, Markus J.] German Ctr Lung Res DZL, Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Tartu; Seinajoki Central Hospital; Seinajoki Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Folkhalsan Research Center; Tampere University; Tampere University Hospital; Bavarian Health & Food Safety Authority	Ege, MJ (corresponding author), Univ Munich, Dr von Hauner Childrens Hosp, Med Ctr, Lindwurmstr 4, D-80337 Munich, Germany.	markus.ege@med.uni-muenchen.de	Peet, Aleksandr/H-6114-2018; Knip, Mikael/AAL-3773-2020; Tillmann, Vallo/G-8118-2012	Tillmann, Vallo/0000-0002-5279-4493; Dorshakova, Natalia/0000-0003-1072-9164; Ege, Markus/0000-0001-6643-3923	European Commission [HEALTH-F2-2008-202063]; German Center for Lung Research (DZL)	European Commission(European CommissionEuropean Commission Joint Research Centre); German Center for Lung Research (DZL)	Supported by the European Commission (grant no. HEALTH-F2-2008-202063) and the German Center for Lung Research (DZL).	Annus T, 2001, CLIN EXP ALLERGY, V31, P1846, DOI 10.1046/j.1365-2222.2001.01238.x; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Beyerlein A, 2016, JAMA-J AM MED ASSOC, V315, P1899, DOI 10.1001/jama.2016.2181; Bjorksten B, 1996, TOXICOL LETT, V86, P93, DOI 10.1016/0378-4274(96)03679-X; BRABACK L, 1994, CLIN EXP ALLERGY, V24, P826, DOI 10.1111/j.1365-2222.1994.tb01805.x; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Cardwell CR, 2008, PEDIATR DIABETES, V9, P191, DOI 10.1111/j.1399-5448.2007.00366.x; Chan-Yeung M, 2010, ALLERGY, V65, P1404, DOI 10.1111/j.1398-9995.2010.02399.x; de Jong AB, 2011, PEDIAT ALLERG IMM-UK, V22, P166, DOI 10.1111/j.1399-3038.2010.00993.x; Depner M, 2014, AM J RESP CRIT CARE, V189, P129, DOI 10.1164/rccm.201307-1198OC; Douroudis K, 2009, HUM IMMUNOL, V70, P536, DOI 10.1016/j.humimm.2009.04.023; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Ege MJ, 2014, J ALLERGY CLIN IMMUN, V133, P1354, DOI 10.1016/j.jaci.2014.01.031; FREIDHOFF LR, 1993, INT ARCH ALLERGY IMM, V100, P355, DOI 10.1159/000236438; Garden FL, 2013, CLIN EXP ALLERGY, V43, P633, DOI 10.1111/cea.12095; Haahtela T, 2015, CLIN EXP ALLERGY, V45, P891, DOI 10.1111/cea.12527; Haahtela T, 2015, ERJ OPEN RES, P1; Havstad S, 2014, J ALLERGY CLIN IMMUN, V134, P722, DOI 10.1016/j.jaci.2014.01.022; Hekkala A, 2011, EUR J ENDOCRINOL, V165, P813, DOI 10.1530/EJE-11-0376; Hose AJ, 2017, J ALLERGY CLIN IMMUN, V139, P1935, DOI 10.1016/j.jaci.2016.08.046; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; Julge K, 2002, CLIN EXP ALLERGY, V32, P1420, DOI 10.1046/j.1365-2745.2002.01503.x; Kondrashova A, 2005, ANN MED, V37, P67, DOI 10.1080/07853890410018952; Kondrashova A, 2014, INT REV IMMUNOL, V33, P284, DOI 10.3109/08830185.2014.889130; Kondrashova A, 2013, APMIS, V121, P478, DOI 10.1111/apm.12023; Kramer U, 1999, INT J EPIDEMIOL, V28, P865, DOI 10.1093/ije/28.5.865; Laar Mart, 2007, BACKGROUNDER, P1; Laatikainen T, 2011, ALLERGY, V66, P886, DOI 10.1111/j.1398-9995.2010.02533.x; Lazic N, 2013, ALLERGY, V68, P764, DOI 10.1111/all.12134; Linzer DA, 2011, J STAT SOFTW, V42, P1, DOI 10.18637/jss.v042.i10; Matricardi PM, 2009, CLIN EXP ALLERGY, V39, P1551, DOI 10.1111/j.1365-2222.2009.03348.x; Mazumder A, 2017, J EVOL MED DENT SCI-, V6, P1, DOI 10.14260/jemds/2017/1; Migueres M, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-16; Mustonen N, 2018, PEDIATR DIABETES, V19, P293, DOI 10.1111/pedi.12547; Oksel C, 2018, CURR OPIN ALLERGY CL, V18, P109, DOI 10.1097/ACI.0000000000000430; Peet A, 2015, EUR J ENDOCRINOL, V173, P129, DOI 10.1530/EJE-14-1078; Platts-Mills TAE, 2000, AM J RESP CRIT CARE, V162, pS128, DOI 10.1164/ajrccm.162.supplement_2.ras-15; Rhodes HL, 2002, AM J RESP CRIT CARE, V165, P176, DOI 10.1164/ajrccm.165.2.2104032; Saleh NM, 2011, DIABETES-METAB RES, V27, P838, DOI 10.1002/dmrr.1259; Sherrill DL, 1999, J ALLERGY CLIN IMMUN, V104, P28, DOI 10.1016/S0091-6749(99)70110-7; Simpson A, 2010, AM J RESP CRIT CARE, V181, P1200, DOI 10.1164/rccm.200907-1101OC; Skaaby T, 2015, AUTOIMMUNITY, V48, P282, DOI 10.3109/08916934.2014.1003640; Sozanska B, 2014, J ALLERGY CLIN IMMUN, V133, P1347, DOI 10.1016/j.jaci.2013.10.035; Stern DA, 2004, CLIN EXP ALLERGY, V34, P1563, DOI 10.1111/j.1365-2222.2004.02088.x; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; Teach SJ, 2015, J ALLERGY CLIN IMMUN, V136, P1476, DOI 10.1016/j.jaci.2015.09.008; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Virtanen SM, 2014, JAMA PEDIATR, V168, P755, DOI 10.1001/jamapediatrics.2014.296; von Hertzen LC, 2008, ALLERGY, V63, P379, DOI 10.1111/j.1398-9995.2007.01595.x; von Mutius E, 1998, LANCET, V351, P862, DOI 10.1016/S0140-6736(97)10100-3; VONMUTIUS E, 1994, AM J RESP CRIT CARE, V149, P358, DOI 10.1164/ajrccm.149.2.8306030; Ziello C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034076; 1996, CLIN EXP ALLERGY, V26, P775; 2013, BIOFIZIKA, V58, P106	55	6	6	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2019	143	5					1904	+		10.1016/j.jaci.2018.12.1014	http://dx.doi.org/10.1016/j.jaci.2018.12.1014			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HW6FP	30682459	Green Published, Bronze			2022-12-18	WOS:000466784600025
J	Chanez, P; McDonald, M; Garin, M; Murphy, K				Chanez, Pascal; McDonald, Mirna; Garin, Margaret; Murphy, Kevin			Early decreases in blood eosinophil levels with reslizumab	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ASTHMA		[Chanez, Pascal] Aix Marseille Univ, Dept Resp Med, Marseille, France; [Chanez, Pascal] Aix Marseille Univ, CIC Nord, Marseille, France; [McDonald, Mirna; Garin, Margaret] Teva Branded Pharmaceut Prod R&D Inc, Malvern, PA USA; [Murphy, Kevin] Boys Town Natl Res Hosp, Allergy Asthma & Pulm Res, Omaha, NE 68131 USA	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Teva Pharmaceutical Industries; Boys Town National Research Hospital	Chanez, P (corresponding author), Aix Marseille Univ, Dept Resp Med, Marseille, France.; Chanez, P (corresponding author), Aix Marseille Univ, CIC Nord, Marseille, France.	pascal.chanez@univ-amu.fr		chanez, pascal/0000-0003-4059-0917	Teva Branded Pharmaceutical Products RD, Inc.	Teva Branded Pharmaceutical Products RD, Inc.	This study was sponsored by Teva Branded Pharmaceutical Products R&D, Inc.	Bjermer L, 2016, CHEST, V150, P789, DOI 10.1016/j.chest.2016.03.032; Castro M, 2015, LANCET RESP MED, V3, P355, DOI [10.1016/S2213-2600(15)00042-9, 10.1016/S2213-2600(15)00119-8]; Corren J, 2016, CHEST, V150, P799, DOI 10.1016/j.chest.2016.03.018; Flood-Page P, 2007, AM J RESP CRIT CARE, V176, P1062, DOI 10.1164/rccm.200701-085OC; Pham TH, 2016, RESP MED, V111, P21, DOI 10.1016/j.rmed.2016.01.003; ULRIK CS, 1995, CLIN EXP ALLERGY, V25, P820, DOI 10.1111/j.1365-2222.1995.tb00024.x; van Veen IH, 2009, J ALLERGY CLIN IMMUN, V124, P615, DOI 10.1016/j.jaci.2009.06.029; Zeiger RS, 2014, J ALLER CL IMM-PRACT, V2, P741, DOI 10.1016/j.jaip.2014.06.005	8	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2019	143	4					1653	1655		10.1016/j.jaci.2018.12.997	http://dx.doi.org/10.1016/j.jaci.2018.12.997			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HR7QE	30654046	Bronze			2022-12-18	WOS:000463348900048
J	Liccardi, G; Calzetta, L; Milanese, M; Passalacqua, G; Rogliani, P				Liccardi, Gennaro; Calzetta, Luigino; Milanese, Manlio; Passalacqua, Giovanni; Rogliani, Paola			Can f 5 as a suitable marker of dog allergy: Assess male dog exposure before banning it	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Liccardi, Gennaro] High Special A Cardarelli Hosp, Dept Pulmonol Haematol & Oncol, Div Pulmol, Unit Allergol, Naples, Italy; [Liccardi, Gennaro; Calzetta, Luigino; Rogliani, Paola] Univ Roma Tor Vergata, Postgrad Sch Resp Med, Dept Expt Med, Rome, Italy; [Calzetta, Luigino; Rogliani, Paola] Univ Roma Tor Vergata, Dept Expt Med, Unit Resp Med, Rome, Italy; [Milanese, Manlio] S Corona Hosp, Div Pulmonol, Pietra Ligure, Italy; [Passalacqua, Giovanni] Univ Genoa, Allergy & Resp Dis, Genoa, Italy	Antonio Cardarelli Hospital; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Genoa	Liccardi, G (corresponding author), High Special A Cardarelli Hosp, Dept Pulmonol Haematol & Oncol, Div Pulmol, Unit Allergol, Naples, Italy.; Liccardi, G (corresponding author), Univ Roma Tor Vergata, Postgrad Sch Resp Med, Dept Expt Med, Rome, Italy.	gennaro.liccardi@tin.it	Rogliani, Paola/AIB-0300-2022	Rogliani, Paola/0000-0001-7801-5040				Gonzalez-de-Olano D, 2018, CLIN EXP ALLERGY, V48, P1368, DOI 10.1111/cea.13226; Kack U, 2018, J ALLERGY CLIN IMMUN, V142, P1113, DOI 10.1016/j.jaci.2018.05.012; Liccardi G, 2018, EUR ANN ALLERGY CLIN, V50, P283, DOI 10.23822/EurAnnACI.1764-1489.41; Liccardi G, 2018, Clin Mol Allergy, V16, P3, DOI 10.1186/s12948-018-0081-z; Liccardi G, 2017, J INVEST ALLERG CLIN, V27, P397, DOI 10.18176/jiaci.0189; Liccardi G, 2018, HUM VACC IMMUNOTHER, V14, P1438, DOI 10.1080/21645515.2018.1434383; Tanaka M, 2019, ALLERGOL INT, V68, P259, DOI 10.1016/j.alit.2018.08.003	7	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2019	143	4					1657	1658		10.1016/j.jaci.2018.12.1007	http://dx.doi.org/10.1016/j.jaci.2018.12.1007			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HR7QE	30745148				2022-12-18	WOS:000463348900050
J	Almoguera, B; Vazquez, L; Mentch, F; March, ME; Connolly, JJ; Peissig, PL; Linneman, JG; Plaza-Seron, MD; Pino-Yanes, M; Burchard, EG; Brilliant, M; Sleiman, P; Hakonarson, H				Almoguera, Berta; Vazquez, Lyam; Mentch, Frank; March, Michael E.; Connolly, John J.; Peissig, Peggy L.; Linneman, James G.; del Carmen Plaza-Seron, Maria; Pino-Yanes, Maria; Burchard, Esteban G.; Brilliant, Murray; Sleiman, Patrick; Hakonarson, Hakon			Novel locus for atopic dermatitis in African Americans and replication in European Americans	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							MAJOR PEANUT ALLERGEN; ASTHMA; STATES		[Almoguera, Berta; Vazquez, Lyam; Mentch, Frank; March, Michael E.; Connolly, John J.; Sleiman, Patrick; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Peissig, Peggy L.; Linneman, James G.; Brilliant, Murray] Marshfield Clin Res Inst, Marshfield, WI USA; [del Carmen Plaza-Seron, Maria; Pino-Yanes, Maria] ULL, Genom & Hlth Grp, Dept Biochem Microbiol Cell Biol & Genet, San Cristobal la Laguna, Tenerife, Spain; [Pino-Yanes, Maria] ULL, Hosp Univ NS de Candelaria, Res Unit, Santa Cruz De Tenerife, Spain; [Pino-Yanes, Maria] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Sleiman, Patrick; Hakonarson, Hakon] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Universidad de la Laguna; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine	Sleiman, P (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.; Sleiman, P (corresponding author), Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.	sleimanp@email.chop.edu	Pino-Yanes, Maria/C-8498-2017; March, Michael/AAB-6502-2019	Pino-Yanes, Maria/0000-0003-0332-437X; March, Michael/0000-0001-9173-6862; Connolly, John/0000-0003-4396-1226	National Human Genome Research Institute (NHGRI) [U01HG006830, U01HG8684, U01HG006389]; Children's Hospital of Philadelphia; Ramon y Cajal Program by the Spanish Ministry of Economy and Competitiveness [RYC-2015-17205]; Instituto de Salud Carlos III through Strategic Action for Health Research (AES) [AC15/00015]; European Community (EC) within the Active and Assisted Living (AAL) Programme framework; SysPharmPedia grant from the ERACoSysMed first Joint Transnational Call from the European Union under the Horizon 2020; Sandler Family Foundation; American Asthma Foundation; RWJF Amos Medical Faculty Development Program; National Institutes of Health [1R01HL117004, R01Hl128439]; National Institute of Health and Environmental Health Sciences [R01ES015794, R21ES24844]; National Institute on Minority Health and Health Disparities [1P60MD006902, U54MD009523, 1R01MDS010443]; Tobacco-Related Disease Research Program [24RT-0025]; National Institutes of Health NHGRI [U01HG8701]; National Center for Advancing Translational Sciences [1UL1TR002373]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002373] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128439, R01HL117004] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG008701, U01HG008684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES024844] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD006902] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Children's Hospital of Philadelphia; Ramon y Cajal Program by the Spanish Ministry of Economy and Competitiveness; Instituto de Salud Carlos III through Strategic Action for Health Research (AES); European Community (EC) within the Active and Assisted Living (AAL) Programme framework; SysPharmPedia grant from the ERACoSysMed first Joint Transnational Call from the European Union under the Horizon 2020; Sandler Family Foundation; American Asthma Foundation; RWJF Amos Medical Faculty Development Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health and Environmental Health Sciences; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Tobacco-Related Disease Research Program(University of California System); National Institutes of Health NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The eMERGE Network was initiated and funded by the National Human Genome Research Institute (NHGRI) through the following grants: U01HG006830 and U01HG8684 (Children's Hospital of Philadelphia) and U01HG006389 (Essentia Institute of Rural Health, Marshfield Clinic Research Foundation and Pennsylvania State University). The study was additionally funded by an Institutional Development Award to the Center for Applied Genomics from the Children's Hospital of Philadelphia. M.P.-Y. was funded by the Ramon y Cajal Program (grant no. RYC-2015-17205) by the Spanish Ministry of Economy and Competitiveness. M.P.-Y. was also supported by Instituto de Salud Carlos III (award no. AC15/00015) through Strategic Action for Health Research (AES) and European Community (EC) within the Active and Assisted Living (AAL) Programme framework and the SysPharmPedia grant awarded from the ERACoSysMed first Joint Transnational Call from the European Union under the Horizon 2020. E.G.B was funded by the Sandler Family Foundation, the American Asthma Foundation, the RWJF Amos Medical Faculty Development Program, Harry Wm. and Diana V. Hind Distinguished Professor in Pharmaceutical Sciences II, National Institutes of Health (grant nos. 1R01HL117004 and R01Hl128439), the National Institute of Health and Environmental Health Sciences (grant nos. R01ES015794 and R21ES24844), the National Institute on Minority Health and Health Disparities (grant nos. 1P60MD006902, U54MD009523, and 1R01MDS010443), and the Tobacco-Related Disease Research Program (award no. 24RT-0025). Marshfield Clinic Research Foundation efforts were supported by National Institutes of Health NHGRI (grant no. U01HG8701) and the National Center for Advancing Translational Sciences (grant no. 1UL1TR002373).	Ackerbauer D, 2015, INT ARCH ALLERGY IMM, V166, P13, DOI 10.1159/000371422; Almoguera B, 2017, AM J RESP CRIT CARE, V195, P456, DOI 10.1164/rccm.201604-0861OC; Bannon GA, 2001, INT ARCH ALLERGY IMM, V124, P70, DOI 10.1159/000053672; Beermann J, 2016, PHYSIOL REV, V96, P1297, DOI 10.1152/physrev.00041.2015; Eiwegger T, 2008, CLIN EXP ALLERGY, V38, P1627, DOI 10.1111/j.1365-2222.2008.03080.x; Eiwegger T, 2006, CLIN EXP ALLERGY, V36, P1281, DOI 10.1111/j.1365-2222.2006.02565.x; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Glaspole IN, 2005, ALLERGY, V60, P35, DOI 10.1111/j.1398-9995.2004.00608.x; Koppelman SJ, 2005, CLIN EXP ALLERGY, V35, P490, DOI 10.1111/j.1365-2222.2005.02204.x; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Margolis DJ, 2014, J ALLERGY CLIN IMMUN, V133, P784, DOI 10.1016/j.jaci.2013.09.015; Otsu K, 2015, CLIN EXP ALLERGY, V45, P471, DOI 10.1111/cea.12407; Paternoster L, 2015, NAT GENET, V47, P1449, DOI 10.1038/ng.3424; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prickett SR, 2011, J ALLERGY CLIN IMMUN, V127, P608, DOI 10.1016/j.jaci.2010.09.027; Sen M, 2002, J IMMUNOL, V169, P882, DOI 10.4049/jimmunol.169.2.882; Shaw TE, 2011, J INVEST DERMATOL, V131, P67, DOI 10.1038/jid.2010.251; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, pS116, DOI 10.1016/j.jaci.2009.08.028; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917	20	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2019	143	3					1229	+		10.1016/j.jaci.2018.10.038	http://dx.doi.org/10.1016/j.jaci.2018.10.038			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN6CQ	30414857	Bronze			2022-12-18	WOS:000460272900046
J	Bourdin, A; Molinari, N				Bourdin, Arnaud; Molinari, Nicolas			Indirect treatment comparison of asthma biologics fraught with methodology issues	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Bourdin, Arnaud] Montpellier Univ Hosp, Arnaud de Villeneuve Hosp, Dept Resp Dis, Montpellier, France; [Bourdin, Arnaud] Univ Montpellier, Arnaud de Villeneuve Hosp, INSERM U 1046, Montpellier, France; [Molinari, Nicolas] Univ Montpellier, CNRS, IMAG, CHU Montpellier, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; CHU de Montpellier	Bourdin, A (corresponding author), Montpellier Univ Hosp, Arnaud de Villeneuve Hosp, Dept Resp Dis, Montpellier, France.; Bourdin, A (corresponding author), Univ Montpellier, Arnaud de Villeneuve Hosp, INSERM U 1046, Montpellier, France.	a-bourdin@chu-montpellier.fr	molinari, nicolas/Y-9681-2019					Bourdin A, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.01393-2018; Busse W, 2019, J ALLERGY CLIN IMMUN, V143, P190, DOI 10.1016/j.jaci.2018.08.031; Cabon Y, 2017, CLIN EXP ALLERGY, V47, P129, DOI 10.1111/cea.12853; Jansen JP, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-159; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Phillippo DM., 2016, 18 NICE DSU; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147	7	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2019	143	3					1266	1267		10.1016/j.jaci.2018.11.024	http://dx.doi.org/10.1016/j.jaci.2018.11.024			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN6CQ	30639069	Bronze, Green Submitted			2022-12-18	WOS:000460272900060
J	Zhang, Y; Siegel, AM; Sun, GP; Dimaggio, T; Freeman, AF; Milner, JD				Zhang, Yuan; Siegel, Andrea M.; Sun, Guangping; Dimaggio, Tom; Freeman, Alexandra F.; Milner, Joshua D.			Human T(H)9 differentiation is dependent on signal transducer and activator of transcription (STAT) 3 to restrain STAT1-mediated inhibition	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Human T(H)9; signal transducer and activator of transcription 1; signal transducer and activator of transcription 3; IL-21; anticancer; allergy	TGF-BETA; T-CELLS; TH9 DIFFERENTIATION; DEFICIENCY; MELANOMA; INTERLEUKIN-21; INFLAMMATION; SUPPRESSOR; INDUCTION; RESPONSES	Background: Patients with loss-of-function (LOF) signal transducer and activator of transcription 3 (STAT3) mutations have dermatitis, enhanced IgE production despite a relative lack of immediate hypersensitivity, recurrent infection, and an increased rate of lymphoma in addition to a number of skeletal and connective tissue abnormalities. Patients with STAT1 gain-of-function (GOF) mutations also have susceptibility to candidiasis and sinopulmonary infection, as well as autoimmunity and squamous cell carcinoma, in addition to even more broad phenotypes. Objective: Because of the link between T(H)9 cells and allergic inflammation, autoimmunity, and antitumor surveillance and because evidence shows a role for either STAT3 or STAT1 in T(H)9 differentiation conflicts, we sought to determine the status on this lineage of STAT1 GOF and STAT3 LOF mutations in human subjects. Methods: We detected IL-9 levels and T(H)9 differentiation in patients withSTAT3LOFand STAT1 GOF mutations, together with T(H)9 transcript factors, and partially rescued their deficiency in vitro by adding cytokines they lacked or transfecting key molecules. Results: We found that PBMCs or sorted naive CD4(+) T cells from patients with STAT3 LOF and STAT1 GOF mutations had impaired T(H)9 generation/differentiation. STAT3 inhibition in normal T(H)9 cultures diminished early IL-21 induction and late IL-9 production, whereas exogenous IL-21 enhanced T(H)9 differentiation, even with STAT3 inhibition, by restoring suppressor of cytokine signaling 3 expression and thus inhibiting excessive phosphorylated signal transducer and activator of transcription (p-STAT) 1 activation. Furthermore, exogenous expression of suppressor of cytokine signaling 3 or either T-bet or STAT1 RNA interference in STAT3 LOF cells partially rescued IL-9 differentiation. Conclusion: Collectively, these results suggest that human TH9 differentiation depends on normal p-STAT3 and IL-21 production to suppress p-STAT1 activation and T-bet transcription.	[Zhang, Yuan; Sun, Guangping; Dimaggio, Tom; Milner, Joshua D.] NIAID, Genet & Pathogenesis Allergy Sect, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Freeman, Alexandra F.] NIAID, Immunopathogenesis Sect, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Siegel, Andrea M.] US FDA, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); US Food & Drug Administration (FDA)	Milner, JD (corresponding author), NIAID, GPAS, LAD, Bldg 10-CRC,Rm 53950,10 Ctr Dr, Bethesda, MD 20814 USA.	joshua.milner@nih.gov	Zhang, Yuan/C-7777-2018	Zhang, Yuan/0000-0001-9932-917X	Intramural Research Program of the National Institutes of Health [1ZIA AI001098-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001247, ZIAAI001098] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Intramural Research Program of the National Institutes of Health (1ZIA AI001098-02).	Barclay JL, 2009, INT J CANCER, V124, P1756, DOI 10.1002/ijc.24172; Becker KL, 2016, CLIN EXP ALLERGY, V46, P1564, DOI 10.1111/cea.12787; Boos AC, 2014, ALLERGY, V69, P943, DOI 10.1111/all.12416; Chandesris MO, 2012, MEDICINE, V91, pE1, DOI 10.1097/MD.0b013e31825f95b9; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Davis ID, 2009, CLIN CANCER RES, V15, P2123, DOI 10.1158/1078-0432.CCR-08-2663; Elyaman W, 2012, IMMUNITY, V36, P623, DOI 10.1016/j.immuni.2012.01.020; GORIN LJ, 1989, J ALLERGY CLIN IMMUN, V83, P5, DOI 10.1016/0091-6749(89)90471-5; Goswami R, 2012, J IMMUNOL, V189, P3026, DOI 10.4049/jimmunol.1201496; Goswami R, 2012, J IMMUNOL, V188, P968, DOI 10.4049/jimmunol.1102840; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Hox V, 2016, J ALLERGY CLIN IMMUN, V138, P187, DOI 10.1016/j.jaci.2015.11.024; Jabeen R, 2013, J CLIN INVEST, V123, P4641, DOI 10.1172/JCI69489; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Kaplan MH, 2015, NAT REV IMMUNOL, V15, P295, DOI 10.1038/nri3824; Leonard GD, 2004, LEUKEMIA LYMPHOMA, V45, P2521, DOI 10.1080/10428190400004463; Liao W, 2014, P NATL ACAD SCI USA, V111, P3508, DOI 10.1073/pnas.1301138111; Lu Y, 2012, J CLIN INVEST, V122, P4160, DOI 10.1172/JCI65459; Lyons JJ, 2017, J EXP MED, V214, P669, DOI 10.1084/jem.20161435; Matsuki A, 2017, J ALLERGY CLIN IMMUN, V139, P1355, DOI 10.1016/j.jaci.2016.08.022; Milner JD, 2013, NAT REV IMMUNOL, V13, P635, DOI 10.1038/nri3493; Murugaiyan G, 2012, J IMMUNOL, V189, P5277, DOI 10.4049/jimmunol.1200808; Olson MR, 2016, J IMMUNOL, V196, P3297, DOI 10.4049/jimmunol.1501801; Ozgur TT, 2007, J PEDIAT HEMATOL ONC, V29, P327, DOI 10.1097/MPH.0b013e318059c236; Purwar R, 2012, NAT MED, V18, P1248, DOI 10.1038/nm.2856; Santegoets SJAM, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24522; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Siegel AM, 2011, IMMUNITY, V35, P806, DOI 10.1016/j.immuni.2011.09.016; Spolski R, 2014, NAT REV DRUG DISCOV, V13, P381, DOI 10.1038/nrd4296; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Steward-Tharp SM, 2014, BLOOD, V123, P2978, DOI 10.1182/blood-2013-09-523167; Thompson JA, 2008, J CLIN ONCOL, V26, P2034, DOI 10.1200/JCO.2007.14.5193; Toubiana J, 2016, BLOOD, V127, P3154, DOI 10.1182/blood-2015-11-679902; Ulrich BJ, 2017, J IMMUNOL, V198, P2302, DOI 10.4049/jimmunol.1601624; Vegran F, 2014, NAT IMMUNOL, V15, P758, DOI 10.1038/ni.2925; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wong MT, 2010, IMMUNOL CELL BIOL, V88, P624, DOI 10.1038/icb.2010.53; Yang XXO, 2013, NAT IMMUNOL, V14, P732, DOI 10.1038/ni.2633; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang Y, 2017, J EXP MED, V214, P2523, DOI 10.1084/jem.20161427	41	6	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2019	143	3					1108	+		10.1016/j.jaci.2018.06.036	http://dx.doi.org/10.1016/j.jaci.2018.06.036			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN6CQ	30030006	Bronze			2022-12-18	WOS:000460272900031
J	Bird, JA; Parrish, C; Patel, K; Shih, JA; Vickery, BP				Bird, J. Andrew; Parrish, Christopher; Patel, Kiran; Shih, Jennifer A.; Vickery, Brian P.			Prevention of food allergy: Beyond peanut	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Food allergy prevention; egg allergy; early introduction	INFANTS; ECZEMA; RISK		[Bird, J. Andrew; Parrish, Christopher] Univ Texas Southwestern, Dept Pediat, Dallas, TX USA; [Patel, Kiran; Shih, Jennifer A.; Vickery, Brian P.] Emory Univ, Sch Med, Dept Pediat, 2015 Uppergate Dr NE, Atlanta, GA 30322 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University	Vickery, BP (corresponding author), Emory Univ, Sch Med, Dept Pediat, 2015 Uppergate Dr NE, Atlanta, GA 30322 USA.	bpvicke@emory.edu		Parrish, Christopher/0000-0002-2788-7778				Bellach J, 2017, J ALLERGY CLIN IMMUN, V139, P1591, DOI 10.1016/j.jaci.2016.06.045; Du Toit G, 2018, J ALLERGY CLIN IMMUN, V141, P30, DOI 10.1016/j.jaci.2017.11.010; Ierodiakonou D, 2016, JAMA-J AM MED ASSOC, V316, P1181, DOI 10.1001/jama.2016.12623; Katz Y, 2010, J ALLERGY CLIN IMMUN, V126, P77, DOI 10.1016/j.jaci.2010.04.020; Koplin JJ, 2018, IMMUNOL ALLERGY CLIN, V38, P1, DOI 10.1016/j.iac.2017.09.001; Natsume O, 2017, LANCET, V389, P276, DOI 10.1016/S0140-6736(16)31418-0; Palmer DJ, 2017, J ALLERGY CLIN IMMUN, V139, P1600, DOI 10.1016/j.jaci.2016.06.052; Palmer DJ, 2013, J ALLERGY CLIN IMMUN, V132, P387, DOI 10.1016/j.jaci.2013.05.002; Tan JWL, 2017, J ALLERGY CLIN IMMUN, V139, P1621, DOI 10.1016/j.jaci.2016.08.035; Yepes-Nunez JJ, 2018, ALLERGY, V73, P37, DOI 10.1111/all.13241	10	6	7	5	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2					545	547		10.1016/j.jaci.2018.12.993	http://dx.doi.org/10.1016/j.jaci.2018.12.993			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HK2DJ	30611674	Bronze			2022-12-18	WOS:000457718700009
J	Peters, R; Koplin, J; Ponsonby, AL; Perret, K; Dharmage, SC; Allen, K				Peters, Rachel; Koplin, Jennifer; Ponsonby, Anne-Louse; Perret, Kirsten; Dharmage, Shyamali C.; Allen, Katrina			The Natural History of Peanut and Egg Allergy and Predictors of Persistence: The Healthnuts Longitudinal Study, 6-Year-Old Follow-up	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Peters, Rachel; Allen, Katrina] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Peters, Rachel] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Koplin, Jennifer; Ponsonby, Anne-Louse; Perret, Kirsten] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Koplin, Jennifer; Ponsonby, Anne-Louse] Univ Melbourne, Sch Populat & Global Hlth, Parkville, Vic, Australia; [Perret, Kirsten; Allen, Katrina] Royal Childrens Hosp, Parkville, Vic, Australia; [Dharmage, Shyamali C.] Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia	Murdoch Children's Research Institute; University of Melbourne; Murdoch Children's Research Institute; University of Melbourne; Royal Children's Hospital Melbourne									0	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		L2	AB421	AB421		10.1016/j.jaci.2018.12.946	http://dx.doi.org/10.1016/j.jaci.2018.12.946			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO		Bronze			2022-12-18	WOS:000457771200931
J	Scheerens, H; Smith, A; Li, O; Honigberg, L; Harris, JM; Holtappels, G; Bachert, C				Scheerens, Heleen; Smith, Ashley; Li, Olga; Honigberg, Lee; Harris, Jeffrey M.; Holtappels, Gabriele; Bachert, Claus			Elevated IgE M1 prime transcripts in nasal tissues in patients with nasal polyps and asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Scheerens, Heleen; Smith, Ashley; Li, Olga; Honigberg, Lee; Harris, Jeffrey M.] Genentech Inc, San Francisco, CA 94080 USA; [Holtappels, Gabriele; Bachert, Claus] Ghent Univ Hosp, ENT Dept, Upper Airways Res Lab, Ghent, Belgium; [Bachert, Claus] Karolinska Inst, Div ENT Dis, CLINTEC, Stockholm, Sweden	Roche Holding; Genentech; Ghent University; Ghent University Hospital; Karolinska Institutet	Scheerens, H (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	scheerens.heleen@gene.com	Bachert, Claus/J-8825-2012		Genentech, Inc	Genentech, Inc(Roche HoldingGenentech)	Genentech, Inc, supported this study and was involved in the collection, analysis, and interpretation of data, the writing of the report, and the decision to submit the article for publication.	Bachert C, 2010, J ALLERGY CLIN IMMUN, V126, P962, DOI 10.1016/j.jaci.2010.07.007; Batista FD, 1996, J EXP MED, V184, P2197, DOI 10.1084/jem.184.6.2197; Brightbill HD, 2010, J CLIN INVEST, V120, P2218, DOI 10.1172/JCI40141; Dullaers M, 2012, J ALLERGY CLIN IMMUN, V129, P635, DOI 10.1016/j.jaci.2011.10.029; Gauvreau GM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008961; Gevaert P, 2013, ALLERGY, V68, P55, DOI 10.1111/all.12054; Gevaert P, 2013, J ALLERGY CLIN IMMUN, V131, P110, DOI 10.1016/j.jaci.2012.07.047; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; Zhang N, 2011, ALLERGY, V66, P141, DOI 10.1111/j.1398-9995.2010.02448.x	9	6	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2					805	+		10.1016/j.jaci.2018.10.011	http://dx.doi.org/10.1016/j.jaci.2018.10.011			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HK2DJ	30359682	Bronze			2022-12-18	WOS:000457718700048
J	Tindemans, I; Vroman, H; Lukkes, M; van Nimwegen, M; de Bruijn, MJW; Li, BWS; Kleinjan, A; de Boer, GM; Tramper-Stranders, GA; Kool, M; Braunstahl, GJ; Hendriks, RW				Tindemans, Irma; Vroman, Heleen; Lukkes, Melanie; van Nimwegen, Menno; de Bruijn, Marjolein J. W.; Li, Bobby W. S.; Kleinjan, Alex; de Boer, Geertje M.; Tramper-Stranders, Gerdien A.; Kool, Mirjam; Braunstahl, Gert-Jan; Hendriks, Rudi W.			Increased surface expression of NOTCH on memory T cells in peripheral blood from patients with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Tindemans, Irma; Vroman, Heleen; Lukkes, Melanie; van Nimwegen, Menno; de Bruijn, Marjolein J. W.; Li, Bobby W. S.; Kleinjan, Alex; de Boer, Geertje M.; Kool, Mirjam; Braunstahl, Gert-Jan; Hendriks, Rudi W.] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands; [Braunstahl, Gert-Jan] Franciscus Gasthuis & Vlietland, Dept Resp Med, Rotterdam, Netherlands; [Tramper-Stranders, Gerdien A.] Franciscus Gasthuis & Vlietland, Dept Pediat Med, Rotterdam, Netherlands; [Tramper-Stranders, Gerdien A.] Sophia Childrens Univ Hosp, Erasmus MC, Dept Neonatol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Franciscus Gasthuis; Franciscus Gasthuis; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	Hendriks, RW (corresponding author), Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands.	r.hendriks@erasmusmc.nl	de Boer, Geertje/K-7308-2019; Tramper, Gerdien/N-5556-2018; Braunstahl, Gert-Jan/AAA-3047-2020	de Boer, Geertje/0000-0002-9615-1123; Tramper, Gerdien/0000-0002-0228-5375; Braunstahl, Gert-Jan/0000-0001-7671-3742	Lung Foundation Netherlands [3.2.12.087, 3.2.12.067]	Lung Foundation Netherlands	This study is supported by Lung Foundation Netherlands (grant nos. 3.2.12.087 and 3.2.12.067).	Amsen D, 2015, TRENDS IMMUNOL, V36, P802, DOI 10.1016/j.it.2015.10.007; Bailis W, 2013, IMMUNITY, V39, P148, DOI 10.1016/j.immuni.2013.07.006; Bousquet J, 2015, EUR RESPIR J, V46, P579, DOI 10.1183/13993003.01084-2015; Juniper EF, 2006, RESP MED, V100, P616, DOI 10.1016/j.rmed.2005.08.012; Kang JH, 2009, AM J RESP CRIT CARE, V179, P875, DOI 10.1164/rccm.200806-893OC; KleinJan A, 2018, J ALLERGY CLIN IMMUN, V142, P76, DOI 10.1016/j.jaci.2017.08.042; Papi A, 2018, LANCET, V391, P783, DOI 10.1016/S0140-6736(17)33311-1; Steinbuck MP, 2018, J IMMUNOL, V200, P997, DOI 10.4049/jimmunol.1700070; Tindemans I, 2017, J ALLERGY CLIN IMMUN, V140, P1079, DOI 10.1016/j.jaci.2016.11.046; Wambre E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam9171	10	6	7	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2					769	+		10.1016/j.jaci.2018.09.012	http://dx.doi.org/10.1016/j.jaci.2018.09.012			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HK2DJ	30296524	Bronze			2022-12-18	WOS:000457718700036
J	Piao, XH; Miura, R; Miyake, S; Komazawa-Sakon, S; Koike, M; Shindo, R; Takeda, J; Hasegawa, A; Abe, R; Nishiyama, C; Mikami, T; Yagita, H; Uchiyama, Y; Nakano, H				Piao, Xuehua; Miura, Ryosuke; Miyake, Sanae; Komazawa-Sakon, Sachiko; Koike, Masato; Shindo, Ryodai; Takeda, Junji; Hasegawa, Akito; Abe, Riichiro; Nishiyama, Chiharu; Mikami, Tetsuo; Yagita, Hideo; Uchiyama, Yasuo; Nakano, Hiroyasu			Blockade of TNF receptor superfamily 1 (TNFR1)-dependent and TNFR1-independent cell death is crucial for normal epidermal differentiation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Cellular FLICE-inhibitory protein; apoptosis; epidermal differentiation; TNF-alpha	NECROSIS-FACTOR RECEPTOR; C-FLIP; SKIN INFLAMMATION; KERATINOCYTES; PSORIASIS; APOPTOSIS; HOMEOSTASIS; CFLIP; MECHANISMS; REGULATOR	Background: A delicate balance between cell death and keratinocyte proliferation is crucial for normal skin development. Previous studies have reported that cellular FLICE (FADD-like ICE)-inhibitory protein plays a crucial role in prevention of keratinocytes from TNF-alpha-dependent apoptosis and blocking of dermatitis. However, a role for cellular FLICE-inhibitory protein in TNF-alpha-independent cell death remains unclear. Objective: We investigated contribution of TNF-alpha-dependent and TNF-alpha-independent signals to the development of dermatitis in epidermis-specific Cflar-deficient (Cflar(E-KO)) mice. Methods: We examined the histology and expression of epidermal differentiation markers and inflammatory cytokines in the skin of Cflar(E-KO); Tnfrsf1a(1/2) and Cflar(E-KO); Tnfrsf1a(-/-) mice. Mice were treated with neutralizing antibodies against Fas ligand and TNF-related apoptosis-inducing ligand to block TNF-alpha-independent cell death of Cflar(E-KO); Tnfrsf1a(-/-) mice. Results: Cflar(E-KO); Tnfrsf1a(-/-) mice were born but experienced severe dermatitis and succumbed soon after birth. Cflar(E-KO); Tnfrsf1a(+/-) mice exhibited embryonic lethality caused by massive keratinocyte apoptosis. Although keratinocytes from Cflar(E-KO); Tnfrsf1a(-/-) mice still died of apoptosis, neutralizing antibodies against Fas ligand and TNF-related apoptosis-inducing ligand substantially prolonged survival of Cflar(E-KO); Tnfrsf1a(-/-) mice. Expression of inflammatory cytokines, such as Il6 and Il17a was increased; conversely, expression of epidermal differentiation markers was severely downregulated in the skin of Cflar(E-KO); Tnfrsf1a(-/-) mice. Treatment of primary keratinocytes with IL-6 and, to a lesser extent, IL-17A suppressed expression of epidermal differentiation markers. Conclusion: TNF receptor superfamily 1 (TNFR1)-dependent or TNFR1-independent apoptosis of keratinocytes promotes inflammatory cytokine production, which subsequently blocks epidermal differentiation. Thus blockade of both TNFR1-dependent and TNFR1-independent cell death might be an alternative strategy to treat skin diseases when treatment with anti-TNF-alpha antibody alone is not sufficient.	[Piao, Xuehua; Miura, Ryosuke; Miyake, Sanae; Komazawa-Sakon, Sachiko; Shindo, Ryodai; Nakano, Hiroyasu] Toho Univ, Sch Med, Dept Biochem, Tokyo, Japan; [Mikami, Tetsuo] Toho Univ, Sch Med, Dept Pathol, Tokyo, Japan; [Nakano, Hiroyasu] Toho Univ, Sch Med, Host Def Res Ctr, Tokyo, Japan; [Miura, Ryosuke; Nishiyama, Chiharu] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Lab Mol Biol & Immunol, Tokyo, Japan; [Koike, Masato] Juntendo Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Tokyo, Japan; [Yagita, Hideo] Juntendo Univ, Grad Sch Med, Dept Immunol, Tokyo, Japan; [Uchiyama, Yasuo] Juntendo Univ, Grad Sch Med, Dept Cellular Mol Neuropathol, Tokyo, Japan; [Takeda, Junji] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Osaka, Japan; [Hasegawa, Akito; Abe, Riichiro] Niigata Univ, Div Dermatol, Grad Sch Med & Dent Sci, Niigata, Japan; [Piao, Xuehua] Walter & Eliza Hall Inst Med Res, Cell Signaling & Cell Death Div, Parkville, Vic, Australia	Toho University; Toho University; Toho University; Tokyo University of Science; Juntendo University; Juntendo University; Juntendo University; Osaka University; Niigata University; Walter & Eliza Hall Institute	Nakano, H (corresponding author), Toho Univ, Sch Med, Dept Biochem, Ota Ku, 5-21-16 Omori Nishi, Tokyo 1438540, Japan.	hiroyasu.nakano@med.toho-u.ac.jp	Nishiyama, Chiharu/GPW-9372-2022	Nakano, Hiroyasu/0000-0003-4843-1427; Komazawa-Sakon, Sachiko/0000-0002-6244-1974; Miura, Ryosuke/0000-0003-1249-7803	Japan Society for the Promotion of Science (JSPS) [17J00933, 14J12413]; JSPS [17H04069, 17K19533, 26893265]; MEXT (Ministry of Education, Culture, Sports, Science and Technology) [26110003]; NOVARTIS Foundation for the Promotion of Science; Naito Science Foundation; Uehara Science Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [17H04069, 16K01378, 17K19533] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NOVARTIS Foundation for the Promotion of Science; Naito Science Foundation; Uehara Science Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	R.M. and R.S. were supported by Research Fellowships 17J00933 (to R.M.) and 14J12413 (to R.S.) from the Japan Society for the Promotion of Science (JSPS). This work was supported in part by Grants-in-Aid from Scientific Research (B) 17H04069 (to H.N.), Challenging Exploratory Research grant 17K19533 (to H.N.), and Research Activity Start-up grant 26893265 (to X.P.) from JSPS and Scientific Research on Innovative areas 26110003 (to H.N.) and Private University Research Branding project (to H.N.) from MEXT (Ministry of Education, Culture, Sports, Science and Technology), research grants from the NOVARTIS Foundation for the Promotion of Science (to H.N.), the Naito Science Foundation (to H.N.), the Uehara Science Foundation (to H.N.), and the Takeda Science Foundation (to H.N.).	Amano W, 2015, J ALLERGY CLIN IMMUN, V136, P667, DOI 10.1016/j.jaci.2015.03.051; Antonopoulos C, 2015, J BIOL CHEM, V290, P20167, DOI 10.1074/jbc.M115.652321; Armbruster N, 2009, J INVEST DERMATOL, V129, P1696, DOI 10.1038/jid.2008.438; Blauvelt A, 2017, J INVEST DERMATOL, V137, P541, DOI 10.1016/j.jid.2016.11.022; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Downey A, 2012, J AM ACAD DERMATOL, V66, P995, DOI 10.1016/j.jaad.2011.09.029; Elsholz F, 2014, EUR J DERMATOL, V24, P650, DOI 10.1684/ejd.2014.2452; Fritz Y, 2017, J INVEST DERMATOL, V137, P696, DOI 10.1016/j.jid.2016.10.021; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Goodman WA, 2009, J IMMUNOL, V183, P3170, DOI 10.4049/jimmunol.0803721; Guinea-Viniegra J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008089; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Kumari S, 2013, IMMUNITY, V39, P899, DOI 10.1016/j.immuni.2013.10.009; Lacour S, 2003, ONCOGENE, V22, P1807, DOI 10.1038/sj.onc.1206127; Lian LH, 2012, J INVEST DERMATOL, V132, P1346, DOI 10.1038/jid.2011.482; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Nakano H, 2017, CURR TOP MICROBIOL, V403, P119, DOI 10.1007/82_2015_448; NASIR J, 1990, GENET RES, V55, P126; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Panayotova-Dimitrova D, 2013, CELL REP, V5, P397, DOI 10.1016/j.celrep.2013.09.035; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Piao XH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003558; Ritchlin CT, 2016, CURR OPIN RHEUMATOL, V28, P204, DOI 10.1097/BOR.0000000000000274; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Sayama K, 2006, J BIOL CHEM, V281, P22013, DOI 10.1074/jbc.M601065200; Schattenberg JM, 2011, J HEPATOL, V55, P1272, DOI 10.1016/j.jhep.2011.03.008; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Siegmund D, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.285; Singh TP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13581; Soong G, 2015, MBIO, V6, DOI 10.1128/mBio.00289-15; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Weinlich R, 2013, CELL REP, V5, P340, DOI 10.1016/j.celrep.2013.08.045; Wittkopf N, 2013, GASTROENTEROLOGY, V145, P1369, DOI 10.1053/j.gastro.2013.08.059; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Zhang N, 2005, J EXP MED, V202, P395, DOI 10.1084/jem.20050117; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	47	6	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2019	143	1					213	+		10.1016/j.jaci.2018.02.043	http://dx.doi.org/10.1016/j.jaci.2018.02.043			26	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HG4BD	29596938				2022-12-18	WOS:000454918300027
J	Keet, CA; Allen, KJ				Keet, Corinne A.; Allen, Katrina J.			Advances in food allergy in 2017	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Food allergy; atopic dermatitis	PROTEIN-INDUCED ENTEROCOLITIS; PEANUT ORAL IMMUNOTHERAPY; INFANT-FEEDING GUIDELINES; HIGH-RISK INFANTS; ARA H 2; EPICUTANEOUS IMMUNOTHERAPY; AMERICAN ACADEMY; DOUBLE-BLIND; EOSINOPHILIC ESOPHAGITIS; ATOPIC-DERMATITIS	This review highlights research and policy advances in food allergy that were published in 2017 in the Journal and beyond. In 2017, many important studies on the treatment of food allergy were published, bringing us ever closer to a standardized treatment for food allergy. Other important advancements included research into other management strategies, including thresholds for avoidance, management of food allergies in schools, and development of new guidelines for prevention of food allergy. There were several important epidemiologic studies helping us understand the phenotypes of allergic disease, and new hypotheses were proposed for how best to prevent food allergy. Finally, there was a welcome increased attention to non-IgE-mediated food allergies.	[Keet, Corinne A.] Johns Hopkins Univ, Sch Med, Johns Hopkins Hosp, Div Pediat Allergy & Immunol, Baltimore, MD USA; [Allen, Katrina J.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Allen, Katrina J.] Royal Childrens Hosp, Dept Allergy & Immunol, Melbourne, Vic, Australia; [Allen, Katrina J.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia	Johns Hopkins University; Johns Hopkins Medicine; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Keet, CA (corresponding author), Johns Hopkins Sch Med, Pediat Allergy & Immunol, 1800 Orleans St,Sheikh Zayed Tower, Baltimore, MD 21287 USA.	ckeet1@jhmi.edu	Allen, Katrina/I-4361-2018	Allen, Katrina/0000-0002-1921-4493	National Institute of Allergy and Infectious Diseases [1U01AI125290]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI125290] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by 1U01AI125290 from the National Institute of Allergy and Infectious Diseases (to C.A.K.).	Acker WW, 2017, J ALLERGY CLIN IMMUN, V140, P1587, DOI 10.1016/j.jaci.2017.04.006; Al Enezi M, 2018, J ALLER CL IMM-PRACT, V6, P674, DOI 10.1016/j.jaip.2017.08.033; Alduraywish SA, 2017, PEDIAT ALLERG IMM-UK, V28, P30, DOI 10.1111/pai.12651; Anvari S, 2017, JAMA PEDIATR, V171, P77, DOI 10.1001/jamapediatrics.2016.2552; Ballardini N, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-1404; Bartnikas LM, 2017, J ALLERGY CLIN IMMUN, V140, P465, DOI 10.1016/j.jaci.2017.01.040; Bellach J, 2017, J ALLERGY CLIN IMMUN, V139, P1591, DOI 10.1016/j.jaci.2016.06.045; Bird JA, 2018, J ALLER CL IMM-PRACT, V6, P476, DOI 10.1016/j.jaip.2017.09.016; Bird JA, 2017, J ALLER CL IMM-PRACT, V5, P301, DOI 10.1016/j.jaip.2016.07.019; Burk CM, 2017, J ALLER CL IMM-PRACT, V5, P498, DOI 10.1016/j.jaip.2016.11.010; Canani RB, 2017, J ALLERGY CLIN IMMUN, V139, P1906, DOI 10.1016/j.jaci.2016.10.050; Caubet JC, 2017, J ALLERGY CLIN IMMUN, V139, P572, DOI 10.1016/j.jaci.2016.02.047; Chan JCK, 2017, J ALLERGY CLIN IMMUN, V5, pe3; Chan JCK, 2017, J ALLER CL IMM-PRACT, V5, P398, DOI 10.1016/j.jaip.2016.12.021; Czarnowicki T, 2017, J ALLERGY CLIN IMMUN, V139, P1723, DOI 10.1016/j.jaci.2017.04.004; Dawicki W, 2017, J ALLERGY CLIN IMMUN, V139, P1608, DOI 10.1016/j.jaci.2016.07.042; Freidl R, 2017, J ALLERGY CLIN IMMUN, V139, P1897, DOI 10.1016/j.jaci.2016.10.018; Frischmeyer-Guerrerio PA, 2017, J ALLERGY CLIN IMMUN, V140, P1043, DOI 10.1016/j.jaci.2017.03.028; Gau J, 2017, J ALLER CL IMM-PRACT, V5, P475, DOI 10.1016/j.jaip.2016.06.027; Goswami R, 2017, J ALLERGY CLIN IMMUN, V139, P1885, DOI 10.1016/j.jaci.2016.12.971; Greenhawt M, 2017, J ALLER CL IMM-PRACT, V5, P1319, DOI 10.1016/j.jaip.2016.11.036; Groetch M, 2017, J ALLER CL IMM-PRACT, V5, P312, DOI 10.1016/j.jaip.2016.12.026; Honjo A, 2017, J ALLERGY CLIN IMMUN, V139, P987, DOI 10.1016/j.jaci.2016.05.046; Hose AJ, 2017, J ALLERGY CLIN IMMUN, V139, P1935, DOI 10.1016/j.jaci.2016.08.046; Hourihane JO, 2017, J ALLERGY CLIN IMMUN, V139, P1583, DOI 10.1016/j.jaci.2017.01.030; Hoyt AEW, 2018, J ALLER CL IMM-PRACT, V6, P677, DOI 10.1016/j.jaip.2017.09.023; Huang YJ, 2017, J ALLERGY CLIN IMMUN, V139, P1099, DOI 10.1016/j.jaci.2017.02.007; Hyytinen M, 2017, GASTROENTEROLOGY, V153, P961, DOI 10.1053/j.gastro.2017.06.049; Ierodiakonou D, 2016, JAMA-J AM MED ASSOC, V316, P11; Johansson EK, 2017, J ALLERGY CLIN IMMUN, V140, P1572, DOI 10.1016/j.jaci.2017.04.008; Jones SM, 2017, NEW ENGL J MED, V377, P1168, DOI 10.1056/NEJMcp1611971; Jones SM, 2017, J ALLERGY CLIN IMMUN, V139, P1242, DOI 10.1016/j.jaci.2016.08.017; Koplin JJ, 2013, CLIN EXP ALLERGY, V43, P826, DOI 10.1111/cea.12090; Koplin JJ, 2016, J ALLERGY CLIN IMMUN, V138, P1131, DOI 10.1016/j.jaci.2016.04.011; Korosec P, 2017, J ALLERGY CLIN IMMUN, V140, P750, DOI 10.1016/j.jaci.2016.12.989; Lee E, 2017, J ALLER CL IMM-PRACT, V5, P486, DOI 10.1016/j.jaip.2016.09.032; Lee S, 2017, J ALLER CL IMM-PRACT, V5, P1295, DOI 10.1016/j.jaip.2017.07.020; Lee S, 2017, J ALLERGY CLIN IMMUN, V139, P182, DOI 10.1016/j.jaci.2016.04.029; MacGinnitie AJ, 2017, J ALLERGY CLIN IMMUN, V139, P873, DOI 10.1016/j.jaci.2016.08.010; Marchisotto MJ, 2017, J ALLER CL IMM-PRACT, V5, P345, DOI 10.1016/j.jaip.2016.09.020; Martin PE, 2015, CLIN EXP ALLERGY, V45, P255, DOI 10.1111/cea.12406; McGowan EC, 2016, J ALLER CL IMM-PRACT, V4, P713, DOI 10.1016/j.jaip.2016.01.017; Mehr S, 2017, J ALLERGY CLIN IMMUN, V140, P1323, DOI 10.1016/j.jaci.2017.03.027; Motosue MS, 2017, J ALLER CL IMM-PRACT, V5, P171, DOI 10.1016/j.jaip.2016.08.013; National Academies of Sciences Engineering and Medicine, 2017, FIND PATH SAF FOOD A; Natsume O, 2017, LANCET, V389, P276, DOI 10.1016/S0140-6736(16)31418-0; Netting MJ, 2017, J ALLER CL IMM-PRACT, V5, P1617, DOI 10.1016/j.jaip.2017.03.013; Nowak-Wegrzyn A, 2017, J ALLERGY CLIN IMMUN, V139, P1111, DOI 10.1016/j.jaci.2016.12.966; Pajno GB, 2018, ALLERGY, V73, P799, DOI 10.1111/all.13319; Palmer DJ, 2017, J ALLERGY CLIN IMMUN, V139, P1600, DOI 10.1016/j.jaci.2016.06.052; Patel DR, 2018, J ALLER CL IMM-PRACT, V6, P671, DOI 10.1016/j.jaip.2017.08.013; Peters RL, 2015, CLIN EXP ALLERGY, V45, P953, DOI 10.1111/cea.12478; Peters RL, 2018, J ALLER CL IMM-PRACT, V6, P440, DOI 10.1016/j.jaip.2017.11.018; Peters RL, 2017, J ALLERGY CLIN IMMUN, V140, P145, DOI 10.1016/j.jaci.2017.02.019; Peters RL, 2013, INT J ENV RES PUB HE, V10, P5039, DOI 10.3390/ijerph10105039; Roduit C, 2017, JAMA PEDIATR, V171, P655, DOI 10.1001/jamapediatrics.2017.0556; Sampson HA, 2017, JAMA-J AM MED ASSOC, V318, P1798, DOI 10.1001/jama.2017.16591; Schoos AMM, 2017, J ALLERGY CLIN IMMUN, V140, P1693, DOI 10.1016/j.jaci.2017.01.041; Scientific Advisory Committee on Nutrition and the Committee on Toxicity of Chemicals in Food Consumer Products and the Environment, STAT TIM INTR ALL FO; Scientific Advisory Committee on Nutrition and the Committee on Toxicity of Chemicals in Food Consumer Products and the Environment, ASS HLTH BEN RISKS I; Shaker M, 2018, ALLERGY, V73, P1707, DOI 10.1111/all.13446; Smith PK, 2017, J ALLERGY CLIN IMMUN, V139, P429, DOI 10.1016/j.jaci.2016.05.040; Stokholm J, 2017, AM J RESP CRIT CARE, V195, P614, DOI 10.1164/rccm.201604-0806OC; Tan JWL, 2017, J ALLERGY CLIN IMMUN, V139, P1621, DOI 10.1016/j.jaci.2016.08.035; Tey D, 2014, J ALLERGY CLIN IMMUN, V133, P476, DOI 10.1016/j.jaci.2013.11.019; Togias A, 2017, J ALLERGY CLIN IMMUN, V139, P29, DOI 10.1016/j.jaci.2016.10.010; Tordesillas L, 2017, J ALLERGY CLIN IMMUN, V139, P189, DOI 10.1016/j.jaci.2016.03.057; Turner PJ, 2017, JAMA-J AM MED ASSOC, V317, P1111, DOI 10.1001/jama.2017.0922; Uotila R, 2017, J ALLERGY CLIN IMMUN, V139, P1393, DOI 10.1016/j.jaci.2016.09.054; Varshney P, 2011, J ALLERGY CLIN IMMUN, V127, P654, DOI 10.1016/j.jaci.2010.12.1111; Vazquez-Ortiz M, 2017, J ALLER CL IMM-PRACT, V5, P512, DOI 10.1016/j.jaip.2016.12.029; Vickery BP, 2017, J ALLERGY CLIN IMMUN, V139, P173, DOI 10.1016/j.jaci.2016.05.027; Virkud YV, 2017, J ALLERGY CLIN IMMUN, V139, P882, DOI 10.1016/j.jaci.2016.07.030; Wasserman RL, 2018, J ALLERGY CLIN IMMUN; Wood RA, 2013, ALLERGY, V68, P803, DOI 10.1111/all.12158; Wood RA, 2016, J ALLERGY CLIN IMMUN, V137, P1103, DOI 10.1016/j.jaci.2015.10.005; Zurzolo GA, 2016, J PAEDIATR CHILD H, V52, P797, DOI 10.1111/jpc.13202; Zurzolo GA, 2016, CURR OPIN ALLERGY CL, V16, P272, DOI 10.1097/ACI.0000000000000262	78	6	8	2	27	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2018	142	6					1719	1729		10.1016/j.jaci.2018.10.020	http://dx.doi.org/10.1016/j.jaci.2018.10.020			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HD2BJ	30539723	Bronze			2022-12-18	WOS:000452315800004
J	Skevaki, C; Renz, H				Skevaki, Chrysanthi; Renz, Harald			Advances in mechanisms of allergic disease in 2017	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergy; immunology; innate; adaptive; inflammation; asthma; food allergy; mast cell; eosinophil; barrier function	INNATE LYMPHOID-CELLS; REGULATORY T-CELLS; DENDRITIC CELLS; AIRWAY INFLAMMATION; MOUSE MODEL; MAST-CELLS; B-CELLS; RESPONSES; IGE; TISSUE	This review highlights advances in mechanisms of allergic disease, particularly type 2 innate lymphoid cells, T(H)2 lymphocytes, B cells, dendritic cells, microbiome and barrier function, eosinophils, and mast cells. During the last year, considerable progress has been made in the further characterization of type 2 inflammation controlled by both adaptive (T(H)2) and type 2 innate lymphoid effector cells. New pathways of lymphocyte activation, trafficking, and recruitment and effector cell mechanisms have been discovered. The plasticity of lymphocyte effector cell responses is another area in which major progress has been achieved. Accumulating evidence will influence both our understanding of allergic disease and our efforts for allergy prevention and treatment.	[Skevaki, Chrysanthi; Renz, Harald] Philipps Univ Marburg, Inst Lab Med, Baldinger Str, D-35043 Marburg, Germany; [Skevaki, Chrysanthi; Renz, Harald] Philipps Univ Marburg, UGMLC, German Ctr Lung Res DZL, Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Renz, H (corresponding author), Philipps Univ Marburg, Inst Lab Med, Baldinger Str, D-35043 Marburg, Germany.	renzh@med.uni-marburg.de			Universities Giessen and Marburg Lung Center (UGMLC); German Center for Lung Research [82DZL00502/A2]; Deutsche Forschungsgemeinschaft (DFG) [SFB 1021]	Universities Giessen and Marburg Lung Center (UGMLC); German Center for Lung Research; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Supported by Universities Giessen and Marburg Lung Center (UGMLC; to H.R. and C.S.), the German Center for Lung Research (DZL; 82DZL00502/A2 to H.R. and C.S.), and the Deutsche Forschungsgemeinschaft (DFG)-funded SFB 1021 (C04, to H.R. and C.S.).	Achour A, 2017, J ALLERGY CLIN IMMUN, V140, P215, DOI 10.1016/j.jaci.2016.09.042; Azizi G, 2017, CELL IMMUNOL, V315, P11, DOI 10.1016/j.cellimm.2016.12.007; Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Beutier H, 2017, J ALLERGY CLIN IMMUN, V139, P269, DOI 10.1016/j.jaci.2016.03.028; Bozyk PD, 2011, STEM CELLS DEV, V20, P1995, DOI 10.1089/scd.2010.0494; Browne SK, 2010, LANCET INFECT DIS, V10, P875, DOI 10.1016/S1473-3099(10)70196-1; Burton OT, 2017, J ALLERGY CLIN IMMUN, V139, P314, DOI 10.1016/j.jaci.2016.04.034; Chen CC, 2017, J ALLERGY CLIN IMMUN, V140, P1351, DOI 10.1016/j.jaci.2017.01.015; De Grove KC, 2017, J ALLERGY CLIN IMMUN, V139, P246, DOI 10.1016/j.jaci.2016.03.044; Deckers J, 2017, J ALLERGY CLIN IMMUN, V140, P1364, DOI 10.1016/j.jaci.2016.12.970; Dietz K, 2017, J ALLERGY CLIN IMMUN, V139, P1343, DOI 10.1016/j.jaci.2016.07.014; Dzidic M, 2017, J ALLERGY CLIN IMMUN, V139, P1017, DOI 10.1016/j.jaci.2016.06.047; Ebbo M, 2017, NAT REV IMMUNOL, V17, P665, DOI 10.1038/nri.2017.86; Fang DF, 2017, J EXP MED, V214, P1861, DOI 10.1084/jem.20170494; Geary CD, 2017, SEMIN IMMUNOL, V31, P11, DOI 10.1016/j.smim.2017.08.012; Hofer H, 2017, J ALLERGY CLIN IMMUN, V140, P525, DOI 10.1016/j.jaci.2016.09.055; Honjo A, 2017, J ALLERGY CLIN IMMUN, V139, P987, DOI 10.1016/j.jaci.2016.05.046; Hose AJ, 2017, J ALLERGY CLIN IMMUN, V139, P1935, DOI 10.1016/j.jaci.2016.08.046; Iberg CA, 2017, TRENDS IMMUNOL, V38, P793, DOI 10.1016/j.it.2017.07.007; Iwasaki N, 2017, J ALLERGY CLIN IMMUN, V139, P258, DOI 10.1016/j.jaci.2016.03.023; Joetham A, 2017, J ALLERGY CLIN IMMUN, V139, P1331, DOI 10.1016/j.jaci.2016.06.051; Johansson K, 2017, J ALLERGY CLIN IMMUN, V139, P1007, DOI 10.1016/j.jaci.2016.06.035; Joulia R, 2017, J ALLERGY CLIN IMMUN, V140, P497, DOI 10.1016/j.jaci.2016.09.049; Kannan Y, 2017, J ALLERGY CLIN IMMUN, V139, P655, DOI 10.1016/j.jaci.2016.05.031; Karta MR, 2018, J ALLERGY CLIN IMMUN, V141, P329, DOI 10.1016/j.jaci.2017.03.010; Kawakami Y, 2017, J ALLERGY CLIN IMMUN, V139, P997, DOI 10.1016/j.jaci.2016.06.034; Kobayashi T, 2017, J ALLERGY CLIN IMMUN, V139, P300, DOI 10.1016/j.jaci.2016.04.021; Kreiner E, 2017, J ALLERGY CLIN IMMUN, V140, P771, DOI 10.1016/j.jaci.2016.10.055; Kumawat K, 2016, CELL MOL LIFE SCI, V73, P567, DOI 10.1007/s00018-015-2076-y; Kumawat K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094801; Kumawat K, 2013, FASEB J, V27, P1631, DOI 10.1096/fj.12-217539; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Lotfi-Emran S, 2018, J ALLERGY CLIN IMMUN, V141, P311, DOI 10.1016/j.jaci.2017.02.048; Maazi H, 2017, IMMUNOL REV, V278, P192, DOI 10.1111/imr.12554; Madouri F, 2017, J ALLERGY CLIN IMMUN, V139, P1650, DOI 10.1016/j.jaci.2016.08.044; Maggi L, 2017, J ALLERGY CLIN IMMUN, V139, P964, DOI 10.1016/j.jaci.2016.06.032; Male V, 2017, TRENDS IMMUNOL, V38, P307, DOI 10.1016/j.it.2017.02.008; Marquardt N, 2017, J ALLERGY CLIN IMMUN, V139, P1321, DOI 10.1016/j.jaci.2016.07.043; Martinez-Gonzalez I, 2017, TRENDS IMMUNOL, V38, P423, DOI 10.1016/j.it.2017.03.005; McFarlane AJ, 2017, J ALLERGY CLIN IMMUN, V140, P1068, DOI 10.1016/j.jaci.2017.01.016; O'Sullivan JA, 2018, J ALLERGY CLIN IMMUN, V141, P1774, DOI 10.1016/j.jaci.2017.06.028; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Peng H, 2017, SEMIN IMMUNOL, V31, P3, DOI 10.1016/j.smim.2017.07.006; Pesce S, 2017, J ALLERGY CLIN IMMUN, V139, P335, DOI 10.1016/j.jaci.2016.04.025; Pothoven KL, 2017, J ALLERGY CLIN IMMUN, V139, P1966, DOI 10.1016/j.jaci.2016.10.039; Qiao YK, 2017, J ALLERGY CLIN IMMUN, V139, P82, DOI 10.1016/j.jaci.2016.03.029; Radonjic-Hoesli S, 2017, J ALLERGY CLIN IMMUN, V140, P1632, DOI 10.1016/j.jaci.2017.01.044; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Renand A, 2018, J ALLERGY CLIN IMMUN, V141, P1750, DOI 10.1016/j.jaci.2017.09.041; Reuter S, 2016, LAB INVEST, V96, P177, DOI 10.1038/labinvest.2015.143; Rothenberg ME, 2017, J ALLERGY CLIN IMMUN, V140, P1622, DOI 10.1016/j.jaci.2017.08.029; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salimi M, 2017, J ALLERGY CLIN IMMUN, V140, P1090, DOI 10.1016/j.jaci.2016.12.958; Sarvaria A, 2017, CELL MOL IMMUNOL, V14, P662, DOI 10.1038/cmi.2017.35; Schulke S, 2018, J ALLERGY CLIN IMMUN, V141, P1786, DOI 10.1016/j.jaci.2017.07.002; Selb R, 2017, J ALLERGY CLIN IMMUN, V139, P290, DOI 10.1016/j.jaci.2016.03.042; Selb R, 2017, J ALLERGY CLIN IMMUN, V139, P281, DOI 10.1016/j.jaci.2016.04.015; Semitekolou M, 2018, J ALLERGY CLIN IMMUN, V141, P671, DOI 10.1016/j.jaci.2017.03.047; Sharkia I, 2017, J ALLERGY CLIN IMMUN, V140, P204, DOI 10.1016/j.jaci.2016.09.047; Shubin NJ, 2017, J ALLERGY CLIN IMMUN, V139, P323, DOI 10.1016/j.jaci.2016.03.051; Siebenhaar F, 2018, TRENDS IMMUNOL, V39, P151, DOI 10.1016/j.it.2017.10.005; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Siroux V, 2017, J ALLERGY CLIN IMMUN, V139, P643, DOI 10.1016/j.jaci.2016.05.023; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spohn G, 2017, J ALLERGY CLIN IMMUN, V139, P1957, DOI 10.1016/j.jaci.2016.09.033; Stein K, 2017, J ALLERGY CLIN IMMUN, V139, P667, DOI 10.1016/j.jaci.2016.06.018; Stephen-Victor E, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12746; Sugita K, 2018, J ALLERGY CLIN IMMUN, V141, P300, DOI 10.1016/j.jaci.2017.02.038; Sun QZ, 2017, J ALLERGY CLIN IMMUN, V140, P510, DOI 10.1016/j.jaci.2016.11.013; Takada S, 2018, J ALLERGY CLIN IMMUN, V141, P339, DOI 10.1016/j.jaci.2017.04.013; Tanaka A, 2017, CELL RES, V27, P109, DOI 10.1038/cr.2016.151; Tindemans I, 2017, J ALLERGY CLIN IMMUN, V140, P1079, DOI 10.1016/j.jaci.2016.11.046; Tolar P, 2017, NAT REV IMMUNOL, V17, P621, DOI 10.1038/nri.2017.67; Trischler J, 2016, AM J RESP CELL MOL, V54, P584, DOI 10.1165/rcmb.2014-0425OC; Wang MQ, 2018, J ALLERGY CLIN IMMUN, V141, P659, DOI 10.1016/j.jaci.2017.04.020; Zhou YF, 2018, J ALLERGY CLIN IMMUN, V141, P350, DOI 10.1016/j.jaci.2017.04.049	76	6	7	1	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2018	142	6					1730	1739		10.1016/j.jaci.2018.09.027	http://dx.doi.org/10.1016/j.jaci.2018.09.027			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HD2BJ	30315828	Bronze			2022-12-18	WOS:000452315800005
J	McGeachie, MJ; Clemmer, GL; Hayete, B; Xing, HM; Runge, K; Wu, AC; Jiang, XF; Lu, Q; Church, B; Khalil, L; Tantisira, K; Weiss, S				McGeachie, Michael J.; Clemmer, George L.; Hayete, Boris; Xing, Heming; Runge, Karl; Wu, Ann Chen; Jiang, Xiaofeng; Lu, Quan; Church, Bruce; Khalil, Lya; Tantisira, Kelan; Weiss, Scott			Systems biology and in vitro validation identifies family with sequence similarity 129 member A (FAM129A) as an asthma steroid response modulator	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Inhaled corticosteroids; steroid response endophenotype; genomics; FAM129A; Reverse Engineering; Forward Simulation modeling; systems biology	AIRWAY SMOOTH-MUSCLE; GENE-EXPRESSION; CORTICOSTEROID RESPONSE; INHALED CORTICOSTEROIDS; R-PACKAGE; ASSOCIATION; GLCCI1; PHARMACOGENETICS; HETEROGENEITY; LOCI	Background: Variation in response to the most commonly used class of asthma controller medication, inhaled corticosteroids, presents a serious challenge in asthma management, particularly for steroid-resistant patients with little or no response to treatment. Objective: We applied a systems biology approach to primary clinical and genomic data to identify and validate genes that modulate steroid response in asthmatic children. Methods: We selected 104 inhaled corticosteroid-treated asthmatic non-Hispanic white children and determined a steroid responsiveness endophenotype (SRE) using observations of 6 clinical measures over 4 years. We modeled each subject's cellular steroid response using data from a previously published study of immortalized lymphoblastoid cell lines under dexamethasone (DEX) and sham treatment. We integrated SRE with immortalized lymphoblastoid cell line DEX responses and genotypes to build a genome-scale network using the Reverse Engineering, Forward Simulation modeling framework, identifying 7 genes modulating SRE. Results: Three of these genes were functionally validated by using a stable nuclear factor k-light-chain-enhancer of activated B cells luciferase reporter in A549 human lung epithelial cells, IL-1 beta cytokine stimulation, and DEX treatment. By using small interfering RNA transfection, knockdown of family with sequence similarity 129 member A (FAM129A) produced a reduction in steroid treatment response (P < .001). Conclusion: With this systems-based approach, we have shown that FAM129A is associated with variation in clinical asthma steroid responsiveness and that FAM129A modulates steroid responsiveness in lung epithelial cells.	[McGeachie, Michael J.; Clemmer, George L.; Wu, Ann Chen; Tantisira, Kelan; Weiss, Scott] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [McGeachie, Michael J.; Wu, Ann Chen; Tantisira, Kelan; Weiss, Scott] Harvard Med Sch, Dept Med, Boston, MA USA; [Hayete, Boris; Runge, Karl; Church, Bruce; Khalil, Lya] GNS Healthcare, Cambridge, England; [Xing, Heming] Novartis Inst Biomed Res, Cambridge, England; [Jiang, Xiaofeng; Lu, Quan] Harvard TH Chan Sch Publ Hlth, Program Mol & Integrat Physiol Sci, Dept Environm Hlth, Boston, MA USA; [Wu, Ann Chen] Harvard Med Sch, Precis Med Translat Res PROMoTeR Ctr, Dept Populat Med, Boston, MA USA; [Wu, Ann Chen] Harvard Pilgrim Hlth Care Inst, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Novartis; University of London; University College London; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	McGeachie, MJ (corresponding author), Channing Div Network Med, 181 Longwood Ave, Boston, MA 02115 USA.	michael.mcgeachie@channing.harvard.edu	Hayete, Boris/ABD-4515-2020; Wu, Ann/AAY-4293-2020	Hayete, Boris/0000-0002-2521-1889; Wu, Ann/0000-0003-0599-9063; Xing, Heming/0000-0002-2253-0163	Parker B. Francis Foundation;  [U01 HL65899];  [R01 HL092197];  [R01 HL127332];  [R01 HL129935];  [R01 HD085993];  [R01 HL114769]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD085993] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL129935, R01HL139634, R01HL114769, U01HL065899, R01HL127332, R01HL092197] Funding Source: NIH RePORTER	Parker B. Francis Foundation; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants U01 HL65899 and R01 HL092197. M.J.M. is supported by a grant from the Parker B. Francis Foundation. K.T. is supported by grants R01 HL127332 and R01 HL129935. A.C.W. is supported by grant R01 HD085993. Q.L. is supported by grant R01 HL114769.	Anderson Jeffrey P, 2015, J Diabetes Sci Technol, V10, P6, DOI 10.1177/1932296815620200; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bigler J, 2017, AM J RESP CRIT CARE, V195, P1311, DOI 10.1164/rccm.201604-0866OC; Bunyavanich S, 2015, J ALLERGY CLIN IMMUN, V135, P31, DOI 10.1016/j.jaci.2014.10.015; Bunyavanich S, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-48; Carvalheira G, 2015, ONCOTARGET, V6, P28357, DOI 10.18632/oncotarget.4947; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; Chiba S, 2018, CLIN RESPIR J, V12, P1166, DOI 10.1111/crj.12647; Choi H, 2017, REV ENVIRON HEALTH, V32, P55, DOI 10.1515/reveh-2016-0054; Clemmer GL, 2015, J ALLERGY CLIN IMMUN, V136, P274, DOI 10.1016/j.jaci.2015.03.029; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Croteau-Chonka DC, 2017, AM J RESP CRIT CARE, V195, P179, DOI 10.1164/rccm.201601-0107OC; Drazen JM, 2000, BRIT MED BULL, V56, P1054, DOI 10.1258/0007142001903535; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Farzan N, 2017, CLIN EXP ALLERGY, V47, P271, DOI 10.1111/cea.12844; Forcheh AC, 2013, R J, V5, P171; Forcheh AC, 2012, STAT APPL GENET MOL, V11, DOI 10.2202/1544-6115.1710; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gendelman R, 2017, CANCER RES, V77, P1575, DOI 10.1158/0008-5472.CAN-16-0512; Hosking L, 2014, J ALLERGY CLIN IMMUN, V133, P587, DOI 10.1016/j.jaci.2013.08.024; Hu CP, 2016, ARCH MED RES, V47, P118, DOI 10.1016/j.arcmed.2016.04.005; Kersten ETG, 2017, CURR OPIN PULM MED, V23, P12, DOI 10.1097/MCP.0000000000000335; King EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053936; Klaus B, 2013, BIOSTATISTICS, V14, P129, DOI 10.1093/biostatistics/kxs030; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Matsumoto F, 2006, HUM PATHOL, V37, P1592, DOI 10.1016/j.humpath.2006.06.022; McGeachie MJ, 2015, J ALLERGY CLIN IMMUN, V136, P1503, DOI 10.1016/j.jaci.2015.04.039; Morrow JD, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-014-0072-y; Newton R, 2014, EUR J PHARMACOL, V724, P231, DOI 10.1016/j.ejphar.2013.05.035; Qiu WL, 2014, HUM MOL GENET, V23, P5017, DOI 10.1093/hmg/ddu191; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schadt EE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002132; Sharma A, 2015, HUM MOL GENET, V24, P3005, DOI 10.1093/hmg/ddv001; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Tantisira KG, 2008, PHARMACOGENET GENOM, V18, P733, DOI 10.1097/FPC.0b013e3282fe6ebf; Tantisira KG, 2011, NEW ENGL J MED, V365, P1173, DOI 10.1056/NEJMoa0911353; Tantisira KG, 2004, HUM MOL GENET, V13, P1353, DOI 10.1093/hmg/ddh149; Vijverberg SJH, 2014, PHARMACOGENOMICS, V15, P799, DOI [10.2217/PGS.14.37, 10.2217/pgs.14.37]; Xing H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001105; Yick CY, 2014, ALLERGY, V69, P1233, DOI 10.1111/all.12452; Yick CY, 2013, AM J RESP CRIT CARE, V187, P1076, DOI 10.1164/rccm.201210-1886OC	44	6	6	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2018	142	5					1479	+		10.1016/j.jaci.2017.11.059	http://dx.doi.org/10.1016/j.jaci.2017.11.059			22	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GZ5BL	29410046	Bronze, Green Accepted			2022-12-18	WOS:000449429800011
J	Soffer, N; Green, BJ; Acosta, L; Divjan, A; Sobek, E; Lemons, AR; Rundle, AG; Jacobson, JS; Goldstein, IF; Miller, RL; Perzanowski, MS				Soffer, Nitzan; Green, Brett J.; Acosta, Luis; Divjan, Adnan; Sobek, Edward; Lemons, Angela R.; Rundle, Andrew G.; Jacobson, Judith S.; Goldstein, Inge F.; Miller, Rachel L.; Perzanowski, Matthew S.			Alternaria is associated with asthma symptoms and exhaled NO among NYC children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ALLERGEN		[Soffer, Nitzan; Acosta, Luis; Divjan, Adnan; Miller, Rachel L.; Perzanowski, Matthew S.] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Green, Brett J.; Lemons, Angela R.] NIOSH, Allergy & Clin Immunol Branch, Hlth Effects Lab Div, Ctr Dis Control & Prevent, Morgantown, WV USA; [Sobek, Edward] Assured Bio Labs, Oak Ridge, TN USA; [Rundle, Andrew G.; Jacobson, Judith S.; Goldstein, Inge F.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Miller, Rachel L.] Columbia Univ Coll Phys & Surg, Dept Med, Div Pulm Allergy Crit Care Med, New York, NY USA	Columbia University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Columbia University; Columbia University	Perzanowski, MS (corresponding author), Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY 10027 USA.	mp2217@columbia.edu	Rundle, Andrew G/A-5282-2009	Rundle, Andrew G/0000-0003-0211-7707; Lemons, Angela/0000-0003-3057-9888; Sobek, Edward/0000-0002-2640-5589	Department of Housing and Urban Development Healthy Homes Technical Studies [NYHHU0003-11, NYHHU0021-13]; Centers for Disease Control and Prevention [CDC-TP-13-001]; National Institute for Environmental Health Sciences (NIEHS) [R01 ES014400, P30 ES009089]; NIOSH funds; National Institute of Occupational Safety and Health [AES12007001-1-0-6]; NIEHS [AES12007001-1-0-6]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089] Funding Source: NIH RePORTER	Department of Housing and Urban Development Healthy Homes Technical Studies; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute for Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIOSH funds; National Institute of Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the Department of Housing and Urban Development Healthy Homes Technical Studies (grant nos. NYHHU0003-11 and NYHHU0021-13), the Centers for Disease Control and Prevention (grant no. CDC-TP-13-001), and the National Institute for Environmental Health Sciences (NIEHS) (grant nos. R01 ES014400 and P30 ES009089). This study was supported by internal NIOSH funds and in part by an interagency agreement between the National Institute of Occupational Safety and Health and NIEHS (AES12007001-1-0-6) as a collaborative National Toxicology Program research activity.	Busse WW, 2010, J ALLERGY CLIN IMMUN, V125, P803, DOI 10.1016/j.jaci.2009.11.048; Busse WW, 2010, J ALLERGY CLIN IMMUN, V125, P529, DOI 10.1016/j.jaci.2010.01.036; Cornell AG, 2012, J EXPO SCI ENV EPID, V22, P258, DOI 10.1038/jes.2012.3; Kustrzeba-Wojcicka I, 2014, CLIN REV ALLERG IMMU, V47, P354, DOI 10.1007/s12016-014-8447-6; O'Connor GT, 2004, J ALLERGY CLIN IMMUN, V114, P599, DOI 10.1016/j.jaci.2004.05.064; Perzanowski MS, 2013, J ALLERGY CLIN IMMUN, V131, P886, DOI 10.1016/j.jaci.2012.12.666; Riedl M, 2005, J ALLERGY CLIN IMMUN, V115, P221, DOI 10.1016/j.jaci.2004.11.047; Saenz-de-Santamaria M, 2006, MYCOSES, V49, P91, DOI 10.1111/j.1439-0507.2006.01195.x; The New York City Community Air Survey, 2011, RES YEAR ON MON 2008; Vesper S, 2007, J OCCUP ENVIRON MED, V49, P829, DOI 10.1097/JOM.0b013e3181255e98	10	6	6	5	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2018	142	4					1366	1368		10.1016/j.jaci.2018.04.043	http://dx.doi.org/10.1016/j.jaci.2018.04.043			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GV7RG	29964057	Bronze			2022-12-18	WOS:000446327300042
J	Jo, A; Lee, SH; Kim, DY; Hong, SJ; Teng, MN; Kolliputi, N; Lockey, RF; Schleimer, RP; Cho, SH				Jo, Ara; Lee, Sun H.; Kim, Dong-Young; Hong, Seung-Jae; Teng, Michael N.; Kolliputi, Narasaiah; Lockey, Richard F.; Schleimer, Robert P.; Cho, Seong H.			Mast cell-derived plasminogen activator inhibitor type 1 promotes airway inflammation and remodeling in a murine model of asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							LYMPH-NODES; PAI-1		[Jo, Ara; Teng, Michael N.; Kolliputi, Narasaiah; Lockey, Richard F.; Cho, Seong H.] Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy Immunol, Tampa, FL 33620 USA; [Lee, Sun H.; Kim, Dong-Young; Schleimer, Robert P.; Cho, Seong H.] Feinberg Sch Med, Dept Med, Div Allergy Immunol, Chicago, IL 60611 USA; [Hong, Seung-Jae; Cho, Seong H.] James A Haley Vet Hosp, Div Allergy Immunol, Tampa, FL 33612 USA; [Cho, Seong H.] Kyung Hee Univ, Sch Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea	State University System of Florida; University of South Florida; Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; Kyung Hee University	Cho, SH (corresponding author), Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy Immunol, Tampa, FL 33620 USA.; Cho, SH (corresponding author), Feinberg Sch Med, Dept Med, Div Allergy Immunol, Chicago, IL 60611 USA.; Cho, SH (corresponding author), James A Haley Vet Hosp, Div Allergy Immunol, Tampa, FL 33612 USA.; Cho, SH (corresponding author), Kyung Hee Univ, Sch Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea.	scho2@health.usf.edu		Jo, Ara/0000-0002-2781-8529; Hong, Seung-Jae/0000-0002-9803-529X	American Heart Association [11SDG7590063]; National Institutes of Health [1K23AI110731]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL068546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI106683, R01AI137174, K23AI110731] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by American Heart Association grant 11SDG7590063 and National Institutes of Health grant 1K23AI110731. This material is the result of work supported with resources and the use of facilities at the James A. Haley Veterans' Hospital. The contents do not represent the views of the Department of Veterans Affairs or the United States Government.	Cao RH, 2011, NAT PROTOC, V6, P817, DOI 10.1038/nprot.2011.359; Cho SH, 2015, AM J RESP CELL MOL, V52, P88, DOI 10.1165/rcmb.2013-0399OC; Cho SH, 2000, J IMMUNOL, V165, P3154, DOI 10.4049/jimmunol.165.6.3154; Han LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108931; Lee SH, 2012, AM J RESP CELL MOL, V46, P842, DOI 10.1165/rcmb.2011-0369OC; Liu Y, 2002, J EXP MED, V195, P259, DOI 10.1084/jem.20010838; Miyamoto S, 2011, AM J PHYSIOL-LUNG C, V301, pL908, DOI 10.1152/ajplung.00115.2011; Oh CK, 2002, BIOCHEM BIOPH RES CO, V294, P1155, DOI 10.1016/S0006-291X(02)00577-6; Orihara Kanami, 2010, Expert Rev Respir Med, V4, P605, DOI 10.1586/ers.10.57; Van de Craen B, 2012, THROMB RES, V130, P576, DOI 10.1016/j.thromres.2012.06.023; Yamagami S, 2001, INVEST OPHTH VIS SCI, V42, P1293; Yu M, 2006, J CLIN INVEST, V116, P1633, DOI 10.1172/JCI25702	12	6	6	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2018	142	1					294	297		10.1016/j.jaci.2018.01.040	http://dx.doi.org/10.1016/j.jaci.2018.01.040			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GM1OC	29477725	Green Accepted, Bronze			2022-12-18	WOS:000437837500035
J	Nishioka, I; Takai, T; Maruyama, N; Kamijo, S; Suchiva, P; Suzuki, M; Kunimine, S; Ochi, H; Shimura, S; Sudo, K; Ogawa, H; Okumura, K; Ikeda, S				Nishioka, Izumi; Takai, Toshiro; Maruyama, Natsuko; Kamijo, Seiji; Suchiva, Punyada; Suzuki, Mayu; Kunimine, Shinya; Ochi, Hirono; Shimura, Sakiko; Sudo, Katsuko; Ogawa, Hideoki; Okumura, Ko; Ikeda, Shigaku			Airway inflammation after epicutaneous sensitization of mice requires protease activity of low-dose allergen inhalation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							EXPRESSION ANALYSIS; GENOME; GENE; ANNOTATION; CELLS		[Nishioka, Izumi; Takai, Toshiro; Maruyama, Natsuko; Kamijo, Seiji; Suchiva, Punyada; Suzuki, Mayu; Kunimine, Shinya; Ochi, Hirono; Shimura, Sakiko; Okumura, Ko; Ikeda, Shigaku] Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Tokyo, Japan; [Nishioka, Izumi; Maruyama, Natsuko; Suchiva, Punyada; Kunimine, Shinya; Ochi, Hirono; Shimura, Sakiko; Ogawa, Hideoki; Ikeda, Shigaku] Juntendo Univ, Grad Sch Med, Dept Dermatol & Allergol, Tokyo, Japan; [Sudo, Katsuko] Tokyo Med Univ, Anim Res Ctr, Tokyo, Japan	Juntendo University; Juntendo University; Tokyo Medical University	Takai, T (corresponding author), Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Tokyo, Japan.	t-takai@juntendo.ac.jp	Takai, Toshiro/K-5690-2013	Takai, Toshiro/0000-0001-8363-0355	Japan Society for the Promotion of Science (JSPS) [25461711, 26860759, 17K10007]; Juntendo University; Grants-in-Aid for Scientific Research [17K10007] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Juntendo University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (KAKENHI) (grant nos. 25461711, 26860759, and 17K10007) and Juntendo University.	Antipov D, 2016, BIOINFORMATICS, V32, P1009, DOI 10.1093/bioinformatics/btv688; Boetzer M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-211; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Brusic V, 2003, ALLERGY, V58, P1093, DOI 10.1034/j.1398-9995.2003.00248.x; Chan TF, 2015, J ALLERGY CLIN IMMUN, V135, P539, DOI 10.1016/j.jaci.2014.09.031; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Endo Y, 2015, IMMUNITY, V42, P294, DOI 10.1016/j.immuni.2015.01.016; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hackl T, 2014, BIOINFORMATICS, V30, P3004, DOI 10.1093/bioinformatics/btu392; Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Kamijo S, 2013, J IMMUNOL, V190, P4489, DOI 10.4049/jimmunol.1201212; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lam EPS, 2016, J ALLERGY CLIN IMMUN, V137, P1514, DOI 10.1016/j.jaci.2015.10.019; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Matsumoto K, 2013, ALLERGOL INT, V62, P291, DOI 10.2332/allergolint.13-RAI-0603; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shimura S, 2016, J INVEST DERMATOL, V136, P1408, DOI 10.1016/j.jid.2016.02.810; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Takai Toshiro, 2011, Allergology International, V60, P25, DOI 10.2332/allergolint.10-RAI-0273; Tarailo-Graovac Maja, 2009, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s25; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Ye CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep31900; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zimin AV, 2013, BIOINFORMATICS, V29, P2669, DOI 10.1093/bioinformatics/btt476	35	6	6	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2018	141	6					2271	2273		10.1016/j.jaci.2017.11.035	http://dx.doi.org/10.1016/j.jaci.2017.11.035			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GI7SD	29426602	Green Submitted, Bronze			2022-12-18	WOS:000434701600032
J	Cagini, N; Veronez, CL; Azevedo, BF; Constantino-Silva, RN; Martin, RP; da Silva, J; Grumach, AS; Pesquero, JB				Cagini, Nathalia; Veronez, Camila Lopez; Azevedo, Bruna Franca; Constantino-Silva, Rosemeire Navickas; Martin, Renan Paulo; da Silva, Jane; Grumach, Anete S.; Pesquero, Joao Bosco			In silico Analysis Of Alterations In ANGPT1 Gene Supports A New Pathway Responsible To Mediate Hereditary Angioedema In Brazilian Patients With No Mutations In SERPING1 And F12 Genes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology / World-Allergy-Organization Joint Congress	MAR 02-08, 2018	Orlando, FL	Amer Acad Allergy Asthma & Immunol, World Allergy Org					[Cagini, Nathalia; Veronez, Camila Lopez; Azevedo, Bruna Franca; Martin, Renan Paulo] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Constantino-Silva, Rosemeire Navickas] Fac Med ABC, Santo Andre, Brazil; [da Silva, Jane] Univ South Santa Catarina, Florianopolis, SC, Brazil; [Grumach, Anete S.] Fac Med ABC, Clin Immunol, Sao Paulo, Brazil; [Pesquero, Joao Bosco] Fed Univ Sao Pauloe, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Faculdade de Medicina do ABC; Universidade do Sul de Santa Catarina; Faculdade de Medicina do ABC			Grumach, Anete S/I-3430-2014; da Silva, Rosemeire Navickas Constantino/Y-1427-2019; Martin, Renan/AAZ-7890-2021						0	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2		S		148	AB46	AB46		10.1016/j.jaci.2017.12.150	http://dx.doi.org/10.1016/j.jaci.2017.12.150			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	GB8DX		Bronze			2022-12-18	WOS:000429306700148
J	Chipps, BE; McDonald, M; Garin, M				Chipps, Bradley E.; McDonald, Mirna; Garin, Margaret			Baseline Characteristics Associated with Quartiles of Reslizumab Effect: Pooled Analysis Of Two Phase 3 Studies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology / World-Allergy-Organization Joint Congress	MAR 02-08, 2018	Orlando, FL	Amer Acad Allergy Asthma & Immunol, World Allergy Org					[Chipps, Bradley E.] Capital Allergy & Resp Dis Ctr, Sacramento, CA USA; [McDonald, Mirna; Garin, Margaret] Teva Branded Pharmaceut Prod R&D Inc, Malvern, PA USA	Teva Pharmaceutical Industries									0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2		S		47	AB16	AB16		10.1016/j.jaci.2017.12.049	http://dx.doi.org/10.1016/j.jaci.2017.12.049			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	GB8DX		Bronze			2022-12-18	WOS:000429306700048
J	Christensen, MJ; Skov, PS; Poulsen, LK; Bindslev-Jensen, C; Mortz, CG				Christensen, Morten J.; Skov, Per Stahl; Poulsen, Lars K.; Bindslev-Jensen, Carsten; Mortz, Charlotte G.			Clinical relevance of sensitization to hydrolyzed wheat protein in wheat-sensitized subjects	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							INTERLEUKIN-6 GENE POLYMORPHISMS; G/C PROMOTER POLYMORPHISM; MYOCARDIAL-INFARCTION; BRONCHIAL-ASTHMA; RISK; ASSOCIATION; SUSCEPTIBILITY; SMOKING; ALLERGY; IL6		[Christensen, Morten J.; Bindslev-Jensen, Carsten; Mortz, Charlotte G.] Odense Univ Hosp, Dept Dermatol, Odense, Denmark; [Christensen, Morten J.; Bindslev-Jensen, Carsten; Mortz, Charlotte G.] Odense Univ Hosp, Allergy Ctr, Odense Res Ctr Anaphylaxis ORCA, Odense, Denmark; [Skov, Per Stahl] RefLab ApS, Copenhagen, Denmark; [Poulsen, Lars K.] Copenhagen Univ Hosp Gentofte, Allergy Clin, Hellerup, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Copenhagen; Herlev & Gentofte Hospital	Christensen, MJ (corresponding author), Odense Univ Hosp, Dept Dermatol, Odense, Denmark.; Christensen, MJ (corresponding author), Odense Univ Hosp, Allergy Ctr, Odense Res Ctr Anaphylaxis ORCA, Odense, Denmark.	morten.junker.christensen@rsyd.dk	Bindslev-Jensen, Carsten/H-1877-2011; Poulsen, Lars K/J-3065-2019	Bindslev-Jensen, Carsten/0000-0002-8940-038X; Poulsen, Lars K/0000-0002-1730-847X; Mortz, Charlotte G/0000-0001-8710-0829	Lantmannen; Novartis; Sandoz A/S	Lantmannen; Novartis(Novartis); Sandoz A/S	P. S. Skov has consultant arrangements with RefLab. L. K. Poulsen has consultant arrangements with Novozymes. C. Bindslev-Jensen received a consulting fee or honorarium from Lantmannen. C. G. Mortz has served on an advisory board for Novartis and has received payment for lectures from Novartis and Sandoz A/S. M. J. Christensen declares that he has no relevant conflicts of interest.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Babusikova E, 2017, ARCH BRONCONEUMOL, V53, P381, DOI 10.1016/j.arbres.2016.09.012; Bottema RWB, 2010, J ALLERGY CLIN IMMUN, V126, P338, DOI 10.1016/j.jaci.2010.04.024; Bottema RW, 2010, J ALLERGY CLIN IMMUN, V126, pe1; Chinuki Y, 2011, CONTACT DERMATITIS, V65, P55, DOI 10.1111/j.1600-0536.2011.01917.x; Christensen MJ, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-39; Cole SW, 2010, P NATL ACAD SCI USA, V107, P5681, DOI 10.1073/pnas.0911515107; Cordoba-Lanus E, 2008, RESP MED, V102, P1805, DOI 10.1016/j.rmed.2008.06.012; Daneshmandi S, 2012, MOL BIOL REP, V39, P1845, DOI 10.1007/s11033-011-0927-7; Dou LY, 2016, PERS MED, V13, P395, DOI 10.2217/pme-2016-0003; Ebadi N, 2014, ASIAN PAC J CANCER P, V15, P7869, DOI 10.7314/APJCP.2014.15.18.7869; Fukutomi Y, 2014, ALLERGY, V69, P1405, DOI 10.1111/all.12481; Georges JL, 2001, J MOL MED, V79, P300, DOI 10.1007/s001090100209; Haddy N, 2005, EUR J HUM GENET, V13, P109, DOI 10.1038/sj.ejhg.5201294; Hatzis G, 2014, INT J CARDIOL, V176, P254, DOI 10.1016/j.ijcard.2014.06.058; He JQ, 2009, THORAX, V64, P698, DOI 10.1136/thx.2008.111278; Humphries SE, 2001, EUR HEART J, V22, P2243, DOI 10.1053/euhj.2001.2678; Ivanova M, 2011, INT J IMMUNOGENET, V38, P17, DOI 10.1111/j.1744-313X.2010.00972.x; Jaakkola MS, 2002, ENVIRON HEALTH PERSP, V110, P543, DOI 10.1289/ehp.02110543; Juvonen R, 2008, RESPIROLOGY, V13, P575, DOI 10.1111/j.1440-1843.2008.01299.x; Kobayashi T, 2015, INT J DERMATOL, V54, pE302, DOI 10.1111/ijd.12767; Kosugi EM, 2013, RHINOLOGY, V51, P70, DOI [10.4193/Rhin12.166, 10.4193/Rhino12.166]; Kumar A, 2015, J HUM GENET, V60, P443, DOI 10.1038/jhg.2015.45; Lajunen TK, 2016, GENES IMMUN, V17, P193, DOI 10.1038/gene.2016.8; Lauriere M, 2006, CONTACT DERMATITIS, V54, P283, DOI 10.1111/j.0105-1873.2006.00830.x; Leduc V, 2003, J ALLERGY CLIN IMMUN, V111, P897, DOI 10.1067/mai.2003.1345; Leng SG, 2016, ENVIRON HEALTH PERSP, V124, P445, DOI 10.1289/ehp.1409437; Li FW, 2015, INT J CLIN EXP MED, V8, P12601; Liu XM, 2008, J ASTHMA, V45, P583, DOI 10.1080/02770900802032925; Mahdaviani SA, 2009, J CLIN IMMUNOL, V29, P57, DOI 10.1007/s10875-008-9232-1; Ministry of Social Affairs and Health, 1994, ASTHM PROGR 1994 200; Nagai Y, 2015, NUCLEIC ACIDS RES, V43, pD868, DOI 10.1093/nar/gku1037; Nilsson N, 2015, PEDIAT ALLERG IMM-UK, V26, P119, DOI 10.1111/pai.12334; Ortlepp JR, 2003, J MOL MED, V81, P578, DOI 10.1007/s00109-003-0471-6; Padron-Morales J, 2013, J INVEST ALLERG CLIN, V23, P487; Pecquet C, 2004, CONTACT DERMATITIS, V50, P182; Pelkonen AS, 2011, ANN ALLERG ASTHMA IM, V106, P343, DOI 10.1016/j.anai.2011.01.003; Piipari R, 2004, EUR RESPIR J, V24, P734, DOI 10.1183/09031936.04.00116903; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rantala A, 2011, SCAND J IMMUNOL, V74, P95, DOI 10.1111/j.1365-3083.2011.02542.x; Rantala A, 2008, J INFECT DIS, V198, P1247, DOI 10.1086/591912; Rosner SA, 2005, HUM GENET, V118, P287, DOI 10.1007/s00439-005-0052-6; Settin A, 2008, INDIAN J PEDIATR, V75, P1019, DOI 10.1007/s12098-008-0161-z; Sunyer J, 2009, NICOTINE TOB RES, V11, P1347, DOI 10.1093/ntr/ntp144; Terry CF, 2000, J BIOL CHEM, V275, P18138, DOI 10.1074/jbc.M000379200; Trajkov D, 2008, IRAN J ALLERGY ASTHM, V7, P143, DOI 07.03/ijaai.143156; Wang K, 2015, GENET MOL RES, V14, P3177, DOI 10.4238/2015.April.10.29; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Zou GY, 2008, AM J EPIDEMIOL, V168, P212, DOI 10.1093/aje/kwn104	50	6	6	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2					802	+		10.1016/j.jaci.2017.09.016	http://dx.doi.org/10.1016/j.jaci.2017.09.016			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FV2PQ	29031598	Bronze, Green Submitted			2022-12-18	WOS:000424410800045
J	Gunawardana, NC; Zhao, Q; Carayannopoulos, LN; Tsai, K; Malkov, VA; Selverian, D; Clarke, G; Mant, T; Butts, BD; Lund, K; Hansel, TT; Nolte, H				Gunawardana, Natasha C.; Zhao, Qing; Carayannopoulos, Leonidas N.; Tsai, Kuenhi; Malkov, Vladislav A.; Selverian, Diana; Clarke, Graham; Mant, Tim; Butts, Brent D.; Lund, Kaare; Hansel, Trevor T.; Nolte, Hendrik			The effects of house dust mite sublingual immunotherapy tablet on immunologic biomarkers and nasal allergen challenge symptoms	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							MACROPHAGE-DERIVED CHEMOKINE; ATOPIC-DERMATITIS; HISTAMINE; INFLAMMATION; ACTIVATION; EFFICACY; CELLS; KERATINOCYTES; RECEPTORS; EXPOSURE		[Gunawardana, Natasha C.; Hansel, Trevor T.] St Marys Hosp, Imperial Clin Resp Res Unit ICRRU, London, England; [Zhao, Qing; Carayannopoulos, Leonidas N.; Tsai, Kuenhi; Malkov, Vladislav A.; Selverian, Diana; Butts, Brent D.; Nolte, Hendrik] Merck & Co Inc, Kenilworth, NJ USA; [Clarke, Graham; Mant, Tim] Quintiles IMS, Reading, Berks, England; [Lund, Kaare] ALK, Horsholm, Denmark	Imperial College London; Merck & Company; IQVIA	Hansel, TT (corresponding author), St Marys Hosp, Imperial Clin Resp Res Unit ICRRU, London, England.	t.hansel@imperial.ac.uk	Butts, Brent/AAB-6412-2022	Butts, Brent/0000-0002-4214-4964; Gunawardana, Natasha/0000-0002-9112-461X; Clarke, Graham/0000-0002-0193-2948	Merck & Co, Inc, Kenilworth, NJ; National Institute for Health Research Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London; Medical Research Council [G1000758B, G1000758] Funding Source: researchfish; Asthma UK [MRC-Asthma UK Centre, MRC-AsthmaUKCentre] Funding Source: researchfish	Merck & Co, Inc, Kenilworth, NJ(Merck & Company); National Institute for Health Research Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	Funding for this research was provided by Merck & Co, Inc, Kenilworth, NJ. T. M. is also supported by the National Institute for Health Research Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London. The concept for this research was developed by Merck & Co, Inc. Editorial support for this manuscript was provided by Merck & Co, Inc. The final decision to submit this article for publication was made by the authors.	Bousquet PJ, 2007, ALLERGY, V62, P301, DOI 10.1111/j.1398-9995.2006.01293.x; Demoly P, 2016, J ALLERGY CLIN IMMUN, V137, P444, DOI 10.1016/j.jaci.2015.06.036; Ehling S, 2016, J DERMATOL SCI, V83, P106, DOI 10.1016/j.jdermsci.2016.04.011; Glatzer F, 2014, INT ARCH ALLERGY IMM, V163, P11, DOI 10.1159/000355960; Glatzer F, 2013, J ALLERGY CLIN IMMUN, V132, P1358, DOI 10.1016/j.jaci.2013.06.023; Gschwandtner M, 2012, J LEUKOCYTE BIOL, V92, P21, DOI 10.1189/jlb.0111017; Hashimoto S, 2006, J DERMATOL SCI, V44, P93, DOI 10.1016/j.jdermsci.2006.08.004; Jahnz-Rozyk K, 2005, ALLERGY, V60, P685, DOI 10.1111/j.1398-9995.2005.00774.x; Jutel M, 2011, ALLERGY, V66, P725, DOI 10.1111/j.1398-9995.2011.02589.x; Jutel M, 2009, CLIN EXP ALLERGY, V39, P1786, DOI 10.1111/j.1365-2222.2009.03374.x; Kasraie S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/942375; Mansouri Y, 2015, J CLIN MED, V4, P858, DOI 10.3390/jcm4050858; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Meiler F, 2008, J EXP MED, V205, P2887, DOI 10.1084/jem.20080193; Mommert S, 2015, INT ARCH ALLERGY IMM, V166, P225, DOI 10.1159/000381340; Morita E, 2010, ALLERGY, V65, P1166, DOI 10.1111/j.1398-9995.2010.02361.x; Mosbech H, 2014, J ALLERGY CLIN IMMUN, V134, P568, DOI 10.1016/j.jaci.2014.03.019; Nolte H, 2016, J ALLERGY CLIN IMMUN, V138, P1631, DOI 10.1016/j.jaci.2016.06.044; Nolte H, 2015, J ALLERGY CLIN IMMUN, V135, P1494, DOI 10.1016/j.jaci.2014.12.1911; Sander K, 2009, BIOORGAN MED CHEM, V17, P7186, DOI 10.1016/j.bmc.2009.08.059; Shamji MH, 2012, ALLERGY, V67, P217, DOI 10.1111/j.1398-9995.2011.02745.x; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Thurmond RL, 2008, NAT REV DRUG DISCOV, V7, P41, DOI 10.1038/nrd2465; Vestergaard C, 2000, J INVEST DERMATOL, V115, P640, DOI 10.1046/j.1523-1747.2000.00115.x; Virchow JC, 2016, JAMA-J AM MED ASSOC, V315, P1715, DOI 10.1001/jama.2016.3964	25	6	6	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2					785	+		10.1016/j.jaci.2017.08.016	http://dx.doi.org/10.1016/j.jaci.2017.08.016			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FV2PQ	28911971	Green Submitted, Bronze			2022-12-18	WOS:000424410800039
J	Mommert, S; Gregor, K; Rossbach, K; Schaper, K; Witte, T; Gutzmer, R; Werfel, T				Mommert, Susanne; Gregor, Karl; Rossbach, Kristine; Schaper, Katrin; Witte, Torsten; Gutzmer, Ralf; Werfel, Thomas			Histamine H2 receptor stimulation upregulates T(H)2 chemokine CCL17 production in human M2a macrophages	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							HISTAMINE; RECEPTOR; CELLS		[Mommert, Susanne; Gregor, Karl; Schaper, Katrin; Gutzmer, Ralf; Werfel, Thomas] Hannover Med Sch, Dept Dermatol & Allergy, Div Immunodermatol & Allergy Res, Hannover, Germany; [Rossbach, Kristine] Univ Vet Med Hannover, Dept Pharmacol Toxicol & Pharm, Hannover, Germany; [Witte, Torsten] Hannover Med Sch, Dept Internal Med, Div Clin Immunol & Rheumatol, Hannover, Germany	Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; Hannover Medical School	Mommert, S (corresponding author), Hannover Med Sch, Dept Dermatol & Allergy, Div Immunodermatol & Allergy Res, Hannover, Germany.	Mommert.Susanne@mh-hannover.de	Werfel, Thomas/B-6921-2012; Witte, Torsten/B-5783-2016		Deutsche Forschungsgemeinschaft [DFG Gu434/6-1]; Janssen Research & Development, LLC	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Janssen Research & Development, LLC	This study was supported by grants from the Deutsche Forschungsgemeinschaft (grant no. DFG Gu434/6-1). Funding for this research was provided by Janssen Research & Development, LLC.	Gros E, 2009, J ALLERGY CLIN IMMUN, V124, P753, DOI 10.1016/j.jaci.2009.07.004; Gschwandtner M, 2011, J INVEST DERMATOL, V131, P1668, DOI 10.1038/jid.2011.72; Gutzmer R, 2005, J IMMUNOL, V174, P5224, DOI 10.4049/jimmunol.174.9.5224; Jutel M, 2001, NATURE, V413, P420, DOI 10.1038/35096564; McIlroy A, 2006, IMMUNOLOGY, V117, P507, DOI 10.1111/j.1365-2567.2006.02326.x; Mommert S, 2012, AM J PATHOL, V180, P177, DOI 10.1016/j.ajpath.2011.09.028; Novak N, 2012, J ALLERGY CLIN IMMUN, V130, P1153, DOI 10.1016/j.jaci.2012.04.039; Stander S, 2002, EXP DERMATOL, V11, P12, DOI 10.1034/j.1600-0625.2002.110102.x; Werfel T, 2016, J ALLERGY CLIN IMMUN, V138, P336, DOI 10.1016/j.jaci.2016.06.010	9	6	6	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2					782	785		10.1016/j.jaci.2017.06.023	http://dx.doi.org/10.1016/j.jaci.2017.06.023			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FV2PQ	28728999				2022-12-18	WOS:000424410800038
J	Langan, SM; Stuart, B; Bradshaw, L; Schmitt, J; Williams, HC; Thomas, KS				Langan, Sinead M.; Stuart, Beth; Bradshaw, Lucy; Schmitt, Jochen; Williams, Hywel C.; Thomas, Kim S.			Measuring long-term disease control in patients with atopic dermatitis: A validation study of well-controlled weeks	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; long-term control; outcome measures	RANDOMIZED CONTROLLED-TRIAL; EXCHANGE WATER SOFTENERS; ORIENTED ECZEMA MEASURE; OUTCOME MEASURES; SEVERITY SCORE; CHILDREN; MULTICENTER; CONSENSUS; INDEX; PROTOCOL	Background: Because atopic dermatitis (AD) is a relapsing remitting disease, assessing long-term control is important. Well-controlled weeks (WCWs) have been used to assess asthma long-term control but have never been validated for AD. Objectives: We sought to assess the feasibility, validity, and interpretability of WCWs in patients with AD. Methods: Three studies of patients with moderate-to-severe AD, including 4 to 6 months of daily/weekly symptom and treatment use data, were evaluated (study A, n 5 336; study B, n 5 60; and study C, n 5 224). WCWs were defined by worsening symptoms and increased medication use. Feasibility, construct validity, and interpretability of WCWs were determined by assessing missing data, association with validated AD outcomes, and floor and ceiling effects. Analysis used linear and logistic regression. Results: WCWs were feasible to collect: 95.2% (study A) and 94.7% (study B) contributed data for at least half of the weekly data points, and 93.2% and 88.7% contributed to all data points up to 4 months. WCWs were significantly associated with validated AD severity instruments, including patient-orientated outcome measures and objective signs (Eczema Area and Severity Index, Three Item Severity Score, and Six Signs, Six Areas Atopic Dermatitis Scale). The odds of experiencing a WCW if AD severity was clear/mild was 5.8 (95% CI, 3.5-9.7), 1.9 (95% CI, 0.8-4.4), and 8.1 (95% CI, 4.5-14.6) in studies A, B, and C, respectively. WCWs were associated with ceiling effects: 31.6% (study A) and 37.5% (study B) of participants had no WCWs more than 90% of the time. Conclusions: WCWs are valid and feasible for measuring long-term control in AD trials. However, ceiling effects and burden of data collection can limit use.	[Langan, Sinead M.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Stuart, Beth] Univ Southampton, Fac Med, Southampton, Hants, England; [Bradshaw, Lucy] Univ Nottingham, Nottingham Clin Trials Unit, Nottingham, England; [Schmitt, Jochen; Williams, Hywel C.; Thomas, Kim S.] Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham, England; [Schmitt, Jochen] Tech Univ Dresden, Med Fac Carl Gustav Carus, Ctr Evidence Based Healthcare, Dresden, Germany	University of London; London School of Hygiene & Tropical Medicine; University of Southampton; University of Nottingham; University of Nottingham; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Langan, SM (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England.	sinead.langan@lshtm.ac.uk		Stuart, Beth/0000-0001-5432-7437; williams, hywel/0000-0002-5646-3093; Schmitt, Jochen/0000-0003-0264-0960; Thomas, Kim/0000-0001-7785-7465; Langan, Sinead/0000-0002-7022-7441	National Institute for Health Research (NIHR) Clinician Scientist Fellowship [NIHR/CS/010/014]; Wellcome Senior Clinical fellowship in Science [205039/Z/16/Z]; NIHR HTA [05/16/01, 11/65/01]; NIHR; National Institute for Health Research [11/65/01, 05/16/01, NF-SI-0611-10246] Funding Source: researchfish	National Institute for Health Research (NIHR) Clinician Scientist Fellowship; Wellcome Senior Clinical fellowship in Science; NIHR HTA; NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by a National Institute for Health Research (NIHR) Clinician Scientist Fellowship (grant no. NIHR/CS/010/014, to S.M.L) and a Wellcome Senior Clinical fellowship in Science (205039/Z/16/Z). Data included in this paper were collected as part of the NIHR HTA-funded Softened Water Eczema Trial (05/16/01), the NIHR HTA-funded Clothing for the Relief of Eczema Symptoms Trial (11/65/01), and a BUPA foundation project grant (to S.M.L.). The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the UK Department of Health. This article presents independent research funded in part by the NIHR.	Barbarot S, 2016, PATIENT REPORTED OUT; Barbarot S, 2016, J AM ACAD DERMATOL, V75, P1038, DOI 10.1016/j.jaad.2016.05.043; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Beattie PE, 2006, BRIT J DERMATOL, V155, P1249, DOI 10.1111/j.1365-2133.2006.07525.x; BerthJones J, 1996, BRIT J DERMATOL, V135, P25, DOI 10.1111/j.1365-2133.1996.tb00706.x; Chalmers JR, 2016, BRIT J DERMATOL, V175, P69, DOI 10.1111/bjd.14773; Charman CR, 2013, BRIT J DERMATOL, V169, P1326, DOI 10.1111/bjd.12590; Charman CR, 2004, ARCH DERMATOL, V140, P1513, DOI 10.1001/archderm.140.12.1513; de Vet HCW, 2011, MEASUREMENT MED PRAC; Harrison EF, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0921-9; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Langan SM, 2009, BRIT J DERMATOL, V161, P640, DOI 10.1111/j.1365-2133.2009.09320.x; Leshem YA, 2015, BRIT J DERMATOL, V172, P1353, DOI 10.1111/bjd.13662; Odhiambo JA, 2009, J ALLERGY CLIN IMMUN, V124, P1251, DOI 10.1016/j.jaci.2009.10.009; Oranje AP, 2007, BRIT J DERMATOL, V157, P645, DOI 10.1111/j.1365-2133.2007.08112.x; Schmitt J, 2011, BRIT J DERMATOL, V164, P415, DOI 10.1111/j.1365-2133.2010.10030.x; Schmitt J, 2007, J ALLERGY CLIN IMMUN, V120, P1389, DOI 10.1016/j.jaci.2007.08.011; Schmitt J, 2012, ALLERGY, V67, P1111, DOI 10.1111/j.1398-9995.2012.02874.x; Schmitt J, 2011, J INVEST DERMATOL, V131, P623, DOI 10.1038/jid.2010.303; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Thomas KS, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15080; Thomas KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124770; Thomas KS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000395; Thomas S, 2008, BRIT J DERMATOL, V159, P561, DOI 10.1111/j.1365-2133.2008.08704.x	24	6	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2017	140	6					1580	1586		10.1016/j.jaci.2017.02.043	http://dx.doi.org/10.1016/j.jaci.2017.02.043			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FO9KI	28456619	Green Accepted, Green Published, hybrid			2022-12-18	WOS:000417206000012
J	Bitar, M; Boldt, A; Binder, S; Borte, M; Kentouche, K; Borte, S; Sack, U				Bitar, Michael; Boldt, Andreas; Binder, Stefanie; Borte, Michael; Kentouche, Karim; Borte, Stephan; Sack, Ulrich			Flow cytometric measurement of STAT1 and STAT3 phosphorylation in CD4(+) and CD8(+) T cells-clinical applications in primary immunodeficiency diagnostics	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHRONIC MUCOCUTANEOUS CANDIDIASIS; EXPRESSION		[Bitar, Michael; Boldt, Andreas; Binder, Stefanie; Sack, Ulrich] Univ Leipzig, Inst Clin Immunol, Med Fac, Leipzig, Germany; [Borte, Michael; Borte, Stephan] Hosp St Georg gGmbH Leipzig, Immuno Deficiency Ctr Leipzig IDCL, Jeffrey Modell Diagnost & Res Ctr Primary Immunod, Leipzig, Germany; [Kentouche, Karim] Jena Univ Hosp, Dept Pediat, Jena, Germany; [Borte, Stephan] Karolinska Univ, Hosp Huddinge, Karolinska Inst, Dept Lab Med,Div Clin Immunol & Transfus Med, Stockholm, Sweden	Leipzig University; Friedrich Schiller University of Jena; Karolinska Institutet; Karolinska University Hospital	Bitar, M (corresponding author), Univ Leipzig, Inst Clin Immunol, Med Fac, Leipzig, Germany.	Michael.Bitar@medizin.uni-leipzig.de	Sack, Ulrich/J-6301-2015	Sack, Ulrich/0000-0002-7813-0492				Betz UAK, 1998, INT IMMUNOL, V10, P1175, DOI 10.1093/intimm/10.8.1175; Casanova JL, 2012, IMMUNITY, V36, P515, DOI 10.1016/j.immuni.2012.03.016; Chapgier A, 2009, J CLIN INVEST, V119, P1502, DOI 10.1172/JCI37083; Ivashkiv LB, 2004, ARTHRITIS RES THER, V6, P159, DOI 10.1186/ar1197; Lafarge S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-64; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Oberg HH, 2006, INT IMMUNOL, V18, P555, DOI 10.1093/intimm/dxh396; Sack U, 2013, CYTOM PART B-CLIN CY, V84B, P135, DOI 10.1002/cyto.b.21079; Yong PFK, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4069; Zheng J, 2015, EUR J IMMUNOL, V45, P2834, DOI 10.1002/eji.201445344	10	6	6	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2017	140	5					1439	+		10.1016/j.jaci.2017.05.017	http://dx.doi.org/10.1016/j.jaci.2017.05.017			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FL5RV	28601682	Bronze			2022-12-18	WOS:000414304300026
J	Joulia, R; Mailhol, C; Valitutti, S; Didier, A; Espinosa, E				Joulia, Regis; Mailhol, Claire; Valitutti, Salvatore; Didier, Alain; Espinosa, Eric			Direct monitoring of basophil degranulation by using avidin-based probes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							FLOW-CYTOMETRY; ACTIVATION; CD63; EXPRESSION		[Joulia, Regis; Valitutti, Salvatore; Espinosa, Eric] INSERM, UMR1043, Toulouse, France; [Joulia, Regis; Valitutti, Salvatore; Espinosa, Eric] Univ Toulouse, UPS, CPTP, Toulouse, France; [Mailhol, Claire; Didier, Alain] CHU Toulouse, Pole Voies Resp, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse	Espinosa, E (corresponding author), INSERM, UMR1043, Toulouse, France.; Espinosa, E (corresponding author), Univ Toulouse, UPS, CPTP, Toulouse, France.	eric.espinosa@inserm.fr	Joulia, Régis/AAX-9773-2021; espinosa, eric/E-4872-2013; Valitutti, Salvatore/M-2999-2014	espinosa, eric/0000-0002-3512-0921; Valitutti, Salvatore/0000-0002-6432-4421; Joulia, Regis/0000-0002-7908-5670	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by INSERM.	Joulia R, 2017, J ALLERGY CLIN IMMUN, V140, P497, DOI 10.1016/j.jaci.2016.09.049; Joulia R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7174; KNOL EF, 1991, J ALLERGY CLIN IMMUN, V88, P328, DOI 10.1016/0091-6749(91)90094-5; MacGlashan D, 2010, CLIN EXP ALLERGY, V40, P1365, DOI 10.1111/j.1365-2222.2010.03572.x; MacGlashan DW, 2013, J ALLERGY CLIN IMMUN, V132, P777, DOI 10.1016/j.jaci.2013.06.038; MACGLASHAN DW, 1995, J LEUKOCYTE BIOL, V58, P177, DOI 10.1002/jlb.58.2.177; NAKAGAWA T, 1981, ALLERGY, V36, P39, DOI 10.1111/j.1398-9995.1981.tb01823.x; Sanz ML, 2001, CLIN EXP ALLERGY, V31, P1007, DOI 10.1046/j.1365-2222.2001.01122.x; Siracusa MC, 2013, J ALLERGY CLIN IMMUN, V132, P789, DOI 10.1016/j.jaci.2013.07.046	9	6	7	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2017	140	4					1159	+		10.1016/j.jaci.2017.03.030	http://dx.doi.org/10.1016/j.jaci.2017.03.030			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FI7JL	28433691	Bronze			2022-12-18	WOS:000412172900031
J	Caillot, N; Bouley, J; Jain, K; Mariano, S; Luce, S; Horiot, S; Airouche, S; Beuraud, C; Beauvallet, C; Devillier, P; Chollet-Martin, S; Kellenberger, C; Mascarell, L; Chabre, H; Batard, T; Nony, E; Lombardi, V; Baron-Bodo, V; Moingeon, P				Caillot, Noemie; Bouley, Julien; Jain, Karine; Mariano, Sandrine; Luce, Sonia; Horiot, Stephane; Airouche, Sabi; Beuraud, Chloe; Beauvallet, Christian; Devillier, Philippe; Chollet-Martin, Sylvie; Kellenberger, Christine; Mascarell, Laurent; Chabre, Henri; Batard, Thierry; Nony, Emmanuel; Lombardi, Vincent; Baron-Bodo, Veronique; Moingeon, Philippe			Sialylated Fetuin-A as a candidate predictive biomarker for successful grass pollen allergen immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergen immunotherapy; biomarker; serum; Fetuin-A	REGULATORY T-CELLS; SUBLINGUAL IMMUNOTHERAPY; CLINICAL-EFFICACY; GLYCOPROTEIN/FETUIN-A; SERUM; MECHANISMS; CORRELATE; AHSG; TOLERANCE; DECREASE	Background: Eligibility to immunotherapy is based on the determination of IgE reactivity to a specific allergen by means of skin prick or in vitro testing. Biomarkers predicting the likelihood of clinical improvement during immunotherapy would significantly improve patient selection. Methods: Proteins were differentially assessed by using 2-dimensional differential gel electrophoresis and label-free mass spectrometry in pretreatment sera obtained from clinical responders and nonresponders within a cohort of 82 patients with grass pollen allergy receiving sublingual immunotherapy or placebo. Functional studies of Fetuin-A (FetA) were conducted by using gene silencing in a mouse asthma model, human dendritic cell in vitro stimulation assays, and surface plasmon resonance. Results: Analysis by using quantitative proteomics of pretreatment sera from patients with grass pollen allergy reveals that high levels of O-glycosylated sialylated FetA isoforms are found in patients exhibiting a strong decrease in rhinoconjunctivitis symptoms after sublingual immunotherapy. Although FetA is involved in numerous inflammatory conditions, its potential role in allergy is unknown. In vivo silencing of the FETUA gene in BALB/c mice results in a dramatic upregulation of airway hyperresponsiveness, lung resistance, and T(H)2 responses after allergic sensitization to ovalbumin. Both sialylated and nonsialytated FetA bind to LPS, but only the former synergizes with LPS and grass pollen or mite allergens to enhance the Toll-like receptor 4-mediated proallergic properties of human dendritic cells. Conclusions: As a reflection of the patient's inflammatory status, pretreatment levels of sialylated FetA in the blood are indicative of the likelihood of clinical responses during grass pollen immunotherapy.	[Caillot, Noemie; Bouley, Julien; Jain, Karine; Mariano, Sandrine; Luce, Sonia; Horiot, Stephane; Airouche, Sabi; Beuraud, Chloe; Mascarell, Laurent; Chabre, Henri; Batard, Thierry; Nony, Emmanuel; Lombardi, Vincent; Baron-Bodo, Veronique; Moingeon, Philippe] Stallergenes Greer, Res Dept, 6 Rue Alexis de Tocqueville, F-92160 Antony, France; [Beauvallet, Christian] INRA, UMR GABI 1313, Res Ctr, Jouy En Josas, France; [Devillier, Philippe] Foch Hosp, UPRES EA 220, Suresnes, France; [Devillier, Philippe] Foch Hosp, Clin Res Dept, Suresnes, France; [Chollet-Martin, Sylvie] Paris Sud Univ, UMR 996, INSERM, Chatenay Malabry, France; [Kellenberger, Christine] AFMB, CNRS, UMR 6098, Marseille, France	Stallergenes Greer; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Hospital Foch; UDICE-French Research Universities; Universite Paris Saclay; Hospital Foch; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Moingeon, P (corresponding author), Stallergenes Greer, Res Dept, 6 Rue Alexis de Tocqueville, F-92160 Antony, France.	pmoingeon@stallergenes.com	kellenberger, christine/AAV-9304-2020	Nony, Emmanuel/0000-0003-1820-8881	CIFRE fellowship from ANRT (Association Nationale de la Recherche et de la Technologie)	CIFRE fellowship from ANRT (Association Nationale de la Recherche et de la Technologie)(French National Research Agency (ANR))	N. Caillot and C. Beuraud were supported by a CIFRE fellowship from ANRT (Association Nationale de la Recherche et de la Technologie).	Akdis CA, 2011, J ALLERGY CLIN IMMUN, V127, P18, DOI 10.1016/j.jaci.2010.11.030; Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Barboza R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067115; Bohle B, 2007, J ALLERGY CLIN IMMUN, V120, P707, DOI 10.1016/j.jaci.2007.06.013; Brix JM, 2010, J CLIN ENDOCR METAB, V95, P4877, DOI 10.1210/jc.2010-0148; Bufe A, 2004, ALLERGY, V59, P498, DOI 10.1111/j.1398-9995.2004.00457.x; Calderon MA, 2011, J ALLERGY CLIN IMMUN, V127, P30, DOI 10.1016/j.jaci.2010.08.024; Canonica GW, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-6; Ciprandi G, 2014, J INVEST ALLERG CLIN, V24, P35; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; Cox LS, 2012, J ALLERGY CLIN IMMUN, V130, P1327, DOI 10.1016/j.jaci.2012.08.032; Di Lorenzo G, 2009, J ALLERGY CLIN IMMUN, V123, P1103, DOI 10.1016/j.jaci.2009.02.012; Eifan AO, 2011, CURR OPIN ALLERGY CL, V11, P586, DOI 10.1097/ACI.0b013e32834cb994; Fujimura T, 2011, CLIN IMMUNOL, V139, P65, DOI 10.1016/j.clim.2010.12.022; Goustin AS, 2013, CELL SIGNAL, V25, P981, DOI 10.1016/j.cellsig.2012.12.011; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Gueguen C, 2016, J ALLERGY CLIN IMMUN, V137, P545, DOI 10.1016/j.jaci.2015.09.015; Halim A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013649; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Heinrichsdorff J, 2012, NAT MED, V18, P1182, DOI 10.1038/nm.2869; Hellmann M, 2012, TRENDS CARDIOVAS MED, V22, P197, DOI 10.1016/j.tcm.2012.07.020; Hildenbrand B, 2008, ANTICANCER RES, V28, P1467; Horak F, 2009, J ALLERGY CLIN IMMUN, V124, P471, DOI 10.1016/j.jaci.2009.06.006; Howarth P, 2012, ALLERGY, V67, P321, DOI 10.1111/j.1398-9995.2011.02759.x; Huang JC, 2014, J PROTEOME RES, V13, P681, DOI 10.1021/pr4012393; Jahnen-Dechent W, 2011, CIRC RES, V108, P1494, DOI 10.1161/CIRCRESAHA.110.234260; Karamessinis PM, 2008, MOL CELL PROTEOMICS, V7, P591, DOI 10.1074/mcp.M700422-MCP200; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Metry G, 2008, EUR J CLIN INVEST, V38, P804, DOI 10.1111/j.1365-2362.2008.02032.x; Mittag D, 2013, EUR J IMMUNOL, V43, P723, DOI 10.1002/eji.201242747; Moingeon P, 2016, IMMUNOL ALLERGY CLIN, V36, P161, DOI 10.1016/j.iac.2015.08.004; Moingeon P, 2013, J ALLER CL IMM-PRACT, V1, P228, DOI 10.1016/j.jaip.2013.03.013; Mori K, 2011, RECENT PATENTS ENDOC, V5, P124, DOI 10.2174/187221411799015372; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Razafindratsita A, 2007, J ALLERGY CLIN IMMUN, V120, P278, DOI 10.1016/j.jaci.2007.04.009; Saroha A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046374; Sato H, 2007, INTERNAL MED, V46, P1685, DOI 10.2169/internalmedicine.46.6269; Shamji MH, 2012, ALLERGY, V67, P217, DOI 10.1111/j.1398-9995.2011.02745.x; Shamji MH, 2011, CLIN EXP ALLERGY, V41, P1235, DOI 10.1111/j.1365-2222.2011.03804.x; Shamji MH, 2013, IMMUNOTHERAPY-UK, V5, P203, DOI [10.2217/IMT.13.6, 10.2217/imt.13.6]; Stefan N, 2008, DIABETES, V57, P2762, DOI 10.2337/db08-0538; Stefan N, 2013, NAT MED, V19, P394, DOI 10.1038/nm.3116; Stenvinkel P, 2005, KIDNEY INT, V67, P2383, DOI 10.1111/j.1523-1755.2005.00345.x; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Tuttolomondo A, 2010, ATHEROSCLEROSIS, V208, P290, DOI 10.1016/j.atherosclerosis.2009.07.032; Van Overtvelt L, 2011, ALLERGY, V66, P1530, DOI 10.1111/j.1398-9995.2011.02696.x; Wang H, 2012, CURR MOL MED, V12, P625, DOI 10.2174/156652412800620039; Wang HC, 2010, J CEREBR BLOOD F MET, V30, P493, DOI 10.1038/jcbfm.2009.247; Weberschock T, 2014, J DTSCH DERMATOL GES, V12, P341, DOI 10.1111/ddg.12298; Willis JCD, 2015, NAT REV IMMUNOL, V15, P323, DOI 10.1038/nri3820; Zimmer A, 2012, J ALLERGY CLIN IMMUN, V129, P1020, DOI 10.1016/j.jaci.2012.02.014	53	6	8	0	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2017	140	3					759	+		10.1016/j.jaci.2016.10.036	http://dx.doi.org/10.1016/j.jaci.2016.10.036			25	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FF8CA	27965111	Bronze			2022-12-18	WOS:000409241500015
J	Bommart, S; Marin, G; Molinari, N; Knabe, L; Petit, A; Chanez, P; Gamez, AS; Devautour, C; Vachier, I; Bourdin, A				Bommart, Sebastien; Marin, Gregory; Molinari, Nicolas; Knabe, Lucie; Petit, Aurelie; Chanez, Pascal; Gamez, Anne Sophie; Devautour, Catherine; Vachier, Isabelle; Bourdin, Arnaud			Club cell secretory protein serum concentration is a surrogate marker of small-airway involvement in asthmatic patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Marin, Gregory; Molinari, Nicolas] Montpellier Univ Hosp, Dept Med Informat, Montpellier, France; [Marin, Gregory; Knabe, Lucie; Petit, Aurelie; Gamez, Anne Sophie; Devautour, Catherine; Vachier, Isabelle; Bourdin, Arnaud] Montpellier Univ Hosp, Dept Resp Dis, Montpellier, France; [Bommart, Sebastien] Montpellier Univ Hosp, Dept Radiol, Montpellier, France; [Bommart, Sebastien; Molinari, Nicolas; Knabe, Lucie; Bourdin, Arnaud] Univ Montpellier, Montpellier Univ Hosp, INSERM U1046, PhyMedExp, Montpellier, France; [Molinari, Nicolas; Bourdin, Arnaud] APARD, Montpellier, France; [Chanez, Pascal] Aix Marseille Univ, INSERM Lab U1067, Dept Resp Dis, AP HM, Marseille, France	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Bourdin, A (corresponding author), Montpellier Univ Hosp, Dept Resp Dis, Montpellier, France.; Bourdin, A (corresponding author), Univ Montpellier, Montpellier Univ Hosp, INSERM U1046, PhyMedExp, Montpellier, France.; Bourdin, A (corresponding author), APARD, Montpellier, France.	a-bourdin@chu-montpellier.fr	Vachier, Isabelle/AAV-5731-2020; molinari, nicolas/Y-9681-2019; Petit, Aurelie/O-1731-2018	Vachier, Isabelle/0000-0003-2730-5165; Petit, Aurelie/0000-0002-9069-9868; chanez, pascal/0000-0003-4059-0917; , Lucie/0000-0003-4560-4273	"Direction Inter-regionale de la Recherche Clinique-Sud Mediterrannee'' (Appel d'Offre Interne du GCS MERRI), Montpellier, France [RCB: 2011-A01396-35]	"Direction Inter-regionale de la Recherche Clinique-Sud Mediterrannee'' (Appel d'Offre Interne du GCS MERRI), Montpellier, France	Supported by "Direction Inter-regionale de la Recherche Clinique-Sud Mediterrannee'' (Appel d'Offre Interne du GCS MERRI 2011), Montpellier, France (ID RCB: 2011-A01396-35).	Alfieri V, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0086-1; Bommart S, 2015, EUR RESPIR J, V45, P1167, DOI 10.1183/09031936.00215314; Guerra S, 2016, J ALLERGY CLIN IMMUN, V138, P932, DOI 10.1016/j.jaci.2016.03.047; Guerra S, 2015, LANCET RESP MED, V3, P613, DOI 10.1016/S2213-2600(15)00196-4; Lomas DA, 2008, THORAX, V63, P1058, DOI 10.1136/thx.2008.102574; McCollough CH, 2015, MAYO CLIN P, V90, P1380; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V129, pS9, DOI 10.1016/j.jaci.2011.12.979; Thompson BR, 2013, J ALLERGY CLIN IMMUN, V131, P1322, DOI 10.1016/j.jaci.2013.01.054	8	6	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2017	140	2					581	+		10.1016/j.jaci.2016.09.063	http://dx.doi.org/10.1016/j.jaci.2016.09.063			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FC5BK	28108336	Green Submitted, Bronze			2022-12-18	WOS:000406855500031
J	Erez, DL; Meyers, KE; Sullivan, KE				Erez, Daniella Levy; Meyers, Kevin E.; Sullivan, Kathleen E.			C3 nephritic factors: A changing landscape	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						C3 nephritic factor; alternative complement activation; membranoproliferative glomerulonephritis; C3 glomerulopathy; dense-deposit disease; partial lipodystrophy; eculizumab	COMPLEMENT		[Erez, Daniella Levy; Meyers, Kevin E.] Childrens Hosp Philadelphia, Div Nephrol, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Sullivan, Kathleen E.] Childrens Hosp Philadelphia, Div Allergy & Immunol, Philadelphia, PA 19104 USA; [Erez, Daniella Levy; Meyers, Kevin E.; Sullivan, Kathleen E.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania	Erez, DL (corresponding author), Childrens Hosp Philadelphia, Div Nephrol, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	levy.erez.daniella@gmail.com		Levy Erez, Daniella/0000-0003-1869-3282	DUET Trial; SHIPAHOY; NEPTUNE II; CureGN; National Institutes of Health; Lupus Foundation of American; Alliance for Lupus Research; American Academy of Allergy, Asthma Immunology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007006] Funding Source: NIH RePORTER	DUET Trial; SHIPAHOY; NEPTUNE II; CureGN; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Foundation of American; Alliance for Lupus Research; American Academy of Allergy, Asthma Immunology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	K. E. Meyers has received grants from the DUET Trial, SHIPAHOY, NEPTUNE II, and CureGN. K. E. Sullivan is employed by the University of Pennsylvania Perelman School of Medicine; has received grants from the National Institutes of Health, the Lupus Foundation of American, and the Alliance for Lupus Research; and has received travel support from the American Academy of Allergy, Asthma & Immunology. D. Levy Erez declares that she has no relevant conflicts of interest.	Bomback AS, 2012, NAT REV NEPHROL, V8, P634, DOI 10.1038/nrneph.2012.213; Egan M, 2016, CLIN IMMUNOL, V169, P14, DOI 10.1016/j.clim.2016.06.001; Misra A, 2004, MEDICINE, V83, P18, DOI 10.1097/01.md.0000111061.69212.59; Paixao-Cavalcante D, 2012, KIDNEY INT, V82, P1084, DOI 10.1038/ki.2012.250; Riedl M, 2017, PEDIATR NEPHROL, V32, P43, DOI 10.1007/s00467-015-3310-4; Sanchez-Moreno A, 2014, PEDIATR NEPHROL, V29, P2055, DOI 10.1007/s00467-014-2839-y; SPITZER RE, 1992, J IMMUNOL, V148, P137; TANUMA Y, 1990, CLIN IMMUNOL IMMUNOP, V56, P226, DOI 10.1016/0090-1229(90)90144-F; Wen L, 2004, J ALLERGY CLIN IMMUN, V113, P585, DOI 10.1016/j.jaci.2004.02.003; Zipfel PF, 2006, MOL IMMUNOL, V43, P97, DOI 10.1016/j.molimm.2005.06.015	10	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2017	140	1					57	59		10.1016/j.jaci.2017.02.018	http://dx.doi.org/10.1016/j.jaci.2017.02.018			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EZ2LY	28322851	Bronze, Green Accepted			2022-12-18	WOS:000404542000005
J	Ono, S; Egawa, G; Kitoh, A; Dainichi, T; Otsuka, A; Nakajima, S; Honda, T; Kabashima, K				Ono, Sachiko; Egawa, Gyohei; Kitoh, Akihiko; Dainichi, Teruki; Otsuka, Atsushi; Nakajima, Saeko; Honda, Tetsuya; Kabashima, Kenji			Local inflammation exacerbates cutaneous manifestations in a murine autoimmune pemphigus model	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							VULGARIS		[Ono, Sachiko; Egawa, Gyohei; Kitoh, Akihiko; Dainichi, Teruki; Otsuka, Atsushi; Nakajima, Saeko; Honda, Tetsuya; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Kabashima, Kenji] ASTAR, Singapore Immunol Network SIgN, Biopolis, Singapore, Singapore; [Kabashima, Kenji] ASTAR, Inst Med Biol, Biopolis, Singapore, Singapore; [Kabashima, Kenji] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	Kyoto University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Japan Science & Technology Agency (JST)	Egawa, G; Kabashima, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan.; Kabashima, K (corresponding author), ASTAR, Singapore Immunol Network SIgN, Biopolis, Singapore, Singapore.; Kabashima, K (corresponding author), ASTAR, Inst Med Biol, Biopolis, Singapore, Singapore.; Kabashima, K (corresponding author), Japan Sci & Technol Agcy, PRESTO, Saitama, Japan.	gyohei@kuhp.kyoto-u.ac.jp; kaba@kuhp.kyoto-u.ac.jp	Nakajima, Saeko/AAB-1577-2021; Dainichi, Teruki/AAL-5400-2020; Kabashima, Kenji/G-2521-2014	Dainichi, Teruki/0000-0002-9497-0029; Nakajima, Saeko/0000-0003-0831-1447; Kabashima, Kenji/0000-0002-0773-0554; Egawa, Gyohei/0000-0002-6101-4719; Otsuka, Atsushi/0000-0001-7365-947X	Japan Society for the Promotion of Science KAKENHI [263395]; Japan Science and Technology Agency [15H05790, 15H1155, 15K15417]; Precursory Research for Embryonic Science and Technology [16021031300]; Japan Agency for Medical Research and Development [16ek0410011h0003, 16he0902003h0002]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Precursory Research for Embryonic Science and Technology; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by the Japan Society for the Promotion of Science KAKENHI (grant no. 263395), Grants-in-Aid for Scientific Research (grant nos. 15H05790, 15H1155, and 15K15417), Japan Science and Technology Agency, Precursory Research for Embryonic Science and Technology (grant no. 16021031300), and the Japan Agency for Medical Research and Development (grant nos. 16ek0410011h0003 and 16he0902003h0002).	AMAGAI M, 1992, J CLIN INVEST, V90, P919, DOI 10.1172/JCI115968; Egawa G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01932; Kano Y, 2000, DERMATOLOGY, V201, P132, DOI 10.1159/000018456; Maruani A, 2010, INT J PHARMACEUT, V385, P37, DOI 10.1016/j.ijpharm.2009.10.024; MEHREGAN DR, 1992, ARCH DERMATOL, V128, P414, DOI 10.1001/archderm.128.3.414; Peters RL, 2013, J ALLERGY CLIN IMMUN, V132, P874, DOI 10.1016/j.jaci.2013.05.038; Sticherling M, 2013, Z RHEUMATOL, V72, P429, DOI 10.1007/s00393-013-1134-9; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Venugopal SS, 2011, DERMATOL CLIN, V29, P373, DOI 10.1016/j.det.2011.03.004	9	6	6	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2017	139	6					2026	+		10.1016/j.jaci.2016.12.959	http://dx.doi.org/10.1016/j.jaci.2016.12.959			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EW7VG	28115214	Green Submitted, Bronze			2022-12-18	WOS:000402724600046
J	Jabara, HH; Lee, JJ; Janssen, E; Ullas, S; Liadaki, K; Garibyan, L; Benson, H; Sannikova, T; Bram, R; Hammarstrom, L; Cruz, AC; Siegel, R; Manis, J; Malley, R; Geha, RS				Jabara, Haifa H.; Lee, John J.; Janssen, Erin; Ullas, Sumana; Liadaki, Kyriaki; Garibyan, Lilit; Benson, Halli; Sannikova, Tatyana; Bram, Richard; Hammarstrom, Lennart; Cruz, Anthony C.; Siegel, Richard; Manis, John; Malley, Richard; Geha, Raif S.			Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Transmembrane activator and calcium modulator ligand interactor; common variable immunodeficiency; natural antibodies; pneumococcal susceptibility; B cells	COMMON VARIABLE IMMUNODEFICIENCY; B-CELLS; STREPTOCOCCUS-PNEUMONIAE; TNFRSF13B VARIANTS; TACI; RECEPTOR; PHOSPHOCHOLINE; MUTATIONS; INFECTION; ANTIBODY	Background: The B-cell receptor transmembrane activator and calcium modulator ligand interactor (TACI) is important for T-independent antibody responses. One in 200 blood donors are heterozygous for the TACI A181E mutation. Objective: We sought to investigate the effect on B-cell function of TACI A181E heterozygosity in reportedly healthy subjects and of the corresponding TACI A144E mutation in mice. Methods: Nuclear factor kappa B(NF-kappa B) activation was measured by using the luciferase assay in 293T cells cotransfected with wild-type and mutant TACI. TACI-driven proliferation, isotype switching, and antibody responses were measured in B cells from heterozygous TACI A144E knock-in mice. Mouse mortality was monitored after intranasal pneumococcal challenge. Results: Levels of natural antibodies to the pneumococcal polysaccharide component phosphocholine were significantly lower in A181E-heterozygous than TACI-sufficient Swedish blood donors never immunized with pneumococcal antigens. Although overexpressed hTACI A181E and mTACI A144E acted as dominant-negative mutations in transfectants, homozygosity for A144E in mice resulted in absent TACI expression in B cells, indicating that the mutant protein is unstable when naturally expressed. A144E heterozygous mice, such as TACI(+/-) mice, expressed half the normal level of TACI on their B cells and exhibited similar defects in a proliferation-inducing ligand-driven B-cell activation, antibody responses to TNP-Ficoll, production of natural antibodies to phosphocholine, and survival after intranasal pneumococcal challenge. Conclusion: These results suggest that TACI A181E heterozygosity results in TACI haploinsufficiency with increased susceptibility to pneumococcal infection. This has important implications for asymptomatic TACI A181E carriers.	[Jabara, Haifa H.; Lee, John J.; Janssen, Erin; Ullas, Sumana; Liadaki, Kyriaki; Garibyan, Lilit; Benson, Halli; Sannikova, Tatyana; Geha, Raif S.] Boston Childrens Hosp, Div Immunol, Boston, MA USA; [Manis, John] Boston Childrens Hosp, Div Transfus Med, Boston, MA USA; [Malley, Richard] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA; Harvard Med Sch, Boston, MA USA; [Bram, Richard] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN USA; [Hammarstrom, Lennart] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Cruz, Anthony C.; Siegel, Richard] NIAMSD, Immunoregulat Sect, Autoimmun Branch, NIH, Bethesda, MD 20892 USA; [Garibyan, Lilit] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Garibyan, Lilit] Harvard Med Sch, Dept Dermatol, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Mayo Clinic; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Geha, RS (corresponding author), Childrens Hosp, Div Immunol, One Blackfan Circle, Boston, MA 02115 USA.	raif.geha@childrens.harvard.edu	Garibyan, Lilit/AAR-1638-2020	Janssen, Erin/0000-0002-0687-2550	National Institutes of Health (NIH) [AI076210, K08AI114968, AI100114]; Translational Research Program at Boston Children's Hospital; National Institute of Arthritis and Musculoskeletal and Skin Diseases Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI114968, R01AI100315, R01AI100114, P01AI076210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041133, ZIAAR041174] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Translational Research Program at Boston Children's Hospital; National Institute of Arthritis and Musculoskeletal and Skin Diseases Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by National Institutes of Health (NIH) grants AI076210 (to R.S.G.), K08AI114968 (to E.J.), AI100114 (to R.M.), the Translational Research Program at Boston Children's Hospital (to R.M.), and the National Institute of Arthritis and Musculoskeletal and Skin Diseases Intramural Research Program.	Avery DT, 2003, J CLIN INVEST, V112, P286, DOI 10.1172/JCI200318025; Bacchelli C, 2011, J ALLERGY CLIN IMMUN, V127, P1253, DOI 10.1016/j.jaci.2011.02.037; BRILES DE, 1981, J EXP MED, V153, P694, DOI 10.1084/jem.153.3.694; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Chinen J, 2011, J ALLERGY CLIN IMMUN, V127, P1579, DOI 10.1016/j.jaci.2011.02.046; Eeva J, 2004, APOPTOSIS, V9, P525, DOI 10.1023/B:APPT.0000038032.22343.de; Fischer W, 2000, RES MICROBIOL, V151, P421, DOI 10.1016/S0923-2508(00)00174-1; Gang TB, 2012, J BIOL CHEM, V287, P43116, DOI 10.1074/jbc.M112.427310; Garibyan L, 2007, J CLIN INVEST, V117, P1550, DOI 10.1172/JCI31023; Goenka R, 2014, J EXP MED, V211, P45, DOI 10.1084/jem.20130505; Goldenberg HB, 2004, J INFECT DIS, V190, P1254, DOI 10.1086/424517; Kanno Y, 2010, J RECEPT SIG TRANSD, V30, P121, DOI 10.3109/10799891003634509; Lee JJ, 2010, J ALLERGY CLIN IMMUN, V126, P1234, DOI 10.1016/j.jaci.2010.08.017; Lee JJ, 2009, BLOOD, V114, P2254, DOI 10.1182/blood-2008-11-189720; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; Martinez-Gallo M, 2013, J ALLERGY CLIN IMMUN, V131, P468, DOI 10.1016/j.jaci.2012.10.029; Martinez-Pomar N, 2009, BLOOD, V114, P2846, DOI 10.1182/blood-2009-05-213025; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Salzer U, 2009, BLOOD, V113, P1967, DOI 10.1182/blood-2008-02-141937; Seshasayee D, 2003, IMMUNITY, V18, P279, DOI 10.1016/S1074-7613(03)00025-6; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Tsuji S, 2014, J CLIN INVEST, V124, P4857, DOI 10.1172/JCI74428; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889; Yan MH, 2001, NAT IMMUNOL, V2, P638, DOI 10.1038/89790; YOTHER J, 1982, INFECT IMMUN, V36, P184, DOI 10.1128/IAI.36.1.184-188.1982	31	6	6	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2017	139	4					1293	+		10.1016/j.jaci.2016.07.028	http://dx.doi.org/10.1016/j.jaci.2016.07.028			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ER4LR	27609654	Bronze, Green Accepted			2022-12-18	WOS:000398771800024
J	Sette, A; Schulten, V				Sette, Alessandro; Schulten, Veronique			It's a lot of work to be nonallergic	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Allergic rhinitis; house dust mite; T cells; nasal allergen challenge; nonallergic	NASAL ALLERGEN CHALLENGE; GRASS-POLLEN		[Sette, Alessandro; Schulten, Veronique] Jolla Inst Allergy & Immunol, 9420 Athena Circle, La Jolla, CA 92037 USA		Schulten, V (corresponding author), Jolla Inst Allergy & Immunol, 9420 Athena Circle, La Jolla, CA 92037 USA.	veronique@lji.org	Sette, Alessandro/AFO-8916-2022		National Institute of Allergy and Infectious Diseases; National Institutes of Health; Department of Health and Human Services [HHSN272200900052C, HHSN272201000052I, 1UM1AI114271-01, U19AI100275]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI114271, U19AI100275] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract numbers HHSN272200900052C and HHSN272201000052I and grant numbers 1UM1AI114271-01 and U19AI100275.	Ahuja SK, 2017, J ALLERGY CLIN IMMUN, V139, P844, DOI 10.1016/j.jaci.2016.08.019; Borgonovo B, 1997, J ALLERGY CLIN IMMUN, V100, P669, DOI 10.1016/S0091-6749(97)70172-6; Brough HA, 2015, J ALLERGY CLIN IMMUN, V135, P164, DOI 10.1016/j.jaci.2014.10.007; Chaussabel D, 2014, NAT REV IMMUNOL, V14, P271, DOI 10.1038/nri3642; Hinz D, 2016, CLIN EXP ALLERGY, V46, P705, DOI 10.1111/cea.12692; LAKHANI S, 1992, J CLIN PATHOL, V45, P756, DOI 10.1136/jcp.45.9.756; Leung DYM, 2014, J ALLERGY CLIN IMMUN, V134, P769, DOI 10.1016/j.jaci.2014.08.008; Platts-Mills TAE, 2015, J ALLERGY CLIN IMMUN, V136, P3, DOI 10.1016/j.jaci.2015.03.048; Scadding GW, 2015, ALLERGY, V70, P689, DOI 10.1111/all.12608; Shamji MH, 2015, ALLERGY, V70, P171, DOI 10.1111/all.12543	10	6	6	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2017	139	3					769	770		10.1016/j.jaci.2016.11.018	http://dx.doi.org/10.1016/j.jaci.2016.11.018			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EP3QC	27993537	Green Accepted, Bronze			2022-12-18	WOS:000397295800007
J	Thijs, JL; Herath, A; de Bruin-Weller, MS; Hijnen, D				Thijs, Judith L.; Herath, Athula; de Bruin-Weller, Marjolein S.; Hijnen, DirkJan			Multiplex platform technology and bioinformatics are essential for development of biomarkers in atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ACTIVATION-REGULATED CHEMOKINE; MACROPHAGE-DERIVED CHEMOKINE; SERUM THYMUS; ALLERGIC DISEASES; SEVERITY; MARKERS		[Thijs, Judith L.; de Bruin-Weller, Marjolein S.; Hijnen, DirkJan] Univ Med Ctr Utrecht, Dept Dermatol & Allergol, Utrecht, Netherlands; [Herath, Athula] Novartis Pharmaceut, E Hanover, NJ USA	Utrecht University; Utrecht University Medical Center; Novartis	Hijnen, D (corresponding author), Univ Med Ctr Utrecht, Dept Dermatol & Allergol, Utrecht, Netherlands.	D.J.Hijnen@umcutrecht.nl	Hijnen, DirkJan/L-1387-2015	Hijnen, DirkJan/0000-0003-3379-3425; Herath, Athula/0000-0002-9465-7841	Regeneron/Sanofi	Regeneron/Sanofi	M. de Bruin-Weller has received board membership, consultancy fees, and grants for Dupilumab studies from Regeneron/Sanofi. The rest of the authors declare that they have no relevant conflicts of interest.	Hijnen DJ, 2004, J ALLERGY CLIN IMMUN, V113, P334, DOI 10.1016/j.jaci.2003.12.007; Jahnz-Rozyk K, 2005, ALLERGY, V60, P685, DOI 10.1111/j.1398-9995.2005.00774.x; Kakinuma T, 2001, J ALLERGY CLIN IMMUN, V107, P535, DOI 10.1067/mai.2001.113237; Krause L, 2016, J ALLERGY CLIN IMMUN, V138, P1207, DOI 10.1016/j.jaci.2016.04.018; Landheer J, 2014, J AM ACAD DERMATOL, V71, P1160, DOI 10.1016/j.jaad.2014.07.031; Leung TF, 2003, PEDIATR ALLERGY IMMU, V14, P296, DOI 10.1034/j.1399-3038.2003.00052.x; MATSUMOTO T, 1991, CLIN EXP IMMUNOL, V85, P288; Shimada Y, 2004, J DERMATOL SCI, V34, P201, DOI 10.1016/j.jdermsci.2004.01.001; Thijs JL, 2015, CLIN EXP ALLERGY, V45, P698, DOI 10.1111/cea.12486; Thijs J, 2015, CURR OPIN ALLERGY CL, V15, P453, DOI 10.1097/ACI.0000000000000198; Thijs JL, 2015, J CLIN MED, V4, P479, DOI 10.3390/jcm4030479	11	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2017	139	3					1065	1065		10.1016/j.jaci.2016.08.023	http://dx.doi.org/10.1016/j.jaci.2016.08.023			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EP3QC	28341480	Bronze			2022-12-18	WOS:000397295800049
J	Kalfus, I; McDonald, A; Qian, S				Kalfus, Ira; McDonald, Andrew; Qian, Shawn			Potency, Selectivity, and Exposure Evaluation of ATN-249, a New Oral Kallikrein Inhibitor for Hereditary Angioedema	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 03-16, 2017	Atlanta, GA	Amer Acad Allergy, Asthma & Immunol					[Kalfus, Ira; McDonald, Andrew; Qian, Shawn] Attune Pharmaceut LLC, New York, NY USA										0	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2017	139	2		S		L11	AB378	AB378		10.1016/j.jaci.2016.12.905	http://dx.doi.org/10.1016/j.jaci.2016.12.905			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	EV4AF		Bronze			2022-12-18	WOS:000401699800782
J	Messina, J; Carothers, J; Obaidi, M; Offman, E; Mahmoud, R				Messina, John; Carothers, Jennifer; Obaidi, Mohammad; Offman, Elliot; Mahmoud, Ramy			Intranasal Fluticasone Propionate Delivered by Exhalation Delivery System (FLU-EDS) Versus Flonase (R) Nasal Spray and Flovent (R) HFA: a Randomized Comparison of Bioavailability	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 03-16, 2017	Atlanta, GA	Amer Acad Allergy, Asthma & Immunol					[Messina, John; Carothers, Jennifer; Mahmoud, Ramy] OptiNose, Yardley, PA USA; [Obaidi, Mohammad; Offman, Elliot] Celerion, Lincoln, NE USA										0	6	6	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2017	139	2		S		795	AB253	AB253		10.1016/j.jaci.2016.12.815	http://dx.doi.org/10.1016/j.jaci.2016.12.815			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	EV4AF					2022-12-18	WOS:000401699800694
J	Prussin, C; Laidlaw, TM; Panettieri, RA; Ferguson, BJ; Adappa, ND; Lane, AP; Lee, S; Sullivan, M; Archibald, D; Dworetzky, SI; Hebrank, G; Bozik, ME				Prussin, Calman; Laidlaw, Tanya M.; Panettieri, Reynold A.; Ferguson, Berrylin J.; Adappa, Nithin D.; Lane, Andrew P.; Lee, Stella; Sullivan, Mary; Archibald, Don; Dworetzky, Steven I.; Hebrank, Greg; Bozik, Michael E.			Dexpramipexole effectively lowers blood and tissue eosinophils in subjects with chronic rhinosinusitis with nasal polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 03-16, 2017	Atlanta, GA	Amer Acad Allergy, Asthma & Immunol					[Prussin, Calman] Knopp Biosci LLC, Rockviile, MD USA; [Laidlaw, Tanya M.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA; [Panettieri, Reynold A.] Rutgers Inst Translat Med & Sci, New Brunswick, NJ USA; [Ferguson, Berrylin J.; Lee, Stella] Univ Pittsburgh, Pittsburgh, PA USA; [Adappa, Nithin D.] Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Lane, Andrew P.] Johns Hopkins Dept Otolaryngol, Baltimore, MD USA; [Sullivan, Mary; Archibald, Don; Dworetzky, Steven I.; Hebrank, Greg; Bozik, Michael E.] Knopp Biosci LLC, Pittsburgh, PA USA	Harvard University; Brigham & Women's Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; Johns Hopkins University			panettieri, reynold/AAG-9485-2019; Lee, Stella/AAI-6029-2021						0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2017	139	2		S		202	AB64	AB64		10.1016/j.jaci.2016.12.256	http://dx.doi.org/10.1016/j.jaci.2016.12.256			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	EV4AF					2022-12-18	WOS:000401699800105
J	Rammohan, R; Dhanabalsamy, N; Dimov, V; Eidelman, FJ				Rammohan, Rajmohan; Dhanabalsamy, Nisha; Dimov, Ves; Eidelman, Frank J.			Smartphone Conversational Agents (Apple Siri, Google, Windows Cortana) and Questions about Allergy and Asthma Emergencies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 03-16, 2017	Atlanta, GA	Amer Acad Allergy, Asthma & Immunol					[Rammohan, Rajmohan; Dhanabalsamy, Nisha; Dimov, Ves; Eidelman, Frank J.] Cleveland Clin Florida, Weston, FL USA	Cleveland Clinic Foundation									0	6	7	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2017	139	2		S		784	AB250	AB250		10.1016/j.jaci.2016.12.804	http://dx.doi.org/10.1016/j.jaci.2016.12.804			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	EV4AF					2022-12-18	WOS:000401699800683
J	Lee, H; Shin, JJ; Bae, HC; Ryu, WI; Son, SW				Lee, Hana; Shin, Jung Jin; Bae, Hyun Cheol; Ryu, Woo-In; Son, Sang Wook			Toluene downregulates filaggrin expression via the extracellular signal-regulated kinase and signal transducer and activator of transcription-dependent pathways	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							EXPOSURE		[Lee, Hana] Korea Univ, Coll Med, Dept Dermatol, Seoul, South Korea; Korea Univ, Div Brain Korea Project Biomed Sci 21, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University	Lee, H (corresponding author), Korea Univ, Coll Med, Dept Dermatol, Seoul, South Korea.	skin4u@korea.ac.kr		Son, Sang Wook/0000-0002-3332-7056	National Research Foundation of Korea - Ministry of Science, Information Communication Technology, and Future Planning [NRF-2016R1A2B4016161]; Korean Health Technology R&D Project, Ministry for Health, Welfare Family Affairs [A101334]	National Research Foundation of Korea - Ministry of Science, Information Communication Technology, and Future Planning; Korean Health Technology R&D Project, Ministry for Health, Welfare Family Affairs	S.W. Son has received research support from the National Research Foundation of Korea, which is funded by the Ministry of Science, Information Communication Technology, and Future Planning (grant no. NRF-2016R1A2B4016161), and the Korean Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs (grant no. A101334). The rest of the authors declare that they have no relevant conflicts of interest.	Ahn K, 2014, J ALLERGY CLIN IMMUN, V134, P993, DOI 10.1016/j.jaci.2014.09.023; Bonisch U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039817; Bowler RP, 2002, J ALLERGY CLIN IMMUN, V110, P349, DOI 10.1067/mai.2002.126780; Carson CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048678; Fujimaki H, 2011, TOXICOLOGY, V286, P28, DOI 10.1016/j.tox.2011.05.002; Huss-Marp J, 2006, CLIN EXP ALLERGY, V36, P338, DOI 10.1111/j.1365-2222.2006.02448.x; Kim EH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119501; Kim JH, 2015, J ALLERGY CLIN IMMUN, V136, P205, DOI 10.1016/j.jaci.2015.04.026; Lecureur V, 2012, TOXICOLOGY, V292, P13, DOI 10.1016/j.tox.2011.11.011	9	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2017	139	1					355	+		10.1016/j.jaci.2016.06.036	http://dx.doi.org/10.1016/j.jaci.2016.06.036			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EK5WM	27498358	Bronze			2022-12-18	WOS:000393996800038
J	Cockcroft, DW; Wenzel, S				Cockcroft, Donald W.; Wenzel, Sally			Airway hyperresponsiveness and chronic obstructive pulmonary disease outcomes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Chronic obstructive pulmonary disease; airway hyperresponsiveness	ASTHMA; METHACHOLINE		[Cockcroft, Donald W.] Univ Saskatchewan, Dept Med, Div Resp Crit Care & Sleep Med, Saskatoon, SK, Canada; [Wenzel, Sally] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, 3459 Fifth Ave, Pittsburgh, PA 15213 USA	University of Saskatchewan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wenzel, S (corresponding author), Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, 3459 Fifth Ave, Pittsburgh, PA 15213 USA.	wenzelse@upmc.edu		Wenzel, Sally/0000-0002-4242-0164				Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Cockcroft DW, 2006, J ALLERGY CLIN IMMUN, V118, P551, DOI 10.1016/j.jaci.2006.07.012; Hospers JJ, 2000, LANCET, V356, P1313, DOI 10.1016/S0140-6736(00)02815-4; Joos GF, 2003, EUR RESPIR J, V21, P1050, DOI 10.1183/09031936.03.00008403; Leuppi JD, 2005, PULM PHARMACOL THER, V18, P83, DOI 10.1016/j.pupt.2004.10.005; Louis R, 2002, ALLERGY, V57, P907, DOI 10.1034/j.1398-9995.2002.23608.x; RAMSDALE EH, 1985, THORAX, V40, P422, DOI 10.1136/thx.40.6.422; Sont JK, 1999, AM J RESP CRIT CARE, V159, P1043, DOI 10.1164/ajrccm.159.4.9806052; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Taube Christian, 2006, COPD, V3, P25, DOI 10.1080/15412550500493360; Thomas B, 2016, PEDIAT PULMONOL; Tkacova R, 2016, J ALLERGY CLIN IMMUN, V138, P1571, DOI 10.1016/j.jaci.2016.04.022; Walker PP, 2009, RESP MED, V103, P535, DOI 10.1016/j.rmed.2008.11.002	13	6	6	2	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2016	138	6					1580	1581		10.1016/j.jaci.2016.06.039	http://dx.doi.org/10.1016/j.jaci.2016.06.039			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EF0MK	27516214	Bronze			2022-12-18	WOS:000390019300012
J	West, NP; Horn, PL; Pyne, DB; Warren, HS; Asad, S; Cox, AJ; Lahtinen, SJ; Lehtinen, MJ; Fricker, PA; Cripps, AW; Fazekas de St Groth, B				West, Nicholas P.; Horn, Peggy L.; Pyne, David B.; Warren, Hilary S.; Asad, Suzanne; Cox, Amanda J.; Lahtinen, Sampo J.; Lehtinen, Markus J.; Fricker, Peter A.; Cripps, Allan W.; Fazekas de St Groth, Barbara			Probiotic supplementation has little effect on peripheral blood regulatory T cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DENDRITIC CELLS; GUT MICROBIOTA; EXERCISE		[West, Nicholas P.; Cox, Amanda J.; Cripps, Allan W.] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Australia; [Horn, Peggy L.; Pyne, David B.; Fricker, Peter A.] Australian Inst Sport, Canberra, ACT, Australia; [Warren, Hilary S.] Canberra Hosp, Canc Immunol Res Unit, Canberra, ACT, Australia; [Asad, Suzanne; Fazekas de St Groth, Barbara] Univ Sydney, Centenary Inst, Sydney, NSW, Australia; [Asad, Suzanne; Fazekas de St Groth, Barbara] Univ Sydney, Discipline Dermatol, Sydney, NSW, Australia; [Lahtinen, Sampo J.; Lehtinen, Markus J.] DuPont Nutr & Hlth, Kantvic, Finland	Griffith University; Menzies Health Institute Queensland; Australian Institute of Sport; Australian National University; Canberra Hospital; University of Sydney; Centenary Institute; University of Sydney	West, NP (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Australia.	n.west@griffith.edu.au	de St Groth, Barbara Fazekas/O-3017-2017	de St Groth, Barbara Fazekas/0000-0001-6817-9690; Pyne, David/0000-0003-1555-5079; West, Nicholas/0000-0002-5482-4182				Fazekas de St Groth B, 2011, METHODS MOL BIOL, V707, P263, DOI 10.1007/978-1-61737-979-6_17; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Gomes AC, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-60; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Handzlik MK, 2013, EUR J APPL PHYSIOL, V113, P1839, DOI 10.1007/s00421-013-2614-y; Johnstone J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108481; Konieczna P, 2012, GUT, V61, P354, DOI 10.1136/gutjnl-2011-300936; Kwon HK, 2013, CLIN IMMUNOL, V146, P217, DOI 10.1016/j.clim.2013.01.001; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Liu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056547; Lyons A, 2010, CLIN EXP ALLERGY, V40, P811, DOI 10.1111/j.1365-2222.2009.03437.x; Papadakis KA, 2003, J IMMUNOL, V171, P159, DOI 10.4049/jimmunol.171.1.159; Smelt MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068952; Varcoe J, 2002, J APPL MICROBIOL, V93, P900, DOI 10.1046/j.1365-2672.2002.01764.x; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P6; Weinhold M, 2016, J ALLERGY CLIN IMMUN, V137, P1607, DOI 10.1016/j.jaci.2015.10.035; Wen K, 2012, VACCINE, V30, P1198, DOI 10.1016/j.vaccine.2011.11.107; West NP, 2014, CLIN NUTR, V33, P581, DOI 10.1016/j.clnu.2013.10.002; Yeh SH, 2006, BRIT J SPORT MED, V40, P239, DOI 10.1136/bjsm.2005.022095	21	6	6	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2016	138	6					1749	+		10.1016/j.jaci.2016.06.055	http://dx.doi.org/10.1016/j.jaci.2016.06.055			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EF0MK	27554813	Bronze			2022-12-18	WOS:000390019300044
J	Suzuki, S; Ogawa, M; Ohta, S; Arima, K; Nunomura, S; Nanri, Y; Mitamura, Y; Yoshihara, T; Nakamura, Y; Yamauchi, K; Chibana, K; Ishii, Y; Lee, JJ; Aratani, Y; Kakuta, S; Kubo, S; Iwakura, Y; Yoshida, H; Izuhara, K				Suzuki, Shoichi; Ogawa, Masahiro; Ohta, Shoichiro; Arima, Kazuhiko; Nunomura, Satoshi; Nanri, Yasuhiro; Mitamura, Yasutaka; Yoshihara, Tomohito; Nakamura, Yutaka; Yamauchi, Kohei; Chibana, Kazuyuki; Ishii, Yoshiki; Lee, James J.; Aratani, Yasuaki; Kakuta, Shigeru; Kubo, Sachiko; Iwakura, Yoichiro; Yoshida, Hiroki; Izuhara, Kenji			The potential for repositioning antithyroid agents as antiasthma drugs	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							BRONCHIAL-ASTHMA; B-CELLS; MIGRATION		[Suzuki, Shoichi; Ogawa, Masahiro; Arima, Kazuhiko; Nunomura, Satoshi; Nanri, Yasuhiro; Mitamura, Yasutaka; Yoshihara, Tomohito; Izuhara, Kenji] Saga Med Sch, Div Med Biochem, Saga, Japan; [Ohta, Shoichiro] Saga Med Sch, Dept Lab Med, Saga, Japan; [Nakamura, Yutaka; Yamauchi, Kohei] Iwate Med Univ, Sch Med, Dept Internal Med, Div Pulm Med Allergy & Rheumatol, Morioka, Iwate, Japan; [Chibana, Kazuyuki; Ishii, Yoshiki] Dokkyo Med Univ, Sch Med, Dept Pulm Med & Clin Immunol, Mibu, Tochigi, Japan; [Lee, James J.] Mayo Clin Arizona, Div Pulm Med, Scottsdale, AZ USA; [Aratani, Yasuaki] Yokohama City Univ, Grad Sch Nanobiosci, Yokohama, Kanagawa, Japan; [Kakuta, Shigeru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomed Sci, Tokyo, Japan; [Kubo, Sachiko; Iwakura, Yoichiro] Univ Tokyo, Ctr Expt Med & Syst Biol, Inst Med Sci, Tokyo, Japan; [Kubo, Sachiko; Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Noda, Chiba, Japan; [Yoshida, Hiroki] Saga Med Sch, Dept Biomol Sci, Div Immunol, Saga, Japan	Saga University; Saga University; Iwate Medical University; Dokkyo Medical University; Mayo Clinic; Mayo Clinic Phoenix; Yokohama City University; University of Tokyo; University of Tokyo; Tokyo University of Science; Saga University	Izuhara, K (corresponding author), Saga Med Sch, Div Med Biochem, Saga, Japan.	kizuhara@cc.saga-u.ac.jp	Kakuta, Shigeru/L-2241-2018; Nunomura, Satoshi/Q-4249-2017; Mitamura, Yasutaka/X-2529-2019; Nakamura, Yutaka/AAE-1546-2019; Mitamura, Yasutaka/AAT-2110-2021; Iwakura, Yoichiro/E-5457-2011; Arima, Kazuhiko/I-8962-2014	Kakuta, Shigeru/0000-0002-5900-1425; Nunomura, Satoshi/0000-0002-9315-4185; Nakamura, Yutaka/0000-0001-8717-1475; Mitamura, Yasutaka/0000-0001-6389-9285; Iwakura, Yoichiro/0000-0002-9934-5775; Arima, Kazuhiko/0000-0002-0607-8787				Barrett TJ, 2012, CHEM RES TOXICOL, V25, P263, DOI 10.1021/tx200219s; Butt D, 2015, IMMUNITY, V42, P890, DOI 10.1016/j.immuni.2015.04.010; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Grembiale RD, 2001, CHEST, V119, P1598, DOI 10.1378/chest.119.5.1598; Hawkins CL, 2009, FREE RADICAL RES, V43, P1147, DOI 10.3109/10715760903214462; Izuhara K, 2015, ALLERGOL INT, V64, pS3, DOI 10.1016/j.alit.2015.04.012; Li YY, 2012, GENOME MED, V4, DOI 10.1186/gm326; NAKAZAWA T, 1991, J ASTHMA, V28, P109, DOI 10.3109/02770909109082735; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Peters MC, 2014, J ALLERGY CLIN IMMUN, V133, P388, DOI 10.1016/j.jaci.2013.07.036; Phan TG, 2005, J IMMUNOL, V174, P4567, DOI 10.4049/jimmunol.174.8.4567; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; SETTIPANE GA, 1972, J ALLERGY CLIN IMMUN, V49, P348, DOI 10.1016/0091-6749(72)90133-9; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tobinick EL, 2009, DRUG NEWS PERSPECT, V22, P119, DOI 10.1358/dnp.2009.22.2.1303818	16	6	6	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2016	138	5					1458	+		10.1016/j.jaci.2016.04.047	http://dx.doi.org/10.1016/j.jaci.2016.04.047			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EE4AA	27444178	Bronze			2022-12-18	WOS:000389542700032
J	Gernez, Y; Waters, J; Tirouvanziam, R; Herzenberg, L; Moss, R				Gernez, Yael; Waters, Jeffrey; Tirouvanziam, Rabindra; Herzenberg, Leonore; Moss, Richard			Basophil activation test determination of CD63 combined with CD203c is not superior to CD203c alone in identifying allergic bronchopulmonary aspergillosis in cystic fibrosis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CELLS; RESPONSES		[Gernez, Yael] Mt Sinai Sch Med, Dept Allergy & Immunol, New York, NY USA; [Waters, Jeffrey; Herzenberg, Leonore] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Tirouvanziam, Rabindra] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Moss, Richard] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA	Icahn School of Medicine at Mount Sinai; Stanford University; Emory University; Stanford University	Moss, R (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.	rmoss@stanford.edu	Moss, Richard B./S-9218-2019	Moss, Richard B./0000-0003-3611-4221; Tirouvanziam, Rabindra/0000-0003-3526-9985				Buhring HJ, 2004, INT ARCH ALLERGY IMM, V133, P317, DOI 10.1159/000077351; Chirumbolo S, 2016, J ALLERGY CLIN IMMUN, V137, P969, DOI 10.1016/j.jaci.2015.11.014; Cooper PR, 2011, BRIT J PHARMACOL, V163, P521, DOI 10.1111/j.1476-5381.2011.01257.x; Gernez Y, 2016, EUR RESPIR J, V47, P177, DOI 10.1183/13993003.01068-2015; Gernez Y, 2012, J CYST FIBROS, V11, P502, DOI 10.1016/j.jcf.2012.04.008; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; MacGlashan D, 2010, CLIN EXP ALLERGY, V40, P1365, DOI 10.1111/j.1365-2222.2010.03572.x; Mirkovic B, 2016, J ALLERGY CLIN IMMUN, V137, P436, DOI 10.1016/j.jaci.2015.07.045; Tsai LM, 2014, IMMUNOL CELL BIOL, V92, P57, DOI 10.1038/icb.2013.68; Tsai SH, 2015, IMMUNITY, V42, P279, DOI 10.1016/j.immuni.2015.01.015; Yang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088441	12	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2016	138	4					1195	1196		10.1016/j.jaci.2016.04.002	http://dx.doi.org/10.1016/j.jaci.2016.04.002			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DZ0AP	27215492	Bronze			2022-12-18	WOS:000385499400027
J	Golz, L; Vestewig, E; Blankart, M; Kraus, D; Appel, T; Frede, S; Jager, A				Goelz, Lina; Vestewig, Elisa; Blankart, Moritz; Kraus, Dominik; Appel, Thorsten; Frede, Stilla; Jaeger, Andreas			Differences in human gingival and dermal fibroblasts may contribute to oral-induced tolerance against nickel	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DENDRITIC CELLS; CYTOKINES		[Goelz, Lina; Vestewig, Elisa; Blankart, Moritz; Jaeger, Andreas] Univ Hosp Bonn, Dent Clin, Dept Orthodont, Bonn, Germany; [Vestewig, Elisa; Frede, Stilla] Univ Hosp Bonn, Clin Anesthesiol & Intens Care Med, Bonn, Germany; [Kraus, Dominik] Univ Bonn, Dept Prosthodont, Bonn, Germany; [Appel, Thorsten] Univ Bonn, Ctr Dentomaxillofacial Med, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University of Bonn	Golz, L (corresponding author), Univ Hosp Bonn, Dent Clin, Dept Orthodont, Bonn, Germany.	lgoelz@uni-bonn.de	Kraus, Dominik/K-6481-2015	Kraus, Dominik/0000-0002-0273-5065				Allam JP, 2011, ALLERGY, V66, P532, DOI 10.1111/j.1398-9995.2010.02510.x; Allam JP, 2008, J ALLERGY CLIN IMMUN, V121, P368, DOI 10.1016/j.jaci.2007.09.045; Golz L, 2015, CONTACT DERMATITIS, V73, P1, DOI 10.1111/cod.12392; Kucuksezer UC, 2013, J ALLERGY CLIN IMMUN, V131, P875, DOI 10.1016/j.jaci.2012.10.051; Mikulewicz M, 2010, BIOL TRACE ELEM RES, V137, P127, DOI 10.1007/s12011-009-8576-6; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Novak N, 2010, CLIN EXP IMMUNOL, V161, P28, DOI 10.1111/j.1365-2249.2010.04162.x; Rietschel RL, 2008, DERMATITIS, V19, P16, DOI 10.2310/6620.2008.06062; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Simonsen AB, 2014, CONTACT DERMATITIS, V70, P104, DOI 10.1111/cod.12129	10	6	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2016	138	4					1202	1205		10.1016/j.jaci.2016.03.036	http://dx.doi.org/10.1016/j.jaci.2016.03.036			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DZ0AP	27264456	hybrid			2022-12-18	WOS:000385499400030
J	Gazendam, RP; van de Geer, A; van Hamme, JL; Helgers, L; Rohr, J; Chrabieh, M; Picard, C; Roos, D; van den Berg, JM; van den Berg, TK; Kuijpers, TW				Gazendam, Roel P.; van de Geer, Annemarie; van Hamme, John L.; Helgers, Leanne; Rohr, Jan; Chrabieh, Maya; Picard, Capucine; Roos, Dirk; van den Berg, J. Merlijn; van den Berg, T. K.; Kuijpers, Taco W.			Proinflammatory cytokine response toward fungi but not bacteria in chronic granulomatous disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							NF-KAPPA-B; GENE-EXPRESSION; NEUTROPHILS; ACTIVATION		[Gazendam, Roel P.; van de Geer, Annemarie; van Hamme, John L.; Helgers, Leanne; Roos, Dirk; van den Berg, T. K.; Kuijpers, Taco W.] Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands; [Gazendam, Roel P.; van den Berg, J. Merlijn; Kuijpers, Taco W.] Univ Amsterdam, Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Hematol Immunol & Infect Dis, Amsterdam, Netherlands; [Rohr, Jan] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany; [Chrabieh, Maya; Picard, Capucine] IMAGINE Inst, Lab Human Genet Infect Dis, Paris, France; [Picard, Capucine] Necker Childrens Hosp, AP HP, Study Ctr Primary Immunodeficiency, Paris, France; [Picard, Capucine] Necker Childrens Hosp, AP HP, Immunohematol Unit, Paris, France; [Picard, Capucine] Paris Descartes Univ, Sorbonne Cite, Fac Med Necker, Paris, France	University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Freiburg; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Gazendam, RP (corresponding author), Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands.; Gazendam, RP (corresponding author), Univ Amsterdam, Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Hematol Immunol & Infect Dis, Amsterdam, Netherlands.	r.gazendam@sanquin.nl	chrabieh, maya/H-7370-2017; van den Berg, Timo K/AAC-2479-2022	chrabieh, maya/0000-0003-0772-4805; van den Berg, J.Merlijn/0000-0001-9431-5457; van Hamme, John/0000-0003-0765-9441; Helgers, Leanne Carijn/0000-0003-1200-2225				Brown KL, 2008, CLIN IMMUNOL, V129, P90, DOI 10.1016/j.clim.2008.06.005; Bylund J, 2007, EUR J IMMUNOL, V37, P1087, DOI 10.1002/eji.200636651; de LA, 2014, P NATL ACAD SCI USA, V111, P3526; Gazendam RP, 2014, BLOOD, V124, P590, DOI 10.1182/blood-2014-01-551473; Kobayashi SD, 2004, J IMMUNOL, V172, P636, DOI 10.4049/jimmunol.172.1.636; Roos D, 2014, CLIN EXP IMMUNOL, V175, P139, DOI 10.1111/cei.12202; Sadikot RT, 2004, J IMMUNOL, V172, P1801, DOI 10.4049/jimmunol.172.3.1801; Schroder AK, 2005, CYTOKINE, V32, P246, DOI 10.1016/j.cyto.2005.10.004; van Bruggen R, 2010, J INNATE IMMUN, V2, P280, DOI 10.1159/000268288	9	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2016	138	3					928	+		10.1016/j.jaci.2016.03.035	http://dx.doi.org/10.1016/j.jaci.2016.03.035			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DY9ZM	27283382	Bronze			2022-12-18	WOS:000385496000039
J	Lane, JP; Stewart, CJ; Cummings, SP; Gennery, AR				Lane, Jonathan P.; Stewart, Christopher J.; Cummings, Stephen P.; Gennery, Andrew R.			Functional changes in gut microbiota during hematopoietic stem cell transplantation for severe combined immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							VERSUS-HOST-DISEASE; DIVERSITY; MORTALITY		[Lane, Jonathan P.; Gennery, Andrew R.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Stewart, Christopher J.; Cummings, Stephen P.] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Northumbria University	Lane, JP (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.	jonathan.lane2@ncl.ac.uk	Stewart, Christopher/M-4615-2017; Cummings, Stephen P/S-8336-2018	Stewart, Christopher/0000-0002-6033-338X; Cummings, Stephen P/0000-0001-5298-2075; Lane, Jonathan/0000-0002-1572-471X	National Institute for Health Research [ACF-2013-01-007] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Burgio GR, 1991, PEDIAT ESSENZIALE; Choi SW, 2014, LANCET ONCOL, V15, P87, DOI 10.1016/S1470-2045(13)70512-6; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; Holler E, 2014, BIOL BLOOD MARROW TR, V20, P640, DOI 10.1016/j.bbmt.2014.01.030; Hossain MS, 2011, J IMMUNOL, V187, P5130, DOI 10.4049/jimmunol.1101334; JONES JM, 1971, RADIAT RES, V45, P577, DOI 10.2307/3573066; Lane JP, 2015, J ALLERGY CLIN IMMUN, V135, P1654, DOI 10.1016/j.jaci.2015.01.024; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Taur Y, 2014, BLOOD, V124, P1174, DOI 10.1182/blood-2014-02-554725; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Zhu QL, 1997, BLOOD, V90, P2680, DOI 10.1182/blood.V90.7.2680.2680_2680_2689	13	6	6	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2016	138	2					622	625		10.1016/j.jaci.2016.02.019	http://dx.doi.org/10.1016/j.jaci.2016.02.019			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DS5PY	27118218	Bronze, Green Published			2022-12-18	WOS:000380835800045
J	Schulke, S; Vieths, S				Schuelke, Stefan; Vieths, Stefan			Dendritic cell targeting with C-type lectins for improvement of allergen immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Dendritic cells; targeting; mannan; C-type lectins; allergen immunotherapy			[Schuelke, Stefan; Vieths, Stefan] Paul Ehrlich Inst, Vice Presidents Res Grp Mol Allergol 1, Paul Ehrlich Str 51-59, D-63225 Langen, Germany	Paul Ehrlich Institute	Vieths, S (corresponding author), Paul Ehrlich Inst, Vice Presidents Res Grp Mol Allergol 1, Paul Ehrlich Str 51-59, D-63225 Langen, Germany.	Stefan.Vieths@pei.de						Burks AW, 2013, J ALLERGY CLIN IMMUN, V131, P1288, DOI 10.1016/j.jaci.2013.01.049; Casale TB, 2014, J ALLERGY CLIN IMMUN, V133, P612, DOI 10.1016/j.jaci.2014.01.007; Funayama H, 2009, INT IMMUNOPHARMACOL, V9, P1518, DOI 10.1016/j.intimp.2009.09.006; Kastenmuller W, 2014, NAT REV IMMUNOL, V14, P705, DOI 10.1038/nri3727; Justicia JL, 2013, J ALLERGY CLIN IMMUN, V131, P1539, DOI 10.1016/j.jaci.2012.11.049; Murakami D, 2014, AURIS NASUS LARYNX, V41, P350, DOI 10.1016/j.anl.2014.02.010; Norimoto A, 2014, AM J RESP CELL MOL, V51, P201, DOI 10.1165/rcmb.2013-0522OC; Salazar F, 2016, J ALLERGY CLIN IMMUN, V137, P1841, DOI 10.1016/j.jaci.2015.10.033; Sheng KC, 2006, IMMUNOLOGY, V118, P372, DOI 10.1111/j.1365-2567.2006.02384.x; Sirvent S, 2016, J ALLERGY CLIN IMMUN, V138, P558, DOI 10.1016/j.jaci.2016.02.029; Tada H, 2002, MICROBIOL IMMUNOL, V46, P503, DOI 10.1111/j.1348-0421.2002.tb02727.x; Tseveleki V, 2015, EXP NEUROL, V267, P254, DOI 10.1016/j.expneurol.2014.10.019; Weinberger EE, 2013, J CONTROL RELEASE, V165, P101, DOI 10.1016/j.jconrel.2012.11.002; Weiss R, 2013, CURR OPIN ALLERGY CL, V13, P669, DOI 10.1097/ACI.0b013e328364f4df; Zhou YF, 2010, NAT MED, V16, P1128, DOI 10.1038/nm.2201	15	6	6	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2016	138	2					568	570		10.1016/j.jaci.2016.06.006	http://dx.doi.org/10.1016/j.jaci.2016.06.006			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DS5PY	27497282	Bronze			2022-12-18	WOS:000380835800029
J	Beattie, B; Cole, D; Nicholson, L; Leech, S; Taylor, A; Robson, H; Guest, J; Wang, XN; Gennery, AR				Beattie, Benjamin; Cole, David; Nicholson, Lindsay; Leech, Suzy; Taylor, Aileen; Robson, Holly; Guest, Julie; Wang, Xiao Nong; Gennery, Andrew R.			Limited thymic recovery after extracorporeal photopheresis in a low-body-weight patient with acute graft-versus-host disease of the skin	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CELLS		[Beattie, Benjamin; Cole, David; Nicholson, Lindsay; Wang, Xiao Nong] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Leech, Suzy; Taylor, Aileen] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Robson, Holly; Guest, Julie] Great North Childrens Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Gennery, Andrew R.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Gennery, AR (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	andrew.gennery@ncl.ac.uk						Das-Gupta E, 2014, BONE MARROW TRANSPL, V49, P1251, DOI 10.1038/bmt.2014.106; Dertschnig S, 2015, BLOOD, V125, P2720, DOI 10.1182/blood-2014-08-597245; Dignan FL, 2012, BRIT J HAEMATOL, V158, P30, DOI 10.1111/j.1365-2141.2012.09129.x; Greinix HT, 2000, BLOOD, V96, P2426; Hautmann AH, 2013, BONE MARROW TRANSPL, V48, P439, DOI 10.1038/bmt.2012.156; Pai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177; Rao V, 2009, CLIN IMMUNOL, V133, P303, DOI 10.1016/j.clim.2009.08.016; Shitara S, 2013, J IMMUNOL, V190, P6173, DOI 10.4049/jimmunol.1202573; Westin JR, 2011, ADV HEMATOL, V2011	9	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2016	137	6					1890	+		10.1016/j.jaci.2015.10.025	http://dx.doi.org/10.1016/j.jaci.2015.10.025			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DO1GT	26684295				2022-12-18	WOS:000377527200034
J	Strom, MA; Silverberg, JI				Strom, Mark A.; Silverberg, Jonathan I.			Allergic disease is associated with childhood seizures: An analysis of the 1997-2013 National Health Interview Survey	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							EPILEPSY; RISK; AGE		[Strom, Mark A.; Silverberg, Jonathan I.] Northwestern Univ, Dept Dermatol, Feinberg Sch Med, Chicago, IL 60611 USA; [Silverberg, Jonathan I.] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Silverberg, Jonathan I.] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Silverberg, Jonathan I.] Northwestern Med Multidisciplinary Eczema Ctr, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Silverberg, JI (corresponding author), Northwestern Univ, Dept Dermatol, Feinberg Sch Med, Chicago, IL 60611 USA.; Silverberg, JI (corresponding author), Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA.; Silverberg, JI (corresponding author), Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Chicago, IL 60611 USA.; Silverberg, JI (corresponding author), Northwestern Med Multidisciplinary Eczema Ctr, Chicago, IL USA.	JonathanISilverberg@Gmail.com	silverberg, jonathan/ABH-2765-2021	silverberg, jonathan/0000-0003-3686-7805	AHRQ HHS [K12HS023011, K12 HS023011] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS023011] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Chen MH, 2014, EPILEPSIA, V55, P1307, DOI 10.1111/epi.12667; Dupuis N, 2015, CNS NEUROSCI THER, V21, P141, DOI 10.1111/cns.12371; Elliott JO, 2008, EPILEPSY BEHAV, V12, P434, DOI 10.1016/j.yebeh.2007.12.001; Frediani T, 2001, ACTA NEUROL SCAND, V104, P349, DOI 10.1034/j.1600-0404.2001.00347.x; Gaitatzis A, 2004, EPILEPSIA, V45, P1613, DOI 10.1111/j.0013-9580.2004.17504.x; Notarangelo LD, 1995, BAMBINO IMMUNODEPRES; PLEBANI A, 1989, EUR J PEDIATR, V149, P164, DOI 10.1007/BF01958271; Schatorje EJH, 2012, SCAND J IMMUNOL, V75, P436, DOI 10.1111/j.1365-3083.2012.02671.x; SENTHILSELVAN A, 1993, J ASTHMA, V30, P185, DOI 10.3109/02770909309054516; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Silverberg JI, 2015, BRIT J DERMATOL, V173, P1400, DOI 10.1111/bjd.14031; Silverberg JI, 2014, ALLERGY, V69, P95, DOI 10.1111/all.12319; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178	13	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2016	137	3					951	953		10.1016/j.jaci.2015.09.021	http://dx.doi.org/10.1016/j.jaci.2015.09.021			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DG2LB	26542034	Green Accepted			2022-12-18	WOS:000371897500047
J	Bernstein, DI; Mansfield, L; Zangrilli, J; Garin, M				Bernstein, David I.; Mansfield, Lyndon; Zangrilli, James; Garin, Margaret			Efficacy of Reslizumab in Older Patients (>= 65 years) with Asthma and Elevated Blood Eosinophils: Results from a Pooled Analysis of Two Phase 3, Placebo-Controlled Trials	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 04-07, 2016	Los Angeles, CA	Amer Acad Allergy, Asthma & Immunol					[Bernstein, David I.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Mansfield, Lyndon] Western Sky Med Res, El Paso, TX USA; [Zangrilli, James; Garin, Margaret] Teva Pharmaceut, N Wales, PA USA	University of Cincinnati									0	6	7	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2016	137	2		S		284	AB86	AB86		10.1016/j.jaci.2015.12.410	http://dx.doi.org/10.1016/j.jaci.2015.12.410			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	DK6BI		Bronze			2022-12-18	WOS:000375005401221
J	O'Mahony, L; Akdis, CA; Eiwegger, T				O'Mahony, Liam; Akdis, Cezmi A.; Eiwegger, Thomas			Innate mechanisms can predict successful allergy immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Dendritic cells; allergen immunotherapy; biomarker; type 2 dendritic cell; regulatory dendritic cells	DENDRITIC CELLS		[O'Mahony, Liam; Akdis, Cezmi A.] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland; [Eiwegger, Thomas] Univ Toronto, Hosp Sick Children, Dept Paediat, Div Immunol & Allergy,Food Allergy & Anaphylaxis, Toronto, ON M5G 1X8, Canada	Swiss Institute of Allergy & Asthma Research; University of Zurich; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Eiwegger, T (corresponding author), Univ Toronto, Hosp Sick Children, Dept Paediat, Div Immunol & Allergy,Food Allergy & Anaphylaxis, Toronto, ON M5G 1X8, Canada.	thomas.eiwegger@sickkids.ca	O'Mahony, Liam/AAG-5838-2019; Akdis, Cezmi/AAV-4844-2020	O'Mahony, Liam/0000-0003-4705-3583; Akdis, Cezmi/0000-0001-8020-019X; Eiwegger, Thomas/0000-0002-2914-7829				Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; Gepp B, 2016, J ALLERGY CLIN IMMUN, V137, P1600, DOI 10.1016/j.jaci.2015.10.022; Gueguen C, 2016, J ALLERGY CLIN IMMUN, V137, P545, DOI 10.1016/j.jaci.2015.09.015; Jutel M, 2015, J ALLERGY CLIN IMMUN, V136, P556, DOI 10.1016/j.jaci.2015.04.047; Li JT, 2016, J ALLERGY CLIN IMMUN, V137, P369, DOI 10.1016/j.jaci.2015.06.046; Schiavi E, 2015, CURR OPIN GASTROEN, V31, P98, DOI 10.1097/MOG.0000000000000155; Schmid JM, 2016, J ALLERGY CLIN IMMUN, V137, P562, DOI 10.1016/j.jaci.2015.05.023; Schmitt J, 2015, J ALLERGY CLIN IMMUN, V136, P1511, DOI 10.1016/j.jaci.2015.07.038; Subbarayal B, 2015, J ALLERGY CLIN IMMUN, V136, P1680, DOI 10.1016/j.jaci.2015.05.025; Szepfalusi Z, 2014, PEDIAT ALLERG IMM-UK, V25, P788, DOI 10.1111/pai.12310; Tjota MY, 2014, J ALLERGY CLIN IMMUN, V134, P706, DOI 10.1016/j.jaci.2014.06.013; Wollmann E, 2015, J ALLERGY CLIN IMMUN, V136, P806, DOI 10.1016/j.jaci.2015.02.034; Zolkipli Z, 2015, J ALLERGY CLIN IMMUN, V136, P1541, DOI 10.1016/j.jaci.2015.04.045	13	6	6	2	20	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2016	137	2					559	561		10.1016/j.jaci.2015.10.047	http://dx.doi.org/10.1016/j.jaci.2015.10.047			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DC5BN	26853131				2022-12-18	WOS:000369235500025
J	Sampson, HA; Agbotounou, W; Thebault, C; Ruban, C; Martin, L; Sussman, GL; Brown-Whitehorn, TF; Yang, WH; Nadeau, KC; Cheema, AS; Leonard, SA; Sauvage, C; Assa'ad, AH; de Blay, F; Bird, JA; Tilles, SA; Boralevi, F; Bourrier, T; Benhamou, PH; Dupont, C				Sampson, Hugh A.; Agbotounou, Wence; Thebault, Claude; Ruban, Charles; Martin, Laurent; Sussman, Gordon L.; Brown-Whitehorn, Terri F.; Yang, William H.; Nadeau, Kari C.; Cheema, Amarjit Singh; Leonard, Stephanie A.; Sauvage, Christine; Assa'ad, Amal H.; de Blay, Frederic; Bird, J. Andrew; Tilles, Stephen A.; Boralevi, Franck; Bourrier, Thierry; Benhamou, Pierre-Henri; Dupont, Christophe			Enhanced Efficacy and Confirmed Safety of a Two-Year Epicutaneous Immunotherapy (EPIT) Treatment of Peanut Allergy with Viaskin (R) Peanut: The Continuation of the Vipes Phase IIb Randomized Controlled Trial (RCT)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 04-07, 2016	Los Angeles, CA	Amer Acad Allergy, Asthma & Immunol					[Sampson, Hugh A.; Ruban, Charles] DBV Technol, New York, NY USA; [Sampson, Hugh A.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Agbotounou, Wence; Thebault, Claude; Martin, Laurent; Benhamou, Pierre-Henri] DBV Technol, Bagneux, France; [Sussman, Gordon L.] Univ Toronto, Toronto, ON M5S 1A1, Canada; [Brown-Whitehorn, Terri F.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Yang, William H.] Univ Ottawa, Fac Med, Sch Med, Ottawa, ON, Canada; [Nadeau, Kari C.] Stanford Univ, Sch Med, Pediat Allergy Immunol, Stanford, CA USA; [Cheema, Amarjit Singh] Alpha Med Res, Mississauga, ON, Canada; [Leonard, Stephanie A.] Univ Calif San Diego, Rady Childrens Hosp, San Diego, CA USA; [Sauvage, Christine] St Vincent Paul Hosp, Lille, France; [Assa'ad, Amal H.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [de Blay, Frederic] CHRU Strasbourg, Strasbourg, France; [Bird, J. Andrew] UT Southwestern Med Ctr, Dallas, TX USA; [Tilles, Stephen A.] Northwest Asthma & Allergy Ctr, Seattle, WA USA; [Boralevi, Franck] Pellegrin Enfants Hosp, Bordeaux, France; [Bourrier, Thierry] CHU Lenval, Hop Pediat Nice, Nice, France; [Dupont, Christophe] Univ Paris 05, Hop Univ Necker Enfants Malades, Dept Digest Funct Explorat & Food Allergy, Sorbonne Paris Cite, Paris, France	Icahn School of Medicine at Mount Sinai; University of Toronto; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Ottawa; Stanford University; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Cincinnati Children's Hospital Medical Center; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Texas System; University of Texas Southwestern Medical Center Dallas; CHU Bordeaux; CHU Nice; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite									0	6	6	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2016	137	2		S		L59	AB408	AB408		10.1016/j.jaci.2015.12.1264	http://dx.doi.org/10.1016/j.jaci.2015.12.1264			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	DK6BI		Bronze			2022-12-18	WOS:000375005405040
J	Wolfgram, PM; Allen, DB				Wolfgram, Peter M.; Allen, David B.			Factors influencing growth effects of inhaled corticosteroids in children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Growth suppression; asthma; methylphenidate; inhaled corticosteroids; children	BECLOMETHASONE DIPROPIONATE; HEIGHT		[Wolfgram, Peter M.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Allen, David B.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53792 USA	Medical College of Wisconsin; University of Wisconsin System; University of Wisconsin Madison	Allen, DB (corresponding author), Univ Wisconsin, Dept Pediat, Clin Sci Ctr H4 448, 600 Highland Ave, Madison, WI 53792 USA.	dballen@wisc.edu			NIDDK NIH HHS [T32 DK077586] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK077586] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agertoft L, 2003, PEDIATR PULM, V35, P192, DOI 10.1002/ppul.10238; Allen DB, 2015, J PEDIAT, V166, P463; [Anonymous], 2011, Prescrire Int, V20, P238; Biederman J, 2010, J PEDIATR-US, V157, P635, DOI 10.1016/j.jpeds.2010.04.025; Bisgaard H, 2004, PEDIATRICS, V113, P87; Dura-Trave T, 2012, J CHILD NEUROL, V27, P604, DOI 10.1177/0883073811422752; Gradman J, 2010, PEDIAT ALLERG IMM-UK, V21, pE206, DOI 10.1111/j.1399-3038.2009.00875.x; Guilbert TW, 2011, J ALLERGY CLIN IMMUN, V128, P956, DOI 10.1016/j.jaci.2011.06.027; Kelly HW, 2012, NEW ENGL J MED, V367, P904, DOI 10.1056/NEJMoa1203229; Kramer S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010352; Martin RJ, 2002, AM J RESP CRIT CARE, V165, P1377, DOI 10.1164/rccm.2105013; Martinez FD, 2011, LANCET, V377, P650, DOI 10.1016/S0140-6736(10)62145-9; Milgrom H, 1996, J ALLERGY CLIN IMMUN, V98, P1051, DOI 10.1016/S0091-6749(96)80190-4; Weintrob N, 2002, ARCH PEDIAT ADOL MED, V156, P696, DOI 10.1001/archpedi.156.7.696; Wolthers OD, 2002, NEW ENGL J MED, V347, P1210, DOI 10.1056/NEJM200210103471522	15	6	7	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2015	136	6					1711	U463		10.1016/j.jaci.2015.09.039	http://dx.doi.org/10.1016/j.jaci.2015.09.039			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CX9RZ	26654199	Green Accepted, Bronze			2022-12-18	WOS:000366044300048
J	Szilagyi, K; Gazendam, RP; van Hamme, JL; Tool, ATJ; van Houdt, M; Vos, WAJW; Verkuijlen, P; Janssen, H; Belot, A; Juillard, L; Forster-Waldl, E; Boztug, K; Kraal, G; de Winther, MPJ; Kuijpers, TW; van den Berg, TK				Szilagyi, Katka; Gazendam, Roel P.; van Hamme, John L.; Tool, Anton T. J.; van Houdt, Michel; Vos, Wilhelm A. J. W.; Verkuijlen, Paul; Janssen, Hans; Belot, Alexandre; Juillard, Laurent; Foerster-Waldl, Elisabeth; Boztug, Kaan; Kraal, Georg; de Winther, Menno P. J.; Kuijpers, Taco W.; van den Berg, Timo K.			Impaired microbial killing by neutrophils from patients with protein kinase C delta deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							RECEPTORS		[Szilagyi, Katka; Gazendam, Roel P.; van Hamme, John L.; Tool, Anton T. J.; van Houdt, Michel; Vos, Wilhelm A. J. W.; Verkuijlen, Paul; Kuijpers, Taco W.; van den Berg, Timo K.] Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, Dept Blood Cell Res, NL-1105 AZ Amsterdam, Netherlands; [Janssen, Hans] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands; [Belot, Alexandre] Hosp Civils Lyon, Hop Femme Mere Enfant, Lyon, France; [Belot, Alexandre] Univ Lyon, Lyon, France; [Juillard, Laurent] Univ Lyon, CarMen U1060, Lyon, France; [Juillard, Laurent] HE Herriot Hosp Civils Lyon, Serv Neonatol, Lyon, France; [Foerster-Waldl, Elisabeth; Boztug, Kaan] Med Univ Vienna, Dept Paediat & Adolescent Med, Div Neonatol Paediat Intens Care & Neuropaediat, Vienna, Austria; [Boztug, Kaan] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Kraal, Georg] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [de Winther, Menno P. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Expt Vasc Biol, NL-1105 AZ Amsterdam, Netherlands; [Kuijpers, Taco W.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Hematol Immunol & Infect Dis, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute; CHU Lyon; CHU Lyon; Medical University of Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Szilagyi, K (corresponding author), Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, Dept Blood Cell Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	k.szilagyi@sanquin.nl; r.gazendam@sanquin.nl	Vos, Willem/AAD-1265-2019; Carmen, Team3/Y-7384-2019; van den Berg, Timo K/AAC-2479-2022; Belot, Alexandre/C-7378-2013; Boztug, Kaan/AAM-4161-2021	Carmen, Team3/0000-0002-3614-0924; Belot, Alexandre/0000-0003-4902-5332; Boztug, Kaan/0000-0001-8387-9185; Lab, Carmen/0000-0002-5935-3236; van Hamme, John/0000-0003-0765-9441; Forster-Waldl, Elisabeth/0000-0002-8484-9890				Belot A, 2013, ARTHRITIS RHEUM-US, V65, P2161, DOI 10.1002/art.38008; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P638, DOI 10.1016/j.intimp.2013.06.034; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Salzer E, 2013, BLOOD, V121, P3112, DOI 10.1182/blood-2012-10-460741; Sergeant S, 1997, J IMMUNOL, V159, P2877; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; Wu-Zhang AX, 2013, BIOCHEM J, V452, P195, DOI 10.1042/BJ20130220; Zhao XW, 2013, BLOOD, V122, P109, DOI 10.1182/blood-2013-03-494039	9	6	6	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2015	136	5					1404	1407		10.1016/j.jaci.2015.06.016	http://dx.doi.org/10.1016/j.jaci.2015.06.016			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CW1YE	26233929	Bronze			2022-12-18	WOS:000364787200033
J	Coleman, AT; Jackson, DJ; Gangnon, RE; Evans, MD; Lemanske, RF; Gern, JE				Coleman, Amaziah T.; Jackson, Daniel J.; Gangnon, Ronald E.; Evans, Michael D.; Lemanske, Robert F., Jr.; Gern, James E.			Comparison of risk factors for viral and nonviral asthma exacerbations	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHILDREN; RHINOVIRUS; LIFE; IGE		[Coleman, Amaziah T.; Jackson, Daniel J.; Lemanske, Robert F., Jr.; Gern, James E.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Coleman, Amaziah T.; Jackson, Daniel J.; Lemanske, Robert F., Jr.; Gern, James E.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA; [Gangnon, Ronald E.; Evans, Michael D.] Univ Wisconsin, Dept Bioinformat, Sch Med & Publ Hlth, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Coleman, AT (corresponding author), Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA.	acoleman@medicine.wisc.edu		Gangnon, Ronald/0000-0003-2587-6714; Evans, Michael/0000-0001-7449-3993	NCATS NIH HHS [UL1 TR000427, UL1TR000427] Funding Source: Medline; NHLBI NIH HHS [P01 HL70831, P01 HL070831] Funding Source: Medline; NIAID NIH HHS [T32 AI007635] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007635] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Dolan CM, 2004, ANN ALLERG ASTHMA IM, V92, P32, DOI 10.1016/S1081-1206(10)61707-3; Durrani SR, 2012, J ALLERGY CLIN IMMUN, V130, P489, DOI 10.1016/j.jaci.2012.05.023; Holt PG, 2012, CURR OPIN ALLERGY CL, V12, P151, DOI 10.1097/ACI.0b013e3283520166; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Lee WM, 2007, J CLIN MICROBIOL, V45, P2626, DOI 10.1128/JCM.02501-06; Rakes CP, 1999, AM J RESP CRIT CARE, V159, P785, DOI 10.1164/ajrccm.159.3.9801052; Vollmer WM, 1999, AM J RESP CRIT CARE, V160, P1647, DOI 10.1164/ajrccm.160.5.9902098	10	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2015	136	4					1127	1129		10.1016/j.jaci.2015.05.038	http://dx.doi.org/10.1016/j.jaci.2015.05.038			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CT7EJ	26194546	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000362976300044
J	Almqvist, C; Lundholm, C				Almqvist, Catarina; Lundholm, Cecilia			Population-based data on asthma and allergic disease call for advanced epidemiologic methods	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Register-based research; epidemiologic analysis; asthma incidence; medications; patient registers; allergic disease; children	RISK-FACTORS		[Almqvist, Catarina; Lundholm, Cecilia] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Almqvist, Catarina] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Lung & Allergy Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Almqvist, C (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, POB 281, SE-17177 Stockholm, Sweden.	catarina.almqvist@ki.se		Lundholm, Cecilia/0000-0002-6546-3650; Almqvist, Catarina/0000-0002-1045-1898				Almqvist C, 2015, J ALLERGY CLIN IMMUN; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Bjerg A, 2010, ALLERGY, V65, P48, DOI 10.1111/j.1398-9995.2009.02105.x; Henriksen L, 2015, J ALLERGY CLIN IMMUN, V136, P360, DOI 10.1016/j.jaci.2015.02.003; Mereckiene J, 2012, EUROSURVEILL, V17; Moth G, 2007, EUR J CLIN PHARMACOL, V63, P605, DOI 10.1007/s00228-007-0286-4; Ortqvist A, 2011, CLIN INFECT DIS, V52, P1203, DOI 10.1093/cid/cir182; Ortqvist AK, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6979; Ortqvist AK, 2013, PHARMACOEPIDEM DR S, V22, P850, DOI 10.1002/pds.3465; von Mutius E, 2006, ALLERGY, V61, P407, DOI 10.1111/j.1398-9995.2006.01009.x	10	6	6	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2015	136	3					656	657		10.1016/j.jaci.2015.06.005	http://dx.doi.org/10.1016/j.jaci.2015.06.005			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CQ9EA	26194537	Green Published, Bronze			2022-12-18	WOS:000360913300017
J	Lambert, A; Drummond, MB; Wei, C; Irvin, C; Kaminsky, D; McCormack, M; Wise, R				Lambert, Allison; Drummond, M. Bradley; Wei, Christine; Irvin, Charles; Kaminsky, David; McCormack, Meredith; Wise, Robert			Diagnostic accuracy of FEV1/forced vital capacity ratio z scores in asthmatic patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; spirometry; accuracy; z score; airflow obstruction	CLINICAL HISTORY; STRATEGIES; VALIDITY; TESTS	Background: The FEV1/forced vital capacity (FVC) ratio is used as a criterion for airflow obstruction; however, the test characteristics of spirometry in the diagnosis of asthma are not well established. The accuracy of a test depends on the pretest probability of disease. Objective: We wanted to estimate the FEV1/FVC ratio z score threshold with optimal accuracy for the diagnosis of asthma for different pretest probabilities. Methods: Asthmatic patients enrolled in 4 trials from the Asthma Clinical Research Centers were included in this analysis. Measured and predicted FEV1/FVC ratios were obtained, with calculation of z scores for each participant. Across a range of asthma prevalences and z score thresholds, the overall diagnostic accuracy was calculated. Results: One thousand six hundred eight participants were included (mean age, 39 years; 71% female; 61% white). The mean FEV1 percent predicted value was 83% (SD, 15%). In a symptomatic population with 50% pretest probability of asthma, optimal accuracy (68%) is achieved with a z score threshold of -1.0 (16th percentile), corresponding to a 6 percentage point reduction from the predicted ratio. However, in a screening population with a 5% pretest probability of asthma, the optimum z score is -2.0 (second percentile), corresponding to a 12 percentage point reduction from the predicted ratio. These findings were not altered by markers of disease control. Conclusion: Reduction of the FEV1/FVC ratio can support the diagnosis of asthma; however, the ratio is neither sensitive nor specific enough for diagnostic accuracy. When interpreting spirometric results, consideration of the pretest probability is an important consideration in the diagnosis of asthma based on airflow limitation.	[Lambert, Allison; Drummond, M. Bradley; Wei, Christine; McCormack, Meredith; Wise, Robert] Johns Hopkins Univ, Dept Med, Div Pulm & Crit Care, Baltimore, MD USA; [Irvin, Charles; Kaminsky, David] Univ Vermont, Dept Med, Div Pulm & Crit Care, Burlington, VT USA	Johns Hopkins University; University of Vermont	Lambert, A (corresponding author), 1830 East Monument St,5th Floor, Baltimore, MD 21205 USA.	alamber5@jhmi.edu		Kaminsky, David/0000-0002-6515-8023; Wise, Robert/0000-0002-8353-2349; Drummond, Michael/0000-0002-6968-4610; Pham, Hewlett/0000-0003-0330-6104; Koehl, Rachelle/0000-0002-7797-7456	National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) [5U10HL051845, 5U10HL051831, 5U10HL051834, 5U10HL051843, 5U10HL056443, 5U10HL051810, 5U10HL051823]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL051810, U10HL051845, T32HL007534, K23HL103192, U10HL056443, U10HL051843, U10HL051831, U10HL051834, U10HL051823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES024021, P50ES015903] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The Asthma Clinical Research Network is supported by National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) grants 5U10HL051845, 5U10HL051831, 5U10HL051834, 5U10HL051843, 5U10HL056443, 5U10HL051810, and 5U10HL051823.	[Anonymous], 2014, GLOB STRAT ASTHM MAN; Bateman ED, 2007, EUR RESPIR J, V29, P56, DOI 10.1183/09031936.00128505; Bime C, 2012, J ALLERGY CLIN IMMUN, V130, P1078, DOI 10.1016/j.jaci.2012.07.058; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Elmore JG, 1997, JAMA-J AM MED ASSOC, V277, P49, DOI 10.1001/jama.277.1.49; HALL GH, 1967, LANCET, V2, P555; Hanania NA, 2009, NEW ENGL J MED, V360, P1487, DOI 10.1056/NEJMoa0806290; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hunter CJ, 2002, CHEST, V121, P1051, DOI 10.1378/chest.121.4.1051; Irvin CG, 2007, AM J RESP CRIT CARE, V175, P235, DOI 10.1164/rccm.200603-416OC; Morris A, 1984, CLIN PULMONARY FUNCT; National Heart Lung and Blood Institute. National Asthma Education and Prevention Program, 2007, 3 NAT HEART LUNG BLO; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Peters SP, 2007, NEW ENGL J MED, V356, P2027; Raab SS, 2000, AM J CLIN PATHOL, V114, P78, DOI 10.1309/4099-QALD-NVGF-TM4G; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Wise RA, 2009, J ALLERGY CLIN IMMUN, V124, P436, DOI 10.1016/j.jaci.2009.05.041	17	6	8	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2015	136	3					649	+		10.1016/j.jaci.2015.02.027	http://dx.doi.org/10.1016/j.jaci.2015.02.027			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CQ9EA	25863976	Green Accepted, Bronze			2022-12-18	WOS:000360913300015
J	Savic, S; Parry, D; Carter, C; Johnson, C; Logan, C; Gutierrez, BM; Thomas, JE; Bacon, CM; Cant, A; Hambleton, S				Savic, Sinisa; Parry, David; Carter, Clive; Johnson, Colin; Logan, Clare; Gutierrez, Beatriz Morillo; Thomas, Julian E.; Bacon, Chris M.; Cant, Andrew; Hambleton, Sophie			A new case of Fas-associated death domain protein deficiency and update on treatment outcomes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DISCOVERY		[Savic, Sinisa; Carter, Clive] St James Univ Hosp, Dept Clin Immunol & Allergy, Leeds, W Yorkshire, England; [Savic, Sinisa] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds LS2 9JT, W Yorkshire, England; [Parry, David; Johnson, Colin; Logan, Clare] Univ Leeds, Genet Sect, Leeds Inst Biomed & Clin Sci, Leeds LS2 9JT, W Yorkshire, England; [Parry, David; Johnson, Colin; Logan, Clare] St James Univ Hosp, Leeds, W Yorkshire, England; [Gutierrez, Beatriz Morillo; Thomas, Julian E.; Cant, Andrew; Hambleton, Sophie] Royal Victoria Infirm, Great North Childrens Hosp, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Bacon, Chris M.] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Cant, Andrew; Hambleton, Sophie] Newcastle Univ, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Saint James's University Hospital; University of Leeds; University of Leeds; Saint James's University Hospital; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Savic, S (corresponding author), St James Univ Hosp, Dept Clin Immunol & Allergy, Leeds, W Yorkshire, England.	s.savic@leeds.ac.uk; sophie.hambleton@newcastle.ac.uk	Savic, Sinisa/Q-6217-2019	Savic, Sinisa/0000-0001-7910-0554; Johnson, Colin/0000-0002-2979-8234; Hambleton, Sophie/0000-0001-7954-3267; Bacon, Chris/0000-0002-8268-2812; Parry, David/0000-0003-0376-7736; Morillo Gutierrez, Beatriz/0000-0001-5160-3627	The Sir Jules Thorn Charitable Trust [09JTA, 12JTA] Funding Source: researchfish	The Sir Jules Thorn Charitable Trust		Bolze A, 2010, AM J HUM GENET, V87, P873, DOI 10.1016/j.ajhg.2010.10.028; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Selby DM, 1999, HUM PATHOL, V30, P734, DOI 10.1016/S0046-8177(99)90132-6	5	6	6	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2015	136	2					502	+		10.1016/j.jaci.2015.02.002	http://dx.doi.org/10.1016/j.jaci.2015.02.002			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CO2RS	25794656	Green Published			2022-12-18	WOS:000359004900040
J	Calogiuri, G; Nettis, E; DiLeo, E; Foti, C; Vacca, A				Calogiuri, Gianfranco; Nettis, Eustachio; DiLeo, Elisabetta; Foti, Caterina; Vacca, Angelo			Is the localized seminal plasma hypersensitivity the mucosal aspect of protein contact dermatitis?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							URTICARIA		[Calogiuri, Gianfranco] Civil Hosp Ninetto Melli San Pietro Vernotico, Dept Pneumol, Brindisi, Italy; [Calogiuri, Gianfranco; Nettis, Eustachio; DiLeo, Elisabetta] Univ Bari, Dept Internal Med, Sect Allergy & Clin Immunol, Bari, Italy; [Foti, Caterina] Univ Bari, Dermatol Clin, Dept Biomed Sci & Human Oncol, Bari, Italy; [Vacca, Angelo] Univ Bari, Sch Med, Dept Internal Med Sci, Bari, Italy; [Vacca, Angelo] Univ Bari, Sch Med, Dept Clin Oncol Sci, Bari, Italy; [Vacca, Angelo] Univ Bari, Sch Med, Dept Basic Med Sci, Bari, Italy; [Vacca, Angelo] Univ Bari, Sch Med, Dept Neurosci & Sensory Organs, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Calogiuri, G (corresponding author), Civil Hosp Ninetto Melli San Pietro Vernotico, Dept Pneumol, Brindisi, Italy.	gf.calogiuri@libero.it	Vacca, Angelo/AAC-9558-2022; Nettis, Eustachio/P-8554-2016	Vacca, Angelo/0000-0002-4567-8216; Nettis, Eustachio/0000-0003-1383-105X; Foti, Caterina/0000-0001-6196-9788				Amaro C, 2008, CONTACT DERMATITIS, V58, P67, DOI 10.1111/j.1600-0536.2007.01267.x; Ghosh D, 2014, J ALLERGY CLIN IMMUN, V134, P969, DOI 10.1016/j.jaci.2014.05.016; Guillet G, 2004, CONTACT DERMATITIS, V50, P318, DOI 10.1111/j.0105-1873.2004.00341f.x; Kanerva L, 1997, Am J Contact Dermat, V8, P167, DOI 10.1016/S1046-199X(97)90099-3; Levin C, 2008, DERMATITIS, V19, P241, DOI 10.2310/6620.2008.08006; POSKITT BL, 1995, J ROY SOC MED, V88, pP108; Shah A, 2004, CLIN EXP ALLERGY, V34, P827, DOI 10.1111/j.1365-2222.2004.01962.x	7	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2015	135	4					1090	1091		10.1016/j.jaci.2014.11.041	http://dx.doi.org/10.1016/j.jaci.2014.11.041			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CF0MQ	25725992				2022-12-18	WOS:000352238600044
J	Pavord, ID; Hilvering, B				Pavord, Ian D.; Hilvering, Bart			Biomarkers and inhaled corticosteroid responsiveness in asthmatic patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Biomarker; exhaled nitric oxide; corticosteroid responsiveness; urinary bromotyrosine; sputum eosinophil count	EXHALED NITRIC-OXIDE; TRIAL		[Pavord, Ian D.; Hilvering, Bart] Nuffield Dept Medicine, Resp Med Unit, Oxford, England		Pavord, ID (corresponding author), Univ Oxford, Nuffield Dept Med, Resp Med Unit, NDM Res Bldg,Old Rd Campus, Oxford OX3 7FZ, England.	ian.pavord@ndm.ox.ac.uk	Hilvering, Bart/ABA-9709-2021	Hilvering, Bart/0000-0002-7223-0281; Pavord, Ian/0000-0002-4288-5973				[Anonymous], MEAS FRACT EXH NITR; [Anonymous], 2014, THORAX S1, V69, P1; BARROS MJ, 1991, CLIN SCI, V81, P539, DOI 10.1042/cs0810539; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Cowan DC, 2015, J ALLERGY CLIN IMMUN, V135, P877, DOI 10.1016/j.jaci.2014.10.026; Cowan DC, 2010, THORAX, V65, P384, DOI 10.1136/thx.2009.126722; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Honkoop PJ, 2015, J ALLERGY CLIN IMMUN, V135, P682, DOI 10.1016/j.jaci.2014.07.016; Malinovschi A, 2013, J ALLERGY CLIN IMMUN, V132, P821, DOI 10.1016/j.jaci.2013.06.007; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Smith AD, 2005, AM J RESP CRIT CARE, V172, P453, DOI 10.1164/rccm.200411-1498OC	12	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2015	135	4					884	885		10.1016/j.jaci.2015.01.031	http://dx.doi.org/10.1016/j.jaci.2015.01.031			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CF0MQ	25843601				2022-12-18	WOS:000352238600006
J	Ramirez-Carrozzi, V; Dressen, A; Lupardus, P; Yaspan, B; Pappu, R				Ramirez-Carrozzi, Vladimir; Dressen, Amy; Lupardus, Patrick; Yaspan, Brian; Pappu, Rajita			Functional analysis of protective IL1RL1 variants associated with asthma risk	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							GENETIC-VARIATION; LEBRIKIZUMAB; CELLS		[Ramirez-Carrozzi, Vladimir; Pappu, Rajita] Genentech Inc, Dept Immunol Discovery, San Francisco, CA 94080 USA; [Dressen, Amy; Yaspan, Brian] Genentech Inc, Dept Human Genet, San Francisco, CA USA; [Lupardus, Patrick] Genentech Inc, Dept Biol Struct, San Francisco, CA USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ramirez-Carrozzi, V (corresponding author), Genentech Inc, Dept Immunol Discovery, San Francisco, CA 94080 USA.	rajitap@gene.com		Yaspan, Brian/0000-0002-3787-2510				Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Grotenboer NS, 2013, J ALLERGY CLIN IMMUN, V131, P856, DOI 10.1016/j.jaci.2012.11.028; Hanania NA, 2013, AM J RESP CRIT CARE, V187, P804, DOI 10.1164/rccm.201208-1414OC; Heger K, 2014, EUR J IMMUNOL, V44, P296, DOI 10.1002/eji.201343731; Ho JE, 2013, J CLIN INVEST, V123, P4208, DOI 10.1172/JCI67119; Jia GQ, 2012, J ALLERGY CLIN IMMUN, V130, P647, DOI 10.1016/j.jaci.2012.06.025; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nakae S, 2013, ALLERGOL INT, V62, P13, DOI 10.2332/allergolint.13-RAI-0538; Noonan M, 2013, J ALLERGY CLIN IMMUN, V132, P567, DOI 10.1016/j.jaci.2013.03.051; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; Scholten J, 2008, TRANSGENIC RES, V17, P307, DOI 10.1007/s11248-007-9153-4; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744	13	6	8	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2015	135	4					1080	1083		10.1016/j.jaci.2014.10.028	http://dx.doi.org/10.1016/j.jaci.2014.10.028			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CF0MQ	25483601				2022-12-18	WOS:000352238600037
J	Buntarickpornpan, P; Veskitkul, J; Pacharn, P; Visitsunthorn, N; Vichyanond, P; Tantilipikorn, P; Jirapongsananuruk, O				Buntarickpornpan, Pichittra; Veskitkul, Jittima; Pacharn, Punchama; Visitsunthorn, Nualanong; Vichyanond, Pakit; Tantilipikorn, Pongsakorn; Jirapongsananuruk, Orathai			The Prevalence and Clinical Characteristics of Local Allergic Rhinitis in Thai Children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 20-24, 2015	Houston, TX	Amer Acad Allergy, Asthma & Immunol					[Buntarickpornpan, Pichittra; Veskitkul, Jittima; Pacharn, Punchama; Visitsunthorn, Nualanong; Vichyanond, Pakit; Jirapongsananuruk, Orathai] Mahidol Univ, Siriraj Hosp, Fac Med, Div Allergy & Immunol,Dept Pediat, Bangkok 10700, Thailand; [Tantilipikorn, Pongsakorn] Mahidol Univ, Siriraj Hosp, Fac Med, Div Rhinol & Allergy,Dept Otolaryngol, Bangkok 10700, Thailand	Mahidol University; Mahidol University			Tantilipikorn, Pongsakorn/D-2797-2019	Tantilipikorn, Pongsakorn/0000-0003-1995-4798					0	6	6	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2015	135	2		S		914	AB282	AB282		10.1016/j.jaci.2014.12.1859	http://dx.doi.org/10.1016/j.jaci.2014.12.1859			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	CR2BN					2022-12-18	WOS:000361129600913
J	Li, XM; Song, Y; Su, Y; Heiland, T; Sampson, HA				Li, Xiu-Min; Song, Ying; Su, Yan; Heiland, Teri; Sampson, Hugh A.			Immunization with ARA h1,2,3-Lamp-Vax Peanut Vaccine Blocked IgE Mediated-Anaphylaxis in a Peanut Allergic Murine Model	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 20-24, 2015	Houston, TX	Amer Acad Allergy, Asthma & Immunol					[Li, Xiu-Min; Song, Ying; Sampson, Hugh A.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Su, Yan; Heiland, Teri] Immunom Therapeut Inc, Rockville, MD USA	Icahn School of Medicine at Mount Sinai			li, xiu/GXV-1745-2022						0	6	8	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2015	135	2		S		542	AB167	AB167		10.1016/j.jaci.2014.12.1482	http://dx.doi.org/10.1016/j.jaci.2014.12.1482			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	CR2BN					2022-12-18	WOS:000361129600541
J	Shaheen, SO				Shaheen, Seif O.			Acetaminophen and childhood asthma: Pill-popping at our peril?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; acetaminophen; ibuprofen; prenatal exposure; birth cohort; randomized trial	CHILDREN; COHORT; FEVER		[Shaheen, Seif O.] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Primary Care & Publ Hlth, London, England	University of London; Queen Mary University London	Shaheen, SO (corresponding author), Barts & London Queen Marys Sch Med & Dent, Blizard Inst, Ctr Primary Care & Publ Hlth, 58 Turner St, London E1 2AB, England.	s.shaheen@qmul.ac.uk						Brandlistuen RE, 2013, INT J EPIDEMIOL, V42, P1702, DOI 10.1093/ije/dyt183; Henderson AJ, 2013, PAEDIATR RESPIR REV, V14, P9, DOI 10.1016/j.prrv.2012.04.004; KRAMER MS, 1991, LANCET, V337, P591, DOI 10.1016/0140-6736(91)91648-E; Kreiner-Moller E, 2012, J ALLERGY CLIN IMMUN, V130, P1434, DOI 10.1016/j.jaci.2012.09.017; Lesko SM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e20; Liew Z, 2014, JAMA PEDIATR, V168, P313, DOI 10.1001/jamapediatrics.2013.4914; Prymula R, 2009, LANCET, V374, P1339, DOI 10.1016/S0140-6736(09)61208-3; SCHMITT BD, 1980, AM J DIS CHILD, V134, P176, DOI 10.1001/archpedi.1980.02130140050015; Shaheen SO, 2010, J ALLERGY CLIN IMMUN, V126, P1141, DOI 10.1016/j.jaci.2010.08.047; Shaheen SO, 2000, THORAX, V55, P266, DOI 10.1136/thorax.55.4.266; Sordillo JE, 2015, J ALLERGY CLIN IMMUN, V135, P441, DOI 10.1016/j.jaci.2014.07.065; Vernacchio L, 2009, PEDIATRICS, V124, P446, DOI 10.1542/peds.2008-2869	12	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2015	135	2					449	450		10.1016/j.jaci.2014.10.030	http://dx.doi.org/10.1016/j.jaci.2014.10.030			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CB1FL	25483600	Bronze			2022-12-18	WOS:000349372300016
J	Chiarella, SE; Budinger, GRS; Mutlu, GM				Chiarella, Sergio E.; Budinger, G. R. Scott; Mutlu, Goekhan M.			beta(2)-Agonist therapy may contribute to the air pollution and IL-6-associated risk of developing severe asthma with dual-positive T(H)2/T(H)17 cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							COAGULATION; EXPOSURE		[Chiarella, Sergio E.] Northwestern Univ, Div Allergy Immunol, Chicago, IL 60611 USA; [Budinger, G. R. Scott] Northwestern Univ, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Mutlu, Goekhan M.] Northwestern Univ, Sect Pulm & Crit Care Med, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University	Chiarella, SE (corresponding author), Northwestern Univ, Div Allergy Immunol, Chicago, IL 60611 USA.	gmutlu@uchicago.edu		Chiarella, Sergio/0000-0002-0445-4929	NIEHS NIH HHS [R01 ES015024, R01 ES013995] Funding Source: Medline; BLRD VA [I01 BX000201] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015024, R01ES013995] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000201] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); BLRD VA; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)		Budinger GRS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018525; Chiarella SE, 2014, J CLIN INVEST, V124, P2935, DOI 10.1172/JCI75157; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Downs SH, 2007, NEW ENGL J MED, V357, P2338, DOI 10.1056/NEJMoa073625; Gong H, 2008, INHAL TOXICOL, V20, P533, DOI 10.1080/08958370801911340 ; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; McCreanor J, 2007, NEW ENGL J MED, V357, P2348, DOI 10.1056/NEJMoa071535; Mutlu GM, 2007, J CLIN INVEST, V117, P2952, DOI 10.1172/JCI30639; Ruckerl R, 2006, AM J RESP CRIT CARE, V173, P432, DOI 10.1164/rccm.200507-1123OC; Tabarani CM, 2013, PEDIATR INFECT DIS J, V32, pE437, DOI 10.1097/INF.0b013e3182a14407; Thompson AMS, 2010, ENVIRON HEALTH PERSP, V118, P120, DOI 10.1289/ehp.0900550; Wang YH, 2010, J EXP MED, V207, P2479, DOI 10.1084/jem.20101376	12	6	6	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2015	135	1					290	291		10.1016/j.jaci.2014.09.037	http://dx.doi.org/10.1016/j.jaci.2014.09.037			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AY0PG	25445822	Green Accepted			2022-12-18	WOS:000347298200046
J	Pino-Yanes, MI; Corrales, A; Acosta-Herrera, M; Perez-Rodriguez, E; Cumplido, J; Campo, P; Barreto-Luis, A; Sanchez-Garcia, F; Felipe, T; Sanchez-Machin, I; Quintela, I; Garcia-Robaina, JC; Villar, J; Blanca, M; Carracedo, A; Carrillo, T; Flores, C				Pino-Yanes, Mar Ia; Corrales, Almudena; Acosta-Herrera, Marialbert; Perez-Rodriguez, Eva; Cumplido, Jose; Campo, Paloma; Barreto-Luis, Amalia; Sanchez-Garcia, Florentino; Felipe, Tobias; Sanchez-Machin, Inmaculada; Quintela, Ines; Garcia-Robaina, Jose Carlos; Villar, Jesus; Blanca, Miguel; Carracedo, Angel; Carrillo, Teresa; Flores, Carlos			HLA-DRB1*15:01 allele protects from asthma susceptibility	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							GENOME-WIDE ASSOCIATION; AUTOIMMUNE-DISEASES; POPULATION; LOCI		[Pino-Yanes, Mar Ia; Corrales, Almudena; Acosta-Herrera, Marialbert; Barreto-Luis, Amalia; Villar, Jesus; Flores, Carlos] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Pino-Yanes, Mar Ia; Corrales, Almudena; Acosta-Herrera, Marialbert; Barreto-Luis, Amalia; Flores, Carlos] Hosp Univ NS de Candelaria, Res Unit, Tenerife, Spain; [Pino-Yanes, Mar Ia] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Acosta-Herrera, Marialbert; Villar, Jesus] Hosp Univ Dr Negrin, MODERN, Res Unit, Gran Canaria, Spain; [Perez-Rodriguez, Eva; Garcia-Robaina, Jose Carlos] Hosp Univ NS de Candelaria, Allergy Unit, Madrid, Spain; [Cumplido, Jose; Sanchez-Machin, Inmaculada; Carrillo, Teresa] Hosp Univ Dr Negrin, Allergy Unit, Gran Canaria, Spain; [Campo, Paloma; Blanca, Miguel] Carlos Haya Hosp, Allergy Serv, Malaga, Spain; [Sanchez-Garcia, Florentino] Hosp Gran Canaria Dr Negrin, Immunol Unit, Gran Canaria, Spain; [Felipe, Tobias] Northwest Res Associates, Boulder, CO USA; [Sanchez-Machin, Inmaculada] Complejo Hosp Univ NS Candelaria, Hosp Torax, Allergy Unit, Tenerife, Spain; [Quintela, Ines] Univ Santiago de Compostela, CEGEN, ISCIII, Grp Med Xenom, Santiago De Compostela, Spain; [Carracedo, Angel] Univ Santiago de Compostela, CIBERER, Fdn Galega Med Xenom, SERGAS,Grp Med Xenom, Santiago De Compostela, Spain; [Carracedo, Angel] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21413, Saudi Arabia; [Flores, Carlos] Univ La Laguna, Inst Univ Enfermedades Trop & Salud Publ Canarias, Genet Lab, Appl Genom Grp G2A, Tenerife, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of California System; University of California San Francisco; Hospital Carlos Haya; NorthWest Research Associates; Instituto de Salud Carlos III; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; King Abdulaziz University; Universidad de la Laguna	Flores, C (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain.	cflores@ull.edu.es	Felipe, Tobías/AAA-8076-2020; Corrales, Almudena/G-5391-2017; Villar, Jesús/R-4526-2019; Carracedo, Angel/D-4257-2012; Pino-Yanes, Maria/C-8498-2017; Flores, Carlos/R-1159-2019; Machín, María Inmaculada Sánchez/ABF-6003-2020	Felipe, Tobías/0000-0003-1732-6632; Corrales, Almudena/0000-0002-2207-5463; Villar, Jesús/0000-0001-5687-3562; Carracedo, Angel/0000-0003-1085-8986; Pino-Yanes, Maria/0000-0003-0332-437X; Flores, Carlos/0000-0001-5352-069X; Perez Rodriguez, Eva Maria/0000-0003-3562-5687; Sanchez-Machin, Inmaculada/0000-0003-0109-8735; Quintela, Ines/0000-0002-0239-7975; Sanchez-Garcia, Florentino/0000-0003-0304-6023				Dilthey A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002877; Gregersen PK, 2006, NAT REV GENET, V7, P917, DOI 10.1038/nrg1944; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Li XN, 2012, J ALLERGY CLIN IMMUN, V130, P861, DOI 10.1016/j.jaci.2012.04.041; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Noguchi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002170; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Pino-Yanes M, 2012, J ALLERGY CLIN IMMUN, V129, P573, DOI 10.1016/j.jaci.2011.10.001	11	6	6	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2014	134	5					1201	1203		10.1016/j.jaci.2014.05.031	http://dx.doi.org/10.1016/j.jaci.2014.05.031			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AT4UN	25034406				2022-12-18	WOS:000344938900031
J	Goldblum, RM; Ning, B; Endsley, MA; Estes, DM; Judy, BM; van Bavel, J; Midoro-Horiuti, T				Goldblum, Randall M.; Ning, Bo; Endsley, Mark A.; Estes, D. Mark; Judy, Barbara M.; van Bavel, Julius; Midoro-Horiuti, Terumi			IgE antibodies to mountain cedar pollen predominantly recognize multiple conformational epitopes on Jun a 1	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALLERGEN-SPECIFIC IMMUNOTHERAPY; JUNIPERUS-ASHEI; IN-VIVO; JUN-A-1; FAMILIES		[Goldblum, Randall M.; Ning, Bo; Endsley, Mark A.; Estes, D. Mark; Judy, Barbara M.; Midoro-Horiuti, Terumi] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [van Bavel, Julius] Allergy & Asthma Associates, Austin, TX USA	University of Texas System; University of Texas Medical Branch Galveston	Goldblum, RM (corresponding author), Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.	tmidoro@utmb.edu	Midoro-Horiuti, Terumi M/AIE-7522-2022	Midoro-Horiuti, Terumi/0000-0002-0527-3644	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI055792, R41AI093032, R01AI052428] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI052428, R01AI052428, R41 AI093032, K08AI055792, K08 AI055792] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alvarez-Cuesta E, 2006, ALLERGY, V61, P1, DOI 10.1111/j.1398-9995.2006.01219_1.x; Czerwinski EW, 2005, J BIOL CHEM, V280, P3740, DOI 10.1074/jbc.M409655200; Fluhr JW, 2006, EXP DERMATOL, V15, P483, DOI 10.1111/j.1600-0625.2006.00437.x; Ivanciuc O, 2009, MOL IMMUNOL, V46, P873, DOI 10.1016/j.molimm.2008.09.004; Ivanciuc O, 2009, MOL IMMUNOL, V46, P559, DOI 10.1016/j.molimm.2008.07.034; Liu Z, 2010, INT ARCH ALLERGY IMM, V153, P347, DOI 10.1159/000316345; Midoro-Horiuti T, 1999, J ALLERGY CLIN IMMUN, V104, P608, DOI 10.1016/S0091-6749(99)70331-3; Midoro-Horiuti T, 2003, MOL IMMUNOL, V40, P555, DOI 10.1016/S0161-5890(03)00168-8; PINNAGODA J, 1990, CONTACT DERMATITIS, V22, P164, DOI 10.1111/j.1600-0536.1990.tb01553.x; Radauer C, 2006, J ALLERGY CLIN IMMUN, V117, P141, DOI 10.1016/j.jaci.2005.09.010; Scholl I, 2005, J IMMUNOL, V175, P6645, DOI 10.4049/jimmunol.175.10.6645; Senti G, 2012, J ALLERGY CLIN IMMUN, V129, P128, DOI 10.1016/j.jaci.2011.08.036; Senti G, 2009, J ALLERGY CLIN IMMUN, V124, P997, DOI 10.1016/j.jaci.2009.07.019; Turjanmaa K, 2006, ALLERGY, V61, P1377, DOI 10.1111/j.1398-9995.2006.01136.x; Varshney S, 2007, MOL IMMUNOL, V44, P2781, DOI 10.1016/j.molimm.2005.12.001; Wiegand TW, 1996, J IMMUNOL, V157, P221	16	6	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2014	134	4					967	969		10.1016/j.jaci.2014.05.009	http://dx.doi.org/10.1016/j.jaci.2014.05.009			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AQ9GC	24975797	Green Accepted			2022-12-18	WOS:000343155700030
J	Bokanovic, D; Schwarz, I; Wutte, N; Komericki, P; Aberer, W; Sturm, GJ				Bokanovic, Danijela; Schwarz, Ines; Wutte, Nora; Komericki, Peter; Aberer, Werner; Sturm, Gunter J.			Specificity of conventional and Ves v 5-spiked venom decreases with increasing total IgE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							API M 1; WASP VENOM; ALLERGY; ASTHMA; DIAGNOSIS; EXACERBATIONS; BEE		[Bokanovic, Danijela; Schwarz, Ines; Wutte, Nora; Komericki, Peter; Aberer, Werner; Sturm, Gunter J.] Med Univ Graz, Dept Dermatol & Venereol, Graz, Austria	Medical University of Graz	Bokanovic, D (corresponding author), Med Univ Graz, Dept Dermatol & Venereol, Graz, Austria.	gunter.sturm@medunigraz.at						Bird HR, 2006, J AM ACAD CHILD PSY, V45, P1032, DOI 10.1097/01.chi.0000227879.65651.cf; BLUMENTHAL MN, 1995, CLIN EXP ALLERGY, V25, P29, DOI 10.1111/j.1365-2222.1995.tb00416.x; Bonifazi F, 2005, ALLERGY, V60, P1459, DOI 10.1111/j.1398-9995.2005.00960.x; Brehm JM, 2012, AM J RESP CRIT CARE, V186, P140, DOI 10.1164/rccm.201203-0431OC; Ebo DG, 2013, CLIN EXP ALLERGY, V43, P255, DOI 10.1111/cea.12057; Fuhlbrigge A, 2012, J ALLERGY CLIN IMMUN, V129, pS34, DOI 10.1016/j.jaci.2011.12.983; Hofmann SC, 2011, J ALLERGY CLIN IMMUN, V127, P265, DOI 10.1016/j.jaci.2010.06.042; *INT STUD ASTHM AL, 1998, PHAS 2 MOD INT STUD; LEIMGRUBER A, 1993, ALLERGY, V48, P415, DOI 10.1111/j.1398-9995.1993.tb00739.x; Muller UR, 2009, ALLERGY, V64, P543, DOI 10.1111/j.1398-9995.2008.01794.x; Pawankar R, 2012, WORLD ALLERGY ORGAN, V5, pS212; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Sturm GJ, 2004, ALLERGY, V59, P1110, DOI 10.1111/j.1398-9995.2004.00400.x; Sturm GJ, 2014, J ALLERGY C IN PRESS; Sturm GJ, 2012, J ALLERGY CLIN IMMUN, V130, P817, DOI 10.1016/j.jaci.2012.05.047; Sturm GJ, 2011, J ALLERGY CLIN IMMUN, V128, P247, DOI 10.1016/j.jaci.2011.02.021; Sturm GJ, 2009, INT ARCH ALLERGY IMM, V148, P261, DOI 10.1159/000161586; Vos B, 2013, J ALLERGY CLIN IMMUN, V131, P1225, DOI 10.1016/j.jaci.2012.07.041	18	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2014	134	3					739	741		10.1016/j.jaci.2014.03.038	http://dx.doi.org/10.1016/j.jaci.2014.03.038			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AO5GR	24835504				2022-12-18	WOS:000341372400033
J	Luccioli, S; Kwegyir-Afful, EK				Luccioli, Stefano; Kwegyir-Afful, Ernest K.			Benefits of understanding allergen thresholds	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Food allergen; threshold; risk; challenge; dose	FOOD CHALLENGES; PEANUT; CHILDREN; MANAGEMENT		[Luccioli, Stefano; Kwegyir-Afful, Ernest K.] Food & Drug Adm, Ctr Food Safety & Appl Nutr, Off Food Addit Safety, College Pk, MD 20740 USA	US Food & Drug Administration (FDA)	Luccioli, S (corresponding author), Food & Drug Adm, Ctr Food Safety & Appl Nutr, 5100 Paint Branch Pkwy,HFS 200, College Pk, MD 20740 USA.	stefano.luccioli@fda.hhs.gov						Allen KJ, 2014, J ALLERGY CLIN IMMUN, V133, P156, DOI 10.1016/j.jaci.2013.06.042; [Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Blumchen K, 2014, J ALLERGY CLIN IMMUN, V134, P390, DOI 10.1016/j.jaci.2014.03.035; Crevel RWR, 2014, FOOD CHEM TOXICOL, V67, P277, DOI 10.1016/j.fct.2014.01.033; Crevel RWR, 2014, FOOD CHEM TOXICOL, V67, P262, DOI 10.1016/j.fct.2014.01.032; Dorland, 2011, DORLANDS ILLUSTRATED; Hattersley S, 2014, FOOD CHEM TOXICOL, V67, P255, DOI 10.1016/j.fct.2014.01.036; Hourihane Jonathan O'B, 2005, Toxicol Appl Pharmacol, V207, P152, DOI 10.1016/j.taap.2005.01.028; Leung DYM, 2003, NEW ENGL J MED, V348, P986, DOI 10.1056/NEJMoa022613; Luccioli S, 2012, CURR OPIN ALLERGY CL, V12, P323, DOI 10.1097/ACI.0b013e3283535aaf; Rolinck-Werninghaus C, 2012, ALLERGY, V67, P951, DOI 10.1111/j.1398-9995.2012.02838.x; Taylor SL, 2010, FOOD CHEM TOXICOL, V48, P814, DOI 10.1016/j.fct.2009.12.013; van der Zee T, 2011, J ALLERGY CLIN IMMUN, V128, P1031, DOI 10.1016/j.jaci.2011.07.050; Vander Leek TK, 2000, J PEDIATR-US, V137, P749, DOI 10.1067/mpd.2000.109376; Varshney P, 2009, J ALLERGY CLIN IMMUN, V124, P1351, DOI 10.1016/j.jaci.2009.09.042; Wensing M, 2002, J ALLERGY CLIN IMMUN, V110, P915, DOI 10.1067/mai.2002.129235	16	6	6	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2014	134	2					399	400		10.1016/j.jaci.2014.05.007	http://dx.doi.org/10.1016/j.jaci.2014.05.007			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AO5GB	24954274	Bronze			2022-12-18	WOS:000341370800020
J	Chirumbolo, S; Olivieri, M				Chirumbolo, Salvatore; Olivieri, Mario			Increase in human basophils IgE-mediated stimulation by omalizumab: A role for membrane Fc gamma Rs?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							AFFINITY; EXPRESSION; RECEPTORS; COMPLEXES		[Chirumbolo, Salvatore] Univ Verona, Dept Med, I-37100 Verona, Italy; [Olivieri, Mario] Univ Hosp Verona, Unit Occupat Med, Verona, Italy	University of Verona	Chirumbolo, S (corresponding author), Univ Verona, Dept Med, I-37100 Verona, Italy.	salvatore.chirumbolo@univr.it						Cassard L, 2012, J IMMUNOL, V189, P2995, DOI 10.4049/jimmunol.1200968; DAERON M, 1995, J CLIN INVEST, V95, P577, DOI 10.1172/JCI117701; Demeule B, 2009, ANAL BIOCHEM, V388, P279, DOI 10.1016/j.ab.2009.03.012; Dombrowicz D, 1998, IMMUNITY, V8, P517, DOI 10.1016/S1074-7613(00)80556-7; Hsu CL, 2010, INT IMMUNOPHARMACOL, V10, P533, DOI 10.1016/j.intimp.2010.02.001; ISHIZAKA T, 1979, J IMMUNOL, V123, P578; Ishmael SS, 2010, J LEUKOCYTE BIOL, V87, P291, DOI 10.1189/jlb.0509336; Kulka M, 2012, J IMMUNOL, V188; MacGlashan DW, 2013, J ALLERGY CLIN IMMUN, V132, P906, DOI 10.1016/j.jaci.2013.04.056; MacGlashan DW, 1997, J IMMUNOL, V158, P1438; Meknache N, 2009, J IMMUNOL, V182, P2542, DOI 10.4049/jimmunol.0801665; Mortensen DL, 2012, MABS-AUSTIN, V4, P724, DOI 10.4161/mabs.22216; Okayama Y, 2003, EUR J IMMUNOL, V33, P1450, DOI 10.1002/eji.200323563; Zaidi AK, 2010, J ALLERGY CLIN IMMUN, V125, P902, DOI 10.1016/j.jaci.2009.12.996; Zhu DC, 2002, NAT MED, V8, P518, DOI 10.1038/nm0502-518	15	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2014	133	5					1493	1494		10.1016/j.jaci.2013.12.1094	http://dx.doi.org/10.1016/j.jaci.2013.12.1094			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AG5HS	24642141				2022-12-18	WOS:000335450700042
J	Ege, MJ; von Mutius, E				Ege, Markus J.; von Mutius, Erika			Atopy: A mirror of environmental changes?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Atopy; environmental exposure; epidemiology; farming	SENSITIZATION; EXPOSURE; CHILDREN; EAST		[Ege, Markus J.; von Mutius, Erika] Univ Munich, Dr von Hauner Childrens Hosp, D-80337 Munich, Germany	University of Munich	Ege, MJ (corresponding author), Univ Munich, Dr von Haunersche Kinderklin, Lindwurmstr 4, D-80337 Munich, Germany.	markus.ege@med.lmu.de	Ege, Markus/C-1962-2012	Ege, Markus/0000-0001-6643-3923; von Mutius, Erika/0000-0002-8893-4515				Annus T, 2005, PEDIAT ALLERG IMM-UK, V16, P315, DOI 10.1111/j.1399-3038.2005.00276.x; Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; Ege MJ, 2008, J ALLERGY CLIN IMMUN, V122, P407, DOI 10.1016/j.jaci.2008.06.011; Ege MJ, 2006, J ALLERGY CLIN IMMUN, V117, P817, DOI 10.1016/j.jaci.2005.12.1307; Elholm G, 2013, J ALLERGY CLIN IMMUN, V132, P1239, DOI 10.1016/j.jaci.2013.07.003; Horak F, 2002, CLIN EXP ALLERGY, V32, P1155, DOI 10.1046/j.1365-2745.2002.01448.x; Kramer U, 2010, CLIN EXP ALLERGY, V40, P289, DOI 10.1111/j.1365-2222.2009.03435.x; Pfefferle PI, 2008, J ALLERGY CLIN IMMUN, V122, P711, DOI 10.1016/j.jaci.2008.06.035; Sachs JD, 1996, AM ECON REV, V86, P128; Sozanska B, 2014, J ALLERGY CLIN IMMUN, V133, P1347, DOI 10.1016/j.jaci.2013.10.035; von Mutius E, 1998, LANCET, V351, P862, DOI 10.1016/S0140-6736(97)10100-3	11	6	6	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2014	133	5					1354	1355		10.1016/j.jaci.2014.01.031	http://dx.doi.org/10.1016/j.jaci.2014.01.031			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AG5HS	24636094				2022-12-18	WOS:000335450700017
J	Ciaccio, CE; Kennedy, K; Barnes, CS; Portnoy, JM; Rosenwasser, LJ				Ciaccio, Christina E.; Kennedy, Kevin; Barnes, Charles S.; Portnoy, Jay M.; Rosenwasser, Lanny J.			The Home Microbiome and Childhood Asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 28-MAR 04, 2014	San Diego, CA	Amer Acad Allergy Asthma & Immunol					[Ciaccio, Christina E.; Kennedy, Kevin; Barnes, Charles S.; Portnoy, Jay M.; Rosenwasser, Lanny J.] Childrens Mercy Hosp, Kansas City, MO 64108 USA	Children's Mercy Hospital									0	6	6	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2014	133	2		S		250	AB70	AB70		10.1016/j.jaci.2013.12.274	http://dx.doi.org/10.1016/j.jaci.2013.12.274			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	297FO		Green Submitted			2022-12-18	WOS:000330241300248
J	Lin, A; Sharma, HP				Lin, Adora; Sharma, Hemant P.			Teasing and Bullying Among Adolescents With Food Allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 28-MAR 04, 2014	San Diego, CA	Amer Acad Allergy Asthma & Immunol					[Lin, Adora] NIAID, Bethesda, MD 20892 USA; [Sharma, Hemant P.] Childrens Natl Med Ctr, Div Allergy & Immunol, Washington, DC 20010 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Children's National Health System			Lin, Adora/AAO-5404-2021	Lin, Adora/0000-0002-1036-2983					0	6	6	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2014	133	2		S		995	AB288	AB288		10.1016/j.jaci.2013.12.1020	http://dx.doi.org/10.1016/j.jaci.2013.12.1020			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	297FO					2022-12-18	WOS:000330241301310
J	Rose, DM; Atkins, J; Holland, SM; Infante, AJ				Rose, David M.; Atkins, Jane; Holland, Steven M.; Infante, Anthony J.			A novel mutation in IFN-gamma receptor 1 presenting as multisystem Mycobacterium intracellulare infection	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INTERFERON-GAMMA; DOMINANT		[Rose, David M.] JBSA Lackland, Dept Allergy & Immunol, Wilford Hall Ambulatory Surg Ctr, Lackland AFB, TX 78236 USA; [Atkins, Jane] Pediat Infect Dis, San Antonio, TX USA; [Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Infante, Anthony J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, San Antonio, TX 78229 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Texas System; University of Texas Health San Antonio	Rose, DM (corresponding author), JBSA Lackland, Dept Allergy & Immunol, Wilford Hall Ambulatory Surg Ctr, Lackland AFB, TX 78236 USA.	infantea@uthscsa.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000646, ZIAAI000647] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Al-Muhsen S, 2008, J ALLERGY CLIN IMMUN, V122, P1043, DOI 10.1016/j.jaci.2008.10.037; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Dorman SE, 2000, CYTOKINE GROWTH F R, V11, P321, DOI 10.1016/S1359-6101(00)00010-1; Dorman SE, 2004, LANCET, V364, P2113, DOI 10.1016/S0140-6736(04)17552-1; Hoshina T, 2011, J CLIN IMMUNOL, V31, P309, DOI 10.1007/s10875-010-9498-y; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Jouanguy E, 1999, NAT GENET, V21, P370, DOI 10.1038/7701; Remiszewski P, 2006, RESPIRATION, V73, P375, DOI 10.1159/000088682	8	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2014	133	2					591	592		10.1016/j.jaci.2013.07.054	http://dx.doi.org/10.1016/j.jaci.2013.07.054			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AC3EF	24220318				2022-12-18	WOS:000332397100042
J	Schroeder, JT; Bieneman, AP; Chichester, KL; Keet, CA; Hamilton, RG; MacGlashan, DW; Wood, R; Frischmeyer-Guerrerio, PA				Schroeder, John T.; Bieneman, Anja P.; Chichester, Kristin L.; Keet, Corinne A.; Hamilton, Robert G.; MacGlashan, Donald W., Jr.; Wood, Robert; Frischmeyer-Guerrerio, Pamela A.			Spontaneous basophil responses in food-allergic children are transferable by plasma and are IgE-dependent	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							SPONTANEOUS RELEASE; EXPRESSION; HISTAMINE; CD203C		[Schroeder, John T.; Bieneman, Anja P.; Hamilton, Robert G.] Johns Hopkins Asthma & Allergy Ctr, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD USA; [Chichester, Kristin L.; Keet, Corinne A.; MacGlashan, Donald W., Jr.; Wood, Robert; Frischmeyer-Guerrerio, Pamela A.] Johns Hopkins Univ, Dept Pediat, Johns Hopkins Childrens Hosp, Div Allergy & Immunol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Schroeder, JT (corresponding author), Johns Hopkins Asthma & Allergy Ctr, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD USA.	schray@jhmi.edu	Guerrerio, Pamela/S-9360-2019	Keet, Corinne/0000-0002-6585-239X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD073557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079853, R21AI092443, K23AI103187, K23AI091869] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI092443, R21AI079853, K23 AI103187, R21 AI079853, K23 AI091869, R21AI092443] Funding Source: Medline; NICHD NIH HHS [R21 HD073557] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ford LS, 2013, J ALLERGY CLIN IMMUN, V131, P180, DOI 10.1016/j.jaci.2012.06.003; Gernez Y, 2011, INT ARCH ALLERGY IMM, V154, P318, DOI 10.1159/000321824; Keet CA, 2012, J ALLERGY CLIN IMMUN, V129, P448, DOI 10.1016/j.jaci.2011.10.023; MacGlashan D, 2012, INT ARCH ALLERGY IMM, V159, P243, DOI 10.1159/000332150; MacGlashan DW, 2007, J ALLERGY CLIN IMMUN, V119, P626, DOI 10.1016/j.jaci.2006.09.040; MAY CD, 1976, J ALLERGY CLIN IMMUN, V58, P432, DOI 10.1016/0091-6749(76)90124-X; Ono E, 2010, J ALLERGY CLIN IMMUN, V125, P483, DOI 10.1016/j.jaci.2009.10.074; PAGANELLI R, 1979, LANCET, V1, P1270; SAMPSON HA, 1989, NEW ENGL J MED, V321, P228, DOI 10.1056/NEJM198907273210405	9	6	6	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2013	132	6					1428	1431		10.1016/j.jaci.2013.08.033	http://dx.doi.org/10.1016/j.jaci.2013.08.033			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	259PG	24139604	Bronze, Green Accepted			2022-12-18	WOS:000327538200023
J	Sharma, M; Kaveri, SV; Bayry, J				Sharma, Meenu; Kaveri, Srini V.; Bayry, Jagadeesh			Human basophils lack the capacity to drive memory CD4(+) T cells toward the IL-22 response	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ANTIGEN-PRESENTING CELLS; MAST-CELLS; ROLES		[Sharma, Meenu; Kaveri, Srini V.; Bayry, Jagadeesh] INSERM, U872, Paris, France; [Sharma, Meenu] Univ Technol Compiegne, Compiegne, France; [Kaveri, Srini V.; Bayry, Jagadeesh] Univ Paris 06, Ctr Rech Cordeliers, Equipe Immunopathol & Therapeut Immunointervent 1, Paris, France; [Kaveri, Srini V.; Bayry, Jagadeesh] Univ Paris 05, Paris, France; [Kaveri, Srini V.; Bayry, Jagadeesh] France Indian Council Med Res, Natl Inst Immunohaematol, Int Associated Lab IMPACT Inst Natl Sante & Rech, Bombay, Maharashtra, India	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Picardie Universites; Universite de Technologie de Compiegne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Indian Council of Medical Research (ICMR); ICMR - National Institute of Immunohaemotology (NIIH)	Bayry, J (corresponding author), INSERM, U872, Paris, France.	jagadeesh.bayry@crc.jussieu.fr	Sharma, Meenu/GWM-5030-2022; Bayry, Jagadeesh/A-6589-2011	Bayry, Jagadeesh/0000-0003-0498-9808; Kaveri, Srini/0000-0002-0837-4053				Gaudenzio N, 2013, J ALLERGY CLIN IMMUN, V131, P1400, DOI 10.1016/j.jaci.2013.01.029; Karasuyama H, 2011, ANNU REV IMMUNOL, V29, P45, DOI 10.1146/annurev-immunol-031210-101257; Kitzmuller C, 2012, ALLERGY, V67, P593, DOI 10.1111/j.1398-9995.2011.02764.x; Sharma M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01188; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427	5	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2013	132	6					1457	1458		10.1016/j.jaci.2013.09.024	http://dx.doi.org/10.1016/j.jaci.2013.09.024			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	259PG	24184151				2022-12-18	WOS:000327538200037
J	Al-Zahrani, D; Al-Ghonaium, A; Al-Mousa, H; Al-Kassar, A; Roifman, CM				Al-Zahrani, Daifulah; Al-Ghonaium, Abdulaziz; Al-Mousa, Hamoud; Al-Kassar, Ahmad; Roifman, Chaim M.			Skeletal abnormalities and successful hematopoietic stem cell transplantation in patients with reticular dysgenesis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							COLONY-STIMULATING FACTOR		[Al-Zahrani, Daifulah] King Abdul Aziz Med City, Dept Pediat, Jeddah, Saudi Arabia; [Al-Kassar, Ahmad] King Abdul Aziz Med City, Jeddah, Saudi Arabia; [Al-Ghonaium, Abdulaziz; Al-Mousa, Hamoud] King Faisal Specialist Hosp & Res Ctr, Allergy & Immunol Sect, Riyadh 11211, Saudi Arabia; [Roifman, Chaim M.] Hosp Sick Children, Canadian Ctr Primary Immunodeficiency, Div Immunol & Allergy, Toronto, ON M5G 1X8, Canada; [Roifman, Chaim M.] Univ Toronto, Toronto, ON, Canada	King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Jeddah; King Faisal Specialist Hospital & Research Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Al-Zahrani, D (corresponding author), King Abdul Aziz Med City, Dept Pediat, Jeddah, Saudi Arabia.	AAIPed@gmail.com	Al-Mousa, Hamoud/AAS-4477-2020					Beekman R, 2010, BLOOD, V115, P5131, DOI 10.1182/blood-2010-01-234120; Bertrand Y, 2002, BONE MARROW TRANSPL, V29, P759, DOI 10.1038/sj.bmt.1703531; BUJAN W, 1992, BRIT J HAEMATOL, V81, P128, DOI 10.1111/j.1365-2141.1992.tb08187.x; BUJAN W, 1993, BLOOD, V82, P1684, DOI 10.1182/blood.V82.5.1684.bloodjournal8251684a; DEVAAL OM, 1959, LANCET, V2, P1123; Heltzer ML, 2007, J ALLERGY CLIN IMMUN, V120, P950, DOI 10.1016/j.jaci.2007.07.026; Lagresle-Peyrou C, 2011, J ALLERGY CLIN IMMUN, V128, P230, DOI 10.1016/j.jaci.2011.02.008; Reubsaet LL, 2007, BONE MARROW TRANSPL, V39, P307, DOI 10.1038/sj.bmt.1705577; Yin EZ, 2001, AM J ROENTGENOL, V176, P1541	9	6	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2013	132	4					993	+		10.1016/j.jaci.2013.04.055	http://dx.doi.org/10.1016/j.jaci.2013.04.055			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	227FR	23763981				2022-12-18	WOS:000325096500035
J	Bringolf-Isler, B; Graf, E; Waser, M; Genuneit, J; von Mutius, E; Loss, G; Kriemler, S; Braun-Fahrlander, C				Bringolf-Isler, Bettina; Graf, Eva; Waser, Marco; Genuneit, Jon; von Mutius, Erika; Loss, Georg; Kriemler, Susi; Braun-Fahrlaender, Charlotte			Association of physical activity, asthma, and allergies: A cohort of farming and nonfarming children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PREVALENCE		[Bringolf-Isler, Bettina; Graf, Eva; Waser, Marco; Loss, Georg; Kriemler, Susi; Braun-Fahrlaender, Charlotte] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Bringolf-Isler, Bettina; Graf, Eva; Waser, Marco; Loss, Georg; Kriemler, Susi; Braun-Fahrlaender, Charlotte] Univ Basel, Basel, Switzerland; [Genuneit, Jon] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [von Mutius, Erika] Univ Munich, Dr von Hauner Childrens Hosp, Munich, Germany	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Ulm University; University of Munich	Bringolf-Isler, B (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	bettina.bringolf@unbias.ch	Loss, Georg/AAE-7296-2019; Genuneit, Jon/I-9323-2012; Loss, Georg/F-1557-2013	Loss, Georg/0000-0003-1090-812X; Genuneit, Jon/0000-0001-5764-1528; von Mutius, Erika/0000-0002-8893-4515				ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Chinapaw MJM, 2010, SPORTS MED, V40, P539, DOI 10.2165/11530770-000000000-00000; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Eijkemans M, 2008, PEDIATRICS, V121, pE666, DOI 10.1542/peds.2007-1236; Genuneit J, 2011, PAEDIATR PERINAT EP, V25, P436, DOI 10.1111/j.1365-3016.2011.01223.x; Kohlhammer Y, 2006, ALLERGY, V61, P1310, DOI 10.1111/j.1398-9995.2006.01131.x; Platts-Mills TAE, 2005, ALLERGY, V60, P25, DOI 10.1111/j.1398-9995.2005.00854.x; Treuth MS, 2004, MED SCI SPORT EXER, V36, P1259, DOI 10.1249/01.MSS.0000074670.03001.98; van Gent R, 2007, PEDIATR PULM, V42, P1018, DOI 10.1002/ppul.20672	9	6	6	0	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2013	132	3					743	746		10.1016/j.jaci.2013.03.042	http://dx.doi.org/10.1016/j.jaci.2013.03.042			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	207OS	23684066				2022-12-18	WOS:000323612000030
J	Vitte, J; Bongrand, P				Vitte, Joana; Bongrand, Pierre			Serum tryptase determination in patients with acute allergic reactions	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ANAPHYLAXIS		[Vitte, Joana; Bongrand, Pierre] Hop Conception, Assistance Publ Hop Marseille, Immunol Lab, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Vitte, J (corresponding author), Hop Conception, Assistance Publ Hop Marseille, Immunol Lab, Marseille, France.	jvitte@ap-hm.fr	Vitte, Joana/G-2572-2013; Bongrand, Pierre/C-4456-2013	Vitte, Joana/0000-0002-3344-9408; Bongrand, Pierre/0000-0001-6185-6572				Bengtsson U, 1996, CLIN EXP ALLERGY, V26, P1387, DOI 10.1111/j.1365-2222.1996.tb00540.x; Borer-Reinhold M, 2011, CLIN EXP ALLERGY, V41, P1777, DOI 10.1111/j.1365-2222.2011.03848.x; Brown AFT, 2001, J ALLERGY CLIN IMMUN, V108, P861, DOI 10.1067/mai.2001.119028; SAMPSON HA, 1992, NEW ENGL J MED, V327, P380, DOI 10.1056/NEJM199208063270603; SCHWARTZ LB, 1989, J CLIN INVEST, V83, P1551, DOI 10.1172/JCI114051; Stone SF, 2009, J ALLERGY CLIN IMMUN, V124, P786, DOI 10.1016/j.jaci.2009.07.055; Vadas P, 2013, J ALLERGY CLIN IMMUN, V131, P144, DOI 10.1016/j.jaci.2012.08.016; VANDERLINDEN PWG, 1992, J ALLERGY CLIN IMMUN, V90, P110, DOI 10.1016/S0091-6749(06)80017-5; Yunginger JW, 1991, J FORENSIC SCI, V36, P1387	9	6	6	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2013	131	6					1714	1714		10.1016/j.jaci.2013.03.028	http://dx.doi.org/10.1016/j.jaci.2013.03.028			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	166CT	23643096	Bronze			2022-12-18	WOS:000320532800039
J	Felix, R; Martorell, C; Martorell, A; Pineda, F; Cerda, JC; De Las Marinas, MD				Felix, Ruben; Martorell, Cristina; Martorell, Antonio; Pineda, Fernando; Carlos Cerda, Juan; Dolores De Las Marinas, Maria			Induced bronchospasm after handling of orange flavedo (zest)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PROFILIN CIT-S-2; ALLERGEN; PROTEINS		[Felix, Ruben; Martorell, Antonio; Carlos Cerda, Juan; Dolores De Las Marinas, Maria] Gen Univ Hosp, Allergy Unit, Valencia, Spain; [Martorell, Cristina] Univ Hosp Clin, Allergy Serv, Valencia, Spain; [Pineda, Fernando] R D Dept, DIATER Labs, Madrid, Spain		Felix, R (corresponding author), Gen Univ Hosp, Allergy Unit, Valencia, Spain.	felix_rub@gva.es	Toledo, Rubén Félix/Z-1686-2019					Ahrazem O, 2005, INT ARCH ALLERGY IMM, V137, P201, DOI 10.1159/000086332; Barasona Villarejo MJ, 2011, J INVESTIG ALLERGOL, V21, P243; CARDULLO AC, 1989, J AM ACAD DERMATOL, V21, P395, DOI 10.1016/S0190-9622(89)80043-X; Crespo JF, 2006, MOL NUTR FOOD RES, V50, P282, DOI 10.1002/mnfr.200500200; Ibanez MD, 2004, J ALLERGY CLIN IMMUN, V113, P175, DOI 10.1016/j.jaci.2003.10.059; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lopez-Torrejon G, 2005, ALLERGY, V60, P1424, DOI 10.1111/j.1398-9995.2005.00903.x; Morimoto K, 2004, ACTA DERM-VENEREOL, V84, DOI 10.1080/00015550310006860; Sen D, 1998, CLIN EXP ALLERGY, V28, P363, DOI 10.1046/j.1365-2222.1998.00244.x	9	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2013	131	5					1423	1425		10.1016/j.jaci.2012.10.007	http://dx.doi.org/10.1016/j.jaci.2012.10.007			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	144AU	23146375	Bronze			2022-12-18	WOS:000318912200023
J	Seltsam, A; Mueller, TH				Seltsam, Axel; Mueller, Thomas H.			Updated hemovigilance data do not show an increased risk of allergic reactions to methylene blue-treated plasma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Seltsam, Axel; Mueller, Thomas H.] German Red Cross Blood Serv NSTOB, Inst Springe, Springe, Germany		Seltsam, A (corresponding author), German Red Cross Blood Serv NSTOB, Inst Springe, Springe, Germany.	axel.seltsam@bsd-nstob.de		Muller, Thomas H./0000-0002-5417-6787				L'Agence nationale de securite du medicament et des produits de sante (ANSM), ANN HEM REP 2010; Mertes PM, 2012, J ALLERGY CLIN IMMUN, V130, P808, DOI 10.1016/j.jaci.2012.03.050	2	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2013	131	4					1253	1254		10.1016/j.jaci.2012.11.046	http://dx.doi.org/10.1016/j.jaci.2012.11.046			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	120QT	23321208				2022-12-18	WOS:000317187200046
J	Busse, WW; Holgate, ST; Kerwin, EM; Chon, Y; Feng, JY; Lin, JH; Lin, SL				Busse, William W.; Holgate, Stephen T.; Kerwin, Edward M.; Chon, Yun; Feng, JingYuan; Lin, Joseph H.; Lin, Shao-Lee			A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab (AMG 827) in Subjects with Moderate to Severe Asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI)	FEB 22-26, 2013	San Antonio, TX	Amer Acad Allergy, Asthma & Immunol (AAAAI)					[Busse, William W.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Holgate, Stephen T.] Southampton Gen Hosp, Southampton SO9 4XY, Hants, England; [Kerwin, Edward M.] Allergy & Asthma Ctr So OR, Medford, OR USA; [Chon, Yun; Feng, JingYuan; Lin, Joseph H.; Lin, Shao-Lee] Amgen Inc, Thousand Oaks, CA 91320 USA	University of Wisconsin System; University of Wisconsin Madison; University of Southampton; Amgen									0	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2		S			AB230	AB230		10.1016/j.jaci.2012.12.1486	http://dx.doi.org/10.1016/j.jaci.2012.12.1486			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	111WC		Bronze			2022-12-18	WOS:000316550800815
J	Mehrotra, N; Dimov, V				Mehrotra, Neha; Dimov, Vesselin			Tweeting the Meeting: Investigating Twitter Activity At the 2012 AAAAI Conference	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI)	FEB 22-26, 2013	San Antonio, TX	Amer Acad Allergy, Asthma & Immunol (AAAAI)					[Mehrotra, Neha] Univ Chicago, Chicago, IL 60637 USA; [Dimov, Vesselin] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	University of Chicago; University of Chicago									0	6	6	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2		S			AB34	AB34		10.1016/j.jaci.2012.12.804	http://dx.doi.org/10.1016/j.jaci.2012.12.804			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	111WC					2022-12-18	WOS:000316550800126
J	Rosenzweig, SD; Fleisher, TA				Rosenzweig, Sergio D.; Fleisher, Thomas A.			Laboratory evaluation for T-cell dysfunction	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Neonatal screening; severe combined immunodeficiency; immunophenotyping; lymphocyte proliferation; T-cell cytotoxicity; regulatory T cells; thymic function	SUBSETS; ASSAYS; TOOLS		NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; NIH, Dept Lab Med, CC, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Fleisher, TA (corresponding author), NIH, Dept Lab Med, 10 Ctr Dr,MSC 1508,Bldg 10,Rm 2C410, Bethesda, MD 20892 USA.	tfleishe@mail.nih.gov			Intramural NIH HHS [Z99 CL999999] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001122] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALARCON B, 1990, Immunodeficiency Reviews, V2, P1; Bryceson YT, 2012, BLOOD, V119, P2754, DOI 10.1182/blood-2011-08-374199; Canavan JB, 2012, BLOOD, V119, pE57, DOI 10.1182/blood-2011-09-380048; Graca L, 2005, EUR J IMMUNOL, V35, P1678, DOI 10.1002/eji.200526303; Kohler S, 2009, BLOOD, V113, P769, DOI 10.1182/blood-2008-02-139154; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Maino VC, 1998, CYTOMETRY, V34, P207, DOI 10.1002/(SICI)1097-0320(19981015)34:5<207::AID-CYTO1>3.0.CO;2-J; Muller SM, 2001, BLOOD, V98, P1847, DOI 10.1182/blood.V98.6.1847; Puck JM, 2007, CURR OPIN ALLERGY CL, V7, P522, DOI 10.1097/ACI.0b013e3282f14a2a; Schiott A, 2004, IMMUNOLOGY, V113, P363, DOI 10.1111/j.1365-2567.2004.01974.x; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; STIEHM E, 2004, IMMUNOLOGIC DISORDER; Toubert A, 2000, VOX SANG, V78, P29; Yu YM, 2009, J IMMUNOL METHODS, V350, P29, DOI 10.1016/j.jim.2009.07.008; Zaritskaya L, 2010, EXPERT REV VACCINES, V9, P601, DOI [10.1586/erv.10.49, 10.1586/ERV.10.49]	15	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2					922	+		10.1016/j.jaci.2012.11.018	http://dx.doi.org/10.1016/j.jaci.2012.11.018			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086CT	23374275	Green Accepted			2022-12-18	WOS:000314661500063
J	Tassone, L; Carvalho, ACC; Calabresi, A; Tortoli, E; Apostoli, A; Scomodon, O; Spina, C; Vairo, D; Villanacci, V; Matteelli, A; Badolato, R				Tassone, Laura; Carvalho, Anna Cristina C.; Calabresi, Alessandra; Tortoli, Enrico; Apostoli, Alessandra; Scomodon, Omar; Spina, Cecilia; Vairo, Donatella; Villanacci, Vincenzo; Matteelli, Alberto; Badolato, Raffaele			Disseminated Mycobacterium genavense infection after immunosuppressive therapy shows underlying new composite heterozygous mutations of beta 1 subunit of IL-12 receptor gene	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							OF-THE-LITERATURE; DEFICIENCY; AIDS		[Tassone, Laura; Scomodon, Omar; Spina, Cecilia; Vairo, Donatella; Badolato, Raffaele] Univ Brescia, Inst Mol Med Angelo Nocivelli, Brescia, Italy; [Tassone, Laura; Scomodon, Omar; Spina, Cecilia; Vairo, Donatella; Badolato, Raffaele] Univ Brescia, Dept Pediat, Brescia, Italy; [Carvalho, Anna Cristina C.; Calabresi, Alessandra; Apostoli, Alessandra; Matteelli, Alberto] Univ Brescia, Inst Infect & Trop Dis, Brescia, Italy; [Tortoli, Enrico] Ist Sci San Raffaele, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy; [Villanacci, Vincenzo] Spedali Civil Brescia, Serv Anat Patol, I-25125 Brescia, Italy	University of Brescia; University of Brescia; University of Brescia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Hospital Spedali Civili Brescia	Tassone, L (corresponding author), Univ Brescia, Inst Mol Med Angelo Nocivelli, Brescia, Italy.	badolato@med.unibs.it	Badolato, Raffaele/A-8081-2010; Carvalho, A/D-4157-2013; Carvalho, Anna C.C./K-2662-2016; Tortoli, Enrico/K-4749-2016; Matteelli, Alberto/M-8784-2015; Carvalho, Anna/AAC-9068-2020	Badolato, Raffaele/0000-0001-7375-5410; Carvalho, Anna C.C./0000-0002-0128-942X; Tortoli, Enrico/0000-0001-5512-704X; Matteelli, Alberto/0000-0001-5109-9248; 				Al-Muhsen S, 2008, J ALLERGY CLIN IMMUN, V122, P1043, DOI 10.1016/j.jaci.2008.10.037; Aytekin C, 2011, J INVEST ALLERG CLIN, V21, P401; Boisson-Dupuis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018524; de Beaucoudrey L, 2010, MEDICINE, V89, P381, DOI 10.1097/MD.0b013e3181fdd832; Doggett JS, 2011, TRANSPL INFECT DIS, V13, P38, DOI 10.1111/j.1399-3062.2010.00545.x; Monill JM, 2001, EUR RADIOL, V11, P193, DOI 10.1007/s003300000606; Pedraza S, 2010, PEDIATRICS, V126, pE971, DOI 10.1542/peds.2009-2504; Schejbel L, 2011, SCAND J IMMUNOL, V74, P548, DOI 10.1111/j.1365-3083.2011.02603.x; Tortoli E, 1998, EUR J EPIDEMIOL, V14, P219, DOI 10.1023/A:1007401305708	9	6	6	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2					607	610		10.1016/j.jaci.2012.05.041	http://dx.doi.org/10.1016/j.jaci.2012.05.041			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086CT	22818764				2022-12-18	WOS:000314661500050
J	Busse, WW; Ballas, ZK; Casale, TB; Cox, L; Dimov, V; Honsinger, RW; Jones, CA; Tracy, JM				Busse, William W.; Ballas, Zuhair K.; Casale, Thomas B.; Cox, Linda; Dimov, Vesselin; Honsinger, Richard W.; Jones, Craig A.; Tracy, James M.			Future of Allergy/Immunology Task Force Report	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Busse, William W.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Div Allergy Pulm & Crit Care Med, Madison, WI 53706 USA; [Ballas, Zuhair K.] Univ Iowa Hlth Care, Div Immunol, Dept Internal Med, Iowa City, IA USA; [Casale, Thomas B.] Creighton Univ, Sch Med, Dept Med, Div Allergy & Immunol, Omaha, NE USA; [Cox, Linda] Ctr Asthma & Allergy, Ft Lauderdale, FL USA; [Dimov, Vesselin] Univ Chicago, Med Ctr, Dept Med, Dept Pediat,Sect Allergy Asthma & Immunol, Chicago, IL 60637 USA; [Honsinger, Richard W.] Los Alamos Med Care Clin, Los Alamos, NM USA; [Jones, Craig A.] Vermont Dept Hlth, Burlington, VT USA; [Tracy, James M.] Allergy Asthma & Immunol Associates PC, Omaha, NE USA	University of Wisconsin System; University of Wisconsin Madison; University of Iowa; Creighton University; University of Chicago; University of Chicago Medical Center	Busse, WW (corresponding author), Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Div Allergy Pulm & Crit Care Med, Madison, WI 53706 USA.	wwb@medicine.wisc.edu	Casale, Thomas B/K-4334-2013; Cox, Linda/AAP-1697-2021	Casale, Thomas B/0000-0002-3149-7377; Cox, Linda/0000-0002-5258-6870; Knaack, Aaron/0000-0001-7712-1415; Ballas, Zuhair/0000-0001-5569-1230					0	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2012	130	4					1009	1010		10.1016/j.jaci.2012.06.045	http://dx.doi.org/10.1016/j.jaci.2012.06.045			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017MT	22921869				2022-12-18	WOS:000309594800032
J	Kirkpatrick, CH				Kirkpatrick, Charles H.			A mechanism for urticaria/angioedema in patients with thyroid disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHRONIC URTICARIA; AUTOIMMUNITY; BASOPHILS		Univ Colorado Denver, Div Allergy & Clin Immunol, Dept Med, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Kirkpatrick, CH (corresponding author), Univ Colorado Denver, Div Allergy & Clin Immunol, Dept Med, Anschutz Med Campus, Aurora, CO USA.	charles.kirkpatrick@ucdenver.edu						Blanchin S, 2003, ENDOCRINOLOGY, V144, P5422, DOI 10.1210/en.2003-0918; FUREDER W, 1995, J IMMUNOL, V155, P3152; Jariwala SP, 2009, ANN ALLERG ASTHMA IM, V102, P475, DOI 10.1016/S1081-1206(10)60120-2; Kikuchi Y, 2002, J ALLERGY CLIN IMMUN, V109, P114, DOI 10.1067/mai.2002.120954; LEZNOFF A, 1989, J ALLERGY CLIN IMMUN, V84, P66, DOI 10.1016/0091-6749(89)90180-2; McLachlan SM, 2007, THYROID, V17, P939, DOI 10.1089/thy.2007.0169; Rumbyrt JS, 1995, J ALLERGY CLIN IMMUN, V96, P901, DOI 10.1016/S0091-6749(95)70226-1; Rumbyrt JS, 2008, THYROID DISORDERS CU, P145; Sheikh J, 2009, J ALLERGY CLIN IMMUN, V123, P1173, DOI 10.1016/j.jaci.2008.12.1130	9	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2012	130	4					988	990		10.1016/j.jaci.2012.05.017	http://dx.doi.org/10.1016/j.jaci.2012.05.017			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017MT	22728088	Bronze			2022-12-18	WOS:000309594800022
J	Posthumus, J; Tinana, A; Mozena, JD; Steinke, JW; Borish, L				Posthumus, Jonathon; Tinana, Adrienne; Mozena, Jonathan D.; Steinke, John W.; Borish, Larry			Autoimmune mechanisms in chronic idiopathic urticaria	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							FC-EPSILON-RI; SERUM SKIN-TEST; HISTAMINE-RELEASE; MAST-CELLS; IN-VITRO; AUTOANTIBODIES; EXPRESSION; BASOPHILS		[Posthumus, Jonathon; Tinana, Adrienne; Mozena, Jonathan D.; Steinke, John W.; Borish, Larry] Univ Virginia, Asthma & Allerg Dis Ctr, Carter Ctr Immunol Res, Charlottesville, VA 22903 USA	University of Virginia	Posthumus, J (corresponding author), Univ Virginia, Asthma & Allerg Dis Ctr, Carter Ctr Immunol Res, Charlottesville, VA 22903 USA.	lb4m@virginia.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070364, R21AI090413, R01AI057438] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI057438, U19 AI070364, R21 AI090413] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altrich ML, 2009, ALLERGY ASTHMA PROC, V30, P28, DOI 10.2500/aap.2009.30.3185; Charlesworth EN, 2002, ALLERGY ASTHMA PROC, V23, P341; Ferrer M, 1998, J ALLERGY CLIN IMMUN, V101, P672, DOI 10.1016/S0091-6749(98)70176-9; Fiebiger E, 1995, J CLIN INVEST, V96, P2606, DOI 10.1172/JCI118325; GRATTAN CEH, 1986, BRIT J DERMATOL, V114, P583, DOI 10.1111/j.1365-2133.1986.tb04065.x; Greaves MW, 2007, CLIN REV ALLERG IMMU, V33, P134, DOI 10.1007/s12016-007-0038-3; HIDE M, 1993, NEW ENGL J MED, V328, P1599, DOI 10.1056/NEJM199306033282204; Kaplan AP, 2007, J ALLERGY CLIN IMMUN, V120, P729, DOI 10.1016/j.jaci.2007.05.008; Kepley CL, 2000, J IMMUNOL, V165, P5913, DOI 10.4049/jimmunol.165.10.5913; Kulthanan K, 2006, ASIAN PAC J ALLERGY, V24, P201; Laidlaw TM, 2011, J ALLERGY CLIN IMMUN, V127, P815, DOI 10.1016/j.jaci.2010.12.1101; LICHTENSTEIN LM, 1986, J ALLERGY CLIN IMMUN, V77, P291, DOI 10.1016/S0091-6749(86)80106-3; MacGlashan D, 2004, J ALLERGY CLIN IMMUN, V114, P1317, DOI 10.1016/j.jaci.2004.08.037; MacGlashan D, 2003, J IMMUNOL, V170, P4914, DOI 10.4049/jimmunol.170.10.4914; Mozena JD, 2010, J INVEST DERMATOL, V130, P1860, DOI 10.1038/jid.2010.35; O'Donnell BF, 2005, BRIT J DERMATOL, V153, P331, DOI 10.1111/j.1365-2133.2005.06646.x; Oliver JM, 2000, IMMUNOPHARMACOLOGY, V48, P269, DOI 10.1016/S0162-3109(00)00224-1; Sabroe RA, 1999, BRIT J DERMATOL, V140, P446; SAITO H, 1987, J IMMUNOL, V138, P3927; Yamaguchi M, 1997, J EXP MED, V185, P663, DOI 10.1084/jem.185.4.663; Yasnowsky KM, 2006, J ALLERGY CLIN IMMUN, V117, P1430, DOI 10.1016/j.jaci.2006.02.016	21	6	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2012	130	3					814	+		10.1016/j.jaci.2012.04.037	http://dx.doi.org/10.1016/j.jaci.2012.04.037			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	001LZ	22694931	Green Accepted			2022-12-18	WOS:000308463500036
J	Abraham, RS				Abraham, Roshini S.			Relevance of antibody testing in patients with recurrent infections	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							COMMON VARIABLE IMMUNODEFICIENCY; VACCINATION; RESPONSES; AGE		Mayo Clin, Cellular & Mol Immunol Lab, Dept Lab Med & Pathol, Rochester, MN 55905 USA	Mayo Clinic	Abraham, RS (corresponding author), Mayo Clin, Cellular & Mol Immunol Lab, Dept Lab Med & Pathol, Hilton 210E,200 1st St SW, Rochester, MN 55905 USA.	abraham.roshini@mayo.edu						Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Balloch A, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.05.008; Brinkman DMC, 2003, J CLIN IMMUNOL, V23, P528, DOI 10.1023/B:JOCI.0000010429.36461.6b; Buckley Rebecca H, 2002, Curr Allergy Asthma Rep, V2, P356, DOI 10.1007/s11882-002-0067-1; Cunningham-Rundles C, 2012, J ALLERGY CLIN IMMUN, V129, pe3; Cunningham-Rundles C, 2012, J ALLERGY CLIN IMMUN, V129, P1425, DOI 10.1016/j.jaci.2012.03.025; Goldacker S, 2007, CLIN IMMUNOL, V124, P294, DOI 10.1016/j.clim.2007.04.011; Irie E, 2010, INT J HEMATOL, V91, P501, DOI 10.1007/s12185-010-0528-6; Licciardi PV, 2012, J ALLERGY CLIN IMMUN, V129, P794, DOI 10.1016/j.jaci.2011.11.043; Mawhorter S, 2008, CURR OPIN ORGAN TRAN, V13, P581, DOI 10.1097/MOT.0b013e3283186bbc; OCHS HD, 1992, BLOOD, V80, P1163; Park MA, 2010, CLIN IMMUNOL, V135, P299; Seidel MG, 2010, VACCINE, V28, P6621, DOI 10.1016/j.vaccine.2010.07.027; Shvarts A, 2012, J ALLERGY CLIN IMMUN, V129, pAB84, DOI 10.1016/j.jaci.2011.12.640; Sorensen RU, 1998, J ALLERGY CLIN IMMUN, V102, P215, DOI 10.1016/S0091-6749(98)70089-2; Vasquez A, 2010, CLIN IMM SOC M PHIL; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744	17	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2012	130	2					558	+		10.1016/j.jaci.2012.06.013	http://dx.doi.org/10.1016/j.jaci.2012.06.013			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	981WC	22846755				2022-12-18	WOS:000307002200053
J	Ledford, DK; Burks, AW; Ballow, M; Cox, L; Wood, RA; Casale, TB				Ledford, Dennis K.; Burks, A. Wesley; Ballow, Mark; Cox, Linda; Wood, Robert A.; Casale, Thomas B.			Statement regarding "The public health benefits of air pollution control''	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Air pollution					Ledford, DK (corresponding author), Univ S Florida, Morsani Coll Med, 13000 Bruce B Downs Blvd,VAR111D, Tampa, FL 33612 USA.	dledford@hsc.usf.edu	Cox, Linda/AAP-1697-2021; Casale, Thomas B/K-4334-2013	Cox, Linda/0000-0002-5258-6870; Casale, Thomas B/0000-0002-3149-7377				Li JH, 2012, J ALLERGY CLIN IMMUN, V130, P22, DOI 10.1016/j.jaci.2012.02.047	1	6	6	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2012	130	1					24	24		10.1016/j.jaci.2012.02.055	http://dx.doi.org/10.1016/j.jaci.2012.02.055			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	977GN	22742836				2022-12-18	WOS:000306644800004
J	Bloch, DB; Nobre, R; Steinbicker, AU; Al-Herz, W; Notarangelo, LD; Recher, M				Bloch, Donald B.; Nobre, Rita; Steinbicker, Andrea U.; Al-Herz, Waleed; Notarangelo, Luigi D.; Recher, Mike			Decreased IL-10 production by EBV-transformed B cells from patients with VODI: Implications for the pathogenesis of Crohn disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INTERLEUKIN-10; MUTATIONS		[Bloch, Donald B.; Nobre, Rita] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Bloch, Donald B.; Nobre, Rita] Massachusetts Gen Hosp, Dept Med, Rheumatol Allergy & Immunol Div, Boston, MA 02114 USA; [Steinbicker, Andrea U.] Massachusetts Gen Hosp, Anesthesia Ctr Crit Care Res, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Steinbicker, Andrea U.; Notarangelo, Luigi D.; Recher, Mike] Harvard Univ, Sch Med, Boston, MA USA; [Steinbicker, Andrea U.] Univ Munster, Dept Anesthesiol & Intens Care Med, Munster, Germany; [Al-Herz, Waleed] Al Sabah Hosp, Dept Pediat, Allergy & Clin Immunol Unit, Kuwait, Kuwait; [Notarangelo, Luigi D.; Recher, Mike] Childrens Hosp Boston, Div Immunol, Boston, MA USA; [Notarangelo, Luigi D.; Recher, Mike] Childrens Hosp Boston, Manton Ctr Orphan Dis Res, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Munster; Al Sabah Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Bloch, DB (corresponding author), Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA.	bloch@helix.mgh.harvard.edu	Notarangelo, Luigi D/F-9718-2016	Notarangelo, Luigi D/0000-0002-8335-0262; Recher, Mike/0000-0002-9121-6936; Bloch, Donald/0000-0002-6828-4754				Davidson NJ, 1996, J EXP MED, V184, P241, DOI 10.1084/jem.184.1.241; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Roscioli T, 2006, NAT GENET, V38, P620, DOI 10.1038/ng1780; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Samanta M, 2008, ONCOGENE, V27, P4150, DOI 10.1038/onc.2008.75	8	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2012	129	6					1678	1680		10.1016/j.jaci.2012.01.046	http://dx.doi.org/10.1016/j.jaci.2012.01.046			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	952BL	22341038				2022-12-18	WOS:000304764600034
J	Camargo, CA				Camargo, Carlos A., Jr.			Potter Stewart and the definition of anaphylaxis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Anaphylaxis	EMERGENCY-DEPARTMENT VISITS; REPEAT EPINEPHRINE TREATMENTS; ALLERGIC REACTIONS; FOOD; MULTICENTER; ORGANIZATION		[Camargo, Carlos A., Jr.] Harvard Univ, Div Rheumatol Allergy & Immunol, Dept Med, Massachusetts Gen Hosp,Med Sch, Boston, MA 02114 USA; [Camargo, Carlos A., Jr.] Harvard Univ, Dept Emergency Med, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Camargo, CA (corresponding author), Harvard Univ, Div Rheumatol Allergy & Immunol, Dept Med, Massachusetts Gen Hosp,Med Sch, 326 Cambridge St,Suite 410, Boston, MA 02114 USA.	ccamargo@partners.org	Camargo, Carlos A./C-2145-2008	Camargo, Carlos A./0000-0002-5071-7654				Banerji A, 2010, ALLERGY ASTHMA PROC, V31, P308, DOI 10.2500/aap.2010.31.3375; Bohlke K, 2004, J ALLERGY CLIN IMMUN, V113, P536, DOI 10.1016/j.jaci.2003.11.033; Campbell RL, 2012, J ALLERGY CLIN IMMUN, V129, P748, DOI 10.1016/j.jaci.2011.09.030; Clark S, 2005, J ALLERGY CLIN IMMUN, V116, P643, DOI 10.1016/j.jaci.2005.06.026; Clark S, 2004, J ALLERGY CLIN IMMUN, V113, P347, DOI 10.1016/j.jaci.2003.10.053; Clark S, 2006, ANN EPIDEMIOL, V16, P696, DOI 10.1016/j.annepidem.2005.12.003; Gaeta TJ, 2007, ANN ALLERG ASTHMA IM, V98, P360, DOI 10.1016/S1081-1206(10)60883-6; Lieberman P, 2010, J ALLERGY CLIN IMMUN, V126, pe1, DOI 10.1016/j.jaci.2010.06.022; Lieberman P, 2010, J ALLERGY CLIN IMMUN, V126, P477, DOI 10.1016/j.jaci.2010.06.022; Rudders SA, 2010, ANN ALLERG ASTHMA IM, V105, P85, DOI 10.1016/j.anai.2010.05.004; Rudders SA, 2010, PEDIATRICS, V125, pE711, DOI 10.1542/peds.2009-2832; Sampson HA, 2005, J ALLERGY CLIN IMMUN, V115, P584, DOI 10.1016/j.jaci.2005.01.009; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Simons FER, 2011, J ALLERGY CLIN IMMUN, V127, P587, DOI 10.1016/j.jaci.2011.01.038; Simons FER, 2009, J ALLERGY CLIN IMMUN, V124, P301, DOI 10.1016/j.jaci.2009.03.050; Simons FER, 2011, J ALLERGY CLIN IMMUN, V127, pe1	16	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2012	129	3					753	754		10.1016/j.jaci.2012.01.030	http://dx.doi.org/10.1016/j.jaci.2012.01.030			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	904IW	22285277	Bronze			2022-12-18	WOS:000301189300021
J	Gonzalo-Garijo, MA; Caballero, ML; Gil-Micharet, MS; Moneo, I; Perez-Calderon, R; Garcia-Borruel, L				Angeles Gonzalo-Garijo, Maria; Luisa Caballero, Maria; Soledad Gil-Micharet, Maria; Moneo, Ignacio; Perez-Calderon, Remedios; Garcia-Borruel, Luis			Hypersensitivity reactions due to nitrile gloves	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CONTACT URTICARIA		[Angeles Gonzalo-Garijo, Maria; Perez-Calderon, Remedios] Infanta Cristina Univ Hosp, Dept Allergol & Clin Immunol, Badajoz, Spain; [Luisa Caballero, Maria; Moneo, Ignacio] Carlos III Hosp, Dept Immunol, Madrid, Spain; [Soledad Gil-Micharet, Maria; Garcia-Borruel, Luis] Perpetuo Socorro Hosp, Basic Unit Occupat Risk Prevent, Badajoz, Spain	Hospital Carlos III	Gonzalo-Garijo, MA (corresponding author), Infanta Cristina Univ Hosp, Dept Allergol & Clin Immunol, Badajoz, Spain.	magonzalog@telefonica.net	Gonzalo-Garijo, M. Angeles/AAA-3418-2019	Gonzalo-Garijo, M. Angeles/0000-0002-0714-2429				Brehler B, 1996, CONTACT DERMATITIS, V34, P296; Brehler R, 1997, CONTACT DERMATITIS, V37, P125, DOI 10.1111/j.1600-0536.1997.tb00317.x; Crippa M, 2003, AM J IND MED, V44, P24, DOI 10.1002/ajim.10232; Estlander T, 1987, Acta Derm Venereol Suppl (Stockh), V134, P98; FITkit, FITKIT 1 SPECIFIC TE; Horn HM, 2003, CONTACT DERMATITIS, V49, P163, DOI 10.1111/j.0105-1873.2003.0185g.x; Peixinho C, 2006, Allergol Immunopathol (Madr), V34, P206, DOI 10.1157/13094028; Villalta D, 2000, ALLERGY, V55, P153	8	6	6	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2012	129	2					562	564		10.1016/j.jaci.2011.09.016	http://dx.doi.org/10.1016/j.jaci.2011.09.016			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	887TC	22018900				2022-12-18	WOS:000299951700040
J	Cahill, KN; Harrison, P; de Asis, M; Castells, M				Cahill, K. N.; Harrison, P.; de Asis, M.; Castells, M.			Use of Omalizumab to Achieve Successful Desensitization After Oxaliplatin Anaphylaxis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 02-06, 2012	Orlando, FL	Amer Acad Allergy Asthma & Immunol (AAAAI)					[Cahill, K. N.; Harrison, P.; Castells, M.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Cahill, K. N.; Castells, M.] Harvard Univ, Sch Med, Boston, MA USA; [de Asis, M.] Asthma & Allergy Consultants Rockland Bergan Cty, W Nyack, NY USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School									0	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2012	129	2		S			AB103	AB103		10.1016/j.jaci.2011.12.515	http://dx.doi.org/10.1016/j.jaci.2011.12.515			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	903QL					2022-12-18	WOS:000301133400393
J	de la Roca, F; Blanca-Lopez, N; Rondon, C; Herrera, R; Rodriguez-Bada, JL; Canto, G; Brito, FF; Gomez, MB				de la Roca, F.; Blanca-Lopez, N.; Rondon, C.; Herrera, R.; Rodriguez-Bada, J. L.; Canto, G.; Feo Brito, F.; Blanca Gomez, M.			Seasonal Local Allergic Rhinitis in Areas with High Exposure to Grass Pollen	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 02-06, 2012	Orlando, FL	Amer Acad Allergy Asthma & Immunol (AAAAI)					[de la Roca, F.; Feo Brito, F.] Gen Hosp, Allergy Sect, Ciudad Real, Spain; [Blanca-Lopez, N.; Canto, G.] Infanta Leonor Hosp, Allergy Serv, Madrid, Spain; [Rondon, C.; Blanca Gomez, M.] Carlos Haya Hosp, Allergy Serv, Malaga, Spain; [Herrera, R.; Rodriguez-Bada, J. L.] Carlos Haya Hosp Fdn IMABIS, Res Lab, Malaga, Spain	Hospital Universitario Infanta Leonor; Hospital Carlos Haya; Hospital Carlos Haya									0	6	6	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2012	129	2		S			AB111	AB111		10.1016/j.jaci.2011.12.546	http://dx.doi.org/10.1016/j.jaci.2011.12.546			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	903QL					2022-12-18	WOS:000301133400424
J	Gilles, S; Traidl-Hoffmann, C				Gilles, Stefanie; Traidl-Hoffmann, Claudia			CD27 expression on allergen-specific T cells: A new surrogate for successful allergen-specific immunotherapy?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Allergen-specific immunotherapy; T cells; differentiation; peptide-MHC class II tetramers; costimulation	RESPONSES; IL-10; IGG4		[Gilles, Stefanie; Traidl-Hoffmann, Claudia] Tech Univ Munich, Ctr Allergy & Environm ZAUM, D-80802 Munich, Germany; [Traidl-Hoffmann, Claudia] Tech Univ Munich, Dept Dermatol, D-80802 Munich, Germany; [Gilles, Stefanie; Traidl-Hoffmann, Claudia] Helmholtz Ctr, Munich, Germany	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Traidl-Hoffmann, C (corresponding author), Tech Univ Munich, Ctr Allergy & Environm ZAUM, Biedersteinerstr 29, D-80802 Munich, Germany.	traidl-hoffmann@lrz.tum.de	Gilles-Stein, Stefanie/AAA-3741-2021	Gilles-Stein, Stefanie/0000-0002-5159-2558; Traidl-Hoffmann, Claudia/0000-0001-5085-5179				Akdis CA, 2011, J ALLERGY CLIN IMMUN, V127, P18, DOI 10.1016/j.jaci.2010.11.030; Di Lorenzo G, 2009, J ALLERGY CLIN IMMUN, V123, P1103, DOI 10.1016/j.jaci.2009.02.012; Francis JN, 2008, J ALLERGY CLIN IMMUN, V121, P1120, DOI 10.1016/j.jaci.2008.01.072; Francis JN, 2008, J ALLERGY CLIN IMMUN, V121, pe2; James LK, 2011, J ALLERGY CLIN IMMUN, V127, P509, DOI 10.1016/j.jaci.2010.12.1080; Kawamura T, 2011, J INVEST DERMATOL, V131, P1252, DOI 10.1038/jid.2011.36; Kwok WW, 2010, J ALLERGY CLIN IMMUN, V125, P1407, DOI 10.1016/j.jaci.2010.03.037; Kwok WW, 2010, J ALLERGY CLIN IMMUN, V125, pe1; Libregts S, 2011, IMMUNOL LETT, V136, P177, DOI 10.1016/j.imlet.2011.01.008; Ring J, 2011, ALLERGY, V66, P713, DOI 10.1111/j.1398-9995.2010.02541.x; Salek-Ardakani S, 2011, J IMMUNOL, V186, P5294, DOI 10.4049/jimmunol.1100406; Satoguina JS, 2008, EUR J IMMUNOL, V38, P3101, DOI 10.1002/eji.200838193; Upadhyaya B, 2011, J IMMUNOL, V187, P3111, DOI 10.4049/jimmunol.1101283; Van Overtvelt L, 2008, J IMMUNOL, V180, P4514, DOI 10.4049/jimmunol.180.7.4514; Wambre E, 2011, CLIN EXP ALLERGY, V41, P192, DOI 10.1111/j.1365-2222.2010.03641.x; Wambre E, 2012, J ALLERGY CLIN IMMUN, V129, P544	16	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2012	129	2					552	554		10.1016/j.jaci.2011.12.967	http://dx.doi.org/10.1016/j.jaci.2011.12.967			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	887TC	22284933				2022-12-18	WOS:000299951700036
J	Bandino, ML; Tankersley, MS				Bandino, Michelle L.; Tankersley, Michael S.			Anaphylaxis in an allergy immunotherapy extract-compounding technician after an extract needle stick	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							SYSTEMIC REACTIONS; INJECTIONS		[Bandino, Michelle L.; Tankersley, Michael S.] Wilford Hall USAF Med Ctr, Dept Med, Div Allergy Immunol, San Antonio, TX USA	United States Department of Defense; United States Air Force	Bandino, ML (corresponding author), Wilford Hall USAF Med Ctr, Dept Med, Div Allergy Immunol, San Antonio, TX USA.							Bernstein DI, 2010, ANN ALLERG ASTHMA IM, V104, P530, DOI 10.1016/j.anai.2010.04.008; Bernstein DI, 2004, J ALLERGY CLIN IMMUN, V113, P1129, DOI 10.1016/j.jaci.2004.02.006; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; Lockey RF, 2001, ANN ALLERG ASTHMA IM, V87, P47, DOI 10.1016/S1081-1206(10)62195-3; Watt AD, 1996, OCCUP ENVIRON MED, V53, P573, DOI 10.1136/oem.53.8.573	5	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2012	129	1					250	251		10.1016/j.jaci.2011.08.028	http://dx.doi.org/10.1016/j.jaci.2011.08.028			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	869XT	21958586				2022-12-18	WOS:000298634000033
J	Matjeka, T; Summerfield, V; Noursadeghi, M; Chain, BM				Matjeka, Theres; Summerfield, Vicki; Noursadeghi, Mahdad; Chain, Benjamin M.			Chemical toxicity to keratinocytes triggers dendritic cell activation via an IL-1 alpha path	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ROLES		[Matjeka, Theres; Noursadeghi, Mahdad; Chain, Benjamin M.] UCL, Div Infect & Immun, London, England; [Summerfield, Vicki] Unilever, Safety & Environm Assurance Ctr, Sharnbrook, Beds, England	University of London; University College London; Unilever	Matjeka, T (corresponding author), UCL, Div Infect & Immun, London, England.	b.chain@ucl.ac.uk		Noursadeghi, Mahdad/0000-0002-4774-0853; Chain, Benny/0000-0002-7417-3970	MRC [G0900950, G9721629] Funding Source: UKRI; Medical Research Council [G9721629B, G0900950B] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council [G0900950, G9721629] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Feliciani C, 1996, CRIT REV ORAL BIOL M, V7, P300, DOI 10.1177/10454411960070040101; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Le Bert N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018346; Nishibu A, 2007, J DERMATOL SCI, V45, P23, DOI 10.1016/j.jdermsci.2006.10.003; Pollara G, 2004, J IMMUNOL, V173, P4108, DOI 10.4049/jimmunol.173.6.4108; Reske A, 2008, J IMMUNOL, V180, P7525, DOI 10.4049/jimmunol.180.11.7525; Tokura Y, 2008, EXP DERMATOL, V17, P81, DOI 10.1111/j.1600-0625.2007.00657.x; Wittmann M, 2006, CURR OPIN ALLERGY CL, V6, P329, DOI 10.1097/01.all.0000244792.95615.3a	9	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2012	129	1					247	250		10.1016/j.jaci.2011.08.018	http://dx.doi.org/10.1016/j.jaci.2011.08.018			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	869XT	21943942				2022-12-18	WOS:000298634000032
J	Oyoshi, MK; Wang, JYT; Geha, RS				Oyoshi, Michiko K.; Wang, James Y. T.; Geha, Raif S.			Immunization with modified vaccinia virus Ankara prevents eczema vaccinatum in a murine model of atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IMMUNE-RESPONSE; SMALLPOX; MVA		[Oyoshi, Michiko K.] Harvard Univ, Childrens Hosp, Sch Med, Div Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Oyoshi, MK (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Immunol, Boston, MA 02115 USA.	raif.geha@childrens.harvard.edu		Wang, James/0000-0003-2711-0827	NIAID NIH HHS [HHSN272201000020I, HHSN272201000020C] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abadie V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008159; Combadiere B, 2004, J EXP MED, V199, P1585, DOI 10.1084/jem.20032083; GOLDSTEIN JA, 1975, PEDIATRICS, V55, P342; Howell MD, 2006, IMMUNITY, V24, P341, DOI 10.1016/j.immuni.2006.02.006; Leung DYM, 2011, J ALLERGY CLIN IMMUN, V127, P965, DOI 10.1016/j.jaci.2011.02.010; LEUNG DY, 2011, J ALLERGY CLIN IMMUN, V127, pE5; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Oyoshi MK, 2009, P NATL ACAD SCI USA, V106, P14954, DOI 10.1073/pnas.0904021106; Ramirez JC, 2003, ARCH VIROL, V148, P827, DOI 10.1007/s00705-003-0006-z; Stittelaar KJ, 2001, VACCINE, V19, P3700, DOI 10.1016/S0264-410X(01)00075-5	10	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2011	128	4					890	U325		10.1016/j.jaci.2011.06.042	http://dx.doi.org/10.1016/j.jaci.2011.06.042			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	841UA	21820712	Green Accepted			2022-12-18	WOS:000296538100030
J	Szczeklik, A				Szczeklik, Andrzej			Hypersensitivity to systemic corticosteroids in aspirin-sensitive patients with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							HYDROCORTISONE SODIUM SUCCINATE; INTRAVENOUS HYDROCORTISONE		Jagiellonian Univ, Coll Med, Dept Med, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University	Szczeklik, A (corresponding author), Jagiellonian Univ, Coll Med, Dept Med, Krakow, Poland.	mmszczek@cyf-kr.edu.pl						DAJANI BM, 1981, J ALLERGY CLIN IMMUN, V68, P201, DOI 10.1016/0091-6749(81)90184-6; FEIGENBAUM BA, 1995, J ALLERGY CLIN IMMUN, V96, P545, DOI 10.1016/S0091-6749(95)70299-7; Gluck J, 2009, POL ARCH MED WEWN, V119, P418, DOI 10.20452/pamw.723; PARTRIDGE MR, 1978, BRIT MED J, V1, P1521, DOI 10.1136/bmj.1.6126.1521; Rachid R, 2011, J ALLERGY CLIN IMMUN, V127, P524, DOI 10.1016/j.jaci.2010.09.030; SZCZEKLIK A, 1985, J ALLERGY CLIN IMMUN, V76, P530, DOI 10.1016/0091-6749(85)90771-7; TANIGUCHI M, 1998, 8 C ALL CLIN IMM MON	7	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2011	128	4					904	905		10.1016/j.jaci.2011.05.026	http://dx.doi.org/10.1016/j.jaci.2011.05.026			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	841UA	21700324	Green Submitted			2022-12-18	WOS:000296538100038
J	Schatz, M; Zeiger, RS; Yang, SJ; Chen, WS; Kosinski, M				Schatz, Michael; Zeiger, Robert S.; Yang, Su-Jau; Chen, Wansu; Kosinski, Mark			Further validation and definition of the psychometric properties of the Asthma Impact Survey	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; quality of life; Asthma Impact Survey; validation; psychometric properties	QUALITY-OF-LIFE; MINIMALLY IMPORTANT DIFFERENCES; DISEASE; RESPONSIVENESS; QUESTIONNAIRE; OUTCOMES; CHILDREN	Background: The Asthma Impact Survey (AIS-6) is a brief disease-specific quality-of-life instrument with limited published validation data. Objective: To obtain additional validation data and psychometric properties of the AIS-6. Methods: In November, 2007, patients with persistent asthma were mailed a survey that included the AIS-6, the mini-Asthma Quality of Life Questionnaire (mAQLQ), and the Asthma Control Test (ACT). Follow-up surveys were sent in April, July, and October 2008. Year 2008 exacerbations and short-acting beta-agonist (SABA) dispensings were captured from administrative data. Results: A total of 2680 patients had complete baseline survey data. Criterion validity was demonstrated by the strong correlations of the AIS-6 with the mAQLQ (r = -0.84 to -0.86); construct validity by significant relationships (P < .0001) of the AIS-6 with mAQLQ domain scores, ACT score, and history of exacerbations; and predictive validity by significant relationships (P < .0001) between AIS-6 scores at the end of 2007 and year 2008 exacerbations and high SABA dispensings. Responsiveness was demonstrated by significant (P < .0001) correlations (r = -0.39 to -0.58) between changes in AIS-6 scores and changes in mAQLQ and ACT scores over time. A preliminary minimally important difference (MID) in AIS-6 was estimated to be 4 by using the mAQLQ MID as an anchor. Excellent internal consistency (alpha = 0.94) and test-retest reliability (intraclass correlation coefficient = 0.86-0.91) were also demonstrated. Conclusion: The AIS-6 demonstrated good psychometric properties in a large independent sample and could be used to assess asthma-specific quality of life in clinical practice and clinical research. (J Allergy Clin Immunol 2011; 128: 44-9.)	[Schatz, Michael; Zeiger, Robert S.] Kaiser Permanente Med Ctr, Dept Allergy, San Diego, CA 92111 USA; [Yang, Su-Jau; Chen, Wansu] Kaiser Permanente Med Ctr, Dept Res & Evaluat, Los Angeles, CA 90034 USA; [Kosinski, Mark] QualityMetric, Lincoln, NE USA	Kaiser Permanente; Kaiser Permanente	Schatz, M (corresponding author), Kaiser Permanente Med Ctr, Dept Allergy, 7060 Clairemont Mesa Blvd, San Diego, CA 92111 USA.	michael.x.schatz@kp.org		Zeiger, Robert/0000-0001-5788-5063	Merck and Co, Inc.; Aerocrine; Genentech; Merck and Co; GlaxoSmithKline	Merck and Co, Inc.(Merck & Company); Aerocrine; Genentech(Roche HoldingGenentech); Merck and Co(Merck & Company); GlaxoSmithKline(GlaxoSmithKline)	This study is an independent secondary analysis of a study initially supported by a research grant from Merck and Co, Inc.; Disclosure of potential conflict of interest: R. S. Zeiger has consultant arrangements with AstraZeneca, Aerocrine, Genentech, Merck and Co, Schering-Plough, MedImmune, and Sunovion and receives research support from Aerocrine, Genentech, Merck and Co, and GlaxoSmithKline. The rest of the authors have declared that they have no conflict of interest.	Bayliss MS, 2000, QUAL LIFE RES, V9, P451, DOI 10.1023/A:1008939328060; Cohen J., 1988, STAT POWER ANAL BEHA; Curtis JR, 1997, AM J RESP CRIT CARE, V156, P1032, DOI 10.1164/ajrccm.156.4.97-02011; Holt EW, 2008, J ALLERGY CLIN IMMUN, V121, P1175, DOI 10.1016/j.jaci.2008.02.015; Juniper EF, 2004, EUR RESPIR J, V23, P287, DOI 10.1183/09031936.04.00064204; Juniper EF, 1999, EUR RESPIR J, V14, P32, DOI 10.1034/j.1399-3003.1999.14a08.x; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Juniper EF, 1999, CHEST, V115, P1265, DOI 10.1378/chest.115.5.1265; Juniper EF, 1996, QUAL LIFE RES, V5, P35, DOI 10.1007/BF00435967; Katz PP, 1999, J CLIN EPIDEMIOL, V52, P667, DOI 10.1016/S0895-4356(99)00026-8; Kerlinger FN, 1973, FDN BEHAV RES, V2nd; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; *NIH, 2011, J ALLERGY C IN PRESS; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Oh EG, 2008, J ASTHMA, V45, P882, DOI 10.1080/02770900802252069; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Riekert KA, 2008, J ALLERGY CLIN IMMUN, V121, P1181, DOI 10.1016/j.jaci.2008.03.023; Rosner B, 2011, FUNDAMENTALS BIOSTAT; Schatz M, 2005, J ALLERGY CLIN IMMUN, V115, P1049, DOI 10.1016/j.jaci.2005.02.008; Schatz M, 2007, QUAL LIFE RES, V16, P345, DOI 10.1007/s11136-006-9103-2; Schatz M, 2006, J ALLERGY CLIN IMMUN, V117, P995, DOI 10.1016/j.jaci.2006.01.053; Schatz M, 2010, AM J MANAG CARE, V16, pE281; Schatz M, 2009, ALLERGY FRONTIERS: DIAGNOSIS AND HEALTH ECONOMICS, VOL 4, P507, DOI 10.1007/978-4-431-98349-1_28; Schatz M, 2009, J ALLERGY CLIN IMMUN, V124, P719, DOI 10.1016/j.jaci.2009.06.053; STEINER DL, 1995, HLTH MEASUREMENT SCA; Thompson B., 2004, EXPLORATORY CONFIRMA, DOI [10.1037/10694-000, DOI 10.1037/10694-000]; Vollmer WM, 2002, AM J RESP CRIT CARE, V165, P195, DOI 10.1164/ajrccm.165.2.2102127; Wyrwich KW, 1999, J CLIN EPIDEMIOL, V52, P861, DOI 10.1016/S0895-4356(99)00071-2; Yost KJ, 2005, EVAL HEALTH PROF, V28, P172, DOI 10.1177/0163278705275340; 2009, FOOD DRUG ADM GUIDAN	32	6	6	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2011	128	1					44	U86		10.1016/j.jaci.2010.12.1112	http://dx.doi.org/10.1016/j.jaci.2010.12.1112			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	785RE	21320719	Bronze			2022-12-18	WOS:000292245600004
J	Fan, YP; Xia, WT; Liu, WL; Chen, R; Li, XM; Xu, R; Xu, G; Shi, JB; Li, HB				Fan, Yunping; Xia, Wentong; Liu, Wenlong; Chen, Rong; Li, Xiaomin; Xu, Rui; Xu, Geng; Shi, Jianbo; Li, Huabin			Increased nasal IL-5 levels act as a predisposing factor of asthma in southern China	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Fan, Yunping; Liu, Wenlong; Xu, Rui; Xu, Geng; Shi, Jianbo; Li, Huabin] Sun Yat Sen Univ, Affiliated Hosp 1, Allergy & Canc Ctr, Otorhinolaryngol Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Fan, Yunping; Liu, Wenlong; Xu, Rui; Xu, Geng; Shi, Jianbo; Li, Huabin] Sun Yat Sen Univ, Otorhinolaryngol Inst, Guangzhou 510275, Guangdong, Peoples R China; [Fan, Yunping; Xia, Wentong] Sun Yat Sen Univ, Affiliated Hosp 1, Allergy Ctr, Zhuhai, Peoples R China; [Chen, Rong] Zhongshan Citys Hosp, Dept Otolaryngol, Zhongshan, Peoples R China; [Li, Xiaomin] Zhuhai Citys Hosp, Dept Otolaryngol, Zhuhai, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Fan, YP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Allergy & Canc Ctr, Otorhinolaryngol Hosp, Guangzhou 510275, Guangdong, Peoples R China.	entxgfess@163.com						Bachert C, 2010, J ALLERGY CLIN IMMUN, V126, P962, DOI 10.1016/j.jaci.2010.07.007; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Fan Y, 2011, J ALLERGY CLIN IMMUN, V127, P520; Liu F, 2010, ALLERGY, V65, P1149, DOI 10.1111/j.1398-9995.2010.02340.x; Xu R, 2002, CHINESE MED J-PEKING, V115, P1386; Zhang L, 2001, Zhonghua Er Bi Yan Hou Ke Za Zhi, V36, P444; Zhang Luo, 2004, Zhonghua Er Bi Yan Hou Ke Za Zhi, V39, P672	7	6	6	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2011	127	5					1312	1313		10.1016/j.jaci.2011.01.059	http://dx.doi.org/10.1016/j.jaci.2011.01.059			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	756NG	21397309				2022-12-18	WOS:000290018600036
J	Frati, F; Incorvaia, C; Scurati, S; Sensi, L; Marcucci, F				Frati, Franco; Incorvaia, Cristoforo; Scurati, Silvia; Sensi, Laura; Marcucci, Francesco			Dose-dependence of sublingual immunotherapy shown by meta-analysis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALLERGIC RHINITIS		[Frati, Franco; Sensi, Laura; Marcucci, Francesco] Inst Pediat, Dept Med & Surg Specialty & Publ Hlth, Perugia, Italy; [Incorvaia, Cristoforo] ICP Hosp, Milan, Italy; [Frati, Franco; Scurati, Silvia] Stallergenes, Dept Med, Milan, Italy	Stallergenes Greer	Frati, F (corresponding author), Inst Pediat, Dept Med & Surg Specialty & Publ Hlth, Perugia, Italy.	frati.f@stallergenes.is						Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Canonica GW, 2009, ALLERGY, V64, P1, DOI 10.1111/j.1398-9995.2009.02309.x; Canonica GW, 2003, J ALLERGY CLIN IMMUN, V111, P437, DOI 10.1067/mai.2003.129; Di Bona D, 2010, J ALLERGY CLIN IMMUN, V126, P558, DOI 10.1016/j.jaci.2010.06.013; Didier A, 2007, J ALLERGY CLIN IMMUN, V120, P1338, DOI 10.1016/j.jaci.2007.07.046; Durham SR, 2006, J ALLERGY CLIN IMMUN, V117, P802, DOI 10.1016/j.jaci.2005.12.1358	6	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2011	127	4					1076	1077		10.1016/j.jaci.2010.12.1091	http://dx.doi.org/10.1016/j.jaci.2010.12.1091			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	743YL	21306764				2022-12-18	WOS:000289055800038
J	Leung, DYM				Leung, Donald Y. M.			Food allergy: Are we getting closer to a cure?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Food allergy; IgE; immunotherapy; filaggrin; gastroenterology	EGG ALLERGY; RISK-FACTOR; PEANUT; IMMUNOTHERAPY; PREVALENCE; CONSUMPTION; FILAGGRIN; CHILDREN; INFANTS; MILK		[Leung, Donald Y. M.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Leung, Donald Y. M.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA	National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Leung, DYM (corresponding author), Natl Jewish Hlth, Dept Pediat, 1400 Jackson St,Room K926I, Denver, CO 80206 USA.	leungd@njhealth.org						[Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Barnes KC, 2010, J ALLERGY CLIN IMMUN, V125, P16, DOI 10.1016/j.jaci.2009.11.008; Ben-Shoshan M, 2010, J ALLERGY CLIN IMMUN, V125, P1327, DOI 10.1016/j.jaci.2010.03.015; Blumchen K, 2010, J ALLERGY CLIN IMMUN, V126, P83, DOI 10.1016/j.jaci.2010.04.030; Boyce Joshua A, 2010, J Allergy Clin Immunol, V126, P1105, DOI 10.1016/j.jaci.2010.10.008; Brown SJ, 2011, J ALLERGY CLIN IMMUN, V127, P661, DOI 10.1016/j.jaci.2011.01.031; Clark S, 2011, J ALLERGY CLIN IMMUN, V127, P682, DOI 10.1016/j.jaci.2010.10.040; De Benedetto Anna, 2011, J Allergy Clin Immunol, V127, P773, DOI 10.1016/j.jaci.2010.10.018; Du Toit G, 2008, J ALLERGY CLIN IMMUN, V122, P984, DOI 10.1016/j.jaci.2008.08.039; DunnGalvin A, 2011, J ALLERGY CLIN IMMUN, V127, P633, DOI 10.1016/j.jaci.2010.12.004; Dupont C, 2010, J ALLERGY CLIN IMMUN, V125, P1165, DOI 10.1016/j.jaci.2010.02.029; Fiocchi A, 2010, J ALLERGY CLIN IMMUN, V126, P1119, DOI 10.1016/j.jaci.2010.10.011; Ford LS, 2010, J ALLERGY CLIN IMMUN, V126, P384, DOI 10.1016/j.jaci.2010.05.034; Fox AT, 2009, J ALLERGY CLIN IMMUN, V123, P417, DOI 10.1016/j.jaci.2008.12.014; Geroldinger-Simic M, 2011, J ALLERGY CLIN IMMUN, V127, P616, DOI 10.1016/j.jaci.2010.10.027; Guttman-Yassky E, 2009, J ALLERGY CLIN IMMUN, V124, P1235, DOI 10.1016/j.jaci.2009.09.031; Katz Y, 2010, J ALLERGY CLIN IMMUN, V126, P77, DOI 10.1016/j.jaci.2010.04.020; Kim Edwin H, 2011, J Allergy Clin Immunol, V127, P640, DOI 10.1016/j.jaci.2010.12.1083; Koplin JJ, 2010, J ALLERGY CLIN IMMUN, V126, P807, DOI 10.1016/j.jaci.2010.07.028; Kotz D, 2011, J ALLERGY CLIN IMMUN, V127, P623, DOI 10.1016/j.jaci.2010.11.021; Le TM, 2011, J ALLERGY CLIN IMMUN, V127, P677, DOI 10.1016/j.jaci.2010.10.003; Leung DYM, 2009, J ALLERGY CLIN IMMUN, V124, P494, DOI 10.1016/j.jaci.2009.07.041; Liu Andrew H, 2010, J Allergy Clin Immunol, V126, P798, DOI 10.1016/j.jaci.2010.07.026; Massanari M, 2010, J ALLERGY CLIN IMMUN, V125, P383, DOI 10.1016/j.jaci.2009.11.022; Nicolaou N, 2011, J ALLERGY CLIN IMMUN, V127, P684, DOI 10.1016/j.jaci.2010.12.012; Nicolaou N, 2010, J ALLERGY CLIN IMMUN, V125, P191, DOI 10.1016/j.jaci.2009.10.008; Nowak-Wegrzyn A, 2011, J ALLERGY CLIN IMMUN, V127, P558, DOI 10.1016/j.jaci.2010.12.1098; Prickett SR, 2011, J ALLERGY CLIN IMMUN, V127, P608, DOI 10.1016/j.jaci.2010.09.027; Rudders SA, 2010, J ALLERGY CLIN IMMUN, V126, P385, DOI 10.1016/j.jaci.2010.05.018; Sampson HA, 2011, J ALLERGY CLIN IMMUN, V127, DOI [10.1016/j.jaci.2011.01.051, DOI 10.1016/J.JACI.2011.01.051]; Savage JH, 2010, J ALLERGY CLIN IMMUN, V125, P683, DOI 10.1016/j.jaci.2009.12.994; Savilahti EM, 2010, J ALLERGY CLIN IMMUN, V125, P1315, DOI 10.1016/j.jaci.2010.03.025; Shek LPC, 2010, J ALLERGY CLIN IMMUN, V126, P324, DOI 10.1016/j.jaci.2010.06.003; Sicherer SH, 2011, J ALLERGY CLIN IMMUN, V127, P594, DOI 10.1016/j.jaci.2010.11.044; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1322, DOI 10.1016/j.jaci.2010.03.029; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, pS116, DOI 10.1016/j.jaci.2009.08.028; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1077, DOI 10.1016/j.jaci.2010.02.038; Song Y, 2010, J ALLERGY CLIN IMMUN, V126, P1208, DOI 10.1016/j.jaci.2010.09.013; Thyagarajan A, 2010, J ALLERGY CLIN IMMUN, V126, P31, DOI 10.1016/j.jaci.2010.05.012; van Nieuwaal NHG, 2010, J ALLERGY CLIN IMMUN, V125, P1391, DOI 10.1016/j.jaci.2010.01.057; Vassallo MF, 2010, J ALLERGY CLIN IMMUN, V126, P217, DOI 10.1016/j.jaci.2010.06.011; Vereda A, 2011, J ALLERGY CLIN IMMUN, V127, P603, DOI 10.1016/j.jaci.2010.09.010; Vickery BP, 2011, J ALLERGY CLIN IMMUN, V127, P576, DOI 10.1016/j.jaci.2010.12.1116; Wang MQ, 2010, J ALLERGY CLIN IMMUN, V126, P306, DOI 10.1016/j.jaci.2010.05.017	44	6	7	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2011	127	3					555	557		10.1016/j.jaci.2011.01.029	http://dx.doi.org/10.1016/j.jaci.2011.01.029			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	730FG	21377029				2022-12-18	WOS:000288018400001
J	Peden, DB; Bush, RK				Peden, David B.; Bush, Robert K.			Advances in environmental and occupational respiratory disease in 2010	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Immunotherapy; allergic disease; occupational respiratory disease; hypoallergens; immunotherapy	HYPOALLERGENIC DERIVATIVES; ASTHMA	2010 found a number of significant advances in environmental and occupational respiratory disease. The role of sensitization and the subsequent production of allergic disease have been explored. New allergens and their T- and B-cell epitopes have been characterized. Novel approaches to the diagnosis and evaluation of food allergy have been described. The role of pollutants as they affect respiratory disease and the effects of age extremes on sensitization and asthma have been addressed. Significant advances in the understanding of inflammatory changes in both the upper and lower respiratory systems occurred. Novel therapeutic approaches have been explored, including the development of hypoallergens from improved molecular biology techniques. New effective approaches to asthma therapy have been identified. Exposure reduction through air filtration and novel immunotherapy approaches, such as sublingual therapy, have made significant advances. (J Allergy Clin Immunol 2011;127:696-700.)	[Peden, David B.] Univ N Carolina, Div Pediat Allergy Immunol Rheumatol & Infect Dis, Sch Med, Chapel Hill, NC 27599 USA; [Bush, Robert K.] Univ Wisconsin, Madison Sch Med & Publ Hlth, Div Allergy Clin Immunol Pulm Crit Care & Sleep M, Madison, WI USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Wisconsin System; University of Wisconsin Madison	Peden, DB (corresponding author), Univ N Carolina, Div Pediat Allergy Immunol Rheumatol & Infect Dis, Sch Med, 104 Mason Farm Rd, Chapel Hill, NC 27599 USA.	david_peden@med.unc.edu		Peden, David/0000-0003-4526-4627				Campana R, 2010, J ALLERGY CLIN IMMUN, V126, P1024, DOI 10.1016/j.jaci.2010.05.023; Contoli M, 2010, J ALLERGY CLIN IMMUN, V125, P830, DOI 10.1016/j.jaci.2010.01.003; Di Bona D, 2010, J ALLERGY CLIN IMMUN, V126, P558, DOI 10.1016/j.jaci.2010.06.013; Durham SR, 2010, J ALLERGY CLIN IMMUN, V125, P131, DOI 10.1016/j.jaci.2009.10.035; Eckl-Dorna J, 2010, J ALLERGY CLIN IMMUN, V126, P1315, DOI 10.1016/j.jaci.2010.06.012; Hernandez ML, 2010, J ALLERGY CLIN IMMUN, V126, P537, DOI 10.1016/j.jaci.2010.06.043; Ilchmann A, 2010, J ALLERGY CLIN IMMUN, V125, P175, DOI 10.1016/j.jaci.2009.08.013; Jin C, 2010, J ALLERGY CLIN IMMUN, V125, P184, DOI 10.1016/j.jaci.2009.08.037; Mittermann I, 2010, J ALLERGY CLIN IMMUN, V125, P1300, DOI 10.1016/j.jaci.2010.03.017; Mueller GA, 2010, J ALLERGY CLIN IMMUN, V125, P909, DOI 10.1016/j.jaci.2009.12.016; Nelson H, 2010, J ALLERGY CLIN IMMUN, V125, P390, DOI 10.1016/j.jaci.2009.11.036; Parviainen S, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.06.005; Pongracic JA, 2010, J ALLERGY CLIN IMMUN, V125, P593, DOI 10.1016/j.jaci.2009.10.036; Price D, 2010, J ALLERGY CLIN IMMUN, V126, P511, DOI 10.1016/j.jaci.2010.06.040; Reed CE, 2010, J ALLERGY CLIN IMMUN, V126, P681, DOI 10.1016/j.jaci.2010.05.035; Saghafian-Hedengren S, 2010, J ALLERGY CLIN IMMUN, V125, P433, DOI 10.1016/j.jaci.2009.09.033; Soeria-Atmadja D, 2010, J ALLERGY CLIN IMMUN, V125, P1379, DOI 10.1016/j.jaci.2010.02.028; Sublett JL, 2010, J ALLERGY CLIN IMMUN, V125, P32, DOI 10.1016/j.jaci.2009.08.036; Thalhamer T, 2010, J ALLERGY CLIN IMMUN, V125, P926, DOI 10.1016/j.jaci.2010.01.031; Tieu DD, 2010, J ALLERGY CLIN IMMUN, V125, P667, DOI 10.1016/j.jaci.2009.11.045; Verbanck S, 2010, J ALLERGY CLIN IMMUN, V125, P611, DOI 10.1016/j.jaci.2009.10.053; Wegienka G, 2010, J ALLERGY CLIN IMMUN, V126, P274, DOI 10.1016/j.jaci.2010.05.001; Williams LK, 2010, J ALLERGY CLIN IMMUN, V126, P225, DOI 10.1016/j.jaci.2010.03.034; Yang AC, 2010, J ALLERGY CLIN IMMUN, V125, P872, DOI 10.1016/j.jaci.2009.11.043	24	6	6	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2011	127	3					696	700		10.1016/j.jaci.2011.01.030	http://dx.doi.org/10.1016/j.jaci.2011.01.030			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	730FG	21377039				2022-12-18	WOS:000288018400025
J	Brough, HA; Costa, J; Penagos, M; Haddad, DF; Davidson, L; Peachey, H; Lack, G				Brough, H. A.; Costa, J.; Penagos, M.; Haddad, D. F.; Davidson, L.; Peachey, H.; Lack, G.			Increase in Multiple Nut Reactivity with Increasing Age is Not an Artefact of Incomplete Allergy Testing	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting	MAR 18-22, 2011	San Francisco, CA	Amer Acad Allergy Asthma & Immunol					[Brough, H. A.; Penagos, M.; Lack, G.] Kings Coll London, London WC2R 2LS, England; [Costa, J.; Davidson, L.] Guys & St Thomas Hosp, London SE1 9RT, England; [Haddad, D. F.; Peachey, H.] St Peters Hosp, Chertsey, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust									0	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2		S			AB186	AB186		10.1016/j.jaci.2010.12.741	http://dx.doi.org/10.1016/j.jaci.2010.12.741			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	832YI					2022-12-18	WOS:000295846400723
J	Brown, TA; Whitworth, HS; Zhou, XY; Lau, L; Eren, E; Walls, AF				Brown, T. A.; Whitworth, H. S.; Zhou, X. Y.; Lau, L.; Eren, E.; Walls, A. F.			Mast Cell Carboxypeptidase as a Confirmatory and Predictive Marker in Allergic Reactions to Drugs	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting	MAR 18-22, 2011	San Francisco, CA	Amer Acad Allergy Asthma & Immunol					[Brown, T. A.; Whitworth, H. S.; Zhou, X. Y.; Lau, L.; Walls, A. F.] Univ Southampton, Southampton, Hants, England; [Eren, E.] Southampton Univ Hosp NHS Trust, Southampton, Hants, England	University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust			Whitworth, Hilary/AAB-1288-2019						0	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2		S			AB143	AB143		10.1016/j.jaci.2010.12.567	http://dx.doi.org/10.1016/j.jaci.2010.12.567			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	832YI					2022-12-18	WOS:000295846400549
J	Ghosh, S; Mega, TL; German, S; Burke, LM; Diegel, ML; Wood, AB; Watson, RL				Ghosh, S.; Mega, T. L.; German, S.; Burke, L. M.; Diegel, M. L.; Wood, A. B.; Watson, R. L.			Isotonic Saline Subjected to Taylor-Couette-Poiseuille Flow Demonstrates Anti-Inflammatory Activity in a Rat Model of Allergic Asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting	MAR 18-22, 2011	San Francisco, CA	Amer Acad Allergy Asthma & Immunol					[Ghosh, S.; Mega, T. L.; German, S.; Burke, L. M.; Diegel, M. L.; Wood, A. B.; Watson, R. L.] Revalesio Corp, Tacoma, WA USA										0	6	6	1	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2		S			AB84	AB84		10.1016/j.jaci.2010.12.343	http://dx.doi.org/10.1016/j.jaci.2010.12.343			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	832YI					2022-12-18	WOS:000295846400326
J	Hemmer, W; Schauer, U; Trinca, A; Neumann, C; Jarisch, R				Hemmer, W.; Schauer, U.; Trinca, A.; Neumann, C.; Jarisch, R.			Ragweed Pollen Allergy in Austria: a Retrospective Analysis of Sensitization Rates from 1997 to 2007	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting	MAR 18-22, 2011	San Francisco, CA	Amer Acad Allergy Asthma & Immunol					[Hemmer, W.; Jarisch, R.] Floridsdorf Allergy Ctr, Vienna, Austria; [Schauer, U.; Trinca, A.] Off Prov Govt Niederosterreich, Dept Environm Hlth, St Polten, Austria; [Neumann, C.] Off Prov Govt Niederosterreich, Dept Reg Dev & Policy, Stat Unit, Maria Enzersdorf, Austria										0	6	6	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2		S			AB170	AB170		10.1016/j.jaci.2010.12.675	http://dx.doi.org/10.1016/j.jaci.2010.12.675			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	832YI					2022-12-18	WOS:000295846400657
J	Mathur, S; Castro, M; Hargreave, F; Xie, F; Wilkins, HJ; Henkel, T; Nair, P				Mathur, S.; Castro, M.; Hargreave, F.; Xie, F.; Wilkins, H. J.; Henkel, T.; Nair, P.			Efficacy of Reslizumab in Patients with Poorly Controlled Eosinophilic Asthma: Subgroup Analysis of Patients with Nasal Polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting	MAR 18-22, 2011	San Francisco, CA	Amer Acad Allergy Asthma & Immunol					[Mathur, S.] Univ Wisconsin, Madison, WI USA; [Castro, M.] Washington Univ, Sch Med, St Louis, MO USA; [Hargreave, F.; Nair, P.] McMaster Univ, Hamilton, ON, Canada; [Xie, F.; Wilkins, H. J.; Henkel, T.] Cephalon Inc, Frazer, PA USA	University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL); McMaster University; Teva Pharmaceutical Industries; Cephalon Inc.									0	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2		S			AB84	AB84		10.1016/j.jaci.2010.12.340	http://dx.doi.org/10.1016/j.jaci.2010.12.340			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	832YI		Bronze			2022-12-18	WOS:000295846400323
J	Guyot-Caquelin, P; Granel, F; Kaminsky, MC; Trechot, P; Schmutz, JL; Barbaud, A				Guyot-Caquelin, Pauline; Granel, Florence; Kaminsky, Marie-Christine; Trechot, Philippe; Schmutz, Jean-Luc; Barbaud, Annick			False positive results can occur on delayed reading of intradermal tests with cisplatin	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ADVERSE DRUG-REACTIONS; HYPERSENSITIVITY		[Guyot-Caquelin, Pauline; Granel, Florence; Schmutz, Jean-Luc; Barbaud, Annick] Univ Nancy, Dept Dermatol, Vandoeuvre Les Nancy, France; [Trechot, Philippe] Univ Nancy, Dept Pharmacol, Vandoeuvre Les Nancy, France; [Kaminsky, Marie-Christine] Alexis Vautrin Oncol Ctr, Vandoeuvre Les Nancy, France	Universite de Lorraine; Universite de Lorraine; UNICANCER; Institut de cancerologie de Lorraine (ICL)	Guyot-Caquelin, P (corresponding author), Univ Nancy, Dept Dermatol, Vandoeuvre Les Nancy, France.	a.barbaud@chu-nancy.fr	, barbaud/AAZ-7250-2021					Baeck M, 2009, ALLERGY, V64, P978, DOI 10.1111/j.1398-9995.2009.02038.x; Barbaud A, 2001, CONTACT DERMATITIS, V45, P321, DOI 10.1034/j.1600-0536.2001.450601.x; Bursztejn AC, 2008, CONTACT DERMATITIS, V58, P365, DOI 10.1111/j.1600-0536.2007.01285.x; Leguy-Seguin V, 2007, J ALLERGY CLIN IMMUN, V119, P726, DOI 10.1016/j.jaci.2006.11.640; MARKMAN M, 2003, J CLIN ONCOL, V21, P2218	5	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2010	125	6					1410	1411		10.1016/j.jaci.2010.01.052	http://dx.doi.org/10.1016/j.jaci.2010.01.052			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	611PH	20338621				2022-12-18	WOS:000278831000039
J	Ayuso, R; Sanchez-Garcia, S; Lin, J; Ibanez, M; Blanco, C; Carrillo, T; Goldis, M; Bardina, L; Sampson, HA				Ayuso, R.; Sanchez-Garcia, S.; Lin, J.; Ibanez, M.; Blanco, C.; Carrillo, T.; Goldis, M.; Bardina, L.; Sampson, H. A.			Epitope Mapping of the Main Four Shrimp Allergens and Comparison of IgE Recognition Between Children and Adults	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	66th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 26-MAR 02, 2010	New Orleans, LA	Amer Acad Allergy, Asthma & Immunol					[Ayuso, R.; Lin, J.; Goldis, M.; Bardina, L.; Sampson, H. A.] Mt Sinai Med Ctr, New York, NY 10029 USA; [Sanchez-Garcia, S.] Fdn Jimenez Diaz, E-28040 Madrid, Spain; [Ibanez, M.] Hosp Univ Nino Jesus, Madrid, Spain; [Blanco, C.] Hosp Univ La Princesa, Madrid, Spain; [Carrillo, T.] Hosp Univ Dr Negrin, Las Palmas Gran Canaria, Spain	Icahn School of Medicine at Mount Sinai; Hospital de La Princesa									0	6	6	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2		1			AB224	AB224		10.1016/j.jaci.2009.12.874	http://dx.doi.org/10.1016/j.jaci.2009.12.874			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	629MS		Bronze			2022-12-18	WOS:000280204100874
J	Breslin, M; Pons, L; Yue, X; Kulis, M; Jones, SM; Vickery, B; Burks, AW				Breslin, M.; Pons, L.; Yue, X.; Kulis, M.; Jones, S. M.; Vickery, B.; Burks, A. W.			Peanut Oral Immunotherapy (OIT) Confers Long-Term Tolerance Mediated by Decreased T-helper Type 2 (TH2) Cytokines and Cytokines Generated by Regulatory T cells (Tregs)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	66th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 26-MAR 02, 2010	New Orleans, LA	Amer Acad Allergy, Asthma & Immunol					[Breslin, M.; Pons, L.; Yue, X.; Kulis, M.; Vickery, B.; Burks, A. W.] Duke Univ, Med Ctr, Durham, NC USA; [Jones, S. M.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA	Duke University; University of Arkansas System; University of Arkansas Medical Sciences									0	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2		1			AB20	AB20		10.1016/j.jaci.2009.12.108	http://dx.doi.org/10.1016/j.jaci.2009.12.108			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	629MS					2022-12-18	WOS:000280204100077
J	Gelardi, M; Spadavecchia, L; Fanelli, P; Fiorella, ML; Russo, C; Fiorella, R; Armenio, L; Passalacqua, G				Gelardi, Matteo; Spadavecchia, Laura; Fanelli, Pietro; Fiorella, Maria Luisa; Russo, Cosimo; Fiorella, Raffaele; Armenio, Lucio; Passalacqua, Giovanni			Nasal inflammation in vernal keratoconjunctivitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							RHINITIS		[Gelardi, Matteo; Fiorella, Maria Luisa; Russo, Cosimo; Fiorella, Raffaele] Univ Bari, Pediat Clin S Maggiore, Dept Ophthalmol & Otolaryngol, I-70121 Bari, Italy; [Spadavecchia, Laura; Fanelli, Pietro; Armenio, Lucio] Univ Bari, Pediat Clin S Maggiore, Dipartimento Biomed Eta Evolutiva, I-70121 Bari, Italy; [Passalacqua, Giovanni] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; University of Genoa	Gelardi, M (corresponding author), Univ Bari, Pediat Clin S Maggiore, Dept Ophthalmol & Otolaryngol, I-70121 Bari, Italy.	passalacqua@unige.it		gelardi, matteo/0000-0003-4406-0008				Anderson DF, 2001, INVEST OPHTH VIS SCI, V42, P995; Bielory L, 2000, J ALLERGY CLIN IMMUN, V106, P1019, DOI 10.1067/mai.2000.111238; Bonini S, 2004, EYE, V18, P345, DOI 10.1038/sj.eye.6700675; Bonini S, 2007, CURR OPIN ALLERGY CL, V7, P436, DOI 10.1097/ACI.0b013e3282efb726; Bousquet J, 2008, ALLERGY, V63, P1, DOI 10.1111/j.1398-9995.2007.01594.x; Ciprandi G, 2005, ALLERGY, V60, P957, DOI 10.1111/j.1398-9995.2005.00664.x; Gelardi M, 2008, INT J IMMUNOPATH PH, V21, P325, DOI 10.1177/039463200802100209; Gelardi M, 2009, AM J RHINOL ALLERGY, V23, P312, DOI 10.2500/ajra.2009.23.3320; Kumar S, 2009, ACTA OPHTHALMOL, V87, P133, DOI 10.1111/j.1755-3768.2008.01347.x; Leonardi A, 2006, ACTA OPHTHALMOL SCAN, V84, P406, DOI 10.1111/j.1600-0420.2005.00622.x; Uchio E, 2000, CLIN EXP ALLERGY, V30, P103	11	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2					496	498		10.1016/j.jaci.2009.10.058	http://dx.doi.org/10.1016/j.jaci.2009.10.058			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	558RU	20159263				2022-12-18	WOS:000274764000033
J	Hallstrand, TS; Henderson, WR				Hallstrand, Teal S.; Henderson, William R., Jr.			The evolving role of intravenous leukotriene modifiers in acute asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Acute asthma; asthma exacerbation; intravenous medication; leukotriene receptor antagonist; anticholinergic bronchodilator; randomized trial	ORAL MONTELUKAST; CONTROLLED-TRIAL; DOUBLE-BLIND; THERAPY; PLACEBO; E-4		[Hallstrand, Teal S.] Univ Washington, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; [Henderson, William R., Jr.] Univ Washington, Allergy Sect, Div Allergy & Infect Dis, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hallstrand, TS (corresponding author), Univ Washington, Div Pulm & Crit Care Med, Box 356522,1959 NE Pacific St, Seattle, WA 98195 USA.	tealh@u.washington.edu		Hallstrand, Teal/0000-0002-5059-6872				Camargo CA, 2003, AM J RESP CRIT CARE, V167, P528, DOI 10.1164/rccm.200208-802OC; Camargo CA, 2010, J ALLERGY CLIN IMMUN, V125, P374, DOI 10.1016/j.jaci.2009.11.015; Dockhorn RJ, 2000, THORAX, V55, P260, DOI 10.1136/thorax.55.4.260; DWORSKI R, 1994, AM J RESP CRIT CARE, V149, P953, DOI 10.1164/ajrccm.149.4.8143061; Fitzgerald JM, 2003, AM J RESP CRIT CARE, V167, P488, DOI 10.1164/rccm.2211008; Gauvreau GM, 2001, AM J RESP CRIT CARE, V164, P1495, DOI 10.1164/ajrccm.164.8.2102033; Hallstrand TS, 2010, CURR OPIN ALLERGY CL, V10, P60, DOI 10.1097/ACI.0b013e32833489c3; Maekawa A, 2008, P NATL ACAD SCI USA, V105, P16695, DOI 10.1073/pnas.0808993105; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; Mougey EB, 2009, PHARMACOGENET GENOM, V19, P129, DOI 10.1097/FPC.0b013e32831bd98c; Nelson KA, 2008, PEDIATR EMERG CARE, V24, P21, DOI 10.1097/pec.0b013e31815f3968; Paruchuri S, 2009, J EXP MED, V206, P2543, DOI 10.1084/jem.20091240; Rodrigo CJ, 2000, AM J RESP CRIT CARE, V161, P1862; Rodrigo GJ, 2004, AM J RESP CRIT CARE, V169, P130; Silverman RA, 2004, CHEST, V126, P1480, DOI 10.1378/chest.126.5.1480	15	6	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2					381	382		10.1016/j.jaci.2009.12.991	http://dx.doi.org/10.1016/j.jaci.2009.12.991			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	558RU	20159248				2022-12-18	WOS:000274764000015
J	Horn, PT; Li, HH; Pullman, WE				Horn, P. T.; Li, H. H.; Pullman, W. E.			Hypersensitivity Reactions Following Ecallantide Treatment for Acute Attacks of HAE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	66th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 26-MAR 02, 2010	New Orleans, LA	Amer Acad Allergy, Asthma & Immunol					[Horn, P. T.; Pullman, W. E.] Dyax Corp, Cambridge, MA USA; [Li, H. H.] Inst Asthma & Allergy, Wheaton, MD USA										0	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2		1			AB163	AB163		10.1016/j.jaci.2009.12.640	http://dx.doi.org/10.1016/j.jaci.2009.12.640			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	629MS		Bronze			2022-12-18	WOS:000280204100640
J	Pagovich, O; Wang, E; Lee-Wong, M				Pagovich, O.; Wang, E.; Lee-Wong, M.			Statins May Improve Asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	66th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 25-MAR 02, 2010	New Orleans, LA	Amer Acad Allergy Asthma & Immunol (AAAAI)					[Pagovich, O.; Wang, E.; Lee-Wong, M.] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA	Harvard University; Beth Israel Deaconess Medical Center									0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2		1			AB45	AB45		10.1016/j.jaci.2009.12.210	http://dx.doi.org/10.1016/j.jaci.2009.12.210			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	629MS					2022-12-18	WOS:000280204100178
J	Poole, JA; Burrell, AM; Wyatt, TA; Kielian, TL; Romberger, DJ				Poole, J. A.; Burrell, A. M.; Wyatt, T. A.; Kielian, T. L.; Romberger, D. J.			NOD2 Negatively Regulates Organic Dust-Induced Inflammation in Monocytes/Macrophages	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	66th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 26-MAR 02, 2010	New Orleans, LA	Amer Acad Allergy, Asthma & Immunol					[Poole, J. A.; Burrell, A. M.; Wyatt, T. A.; Kielian, T. L.; Romberger, D. J.] Univ NE Med Ctr, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center									0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2		1			AB118	AB118		10.1016/j.jaci.2009.12.467	http://dx.doi.org/10.1016/j.jaci.2009.12.467			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	629MS					2022-12-18	WOS:000280204100468
J	Ortega, FB; Lee, DC; Sui, XM; Ruiz, JR; Cheng, YJ; Church, TJ; Miller, CC; Blair, SN				Ortega, Francisco B.; Lee, Duck-chul; Sui, Xuemei; Ruiz, Jonatan R.; Cheng, Yiling J.; Church, Timothy J.; Miller, Charles C.; Blair, Steven N.			Cardiorespiratory fitness, adiposity, and incident asthma in adults	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALL-CAUSE MORTALITY; PHYSICAL-FITNESS; CARDIOVASCULAR-DISEASE; MEN; OBESITY; WOMEN		[Ortega, Francisco B.; Ruiz, Jonatan R.] Univ Granada, Sch Med, Dept Med Physiol, E-18071 Granada, Spain; [Ortega, Francisco B.; Ruiz, Jonatan R.] Karolinska Inst, Novum, Dept Biosci & Nutr, Unit Prevent Nutr, Huddinge, Sweden; [Ortega, Francisco B.; Lee, Duck-chul; Sui, Xuemei; Blair, Steven N.] Univ S Carolina, Dept Exercise Sci, Columbia, SC 29208 USA; [Blair, Steven N.] Univ S Carolina, Dept Epidemiol & Biostat, Columbia, SC 29208 USA; [Cheng, Yiling J.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Church, Timothy J.] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Miller, Charles C.] Univ Texas Houston, Sch Med, Dept Cardiothorac & Vasc Surg, Houston, TX USA	University of Granada; Karolinska Institutet; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Centers for Disease Control & Prevention - USA; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Texas System; University of Texas Health Science Center Houston	Ortega, FB (corresponding author), Univ Granada, Sch Med, Dept Med Physiol, E-18071 Granada, Spain.	ortegaf@ugr.es	Ortega, Francisco B/B-4002-2010; RUIZ, JONATAN R/M-1338-2015; Ortega, Francisco B./AAG-5195-2021; Cheng, Yiling J/A-6547-2009	Ortega, Francisco B/0000-0003-2001-1121; RUIZ, JONATAN R/0000-0002-7548-7138; Ortega, Francisco B./0000-0003-2001-1121; Cheng, Yiling J/0000-0002-5053-0814	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG006945, R01AG006945] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL62508, R01 HL062508] Funding Source: Medline; NIA NIH HHS [R37 AG006945-19S3, R01 AG006945, AG06945, R37 AG006945] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; BLAIR SN, 1984, JAMA-J AM MED ASSOC, V252, P487, DOI 10.1001/jama.252.4.487; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Ford ES, 2005, J ALLERGY CLIN IMMUN, V115, P897, DOI 10.1016/j.jaci.2004.11.050; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Lee CD, 1999, AM J CLIN NUTR, V69, P373; Lee DC, 2009, BRIT J SPORT MED, V43, P49, DOI 10.1136/bjsm.2008.054536; Rasmussen F, 2000, EUR RESPIR J, V16, P866, DOI 10.1183/09031936.00.16586600	9	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2010	125	1					271	273		10.1016/j.jaci.2009.10.040	http://dx.doi.org/10.1016/j.jaci.2009.10.040			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	544MG	20109755	Green Accepted, Green Submitted			2022-12-18	WOS:000273660500037
J	Seidl, B; Kalali, B; Gerhard, M; Ring, J; Ollert, M; Mempel, M				Seidl, Bettina; Kalali, Behnam; Gerhard, Markus; Ring, Johannes; Ollert, Markus; Mempel, Martin			Thymic stromal lymphopoietin induction by polyinosinic:polycytidylic acid in human keratinocytes is preferentially mediated through protein kinase R and retinoid-inducible gene I and not Toll-like receptor 3	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							EPIDERMAL-KERATINOCYTES; CELLS		[Seidl, Bettina; Kalali, Behnam; Ring, Johannes; Ollert, Markus; Mempel, Martin] Tech Univ Munich, Dept Dermatol & Allergy, Munich, Germany; [Kalali, Behnam; Gerhard, Markus] Tech Univ Munich, Dept Gastroenterol, Munich, Germany; [Ollert, Markus; Mempel, Martin] Tech Univ Munich, Clin Res Div Mol & Clin Allergotoxicol, Munich, Germany; [Mempel, Martin] Tech Univ Munich, Helmholtz Zentrum Munchen, Div Environm Dermatol & Allergy, Munich, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Seidl, B (corresponding author), Tech Univ Munich, Dept Dermatol & Allergy, Munich, Germany.	m.mempel@lrz.tum.de	Gerhard, Markus/N-3387-2014; Gerhard, Markus/P-8996-2019; Ring, Johannes/GLN-4341-2022	Gerhard, Markus/0000-0001-9110-3950; Gerhard, Markus/0000-0001-9110-3950; Ring, Johannes/0000-0001-8236-3152; Ollert, Markus W./0000-0002-8055-0103				Jung T, 2008, J ALLERGY CLIN IMMUN, V122, P1074, DOI 10.1016/j.jaci.2008.09.042; Kalali BN, 2008, J IMMUNOL, V181, P2694, DOI 10.4049/jimmunol.181.4.2694; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Kinoshita H, 2009, J ALLERGY CLIN IMMUN, V123, P179, DOI 10.1016/j.jaci.2008.10.008; Kollisch G, 2005, IMMUNOLOGY, V114, P531, DOI 10.1111/j.1365-2567.2005.02122.x; Terhorst D, 2007, CLIN EXP ALLERGY, V37, P381, DOI 10.1111/j.1365-2222.2006.02639.x	6	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2009	124	4					862	864		10.1016/j.jaci.2009.07.028	http://dx.doi.org/10.1016/j.jaci.2009.07.028			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	506UV	19767083	Bronze			2022-12-18	WOS:000270802800044
J	Takai, T; Vu, AT; Le, TA; Kinoshita, H; Ushio, H; Ikeda, S; Ogawa, H; Okumura, K				Takai, Toshiro; Vu, Anh Tuan; Le, Tuan Anh; Kinoshita, Hirokazu; Ushio, Hiroko; Ikeda, Shigaku; Ogawa, Hideaki; Okumura, Ko			Thymic stromal lymphopoietin induction by polyinosinic:polycytidylic acid in human keratinocytes is preferentially mediated through protein kinase R and retinoid-inducible gene I and not Toll-like receptor 3 Reply	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							AIRWAY EPITHELIAL-CELLS; INFLAMMATION; TSLP		[Takai, Toshiro; Vu, Anh Tuan; Le, Tuan Anh; Kinoshita, Hirokazu; Ushio, Hiroko; Ikeda, Shigaku; Ogawa, Hideaki; Okumura, Ko] Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Tokyo, Japan; [Vu, Anh Tuan; Le, Tuan Anh; Kinoshita, Hirokazu; Ikeda, Shigaku] Juntendo Univ, Grad Sch Med, Dept Dermatol & Allergol, Tokyo, Japan	Juntendo University; Juntendo University	Takai, T (corresponding author), Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Tokyo, Japan.	t-takai@juntendo.ac.jp	Takai, Toshiro/K-5690-2013; Ushio, Hiroko/K-5718-2013	Takai, Toshiro/0000-0001-8363-0355; 				Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Harada M, 2009, AM J RESP CELL MOL, V40, P368, DOI 10.1165/rcmb.2008-0041OC; He R, 2008, P NATL ACAD SCI USA, V105, P11875, DOI 10.1073/pnas.0801532105; Kalali BN, 2008, J IMMUNOL, V181, P2694, DOI 10.4049/jimmunol.181.4.2694; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Kinoshita H, 2009, J ALLERGY CLIN IMMUN, V123, P179, DOI 10.1016/j.jaci.2008.10.008; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Le TA, 2009, ALLERGY, V64, P1231, DOI 10.1111/j.1398-9995.2009.02032.x; Seidl B, 2009, J ALLERGY CLIN IMMUN, V124, P862, DOI 10.1016/j.jaci.2009.07.028; Seshasayee D, 2007, J CLIN INVEST, V117, P3868, DOI 10.1172/JCI33559	10	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2009	124	4					864	865		10.1016/j.jaci.2009.07.029	http://dx.doi.org/10.1016/j.jaci.2009.07.029			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	506UV					2022-12-18	WOS:000270802800045
J	Schwartzstein, RM; Gold, DR				Schwartzstein, Richard M.; Gold, Diane R.			Dyspnea in overweight children: Is it asthma?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; dyspnea; obesity; overweight; children; deconditioning	ACUTE BRONCHOCONSTRICTION; OBESITY; BREATHLESSNESS; MECHANISMS; DESCRIPTORS		[Schwartzstein, Richard M.] Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA; [Gold, Diane R.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Schwartzstein, Richard M.; Gold, Diane R.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Schwartzstein, RM (corresponding author), Beth Israel Deaconess Med Ctr, Div Pulm Med, Kirstein Bldg,Basement Rm 23,330 Brookline Ave, Boston, MA 02215 USA.	rschwart@bidmc.harvard.edu	Schwartzstein, Richard/AGO-8549-2022; Schwartzstein, Richard/L-4420-2019					Aaron SD, 2008, CAN MED ASSOC J, V179, P1121, DOI 10.1503/cmaj.081332; Binks AP, 2002, AM J RESP CRIT CARE, V165, P78, DOI 10.1164/ajrccm.165.1.2105061; CHEVALIER B, 2001, J RESP DIS, V22, P153; ELLIOTT MW, 1991, AM REV RESPIR DIS, V144, P826, DOI 10.1164/ajrccm/144.4.826; GARFINKEL SK, 1992, AM REV RESPIR DIS, V145, P741, DOI 10.1164/ajrccm/145.4_Pt_1.741; Killian KJ, 2000, AM J RESP CRIT CARE, V162, P490, DOI 10.1164/ajrccm.162.2.9905079; Kipping RR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1824; LOUGHEED MD, 1993, AM REV RESPIR DIS, V148, P1452, DOI 10.1164/ajrccm/148.6_Pt_1.1452; LUDWICK SK, 1986, J PEDIATR-US, V109, P446, DOI 10.1016/S0022-3476(86)80115-9; Mahler DA, 1996, AM J RESP CRIT CARE, V154, P1357, DOI 10.1164/ajrccm.154.5.8912748; Meek PM, 1999, AM J RESP CRIT CARE, V159, P321; Moy ML, 2000, AM J RESP CRIT CARE, V162, P451, DOI 10.1164/ajrccm.162.2.9907138; National Heart Lung and Blood Institute, 1997, GUID DIAGN MAN ASTHM; ORENSTEIN DM, 1985, J PEDIATR-US, V106, P556, DOI 10.1016/S0022-3476(85)80071-8; Scholtens S, 2009, J ALLERGY CLIN IMMUN, V123, P1312, DOI 10.1016/j.jaci.2009.02.029; Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004; SIMON PM, 1990, AM REV RESPIR DIS, V142, P1009, DOI 10.1164/ajrccm/142.5.1009; Sin DD, 2002, ARCH INTERN MED, V162, P1477, DOI 10.1001/archinte.162.13.1477; Waggoner D, 2008, ANN ALLERG ASTHMA IM, V101, P644, DOI 10.1016/S1081-1206(10)60230-X	19	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2009	123	6					1319	1320		10.1016/j.jaci.2009.04.034	http://dx.doi.org/10.1016/j.jaci.2009.04.034			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	455WO	19501234				2022-12-18	WOS:000266799100023
J	Buyukozturk, S; Eroglu, BK; Gelincik, A; Uzumcu, A; Ozseker, F; Colakoglu, B; Dal, M; Uyguner, ZO				Bueyuekoeztuerk, Suna; Eroglu, Belgin Kesim; Gelincik, Asli; Uezuemcue, Abdullah; Oezseker, Ferhan; Colakoglu, Bahattin; Dal, Murat; Uyguner, Z. Oya			A Turkish family with a novel mutation in the promoter region of the C1 inhibitor gene	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							HEREDITARY ANGIOEDEMA; C1-INHIBITOR		[Bueyuekoeztuerk, Suna; Gelincik, Asli; Oezseker, Ferhan; Colakoglu, Bahattin; Dal, Murat] Istanbul Univ, Istanbul Fac Med, Dept Internal Med, Div Allergy, Istanbul, Turkey; [Eroglu, Belgin Kesim] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, Istanbul, Turkey; [Uezuemcue, Abdullah; Uyguner, Z. Oya] Sisli Etfal Training & Educ Hosp, Med Genet Clin, Istanbul, Turkey	Istanbul University; Istanbul University; Istanbul Sisli Hamidiye Etfal Training & Research Hospital	Buyukozturk, S (corresponding author), Istanbul Univ, Istanbul Fac Med, Dept Internal Med, Div Allergy, Istanbul, Turkey.	gelincik@istanbul.edu.tr	Özşeker, Zeynep Ferhan Özşeker or Ferhan/AAI-1713-2019; Gelincik, Asli/AAS-6401-2020; UYGUNER, OYA Z/Y-3899-2018	Özşeker, Zeynep Ferhan Özşeker or Ferhan/0000-0002-3387-4818; Uyguner, Zehra Oya/0000-0002-2035-4338				Blanch A, 2007, J ALLERGY CLIN IMMUN, V119, P745; Blanch A, 2006, J ALLERGY CLIN IMMUN, V118, P1330, DOI 10.1016/j.jaci.2006.07.035; Dewald G, 2006, BIOCHEM BIOPH RES CO, V343, P1286, DOI 10.1016/j.bbrc.2006.03.092; Pappalardo E, 2003, IMMUNOL LETT, V86, P271, DOI 10.1016/S0165-2478(03)00029-4; Pappalardo E, 2008, MOL IMMUNOL, V45, P3536, DOI 10.1016/j.molimm.2008.05.007; Tosi M, 1998, IMMUNOBIOLOGY, V199, P358, DOI 10.1016/S0171-2985(98)80040-5; Verpy E, 1996, AM J HUM GENET, V59, P308	7	6	6	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2009	123	4					962	964		10.1016/j.jaci.2008.12.022	http://dx.doi.org/10.1016/j.jaci.2008.12.022			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	431JW	19201015				2022-12-18	WOS:000265058600029
J	Howell, DL; Jacobs, C; Metz, G; Rhodd, C; Zhang, J; Dave, S; Lugar, P				Howell, D. L.; Jacobs, C.; Metz, G.; Rhodd, C.; Zhang, J.; Dave, S.; Lugar, P.			Molecular Profiling Distinguishes Patients With Active Idiopathic Anaphylaxis From Normal Volunteers And Reveals Novel Aspects Of Disease Biology	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 13-17, 2009	Washington, DC	Amer Acad Allergy, Asthma & Immunol					[Howell, D. L.; Jacobs, C.; Metz, G.; Rhodd, C.; Zhang, J.; Dave, S.; Lugar, P.] Duke Univ, Durham, NC USA	Duke University			Zhang, Junyi/HDN-7815-2022						0	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2				575	S150	S150		10.1016/j.jaci.2008.12.563	http://dx.doi.org/10.1016/j.jaci.2008.12.563			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	410RR					2022-12-18	WOS:000263596301048
J	Lowe, P; Tannenbaum, S; Gautier, A; Massanari, M; Panahloo, Z				Lowe, P.; Tannenbaum, S.; Gautier, A.; Massanari, M.; Panahloo, Z.			Omalizumab (Xolair) May Normalize IgE Production Rate In Patients With Moderate-To-Severe Atopic Asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 13-17, 2009	Washington, DC	Amer Acad Allergy, Asthma & Immunol					[Lowe, P.; Gautier, A.] Novartis Pharma AG, Basel, Switzerland; [Tannenbaum, S.; Massanari, M.] Nova Pharmaceut Corp, E Hanover, NJ USA; [Panahloo, Z.] Novartis Horsham Res Ctr, Horsham, W Sussex, England	Novartis; Novartis; Novartis									0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2				583	S152	S152		10.1016/j.jaci.2008.12.571	http://dx.doi.org/10.1016/j.jaci.2008.12.571			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	410RR					2022-12-18	WOS:000263596301056
J	Nguyen, DK; Davis, CM; Chinen, J; Vallejo, JG; Noroski, LM				Nguyen, D. K.; Davis, C. M.; Chinen, J.; Vallejo, J. G.; Noroski, L. M.			Basidiomycetous Inonotus (Phellinus) tropicalis Osteomyelitis in Pediatric and Adult X-linked Chronic Granulomatous Disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 13-17, 2009	Washington, DC	Amer Acad Allergy, Asthma & Immunol					[Nguyen, D. K.; Davis, C. M.; Chinen, J.; Vallejo, J. G.; Noroski, L. M.] Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine									0	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2				33	S13	S13		10.1016/j.jaci.2008.12.060	http://dx.doi.org/10.1016/j.jaci.2008.12.060			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	410RR					2022-12-18	WOS:000263596300044
J	Pecora, V; Nucera, E; Schiavino, D; Lombardo, C; Bardina, L; Lin, J; Goldis, M; Patriarca, G; Sampson, HA				Pecora, V.; Nucera, E.; Schiavino, D.; Lombardo, C.; Bardina, L.; Lin, J.; Goldis, M.; Patriarca, G.; Sampson, H. A.			Evaluation Of Specific Sequential IgE- and IgG4-binding Epitopes, Recognized in Cow's Milk Allergic Patients during Specific Oral Desensitization, using Peptide Microarray Immunoassay	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 13-17, 2009	Washington, DC	Amer Acad Allergy, Asthma & Immunol					[Pecora, V.; Nucera, E.; Schiavino, D.; Lombardo, C.; Patriarca, G.] Univ Cattolica Sacro Cuore, Policlin A Gemelli, Dept Allergol, Rome, Italy; [Bardina, L.; Lin, J.; Goldis, M.; Sampson, H. A.] Mt Sinai Sch Med, Div Pediat Allergy & Immunol, New York, NY USA; [Bardina, L.; Lin, J.; Goldis, M.; Sampson, H. A.] Mt Sinai Sch Med, Jaffe Inst Food Allergy, New York, NY USA	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai			Pecora, Valentina/ABA-3939-2021						0	6	7	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2				682	S178	S178		10.1016/j.jaci.2008.12.673	http://dx.doi.org/10.1016/j.jaci.2008.12.673			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	410RR		Bronze			2022-12-18	WOS:000263596301155
J	Beggs, PJ				Beggs, Paul John			Climate change and plant food allergens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ATMOSPHERIC CO2; COMMON RAGWEED		Macquarie Univ, Div Environm & Life Sci, Dept Phys Geog, Sydney, NSW 2109, Australia	Macquarie University	Beggs, PJ (corresponding author), Macquarie Univ, Div Environm & Life Sci, Dept Phys Geog, Sydney, NSW 2109, Australia.	paul.beggs@mq.edu.au		Beggs, Paul/0000-0001-9949-1783				Beggs PJ, 2008, AIR QUAL ATMOS HLTH, V1, P119, DOI 10.1007/s11869-008-0013-z; Beggs PJ, 2005, ENVIRON HEALTH PERSP, V113, P915, DOI 10.1289/ehp.7724; Mohan JE, 2006, P NATL ACAD SCI USA, V103, P9086, DOI 10.1073/pnas.0602392103; Shea KM, 2008, J ALLERGY CLIN IMMUN, V122, P443, DOI 10.1016/j.jaci.2008.06.032; Singer BD, 2005, FUNCT PLANT BIOL, V32, P667, DOI 10.1071/FP05039; Ziska LH, 2003, J ALLERGY CLIN IMMUN, V111, P290, DOI 10.1067/mai.2003.53	6	6	6	1	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2009	123	1					271	272		10.1016/j.jaci.2008.10.025	http://dx.doi.org/10.1016/j.jaci.2008.10.025			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	399IP	19130942				2022-12-18	WOS:000262793900053
J	Teague, WG				Teague, W. Gerald			Food allergen sensitization as a determinant of disturbed airway function in young infants: First step on the path to persistent asthma?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						asthma; asthma control; asthma impairment; asthma risk; asthma exacerbations	EXHALED NITRIC-OXIDE; CHILDHOOD ASTHMA; EXPOSURE; CHILDREN; WHEEZE		[Teague, W. Gerald] Emory Univ, Sch Med, Atlanta, GA USA	Emory University	Teague, WG (corresponding author), Dept Pediat, Div Pulm Allergy Cyst Fibrosis & Sleep Med, 2015 Uppergate Dr, Atlanta, GA 30322 USA.	wteague@emory.edu						Frey U, 2004, AM J RESP CRIT CARE, V170, P260, DOI 10.1164/rccm.200307-1002OC; GASTON B, 1994, AM J RESP CRIT CARE, V149, P538, DOI 10.1164/ajrccm.149.2.7508323; Gern JE, 2005, J ALLERGY CLIN IMMUN, V115, P668, DOI 10.1016/j.jaci.2005.01.057; Hall GL, 2002, J APPL PHYSIOL, V92, P59, DOI 10.1152/jappl.2002.92.1.59; Kummeling I, 2007, PEDIATRICS, V119, pE225, DOI 10.1542/peds.2006-0896; Kurukulaaratchy RJ, 2004, THORAX, V59, P563, DOI 10.1136/thx.2003.010462; Moeller A, 2004, PEDIATR PULM, V38, P250, DOI 10.1002/ppul.20055; Moeller A, 2008, J ALLERGY CLIN IMMUN, V121, P705, DOI 10.1016/j.jaci.2007.11.008; Smith AD, 2005, NEW ENGL J MED, V352, P2163, DOI 10.1056/NEJMoa043596; Straub DA, 2005, EUR RESPIR J, V25, P289, DOI 10.1183/09031936.05.00031904; Tepper RS, 2008, J ALLERGY CLIN IMMUN, V122, P760, DOI 10.1016/j.jaci.2008.07.022; Wildhaber JH, 1999, AM J RESP CRIT CARE, V159, P74, DOI 10.1164/ajrccm.159.1.9805021; YOUNG S, 1991, NEW ENGL J MED, V324, P1168, DOI 10.1056/NEJM199104253241704	13	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2008	122	4					766	767		10.1016/j.jaci.2008.08.030	http://dx.doi.org/10.1016/j.jaci.2008.08.030			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	359LU	19014768				2022-12-18	WOS:000259989000022
J	Yocoub, MR; Perfetti, L; Pignatti, P; Frascaroli, M; Caminati, M; Moscato, G				Yocoub, Mona-Rita; Perfetti, Luca; Pignatti, Patrizia; Frascaroli, Mary; Caminati, Marco; Moscato, Gianna			Usefulness of induced sputum in investigating occupational asthma with normal responsiveness to methacholine: A case report	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Yocoub, Mona-Rita; Perfetti, Luca; Pignatti, Patrizia; Frascaroli, Mary; Caminati, Marco; Moscato, Gianna] Sci Inst Pavia, Allergy & Immunol Unit, Fdn Salvatore Maugeri, Inst Care & Res, Pavia, Italy; [Pignatti, Patrizia; Moscato, Gianna] ISPESL, Occupat Immunol & Allergy Lab, Rome, Italy	Istituti Clinici Scientifici Maugeri IRCCS	Yocoub, MR (corresponding author), Sci Inst Pavia, Allergy & Immunol Unit, Fdn Salvatore Maugeri, Inst Care & Res, Pavia, Italy.	myacoub@fsm.it	perfetti, luca/AAE-1094-2020; Yacoub, Mona Rita/AAP-6227-2020; Caminati, Marco/AAC-6302-2022; Pignatti, Patrizia/K-9595-2016	Yacoub, Mona Rita/0000-0003-2417-0410; Caminati, Marco/0000-0001-7383-1487; Pignatti, Patrizia/0000-0001-5283-3897; perfetti, luca/0000-0001-7646-8214				Girard F, 2004, AM J RESP CRIT CARE, V170, P845, DOI 10.1164/rccm.200403-380OC; Malo JL, 2007, OCCUP ENVIRON MED, V64, P359, DOI 10.1136/oem.2006.030064; Malo JL, 2001, J ALLERGY CLIN IMMUN, V108, P317, DOI 10.1067/mai.2001.116432; Moscato G, 2005, CHEST, V128, P3590, DOI 10.1378/chest.128.5.3590; Moscato G, 2003, EUR RESPIR J, V21, P879, DOI 10.1183/09031936.03.00000403; Vandenplas O, 1997, EUR RESPIR J, V10, P2612, DOI 10.1183/09031936.97.10112612; Yacoub MR, 2005, J ALLERGY CLIN IMMUN, V116, P462, DOI 10.1016/j.jaci.2005.04.015	7	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2008	122	4					831	832		10.1016/j.jaci.2008.07.009	http://dx.doi.org/10.1016/j.jaci.2008.07.009			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	359LU	18789817				2022-12-18	WOS:000259989000033
J	Makela, MJ; Virta, L; Kaila, M; Gronlund, J; Vanto, T; Klaukka, T				Makela, Mika J.; Virta, Lauri; Kaila, Minna; Gronlund, Juhani; Vanto, Timo; Klaukka, Timo			Medication use in children with asthma in Finland from 1995 to 2006	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Makela, Mika J.] Univ Helsinki, Cent Hosp, Dept Allergy, Helsinki, Finland; [Virta, Lauri] Social Insurance Inst, Res Dept, Turku, Finland; [Kaila, Minna; Gronlund, Juhani] Tampere Univ Hosp, Dept Pediat, Tampere, Finland; [Kaila, Minna] Tampere Satellite Off, Finnish Off Hlth Technol Assessment, Tampere, Finland; [Vanto, Timo] Turku Univ Hosp, Dept Pediat, FIN-20520 Turku, Finland; [Klaukka, Timo] Social Insurance Inst, Res Dept, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; Tampere University; Tampere University Hospital; University of Turku	Makela, MJ (corresponding author), Univ Helsinki, Cent Hosp, Dept Allergy, Helsinki, Finland.	mika.makela@hus.fi		Makela, Mika/0000-0002-2933-3111				Bisgaard H, 2006, LANCET, V367, P286, DOI 10.1016/S0140-6736(06)68051-3; Bisgaard H, 2007, J ALLERGY CLIN IMMUN, V120, P969, DOI 10.1016/j.jaci.2007.06.011; Fuhlbrigge AL, 2006, PEDIATRICS, V118, P619, DOI 10.1542/peds.2005-2963; Haahtela T, 2006, THORAX, V61, P663, DOI 10.1136/thx.2005.055699; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; Van der Wouden JC, 2003, COCHRANE DB SYST REV, V3	6	6	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2008	122	3					648	649		10.1016/j.jaci.2008.05.042	http://dx.doi.org/10.1016/j.jaci.2008.05.042			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	348TW	18602154				2022-12-18	WOS:000259234000031
J	Spycher, BD; Silverman, M; Kuehni, CE				Spycher, Ben Daniel; Silverman, Michael; Kuehni, Claudia Elisabeth			Timing of routine vaccinations and the risk of childhood asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Spycher, Ben Daniel; Kuehni, Claudia Elisabeth] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Silverman, Michael] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England	University of Bern; University of Leicester	Spycher, BD (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	kuehni@ispm.unibe.ch	Spycher, Ben D/B-3308-2008	Spycher, Ben D/0000-0002-1430-5695; Kuehni, Claudia E./0000-0001-8957-2002				Balicer RD, 2007, PEDIATRICS, V120, pE1269, DOI 10.1542/peds.2006-3569; Destefano F, 2002, PEDIATR INFECT DIS J, V21, P498, DOI 10.1097/00006454-200206000-00004; Enriquez R, 2007, PEDIATRICS, V119, P222, DOI 10.1542/peds.2006-2757; Kuehni CE, 2001, LANCET, V358, P1186, DOI 10.1016/S0140-6736(01)06290-0; Kuehni CE, 2007, INT J EPIDEMIOL, V36, P977, DOI 10.1093/ije/dym090; McDonald KL, 2008, J ALLERGY CLIN IMMUN, V121, P626, DOI 10.1016/j.jaci.2007.11.034; McKeever TM, 2004, AM J PUBLIC HEALTH, V94, P985, DOI 10.2105/AJPH.94.6.985	7	6	6	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2008	122	3					656	656		10.1016/j.jaci.2008.06.037	http://dx.doi.org/10.1016/j.jaci.2008.06.037			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	348TW	18774398	Green Submitted			2022-12-18	WOS:000259234000035
J	Riekert, KA; Eakin, M				Riekert, Kristin A.; Eakin, Michelle			Factor analysis: A primer for asthma researchers	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									[Riekert, Kristin A.; Eakin, Michelle] Johns Hopkins Univ, Div Pulm & Crit Care Med, Sch Med, Baltimore, MD 21224 USA	Johns Hopkins University	Riekert, KA (corresponding author), Johns Hopkins Univ, Div Pulm & Crit Care Med, Sch Med, 5501 Hopkins Bayview Circle,JHAAC Rm 4B-74, Baltimore, MD 21224 USA.	krieker1@jhem.jhmi.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL075344] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL075344] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Freemantle N, 2003, JAMA-J AM MED ASSOC, V289, P2554, DOI 10.1001/jama.289.19.2554; Holt EW, 2008, J ALLERGY CLIN IMMUN, V121, P1175, DOI 10.1016/j.jaci.2008.02.015; Juniper EF, 2004, EUR RESPIR J, V23, P287, DOI 10.1183/09031936.04.00064204; Leung TF, 2005, THORAX, V60, P822, DOI 10.1136/thx.2004.039321; *NIH, 2007, PUB NIH; Pillai SG, 2008, CLIN EXP ALLERGY, V38, P421, DOI 10.1111/j.1365-2222.2007.02918.x; Schatz M, 2006, J ALLERGY CLIN IMMUN, V117, P995, DOI 10.1016/j.jaci.2006.01.053; TABACHNICK BG, 2001, USING MULTICVARIATE	8	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2008	121	5					1181	1183		10.1016/j.jaci.2008.03.023	http://dx.doi.org/10.1016/j.jaci.2008.03.023			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	302IJ	18466786	Bronze			2022-12-18	WOS:000255961700016
J	Wjst, M				Wjst, Matthias			Allergy risk of vitamin D supplements has been described in various settings	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ASTHMA; VEGETABLES; DISEASES; CHILDREN		German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Wjst, M (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Munich, Germany.							Chatzi L, 2007, THORAX, V62, P677, DOI 10.1136/thx.2006.069419; Hypponen E, 2004, ANN NY ACAD SCI, V1037, P84, DOI 10.1196/annals.1337.013; Kull I, 2006, J ALLERGY CLIN IMMUN, V118, P1299, DOI 10.1016/j.jaci.2006.08.022; Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028; Milner JD, 2004, PEDIATRICS, V114, P27, DOI 10.1542/peds.114.1.27; Nja F, 2005, ACTA PAEDIATR, V94, P147, DOI 10.1080/08035250410023638; Wjst M, 1999, ALLERGY, V54, P757, DOI 10.1034/j.1398-9995.1999.00193.x	7	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2008	121	4					1065	1066		10.1016/j.jaci.2008.01.020	http://dx.doi.org/10.1016/j.jaci.2008.01.020			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	286YY	18314184	Bronze			2022-12-18	WOS:000254884000046
J	Gevaert, P; van Bruaene, N; Blomme, K; Sousa, AR; Marshal, RP; Bachert, C				Gevaert, P.; van Bruaene, N.; Blomme, K.; Sousa, A. R.; Marshal, R. P.; Bachert, C.			Mepolizumab, a humanised anti-IL-5 monoclonal antibody, as treatment of severe nasal polyposis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Gevaert, P.; van Bruaene, N.; Blomme, K.; Bachert, C.] Univ Ghent, B-9000 Ghent, Belgium; [Sousa, A. R.; Marshal, R. P.] GSK, Resp Discovery Med, Stevenage, Herts, England	Ghent University; GlaxoSmithKline			Gevaert, Philippe/ABA-4588-2021; Bachert, Claus/J-8825-2012; Gevaert, Philippe/AAP-1892-2020	Gevaert, Philippe/0000-0002-1629-8468					0	6	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2008	121	3				LB26	797	797		10.1016/j.jaci.2008.01.062	http://dx.doi.org/10.1016/j.jaci.2008.01.062			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	273GR					2022-12-18	WOS:000253918900079
J	Craig, T; Wassermann, RL; Levy, R; Bewtra, A; Hurewitz, D; Peters, C; Kiessling, P				Craig, T.; Wassermann, R. L.; Levy, R.; Bewtra, A.; Hurewitz, D.; Peters, C.; Kiessling, P.			C1 esterase inhibitor (C1-INH) - Standard of care for the treatment of acute attacks in hereditary angioedema (HAE): Initial results of an ongoing, prospective, open label study in North America (IMPACT2)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Craig, T.] Penn State Univ, Hershey, PA USA; [Wassermann, R. L.] Dallas Allergy Immunol, Dallas, TX USA; [Levy, R.] Family Allergy & Asthma Ctr, Atlanta, GA USA; [Bewtra, A.] Creighton Univ, Sch Med, Omaha, NE 68178 USA; [Hurewitz, D.] Allergy Clin Tulsa Inc, Tulsa, OK USA; [Peters, C.] CSL Behring, King Of Prussia, PA USA; [Kiessling, P.] CSL Behring, Marburg, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Creighton University; CSL; CSL									0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		380	S98	S99		10.1016/j.jaci.2007.12.392	http://dx.doi.org/10.1016/j.jaci.2007.12.392			2	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426400381
J	Flokstra-de Blok, BMJ; van der Velde, JL; DunnGalvin, A; Oude Elberink, JNG; Vlieg-Boerstra, BJ; Duiverman, EJ; Schouten, JP; Hourihane, JO; Dubois, AEJ				Flokstra-de Blok, B. M. J.; van der Velde, J. L.; DunnGalvin, A.; Oude Elberink, J. N. G.; Vlieg-Boerstra, B. J.; Duiverman, E. J.; Schouten, J. P.; Hourihane, J. O.; Dubois, A. E. J.			Reliability of the food allergy quality of life questionnaires (FAQLQs) for children, teenagers and adults	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Flokstra-de Blok, B. M. J.; van der Velde, J. L.; Vlieg-Boerstra, B. J.; Duiverman, E. J.; Dubois, A. E. J.] Univ Groningen, Univ Med Ctr, Dept Pediat, NL-9700 AB Groningen, Netherlands; [DunnGalvin, A.; Hourihane, J. O.] Univ Coll, Dept Paediat & Child Hlth, Cork, Ireland; [Oude Elberink, J. N. G.] Univ Groningen, Univ Med Ctr, Dept Internal Med, NL-9700 AB Groningen, Netherlands; [Schouten, J. P.] Univ Groningen, Univ Med Ctr, Dept Epidemiol, NL-9700 AB Groningen, Netherlands	University of Groningen; University College Cork; University of Groningen; University of Groningen			Vlieg-Boerstra, Berber/O-1922-2019; DunnGalvin, Audrey/G-1741-2012	Vlieg-Boerstra, Berber/0000-0001-7962-5406; 					0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		415	S108	S108		10.1016/j.jaci.2007.12.428	http://dx.doi.org/10.1016/j.jaci.2007.12.428			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426400417
J	Furlong, TJ; MeMorris, MS; Greenhawt, MJ				Furlong, T. J.; MeMorris, M. S.; Greenhawt, M. J.			Self-reported allergic reactions to peanuts and tree nuts occurring in restaurants and food service establishments	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Furlong, T. J.] Food Allergy & Anaphylaxis Network, Fairfax, VA USA; [MeMorris, M. S.; Greenhawt, M. J.] Univ Michigan Hlth Syst, Ann Arbor, MI USA	University of Michigan System; University of Michigan									0	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		956	S248	S248		10.1016/j.jaci.2007.12.981	http://dx.doi.org/10.1016/j.jaci.2007.12.981			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426401420
J	Gordon, B; Blaiss, M; Meltzer, E; Mahr, T; Boyle, J				Gordon, B.; Blaiss, M.; Meltzer, E.; Mahr, T.; Boyle, J.			Prevalence of seasonal and perennial allergic rhinitis children and adults	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Gordon, B.] Cape Cod Ear Nose & Throat Specialists, Hyannis, MA USA; [Blaiss, M.] Univ Tennessee, Hlth Sci Ctr, Germantown, TN USA; [Meltzer, E.] Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA; [Mahr, T.] Gundersen Lutheran Med Ctr, La Crosse, WI USA; [Boyle, J.] Schulman Ronca & Bucuvalas Inc, Silver Spring, MD USA	University of Tennessee System; University of Tennessee Health Science Center; Gundersen Lutheran Medical Center									0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		801	S209	S209		10.1016/j.jaci.2007.12.778	http://dx.doi.org/10.1016/j.jaci.2007.12.778			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426401265
J	Hatam, LJ; Rosenthal, DW; DeVoti, JA; Lam, F; Abramson, A; Steinberg, BM; Bonagura, VR				Hatam, L. J.; Rosenthal, D. W.; DeVoti, J. A.; Lam, F.; Abramson, A.; Steinberg, B. M.; Bonagura, V. R.			CD4(+)Foxp3(+)CD127(+low) T-Regulatory cells are increased in HPV infected papillomas in patients with recurrent respiratory papillomatosis (RRP)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Hatam, L. J.; Rosenthal, D. W.; DeVoti, J. A.; Lam, F.; Steinberg, B. M.; Bonagura, V. R.] Feinstein Inst Med Res, N Shore Long Isl Jewish Hlth Syst, Manhasset, NY USA; [Hatam, L. J.; Rosenthal, D. W.; DeVoti, J. A.; Lam, F.; Bonagura, V. R.] Div Allergy Immunol, N Shore Long Isl Jewish Hlth Syst, Great Neck, NY USA; [Abramson, A.; Steinberg, B. M.] Dept Otolaryngol, N Shore Long Isl Jewish Hlth Syst, New Hyde Pk, NY USA	Northwell Health; Northwell Health; Northwell Health			Rosenthal, David W/E-2199-2011	Rosenthal, David W/0000-0003-2136-4287					0	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		812	S211	S211		10.1016/j.jaci.2007.12.789	http://dx.doi.org/10.1016/j.jaci.2007.12.789			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426401276
J	Lierl, MB				Lierl, M. B.			Efficacy of montelukast for treatment of periodic fever with aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Lierl, M. B.] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center									0	6	6	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		876	S228	S228		10.1016/j.jaci.2007.12.899	http://dx.doi.org/10.1016/j.jaci.2007.12.899			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426401340
J	Park, AY; Pien, GC; Stinson, R; Brown-Whitehorn, TF; Spergel, JM				Park, A. Y.; Pien, G. C.; Stinson, R.; Brown-Whitehorn, T. F.; Spergel, J. M.			Administration of influenza vaccine to patients with egg allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Park, A. Y.; Pien, G. C.; Stinson, R.; Brown-Whitehorn, T. F.; Spergel, J. M.] Childrens Hosp Philadelphia, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia									0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		925	S240	S240		10.1016/j.jaci.2007.12.949	http://dx.doi.org/10.1016/j.jaci.2007.12.949			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426401389
J	Perzanowski, MS; Miller, RL; Ali, DB; Garfinkel, RS; Chew, GL; Goldstein, IF; Perera, FP; Barr, RG				Perzanowski, M. S.; Miller, R. L.; Ali, D. B.; Garfinkel, R. S.; Chew, G. L.; Goldstein, I. F.; Perera, F. P.; Barr, R. G.			Prenatal acetaminophen use is a risk for wheeze at age 5 years in a low income urban population with a high risk for asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Perzanowski, M. S.; Miller, R. L.; Ali, D. B.; Garfinkel, R. S.; Chew, G. L.; Goldstein, I. F.; Perera, F. P.; Barr, R. G.] Columbia Univ, Columbia Ctr Childrens Environm Hlth, New York, NY 10027 USA	Columbia University									0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		890	S231	S231		10.1016/j.jaci.2007.12.914	http://dx.doi.org/10.1016/j.jaci.2007.12.914			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426401354
J	Radulovic, S; Calderon, MA; Wilson, DR; Durham, SR				Radulovic, S.; Calderon, M. A.; Wilson, D. R.; Durham, S. R.			Cochrane systematic review: Safety profile of sublingual immunotherapy (SLIT) for allergic rhinitis (AR)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Radulovic, S.; Calderon, M. A.; Durham, S. R.] Univ London Imperial Coll Sci & Technol, London, England; [Wilson, D. R.] Univ Hosp, Royal Ctr Defense Med, Birmingham, W Midlands, England	Imperial College London; Royal Centre for Defence Medicine; University of Birmingham									0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		550	S142	S142		10.1016/j.jaci.2007.12.1105	http://dx.doi.org/10.1016/j.jaci.2007.12.1105			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426401014
J	Rerinck, HC; Rueff, F; Przybilla, B				Rerinck, H. C.; Rueeff, F.; Przybilla, B.			Recurrent severe anaphylactic reactions to venom immunotherapy (VIT): Omalizumab induces tolerance	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Rerinck, H. C.; Rueeff, F.; Przybilla, B.] Univ Munich, Munich, Germany	University of Munich									0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		111	S29	S29		10.1016/j.jaci.2007.12.118	http://dx.doi.org/10.1016/j.jaci.2007.12.118			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426400112
J	Peroni, DG; Piacentini, GL; Bodini, A; Boner, AL				Peroni, Diego G.; Piacentini, Giorgio L.; Bodini, Alesscindro; Boner, Attilio L.			Childhood Asthma Control Test in asthmatic children with dysfunctional breathing	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Peroni, Diego G.; Piacentini, Giorgio L.; Bodini, Alesscindro; Boner, Attilio L.] Univ Verona, Dept Pediat, I-37100 Verona, Italy	University of Verona	Peroni, DG (corresponding author), Univ Verona, Dept Pediat, I-37100 Verona, Italy.	peroni.diego@tiscalinet.it	Peroni, Diego G/K-4002-2018; Peroni, Diego/K-8795-2016	Peroni, Diego/0000-0002-0234-1373				Liu AH, 2007, J ALLERGY CLIN IMMUN, V119, P817, DOI 10.1016/j.jaci.2006.12.662; POWELL CVE, 1995, ARCH DIS CHILD, V72, P209, DOI 10.1136/adc.72.3.209; VANDIXHOORN J, 1985, J PSYCHOSOM RES, V29, P199, DOI 10.1016/0022-3999(85)90042-X	3	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2008	121	1					266	267		10.1016/j.jaci.2007.06.049	http://dx.doi.org/10.1016/j.jaci.2007.06.049			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	251KM	17920668	Bronze			2022-12-18	WOS:000252372000050
J	Krishnan, JA; Gould, M				Krishnan, Jerry A.; Gould, Michael			Ornalizumab for severe allergic asthma: Dollars and sense	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							COST-EFFECTIVENESS; OMALIZUMAB; ADULTS		Univ Chicago, Sect Pulm & Crit Care, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; Stanford Sch Med, Div Pulm & Crit Care Med, Dept Med, Stanford, CA USA	University of Chicago; University of Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Krishnan, JA (corresponding author), Univ Chicago, Sect Pulm & Crit Care, Dept Med, 5841 S Maryland Ave,MC 6076, Chicago, IL 60637 USA.	jkrishna@medicine.bsd.uchicago.edu						Brown R, 2007, ALLERGY, V62, P149, DOI 10.1111/j.1398-9995.2006.01310.x; Dewilde S, 2006, CURR MED RES OPIN, V22, P1765, DOI 10.1185/030079906X132389; Krishnan JA, 2004, AM J RESP CRIT CARE, V170, P1281, DOI 10.1164/rccm.200403-409OC; Levinsky NG, 1998, NEW ENGL J MED, V338, P913, DOI 10.1056/NEJM199803263381313; *NAT HEART LUNG BL, 2007, J ALLERGY CLIN IMMUN, V120, pS93; Oba Y, 2004, J ALLERGY CLIN IMMUN, V114, P265, DOI 10.1016/j.jaci.2004.05.049; UBEL PA, 1995, ARCH INTERN MED, V155, P1837, DOI 10.1001/archinte.155.17.1837; Walker S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003559.pub3; World Health Organization, 2002, WHO REP 2002 RED RIS; Wu AC, 2007, J ALLERGY CLIN IMMUN, V120, P1146, DOI 10.1016/j.jaci.2007.07.055	10	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2007	120	5					1015	1017		10.1016/j.jaci.2007.09.027	http://dx.doi.org/10.1016/j.jaci.2007.09.027			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	231TZ	17983869				2022-12-18	WOS:000250973400004
J	Heltzer, ML; Paessler, M; Raffini, L; Bunin, N; Perez, EE				Heltzer, Meredith Lee; Paessler, Michele; Raffini, Leslie; Bunin, Nancy; Perez, Elena Elizabeth			Successful haploidentical bone marrow transplantation in a patient with reticular dysgenesis: Three-year follow-up	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							SEVERE COMBINED IMMUNODEFICIENCY; CORD BLOOD TRANSPLANTATION; EXPERIENCE		Childrens Hosp Philadelphia, Div Allergy, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Immunol, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Pathol, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Hematol Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Heltzer, ML (corresponding author), Childrens Hosp Philadelphia, Div Allergy, Philadelphia, PA 19104 USA.	perez@email.chop.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007775] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL007775] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Antoine C, 2003, LANCET, V361, P553, DOI 10.1016/S0140-6736(03)12513-5; Bertrand Y, 2002, BONE MARROW TRANSPL, V29, P759, DOI 10.1038/sj.bmt.1703531; Bhattacharya A, 2005, BONE MARROW TRANSPL, V36, P295, DOI 10.1038/sj.bmt.1705054; Buckley RH, 1997, J PEDIATR-US, V130, P378, DOI 10.1016/S0022-3476(97)70199-9; DeSantes KB, 1996, BONE MARROW TRANSPL, V17, P1171; DEVAAL OM, 1959, LANCET, V2, P1123; Haddad E, 1998, BLOOD, V91, P3646; Knutsen AP, 2000, J CLIN IMMUNOL, V20, P466, DOI 10.1023/A:1026463900925; Reubsaet LL, 2007, BONE MARROW TRANSPL, V39, P307, DOI 10.1038/sj.bmt.1705577; Small TN, 1999, J PEDIATR-US, V135, P387, DOI 10.1016/S0022-3476(99)70141-1	10	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2007	120	4					950	952		10.1016/j.jaci.2007.07.026	http://dx.doi.org/10.1016/j.jaci.2007.07.026			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	220LH	17854878				2022-12-18	WOS:000250157700033
J	Schatz, M; Blaiss, M; Green, G; Aaronson, D				Schatz, Michael; Blaiss, Michael; Green, George; Aaronson, Donald			Pay for performance for the allergist-immunologist: Potential promise and problems	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						pay for performance; quality measures; practice management	FOR-PERFORMANCE; HEDIS CRITERIA; ASTHMA; QUALITY; IMPROVE; PAYMENT; IMPACT	Pay for performance is one component of a growing movement in this country to better align incentives so as to increase the quality of medical care and reduce unnecessary costs. The Physician Consortium for Quality Improvement is a national multistakeholder organization that is developing performance measures. Concerns regarding performance measures include technical concerns (eg, validity, risk adjustment, sample size, and accuracy considerations), concerns regarding the cost of implementation, and concerns regarding unintended consequences. Some data support the effectiveness of pay-for-performance programs, but more and better-designed studies are needed to rigorously assess the effectiveness of pay-for- performance programs. The Institute of Medicine 2006 report supports pay for performance "as a stimulus to foster comprehensive and system-wide improvements in the quality of healthcare." This report also recommends that implementation of pay-for-performance programs should be carefully monitored to be sure that the stated goals are being achieved and that unintended consequences are recognized as early as possible. It is important for the allergist-immunologist to be an active participant in the evolving paradigm of pay for performance, advocating for the best interests of patients and providers alike.	Kaiser Permanente Med Ctr, Dept Allergy, San Diego, CA 92111 USA; Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Chicago Med Sch, Dept Med, Chicago, IL USA	Kaiser Permanente; University of Tennessee System; University of Tennessee Health Science Center; University of Pennsylvania; Chicago Medical School	Schatz, M (corresponding author), Kaiser Permanente Med Ctr, Dept Allergy, 7060 Clairemont Mesa Blvd, San Diego, CA 92111 USA.	michael.x.schatz@kp.org						Beckman H, 2006, AM J MED QUAL, V21, P192, DOI 10.1177/1062860606287577; Berger WE, 2004, ANN ALLERG ASTHMA IM, V93, P538, DOI 10.1016/S1081-1206(10)61260-4; Cabana MD, 2004, PEDIATRICS, V114, P1049, DOI 10.1542/peds.2003-1162-L; Damberg Cheryl L, 2005, Qual Manag Health Care, V14, P66; De Vries MP, 2005, J ASTHMA, V42, P659, DOI 10.1080/02770900500264903; Endsley Scott, 2006, Fam Pract Manag, V13, P69; Fisher ES, 2006, NEW ENGL J MED, V355, P1845, DOI 10.1056/NEJMp068221; Freed GL, 2006, J PEDIATR-US, V149, P120, DOI 10.1016/j.jpeds.2006.03.023; Frolich A, 2007, HEALTH POLICY, V80, P179, DOI 10.1016/j.healthpol.2006.03.001; Fuhlbrigge AL, 2005, AM J MANAG CARE, V11, P325; Huang IC, 2005, MED DECIS MAKING, V25, P20, DOI 10.1177/0272989X04273138; Huang IC, 2005, AM J MANAG CARE, V11, P38; *I MED, 1909, REW PROV PERF AL INC; Institute of Medicine, 2001, CROSSING QUALITY CHA; Levin-Scherz J, 2006, MED CARE RES REV, V63, p14S, DOI 10.1177/1077558705284057; McMahon LF, 2007, AM J MANAG CARE, V13, P233; Mehrotra A, 2007, AM J MANAG CARE, V13, P249; Mosen DM, 2005, AM J MANAG CARE, V11, P650; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; Rosenthal MB, 2006, MED CARE RES REV, V63, P135, DOI 10.1177/1077558705285291; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Rosenthal MB, 2007, JAMA-J AM MED ASSOC, V297, P740, DOI 10.1001/jama.297.7.740; Rosenthal MB, 2006, NEW ENGL J MED, V355, P1895, DOI 10.1056/NEJMsa063682; Rowe JW, 2006, ANN INTERN MED, V145, P695, DOI 10.7326/0003-4819-145-9-200611070-00013; Schatz M, 2005, CHEST, V128, P1968, DOI 10.1378/chest.128.4.1968; Schatz M, 2007, J ASTHMA, V44, P341, DOI 10.1080/02770900701344421; Tang PC, 2007, J AM MED INFORM ASSN, V14, P10, DOI 10.1197/jamia.M2198; Young GJ, 2007, J HEALTHC MANAG, V52, P10, DOI 10.1097/00115514-200701000-00004; Zaslavsky AM, 2000, MED CARE, V38, P981, DOI 10.1097/00005650-200010000-00002	30	6	6	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2007	120	4					769	775		10.1016/j.jaci.2007.05.048	http://dx.doi.org/10.1016/j.jaci.2007.05.048			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	220LH	17681367				2022-12-18	WOS:000250157700009
J	van den Biggelaar, AHJ; Hua, TD; Rodrigues, LC; Kremsner, PG; Yazdanbakhsh, M; Kube, D				van den Biggelaar, Anita H. J.; Hua, Thanh-Duc; Rodrigues, Laura C.; Kremsner, Peter G.; Yazdanbakhsh, Maria; Kube, Dieter			Genetic variation in IL-10 is associated with atopic reactivity in Gabonese schoolchildren	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INTERLEUKIN-10 PRODUCTION; POLYMORPHISMS		Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; Leiden Univ, Dept Parasitol, NL-2300 RA Leiden, Netherlands; Univ Gottingen, Div Hematol Oncol, D-3400 Gottingen, Germany; London Sch Hyg & Trop Med, Dept Epidemiol & Populat Sci, London WC1, England; Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon, Germany; Univ Tubingen, Inst Trop Med, Dept Parasitol, Tubingen, Germany	Telethon Kids Institute; University of Western Australia; Leiden University; Leiden University - Excl LUMC; University of Gottingen; University of London; London School of Hygiene & Tropical Medicine; Eberhard Karls University of Tubingen	van den Biggelaar, AHJ (corresponding author), Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia.	anitav@ichr.uwa.edu.au	Yazdanbakhsh, Maria/AAI-3996-2020; RODRIGUES, LAURA CUNHA/AAO-4130-2021	Yazdanbakhsh, Maria/0000-0002-7666-1441; Rodrigues, Laura Cunha/0000-0001-9008-660X				Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Gibson AW, 2001, J IMMUNOL, V166, P3915, DOI 10.4049/jimmunol.166.6.3915; Lim S, 1998, LANCET, V352, P113, DOI 10.1016/S0140-6736(98)85018-6; Meenagh A, 2002, HUM IMMUNOL, V63, P1055, DOI 10.1016/S0198-8859(02)00440-8; Mormann M, 2004, GENES IMMUN, V5, P246, DOI 10.1038/sj.gene.6364073; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Timmann C, 2004, GENES IMMUN, V5, P256, DOI 10.1038/sj.gene.6364094; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; van den Biggelaar AHJ, 2000, LANCET, V356, P1723, DOI 10.1016/S0140-6736(00)03206-2	9	6	6	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2007	120	4					973	975		10.1016/j.jaci.2007.06.044	http://dx.doi.org/10.1016/j.jaci.2007.06.044			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	220LH	17825889	Bronze			2022-12-18	WOS:000250157700043
J	Irani, C; Gordon, ND; Levinson, AI				Irani, Carta; Gordon, Nancy D.; Levinson, Arnold I.			Normothermic cardioplegia in a patient with cold-induced urticaria	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Univ Hosp, Hotel Dieu, Allergy & Immunol Sect, Dept Internal Med, Beirut, Lebanon; Hosp Univ Penn, Allergy & Clin Immunol Sect, Dept Pulm & Crit Care Med, Philadelphia, PA 19104 USA	American University of Beirut; University of Pennsylvania	Irani, C (corresponding author), Univ Hosp, Hotel Dieu, Allergy & Immunol Sect, Dept Internal Med, Beirut, Lebanon.	iranica@yahoo.com						Arino P, 1999, ANESTHESIOLOGY, V90, P907, DOI 10.1097/00000542-199903000-00035; Delorme N, 2002, Allerg Immunol (Paris), V34, P255; JOHNSTON WE, 1982, NEW ENGL J MED, V306, P219, DOI 10.1056/NEJM198201283060406; Lancey RA, 2004, ANN ALLERG ASTHMA IM, V92, P273, DOI 10.1016/S1081-1206(10)61560-8; MALM T, 1988, THORAC CARDIOV SURG, V36, P49, DOI 10.1055/s-2007-1020043; Pouard P, 2006, EUR J CARDIO-THORAC, V30, P695, DOI 10.1016/j.ejcts.2006.07.032; WANDERER AA, 1990, J ALLERGY CLIN IMMUN, V85, P965, DOI 10.1016/0091-6749(90)90037-5	7	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2007	120	3					722	723		10.1016/j.jaci.2007.05.012	http://dx.doi.org/10.1016/j.jaci.2007.05.012			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	211DV	17610941				2022-12-18	WOS:000249505400038
J	Sorkness, CA				Sorkness, C. A.			Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial (vol 119, pg 64, 2007)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Correction																		SORKNESS CA, 2007, J ALLERGY CLIN IMMUN, V64, P119	1	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2007	120	2					285	285						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	198VF					2022-12-18	WOS:000248654900009
J	Baroody, FM; Foster, K; Markarian, A; Detineo, M; Naclerio, R				Baroody, F. M.; Foster, K.; Markarian, A.; deTineo, M.; Naclerio, R.			Nasal ocular reflexes occur after nasal challenge with allergen	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Baroody, F. M.; Foster, K.; Markarian, A.; deTineo, M.; Naclerio, R.] Univ Chicago, Chicago, IL 60637 USA	University of Chicago									0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		637	S162	S162		10.1016/j.jaci.2006.11.573	http://dx.doi.org/10.1016/j.jaci.2006.11.573			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT					2022-12-18	WOS:000251460401022
J	Early, SB; Han, J; Borish, L; Steinke, J				Early, S. B.; Han, J.; Borish, L.; Steinke, J.			Histologic examination reveals distinct disease subsets of chronic sinusitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Early, S. B.; Han, J.; Borish, L.; Steinke, J.] Univ Virginia, Charlottesville, VA USA	University of Virginia									0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		952	S243	S243		10.1016/j.jaci.2006.12.320	http://dx.doi.org/10.1016/j.jaci.2006.12.320			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT					2022-12-18	WOS:000251460401336
J	Hampel, FC; Jacobs, R; Martin, B; Toler, T; Ellsworth, A; Philpot, E				Hampel, F. C., Jr.; Jacobs, R.; Martin, B.; Toler, T.; Ellsworth, A.; Philpot, E.			Once-daily fluticasone furoate* nasal spray (FF) provides 24-hour symptom relief in subjects with seasonal allergic rhinitis (SAR) caused by mountain cedar pollen - *USAN approved name	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Hampel, F. C., Jr.] Cent Texas Hlth Res, New Braunfels, TX USA; [Jacobs, R.] Biogen Res Inst, San Antonio, TX USA; [Martin, B.] SW Allergy & Asthma Res, San Antonio, TX USA; [Toler, T.; Ellsworth, A.; Philpot, E.] GlaxoSmithKline Inc, Res Triangle Pk, NC USA	GlaxoSmithKline									0	6	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		1190	S304	S305		10.1016/j.jaci.2006.12.563	http://dx.doi.org/10.1016/j.jaci.2006.12.563			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT					2022-12-18	WOS:000251460401573
J	Katz, RM; Rafi, AW; Do, L; Lin, M; Mangat, R; Azad, N; Sender, S				Katz, R. M.; Rafi, A. W.; Do, L.; Lin, M.; Mangat, R.; Azad, N.; Sender, S.			Efficacy of Omalizumab using extended dose intervals	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Katz, R. M.; Rafi, A. W.; Do, L.; Lin, M.; Mangat, R.; Azad, N.; Sender, S.] Univ Calif Los Angeles, Allergy Asthma Care Ctr, Santa Monica, CA USA	University of California System; University of California Los Angeles									0	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		833	S212	S212		10.1016/j.jaci.2006.12.199	http://dx.doi.org/10.1016/j.jaci.2006.12.199			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT		Bronze			2022-12-18	WOS:000251460401218
J	Oswalt, ML; Foote, JT; Kemp, SF				Oswalt, M. L.; Foote, J. T.; Kemp, S. F.			Anaphylaxis: Report of two fatal yellow jacket (YJ) stings in Alaska (AK)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; Tanana Valley Clin, Fairbanks, AK USA	University of Mississippi; University of Mississippi Medical Center									0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		129	S34	S34		10.1016/j.jaci.2006.11.150	http://dx.doi.org/10.1016/j.jaci.2006.11.150			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT					2022-12-18	WOS:000251460400130
J	Rondon, C; Romero, JJ; Lopez, S; R-Pena, R; Rodriguez-Bada, JL; Chaves, P; Dona, I; Blanca, M				Rondon, C.; Romero, J. J.; Lopez, S.; R-Pena, R.; Rodriguez-Bada, J. L.; Chaves, P.; Dona, I.; Blanca, M.			Positive nasal allergen provocation test and nasal specific-IgE to grass pollen in patients with idiopathic rhinitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Rondon, C.; Romero, J. J.; Dona, I.; Blanca, M.] Carlos Haya Hosp, Allergy Serv, Malaga, Spain; [Lopez, S.; R-Pena, R.; Rodriguez-Bada, J. L.; Chaves, P.] Carlos Haya Hosp, Fdn IMABIS, Res Lab, Malaga, Spain	Hospital Carlos Haya; FIMABIS; Hospital Carlos Haya									0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		1228	S314	S314		10.1016/j.jaci.2006.12.601	http://dx.doi.org/10.1016/j.jaci.2006.12.601			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT					2022-12-18	WOS:000251460401611
J	Tashkin, D; Varghese, S				Tashkin, D.; Varghese, S.			Formoterol treatment plus tiotropium results in greater improvements in lung function compared with tiotropium administered alone in patients with COPD	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Tashkin, D.] David Geffen Sch Med, Los Angeles, CA USA; [Varghese, S.] Schering Plough SpA, Kenilworth, NJ USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Merck & Company; Schering Plough Corporation									0	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		12	S4	S4		10.1016/j.jaci.2006.11.031	http://dx.doi.org/10.1016/j.jaci.2006.11.031			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT					2022-12-18	WOS:000251460400014
J	Kessel, JM; Sedgwick, JB; Busse, WW				Kessel, Julie M.; Sedgwick, Julie B.; Busse, William W.			Ligation of intercellular adhesion molecule 3 induces apoptosis of human blood eosinophils and neutrophil	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ICAM-3; adhesion molecules; neutrophils; eosinophils; apoptosis	COLONY-STIMULATING FACTOR; BETA(2) INTEGRINS; TYROSINE KINASE; CD50 ICAM-3; CELL-DEATH; ACTIVATION; CASPASES; INTERLEUKIN-5; MITOCHONDRIA; INVOLVEMENT	Background: Intercellular adhesion molecule 3 (ICAM-3) is highly expressed on human granulocytes, including eosinophils and neutrophils, but the functions of ICAM-3 in these cells are not well understood. Objective: Our studies test the hypothesis that ICAM-3 regulates granulocyte apoptosis. Methods: Intercellular adhesion molecule 3 was activated by a mAb that recognizes an ICAM-3 epitope that binds its ligand, CD11a/CD18. In some experiments with eosinophils, recombinant human IL-5 or GM-CSF was added to mimic in vivo antiapoptotic conditions. Staining with annexin V-fluorescein isothiocyanate and propidium iodide identified apoptotic cells. Results: Binding of ICAM-3 increased apoptosis of both eosinophils (18 and 48 hours) and neutrophils (18 hours). At 18 hours, eosinophil apoptosis increased from 31.4%+/- 3.5 SE (IgG control) to 45.2%+/- 3.8 SE (anti-ICAM-3), and neutrophil apoptosis increased from 48%+/- 4.1 SE (IgG control) to 55.3%+/- 4.5 SE (anti-ICAM-3). At 48 hours, eosinophil apoptosis increased 2-fold under baseline conditions and also in the presence of recombinant human IL-5 or GM-CSF. In both eosinophils and neutrophils, incubation with a blocking antibody against CD18 integrins blunted ICAM-3-induced apoptosis. In eosinophils, blocking peptides for caspases 8 and 9, proteases critical to apoptosis, also decreased ICAM-3-induced apoptosis to control levels. Conclusion: Through its effect on eosinophil and neutrophil apoptosis, ICAM-3 may be an important anti-inflammatory molecule that can oppose the proinflammatory effects of IL-5 and GM-CSF. cClinical implications: These findings provide a mechanism for apoptotic clearance of eosinophils and neutrophils involved in allergic inflammation that, unlike necrosis, does not cause nonspecific tissue injury.	Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Div Neonatol, Madison, WI 53715 USA; Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53706 USA; Meriter Hosp, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kessel, JM (corresponding author), Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Div Neonatol, 202 S Pk St,6 Ctr, Madison, WI 53715 USA.	jmkessel@wisc.edu			PHS HHS [K08-A145923] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Berro AI, 2004, J IMMUNOL, V173, P2174, DOI 10.4049/jimmunol.173.3.2174; Blaylock MG, 1999, J ALLERGY CLIN IMMUN, V104, P1244, DOI 10.1016/S0091-6749(99)70020-5; Bochner Bruce S., 2003, Journal of Allergy and Clinical Immunology, V111, pS819, DOI 10.1067/mai.2003.149; BOSSY D, 1995, EUR J IMMUNOL, V25, P459, DOI 10.1002/eji.1830250223; Dewson G, 2001, BLOOD, V98, P2239, DOI 10.1182/blood.V98.7.2239; Druilhe A, 1996, BLOOD, V87, P2822, DOI 10.1182/blood.V87.7.2822.bloodjournal8772822; Esnault S, 2001, J IMMUNOL, V166, P4658, DOI 10.4049/jimmunol.166.7.4658; FAWCETT J, 1992, NATURE, V360, P481, DOI 10.1038/360481a0; Feldhaus MJ, 1998, J IMMUNOL, V161, P6280; Gardai SJ, 2003, J IMMUNOL, V170, P556, DOI 10.4049/jimmunol.170.1.556; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Green JM, 1996, CELL IMMUNOL, V171, P126, DOI 10.1006/cimm.1996.0182; Haslett C, 1999, AM J RESP CRIT CARE, V160, pS5, DOI 10.1164/ajrccm.160.supplement_1.4; HOLNESS CL, 1995, J BIOL CHEM, V270, P877, DOI 10.1074/jbc.270.2.877; Kankaanranta H, 2002, INT ARCH ALLERGY IMM, V127, P73, DOI 10.1159/000048171; Kessel JM, 2003, J ALLERGY CLIN IMMUN, V111, P1024, DOI 10.1067/mai.2003.1393; Kessel JM, 1998, J IMMUNOL, V160, P5579; Kobayashi SD, 2003, J IMMUNOL, V170, P3357, DOI 10.4049/jimmunol.170.6.3357; Letuve S, 2001, J LEUKOCYTE BIOL, V70, P767; MartinezCaceres E, 1996, TISSUE ANTIGENS, V48, P626, DOI 10.1111/j.1399-0039.1996.tb02685.x; MATSUMOTO K, 1995, BLOOD, V86, P1437, DOI 10.1182/blood.V86.4.1437.bloodjournal8641437; Matsumoto K, 2004, J IMMUNOL, V172, P2186, DOI 10.4049/jimmunol.172.4.2186; Mayadas TN, 2005, TRENDS IMMUNOL, V26, P388, DOI 10.1016/j.it.2005.05.002; Moffatt OD, 1999, J IMMUNOL, V162, P6800; Nagahata H, 2004, IMMUNOL CELL BIOL, V82, P32, DOI 10.1111/j.1440-1711.2004.01202.x; NAGATA M, 1995, J IMMUNOL, V155, P4948; Simon HU, 1997, EUR J IMMUNOL, V27, P3536, DOI 10.1002/eji.1830271256; Simon HU, 1998, BLOOD, V92, P547, DOI 10.1182/blood.V92.2.547.414k02_547_557; Simon HU, 2001, SWISS MED WKLY, V131, P455; Simon HU, 2001, IMMUNOL REV, V179, P156, DOI 10.1034/j.1600-065X.2001.790115.x; SIMON HU, 1995, INT ARCH ALLERGY IMM, V107, P338, DOI 10.1159/000237021; SKUBITZ KM, 1995, J IMMUNOL, V154, P2888; Stucki A, 2000, BRIT J HAEMATOL, V108, P157, DOI 10.1046/j.1365-2141.2000.01811.x; Tibbetts MD, 2003, NAT IMMUNOL, V4, P404, DOI 10.1038/ni0503-404; VanderVieren M, 1995, IMMUNITY, V3, P683, DOI 10.1016/1074-7613(95)90058-6; VAZEUX R, 1992, NATURE, V360, P485, DOI 10.1038/360485a0; Walsh GM, 1996, BLOOD, V87, P2815, DOI 10.1182/blood.V87.7.2815.bloodjournal8772815; Walsh GM, 2000, BRIT J HAEMATOL, V111, P61; Walzog B, 1997, FASEB J, V11, P1177, DOI 10.1096/fasebj.11.13.9367353; Wedi B, 1999, BLOOD, V94, P2365, DOI 10.1182/blood.V94.7.2365.419k08_2365_2373; Woolley KL, 1996, AM J RESP CRIT CARE, V154, P237, DOI 10.1164/ajrccm.154.1.8680686; Yamamoto H, 1998, J IMMUNOL, V161, P971; Zhang JP, 2000, CLIN EXP IMMUNOL, V122, P20, DOI 10.1046/j.1365-2249.2000.01344.x; Zimmermann KC, 2001, J ALLERGY CLIN IMMUN, V108, pS99, DOI 10.1067/mai.2001.117819	44	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2006	118	4					831	836		10.1016/j.jaci.2006.05.026	http://dx.doi.org/10.1016/j.jaci.2006.05.026			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	097GD	17030234				2022-12-18	WOS:000241434200008
J	Ponikau, JU; Sherris, DA				Ponikau, Jens U.; Sherris, David A.			The role of airborne mold in chronic rhinosinusitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALLERGIC FUNGAL SINUSITIS; NASAL MUCUS; DIAGNOSIS; PROTEIN; TRIAL		SUNY Buffalo, Dept Clin Otorhinolaryngol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Ponikau, JU (corresponding author), SUNY Buffalo, Dept Clin Otorhinolaryngol, Buffalo, NY 14260 USA.							BENT JP, 1994, OTOLARYNG HEAD NECK, V111, P580, DOI 10.1016/S0194-5998(94)70525-9; Braun H, 2003, LARYNGOSCOPE, V113, P264, DOI 10.1097/00005537-200302000-00013; Bush RK, 2006, J ALLERGY CLIN IMMUN, V117, P326, DOI 10.1016/j.jaci.2005.12.001; Buzina W, 2003, MED MYCOL, V41, P149, DOI 10.1080/714043911; Collins M, 2004, LARYNGOSCOPE, V114, P1242, DOI 10.1097/00005537-200407000-00019; DESHAZO RD, 1995, J ALLERGY CLIN IMMUN, V96, P24, DOI 10.1016/S0091-6749(95)70029-3; Gosepath J, 2004, AM J RHINOL, V18, P9, DOI 10.1177/194589240401800104; Inoue Y, 2005, J IMMUNOL, V175, P5439, DOI 10.4049/jimmunol.175.8.5439; Krouse JH, 2004, LARYNGOSCOPE, V114, P1389, DOI 10.1097/00005537-200408000-00013; Lackner A, 2005, AM J RHINOL, V19, P125, DOI 10.1177/194589240501900203; Ponikau JU, 2005, J ALLERGY CLIN IMMUN, V116, P362, DOI 10.1016/j.jaci.2005.03.049; Ponikau JU, 2005, J ALLERGY CLIN IMMUN, V115, P125, DOI 10.1016/j.jaci.2004.09.037; Ponikau JU, 1999, MAYO CLIN PROC, V74, P877, DOI 10.4065/74.9.877; Shin SH, 2004, J ALLERGY CLIN IMMUN, V114, P1369, DOI 10.1016/j.jaci.2004.08.012; Taylor MJ, 2002, OTOLARYNG HEAD NECK, V127, P377, DOI 10.1067/mhn.2002.128896; Weschta M, 2004, J ALLERGY CLIN IMMUN, V113, P1122, DOI 10.1016/j.jaci.2004.03.038	16	6	6	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2006	118	3					762	763		10.1016/j.jaci.2006.06.035	http://dx.doi.org/10.1016/j.jaci.2006.06.035			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086BV	16950303				2022-12-18	WOS:000240649000039
J	Feeney, ME; Tang, YH; Rathod, A; Kneut, C; McIntosh, K				Feeney, Margaret E.; Tang, Yanhua; Rathod, Almas; Kneut, Catherine; McIntosh, Kenneth			Absence of detectable viremia in a perinatally HIV-1-infected teenager after discontinuation of antiretroviral therapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						perinatal HIV; long-term nonprogressor; CCR5; cytotoxic T lymphocytes; CD4 T-H cells	T-LYMPHOCYTE RESPONSE; GB-VIRUS-C; DISEASE PROGRESSION; HIV-1 INFECTION; GENETIC RESTRICTION; CELL PROLIFERATION; CCR5; RECEPTOR; ALLELE; TRANSMISSION	A 15-year-old girl with perinatal HIV-1 infection has remained asymptomatic with undetectable plasma HIV-1 viremia for more than 5 years after discontinuing all antiretroviral therapy. Viral sequence analysis of proviral HIV-1 DNA revealed no evident fitness-attenuating deletions or mutations. This subject exhibited an unusually robust HIV-specific T-cell response, with an intact CD4(+) T cell-proliferative response to HIV-1 antigens. In addition, the subject was found to be heterozygous for the 32-bp deletion in the CCR5 gene, which encodes the primary coreceptor for HIV-1 entry into cells. This mutation mediates profound resistance to HIV infection in homozygotes and has been associated with delayed disease progression in heterozygotes after both horizontal and vertical HIV-1 infection. Although adults with long-term nonprogressive HIV disease have been studied at length, there is no prior description in the literature of a perinatally HIV-infected child whose plasma HIV-1 viremia is controlled to undetectable levels in the absence of antiretroviral therapy.	Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Childrens Hosp, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Feeney, ME (corresponding author), 149 13th St,5th Floor, Charlestown, MA 02129 USA.	mfeeney@partners.org						Alexander L, 2006, PEDIATR INFECT DIS J, V25, P135, DOI 10.1097/01.inf.0000199299.00345.83; Alexander L, 2000, J VIROL, V74, P4361, DOI 10.1128/JVI.74.9.4361-4376.2000; Alexander L, 2002, J VIROL, V76, P10533, DOI 10.1128/JVI.76.20.10533-10539.2002; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Barroga CF, 2000, J INFECT DIS, V182, P413, DOI 10.1086/315704; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Colgrove RC, 2005, AIDS RES HUM RETROV, V21, P191, DOI 10.1089/aid.2005.21.191; Dean M, 1996, SCIENCE, V274, P1069; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Feeney ME, 2003, J IMMUNOL, V171, P6968, DOI 10.4049/jimmunol.171.12.6968; Feeney ME, 2003, J VIROL, V77, P7492, DOI 10.1128/JVI.77.13.7492-7501.2003; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Ioannidis JPA, 2003, AIDS, V17, P1631, DOI 10.1097/00002030-200307250-00007; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Kostrikis LG, 1998, NAT MED, V4, P350, DOI 10.1038/nm0398-350; Learmont JC, 1999, NEW ENGL J MED, V340, P1715, DOI 10.1056/NEJM199906033402203; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Mangano A, 2001, J INFECT DIS, V183, P1574, DOI 10.1086/320705; Michael NL, 1997, NAT MED, V3, P1160, DOI 10.1038/nm1097-1160; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Misrahi M, 1998, JAMA-J AM MED ASSOC, V279, P277, DOI 10.1001/jama.279.4.277; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Pikora CA, 2006, VIROLOGY, V346, P479, DOI 10.1016/j.virol.2005.10.040; Rhodes DI, 2000, J VIROL, V74, P10581, DOI 10.1128/JVI.74.22.10581-10588.2000; Rizzardi GP, 1998, NAT MED, V4, P252, DOI 10.1038/nm0398-252; Romiti ML, 2000, MOL MED, V6, P28, DOI 10.1007/BF03401932; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Williams CF, 2004, NEW ENGL J MED, V350, P981, DOI 10.1056/NEJMoa030107; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	48	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2006	118	2					324	330		10.1016/j.jaci.2006.05.016	http://dx.doi.org/10.1016/j.jaci.2006.05.016			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	075IH	16890753				2022-12-18	WOS:000239877700004
J	Rambasek, T; Kavuru, MS				Rambasek, T; Kavuru, MS			Omalizumab dosing via the recommended card versus use of the published formula	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ASTHMA		ENT Hlth Serv Inc, Sandusky, OH 44870 USA; E Carolina Univ, Brody Sch Med, Div Pulm & Crit Care Med, Greenville, NC USA	University of North Carolina; East Carolina University	Rambasek, T (corresponding author), ENT Hlth Serv Inc, 1221 Hayes Ave, Sandusky, OH 44870 USA.							BORISH L, 2005, ANN ALLERG ASTHMA IM, V108, P184; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; Rambasek TE, 2004, CLEV CLIN J MED, V71, P251, DOI 10.3949/ccjm.71.3.251	3	6	7	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2006	117	3					708	709		10.1016/j.jaci.2005.11.042	http://dx.doi.org/10.1016/j.jaci.2005.11.042			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	025JY	16522477				2022-12-18	WOS:000236263100033
J	Valovirta, E; Jacobsen, L; Niggemann, B; Dreborg, S; Ferdousi, H; Halken, S; Host, A; Nordborg, LA; Koivikko, A; Moller, C				Valovirta, E; Jacobsen, L; Niggemann, B; Dreborg, S; Ferdousi, H; Halken, S; Host, A; Nordborg, LA; Koivikko, A; Moller, C			A 3-year course of subcutaneous specific immunotherapy results in long-term prevention of asthma in children. Ten year follow-up on the PAT-study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Allergy Ctr, Turku, Finland; ALK Abello, Horsholm, Denmark; Charite, Berlin, Germany; Univ Hosp, Linkoping, Sweden; Univ Hosp, Odense, Denmark; Univ Hosp, Umea, Sweden	ALK-Abello AS; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Southern Denmark; Odense University Hospital; Umea University									0	6	9	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2006	117	3					721	721		10.1016/j.jaci.2006.01.023	http://dx.doi.org/10.1016/j.jaci.2006.01.023			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	025JY					2022-12-18	WOS:000236263100044
J	Behncke, VB; Alemar, G; Kaufman, DA; Eidelman, FJ				Behncke, VB; Alemar, G; Kaufman, DA; Eidelman, FJ			Azelastine nasal spray and fluticasone nasal spray in the treatment of geriatric patients with rhinitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Cleveland Clin Florida, Weston, FL USA	Cleveland Clinic Foundation									0	6	6	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		1017	S263	S263		10.1016/j.jaci.2005.12.1040	http://dx.doi.org/10.1016/j.jaci.2005.12.1040			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	019VR					2022-12-18	WOS:000235865302095
J	Brockow, K; Jofer, C; Rings, J				Brockow, K; Jofer, C; Rings, J			Anaphylaxis in patients with mastocytosis - A prospective study on prevalence, severity and trigger factors in 121 patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Tech Univ Munich, Dept Dermatol & Allergol Biederstein, D-8000 Munich, Germany	Technical University of Munich									0	6	6	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		1186	S307	S307		10.1016/j.jaci.2005.12.1213	http://dx.doi.org/10.1016/j.jaci.2005.12.1213			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	019VR					2022-12-18	WOS:000235865302264
J	Chen, H; Blanc, PD; Chawla, A; Hayden, M; Bleecker, ER; Lee, JH				Chen, H; Blanc, PD; Chawla, A; Hayden, M; Bleecker, ER; Lee, JH			Assessing productivity impairment in patients with severe or difficult-to-treat asthma: Validation of the work productivity activity impairment - Asthma questionnaire	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Genentech Inc, San Francisco, CA USA; Univ Virginia, Sch Nursing, Charlottesville, VA USA; Wake Forest Univ, Winston Salem, NC 27109 USA	University of California System; University of California San Francisco; Roche Holding; Genentech; University of Virginia; Wake Forest University									0	6	6	0	3	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		705	S181	S181		10.1016/j.jaci.2005.12.721	http://dx.doi.org/10.1016/j.jaci.2005.12.721			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	019VR					2022-12-18	WOS:000235865301202
J	Fiorillo, A; Fonacier, L; Diola, C				Fiorillo, A; Fonacier, L; Diola, C			Safety of allergenic immunotherapy in systemic lupus erythematosus	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Winthrop Univ Hosp, Mineola, NY 11501 USA	Winthrop University Hospital									0	6	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		1024	S264	S264		10.1016/j.jaci.2005.12.1048	http://dx.doi.org/10.1016/j.jaci.2005.12.1048			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	019VR					2022-12-18	WOS:000235865302102
J	Kurup, VP; Barrios, CS; Johnson, BD; Fink, JN				Kurup, VP; Barrios, CS; Johnson, BD; Fink, JN			Intragastric curcumin downregulates aspergillus antigen induced Th2 response in a murine model of allergic aspergillosis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Med Coll Wisconsin, Res Serv, Milwaukee, WI 53226 USA	Medical College of Wisconsin									0	6	6	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		784	S203	S203		10.1016/j.jaci.2005.12.802	http://dx.doi.org/10.1016/j.jaci.2005.12.802			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	019VR					2022-12-18	WOS:000235865301281
J	Ozdemir, O				Ozdemir, O			Human mast cell cytotoxicity against human lymphoma and myeloid leukemia cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans									0	6	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		67	S17	S17		10.1016/j.jaci.2005.12.071	http://dx.doi.org/10.1016/j.jaci.2005.12.071			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	019VR					2022-12-18	WOS:000235865300068
J	Roberts, JR; Gerstner, TV; Grewar, DA; Dilay, DJ; Cochrane-Fones, RD; Bouwman, TS				Roberts, JR; Gerstner, TV; Grewar, DA; Dilay, DJ; Cochrane-Fones, RD; Bouwman, TS			Allergy to caribou and seal meats in Inuit children: A report of three cases	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Meadowood Med Ctr, Winnipeg, MB, Canada; Univ Manitoba, Winnipeg, MB, Canada	University of Manitoba									0	6	7	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		167	S42	S42		10.1016/j.jaci.2005.12.173	http://dx.doi.org/10.1016/j.jaci.2005.12.173			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	019VR					2022-12-18	WOS:000235865300167
J	Torres, MJ; Blanca, M				Torres, MJ; Blanca, M			The contribution of major and minor determinants from benzylpenicillin to the diagnosis of immediate allergy to beta-lactams	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Carlos Haya Hosp, Allergy Serv, Malaga, Spain	Hospital Carlos Haya	Torres, MJ (corresponding author), Carlos Haya Hosp, Allergy Serv, Malaga, Spain.		Torres, María José/T-3518-2017; Torres, Maria/GVU-3391-2022	Torres, María José/0000-0001-5228-471X; 				Bousquet PJ, 2005, J ALLERGY CLIN IMMUN, V115, P1314, DOI 10.1016/j.jaci.2005.02.026; GADDE J, 1993, JAMA-J AM MED ASSOC, V270, P2456, DOI 10.1001/jama.270.20.2456; Torres MJ, 2003, ALLERGY, V58, P961, DOI 10.1034/j.1398-9995.2003.00280.x	3	6	7	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2006	117	1					220	221		10.1016/j.jaci.2005.08.012	http://dx.doi.org/10.1016/j.jaci.2005.08.012			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IK	16387613	Bronze			2022-12-18	WOS:000235687100040
J	Karjalainen, J; Virta, M; Pessi, T; Hulkkonen, J; Nieminen, MM; Hurme, M				Karjalainen, J; Virta, M; Pessi, T; Hulkkonen, J; Nieminen, MM; Hurme, M			Childhood cat exposure-related tolerance is associated with IL1A and IL10 polymorphisms	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALLERGIC SENSITIZATION; DOG OWNERSHIP; ASTHMA; GENOTYPE; ATOPY		Tampere Univ Hosp, Dept Resp Med, FIN-33014 Tampere, Finland; Tampere Univ Hosp, Ctr Lab Med, FIN-33014 Tampere, Finland; Univ Tampere, Sch Med, Dept Microbiol & Immunol, FIN-33014 Tampere, Finland	Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Tampere University	Karjalainen, J (corresponding author), Tampere Univ Hosp, Dept Resp Med, FIN-33014 Tampere, Finland.			Hurme, Mikko/0000-0002-8614-1044				Gern JE, 2004, J ALLERGY CLIN IMMUN, V113, P307, DOI 10.1016/j.jaci.2003.11.017; Hulkkonen J, 2001, ARTHRITIS RHEUM, V44, P176, DOI 10.1002/1529-0131(200101)44:1<176::AID-ANR23>3.0.CO;2-K; Karjalainen J, 2003, CLIN EXP ALLERGY, V33, P78, DOI 10.1046/j.1365-2222.2003.01577.x; Karjalainen J, 2002, J ALLERGY CLIN IMMUN, V110, P429, DOI 10.1067/mai.2002.126784; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Perzanowski MS, 2002, AM J RESP CRIT CARE, V166, P696, DOI 10.1164/rccm.2201035; Platts-Mills TAE, 2002, JAMA-J AM MED ASSOC, V288, P1012, DOI 10.1001/jama.288.8.1012; Roost HP, 1999, J ALLERGY CLIN IMMUN, V104, P941, DOI 10.1016/S0091-6749(99)70072-2	8	6	6	0	3	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2005	116	1					223	225		10.1016/j.jaci.2005.03.026	http://dx.doi.org/10.1016/j.jaci.2005.03.026			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IC	15990800				2022-12-18	WOS:000235686300035
J	Novak, N; Leung, DYM				Novak, N; Leung, DYM			Diet and allergy: You are what you eat?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						diet; nutrition; allergy	ATOPIC DISEASE; 2 PARTS; IMMUNOLOGY; STRESS		Univ Bonn, Dept Dermatol, D-53105 Bonn, Germany; Natl Jewish Med & Res Ctr, Dept Pediat, Denver, CO USA	University of Bonn; National Jewish Health	Novak, N (corresponding author), Univ Bonn, Dept Dermatol, Sigmund Freud Str 25, D-53105 Bonn, Germany.	Novak@ukb.uni-bonn.de						Ahmad-Nejad P, 2004, J ALLERGY CLIN IMMUN, V113, P565, DOI 10.1016/j.jaci.2003.12.583; Cabana MD, 2005, J ALLERGY CLIN IMMUN, V115, P1225, DOI 10.1016/j.jaci.2005.03.004; CUNINGHAMRUNDLE.C, 2005, PEDIATRICS, V115, P1119; Devereux G, 2005, J ALLERGY CLIN IMMUN, V115, P1109, DOI 10.1016/j.jaci.2004.12.1139; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Friedman NJ, 2005, J ALLERGY CLIN IMMUN, V115, P1238, DOI 10.1016/j.jaci.2005.01.069; Greene LS, 1999, NUTRITION, V15, P899, DOI 10.1016/S0899-9007(99)00209-9; Helm RM, 2004, CURR OPIN ALLERGY CL, V4, P125, DOI [10.1097/00130832-200404000-00010, 10.1097/01.all.0000123969.96233.2a]; ISOLAURI E, 2005, IN PRESS J ALLERGY C; Kabesch M, 2003, J ALLERGY CLIN IMMUN, V111, P813, DOI 10.1067/mai.2003.1336; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kalliomaki M, 1999, J ALLERGY CLIN IMMUN, V104, P1251, DOI 10.1016/S0091-6749(99)70021-7; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kay AB, 2001, NEW ENGL J MED, V344, P109, DOI 10.1056/NEJM200101113440206; McGeady SJ, 2004, PEDIATRICS, V113, P1107; Prescott SL, 2004, CURR OPIN CLIN NUTR, V7, P123, DOI 10.1097/00075197-200403000-00004; Rahman I, 2003, J BIOCHEM MOL BIOL, V36, P95; Strachan DP, 1999, LANCET, V353, P1457, DOI 10.1016/S0140-6736(99)90038-7; Untersmayr E, 2005, J ALLERGY CLIN IMMUN, V115, P377, DOI 10.1016/j.jaci.2004.10.029; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490	20	6	6	1	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2005	115	6					1235	1237		10.1016/j.jaci.2005.04.004	http://dx.doi.org/10.1016/j.jaci.2005.04.004			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	935WZ	15940140	Bronze			2022-12-18	WOS:000229815400020
J	Asche, CV; Brixner, DI; Oderda, GM				Asche, CV; Brixner, DI; Oderda, GM			Has the cost-effectiveness of Xolair (omalizumab) been underestimated?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							SEVERE ALLERGIC-ASTHMA		Univ Utah, Coll Pharm, Pharmacotherapy Outcomes Res Ctr, Dept Pharmacotherapy, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah	Asche, CV (corresponding author), Univ Utah, Coll Pharm, Pharmacotherapy Outcomes Res Ctr, Dept Pharmacotherapy, 421 Wakara Way,Suite 208, Salt Lake City, UT 84108 USA.							Birnbaum HG, 2002, J ALLERGY CLIN IMMUN, V109, P264, DOI 10.1067/mai.2002.121310; Finn A, 2003, J ALLERGY CLIN IMMUN, V111, P278, DOI 10.1067/mai.2003.54; Oba Y, 2004, J ALLERGY CLIN IMMUN, V114, P265, DOI 10.1016/j.jaci.2004.05.049	3	6	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2005	115	5					1095	1095		10.1016/j.jaci.2004.12.1136	http://dx.doi.org/10.1016/j.jaci.2004.12.1136			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	925LR	15867875				2022-12-18	WOS:000229055100033
J	Wanderer, AA				Wanderer, AA			Cold temperature challenges for acquired cold urticaria	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Univ Colorado, Hlth Sci Ctr, Bozeman, MT 59718 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Wanderer, AA (corresponding author), Univ Colorado, Hlth Sci Ctr, 2055 N 22nd Ave,Suite 1, Bozeman, MT 59718 USA.			Maurer, Marcus/0000-0002-4121-481X				Siebenhaar F, 2004, J ALLERGY CLIN IMMUN, V114, P1224, DOI 10.1016/j.jaci.2004.07.018; Wanderer AA, 2004, IMMUNOL ALLERGY CLIN, V24, P259, DOI 10.1016/j.iac.2004.01.001	2	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2005	115	5					1096	1096		10.1016/j.jaci.2005.01.013	http://dx.doi.org/10.1016/j.jaci.2005.01.013			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	925LR	15867876	Bronze			2022-12-18	WOS:000229055100035
J	Vandenberg, JJ				Vandenberg, JJ			The role of air quality management programs in improving public health: A brief synopsis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						air pollution; clean air act; public health	UTAH VALLEY; POLLUTION; INTERVENTION	Observations of adverse effects of air pollution on public health, illustrated by the London smog events in the 1950s, led to legislation in the United States requiring development of federal, state, and local air quality management programs. The implementation of management programs has resulted in significant reductions in air pollutant emissions from stationary and mobile sources and hence their ambient concentrations and associated health risks. Evidence of benefits from improvements in air quality can be identified from studies in which rapid changes in air quality have occurred. Health risk assessment and benefits estimates also can be predictive, resulting in mean estimates of avoided mortality in excess of many thousands of cases per year as a result of implementation of air quality management programs in the United States.	US EPA, Off Res & Dev, Res Triangle Pk, NC 27711 USA	United States Environmental Protection Agency	Vandenberg, JJ (corresponding author), US EPA, Off Res & Dev, B248, Res Triangle Pk, NC 27711 USA.	Vandenberg.john@epa.gov		Vandenberg, John/0000-0003-2619-9460				Clancy L, 2002, LANCET, V360, P1210, DOI 10.1016/S0140-6736(02)11281-5; Dye JA, 2001, ENVIRON HEALTH PERSP, V109, P395, DOI 10.2307/3434787; Ghio AJ, 2001, AM J RESP CRIT CARE, V164, P704, DOI 10.1164/ajrccm.164.4.2011089; Hedley AJ, 2002, LANCET, V360, P1646, DOI 10.1016/S0140-6736(02)11612-6; POPE CA, 1989, AM J PUBLIC HEALTH, V79, P623, DOI 10.2105/AJPH.79.5.623; *US EPA, 1999, EPA41R99001 OFF AIR; *US EPA, 2004, EPA600P99002ABF	7	6	7	2	24	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2005	115	2					334	336		10.1016/j.jaci.2004.11.038	http://dx.doi.org/10.1016/j.jaci.2004.11.038			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	897YU	15696091				2022-12-18	WOS:000227043600020
J	Platts-Mills, TAE; Rosenwasser, LJ				Platts-Mills, TAE; Rosenwasser, LJ			Chronic sinusitis consensus and the way forward	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							INFLAMMATORY CELLS; NASAL POLYPOSIS; SEVERE ASTHMA; RHINOSINUSITIS; EXPRESSION; EOSINOPHILIA; ASPIRIN		Univ Virginia, Asthma & Allerg Dis Ctr, Charlottesville, VA 22908 USA; Natl Jewish Med & Res Ctr, Denver, CO USA	University of Virginia; National Jewish Health	Platts-Mills, TAE (corresponding author), Univ Virginia, Asthma & Allerg Dis Ctr, POB 800225, Charlottesville, VA 22908 USA.	tap2z@virginia.edu		Platts-Mills, Thomas/0000-0002-1263-329X				Bresciani M, 2001, J ALLERGY CLIN IMMUN, V107, P73, DOI 10.1067/mai.2001.111593; Chrzanowski RR, 1997, ANN ALLERG ASTHMA IM, V79, P431, DOI 10.1016/S1081-1206(10)63039-6; Denburg JA, 2000, THORAX, V55, pS24, DOI 10.1136/thorax.55.suppl_2.S24; Figueroa DJ, 2003, CLIN EXP ALLERGY, V33, P1380, DOI 10.1046/j.1365-2222.2003.01786.x; Hamilos DL, 1998, CLIN EXP ALLERGY, V28, P1145; HARLIN SL, 1988, J ALLERGY CLIN IMMUN, V81, P867, DOI 10.1016/0091-6749(88)90944-X; KEITH PK, 1994, J ALLERGY CLIN IMMUN, V93, P567, DOI 10.1016/S0091-6749(94)70068-0; Lund V J, 1995, Ann Otol Rhinol Laryngol Suppl, V167, P17; MELTZER EO, 2000, J ALLERGY CLIN IMMUN, V114, pS155; NEWMAN LJ, 1994, JAMA-J AM MED ASSOC, V271, P363, DOI 10.1001/jama.271.5.363; Ponikau JU, 2003, J ALLERGY CLIN IMMUN, V112, P877, DOI 10.1016/j.jaci.2003.08.009; SAMTER M, 1968, ANN INTERN MED, V68, P975, DOI 10.7326/0003-4819-68-5-975; Sousa AR, 2002, NEW ENGL J MED, V347, P1493, DOI 10.1056/NEJMoa013508; Taylor MJ, 2002, OTOLARYNG HEAD NECK, V127, P377, DOI 10.1067/mhn.2002.128896; ten Brinke A, 2002, J ALLERGY CLIN IMMUN, V109, P621, DOI 10.1067/mai.2002.122458	15	6	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2004	114	6					1359	1361		10.1016/j.jaci.2004.09.036	http://dx.doi.org/10.1016/j.jaci.2004.09.036			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	877NN	15577835				2022-12-18	WOS:000225577400016
J	van Ort, E; de Heer, PG; Dieker, M; van Leeuvven, AW; Aalberse, RC; van Ree, R				van Ort, E; de Heer, PG; Dieker, M; van Leeuvven, AW; Aalberse, RC; van Ree, R			Characterization of natural Dac g 1 variants: An alternative to recombinant group 1 allergens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Dactylis glomerata; group 1allergens; recombinant allergens; size exclusion chromatography; hydrophobic interaction chromatography	GRASS-POLLEN ALLERGEN; GROUP-I ALLERGENS; LOL-P-I; BASIC GLYCOPROTEIN ALLERGEN; PHLEUM-PRATENSE POLLEN; GROUP-V ALLERGENS; HOUSE-DUST MITE; PICHIA-PASTORIS; MAJOR ALLERGEN; IGE-BINDING	Background: Production of soluble correctly folded recombinant group 1 allergens has proven to be difficult. Purified natural group 1 allergens could be an alternative for application in immunotherapy. Objective: Cloning and expression of recombinant Dac g 1; purification of natural Dac g 1 variants and immunochemical characterization of these molecules. Methods: Dac g 1 was cloned and expressed in the yeast Pichia pastoris. Hydrophobic interaction (HIC), size exclusion, and/or affinity chromatography were used to purify Dac g 1 from Dactylis glomerata pollen extract. Dac g 1 variants were analyzed by N-terminal sequencing. Immune reactivity was assessed by sandwich ELISA, competitive RIA, RAST (inhibition), and in vitro basophil histamine release tests. Results: Dac g 1 was cloned, revealing up to 98% amino acid sequence homology to other group 1 allergens. Purification of natural Dac g 1 revealed at least 3 variants, with an apparent molecular mass (M-r) on SDS-PAGE of 33 kd (HMr), 30 kd (IMr) and 28 kd (LMr). Extraction of IMr Dac g 1 required 0.9% saline, whereas the other 2 variants were also extractable in water. The N-terminus of HMr and IMr Dac g 1 differs at 2 positions, and LMr Dac g 1 was shown to be N-terminally truncated, lacking the first 30 amino acids. The nonretarded fraction of HIC commonly used in group 1 purification protocols does not contain this LMr molecule. IMr Dac g 1 was poorly recognized in 2 of 3 sandwich ELISAs and competitive RIA but demonstrated similar biological activity compared with HMr Dac g 1. Conclusions: Natural Dac g 1 variants can be separated by extraction of pollen in the presence or absence of saline followed by HIC and size exclusion chromatography. Thus, purified Dac g 1 is an alternative to recombinant group 1 allergens.	Sanquin Res, Dept Immunopathol, NL-1066 CX Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Lab Expt & Clin Immunol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	van Ree, R (corresponding author), Sanquin Res, Dept Immunopathol, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	r.vanree@sanquin.nl						AALBERSE RC, 1981, J ALLERGY CLIN IMMUN, V68, P356, DOI 10.1016/0091-6749(81)90133-0; ASTALDI GCB, 1980, J IMMUNOL, V125, P1411; Becker W.-M., 1993, Immunitaet und Infektion, V21, P37; Benson DA, 2003, NUCLEIC ACIDS RES, V31, P23, DOI 10.1093/nar/gkg057; Budde IK, 2000, ALLERGY, V55, P653; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P6559, DOI 10.1073/pnas.94.12.6559; COTTAM GP, 1986, BIOCHEM J, V234, P305, DOI 10.1042/bj2340305; ESCH RE, 1989, J IMMUNOL, V142, P179; ESCH RE, 1989, MOL IMMUNOL, V26, P557, DOI 10.1016/0161-5890(89)90007-2; FAYE L, 1985, ANAL BIOCHEM, V149, P218, DOI 10.1016/0003-2697(85)90498-1; HAAVIK S, 1987, INT ARCH ALLER A IMM, V83, P225, DOI 10.1159/000234301; HAAVIK S, 1985, INT ARCH ALLER A IMM, V78, P197, DOI 10.1159/000233884; HAAVIK S, 1985, INT ARCH ALLER A IMM, V78, P260, DOI 10.1159/000233896; Himly M, 2002, FASEB J, V16, P106, DOI 10.1096/fj.02-0472fje; JOHNSON P, 1966, IMMUNOCHEMISTRY, V3, P101, DOI 10.1016/0019-2791(66)90291-6; JOHNSON P, 1966, IMMUNOCHEMISTRY, V3, P91, DOI 10.1016/0019-2791(66)90290-4; KNOL EF, 1993, J IMMUNOL, V151, P4926; KOHLER G, 1976, EUR J IMMUNOL, V6, P511, DOI 10.1002/eji.1830060713; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; LAFFER S, 1994, J ALLERGY CLIN IMMUN, V94, P689, DOI 10.1016/0091-6749(94)90176-7; LAFFER S, 1994, J ALLERGY CLIN IMMUN, V94, P88, DOI 10.1016/0091-6749(94)90075-2; Laffer S, 1996, MOL IMMUNOL, V33, P417, DOI 10.1016/0161-5890(95)00152-2; LIS H, 1993, EUR J BIOCHEM, V218, P1, DOI 10.1111/j.1432-1033.1993.tb18347.x; MARSH DG, 1966, INT ARCH ALLER A IMM, V29, P521, DOI 10.1159/000229739; MATTHIESEN F, 1991, CLIN EXP ALLERGY, V21, P309, DOI 10.1111/j.1365-2222.1991.tb01662.x; MATTHIESEN F, 1991, CLIN EXP ALLERGY, V21, P297, DOI 10.1111/j.1365-2222.1991.tb01661.x; MOURAD W, 1986, J IMMUNOL METHODS, V89, P53, DOI 10.1016/0022-1759(86)90031-1; PEREZ M, 1990, J BIOL CHEM, V265, P16210; Petersen A, 1997, ELECTROPHORESIS, V18, P819, DOI 10.1002/elps.1150180528; PETERSEN A, 1993, J ALLERGY CLIN IMMUN, V92, P789, DOI 10.1016/0091-6749(93)90055-K; PETERSEN A, 1995, ELECTROPHORESIS, V16, P869, DOI 10.1002/elps.11501601144; Schramm G, 1997, J ALLERGY CLIN IMMUN, V99, P781, DOI 10.1016/S0091-6749(97)80012-7; Schuurman J, 1997, J ALLERGY CLIN IMMUN, V99, P545, DOI 10.1016/S0091-6749(97)70083-6; SIRAGANIAN RP, 1975, J IMMUNOL METHODS, V7, P283, DOI 10.1016/0022-1759(75)90025-3; SMITH PM, 1994, INT ARCH ALLERGY IMM, V104, P57, DOI 10.1159/000236709; Smith PM, 1996, J ALLERGY CLIN IMMUN, V98, P331, DOI 10.1016/S0091-6749(96)70158-6; SUPHIOGLU C, 1995, CLIN EXP ALLERGY, V25, P853, DOI 10.1111/j.1365-2222.1995.tb00028.x; Tamborini E, 1997, EUR J BIOCHEM, V249, P886, DOI 10.1111/j.1432-1033.1997.00886.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Oort E, 2002, EUR J BIOCHEM, V269, P671, DOI 10.1046/j.0014-2956.2001.02700.x; van Oort E, 2001, INT ARCH ALLERGY IMM, V126, P196, DOI 10.1159/000049514; van Ree R, 1998, J ALLERGY CLIN IMMUN, V102, P184, DOI 10.1016/S0091-6749(98)70084-3; VANREE R, 1994, ALLERGY, V49, P254; VANREE R, 1989, J ALLERGY CLIN IMMUN, V83, P144, DOI 10.1016/0091-6749(89)90489-2; VANREE R, 1995, INT ARCH ALLERGY IMM, V106, P250, DOI 10.1159/000236850; WEBER RW, 1985, CLIN REV ALLERG, V3, P291, DOI 10.1007/BF02992997	46	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2004	114	5					1124	1130		10.1016/j.jaci.2004.06.050	http://dx.doi.org/10.1016/j.jaci.2004.06.050			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	870HI	15536420				2022-12-18	WOS:000225047800020
J	Das, UN				Das, UN			Breast-feeding, atopy, and asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							FATTY-ACIDS; T-BET; CHILDREN; WHEEZE		EFA Sci LLC, Norwood, MA USA		Das, UN (corresponding author), EFA Sci LLC, Norwood, MA USA.							Chulada PC, 2003, J ALLERGY CLIN IMMUN, V111, P328, DOI 10.1067/mai.2003.127; Das UN, 2002, NUTRITION, V18, P786, DOI 10.1016/S0899-9007(02)00840-7; Dell S, 2001, ARCH PEDIAT ADOL MED, V155, P1261, DOI 10.1001/archpedi.155.11.1261; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; GALLI E, 1994, BRIT J DERMATOL, V130, P752, DOI 10.1111/j.1365-2133.1994.tb03413.x; Oddy WH, 1999, BMJ-BRIT MED J, V319, P815, DOI 10.1136/bmj.319.7213.815; Oddy WH, 2003, J ALLERGY CLIN IMMUN, V112, P723, DOI 10.1016/S0091-6749(03)01941-9; Romieu I, 2000, J ASTHMA, V37, P575, DOI 10.3109/02770900009090812; Rust GS, 2001, J NATL MED ASSOC, V93, P139; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543	10	6	6	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2004	113	5					1002	1002		10.1016/j.jaci.2003.12.013	http://dx.doi.org/10.1016/j.jaci.2003.12.013			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	818UC	15148965				2022-12-18	WOS:000221269000030
J	Enelow, R; Baramki, DF; Borish, LC				Enelow, R; Baramki, DF; Borish, LC			Inhibition of effector T lymphocytes mediated through antagonism of IL-4	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CELLS; SURVIVAL		Univ Virginia, Dept Med, Beirne Carter Ctr Immunol Res, Asthma & Allerg Dis Ctr, Charlottesville, VA 22908 USA	University of Virginia	Enelow, R (corresponding author), Univ Virginia, Dept Med, Beirne Carter Ctr Immunol Res, Asthma & Allerg Dis Ctr, Charlottesville, VA 22908 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI001793, R01AI047737] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1 RR00847] Funding Source: Medline; NIAID NIH HHS [K24 AI001793-05, AI47737, R01 AI047737-04, AI01793] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Borish L, 1996, J ALLERGY CLIN IMMUN, V97, P1288, DOI 10.1016/S0091-6749(96)70197-5; Stack RM, 1998, J IMMUNOL, V160, P2255; Vella A, 1997, J EXP MED, V186, P325, DOI 10.1084/jem.186.2.325; Vella AT, 1998, P NATL ACAD SCI USA, V95, P3810, DOI 10.1073/pnas.95.7.3810; Wells AD, 2001, J CLIN INVEST, V108, P895, DOI 10.1172/JCI200113220	5	6	7	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2004	113	3					560	562		10.1016/j.jaci.2003.12.004	http://dx.doi.org/10.1016/j.jaci.2003.12.004			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	802DM	15007362	Bronze			2022-12-18	WOS:000220144200032
J	Isogai, S; Miuyata, S; Taha, R; Yoshizawa, Y; Martin, JG; Hamid, Q				Isogai, S; Miuyata, S; Taha, R; Yoshizawa, Y; Martin, JG; Hamid, Q			CD4(+)T cells migrate from airway to bone marrow after antigen inhalation in rats	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						T-cell trafficking; CFSE; bone marrow lung; eotaxin; interleukin-16; eosinophilia	ALLERGEN-INDUCED INCREASES; EOTAXIN RECEPTOR CCR3; BROWN-NORWAY RATS; T-CELLS; INTERLEUKIN-5 EXPRESSION; CHEMOATTRACTANT ACTIVITY; BRONCHOALVEOLAR LAVAGE; FUNCTIONAL EXPRESSION; LYMPHOCYTE MIGRATION; ASTHMATIC SUBJECTS	Background: IL-5-producing T lymphocytes increase in rat bone marrow after inhalational challenge with allergen. Objective: To test the hypothesis that T cells migrate from the airways to the marrow, we examined the trafficking of T cells in Brown Norway rats after sensitization and challenge with ovalbumin. Methods: Purified CD4(+) T cells, harvested from cervical lymph nodes of naive and ovalbumin-sensitized donors, were labeled with carboxy fluorescein diacetate succinimidyl ester; 20 x 10(6) cells were placed in the trachea of naive or sensitized recipients under anesthesia, and 18 hours later, animals were challenged with inhaled ovalbumin. Cells were harvested 24 hours later from the bone marrow, bronchoalveolar lavage fluid, lungs, the lung blood pool of cells, lung draining lymph nodes, peripheral blood, and spleen. Results: The number of carboxy fluorescein diacetate succinimidyl ester-positive cells, measured by fluorescence-activated cell sorter, in the bone marrow of ovalbumin sensitized, primed T-cell recipients was higher than either the sham-sensitized, primed T-cell recipients or sham-sensitized, naive T-cell recipients (P < .05). The number of eosinophils in both bone marrow and bronchoalveolar lavage fluid was increased in ovalbumin-sensitized, primed T-cell recipients. The expression of the T-cell chemoattractants eotaxin and IL-16, evaluated by immunohistochemistry, was higher in the bone marrow of ovalbumin-sensitized, primed T-cell recipients. Conclusions: CD4(+) T cells travel from airway to bone marrow after antigen inhalation. The homing of the CD4(+) T cells might be facilitated by eotaxin and IL-16 expression in the bone marrow and might contribute to the stimulation of eosinophilopoiesis after airway allergen exposure.	McGill Univ, Meakins Christie Labs, Dept Med, Montreal, PQ H2X 2P2, Canada; Tokyo Med & Dent Univ, Dept Pulm Med, Bunkyo Ku, Tokyo, Japan	McGill University; Tokyo Medical & Dental University (TMDU)	Hamid, Q (corresponding author), McGill Univ, Meakins Christie Labs, Dept Med, 3626 St Urbain St, Montreal, PQ H2X 2P2, Canada.			Martin, James/0000-0001-7574-5363				CENTER DM, 1982, J IMMUNOL, V128, P2563; COMBADIERE C, 1995, J BIOL CHEM, V270, P16491, DOI 10.1074/jbc.270.28.16491; CRUIKSHANK W, 1982, J IMMUNOL, V128, P2569; Cuvelier SL, 2001, J EXP MED, V194, P1699, DOI 10.1084/jem.194.12.1699; Daugherty BL, 1996, J EXP MED, V183, P2349, DOI 10.1084/jem.183.5.2349; Elsas MICG, 1997, AM J RESP CELL MOL, V17, P404, DOI 10.1165/ajrcmb.17.4.2691; EURN SY, 2003, AM J RESP CELL MOL B, V28, P25; Fukuda T, 1996, AM J RESP CELL MOL, V14, P84, DOI 10.1165/ajrcmb.14.1.8534490; Gerber BO, 1997, CURR BIOL, V7, P836, DOI 10.1016/S0960-9822(06)00371-X; GLEICH GJ, 1987, J ALLERGY CLIN IMMUN, V80, P412, DOI 10.1016/0091-6749(87)90063-7; Haczku A, 1997, IMMUNOLOGY, V91, P176, DOI 10.1046/j.1365-2567.1997.d01-2221.x; Hamid Q, 1997, J ALLERGY CLIN IMMUN, V100, P44, DOI 10.1016/S0091-6749(97)70193-3; HAMID Q, 1991, INT ARCH ALLER A IMM, V94, P169, DOI 10.1159/000235353; Inman MD, 1999, AM J RESP CELL MOL, V21, P473, DOI 10.1165/ajrcmb.21.4.3622; Krug N, 2000, AM J RESP CRIT CARE, V162, P105, DOI 10.1164/ajrccm.162.1.9908055; KUNG TT, 1994, J ALLERGY CLIN IMMUN, V94, P1217, DOI 10.1016/0091-6749(94)90335-2; Lefort J, 1996, J ALLERGY CLIN IMMUN, V97, P788, DOI 10.1016/S0091-6749(96)80157-6; Lehmann C, 2001, ANAT REC, V264, P229, DOI 10.1002/ar.1163; Majka M, 2001, BLOOD, V97, P3075, DOI 10.1182/blood.V97.10.3075; METZGER WJ, 1986, CHEST, V89, P477, DOI 10.1378/chest.89.4.477; Minshall EM, 1998, AM J RESP CRIT CARE, V158, P951, DOI 10.1164/ajrccm.158.3.9709114; Mishima H, 1998, AM J RESP CRIT CARE, V158, P1863, DOI 10.1164/ajrccm.158.6.9709123; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; PABST R, 1995, AM J RESP CRIT CARE, V151, P495, DOI 10.1164/ajrccm.151.2.7842212; Ponath PD, 1996, J EXP MED, V183, P2437, DOI 10.1084/jem.183.6.2437; RENZI PM, 1993, AM REV RESPIR DIS, V147, P967, DOI 10.1164/ajrccm/147.4.967; Rothenberg ME, 1999, AM J RESP CELL MOL, V21, P291, DOI 10.1165/ajrcmb.21.3.f160; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Sehmi R, 1997, J CLIN INVEST, V100, P2466, DOI 10.1172/JCI119789; Tang C, 1997, Respirology, V2, P45, DOI 10.1111/j.1440-1843.1997.tb00053.x; Tietz W, 1997, EUR J IMMUNOL, V27, P2225, DOI 10.1002/eji.1830270916; Venge P, 1999, CLIN EXP ALLERGY, V29, P1172; WALKER C, 1991, J ALLERGY CLIN IMMUN, V88, P935, DOI 10.1016/0091-6749(91)90251-I; WATANABE A, 1995, J CLIN INVEST, V96, P1303, DOI 10.1172/JCI118165; WELLER PF, 1992, CLIN IMMUNOL IMMUNOP, V62, P55; Wood LJ, 2002, AM J RESP CRIT CARE, V166, P883, DOI 10.1164/rccm.2108015; YAMAGUCHI Y, 1988, J EXP MED, V167, P43, DOI 10.1084/jem.167.1.43; Young A J, 1993, Curr Top Microbiol Immunol, V184, P161; Zimmermann N, 1998, BBA-GENE STRUCT EXPR, V1442, P170, DOI 10.1016/S0167-4781(98)00162-6	39	6	6	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2004	113	3					455	461		10.1016/j.jaci.2003.11.035	http://dx.doi.org/10.1016/j.jaci.2003.11.035			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	802DM	15007347				2022-12-18	WOS:000220144200017
J	[Anonymous]				[Anonymous]			Potential adverse effects of the inhaled corticosteroids	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																			0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2003	112	3					479	479						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	719XW					2022-12-18	WOS:000185231200002
J	Eggleston, PA				Eggleston, PA			Cockroach allergen abatement: The good, the bad, and the ugly	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						cockroach; indoor allergens; environmental control	INNER-CITY HOMES; EXPOSURE; ASTHMA; REMOVAL; DUST		Johns Hopkins Univ, Baltimore, MD USA	Johns Hopkins University	Eggleston, PA (corresponding author), Johns Hopkins Univ Hosp, CMSC 1102,600 N Wolfe St, Baltimore, MD 21287 USA.							Arbes SJ, 2003, J ALLERGY CLIN IMMUN, V112, P339, DOI 10.1067/mai.2003.1597; Bennet G.W., 1988, TRUMANS SCI GUIDE PE; Campbell WW, 1989, IVERMECTIN ABAMECTIN; Custovic A, 1998, THORAX, V53, P63, DOI 10.1136/thx.53.1.63; deBlay F, 1997, J ALLERGY CLIN IMMUN, V99, P107, DOI 10.1016/S0091-6749(97)70307-5; Eggleston PA, 1999, J ALLERGY CLIN IMMUN, V104, P842, DOI 10.1016/S0091-6749(99)70296-4; *EPA, EPA CONS ANN PROP WI; Gergen PJ, 1999, J ALLERGY CLIN IMMUN, V103, P501, DOI 10.1016/S0091-6749(99)70477-X; Matsui EC, 2003, J ALLERGY CLIN IMMUN, V112, P87, DOI 10.1067/mai.2003.1588; MEINKING TL, 1995, NEW ENGL J MED, V333, P26, DOI 10.1056/NEJM199507063330105; National Research Council (US) Committee on Pesticides in the Diets of Infants and Children, 1993, PEST DIETINF CHILD; Slotkin TA, 1999, ENVIRON HEALTH PERSP, V107, P71, DOI 10.2307/3434474; VIJVERBERG HPM, 1990, CRIT REV TOXICOL, V21, P105, DOI 10.3109/10408449009089875; WOOD RA, 1989, J ALLERGY CLIN IMMUN, V83, P730, DOI 10.1016/0091-6749(89)90006-7; Wood RA, 2001, ANN ALLERG ASTHMA IM, V87, P60, DOI 10.1016/S1081-1206(10)62324-1; Wood RA, 2001, J ALLERGY CLIN IMMUN, V107, pS218	16	6	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2003	112	2					265	267		10.1067/mai.2003.1674	http://dx.doi.org/10.1067/mai.2003.1674			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	709WY	12897730				2022-12-18	WOS:000184650600005
J	Towers, GHN				Towers, GHN			FAHF-1 purporting to block peanut-induced anaphylaxis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Univ British Columbia, Dept Bot Biol Sci, Phytochem Lab, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Towers, GHN (corresponding author), Univ British Columbia, Dept Bot Biol Sci, Phytochem Lab, 3529-6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.							Claman HN, 2002, J ALLERGY CLIN IMMUN, V109, P1038, DOI 10.1067/mai.2002.125261; Li XM, 2001, J ALLERGY CLIN IMMUN, V108, P639, DOI 10.1067/mai.2001.118787; Ming DS, 2002, FITOTERAPIA, V73, P147, DOI 10.1016/S0367-326X(02)00013-8	3	6	6	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2003	111	5					1140	1140		10.1067/mai.2003.1493	http://dx.doi.org/10.1067/mai.2003.1493			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	679DA	12743589				2022-12-18	WOS:000182904500039
J	Holtzman, MJ				Holtzman, MJ			Where are the gaps in asthma research? A counter-perspective	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							RESPIRATORY VIRUS-INFECTIONS; T-CELLS; EOSINOPHILIA; EXPRESSION; IMMUNOLOGY; SECRETION; PERSIST; LUNGS; STAT1		Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Holtzman, MJ (corresponding author), Washington Univ, Sch Med, Dept Med, Campus Box 8052,660 S Euclid Ave, St Louis, MO 63110 USA.							Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; COYLE AJ, 1995, J EXP MED, V181, P1229, DOI 10.1084/jem.181.3.1229; Coyle AJ, 1996, J IMMUNOL, V156, P2680; Grayson MH, 2002, IMMUNOL ALLERGY CLIN, V22, P845, DOI 10.1016/S0889-8561(02)00027-9; Hakonarson H, 2001, AM J RESP CRIT CARE, V164, P2036, DOI 10.1164/ajrccm.164.11.2101086; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; Holtzman MJ, 1996, AM J RESP CELL MOL, V14, P316, DOI 10.1165/ajrcmb.14.4.8600934; Holtzman MJ, 2002, PHYSIOL REV, V82, P19, DOI 10.1152/physrev.00020.2001; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Koga T, 1999, P NATL ACAD SCI USA, V96, P5680, DOI 10.1073/pnas.96.10.5680; Look DC, 1998, IMMUNITY, V9, P871, DOI 10.1016/S1074-7613(00)80652-4; MELHOP PD, 1997, P NATL ACAD SCI USA, V94, P1344; Sampath D, 1999, J CLIN INVEST, V103, P1353, DOI 10.1172/JCI6130; Schwarze J, 1999, J IMMUNOL, V162, P4207; Shen YQ, 1997, P NATL ACAD SCI USA, V94, P3341, DOI 10.1073/pnas.94.7.3341; Srikiatkhachorn A, 1997, J EXP MED, V186, P421, DOI 10.1084/jem.186.3.421; Stephens R, 2002, J IMMUNOL, V169, P5458, DOI 10.4049/jimmunol.169.10.5458; Taguchi M, 1998, J EXP MED, V187, P1927, DOI 10.1084/jem.187.12.1927; Walter MJ, 1997, J BIOL CHEM, V272, P28582, DOI 10.1074/jbc.272.45.28582; Walter MJ, 2002, J CLIN INVEST, V110, P165, DOI 10.1172/JCI200214345; Walter MJ, 2001, J EXP MED, V193, P339, DOI 10.1084/jem.193.3.339; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258	25	6	6	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2003	111	2					244	247		10.1067/mai.2003.141	http://dx.doi.org/10.1067/mai.2003.141			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	644WF	12589339				2022-12-18	WOS:000180942700003
J	Leung, DYM; Nelson, HS; Szefler, SJ				Leung, DYM; Nelson, HS; Szefler, SJ			The editors' choice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material																			0	6	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2003	111	1					1	2		10.1067/mai.2003.62	http://dx.doi.org/10.1067/mai.2003.62			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	636PR		Bronze			2022-12-18	WOS:000180465500001
J	Tamaoki, J; Takeyama, K; Aoshiba, K; Nakata, J; Nishimura, K; Nagai, A				Tamaoki, J; Takeyama, K; Aoshiba, K; Nakata, J; Nishimura, K; Nagai, A			A T(H)2 cytokine inhibitor for airway inflammation in mild asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Tokyo Womens Med Univ, Sch Med, Dept Med 1, Tokyo 1628666, Japan; Minami Tohoku Gen Hosp, Resp Ctr, Koriyama, Fukushima 9638051, Japan; Kureha Gen Hosp, Dept Med, Iwaki, Fukushima 9748232, Japan; Kurihashi Saiseikai Hosp, Dept Pulm Med, Kurihashi 3491105, Japan	Tokyo Women's Medical University	Tamaoki, J (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Med 1, 8-1 Kawada Cho, Tokyo 1628666, Japan.							FAHY JV, 1993, AM REV RESPIR DIS, V147, P1126, DOI 10.1164/ajrccm/147.5.1126; Kon OM, 1999, INT ARCH ALLERGY IMM, V118, P133, DOI 10.1159/000024049; Lipworth BJ, 1999, ARCH INTERN MED, V159, P941, DOI 10.1001/archinte.159.9.941; Taira M, 2002, J ASTHMA, V39, P315, DOI 10.1081/JAS-120002288; Tamaoki J, 2000, LANCET, V356, P273, DOI 10.1016/S0140-6736(00)02501-0; YAMAYA H, 1995, LIFE SCI, V56, P1647, DOI 10.1016/0024-3205(95)00132-P	6	6	6	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2003	111	1					197	198		10.1067/mai.2003.318	http://dx.doi.org/10.1067/mai.2003.318			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	636PR	12532121	Bronze			2022-12-18	WOS:000180465500033
J	Scurlock, AM; Althage, KA; Christie, L; Burks, AW; Jones, SM				Scurlock, AM; Althage, KA; Christie, L; Burks, AW; Jones, SM			Anaphylaxis after ingestion of gummy bears	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							GELATIN; IGE		Univ Arkansas Med Sci, Dept Pediat, Div Allergy & Immunol, Arkansas Childrens Hosp, Little Rock, AR 72202 USA	Arkansas Children's Hospital; University of Arkansas System; University of Arkansas Medical Sciences	Scurlock, AM (corresponding author), Univ Arkansas Med Sci, Dept Pediat, Div Allergy & Immunol, Arkansas Childrens Hosp, Little Rock, AR 72202 USA.							BOSSO JV, 1991, FOOD ALLERGY ADVERSE, P288; KELSO JM, 1993, J ALLERGY CLIN IMMUN, V91, P867, DOI 10.1016/0091-6749(93)90344-F; Sakaguchi M, 1996, J ALLERGY CLIN IMMUN, V98, P1058, DOI 10.1016/S0091-6749(96)80191-6; WAHL R, 1989, CLIN EXP ALLERGY, V19, P77, DOI 10.1111/j.1365-2222.1989.tb02348.x	4	6	6	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2002	110	6					936	936		10.1067/mai.2002.129434	http://dx.doi.org/10.1067/mai.2002.129434			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	624TL	12464963				2022-12-18	WOS:000179777400019
J	Laske, N; Volk, HD; Liebenthal, C; Gruber, C; Lau, S; Sommerfeld, C; Nickel, R; Wahn, U				Laske, N; Volk, HD; Liebenthal, C; Gruber, C; Lau, S; Sommerfeld, C; Nickel, R; Wahn, U			Infantile natural immunization to herpes group viruses is unrelated to the development of asthma and atopic phenotypes in childhood	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							AGE		Humboldt Univ, Charite, Dept Pediat Pneumol & Immunol, Berlin, Germany; Humboldt Univ, Charite, Inst Med Immunol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Laske, N (corresponding author), Humboldt Univ, Charite, Dept Pediat Pneumol & Immunol, Berlin, Germany.		volk, hans-dieter/AAV-8053-2021	volk, hans-dieter/0000-0002-7743-6668				Fujimura T, 1997, J ALLERGY CLIN IMMUN, V100, P274, DOI 10.1016/S0091-6749(97)70236-7; Grunstein MM, 2001, J ALLERGY CLIN IMMUN, V108, P997, DOI 10.1067/mai.2001.120276; ILLI S, 2001, BMJ-BRIT MED J, V322, P376; Kern F, 2000, EUR J IMMUNOL, V30, P1676, DOI 10.1002/1521-4141(200006)30:6<1676::AID-IMMU1676>3.0.CO;2-V; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; Matricardi PM, 1997, BRIT MED J, V314, P999, DOI 10.1136/bmj.314.7086.999; Nystad W, 1998, ALLERGY, V53, P1189, DOI 10.1111/j.1398-9995.1998.tb03840.x; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; Steigerwald-Mullen P, 2000, J VIROL, V74, P6748, DOI 10.1128/JVI.74.15.6748-6759.2000	10	6	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2002	110	5					811	813		10.1067/mai.2002.128593	http://dx.doi.org/10.1067/mai.2002.128593			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	612NN	12417894				2022-12-18	WOS:000179082500020
J	Higashi, N; Taniguchi, M; Mita, H; Higashi, A; Akiyama, K				Higashi, N; Taniguchi, M; Mita, H; Higashi, A; Akiyama, K			Aspirin-induced urticaria and angioedema, but not bronchoconstriction, associated with cysteinyl leukotriene overproduction in 2 patients with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ANTAGONIST		Natl Sagamihara Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa 2288522, Japan		Higashi, N (corresponding author), Natl Sagamihara Hosp, Clin Res Ctr Allergy & Rheumatol, 18-1 Sakuradai, Sagamihara, Kanagawa 2288522, Japan.							CHRISTIE PE, 1991, AM REV RESPIR DIS, V143, P1025, DOI 10.1164/ajrccm/143.5_Pt_1.1025; Dahlen SE, 2002, AM J RESP CRIT CARE, V165, P9, DOI 10.1164/ajrccm.165.1.2010080; Kawagishi Y, 2002, J ALLERGY CLIN IMMUN, V109, P936, DOI 10.1067/mai.2002.124466; Pacor ML, 2001, CLIN EXP ALLERGY, V31, P1607, DOI 10.1046/j.1365-2222.2001.01189.x; Perez C, 2001, J ALLERGY CLIN IMMUN, V108, P1060, DOI 10.1067/mai.2001.120275; RASMUSSEN JB, 1992, ALLERGY, V47, P599, DOI 10.1111/j.1398-9995.1992.tb02381.x; Sanchez-Borges N, 2000, ANN ALLERG ASTHMA IM, V84, P101, DOI 10.1016/S1081-1206(10)62748-2	7	6	6	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2002	110	4					666	667		10.1067/mai.2002.128016	http://dx.doi.org/10.1067/mai.2002.128016			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	602JJ	12373280				2022-12-18	WOS:000178501900022
J	Polosa, R				Polosa, R			Can immunotherapy prevent progression to asthma in allergic individuals?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Univ Catania, Dipartimento Med Interna & Specialist, I-95125 Catania, Italy	University of Catania	Polosa, R (corresponding author), Univ Catania, Dipartimento Med Interna & Specialist, Via Passo Gravina 187, I-95125 Catania, Italy.							BRAMAN SS, 1987, CHEST, V91, P671, DOI 10.1378/chest.91.5.671; Mastruzzo C, 2002, J ALLERGY CLIN IMMUN, V109, pS201, DOI 10.1016/S0091-6749(02)81737-7; Moller C, 2002, J ALLERGY CLIN IMMUN, V109, P251, DOI 10.1067/mai.2002.121317; Sarva M, 2002, J ALLERGY CLIN IMMUN, V109, pS91, DOI 10.1016/S0091-6749(02)81375-6; Venn A, 1998, BRIT MED J, V316, P1945, DOI 10.1136/bmj.316.7149.1945	5	6	7	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2002	110	4					672	673		10.1067/mai.2002.128013	http://dx.doi.org/10.1067/mai.2002.128013			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	602JJ	12373284				2022-12-18	WOS:000178501900028
J	Shearer, WT				Shearer, WT			Recognition of clinical immunology as a distinct medical subspecialty: Importance for the practice of allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						clinical immunology; allergy; rheumatology; certification; career opportunities; immune-based therapies		Background: Although residents trained in accredited teaching programs in allergy and immunology are exposed to many areas of clinical immunology, the vast majority of these residents' subsequent practices are composed of caring for patients with allergic and asthmatic conditions. Except for rhemnatologists, almost all other clinical immunologists appear to lack organized training programs, defined certification pathways, and clear career opportunities. Objective: Recognition of clinical immunology as a distinct medical subspecialty with many areas of expertise will enhance the image of allergists and clinical immunologists, ensure subspecialty certification, and provide better career opportunities. Methods: Documents, publications, and private opinions of individuals within professional allergy and clinical immunology organizations were evaluated for possible contribution to the subject content of this article. Results: There is a need for defined residency programs, medical board certification, and professional organizations that speak for and provide postgraduate education for all clinical immunologists. Molecular and genetic discoveries are delineating the central role of fundamental immunology in all immune-mediated diseases and future therapy of allergic and immunologic diseases. Conclusions: Allergists of the 21st century should participate in the growing recognition of clinical immunology as an important medical subspecialty that can provide science-based therapies for allergic and immunologic disorders. The future practice of allergy depends largely on the molecular and genetic discoveries that serve to unite all practitioners of clinical immunology. Forging common alliances of education, certification, and career pathways with other clinical immunologists is the correct investment for a bright future for allergy.	Baylor Coll Med, Dept Pediat, Sect Allergy & Immunol, Houston, TX 77030 USA	Baylor College of Medicine	Shearer, WT (corresponding author), Texas Childrens Hosp, 6621 Fannin St,MC 1-3291, Houston, TX 77030 USA.			Shearer, William/0000-0002-2483-2130				Adkinson NF, 1996, J ALLERGY CLIN IMMUN, V97, P868, DOI 10.1016/S0091-6749(96)70004-0; Austen KF, 1996, J ALLERGY CLIN IMMUN, V97, P861, DOI 10.1016/S0091-6749(96)70001-5; COHEN SG, 1979, J ALLERGY CLIN IMMUN, V64, P375; Des Prez L, 2001, J ALLERGY CLIN IMMUN, V107, P592; EGGLESTON PA, 1992, J ALLERGY CLIN IMMUN, V90, P999, DOI 10.1016/0091-6749(92)90476-I; FREW AJ, 2001, CLIN IMMUNOLOGY PRIN; HALLSTRANT RS, 2001, CLIN IMMUNOLOGY PRIN; Metcalfe DD, 1997, J ALLERGY CLIN IMMUN, V100, P441; Nelson HS, 2000, J ALLERGY CLIN IMMUN, V106, P41, DOI 10.1067/mai.2000.107197; PlattsMills TAE, 1996, J ALLERGY CLIN IMMUN, V97, P865; Reed C, 1996, A ROGER FRY READER, P50; RICH RR, 1994, FASEB J, V8, P799, DOI 10.1096/fasebj.8.11.8070627; Rich RR, 1998, ALLERGY ASTHMA PROC, V19, P295, DOI 10.2500/108854198778557746; RICH RR, 1995, J IMMUNOL, V155, P4992; SHEARER WT, 1994, J ALLERGY CLIN IMMUN, V94, P933, DOI 10.1016/0091-6749(94)90110-4; Shearer WT, 1996, J ALLERGY CLIN IMMUN, V98, P719; SHEARER WT, IN PRESS J ALLERGY C; SHEARER WT, 2002, IN PRESS ALLERGY PRI; 1994, J ALLERGY CLIN IMMUN, V94, P440	19	6	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2002	110	4					567	570		10.1067/mai.2002.128243	http://dx.doi.org/10.1067/mai.2002.128243			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	602JJ	12373262	Bronze			2022-12-18	WOS:000178501900004
J	Benn, CS; Bendixen, M; Krause, TG; Olesen, AB				Benn, CS; Bendixen, M; Krause, TG; Olesen, AB			Questionable coexistence of T(H)1- and T(H)2-related diseases	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; Aarhus Univ Hosp, Dept Dermatol, Sect AAS, Aarhus, Denmark	Aarhus University; Statens Serum Institut; Aarhus University	Benn, CS (corresponding author), Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark.							Gissler M, 1998, PAEDIATR PERINAT EP, V12, P437; Kero J, 2001, J ALLERGY CLIN IMMUN, V108, P781, DOI 10.1067/mai.2001.119557; Simpson CR, 2002, CLIN EXP ALLERGY, V32, P37, DOI 10.1046/j.0022-0477.2001.01250.x	3	6	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2002	110	2					328	329	UNSP 1/8/126480	10.1067/mai.2002.126480	http://dx.doi.org/10.1067/mai.2002.126480			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	585DY	12170278				2022-12-18	WOS:000177509800023
J	Chowdhury, BA				Chowdhury, BA			Comparative efficacy of levalbuterol and racemic albuterol in the treatment of asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									US FDA, CDER, Div Pulm & Allergy Drug Prod, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Chowdhury, BA (corresponding author), US FDA, CDER, Div Pulm & Allergy Drug Prod, Mail Code HFD-570, Rockville, MD 20857 USA.							Ahrens R, 2001, J ALLERGY CLIN IMMUN, V108, P681; Lotvall J, 2001, J ALLERGY CLIN IMMUN, V108, P726; Milgrom H, 2001, J ALLERGY CLIN IMMUN, V108, P938, DOI 10.1067/mai.2001.120134; Nelson HS, 1999, J ALLERGY CLIN IMMUN, V104, pS77, DOI 10.1016/S0091-6749(99)70277-0; Nelson HS, 1998, J ALLERGY CLIN IMMUN, V102, P943, DOI 10.1016/S0091-6749(98)70332-X; 2002, MED ECONOMICS	6	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2002	110	2					324	324	UNSP 1/8/126374	10.1067/mai.2002.126374	http://dx.doi.org/10.1067/mai.2002.126374			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	585DY	12170276	Bronze			2022-12-18	WOS:000177509800020
J	Milgrom, H; Skoner, D; Bensch, G; Kim, K; Claus, R; Baumgartner, R				Milgrom, H; Skoner, D; Bensch, G; Kim, K; Claus, R; Baumgartner, R			Levalbuterol has not been established to have therapeutic advantage over racemic albuterol - Reply	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PLACEBO; ASTHMA; SALBUTAMOL		Natl Jewish Med & Res Ctr, Denver, CO 80206 USA; Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; Bensch Res Associates, Stockton, CA USA; Allergy & Asthma & Resp Care Ctr, Long Beach, CA USA; Sepracor Inc, Marlborough, MA USA	National Jewish Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Dainippon Sumitomo Pharmaceutical Company; Sunovion Pharmaceuticals Inc.	Milgrom, H (corresponding author), Natl Jewish Med & Res Ctr, Denver, CO 80206 USA.							Asmus MJ, 2002, J ALLERGY CLIN IMMUN, V110, P325, DOI 10.1067/mai.2002.126375; Baramki D, 2002, J ALLERGY CLIN IMMUN, V109, P449, DOI 10.1067/mai.2002.122159; CARL J, 2001, CHEST, V120, pS137; Chowdhury BA, 2002, J ALLERGY CLIN IMMUN, V110, P324, DOI 10.1067/mai.2002.126374; Cockcroft DW, 1997, THORAX, V52, P845, DOI 10.1136/thx.52.10.845; Cockcroft DW, 1999, J ALLERGY CLIN IMMUN, V103, P1049, DOI 10.1016/S0091-6749(99)70178-8; Gawchik SM, 1999, J ALLERGY CLIN IMMUN, V103, P615, DOI 10.1016/S0091-6749(99)70233-2; GIRI V, 2002, AM J RESP CRIT CARE, V165, pA185; Lotvall J, 2001, J ALLERGY CLIN IMMUN, V108, P726; Milgrom H, 2001, J ALLERGY CLIN IMMUN, V108, P938, DOI 10.1067/mai.2001.120134; Nelson HS, 1998, J ALLERGY CLIN IMMUN, V102, P943, DOI 10.1016/S0091-6749(98)70332-X; Ramsay CM, 1999, EUR J CLIN PHARMACOL, V55, P353, DOI 10.1007/s002280050640; SCHRECK DM, 2001, ANN EMERG MED, V38, pS10; TRUITT T, 2002, IN PRESS CHEST; *US DEP HHS PHS NI, 1997, US HDDS PUBL; *US FDA CTR DRUG E, 1999, SUMM BAS APPR XOP LE; Vaickus L, 2002, J ALLERGY CLIN IMMUN, V109, pS233, DOI 10.1016/S0091-6749(02)81842-5; VAICKUS L, 1999, J ALLERGY CLIN IMMUN, V104, pS47; 1994, FED REG, V59, P55972	19	6	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2002	110	2					325	328	UNSP 1/8/126376	10.1067/mai.2002.126376	http://dx.doi.org/10.1067/mai.2002.126376			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	585DY					2022-12-18	WOS:000177509800022
J	Tyler, D				Tyler, D			Disability and medical management of natural latex sensitivity claims	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Meeting on Natural Rubber Latex Sensitivity	FEB 09-10, 2001	SAN FRANCISCO, CALIFORNIA	Malaysian Rubber Res Inst		latex; claim; cost; worker; spirometry	ALLERGY	In 1995 a latex allergy case incurred a cost of $220,000 within the first year of the claim. A number of factors were thought to contribute to the cost of these claims. In 1996 Michigan Health & Hospital Association Service Corporation identified and implemented protocols to intervene early with latex sensitivity claims. The average cost per case has decreased dramatically since the implementation of the protocols. Decreasing the frequency and the average cost of latex sensitivity claims through the identification, treatment, and return to work of legitimate latex sensitivity cases has been the focus. Equally important was to minimize the impact of latex sensitivity on the life of the health care worker. In 1999 and subsequent years, data from glove- or latex-related claims that began from 1996 were analyzed. Latex sensitivity-related claims were sorted as lost-time claims and medical-only claims from the Michigan Health & Hospital Association Service Corporation claims database. The average cost per claim and the frequency of latex-related claims were identified. The average cost of latex-related lost-time claims has decreased significantly; however, the frequency in lost-time claims has been consistent. Health care workers consistently were returned to work successfully. Implementation of latex-sensitivity protocols is effective in the reduction of the average cost of latex-related claims and the impact of those claims on the lives of health care workers. This has been afforded through the confirmation of the diagnosis of latex sensitivity, followed by the implementation of a method to evaluate the physiologic response to the workplace objectively.	Michigan Hlth & Hosp Assoc Serv Corp, Southfield, MI 48034 USA		Tyler, D (corresponding author), Michigan Hlth & Hosp Assoc Serv Corp, 24725 W 12 Mile Rd,Suite 104C, Southfield, MI 48034 USA.							BEEZHOLD D, 1997, SURG SERV MANAGE, V3, P35; Burton AD, 1997, OCCUP MED-STATE ART, V12, P609; Czuppon A B, 2000, ACI INT, V12, P98; Kim KT, 1998, ANN ALLERG ASTHMA IM, V80, P66, DOI 10.1016/S1081-1206(10)62942-0; Neugut AI, 2001, ARCH INTERN MED, V161, P15, DOI 10.1001/archinte.161.1.15; SUSSMAN G, 1996, GUIDELINES MANAGMENT; *US EPA, 2002, COMM PUBL, pCH11; YASSIN MS, 1998, NAT RUBB LAT ALL REC	8	6	6	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2002	110	2		S			S129	S136		10.1067/mai.2002.125259	http://dx.doi.org/10.1067/mai.2002.125259			8	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	586ET	12170254				2022-12-18	WOS:000177572200019
J	Sercombe, JK; Taylor, DJM; Battucci, S; Brown, LK; Counts, JL; Tovey, ER				Sercombe, JK; Taylor, DJM; Battucci, S; Brown, LK; Counts, JL; Tovey, ER			Allergen removal from hard floors: Assessment of a range of sweeping devices	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ENVIRONMENTAL-CONTROL		Univ Sydney, Inst Resp Med, Sydney, NSW 2006, Australia; Procter & Gamble Co, Italian Res Ctr, Rome, Italy; Procter & Gamble Co, Cincinnati, OH USA	University of Sydney; Procter & Gamble; Procter & Gamble	Sercombe, JK (corresponding author), Univ Sydney, Inst Resp Med, Sydney, NSW 2006, Australia.		Tovey, Euan R/G-8604-2017	Tovey, Euan R/0000-0002-1802-7266				Custovic A, 1998, THORAX, V53, P63, DOI 10.1136/thx.53.1.63; DEBLAY F, 1991, AM REV RESPIR DIS, V143, P1334, DOI 10.1164/ajrccm/143.6.1334; Gaynor PT, 1998, MED BIOL ENG COMPUT, V36, P615, DOI 10.1007/BF02524433; Hill DJ, 1997, J ALLERGY CLIN IMMUN, V99, P323, DOI 10.1016/S0091-6749(97)70049-6; Tovey E, 1999, J ALLERGY CLIN IMMUN, V103, P179, DOI 10.1016/S0091-6749(99)70488-4	5	6	7	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2002	109	4					716	717		10.1067/mai.2002.122502	http://dx.doi.org/10.1067/mai.2002.122502			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	543YZ	11941326				2022-12-18	WOS:000175132600025
J	Fernandez-Melendez, S; Miranda, A; Carmona, MJ; Diaz, J; Barcelo, JM; Vega, JM; Garcia, JJ				Fernandez-Melendez, S; Miranda, A; Carmona, MJ; Diaz, J; Barcelo, JM; Vega, JM; Garcia, JJ			Tolerance of rofecoxib in patients with adverse reactions to nonsteroidal anti-inflammatory drugs (NSAIDs)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Carlos Haya Reg Hosp Civil Hosp, Allergy Sect, Malaga, Spain										0	6	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		410	S140	S140		10.1016/S0091-6749(02)81546-9	http://dx.doi.org/10.1016/S0091-6749(02)81546-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX					2022-12-18	WOS:000173744800409
J	Gupta, A; Yong, CL; Madwed, JB; Staehle, H; Wood, CC				Gupta, A; Yong, CL; Madwed, JB; Staehle, H; Wood, CC			Safety, pharmacokinetics, and pharmacodynamics of single doses of an oral p38 MAP kinase inhibitor (BIRB 796 BS) in healthy human males - a placebo-controlled, randomised study, double blinded at each dose level	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Boehringer Ingelheim Pharmaceut Inc, Biberach, Germany; Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA	Boehringer Ingelheim; Boehringer Ingelheim									0	6	6	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		158	S67	S67		10.1016/S0091-6749(02)81294-5	http://dx.doi.org/10.1016/S0091-6749(02)81294-5			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX					2022-12-18	WOS:000173744800157
J	Hacena, M; Moll, B; Goodwin, C; Fornari, E; Rodriguez, M; Frieri, M				Hacena, M; Moll, B; Goodwin, C; Fornari, E; Rodriguez, M; Frieri, M			Assessment of IL-8, TNF alpha, TGF beta and nitric oxide release and expression from antigen and growth factor stimulated human pulmonary epithelial cells with budesonide	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Nassau Univ, Med Ctr, E Meadow, NY USA; N Shore Univ Hosp, Manhasset, NY USA	Northwell Health; North Shore University Hospital									0	6	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		38	S31	S31		10.1016/S0091-6749(02)81175-7	http://dx.doi.org/10.1016/S0091-6749(02)81175-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX					2022-12-18	WOS:000173744800039
J	Nouri-Aria, KT; Jacobson, MR; Durham, S				Nouri-Aria, KT; Jacobson, MR; Durham, S			Grass pollen immunotherapy (IT) increases IL-10- and TGF-beta-mRNA expression in the nasal mucosa during the pollen season	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ London Imperial Coll Sci & Technol, London, England	Imperial College London									0	6	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		506	S171	S171		10.1016/S0091-6749(02)81642-6	http://dx.doi.org/10.1016/S0091-6749(02)81642-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX					2022-12-18	WOS:000173744800505
J	O'Rourke, SD; Tovey, ER; O'Meara, TJ				O'Rourke, SD; Tovey, ER; O'Meara, TJ			Personal exposure to mite and cat allergen	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Inst Resp Med, Sydney, NSW, Australia; Univ Sydney, Sydney, NSW 2006, Australia	University of Sydney			Tovey, Euan R/G-8604-2017	Tovey, Euan R/0000-0002-1802-7266					0	6	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		91	S47	S47		10.1016/S0091-6749(02)81228-3	http://dx.doi.org/10.1016/S0091-6749(02)81228-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX					2022-12-18	WOS:000173744800091
J	Phillips, EJ; Knowles, SR; O'Brien, L; Weber, EA				Phillips, EJ; Knowles, SR; O'Brien, L; Weber, EA			The utility of penicillin skin testing in a tertiary care clinic	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center									0	6	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		418	S143	S143		10.1016/S0091-6749(02)81554-8	http://dx.doi.org/10.1016/S0091-6749(02)81554-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX					2022-12-18	WOS:000173744800417
J	Reese, G; Ayuso, R; Leong-Kee, SM; Plante, M; Lehrer, SB				Reese, G; Ayuso, R; Leong-Kee, SM; Plante, M; Lehrer, SB			Epitope mapping and mutational substitution analysis of the major shrimp allergen Pen a 1 (tropomyosin)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Paul Ehrlich Inst, D-6070 Langen, Germany; Tulane Univ, New Orleans, LA 70118 USA	Paul Ehrlich Institute; Tulane University									0	6	7	1	5	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		943	S307	S307		10.1016/S0091-6749(02)82078-4	http://dx.doi.org/10.1016/S0091-6749(02)82078-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX		Bronze			2022-12-18	WOS:000173744800940
J	Sales, VS; Rodrigues, CE; Cavalcanti, GB; Trombone, APF; Lima, RC; Santos, ABR; Oliver, C; Ferriani, VPL; Chapman, MD; Arruda, LK				Sales, VS; Rodrigues, CE; Cavalcanti, GB; Trombone, APF; Lima, RC; Santos, ABR; Oliver, C; Ferriani, VPL; Chapman, MD; Arruda, LK			Infection with Ascaris lumbricoides in pre-school children: Role in wheezing and IgE responses to inhalant allergens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Fed Rio Grande Norte, BR-59072970 Natal, RN, Brazil; Univ Sao Paulo, Sch Med, BR-14049 Ribeirao Preto, Brazil; Indoor Biotechnol Inc, Charlottesville, VA USA	Universidade Federal do Rio Grande do Norte; Universidade de Sao Paulo; INDOOR Biotechnologies			Ferriani, Virginia PL/E-2209-2012; Júnior, Geraldo Barroso Cavalcanti/F-6780-2010; Garlet, Ana Paula Trombone/N-9346-2013; Arruda, L. Karla/D-5845-2013	Garlet, Ana Paula Trombone/0000-0002-8102-6098; Arruda, L. Karla/0000-0002-7505-210X					0	6	8	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		23	S27	S27		10.1016/S0091-6749(02)81160-5	http://dx.doi.org/10.1016/S0091-6749(02)81160-5			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX					2022-12-18	WOS:000173744800024
J	Chapoval, SP; Marietta, EV; Smart, MK; David, CS				Chapoval, SP; Marietta, EV; Smart, MK; David, CS			Requirements for allergen-induced airway inflammation and hyperreactivity in CD4-deficient and CD4-sufficient HLA-DQ transgenic mice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						MHC; HLA; human CD4; transgenic/knockout; short ragweed allergen; in vivo animal models; asthma	COLLAGEN-INDUCED ARTHRITIS; SHORT RAGWEED ALLERGEN; MAST-CELLS; ASTHMA MODEL; EOSINOPHIL INFILTRATION; HISTAMINE-RELEASE; HUMAN CD4; T-CELLS; HYPERRESPONSIVENESS; EXPRESSION	Background: Airway inflammation is central to the pathogenesis of allergic asthma, and molecules that mediate this process obviously represent targets for therapy. Objective: To study the role of CD4+ T cells and/or HLA-DQ molecules in allergic asthma, we have generated and characterized models of short ragweed allergen (SRW)-induced inflammation using transgenic mice with HLA-DQ (DQ6 or DQ8), human CD4 (hCD4), or both on a genetic background that lacks mouse MHC II and CD4 (A beta (0)/mCD4(0)). Methods: Mice were actively sensitized and later challenged intranasally with SRW allergenic extract. Bronchoalveolar lavage fluid composition, airway inflammation and hyperresponsiveness, blood eosinophil levels, and cell proliferation were examined. Results: In response to SRW treatment, both DQ6 and DQ8 transgenic mice expressing hCD4 developed pulmonary eosinophilia and associated lung tissue damage with increase in eosinophil peroxidase and T(H)2 cytokines in bronchoalveolar lavage fluid, strong airway hyperreactivity, and persistent blood eosinophilia. The response was independent of mast cells/histamine pathway and was mediated by DQ-restricted hCD4+ T cells. Interestingly, lungs of CD4-deficient DQ6 transgenic mice showed an eosinophilic inflammation without local increase in cytokines and eosinophil peroxidase. The allergic reaction was absent in double-knockout mice and mice expressing either DQ8 or hCD4 alone. Conclusions: DQ6 molecules are critical to SRW-induced allergy and can operate in the presence or absence of CD4. However, both DQ antigens and CD4 molecules are critical for full manifestation of allergen-induced asthma in transgenic mice.	Mayo Clin, Dept Immunol, Rochester, MN 55905 USA	Mayo Clinic	David, CS (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.			Chapoval, Svetlana/0000-0002-7590-4421	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014764, R37AI014764] Funding Source: NIH RePORTER; NCI NIH HHS [CA09127] Funding Source: Medline; NIAID NIH HHS [AI 14764] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Batanero E, 1999, J ALLERGY CLIN IMMUN, V103, P147, DOI 10.1016/S0091-6749(99)70538-5; BLUMENTHAL M, 1992, J IMMUNOL, V148, P411; Blumenthal MN, 2000, ALLERGY ASTHMA PROC, V21, P55, DOI 10.2500/108854100778249042; Bradley DS, 1997, J CLIN INVEST, V100, P2227, DOI 10.1172/JCI119760; Cerutti A, 1998, J IMMUNOL, V160, P2145; Chapoval SP, 1999, J CLIN INVEST, V103, P1707, DOI 10.1172/JCI6175; Chapoval SP, 1998, J IMMUNOL, V161, P2032; Cieslewicz G, 1999, J CLIN INVEST, V104, P301, DOI 10.1172/JCI7010; Dewar JC, 1996, MONOGR ALLERGY, V33, P4; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Galli SJ, 1997, J EXP MED, V186, P343, DOI 10.1084/jem.186.3.343; GARLISI CG, 1995, CLIN IMMUNOL IMMUNOP, V75, P75, DOI 10.1006/clin.1995.1055; GAVETT SH, 1994, AM J RESP CELL MOL, V10, P587, DOI 10.1165/ajrcmb.10.6.8003337; Gavett SH, 1997, AM J PHYSIOL-LUNG C, V272, pL253, DOI 10.1152/ajplung.1997.272.2.L253; Gleich GJ, 2000, J ALLERGY CLIN IMMUN, V105, P651, DOI 10.1067/mai.2000.105712; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Henderson WR, 2000, J IMMUNOL, V164, P1086, DOI 10.4049/jimmunol.164.2.1086; Herrick CA, 2000, J CLIN INVEST, V105, P765, DOI 10.1172/JCI8624; Hizawa N, 1998, J ALLERGY CLIN IMMUN, V102, P443, DOI 10.1016/S0091-6749(98)70133-2; Howard TD, 2000, J ALLERGY CLIN IMMUN, V105, pS477, DOI 10.1016/S0091-6749(00)90046-0; Imamura T, 1996, INT ARCH ALLERGY IMM, V111, P161, DOI 10.1159/000237362; Kobayashi T, 2000, J IMMUNOL, V164, P3855, DOI 10.4049/jimmunol.164.7.3855; KRIUSBEEK AM, 1991, CURRENT PROTOCOLS IM; LAW YM, 1994, J EXP MED, V179, P1233, DOI 10.1084/jem.179.4.1233; LEVINE BB, 1972, SCIENCE, V178, P1201, DOI 10.1126/science.178.4066.1201; LOPEZ AF, 1988, J EXP MED, V167, P219, DOI 10.1084/jem.167.1.219; LUKACS NW, 1994, AM J RESP CELL MOL, V10, P526, DOI 10.1165/ajrcmb.10.5.8179915; Makela MJ, 2000, P NATL ACAD SCI USA, V97, P6007, DOI 10.1073/pnas.100118997; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; Nabozny GH, 1996, J EXP MED, V183, P27, DOI 10.1084/jem.183.1.27; Ochi H, 1999, J EXP MED, V190, P267, DOI 10.1084/jem.190.2.267; OHASHI Y, 1992, AM REV RESPIR DIS, V145, P1469, DOI 10.1164/ajrccm/145.6.1469; Olivenstein R, 1999, J ALLERGY CLIN IMMUN, V103, P238, DOI 10.1016/S0091-6749(99)70497-5; Ono SJ, 2000, ANNU REV IMMUNOL, V18, P347, DOI 10.1146/annurev.immunol.18.1.347; RAHEMTULLA A, 1994, EUR J IMMUNOL, V24, P2213, DOI 10.1002/eji.1830240942; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Rankin JA, 1996, P NATL ACAD SCI USA, V93, P7821, DOI 10.1073/pnas.93.15.7821; Richards IM, 1996, CLIN EXP ALLERGY, V26, P618, DOI 10.1111/j.1365-2222.1996.tb00586.x; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; SENTMAN CL, 1989, J IMMUNOL, V142, P1847; Takeda K, 1997, J EXP MED, V186, P449, DOI 10.1084/jem.186.3.449; Torres-Galvan MJ, 2000, ALLERGY, V55, P398, DOI 10.1034/j.1398-9995.2000.00524.x; Williams CMM, 2000, J EXP MED, V192, P455, DOI 10.1084/jem.192.3.455; Williams CMM, 2000, J ALLERGY CLIN IMMUN, V105, P847, DOI 10.1067/mai.2000.106485; Wolyniec WW, 1998, AM J RESP CELL MOL, V18, P777, DOI 10.1165/ajrcmb.18.6.3056; YAMAGUCHI Y, 1988, J EXP MED, V167, P1737, DOI 10.1084/jem.167.5.1737; Yeung RSM, 1996, EUR J IMMUNOL, V26, P1074, DOI 10.1002/eji.1830260518; ZWOLLO P, 1991, IMMUNOGENETICS, V33, P141	49	6	6	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2001	108	5					764	771		10.1067/mai.2001.118794	http://dx.doi.org/10.1067/mai.2001.118794			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	498RG	11692102				2022-12-18	WOS:000172523800017
J	Nelson, HS; Busse, WW; Kerwin, E; Church, N; Emmett, A; Rickard, K; Knobil, K				Nelson, HS; Busse, WW; Kerwin, E; Church, N; Emmett, A; Rickard, K; Knobil, K			Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast (vol 106, pg 1088, 2000)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Correction																		Nelson HS, 2000, J ALLERGY CLIN IMMUN, V106, P1088, DOI 10.1067/mai.2000.110920	1	6	6	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2001	107	4					614	614						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	423RG					2022-12-18	WOS:000168190100010
J	Bannon, GA; Ling, M; Cockrell, G; Sampson, HA; Burks, AW				Bannon, GA; Ling, M; Cockrell, G; Sampson, HA; Burks, AW			Cloning, expression and characterization of two major allergens, Jug n 1 and Jug n 2, from the black walnut, Juglans niger	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Arkansas Med Sci, Little Rock, AR 72205 USA; Mt Sinai Sch Med, New York, NY USA	University of Arkansas System; University of Arkansas Medical Sciences; Icahn School of Medicine at Mount Sinai									0	6	6	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		463	S140	S140						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300462
J	Berger, WE				Berger, WE		Desloratadine Study Grp	Desloratadine reduces seasonal allergic rhinitis symptoms in patients with seasonal allergic rhinitis and asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									So Calif Res, Mission Viejo, CA USA										0	6	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		533	S162	S162						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300531
J	Chervinsky, P; Busse, W; Casale, T; Nayak, A; Tripathy, I; Fowler-Taylor, A; Gupta, N; Rohane, P; Shen, H				Chervinsky, P; Busse, W; Casale, T; Nayak, A; Tripathy, I; Fowler-Taylor, A; Gupta, N; Rohane, P; Shen, H			Xolair (R) in the treatment of perennial allergic rhinitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									New England Res Studies, N Dartmouth, MA USA; Univ Wisconsin Hosp, Madison, WI USA; Creighton Univ Ctr, Omaha, NE USA; Asthma & Allergy Res Assoc, Normal, IL USA; Clin Res Ozarks Inc, Rolla, MO USA; Nova Pharmaceut, E Hanover, NJ USA	University of Wisconsin System; University of Wisconsin Madison; Creighton University									0	6	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		513	S156	S156						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300512
